data_2lst_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lst _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 51' ' ' LEU . 46.0 tp . . . . . 0 C--O 1.236 0.374 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.657 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 1.9 mmt180 -90.66 104.31 16.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.52 0.2 . . . . 0.0 111.382 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -106.77 103.87 13.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.657 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.3 m-85 -111.28 166.67 10.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.443 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 17.4 Cg_exo -64.92 160.1 42.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.895 1.73 . . . . 0.0 110.836 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.541 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -49.2 -50.67 62.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.9 Cg_exo -58.55 -46.28 25.0 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 121.886 1.724 . . . . 0.0 112.685 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -67.47 -44.28 78.98 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.535 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HA ' HG13 ' A' ' 56' ' ' VAL . . . -55.42 -41.75 73.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.396 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.72 -36.12 75.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.744 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.79 60.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.576 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 tp -60.26 -43.81 95.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.996 0.426 . . . . 0.0 109.879 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.82 -46.94 82.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.896 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -65.93 -43.22 88.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.599 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.0 54.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -119.04 6.38 11.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.633 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.12 46.11 95.19 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.296 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.7 mmp_? -110.78 -173.74 2.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.836 0.35 . . . . 0.0 110.671 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.46 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 81.6 mtp -113.77 155.59 25.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 43.6 t -106.73 127.43 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.016 0.436 . . . . 0.0 111.585 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.4 ttt -109.42 103.69 12.65 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.508 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 31.7 t -85.75 108.87 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 82.6 t80 -104.28 103.18 12.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.526 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.884 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.0 m-85 -84.19 122.21 28.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.57 ' HE1' ' OG ' ' A' ' 61' ' ' SER . 8.3 p80 -132.37 145.89 51.57 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.6 0.562 . . . . 0.0 111.785 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.442 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 66.9 m -142.24 153.04 43.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.544 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -13.65 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.42 0.629 . . . . 0.0 109.828 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -82.89 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.603 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.06 83.01 37.51 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.63 26.3 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.043 2.495 . . . . 0.0 113.909 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -83.69 -23.52 31.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.177 0.513 . . . . 0.0 110.599 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 43.9 t -83.16 -30.85 27.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -55.93 -29.84 60.72 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -170.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.03 -46.59 67.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 110.724 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 42' ' ' LEU . 13.9 tmm? -79.46 -44.41 21.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.672 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 7.5 t30 -53.82 -45.98 70.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.781 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.3 m -60.54 -54.87 40.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.85 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -91.78 -69.39 0.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.558 0.694 . . . . 0.0 111.708 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.53 HG11 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -59.6 -44.57 93.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.829 -169.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HB2' ' SD ' ' A' ' 37' ' ' MET . 26.6 tp -79.09 -27.0 42.94 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.242 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 m -88.97 -2.33 58.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -47.79 128.76 11.31 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.546 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.1 -33.53 95.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.072 2.515 . . . . 0.0 112.686 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.23 -48.24 53.8 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.662 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.536 HG23 HD21 ' A' ' 108' ' ' LEU . 99.8 t -59.77 -53.51 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.12 0.486 . . . . 0.0 110.48 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -56.24 -32.21 64.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.625 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -67.11 -34.25 77.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.601 0.239 . . . . 0.0 111.066 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.565 HD11 HD22 ' A' ' 108' ' ' LEU . 53.8 mt -68.85 -37.37 79.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.713 175.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HB3' HD11 ' A' ' 3' ' ' LEU . 3.0 mm? -67.74 -48.76 65.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.706 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' OE2' ' HA ' ' A' ' 3' ' ' LEU . 21.1 mm-40 -53.79 -32.32 52.06 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.972 0.415 . . . . 0.0 111.87 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.487 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -61.45 -54.6 41.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.495 HH12 HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -136.88 4.47 2.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.431 ' HE2' ' HE ' ' A' ' 54' ' ' ARG . 59.6 m-85 -112.3 149.96 31.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' A' ' 11' ' ' ALA . 47.1 t -115.39 115.98 51.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.775 167.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 29.8 t -89.05 129.03 40.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.871 -173.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -99.45 117.14 33.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.372 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -93.05 101.35 13.67 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.511 HG13 HD13 ' A' ' 70' ' ' LEU . 42.6 t -114.22 133.3 60.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.046 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.57 ' OG ' ' HE1' ' A' ' 27' ' ' HIS . 18.8 m -95.16 117.67 30.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.442 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 41.4 t -71.61 -23.57 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.074 0.464 . . . . 0.0 111.484 -174.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.38 -19.21 43.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.689 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.578 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.8 p -95.85 161.22 28.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -49.73 -49.96 14.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.765 2.977 . . . . 0.0 114.537 -168.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -60.41 -44.04 96.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -69.27 -39.24 82.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.695 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.659 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 55.1 mt-30 -57.67 -40.35 79.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.75 -45.56 74.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.511 HD13 HG13 ' A' ' 60' ' ' VAL . 78.9 mt -66.4 -29.47 69.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.485 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -68.81 -29.22 67.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.659 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 62.7 mtm180 -75.9 -45.7 33.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.478 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -65.5 -56.56 11.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.727 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -91.27 -12.51 34.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 71' ' ' ALA . 74.7 mtt180 62.28 87.21 0.1 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.678 0.751 . . . . 0.0 110.131 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG12 HG23 ' A' ' 81' ' ' THR . 56.1 t -128.1 137.96 31.95 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.529 -171.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.499 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 60.0 Cg_endo -74.29 -138.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.902 2.401 . . . . 0.0 111.361 170.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.499 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -91.31 -104.76 1.37 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.169 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.587 ' CG2' ' HA ' ' A' ' 80' ' ' PRO . 1.2 m -145.1 147.57 35.01 Favored Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.885 -0.185 . . . . 0.0 110.576 -169.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.622 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 36.7 Cg_endo -90.09 131.72 8.91 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.113 -1.203 . . . . 0.0 112.83 -1.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.884 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 22.5 m -114.51 108.22 16.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.484 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 23.8 m-85 -103.06 112.53 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.45 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.508 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -112.46 120.71 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.34 118.85 36.9 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.803 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 33.4 mt -114.86 132.58 56.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.704 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 40.2 t -109.73 127.56 26.92 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.414 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.415 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.2 Cg_endo -80.56 117.57 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.469 2.113 . . . . 0.0 110.383 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -142.58 124.53 15.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.426 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.46 -77.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.147 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.86 27.25 0.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.33 161.0 39.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 110.675 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.415 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 83.0 m95 -102.55 132.7 48.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.954 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 39.3 tt0 -117.87 120.51 38.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.509 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HA ' HD21 ' A' ' 85' ' ' LEU . 34.3 tt0 -84.34 115.0 22.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.723 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 32.8 m -100.76 8.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.32 166.6 11.03 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.239 -0.982 . . . . 0.0 112.888 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.47 ' HG2' HG23 ' A' ' 83' ' ' VAL . 92.5 mtt180 -133.78 135.74 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' A' ' 110' ' ' GLU . 69.1 mt -108.88 127.06 53.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.079 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -137.38 143.99 42.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.3 12.65 26.61 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.26 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.432 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 49.2 m 69.64 -73.29 0.09 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.109 0.564 . . . . 0.0 111.642 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 68.14 156.69 0.14 Allowed Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 123.316 0.646 . . . . 0.0 111.284 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.23 159.15 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.178 1.919 . . . . 0.0 110.557 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.53 ' HB3' HG11 ' A' ' 41' ' ' VAL . 32.1 ptt180 -59.89 -25.48 65.13 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.66 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -54.34 -53.82 48.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.734 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.576 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 22.2 mm-40 -72.81 -34.44 66.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 40.2 t80 -65.02 -43.6 91.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 50' ' ' LEU . 88.8 mt -69.83 -30.73 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.576 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.6 mttt -55.93 -53.56 55.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.494 ' HB3' HD12 ' A' ' 98' ' ' LEU . 9.5 tp10 -70.72 -38.03 73.55 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.557 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -60.09 -33.93 72.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.376 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 115' ' ' CYS . 7.7 tpt180 -80.25 -38.25 31.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.449 ' HG2' ' HE3' ' A' ' 117' ' ' LYS . 7.3 tt0 -62.9 -46.31 88.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.675 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.603 HG11 HG22 ' A' ' 95' ' ' VAL . 91.5 t -60.22 -37.05 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.5 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 112' ' ' ARG . 52.4 t -54.02 -36.7 63.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.32 -38.29 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.289 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.723 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 96.7 mttt -53.58 -28.59 32.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.22 -34.35 24.92 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.138 -0.554 . . . . 0.0 112.684 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.338 177.086 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.715 HD23 HG23 ' A' ' 57' ' ' VAL . 22.2 tp . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.43 0.157 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.611 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.3 mmt180 -88.44 104.52 16.87 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.984 0.421 . . . . 0.0 111.201 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -99.94 113.44 26.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.009 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.8 m-85 -122.93 160.48 49.15 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 20.4 Cg_exo -62.97 158.7 41.94 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.957 1.771 . . . . 0.0 111.343 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.564 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.7 t80 -47.1 -51.3 41.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 37.6 Cg_exo -60.79 -43.39 31.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.793 1.662 . . . . 0.0 112.266 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -68.49 -45.19 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 -177.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -54.71 -43.21 72.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.8 mp -66.97 -39.4 87.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.647 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.0 -44.19 66.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.214 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 56' ' ' VAL . 14.4 tp -59.06 -51.33 70.51 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.67 96.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.15 -41.46 99.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.474 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.1 -15.47 50.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.918 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -113.51 -0.55 14.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.09 37.84 95.6 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.158 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.739 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 2.1 mmp_? -107.15 -179.68 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.277 0.231 . . . . 0.0 110.47 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.646 ' HG3' HG21 ' A' ' 86' ' ' VAL . 41.2 ttm -102.12 156.08 17.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.8 t -105.79 122.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.798 0.333 . . . . 0.0 110.702 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.8 ttt -100.38 103.58 14.97 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 48.9 t -86.97 105.64 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.533 ' HE1' ' CE1' ' A' ' 82' ' ' PHE . 84.2 t80 -104.9 108.82 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.949 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 69.4 m-85 -81.02 111.25 17.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.579 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.512 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 22.4 p80 -119.76 156.41 30.64 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.949 0.781 . . . . 0.0 109.713 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.593 ' HA ' ' OD1' ' A' ' 63' ' ' ASP . 40.8 t -144.11 160.04 41.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HG3' ' OD2' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -89.16 -6.28 57.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.81 0.814 . . . . 0.0 108.927 169.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -103.24 10.68 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.485 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.593 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 20.2 p -69.12 154.63 94.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.7 -90.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.004 1.802 . . . . 0.0 113.482 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -79.59 -17.24 54.33 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.933 0.396 . . . . 0.0 111.434 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 8.1 t -56.42 -25.76 51.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.365 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -50.81 -41.63 57.49 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 111.108 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.3 -39.35 25.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 110.447 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.501 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 81.6 mtp -68.58 -48.46 64.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.62 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -63.33 -48.07 79.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.985 0.422 . . . . 0.0 111.053 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 43' ' ' SER . 10.6 m -72.68 -54.31 9.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.863 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -92.3 -68.34 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.996 0.427 . . . . 0.0 112.107 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 104' ' ' ARG . 95.8 t -51.66 -52.23 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -81.68 -16.33 51.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.4 m -93.59 -0.93 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.73 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -52.57 134.13 44.77 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.931 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.93 -39.57 85.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.024 2.483 . . . . 0.0 113.228 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.23 -41.1 54.28 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.67 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.759 HG23 HD22 ' A' ' 108' ' ' LEU . 29.0 t -63.56 -46.82 93.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -53.92 -44.24 70.42 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.92 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -62.67 -26.12 68.48 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -70.31 -45.12 66.87 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.659 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 1.6 mm? -71.78 -43.73 65.21 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.739 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.13 -32.1 9.41 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -79.31 -48.7 13.64 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.739 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -136.11 19.06 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 51' ' ' LEU . 77.8 m-85 -129.28 145.29 51.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 0.0 111.43 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 14' ' ' LEU . 47.3 t -116.3 120.5 65.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.715 HG23 HD23 ' A' ' 3' ' ' LEU . 35.5 t -91.89 123.36 43.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.15 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -92.31 117.44 29.9 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.235 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 p -80.81 101.6 9.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.432 HG23 HG11 ' A' ' 24' ' ' VAL . 58.7 t -110.05 119.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.165 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.56 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.9 OUTLIER -103.1 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -66.39 -15.4 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.724 0.773 . . . . 0.0 110.166 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.593 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 1.6 m-20 -71.58 -32.69 68.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.666 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -108.71 167.02 9.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.087 -173.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.7 Cg_endo -51.03 -48.33 21.55 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 124.174 3.249 . . . . 0.0 114.493 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.39 -35.57 80.86 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.912 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.3 -40.05 29.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.352 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -58.26 -35.57 71.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.437 0.637 . . . . 0.0 110.542 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.66 -51.18 61.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.439 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 9.3 mp -64.04 -33.71 76.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.956 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -63.42 -38.94 93.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.274 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.619 ' HA ' HH21 ' A' ' 75' ' ' ARG . 25.1 ptt180 -79.06 -34.81 43.39 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.23 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -68.97 -56.06 8.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.6 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.498 ' HE1' ' HG ' ' A' ' 70' ' ' LEU . 92.0 m-85 -85.89 -6.66 59.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.981 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.667 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 1.5 mmp_? 63.08 79.1 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.847 0.832 . . . . 0.0 110.127 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 71' ' ' ALA . 94.5 t -125.98 135.71 27.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.996 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.492 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 23.0 Cg_exo -65.56 -90.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.752 2.301 . . . . 0.0 112.067 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.492 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -143.14 -75.31 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.895 172.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -156.54 148.25 17.15 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.672 -0.311 . . . . 0.0 111.37 -170.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HA ' HG23 ' A' ' 79' ' ' THR . 5.1 Cg_endo -88.83 137.75 14.49 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.432 -1.07 . . . . 0.0 111.477 -3.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.949 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 6.3 m -122.71 123.93 42.23 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.924 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.685 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.7 m-85 -114.16 114.31 25.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.869 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -123.48 112.78 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.929 0.395 . . . . 0.0 110.316 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.81 120.43 39.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 35.4 mt -117.16 129.33 55.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.462 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.646 HG21 ' HG3' ' A' ' 21' ' ' MET . 21.6 t -108.61 122.87 38.92 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.203 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.3 118.07 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.188 1.925 . . . . 0.0 110.888 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.495 ' HZ1' ' CD ' ' A' ' 93' ' ' GLU . 13.7 ptmt -154.44 140.76 18.64 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.579 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.48 -76.13 0.06 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.084 0.865 . . . . 0.0 111.291 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.6 26.06 0.12 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.64 176.58 12.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 0.0 110.481 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -106.28 130.43 54.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.216 0.532 . . . . 0.0 110.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.495 ' CD ' ' HZ1' ' A' ' 88' ' ' LYS . 37.2 tt0 -101.47 112.29 24.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.853 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.647 ' CD ' ' HD2' ' A' ' 97' ' ' ARG . 33.2 tt0 -75.29 95.8 3.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.28 -14.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.532 -168.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -156.04 123.67 1.36 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.547 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.647 ' HD2' ' CD ' ' A' ' 94' ' ' GLU . 27.3 mtp180 -130.42 126.14 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.809 HD11 ' HG2' ' A' ' 110' ' ' GLU . 42.9 mt -136.03 135.57 39.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.785 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.01 143.2 40.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.19 -86.0 0.28 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.949 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.7 p 179.95 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.319 0.248 . . . . 0.0 111.056 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.685 ' HB3' ' HB3' ' A' ' 106' ' ' GLU . 54.0 mtm180 66.65 119.13 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 123.726 0.811 . . . . 0.0 110.495 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.69 171.05 3.84 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.198 2.599 . . . . 0.0 112.932 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.504 ' HB2' HG11 ' A' ' 41' ' ' VAL . 54.8 ttp180 -46.66 -41.41 14.8 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.828 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.76 86.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.016 0.436 . . . . 0.0 111.808 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.685 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 12.1 tp10 -80.77 -37.48 30.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.64 -37.28 87.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.103 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.759 HD22 HG23 ' A' ' 47' ' ' VAL . 42.6 mt -63.6 -44.78 92.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.286 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.48 ' HZ2' ' CD ' ' A' ' 106' ' ' GLU . 33.9 mtmm -61.17 -44.2 97.67 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.715 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.809 ' HG2' HD11 ' A' ' 98' ' ' LEU . 13.5 tp10 -59.05 -50.56 73.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.418 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -59.44 -34.59 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.614 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -60.54 -43.25 97.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.463 174.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -72.52 -38.74 67.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 110' ' ' GLU . 91.1 t -56.48 -38.77 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.805 0.335 . . . . 0.0 110.665 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.0 m -56.68 -35.01 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.3 t -84.66 -50.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -55.81 -40.76 73.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.932 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.509 ' CA ' HG23 ' A' ' 86' ' ' VAL . . . -66.54 -24.3 72.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.751 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.734 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.101 -179.797 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.728 HD23 HG21 ' A' ' 57' ' ' VAL . 53.8 tp . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.543 0.211 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -82.28 104.88 12.91 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.273 0.559 . . . . 0.0 112.196 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.525 ' HZ2' ' HG ' ' A' ' 42' ' ' LEU . 43.0 m95 -107.9 131.37 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.669 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 89.8 m-85 -132.84 155.03 81.61 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 25.2 Cg_exo -58.09 160.85 14.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.003 1.802 . . . . 0.0 111.245 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.564 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 88.4 t80 -45.61 -53.95 17.47 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 19.7 Cg_exo -66.24 -42.19 11.02 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.668 1.579 . . . . 0.0 112.205 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.429 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 38.8 tt0 -69.4 -42.73 74.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.065 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.24 94.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.204 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 8' ' ' TYR . 9.1 mp -63.01 -35.82 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.77 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.6 69.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 110.203 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.51 ' HB3' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -60.12 -50.51 73.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.396 176.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -43.8 93.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.199 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -57.63 -52.15 66.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.493 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.96 59.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.756 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -115.91 2.9 13.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.499 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.3 44.58 96.42 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.626 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -108.7 -179.42 3.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.694 0.283 . . . . 0.0 110.919 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.673 ' HE2' HG22 ' A' ' 86' ' ' VAL . 87.3 mtp -100.92 158.48 15.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.2 125.84 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.008 0.432 . . . . 0.0 111.106 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.0 ttt -103.6 102.65 12.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 61.3 t -89.93 106.26 16.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.095 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.798 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 45.1 t80 -104.95 123.18 47.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.306 0.574 . . . . 0.0 111.36 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.903 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 67.1 m-85 -94.18 126.18 39.26 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.217 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.798 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 34.5 p80 -130.96 157.44 42.96 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.971 0.794 . . . . 0.0 110.679 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 79' ' ' THR . 30.3 t -143.01 159.12 42.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.565 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -6.6 58.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.42 0.629 . . . . 0.0 110.121 173.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -103.38 19.68 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.375 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.691 ' HB3' ' CG2' ' A' ' 79' ' ' THR . 26.9 p -74.68 131.32 79.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.567 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.11 -92.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.466 2.111 . . . . 0.0 114.031 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -74.43 -17.14 60.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.071 0.463 . . . . 0.0 111.433 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.4 t -58.49 -23.46 57.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.038 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -49.29 -47.81 46.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.218 0.532 . . . . 0.0 111.714 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.749 ' HA ' HE21 ' A' ' 36' ' ' GLN . 0.0 OUTLIER -75.26 -31.7 60.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -176.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.44 ' SD ' ' HA ' ' A' ' 101' ' ' SER . 83.5 mtp -67.11 -49.8 63.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.47 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 58.5 m-20 -64.55 -37.07 86.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.315 -174.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 m -64.77 -61.29 2.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.375 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.32 -70.6 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 104' ' ' ARG . 60.3 t -57.9 -44.64 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -170.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 15.1 tp -81.57 -11.1 59.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 -173.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -112.62 3.34 16.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.066 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.83 131.81 57.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.561 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -58.29 -28.57 84.98 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.933 2.422 . . . . 0.0 112.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.48 14.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.601 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.656 HG21 HD21 ' A' ' 108' ' ' LEU . 84.4 t -58.23 -53.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.161 0.505 . . . . 0.0 110.102 174.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.504 ' HA ' HD12 ' A' ' 3' ' ' LEU . 32.5 m -54.36 -38.29 65.92 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.234 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -60.86 -32.08 71.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.788 0.328 . . . . 0.0 111.387 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 108' ' ' LEU . 69.0 mt -71.83 -42.1 67.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.741 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.74 -53.19 16.47 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.195 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.555 ' OE2' HD11 ' A' ' 3' ' ' LEU . 32.9 mm-40 -45.33 -38.19 5.53 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.595 ' HB2' HH11 ' A' ' 54' ' ' ARG . . . -64.68 -51.51 62.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.595 HH11 ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.58 14.61 3.43 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -173.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -125.29 150.86 46.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.498 . . . . 0.0 111.251 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.51 HG13 ' HB3' ' A' ' 14' ' ' LEU . 61.0 t -119.02 122.06 68.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.728 HG21 HD23 ' A' ' 3' ' ' LEU . 33.1 t -89.11 124.31 41.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.994 -173.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.96 117.58 31.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.482 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -83.99 101.64 11.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.62 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.71 114.46 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 110.196 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.609 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -89.17 107.62 19.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.308 -178.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.463 HG11 ' HA2' ' A' ' 78' ' ' GLY . 44.3 t -80.7 -7.79 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 122.697 1.237 . . . . 0.0 107.694 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -33.78 76.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.826 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -124.64 167.14 16.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.204 -174.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -50.62 -50.77 12.69 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.312 3.341 . . . . 0.0 114.76 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -44.1 84.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.0 111.462 -174.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.61 -27.44 59.08 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.806 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -63.89 -37.69 88.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.7 -51.36 70.26 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.289 0.566 . . . . 0.0 109.874 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 4.0 mm? -56.91 -43.64 81.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.019 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.78 -54.68 44.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 72' ' ' ARG . 21.5 ptt85 -68.73 -23.36 64.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.102 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -72.64 -36.54 68.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.715 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -106.2 8.51 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.376 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 62.07 36.98 15.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.913 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.0 t -93.48 133.67 27.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.504 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 29.3 Cg_exo -61.56 -83.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.61 2.207 . . . . 0.0 111.552 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.463 ' HA2' HG11 ' A' ' 62' ' ' VAL . . . -145.5 -52.76 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.807 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.691 ' CG2' ' HB3' ' A' ' 31' ' ' CYS . 3.6 t 175.57 158.09 0.39 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.684 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 2.4 Cg_endo -79.75 126.61 13.21 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.29 0.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.903 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 29.3 m -129.77 119.67 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.115 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.16 110.72 20.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 60.8 t -113.99 114.21 46.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.862 0.363 . . . . 0.0 110.056 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.6 117.55 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.857 0.361 . . . . 0.0 110.754 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 26.5 mt -110.73 136.56 49.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.21 0.529 . . . . 0.0 111.303 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.673 HG22 ' HE2' ' A' ' 21' ' ' MET . 49.0 t -109.94 120.07 45.73 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 52.2 Cg_endo -74.95 117.49 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.72 1.614 . . . . 0.0 110.938 173.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.407 ' HE3' ' CB ' ' A' ' 93' ' ' GLU . 20.7 pttp -141.58 132.63 26.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.517 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.01 -76.8 0.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.008 0.818 . . . . 0.0 111.262 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.58 24.77 0.19 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -146.25 152.5 39.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.7 0.286 . . . . 0.0 110.695 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.479 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 32.8 m95 -92.95 120.77 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 7.6 tp10 -102.21 139.88 37.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.888 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.66 104.78 17.33 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.531 HG22 ' HD3' ' A' ' 117' ' ' LYS . 4.3 p -97.19 6.39 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 -172.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.85 134.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.488 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -122.84 135.88 54.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 110.441 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.48 136.77 52.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.737 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -137.13 136.67 38.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.856 0.36 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.14 -174.71 18.53 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.86 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.44 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.5 m -92.43 127.13 37.81 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.976 0.417 . . . . 0.0 110.566 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -127.87 137.61 31.15 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.88 157.18 58.01 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.911 1.741 . . . . 0.0 110.016 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB2' HG13 ' A' ' 41' ' ' VAL . 46.4 ttp180 -58.0 -26.82 62.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.89 -50.78 67.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.582 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -69.02 -42.67 76.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.979 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.18 -50.39 74.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 50' ' ' LEU . 56.8 mt -72.23 -19.16 61.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.512 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -73.16 -49.9 25.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.409 0.623 . . . . 0.0 109.946 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.448 ' O ' HG21 ' A' ' 114' ' ' VAL . 50.4 mt-10 -72.76 -35.33 67.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.213 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.54 -32.73 74.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.089 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -59.68 -47.29 86.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -56.31 -45.16 80.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.532 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.483 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 95.6 t -62.4 -45.58 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.922 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.434 ' HB2' HH21 ' A' ' 54' ' ' ARG . 21.0 p -67.12 -22.25 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 111.044 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 112' ' ' ARG . 80.3 t -79.23 -37.7 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 109.918 174.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.531 ' HD3' HG22 ' A' ' 95' ' ' VAL . 83.5 mttt -61.57 -27.49 68.67 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.635 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.462 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -65.0 -32.9 85.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.337 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.078 179.575 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.2 tp . . . . . 0 C--O 1.237 0.412 0 CA-C-O 121.154 0.502 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.627 ' NE ' ' HA ' ' A' ' 4' ' ' ARG . 3.1 mmp_? -109.05 123.1 48.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.246 -171.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -115.56 115.98 27.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.588 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 86.2 m-85 -133.69 160.88 66.86 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 31.7 Cg_exo -58.55 166.47 6.26 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.406 2.071 . . . . 0.0 111.483 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CD1' HD21 ' A' ' 70' ' ' LEU . 61.8 t80 -51.58 -51.43 69.76 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.5 Cg_exo -62.12 -45.69 15.11 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.866 1.71 . . . . 0.0 112.233 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.47 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 80.2 tt0 -67.09 -40.2 86.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.929 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.81 94.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.225 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.42 HD22 HG23 ' A' ' 22' ' ' VAL . 2.8 mt -63.25 -35.75 81.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.832 0.348 . . . . 0.0 110.332 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.73 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.229 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.31 -44.6 91.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.612 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.75 -42.28 95.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.697 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.25 -44.74 90.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.54 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.76 -14.67 56.14 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -119.14 1.78 11.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.93 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.59 44.32 97.72 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.242 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.612 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 12.5 mmm180 -107.96 -178.04 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 111.342 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.589 ' HE2' HG21 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -101.22 165.06 11.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.546 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 84.1 t -122.53 133.6 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.737 0.303 . . . . 0.0 111.189 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 23' ' ' MET . 20.1 ptm -126.79 113.58 16.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.182 0.515 . . . . 0.0 109.645 170.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.534 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 46.5 t -87.22 109.62 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.521 ' HH ' ' HB2' ' A' ' 38' ' ' ASN . 88.6 t80 -97.49 103.6 15.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.378 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.944 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 77.0 m-85 -82.27 119.33 23.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.604 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 61' ' ' SER . 28.5 p80 -133.02 146.24 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.21 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 47.4 t -134.14 164.84 26.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 -17.87 30.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.114 0.483 . . . . 0.0 110.22 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.49 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 76.9 m-70 -89.56 -16.76 29.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.768 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.856 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 63.9 m -108.84 84.9 2.78 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.332 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.7 Cg_endo -92.08 -0.84 4.22 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.002 2.468 . . . . 0.0 114.896 -169.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -74.58 -21.7 59.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.837 -0.539 . . . . 0.0 111.409 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 17.5 p -72.52 -30.83 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 3.2 pt20 -67.9 -27.14 66.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.651 0.262 . . . . 0.0 110.97 -176.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.69 -50.49 66.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.638 ' HG3' ' HB3' ' A' ' 101' ' ' SER . 11.3 tmm? -67.95 -42.41 80.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.842 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.521 ' HB2' ' HH ' ' A' ' 25' ' ' TYR . 6.7 t30 -54.67 -47.2 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.504 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 m -61.59 -51.76 67.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.98 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.01 -70.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.258 0.551 . . . . 0.0 112.055 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.614 ' HB ' ' SD ' ' A' ' 37' ' ' MET . 96.9 t -63.37 -41.35 92.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.533 -168.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.3 tp -80.86 -30.61 35.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.2 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 m -87.6 -1.56 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.68 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.01 131.16 8.98 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.049 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.52 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 54.4 Cg_exo -52.99 -38.02 79.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.047 2.498 . . . . 0.0 113.305 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.7 -43.59 35.2 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.069 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.94 -51.09 73.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.436 0.636 . . . . 0.0 109.923 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.2 m -53.8 -39.21 65.27 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.128 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 17.7 mtp180 -60.61 -29.2 69.08 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.78 -39.11 67.0 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.599 174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.44 -43.62 72.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.584 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.23 -34.53 64.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.85 0.46 . . . . 0.0 111.327 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -54.22 47.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.205 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -11.39 2.07 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -90.48 151.63 21.29 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.9 t -115.41 122.73 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 163.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.414 HG22 ' SD ' ' A' ' 23' ' ' MET . 16.1 t -87.45 125.29 41.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.035 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -96.91 117.1 30.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.862 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.8 p -91.42 100.53 13.29 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 24' ' ' VAL . 96.4 t -109.04 119.25 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.13 0.49 . . . . 0.0 110.985 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.618 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -96.53 119.56 35.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.467 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 16.4 t -81.24 66.31 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.876 0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.618 ' OD1' ' HB2' ' A' ' 61' ' ' SER . 3.1 p-10 -163.21 -33.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -94.9 164.02 20.6 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.454 175.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.6 Cg_endo -51.5 -55.03 4.37 Favored 'Trans proline' 0 N--CA 1.477 0.54 0 C-N-CA 123.497 2.798 . . . . 0.0 113.996 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.428 ' O ' HD11 ' A' ' 70' ' ' LEU . 10.7 pt-20 -57.68 -41.48 81.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.177 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.05 -34.23 64.96 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.642 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -68.79 -42.79 76.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.334 -0.433 . . . . 0.0 111.474 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.74 -33.82 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.883 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.611 HD21 ' CD1' ' A' ' 8' ' ' TYR . 5.5 mp -62.92 -36.06 82.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.435 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -65.14 -31.96 73.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.486 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -68.89 -41.82 77.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.481 0.658 . . . . 0.0 109.997 173.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -71.32 -57.38 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.601 ' HE1' ' HG ' ' A' ' 70' ' ' LEU . 96.9 m-85 -82.9 -18.44 40.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.022 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 74' ' ' TYR . 10.5 ptp180 44.85 73.19 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.357 1.035 . . . . 0.0 112.114 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.463 HG12 ' CG2' ' A' ' 81' ' ' THR . 35.0 t -135.92 100.65 10.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.636 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.6 130.11 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.991 2.461 . . . . 0.0 111.995 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' A' ' 99' ' ' PHE . . . 151.01 -77.41 0.23 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.44 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.856 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.2 m 71.62 138.94 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.919 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.693 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 51.5 Cg_endo -71.72 143.88 78.16 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 123.666 -1.389 . . . . 0.0 113.191 0.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.944 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 27.6 m -120.49 122.29 40.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.894 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.56 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 4.3 m-85 -114.35 110.95 20.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 74' ' ' TYR . 66.0 t -115.38 111.32 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.513 ' HB2' HG11 ' A' ' 95' ' ' VAL . 51.5 m-85 -93.1 135.83 33.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.473 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 37.2 mt -125.26 132.71 52.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.866 0.365 . . . . 0.0 110.184 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.589 HG21 ' HE2' ' A' ' 21' ' ' MET . 16.0 t -109.01 121.41 43.0 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.736 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.4 116.76 4.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.331 1.354 . . . . 0.0 110.124 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -137.19 126.73 25.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.642 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.72 -71.55 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.156 0.91 . . . . 0.0 111.024 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.13 23.81 0.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.027 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.96 157.1 44.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.673 0.273 . . . . 0.0 110.903 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -93.07 124.31 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.698 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -109.05 118.53 37.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.342 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 35.6 tt0 -69.78 98.93 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.634 0.731 . . . . 0.0 109.413 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 84' ' ' PHE . 1.8 p -80.05 -28.21 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.036 -170.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.18 152.02 10.76 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.388 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -120.05 127.33 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 85.9 mt -111.53 137.06 49.86 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CE1' ' HA3' ' A' ' 78' ' ' GLY . 91.0 t80 -137.87 143.09 40.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.84 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.75 23.92 59.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.745 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.638 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 43.1 m 68.15 174.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.422 ' O ' HG11 ' A' ' 41' ' ' VAL . 4.9 mmt180 -148.61 148.73 29.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 172.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.58 149.77 88.31 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 N-CA-C 108.626 -1.336 . . . . 0.0 108.626 164.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.635 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 10.9 ptt180 -59.8 -29.53 68.29 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.576 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.73 88.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.611 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 2.0 mt-10 -80.92 -35.44 32.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.342 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.38 -37.18 86.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 91.2 mt -62.77 -43.2 99.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.044 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.609 ' HD3' ' HA ' ' A' ' 106' ' ' GLU . 8.2 mtpm? -52.59 -56.57 14.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 175.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 3.7 mm-40 -61.23 -40.78 95.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.55 -20.9 66.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.345 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.4 mmt180 -78.54 -45.34 22.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.72 -38.4 78.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.383 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.488 HG11 HG12 ' A' ' 95' ' ' VAL . 78.7 t -74.66 -38.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.526 ' SG ' ' HA ' ' A' ' 112' ' ' ARG . 24.6 p -65.53 -31.77 73.0 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.506 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.2 t -71.26 -43.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.165 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.488 ' HD3' HG23 ' A' ' 95' ' ' VAL . 30.6 mtpt -68.92 -11.5 60.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 111.841 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.499 ' HA2' HG13 ' A' ' 86' ' ' VAL . . . -71.73 -33.48 63.29 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.405 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.251 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.147 -177.349 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 22.3 tp . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.4 0.619 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.604 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.4 mmt180 -97.99 108.64 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.067 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -106.09 104.19 13.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.38 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 92.4 m-85 -116.23 168.9 7.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 12.4 Cg_exo -67.74 158.48 57.04 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.604 1.536 . . . . 0.0 110.094 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.534 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.7 t80 -47.11 -50.3 47.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 51.5 Cg_exo -56.57 -50.26 12.36 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.159 1.906 . . . . 0.0 112.981 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.04 -42.34 89.7 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.17 71.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.46 HD23 HG23 ' A' ' 22' ' ' VAL . 6.3 mt -70.81 -36.86 73.16 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.329 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.29 70.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.055 0.455 . . . . 0.0 110.065 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -59.75 -44.57 93.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.874 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.75 -53.42 33.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.446 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 7.7 tp60 -58.67 -53.14 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.069 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.22 60.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.999 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -116.72 -0.14 12.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.094 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.26 91.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.814 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.632 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 74.6 mmt-85 -112.79 179.59 3.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 111.653 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.602 ' HE3' HG21 ' A' ' 86' ' ' VAL . 90.2 mtp -101.69 159.06 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.285 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.689 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 47.8 t -105.8 119.53 55.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.508 ' HE3' ' HB2' ' A' ' 25' ' ' TYR . 10.2 tpt -99.6 103.3 14.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.235 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 16.4 t -94.88 106.28 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.508 ' HB2' ' HE3' ' A' ' 23' ' ' MET . 90.4 t80 -106.61 104.43 14.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.226 0.536 . . . . 0.0 111.143 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.918 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.5 m-85 -82.38 115.82 21.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.218 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -121.3 158.37 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.748 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.651 ' HG ' ' HB ' ' A' ' 62' ' ' VAL . 42.8 m -137.69 162.24 34.37 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -64.62 -60.77 2.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -94.42 48.72 1.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.314 0.578 . . . . 0.0 110.844 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.675 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 27.3 p -76.19 149.26 81.97 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.135 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.517 ' HB2' ' H ' ' A' ' 33' ' ' TYR . 39.0 Cg_exo -58.93 -98.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.076 2.518 . . . . 0.0 114.053 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.517 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 90.2 t80 -87.72 -17.83 30.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 0.0 111.565 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.488 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 1.6 t -51.4 -38.97 56.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.665 -174.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -56.85 -31.47 64.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.18 -48.16 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 110.084 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.488 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 15.1 ptm -68.96 -33.47 73.76 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.2 -27.73 65.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.208 0.527 . . . . 0.0 110.206 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.8 m -92.13 -61.58 1.59 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.378 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.45 -70.58 0.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.71 -47.03 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.223 -0.898 . . . . 0.0 113.305 -168.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 tp -81.89 -19.03 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.773 0.321 . . . . 0.0 110.984 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.2 m -92.92 -6.44 48.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.443 ' HB3' HG23 ' A' ' 47' ' ' VAL . 11.4 t70 -46.55 136.23 7.46 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.743 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 53.1 Cg_exo -56.86 -35.28 98.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.375 2.717 . . . . 0.0 113.698 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . -79.41 -24.35 61.09 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 44' ' ' ASP . 19.9 t -79.48 -43.56 23.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 109.003 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -62.77 -33.55 75.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.319 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 15.2 ptm180 -67.95 -24.49 65.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.798 0.333 . . . . 0.0 111.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -71.84 -46.43 58.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -62.45 -44.82 95.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.911 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -50.23 -31.34 13.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.537 ' HB1' ' HD3' ' A' ' 54' ' ' ARG . . . -82.91 -54.49 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -171.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.632 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.56 12.04 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -170.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 84.4 m-85 -118.84 138.41 52.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.529 0.68 . . . . 0.0 112.026 -176.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 14' ' ' LEU . 51.0 t -109.33 116.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.43 HG11 ' HG3' ' A' ' 23' ' ' MET . 15.5 t -89.21 127.36 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.215 0.531 . . . . 0.0 110.978 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.09 117.8 34.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.029 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.1 p -81.44 101.26 9.76 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.61 120.46 56.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.723 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.622 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 m -101.78 108.9 20.54 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.651 ' HB ' ' HG ' ' A' ' 28' ' ' SER . 24.0 t -68.19 -13.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.645 0.736 . . . . 0.0 110.439 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD2' ' HA ' ' A' ' 28' ' ' SER . 2.8 m-20 -79.72 -28.86 40.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.055 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -105.43 165.38 13.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.654 -175.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.6 Cg_endo -49.07 -52.35 8.9 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.035 3.157 . . . . 0.0 114.495 -171.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -59.49 -39.3 83.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -179.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.622 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.22 -35.74 47.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.839 175.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.39 -35.65 79.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.67 0.747 . . . . 0.0 110.089 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.59 -46.66 71.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.412 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.434 ' O ' ' HD1' ' A' ' 74' ' ' TYR . 45.1 mt -66.29 -31.44 72.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.33 -33.79 76.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.283 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -85.17 -28.45 25.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.632 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.49 -50.36 52.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD1' ' HZ ' ' A' ' 26' ' ' PHE . 89.3 m-85 -85.23 -20.91 29.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.312 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 58.4 62.26 2.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.834 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.4 t -137.37 101.47 9.09 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.791 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -96.58 128.2 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 111.292 168.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 107.85 1.65 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.72 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.675 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -92.64 147.83 34.98 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.203 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HA ' HG21 ' A' ' 79' ' ' THR . 10.3 Cg_endo -88.26 154.45 37.99 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.595 -1.002 . . . . 0.0 112.345 -0.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.918 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 23.9 m -120.01 115.02 22.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.319 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.532 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 11.8 m-85 -106.48 112.35 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 97' ' ' ARG . 46.5 t -118.13 129.6 74.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.472 ' CG ' HG12 ' A' ' 114' ' ' VAL . 68.1 m-85 -110.79 122.97 49.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.809 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.689 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 28.5 mt -112.86 131.36 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.472 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.602 HG21 ' HE3' ' A' ' 21' ' ' MET . 15.8 t -114.13 113.54 46.4 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.726 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.29 116.83 4.22 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.378 1.385 . . . . 0.0 110.326 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.517 ' HZ2' ' CD ' ' A' ' 93' ' ' GLU . 15.4 pttm -158.85 150.43 20.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.998 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.66 -65.49 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.038 0.836 . . . . 0.0 110.884 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.15 23.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.545 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.62 171.85 19.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 110.892 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.446 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 73.1 m95 -95.73 126.43 40.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.049 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.517 ' CD ' ' HZ2' ' A' ' 88' ' ' LYS . 35.6 tt0 -103.31 112.14 24.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.064 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HA ' HD21 ' A' ' 85' ' ' LEU . 39.4 tt0 -78.14 97.29 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' A' ' 84' ' ' PHE . 15.7 m -81.42 -6.63 9.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.63 171.49 15.24 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.077 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.64 ' HG2' HG22 ' A' ' 83' ' ' VAL . 89.8 mtt180 -133.37 137.99 46.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.815 -0.693 . . . . 0.0 109.752 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.5 mt -108.38 128.28 54.63 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -138.39 144.02 40.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.185 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.29 -2.73 7.75 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.367 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.9 m 71.44 128.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.414 0.626 . . . . 0.0 110.589 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -131.8 129.46 21.97 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.517 ' HD2' ' HG3' ' A' ' 106' ' ' GLU . 27.7 Cg_exo -62.44 166.19 13.79 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.394 2.062 . . . . 0.0 110.502 168.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.44 -44.75 76.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.0 111.39 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.18 85.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 120.966 0.412 . . . . 0.0 111.256 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.517 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 11.6 mm-40 -66.95 -54.64 19.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 111' ' ' LEU . 26.3 t80 -57.92 -42.77 85.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.863 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 60.4 mt -58.4 -43.75 88.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.387 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.575 ' HZ2' ' HB2' ' A' ' 109' ' ' LYS . 10.3 mtmp? -63.95 -50.17 69.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 114' ' ' VAL . 3.1 pt-20 -75.31 -33.06 61.13 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 107' ' ' PHE . 4.7 tt -59.57 -43.37 93.63 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 45.1 mtm180 -65.13 -33.05 75.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.519 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.36 -37.74 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 110.499 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 110' ' ' GLU . 78.9 t -63.65 -34.53 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.592 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.9 m -57.25 -37.05 71.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.509 . . . . 0.0 110.209 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.2 -37.95 53.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.323 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.702 ' HB3' ' HZ2' ' A' ' 117' ' ' LYS . 9.1 mtpm? -68.11 -10.8 56.79 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.059 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 86' ' ' VAL . . . -63.75 -41.41 98.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.708 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 176.44 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' A' ' 52' ' ' GLU . 4.3 tp . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.216 0.531 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -103.34 116.77 33.06 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.496 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -108.88 127.13 53.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.754 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 30.1 m-85 -130.52 170.6 10.72 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.127 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.65 166.65 26.74 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.506 2.137 . . . . 0.0 110.566 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.594 ' CD1' HD22 ' A' ' 70' ' ' LEU . 63.0 t80 -44.97 -54.04 14.45 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.8 Cg_exo -59.36 -52.82 4.18 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.881 1.721 . . . . 0.0 113.089 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -66.18 -36.39 82.96 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.795 0.331 . . . . 0.0 110.452 -175.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.42 -43.42 93.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.81 -32.03 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.64 -46.24 32.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.871 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.454 ' HB3' HG11 ' A' ' 56' ' ' VAL . 12.0 tp -59.3 -46.37 88.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 110.305 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.428 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.64 -44.21 96.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 -14.58 59.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.141 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -117.92 5.44 12.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.548 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.22 37.18 94.11 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.472 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.783 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.7 mmp_? -108.19 175.66 5.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.522 ' SD ' HG23 ' A' ' 86' ' ' VAL . 69.5 mtm -102.62 162.67 12.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.97 121.2 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.832 0.348 . . . . 0.0 111.043 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.06 103.28 15.16 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 17.0 t -87.12 101.19 10.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 73.8 t80 -92.57 103.0 15.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.463 ' CB ' HG12 ' A' ' 76' ' ' VAL . 84.7 m-85 -81.83 112.23 18.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.254 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.634 ' HA ' HG21 ' A' ' 79' ' ' THR . 17.0 p80 -131.29 138.91 49.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.093 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.459 ' HG ' ' HB ' ' A' ' 62' ' ' VAL . 29.6 m -94.45 153.12 18.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 164.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 63' ' ' ASP . 1.1 pm0 -85.49 -13.11 50.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -105.52 24.39 12.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.684 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.853 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 14.8 p -73.03 161.62 78.52 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.927 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.25 -105.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.388 2.059 . . . . 0.0 114.415 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -70.37 -17.52 63.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.491 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 5.4 t -55.46 -30.89 61.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.015 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -55.03 -31.72 61.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.589 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.76 -50.78 8.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -63.43 -47.2 82.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.632 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.29 -42.48 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.291 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 m -68.98 -55.77 9.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.61 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -91.34 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.173 0.511 . . . . 0.0 112.102 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.02 -39.91 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.883 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -79.66 -28.45 40.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.763 0.315 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.6 m -88.2 -1.47 58.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -45.25 130.63 5.84 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.858 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.62 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 50.3 Cg_exo -55.66 -35.43 92.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.115 2.543 . . . . 0.0 113.259 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.41 ' HA2' ' NE ' ' A' ' 49' ' ' ARG . . . -75.6 -39.44 34.83 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.016 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HA ' HD21 ' A' ' 108' ' ' LEU . 61.1 t -65.41 -44.57 94.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.36 0.6 . . . . 0.0 109.588 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.56 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 14.7 t -49.49 -46.91 48.79 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.297 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 77.5 mtm180 -50.31 -39.08 44.74 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.484 ' HB3' HD12 ' A' ' 111' ' ' LEU . 56.5 mt -73.26 -46.53 49.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.64 -35.7 73.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.105 0.478 . . . . 0.0 110.391 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -48.47 -48.5 37.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.304 1.041 . . . . 0.0 112.405 -177.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . . . -76.27 -43.18 42.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -167.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.783 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.26 17.94 3.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CE2' ' HE3' ' A' ' 21' ' ' MET . 94.7 m-85 -129.84 139.63 51.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.878 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.454 HG11 ' HB3' ' A' ' 14' ' ' LEU . 99.1 t -107.8 116.35 51.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.85 126.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.234 0.54 . . . . 0.0 110.973 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -95.46 117.32 30.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.901 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.3 p -86.41 101.36 13.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.1 t -103.88 113.55 41.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.702 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.514 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 3.0 p -91.22 114.31 26.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.237 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.491 HG13 ' HB3' ' A' ' 71' ' ' ALA . 99.4 t -74.16 -19.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.58 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 5.3 m-20 -82.55 -7.22 59.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.8 p -111.39 156.16 41.66 Favored Pre-proline 0 C--O 1.22 -0.472 0 O-C-N 122.36 -0.212 . . . . 0.0 111.078 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.2 Cg_endo -50.43 -55.3 4.22 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 124.062 3.175 . . . . 0.0 114.665 -167.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -35.48 76.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.97 -32.56 52.79 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.822 174.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 64' ' ' THR . 54.5 mt-30 -62.2 -42.91 99.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.142 0.577 . . . . 0.0 110.477 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.4 -41.55 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.274 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.594 HD22 ' CD1' ' A' ' 8' ' ' TYR . 3.9 mp -62.05 -34.88 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.234 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.491 ' HB3' HG13 ' A' ' 62' ' ' VAL . . . -63.78 -38.25 90.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.49 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -84.74 -27.92 26.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.891 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.88 -51.3 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.423 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.1 0.56 46.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.838 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 53.81 76.85 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.13 0.894 . . . . 0.0 111.161 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.463 HG12 ' CB ' ' A' ' 26' ' ' PHE . 61.6 t -128.48 84.01 64.44 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.035 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -102.5 105.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.638 2.892 . . . . 0.0 111.631 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.4 90.88 0.67 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.519 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.853 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 25.7 m -82.55 143.35 47.37 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.492 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 83.1 Cg_endo -88.76 151.0 30.17 Favored 'Cis proline' 0 C--N 1.35 0.609 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.734 0.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 91.0 m -128.05 129.16 46.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.907 171.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.736 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.2 m-85 -110.11 114.08 27.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.226 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.8 t -117.79 128.73 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.962 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.18 121.71 45.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.757 0.313 . . . . 0.0 110.733 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 94' ' ' GLU . 29.5 mt -110.39 136.16 49.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.522 HG23 ' SD ' ' A' ' 21' ' ' MET . 14.6 t -109.52 133.99 20.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.412 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 4.0 Cg_exo -79.58 118.11 3.81 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.47 2.113 . . . . 0.0 110.63 171.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -133.83 151.47 51.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.59 93.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.278 0.561 . . . . 0.0 111.134 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.54 -47.27 0.74 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.058 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.95 -168.36 0.21 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.855 0.36 . . . . 0.0 110.771 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -97.67 140.35 32.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.858 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -124.61 129.38 50.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.449 -175.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.429 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 35.5 tt0 -80.33 108.63 14.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.473 HG21 ' HZ3' ' A' ' 117' ' ' LYS . 5.5 p -104.34 -13.16 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.986 -169.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.28 140.63 7.6 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.874 -1.155 . . . . 0.0 113.441 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.429 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 18.6 mmt180 -127.36 126.25 42.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 89.7 mt -131.71 135.7 47.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -137.47 142.78 41.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.559 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.93 138.42 9.96 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.895 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -76.44 124.41 27.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -141.33 160.57 56.78 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.94 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.81 161.3 22.1 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.54 2.16 . . . . 0.0 111.88 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.521 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 5.4 ptt180 -59.69 -28.92 67.71 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.976 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.2 91.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.945 0.402 . . . . 0.0 110.501 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.1 -47.04 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.776 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.06 -46.59 88.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.294 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 94.7 mt -57.46 -38.35 74.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.036 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -57.72 -63.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.521 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.6 mp0 -70.12 -34.61 73.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.538 -175.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 50' ' ' LEU . 2.1 tm? -63.12 -38.55 91.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -57.74 -47.76 81.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.633 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 13.1 mm100 -65.26 -36.26 83.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.086 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -61.84 -37.83 79.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.318 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.57 -34.38 74.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.537 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.06 -32.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.969 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HZ3' HG21 ' A' ' 95' ' ' VAL . 7.9 mtpm? -68.05 -8.62 39.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.28 88.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.148 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.364 178.829 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.693 HD23 HD23 ' A' ' 51' ' ' LEU . 56.8 tp . . . . . 0 C--O 1.236 0.363 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.41 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 2.7 mmp_? -80.66 102.76 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.976 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -107.85 104.56 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.48 . . . . 0.0 110.235 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -113.52 145.35 33.16 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.435 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 31.3 Cg_exo -59.41 166.93 6.93 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.975 1.783 . . . . 0.0 111.389 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.518 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 77.8 t80 -48.71 -50.03 62.62 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.9 Cg_exo -60.76 -55.63 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.702 1.601 . . . . 0.0 111.986 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.1 mp0 -54.14 -44.88 71.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.389 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.452 ' HA ' HG13 ' A' ' 56' ' ' VAL . . . -59.4 -47.45 85.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 0.0 111.279 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.9 -39.96 94.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.87 62.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.947 0.404 . . . . 0.0 110.484 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.84 -49.59 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.436 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.38 -46.98 68.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.238 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.25 -49.01 79.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.017 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -13.96 59.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.863 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -117.0 4.77 12.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.425 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.28 41.97 99.65 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.719 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.526 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.2 mmp_? -109.19 -179.93 3.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.764 0.316 . . . . 0.0 110.539 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.3 mtp -102.04 155.62 18.07 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 54.0 t -105.95 124.72 61.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.525 ' SD ' HD21 ' A' ' 51' ' ' LEU . 22.0 ttt -107.67 103.24 12.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 46.0 t -84.26 105.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -99.15 103.39 15.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.443 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.815 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 92.4 m-85 -81.67 115.9 21.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.606 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.458 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 27.8 p80 -120.12 150.42 40.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.543 0.527 . . . . 0.0 110.427 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 t -143.41 147.91 35.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.442 ' OE1' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -88.04 -26.99 22.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.111 0.481 . . . . 0.0 110.212 175.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -72.92 -21.71 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.903 ' HB3' HG21 ' A' ' 79' ' ' THR . 9.4 t -103.93 94.99 7.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.15 23.42 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.691 2.26 . . . . 0.0 113.453 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -86.65 -29.79 22.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.893 0.378 . . . . 0.0 111.092 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.549 ' HG ' HG23 ' A' ' 79' ' ' THR . 28.5 p -82.81 -32.79 27.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -55.54 -34.65 64.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -168.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.37 -48.2 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.891 0.377 . . . . 0.0 110.759 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.473 ' HE3' ' CZ ' ' A' ' 82' ' ' PHE . 26.3 ttp -74.51 -44.42 51.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -177.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -57.76 -45.67 85.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.751 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -64.17 -56.93 11.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.648 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.81 -70.13 0.7 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.171 0.51 . . . . 0.0 111.959 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.81 -41.97 76.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.797 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.3 tp -81.11 -27.05 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.25 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 t -92.55 1.11 57.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.356 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -50.82 134.63 27.85 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.074 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.577 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 75.0 Cg_exo -52.3 -40.58 69.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.139 2.559 . . . . 0.0 113.485 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.44 -46.84 18.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.098 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.9 -50.85 78.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.215 0.531 . . . . 0.0 110.392 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 64.0 m -59.84 -38.28 81.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.292 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -63.34 -39.95 95.96 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.711 HD21 HH22 ' A' ' 54' ' ' ARG . 64.7 mt -63.3 -38.05 89.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.953 0.406 . . . . 0.0 110.571 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.693 HD23 HD23 ' A' ' 3' ' ' LEU . 2.0 tp -70.08 -56.37 7.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.412 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.562 ' HG3' HH21 ' A' ' 49' ' ' ARG . 5.0 mm-40 -46.05 -40.59 10.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.414 0.686 . . . . 0.0 112.621 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB2' HH11 ' A' ' 54' ' ' ARG . . . -61.73 -49.7 75.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.711 HH22 HD21 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.79 9.05 3.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -174.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -119.28 138.94 52.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.572 . . . . 0.0 111.042 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 14' ' ' LEU . 46.2 t -109.32 116.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.6 HG21 HD23 ' A' ' 3' ' ' LEU . 19.6 t -87.26 119.49 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.554 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.21 117.48 28.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.852 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 p -83.2 100.33 10.51 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.622 HG11 HD22 ' A' ' 70' ' ' LEU . 59.0 t -111.33 124.3 67.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.696 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.455 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -95.41 118.14 31.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.62 -178.339 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.87 10.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 122.74 1.257 . . . . 0.0 108.328 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.442 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -97.37 -24.24 15.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.432 175.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 42.4 p -108.58 152.97 42.4 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.857 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 27.2 Cg_endo -55.86 -51.57 9.37 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.042 3.161 . . . . 0.0 114.778 -168.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -37.05 85.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.634 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -73.49 -37.3 53.45 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.335 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 64' ' ' THR . 93.4 mt-30 -61.91 -32.07 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 110.466 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 72' ' ' ARG . 6.0 tp10 -68.87 -43.45 75.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.802 175.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.622 HD22 HG11 ' A' ' 60' ' ' VAL . 23.5 tp -63.59 -31.18 72.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.807 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.14 81.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 69' ' ' GLU . 42.0 mtm180 -65.42 -32.46 74.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.117 0.484 . . . . 0.0 110.041 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -66.04 -53.29 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.227 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.82 2.07 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 61.7 56.22 2.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.497 0.665 . . . . 0.0 109.947 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 55.3 t -104.45 136.33 19.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.907 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.0 Cg_exo -73.97 -143.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.233 2.622 . . . . 0.0 111.265 171.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -80.16 -71.57 1.26 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.514 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.903 HG21 ' HB3' ' A' ' 31' ' ' CYS . 14.3 t 176.7 158.42 0.46 Allowed Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.715 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 12.4 Cg_endo -87.84 127.21 8.64 Favored 'Cis proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.21 -1.162 . . . . 0.0 112.385 -1.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.815 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 7.2 m -115.95 119.65 36.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.597 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.1 m-85 -108.14 112.11 24.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.032 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.55 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 80.4 t -113.81 107.36 22.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -93.98 123.2 37.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.1 mt -114.56 140.51 48.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 111.211 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.31 123.31 37.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.408 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 5.7 Cg_exo -77.7 118.0 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.398 2.066 . . . . 0.0 110.286 171.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' HZ2' ' HB2' ' A' ' 93' ' ' GLU . 24.2 pttm -128.18 112.62 14.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 0.0 111.05 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.75 -80.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.547 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 23.05 1.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.09 155.1 43.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.824 0.345 . . . . 0.0 110.452 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 91.6 m95 -90.94 163.62 14.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.551 ' HB2' ' HZ2' ' A' ' 88' ' ' LYS . 9.7 tp10 -148.1 140.85 24.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.681 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 37.2 tt0 -94.13 104.65 16.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.78 -12.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.616 -170.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.94 144.79 5.08 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.366 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 99.2 mtt180 -113.9 128.02 56.22 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 96.0 mt -121.72 141.83 50.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -137.66 143.93 41.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.326 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.21 141.37 11.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.403 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -70.21 122.45 19.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.595 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 23.4 mmt85 -108.03 142.11 24.57 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.92 158.25 25.63 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.022 1.815 . . . . 0.0 110.183 168.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -54.4 -49.05 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.567 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.48 72.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.39 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.542 ' OE1' ' HD2' ' A' ' 102' ' ' ARG . 4.5 tm-20 -76.05 -48.39 21.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.595 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 67.0 t80 -66.4 -36.76 83.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 108' ' ' LEU . 40.8 mt -62.64 -35.43 79.59 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.619 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -60.34 -49.17 78.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 114' ' ' VAL . 4.3 mm-40 -64.1 -47.2 80.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.19 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.62 -38.54 90.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -58.08 -41.91 84.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.11 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -66.1 -56.72 10.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.008 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -58.47 -39.92 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.252 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.44 ' CB ' HH21 ' A' ' 54' ' ' ARG . 22.8 p -63.07 -24.17 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 0.0 111.193 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.6 t -84.84 -33.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.352 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -62.94 -21.43 66.06 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.322 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.08 -17.58 77.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.58 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.491 178.618 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.444 HD13 ' CB ' ' A' ' 51' ' ' LEU . 30.1 tp . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.007 0.432 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.421 HH21 ' CD ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -79.52 102.41 8.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.319 -178.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.482 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 75.2 m95 -106.73 125.92 51.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.115 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.3 m-85 -130.62 153.38 81.48 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 24.5 Cg_exo -61.6 161.47 24.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.789 1.659 . . . . 0.0 110.667 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.533 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 75.6 t80 -46.92 -51.11 41.66 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.4 Cg_exo -58.7 -52.5 5.22 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 121.694 1.596 . . . . 0.0 112.23 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 37.5 mt-10 -62.23 -38.89 90.93 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.455 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.17 78.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 0.0 111.6 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.4 mm? -62.88 -40.57 97.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.931 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.28 -37.28 63.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.23 0.538 . . . . 0.0 110.31 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.57 -50.11 74.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.822 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.47 88.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.427 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 24.2 tp60 -62.65 -46.28 88.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.21 -14.49 58.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.918 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -114.6 3.49 14.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.41 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.66 96.09 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.594 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.502 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.4 mmp_? -107.46 177.21 4.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.433 ' SD ' HG23 ' A' ' 86' ' ' VAL . 8.0 mmm -100.5 160.33 14.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.5 t -105.6 124.74 60.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 -174.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.578 ' SD ' HG13 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -113.4 103.65 11.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -92.33 109.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.093 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.694 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 84.0 t80 -103.86 103.62 13.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.462 0.649 . . . . 0.0 111.028 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.871 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 54.6 m-85 -84.64 116.1 23.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.082 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.694 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 24.3 p80 -124.54 138.3 54.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 39.2 t -100.46 141.47 33.27 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.026 168.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.65 -25.1 67.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -102.59 16.27 26.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.095 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.808 ' SG ' ' HA ' ' A' ' 79' ' ' THR . 50.6 t -70.81 112.02 11.77 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.06 -67.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.484 2.789 . . . . 0.0 114.905 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -86.69 -19.49 29.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -167.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 17.1 t -70.9 -22.85 62.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -30.06 59.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -71.29 -44.53 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.221 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.527 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 51.8 ttm -66.73 -49.18 66.83 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.358 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -54.09 -44.7 71.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.233 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.5 m -72.93 -59.77 2.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.659 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.45 -67.72 0.83 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.023 0.44 . . . . 0.0 112.153 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.527 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 98.9 t -55.14 -51.59 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.74 -21.9 37.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.769 0.319 . . . . 0.0 111.481 -170.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.6 m -92.55 -10.58 37.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.087 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -47.28 133.26 9.64 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.625 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.35 -33.77 57.61 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.573 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.56 -52.41 7.38 Favored Glycine 0 CA--C 1.51 -0.247 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.01 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 HD22 ' A' ' 108' ' ' LEU . 62.6 t -58.38 -51.3 73.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.642 0.734 . . . . 0.0 110.184 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -52.74 -44.11 66.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.711 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 49' ' ' ARG . 45.0 ttm180 -59.39 -38.45 80.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.256 0.347 . . . . 0.0 111.598 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.48 HD11 HD22 ' A' ' 111' ' ' LEU . 50.2 mt -64.0 -39.88 95.11 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.623 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.43 -52.9 13.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.094 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' OE1' ' HA ' ' A' ' 3' ' ' LEU . 6.1 mm-40 -48.84 -43.12 38.28 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.092 0.557 . . . . 0.0 112.32 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.09 -57.02 13.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.591 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.13 22.75 3.26 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -171.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.591 ' CE1' ' HD3' ' A' ' 54' ' ' ARG . 50.5 m-85 -133.23 142.02 48.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.417 0.627 . . . . 0.0 111.58 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' A' ' 14' ' ' LEU . 82.6 t -108.01 118.91 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.664 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.578 HG13 ' SD ' ' A' ' 23' ' ' MET . 17.9 t -92.23 120.63 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 -173.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.95 118.17 29.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.3 p -90.07 101.32 14.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 110.039 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.489 HG12 ' HG ' ' A' ' 70' ' ' LEU . 57.3 t -111.06 120.0 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.734 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 9.8 m -88.83 109.12 19.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 8.9 p -86.48 6.9 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.466 0.65 . . . . 0.0 111.262 -170.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 5.0 m-20 -90.2 -30.65 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.203 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.626 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -92.5 165.58 19.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.154 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.65 -50.24 14.6 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.565 2.844 . . . . 0.0 114.38 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -70.85 -30.08 66.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.734 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.6 -33.57 47.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.99 172.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.691 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 40.5 mm-40 -63.83 -36.74 84.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -55.05 -52.57 62.78 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.901 170.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.489 ' HG ' HG12 ' A' ' 60' ' ' VAL . 3.1 mm? -53.74 -38.36 64.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.121 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.427 ' HB2' ' CG2' ' A' ' 62' ' ' VAL . . . -71.32 -34.17 70.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.635 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.691 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -72.14 -40.88 67.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.188 0.518 . . . . 0.0 110.475 174.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -63.11 -55.49 24.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.238 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.66 -15.87 40.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.212 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 67.55 37.55 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -134.44 147.75 64.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.724 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.35 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.218 1.946 . . . . 0.0 111.185 165.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.427 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . -159.63 56.94 0.33 Allowed Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.808 ' HA ' ' SG ' ' A' ' 31' ' ' CYS . 11.5 p -130.12 46.14 2.1 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -167.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.742 ' HD3' ' HG ' ' A' ' 101' ' ' SER . 34.1 Cg_endo -94.4 172.79 15.78 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 120.731 1.297 . . . . 0.0 111.215 -5.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.871 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 36.1 m -132.83 129.26 38.25 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.613 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.489 ' CZ ' ' HG2' ' A' ' 80' ' ' PRO . 2.1 m-85 -124.66 114.56 19.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.14 119.17 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.883 0.373 . . . . 0.0 110.152 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -99.65 126.68 45.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.55 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.62 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 23.5 mt -117.04 144.87 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 0.0 111.239 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.433 HG23 ' SD ' ' A' ' 21' ' ' MET . 90.2 t -109.15 125.91 30.45 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.372 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.533 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 74.2 Cg_endo -79.04 117.93 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.043 1.829 . . . . 0.0 110.839 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.06 109.41 10.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.202 0.525 . . . . 0.0 110.849 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.02 -82.06 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.674 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.56 20.37 1.67 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.01 157.8 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.533 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 89.3 m95 -92.56 169.93 10.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.655 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.5 tp10 -145.21 139.1 26.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.21 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.455 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 33.8 tt0 -95.2 103.19 15.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.8 p -99.74 9.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.689 -168.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.94 146.21 4.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.505 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.408 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 77.5 mtt180 -120.94 127.37 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD23 ' NH1' ' A' ' 102' ' ' ARG . 84.3 mt -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -136.96 143.27 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.605 0.241 . . . . 0.0 110.398 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.66 146.05 19.22 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.477 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.742 ' HG ' ' HD3' ' A' ' 80' ' ' PRO . 5.9 m -83.33 107.46 15.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.604 0.716 . . . . 0.0 110.601 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.586 ' NH1' ' HG3' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -108.68 152.34 42.16 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.04 178.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.87 158.61 13.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.797 2.331 . . . . 0.0 111.974 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.469 ' HB2' HG12 ' A' ' 41' ' ' VAL . 16.1 ttt-85 -60.92 -31.66 71.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.51 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -45.1 94.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.147 0.499 . . . . 0.0 110.054 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.87 -42.92 94.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.902 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.31 -47.38 79.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.776 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 28.9 mt -61.72 -38.57 88.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.555 0.217 . . . . 0.0 110.795 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -56.06 -56.03 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.647 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.586 ' HG3' ' NH1' ' A' ' 102' ' ' ARG . 6.8 mm-40 -63.96 -44.96 91.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.48 HD22 HD11 ' A' ' 50' ' ' LEU . 35.0 tp -55.48 -47.87 75.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.425 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -64.46 -39.58 94.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.516 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.513 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 15.9 mm100 -70.49 -23.48 62.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.341 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 110' ' ' GLU . 73.8 t -73.41 -41.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 172.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.1 m -58.77 -37.73 76.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.493 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 112' ' ' ARG . 68.1 t -63.58 -40.0 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.977 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 113' ' ' GLN . 62.7 mttp -64.03 -41.77 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.162 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.29 -14.16 82.84 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.565 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.874 -178.538 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.479 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 15.1 tp . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.289 0.566 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -90.55 103.98 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.546 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -99.7 129.89 45.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.428 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.514 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 38.2 m-85 -131.49 167.12 23.31 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.083 171.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 15.0 Cg_exo -68.09 163.05 37.45 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.965 1.777 . . . . 0.0 110.974 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.569 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.9 t80 -47.53 -52.97 33.39 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 49.0 Cg_exo -57.62 -49.74 12.56 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.972 1.781 . . . . 0.0 112.935 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.14 -42.61 88.83 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.443 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.19 -42.03 72.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.0 111.528 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.47 -37.76 77.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.6 -43.67 63.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.638 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.97 0.415 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.13 -47.76 81.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.687 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.069 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.02 -14.59 55.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -118.43 6.61 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.564 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.4 39.42 97.73 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.76 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.3 mmp_? -110.53 -179.99 3.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' HG22 ' A' ' 86' ' ' VAL . 56.0 mtm -110.58 160.22 16.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 93.5 t -106.07 127.93 60.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.66 0.267 . . . . 0.0 111.52 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.2 ttt -105.69 103.15 12.6 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 171.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 41.1 t -86.79 107.53 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.505 ' HE1' ' HE2' ' A' ' 82' ' ' PHE . 65.4 t80 -98.99 103.65 15.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 88.3 m-85 -82.71 115.07 21.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.177 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.689 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 32.5 p80 -123.17 138.8 54.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.652 ' H ' HG23 ' A' ' 79' ' ' THR . 24.0 t -117.99 163.64 16.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.954 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -76.69 -2.43 32.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.586 0.708 . . . . 0.0 109.522 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -112.17 14.45 20.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 30.4 p -76.8 129.95 77.54 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.834 0.349 . . . . 0.0 111.457 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.62 -78.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.649 2.232 . . . . 0.0 113.829 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 37' ' ' MET . 89.3 t80 -86.08 -17.45 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.48 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 12.9 t -47.73 -44.36 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.133 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -57.35 -33.32 67.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.05 -45.97 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.902 0.382 . . . . 0.0 110.508 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.695 ' HG2' ' HB ' ' A' ' 41' ' ' VAL . 10.9 tmm? -65.42 -40.94 93.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.344 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.42 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 7.2 t30 -59.41 -41.24 89.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.32 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.3 m -77.17 -56.51 4.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -90.13 -64.65 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.146 0.498 . . . . 0.0 111.803 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.695 ' HB ' ' HG2' ' A' ' 37' ' ' MET . 77.8 t -55.71 -44.23 76.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.405 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.27 -13.96 57.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.861 0.362 . . . . 0.0 111.194 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -100.36 -6.78 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.684 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.19 135.55 8.94 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.746 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 80.8 Cg_exo -49.68 -45.45 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.351 2.701 . . . . 0.0 113.623 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.41 -45.64 67.69 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.111 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.684 HG21 HD23 ' A' ' 108' ' ' LEU . 43.4 t -59.41 -47.78 89.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 121.648 0.737 . . . . 0.0 109.778 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.539 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 23.5 t -52.86 -43.14 65.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.387 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 82.7 mtt180 -62.27 -21.38 65.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.41 HD12 HD21 ' A' ' 108' ' ' LEU . 23.3 mt -80.39 -38.11 30.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.756 174.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.32 -50.53 11.63 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 48' ' ' SER . 7.1 mm-40 -44.38 -47.69 9.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.715 ' HB2' HH11 ' A' ' 54' ' ' ARG . . . -67.98 -48.27 66.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -168.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.715 HH11 ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -134.44 16.45 3.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.501 ' CE2' ' HE3' ' A' ' 21' ' ' MET . 90.4 m-85 -125.18 141.01 52.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.393 0.616 . . . . 0.0 111.688 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.2 t -106.6 114.95 47.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.94 121.07 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.806 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -94.58 117.6 30.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.3 p -85.83 101.61 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.92 109.07 23.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.956 0.407 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.645 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -94.96 107.87 19.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.158 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.607 ' HB ' ' HA ' ' A' ' 28' ' ' SER . 38.3 t -75.04 -8.29 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.292 1.044 . . . . 0.0 108.549 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.041 176.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.609 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -125.11 163.51 37.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.069 -174.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.8 Cg_endo -50.75 -47.76 23.71 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.323 3.349 . . . . 0.0 114.85 -169.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.99 -36.44 81.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.082 -176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -82.47 -31.8 29.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.559 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 64' ' ' THR . 96.9 mt-30 -59.22 -38.0 78.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.514 0.673 . . . . 0.0 109.479 171.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 6.0 tp10 -61.51 -50.6 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.97 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.68 -40.25 83.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.686 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.62 -50.25 73.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.49 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.266 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 30.4 ttt85 -65.12 -56.02 15.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.221 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.55 3.29 55.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.565 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 58.47 64.75 1.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.623 0.577 . . . . 0.0 109.714 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.55 92.92 48.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -102.31 129.03 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.712 2.941 . . . . 0.0 112.052 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 140.23 -85.09 0.21 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.834 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.689 ' CG2' ' HA ' ' A' ' 27' ' ' HIS . 85.0 m 75.07 137.21 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 122.49 0.316 . . . . 0.0 111.325 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 79' ' ' THR . 70.1 Cg_endo -76.52 137.48 49.33 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.724 -1.365 . . . . 0.0 112.881 0.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.7 m -124.69 129.06 49.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.997 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.569 ' HE1' ' CA ' ' A' ' 100' ' ' GLY . 1.4 m-85 -115.27 122.07 44.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.044 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.8 t -121.47 108.31 22.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.881 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 59.1 m-85 -94.34 120.07 34.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.043 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 94' ' ' GLU . 32.4 mt -109.22 130.66 55.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.663 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.539 HG22 ' SD ' ' A' ' 21' ' ' MET . 22.6 t -108.56 123.91 35.94 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.378 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.5 117.69 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.901 1.734 . . . . 0.0 110.559 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 93' ' ' GLU . 18.0 ptmt -157.67 143.29 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.739 -175.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.18 -77.39 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.988 0.805 . . . . 0.0 111.43 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.18 24.38 0.13 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.797 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.42 -177.48 6.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.687 0.28 . . . . 0.0 110.453 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.07 132.62 51.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.427 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 88' ' ' LYS . 30.1 tt0 -107.11 119.71 40.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.266 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.501 ' HG3' HG12 ' A' ' 83' ' ' VAL . 39.9 tt0 -77.0 95.96 4.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.75 -7.46 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.094 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.74 118.3 0.6 Allowed Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.796 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.476 ' HG3' HG23 ' A' ' 83' ' ' VAL . 16.7 ttm180 -108.92 126.67 53.33 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.451 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 86.1 mt -124.41 139.03 54.28 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.032 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -102.58 117.13 34.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 164.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.569 ' CA ' ' HE1' ' A' ' 82' ' ' PHE . . . -90.78 -134.27 5.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.461 -167.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 m 75.67 -12.09 1.03 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.793 0.837 . . . . 0.0 110.578 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 100' ' ' GLY . 62.1 mtp180 -65.25 156.31 81.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.247 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.49 155.55 25.4 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 111.543 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.486 ' HB3' HG13 ' A' ' 41' ' ' VAL . 30.8 ptt180 -67.62 -25.12 65.59 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.083 -174.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.6 74.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.107 0.479 . . . . 0.0 109.956 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 21.7 mm-40 -75.25 -37.88 60.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.388 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.63 -47.95 83.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.638 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.684 HD23 HG21 ' A' ' 47' ' ' VAL . 88.6 mt -68.16 -31.43 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.732 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 109' ' ' LYS . 5.0 tmmm? -63.15 -47.9 80.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.951 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 5.4 mm-40 -69.92 -41.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 111' ' ' LEU . 4.1 tt -61.16 -36.32 79.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -63.46 -45.07 92.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.23 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 5.5 pt20 -62.81 -38.43 90.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.426 ' N ' ' HG3' ' A' ' 113' ' ' GLN . 69.9 t -66.78 -42.68 89.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.683 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 52.4 t -57.22 -30.48 64.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.864 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.15 -53.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.873 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -59.15 -28.13 66.29 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.445 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -62.46 -41.42 99.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.505 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.755 179.721 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 57' ' ' VAL . 24.6 tp . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.869 0.366 . . . . 0.0 111.724 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.656 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 5.4 mmt180 -88.34 104.64 16.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.328 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -106.38 104.63 14.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 96.8 m-85 -111.12 157.39 38.95 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 19.3 Cg_exo -63.48 162.02 29.14 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.957 1.771 . . . . 0.0 111.172 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.596 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.3 t80 -45.82 -55.73 12.03 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.8 Cg_exo -65.0 -41.52 16.89 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.654 1.569 . . . . 0.0 112.126 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 37.1 tt0 -70.13 -36.92 75.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.847 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.68 86.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.997 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.91 -39.67 92.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.653 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.08 70.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.778 0.323 . . . . 0.0 110.651 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -59.67 -50.08 75.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -65.52 -45.57 83.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.978 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -58.85 -46.63 87.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.729 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -14.32 58.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.933 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -115.29 0.37 13.46 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.686 -175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.72 41.36 97.7 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.355 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.824 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 76.6 mmt-85 -112.87 178.44 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 0.0 111.946 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.7 mtp -101.46 154.36 18.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.345 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 48.5 t -106.19 135.05 45.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.801 0.334 . . . . 0.0 110.786 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.491 ' HE2' HD12 ' A' ' 42' ' ' LEU . 24.1 ttt -118.17 103.21 9.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.683 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 38.9 t -89.58 111.18 22.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.4 t80 -102.92 109.15 20.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.435 0.636 . . . . 0.0 111.006 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.992 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.8 m-85 -85.49 118.87 25.28 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.563 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.551 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 29.3 p80 -133.89 163.93 28.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.943 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 22.6 m -143.36 149.68 38.08 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.555 174.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -39.53 86.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -84.26 4.61 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.397 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 9.0 t -134.83 65.73 66.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.83 31.98 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.004 2.469 . . . . 0.0 114.476 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -83.35 -58.11 2.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.865 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 46.6 t -74.6 -22.34 59.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -67.04 -19.75 65.74 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.296 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -69.7 -47.87 61.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 28.1 mtm -61.99 -35.76 79.48 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.299 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.534 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 7.3 t30 -56.24 -43.67 78.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' SER . 30.7 m -65.17 -49.73 68.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -90.87 -70.91 0.66 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.325 0.583 . . . . 0.0 111.375 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.481 HG13 ' CB ' ' A' ' 104' ' ' ARG . 71.1 t -56.04 -51.77 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.753 -173.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.6 tp -81.87 -22.57 36.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -170.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' THR . 62.1 m -93.95 -3.42 51.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.059 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 47' ' ' VAL . 9.6 t70 -48.59 129.13 13.76 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.544 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.99 -36.61 76.43 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.127 2.552 . . . . 0.0 113.212 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.43 -34.85 68.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.87 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 44' ' ' ASP . 20.6 t -74.9 -49.0 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.366 0.603 . . . . 0.0 109.598 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -54.49 -37.03 64.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.886 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -63.31 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 0.0 111.262 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.26 -46.01 68.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.476 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 2.4 mm? -67.29 -47.25 71.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.15 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -46.01 -41.79 12.35 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.723 ' HB1' HH11 ' A' ' 54' ' ' ARG . . . -70.84 -49.95 40.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -171.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.824 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.82 16.38 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.436 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 87.4 m-85 -127.18 143.67 51.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.334 0.588 . . . . 0.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 14' ' ' LEU . 61.6 t -115.72 117.28 55.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.45 HG23 HD21 ' A' ' 3' ' ' LEU . 15.2 t -91.07 131.76 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.855 -173.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -101.36 119.63 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -85.22 102.31 13.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.227 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.72 125.79 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.301 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -109.28 121.8 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.52 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 56.5 t -68.97 -16.03 20.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.219 0.533 . . . . 0.0 110.992 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.29 -34.49 77.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.909 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.539 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 61.5 p -97.04 158.29 33.59 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.024 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.545 ' HG2' ' OE2' ' A' ' 66' ' ' GLU . 15.1 Cg_endo -51.02 -41.55 56.26 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.636 2.891 . . . . 0.0 113.127 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.545 ' OE2' ' HG2' ' A' ' 65' ' ' PRO . 1.7 mp0 -52.0 -57.75 8.56 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.041 0.448 . . . . 0.0 110.036 175.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.11 -33.06 65.29 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.259 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 51.3 mt-30 -56.02 -51.14 68.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.606 0.362 . . . . 0.0 111.114 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.41 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -76.84 -29.41 55.87 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.777 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.586 HD23 ' CD1' ' A' ' 8' ' ' TYR . 1.7 mp -61.61 -42.23 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 0.0 110.549 170.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.26 77.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.799 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 86.5 mtt180 -71.64 -27.44 63.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -80.96 -52.58 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.28 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -85.47 -14.02 47.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.763 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 65.05 78.08 0.29 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 77' ' ' PRO . 54.5 t -135.35 142.01 39.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 -171.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.432 ' O ' HG11 ' A' ' 76' ' ' VAL . 9.0 Cg_exo -73.49 -143.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.262 2.641 . . . . 0.0 111.142 169.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.49 -49.31 3.02 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.239 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.705 ' OG1' ' HA ' ' A' ' 80' ' ' PRO . 1.1 t 179.89 160.38 0.83 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.806 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -88.96 126.75 7.67 Favored 'Cis proline' 0 N--CA 1.456 -0.711 0 C-N-CA 124.246 -1.147 . . . . 0.0 112.035 -1.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.992 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.4 m -125.24 108.17 11.47 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.98 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.487 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.6 m-85 -102.67 111.59 23.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.235 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.683 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.7 t -110.65 108.9 26.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.88 0.372 . . . . 0.0 110.775 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.27 118.44 32.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.891 0.377 . . . . 0.0 110.538 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 32.8 mt -114.25 131.75 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 95' ' ' VAL . 24.3 t -110.61 124.69 32.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.517 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.7 Cg_endo -80.38 117.2 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.166 1.911 . . . . 0.0 110.387 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -146.37 133.81 20.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.406 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.14 -75.67 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.029 0.831 . . . . 0.0 111.144 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.82 29.49 0.15 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.713 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.99 165.53 33.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.587 0.232 . . . . 0.0 110.528 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.517 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 80.0 m95 -98.99 126.47 44.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.972 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 26.5 tt0 -106.94 121.38 44.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.445 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.446 ' HA ' HD22 ' A' ' 85' ' ' LEU . 49.0 tt0 -76.25 96.46 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.436 ' HB ' HG23 ' A' ' 86' ' ' VAL . 9.7 p -82.62 -14.51 12.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.009 -169.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.16 129.58 1.26 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.304 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.479 ' HG3' HG23 ' A' ' 83' ' ' VAL . 27.7 ttm180 -115.61 127.45 55.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.487 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 99.0 mt -109.37 133.89 52.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.662 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -136.93 116.54 12.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.65 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.3 173.06 18.86 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.054 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 m -109.98 120.36 42.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.745 0.307 . . . . 0.0 110.327 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -146.23 147.44 31.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.39 163.09 13.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.809 2.34 . . . . 0.0 112.085 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.58 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -63.73 -25.97 68.44 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.778 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.49 95.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.022 0.439 . . . . 0.0 110.337 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.3 mm-40 -64.89 -44.98 87.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.464 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.441 ' CE2' HD11 ' A' ' 111' ' ' LEU . 44.7 t80 -62.58 -37.58 86.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.516 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 62.3 mt -61.68 -42.24 98.66 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 110.943 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -57.31 -54.23 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.165 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 2.7 mm-40 -65.91 -41.04 91.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.126 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 111' ' ' LEU . 3.8 tt -60.98 -39.51 89.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.667 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 116' ' ' VAL . 12.6 tpt180 -59.23 -41.05 87.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.95 -43.31 75.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.571 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 110' ' ' GLU . 90.1 t -59.46 -39.63 79.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.743 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.12 -40.1 88.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.666 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 112' ' ' ARG . 97.6 t -66.55 -37.58 79.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 109.997 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 95' ' ' VAL . 34.0 mtpt -72.74 -8.17 54.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.712 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.65 -27.09 11.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.259 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.325 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 174.52 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 51' ' ' LEU . 14.8 tp . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.58 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.7 mmm180 -91.13 103.12 15.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.782 0.325 . . . . 0.0 111.851 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.508 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 46.4 m95 -102.88 113.26 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.335 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 90.0 m-85 -118.14 161.8 33.0 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.021 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 16.7 Cg_exo -66.18 160.95 42.46 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.274 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.579 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 91.4 t80 -47.27 -53.84 25.68 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 35.3 Cg_exo -61.42 -46.96 12.93 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.83 1.687 . . . . 0.0 112.355 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -43.97 87.22 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 56' ' ' VAL . . . -54.97 -42.34 72.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.741 0.305 . . . . 0.0 111.478 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.8 mp -68.1 -38.69 82.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.81 63.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.755 0.312 . . . . 0.0 110.586 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -57.42 -40.62 78.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.564 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.09 -56.07 6.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.935 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.406 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 24.9 tt0 -60.46 -49.18 78.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.5 -175.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -14.02 59.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.535 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 15.7 m-70 -118.3 4.35 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.295 -175.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.64 34.06 72.43 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.261 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.564 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.6 mmp_? -108.64 178.87 4.35 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.589 -0.359 . . . . 0.0 110.108 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.532 ' HE2' ' CE2' ' A' ' 55' ' ' PHE . 48.3 mtm -108.06 165.49 11.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.4 t -105.69 125.04 61.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.818 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.543 ' SD ' HG11 ' A' ' 57' ' ' VAL . 1.4 tmt? -109.06 103.12 12.07 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.645 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 26.1 t -90.41 111.44 23.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.411 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 65.7 t80 -99.58 103.49 15.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.128 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.706 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 51.4 m-85 -81.39 121.67 26.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.639 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.566 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 25.4 p80 -135.28 138.54 43.6 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.165 0.915 . . . . 0.0 109.924 177.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.426 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 1.5 t -99.39 168.12 10.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.495 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -7.0 44.02 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -114.07 -80.12 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.382 -0.199 . . . . 0.0 111.027 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.667 ' SG ' HG22 ' A' ' 79' ' ' THR . 4.0 m 60.42 152.47 0.1 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.897 0.879 . . . . 0.0 112.915 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.22 -89.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.364 2.043 . . . . 0.0 113.08 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.02 -16.83 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 5.8 t -49.5 -52.57 28.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.241 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -57.8 -39.13 76.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.099 0.249 . . . . 0.0 111.613 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -66.84 -50.6 62.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.503 ' HE2' ' CZ ' ' A' ' 82' ' ' PHE . 30.3 ttp -62.25 -46.13 90.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.744 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.6 -43.07 84.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.498 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.7 m -66.44 -56.77 9.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.638 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -91.89 -70.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.563 0.697 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' A' ' 104' ' ' ARG . 94.0 t -52.89 -48.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.065 -171.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 tp -81.41 -15.24 55.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -173.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.6 m -95.79 -1.09 50.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.606 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 47' ' ' VAL . 13.0 t70 -47.03 129.17 9.08 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.658 171.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.89 -37.52 85.47 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.131 2.554 . . . . 0.0 113.229 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.87 -42.59 30.28 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.026 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.692 HG22 HD22 ' A' ' 108' ' ' LEU . 8.1 t -66.66 -44.3 89.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -55.24 -40.64 71.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.688 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -70.22 -21.37 63.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.85 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 108' ' ' LEU . 72.5 mt -70.16 -44.56 68.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' HB2' HD12 ' A' ' 3' ' ' LEU . 3.1 mm? -66.54 -60.56 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.361 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.453 ' OE1' HD13 ' A' ' 3' ' ' LEU . 9.5 mm-40 -50.08 -34.73 22.77 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.623 ' HB1' HH11 ' A' ' 54' ' ' ARG . . . -64.61 -53.15 52.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.623 HH11 ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.38 11.61 3.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.532 ' CE2' ' HE2' ' A' ' 21' ' ' MET . 91.4 m-85 -123.28 145.79 48.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.039 0.447 . . . . 0.0 110.959 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 11' ' ' ALA . 22.0 t -107.98 118.09 54.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.543 HG11 ' SD ' ' A' ' 23' ' ' MET . 21.3 t -86.93 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.044 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -92.68 117.28 29.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.159 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 42.9 t -88.15 100.57 13.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.522 HG12 HD22 ' A' ' 70' ' ' LEU . 61.2 t -113.57 122.79 68.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.295 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.528 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 4.4 p -85.84 109.4 18.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.374 0.606 . . . . 0.0 109.679 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.518 HG21 ' HB1' ' A' ' 71' ' ' ALA . 5.1 p -88.99 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 123.091 1.424 . . . . 0.0 109.008 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.14 -38.7 0.07 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.075 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.631 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 3.1 p -81.63 164.66 48.22 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.511 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.3 Cg_endo -51.39 -55.23 4.2 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.534 2.823 . . . . 0.0 114.524 -170.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -36.63 84.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.585 0.231 . . . . 0.0 111.182 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.38 -34.02 64.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.649 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -71.19 -28.51 64.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.306 0.574 . . . . 0.0 110.714 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.31 -44.83 93.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.217 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.522 HD22 HG12 ' A' ' 60' ' ' VAL . 9.0 mp -65.86 -30.9 71.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 174.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.518 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -67.14 -35.24 79.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.589 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.579 ' HA ' ' NH2' ' A' ' 75' ' ' ARG . 20.1 ptt180 -83.37 -33.17 25.86 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.314 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.519 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 28.4 ttm180 -73.18 -56.67 4.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.519 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 90.7 m-85 -91.38 -11.89 36.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.329 -174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.709 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 1.2 mmp_? 64.74 91.16 0.08 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.686 0.616 . . . . 0.0 110.247 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.444 HG11 ' CG ' ' A' ' 26' ' ' PHE . 39.1 t -129.51 85.85 57.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -105.29 125.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.512 2.808 . . . . 0.0 113.196 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.453 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 124.95 -68.31 0.51 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.422 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.667 HG22 ' SG ' ' A' ' 31' ' ' CYS . 60.3 m 72.26 138.58 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.463 0.305 . . . . 0.0 110.836 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.49 ' HA ' HG21 ' A' ' 79' ' ' THR . 73.0 Cg_endo -78.51 143.76 73.07 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.707 0.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.706 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 35.5 m -122.77 122.66 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.038 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.649 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 9.7 m-85 -106.51 122.9 47.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.053 -175.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.645 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 45.2 t -124.11 105.43 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.04 118.89 32.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.327 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 94' ' ' GLU . 38.6 mt -113.11 137.28 51.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.441 HG22 ' SD ' ' A' ' 21' ' ' MET . 13.5 t -108.28 135.87 19.9 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.968 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.21 115.39 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.405 1.403 . . . . 0.0 108.794 166.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.86 111.28 5.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.831 0.348 . . . . 0.0 110.572 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.22 18.25 11.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.142 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.05 -23.64 34.83 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.852 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.87 -175.53 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.693 0.283 . . . . 0.0 110.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.406 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 95.0 m95 -115.7 136.9 52.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.472 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 32.4 tt0 -122.37 125.22 45.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.508 ' HA ' HD22 ' A' ' 85' ' ' LEU . 35.5 tt0 -78.58 95.98 5.35 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.495 HG23 ' HD3' ' A' ' 117' ' ' LYS . 1.4 p -102.38 -11.9 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.836 -170.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.72 104.48 0.36 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.744 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.501 ' HD3' ' CD ' ' A' ' 94' ' ' GLU . 8.5 tpt180 -111.97 124.76 53.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.9 mt -137.62 143.54 41.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -137.82 133.16 33.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.71 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.02 149.2 15.65 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.586 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.477 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 49.2 m -76.02 151.12 37.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.586 0.231 . . . . 0.0 110.872 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.829 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 16.9 mmt-85 -130.96 165.66 33.27 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.633 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 106' ' ' GLU . 21.5 Cg_exo -67.96 154.68 72.16 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.272 1.981 . . . . 0.0 109.808 162.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -57.41 -42.95 83.28 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -170.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.624 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . . . -79.76 -27.2 40.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.384 -175.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.56 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.4 mm-40 -76.9 -38.46 53.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.829 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 86.8 t80 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.042 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.692 HD22 HG22 ' A' ' 47' ' ' VAL . 4.3 pp -68.12 -22.95 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.629 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.4 ' N ' HD13 ' A' ' 108' ' ' LEU . 37.6 ttmt -67.14 -53.81 27.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.856 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 8.3 pt-20 -71.56 -32.13 67.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.195 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD13 ' CE2' ' A' ' 107' ' ' PHE . 5.9 tt -59.21 -42.53 91.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.441 ' O ' HG21 ' A' ' 116' ' ' VAL . 43.9 ttt180 -59.92 -43.7 94.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.252 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.6 OUTLIER -67.97 -23.43 65.04 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.327 -179.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 110' ' ' GLU . 93.9 t -81.73 -36.75 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.2 t -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.026 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 112' ' ' ARG . 57.9 t -65.72 -30.18 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.495 ' HD3' HG23 ' A' ' 95' ' ' VAL . 63.2 mttp -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.274 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.5 -18.97 68.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.557 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 175.776 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.238 0.455 0 CA-C-O 121.596 0.712 . . . . 0.0 112.484 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.52 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 36.7 mmt-85 -87.71 108.91 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.746 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.511 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.8 m95 -111.15 109.17 19.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 87.3 m-85 -124.31 156.36 67.03 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.53 159.75 19.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.935 1.757 . . . . 0.0 111.198 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.574 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.1 t80 -45.38 -54.02 16.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.7 Cg_exo -63.91 -39.74 31.46 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.643 1.562 . . . . 0.0 112.179 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.19 -36.97 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.832 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.37 -48.31 70.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.038 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 8' ' ' TYR . 4.3 mm? -56.45 -42.67 78.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.695 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.12 63.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.074 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.11 -51.04 70.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.18 -38.67 91.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.681 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.43 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 48.9 tt0 -65.86 -42.35 90.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.877 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.43 -16.04 44.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -112.06 2.11 16.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.753 -175.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.4 40.56 97.89 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.296 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -108.54 179.67 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 110.412 178.211 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.58 ' HE3' HG23 ' A' ' 86' ' ' VAL . 85.5 mtp -104.82 154.98 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 12' ' ' LEU . 85.0 t -106.15 130.54 57.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.412 . . . . 0.0 111.324 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.42 103.61 11.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.397 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.5 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 21.6 t -84.54 113.7 23.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CD2' ' HZ3' ' A' ' 5' ' ' TRP . 56.7 t80 -104.48 106.67 17.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.995 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.08 125.61 37.76 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.892 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -141.93 160.93 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.474 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' ' 31' ' ' CYS . 3.4 m -142.11 150.92 41.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.89 -40.77 83.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 172.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -82.16 1.53 35.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.8 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.649 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 86.0 m -132.86 68.05 78.47 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.175 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.39 38.49 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.076 2.517 . . . . 0.0 114.178 -167.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -73.61 -43.06 60.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.155 0.502 . . . . 0.0 111.124 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.694 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 16.1 t -77.46 -19.16 56.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.34 -176.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -54.81 -26.25 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.78 -32.16 31.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.424 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.2 ttm -78.97 -46.14 18.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.751 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 32.0 p30 -66.36 -21.07 66.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -78.68 -59.11 2.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.23 -70.19 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.932 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.52 HG11 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -54.98 -49.53 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.873 -170.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 25.0 tp -81.57 -21.48 38.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.465 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -95.34 -2.22 49.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 0.0 110.609 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -50.81 133.26 28.49 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.226 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.33 -44.27 39.78 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.246 2.631 . . . . 0.0 113.451 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.65 68.21 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.028 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG23 HD21 ' A' ' 108' ' ' LEU . 84.6 t -57.73 -48.18 84.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 109.845 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.411 ' HA ' HD22 ' A' ' 3' ' ' LEU . 66.4 m -53.53 -50.91 64.45 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.013 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -54.57 -29.42 51.28 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.817 HD11 HD22 ' A' ' 108' ' ' LEU . 74.9 mt -73.42 -54.02 9.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 111.313 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HB3' HD13 ' A' ' 3' ' ' LEU . 3.5 mm? -68.74 -39.62 80.26 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.12 -33.75 67.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.736 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . . . -71.56 -49.84 36.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.508 ' HD3' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.12 15.25 3.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -173.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 78.4 m-85 -121.2 143.46 49.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.424 0.63 . . . . 0.0 112.073 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.91 113.7 44.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.297 170.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.1 t -87.17 127.44 40.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.099 0.476 . . . . 0.0 110.881 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -93.4 117.09 29.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.986 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 p -83.82 102.09 12.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.098 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.04 126.03 74.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.028 0.442 . . . . 0.0 110.842 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.424 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.9 OUTLIER -113.09 132.64 55.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.464 HG12 ' CB ' ' A' ' 71' ' ' ALA . 46.3 t -79.68 -16.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.421 0.629 . . . . 0.0 111.244 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -76.21 -10.97 59.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.951 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.617 ' OG1' ' HD2' ' A' ' 65' ' ' PRO . 5.0 t -114.04 149.17 41.49 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.402 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.617 ' HD2' ' OG1' ' A' ' 64' ' ' THR . 19.0 Cg_endo -53.14 -50.91 12.36 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 123.523 2.815 . . . . 0.0 114.534 -169.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -31.88 62.75 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.138 -174.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -74.82 -30.42 59.61 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.653 174.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 64' ' ' THR . 4.6 tt0 -69.74 -36.89 76.22 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -54.34 -48.86 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.205 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.19 -43.42 92.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.297 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 62' ' ' VAL . . . -57.99 -49.19 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.257 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.88 -20.79 41.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.262 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -62.3 -48.84 78.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 110.009 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.48 -15.06 29.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.007 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 65.04 79.64 0.25 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.516 0.674 . . . . 0.0 110.245 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.3 t -123.1 97.55 43.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.382 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -101.29 130.42 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.387 2.725 . . . . 0.0 113.35 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 31' ' ' CYS . . . 104.04 -56.49 0.57 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.568 169.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.601 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 20.1 p 60.38 161.19 0.11 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.652 0.781 . . . . 0.0 111.638 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.694 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 45.3 Cg_endo -69.64 145.74 80.01 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 124.035 -1.235 . . . . 0.0 112.367 -0.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.528 ' HG1' ' HD1' ' A' ' 99' ' ' PHE . 40.3 m -134.21 116.58 15.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.185 0.517 . . . . 0.0 110.037 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 6.1 m-85 -106.27 112.34 25.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.666 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 47.0 t -108.88 113.46 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.788 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 18.0 m-85 -96.61 127.69 42.83 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.566 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.688 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.3 mt -116.52 131.13 57.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.972 0.415 . . . . 0.0 110.73 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.58 HG23 ' HE3' ' A' ' 21' ' ' MET . 91.7 t -109.64 129.8 23.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.774 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.39 117.88 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.841 1.694 . . . . 0.0 110.8 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.16 125.01 31.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.15 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.808 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -155.69 25.04 0.57 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.156 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.83 166.78 23.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.483 0.183 . . . . 0.0 110.852 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 91.3 m95 -103.25 153.21 20.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 59.0 mt-10 -119.74 133.56 55.57 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.387 167.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.461 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 34.1 tt0 -81.6 94.96 7.02 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.78 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 22.7 m -85.17 -5.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.943 -166.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.17 158.78 9.41 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.362 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -129.72 130.23 45.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 68.0 mt -108.49 134.47 51.22 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.528 ' HD1' ' HG1' ' A' ' 81' ' ' THR . 71.9 t80 -137.52 143.4 41.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.843 0.354 . . . . 0.0 111.044 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.84 162.35 25.85 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.281 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -74.55 116.26 15.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.118 0.485 . . . . 0.0 109.814 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -124.36 143.36 42.74 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.722 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.03 158.03 45.79 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.117 1.878 . . . . 0.0 110.268 169.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.52 ' HB3' HG11 ' A' ' 41' ' ' VAL . 33.5 ptt180 -62.55 -26.8 68.76 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.722 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.99 97.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.363 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.503 ' CD ' ' HZ1' ' A' ' 109' ' ' LYS . 26.2 mm-40 -69.18 -48.55 61.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.34 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.72 -52.4 65.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.883 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.817 HD22 HD11 ' A' ' 50' ' ' LEU . 71.0 mt -65.96 -30.23 70.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.258 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.503 ' HZ1' ' CD ' ' A' ' 106' ' ' GLU . 11.2 ttmt -55.57 -62.45 1.68 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.102 175.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.495 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.1 mt-10 -70.76 -32.8 70.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.407 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD23 HD13 ' A' ' 51' ' ' LEU . 2.7 tm? -62.08 -41.29 98.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.209 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 42.7 mtm180 -68.5 -32.69 72.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.267 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 12.2 mm-40 -67.42 -35.46 79.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.043 0.449 . . . . 0.0 110.651 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 110' ' ' GLU . 95.6 t -66.75 -36.36 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.05 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.64 -34.55 71.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.35 -51.46 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.131 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.78 ' HE3' ' HB ' ' A' ' 95' ' ' VAL . 16.2 mtpp -59.79 -24.36 64.05 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -53.39 -31.58 43.34 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.44 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.217 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.427 HD11 ' CB ' ' A' ' 51' ' ' LEU . 17.9 tp . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.4 0.143 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.481 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.4 mmt180 -86.81 103.07 14.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.971 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -105.59 103.95 13.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 85.6 m-85 -118.74 149.06 45.71 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.632 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.7 Cg_exo -59.67 166.26 8.46 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.423 2.082 . . . . 0.0 111.487 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.548 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -48.31 -50.99 53.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.1 Cg_exo -58.46 -49.25 12.56 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.823 1.682 . . . . 0.0 112.389 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 9.3 mt-10 -63.8 -42.94 97.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.704 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -59.99 -48.25 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.644 0.259 . . . . 0.0 111.54 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.6 mm? -63.29 -39.84 95.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.82 -37.69 48.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.08 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 56' ' ' VAL . 9.8 tp -64.15 -46.71 82.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.93 96.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -64.52 -45.66 86.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.516 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.8 -14.49 59.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -116.8 3.11 12.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.576 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.11 37.07 94.32 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.59 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.727 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.3 mmp_? -106.94 177.48 4.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.531 ' SD ' HG22 ' A' ' 86' ' ' VAL . 31.7 mtm -103.93 158.32 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG21 HD12 ' A' ' 12' ' ' LEU . 59.3 t -105.93 123.74 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.934 0.397 . . . . 0.0 111.17 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.506 ' HE2' HD11 ' A' ' 42' ' ' LEU . 21.1 ttt -103.4 103.58 13.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 173.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.575 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 40.6 t -85.42 108.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.416 ' HH ' ' HG3' ' A' ' 37' ' ' MET . 81.5 t80 -106.59 103.57 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 110.793 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.612 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.3 m-85 -80.63 120.76 24.98 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.197 176.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.57 ' HA ' HG21 ' A' ' 79' ' ' THR . 31.5 p80 -129.3 155.94 44.79 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.918 0.761 . . . . 0.0 109.316 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 31' ' ' CYS . 92.7 p -137.03 166.28 24.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.679 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -78.08 -5.89 52.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.761 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -119.58 -0.5 10.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.455 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 28' ' ' SER . 21.8 p -58.44 130.26 84.44 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.534 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 63.6 Cg_endo -76.91 -86.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.225 1.95 . . . . 0.0 114.045 -175.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.84 -18.77 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.578 . . . . 0.0 110.735 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.567 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 29.3 t -63.27 -42.06 99.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 4.3 pt20 -66.93 -23.49 65.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.402 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -79.3 -48.44 14.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.406 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.567 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 17.2 ptp -66.98 -39.15 87.12 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.781 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.07 -34.59 68.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.467 . . . . 0.0 110.672 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 43' ' ' SER . 26.0 m -83.25 -61.04 1.95 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.525 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -91.38 -70.6 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.657 HG13 ' HB2' ' A' ' 104' ' ' ARG . 70.8 t -49.31 -55.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.077 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD11 ' HE2' ' A' ' 23' ' ' MET . 21.2 tp -83.03 -27.07 30.59 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.738 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 39' ' ' THR . 31.2 t -88.39 -4.99 58.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.09 -175.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB3' HG21 ' A' ' 47' ' ' VAL . 13.3 t70 -51.26 130.88 32.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.644 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.706 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 27.5 Cg_exo -62.14 -20.94 71.54 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.854 2.37 . . . . 0.0 113.504 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.87 -34.52 38.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.174 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.53 HG23 HD22 ' A' ' 108' ' ' LEU . 14.8 t -76.89 -40.54 31.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 108.861 175.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 45' ' ' PRO . 36.8 p -59.08 -33.49 70.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.105 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.706 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 87.3 mtt180 -56.78 -35.54 68.8 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.743 0.306 . . . . 0.0 111.45 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.75 -43.42 84.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.735 0.302 . . . . 0.0 110.448 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.427 ' CB ' HD11 ' A' ' 3' ' ' LEU . 2.7 mm? -73.94 -45.78 48.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.762 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -44.79 -48.98 10.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.663 ' HB2' HH11 ' A' ' 54' ' ' ARG . . . -66.87 -48.54 68.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.727 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.67 16.3 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -170.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.463 ' CE2' ' HE3' ' A' ' 21' ' ' MET . 92.7 m-85 -130.05 145.71 51.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.407 0.623 . . . . 0.0 111.447 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 11' ' ' ALA . 60.4 t -114.86 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 21.6 t -86.95 121.31 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.193 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -89.62 117.1 28.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.868 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.0 p -84.65 100.14 11.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.5 t -104.28 106.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.995 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.639 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -90.04 109.16 20.22 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.944 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.477 HG12 ' HB2' ' A' ' 71' ' ' ALA . 25.9 t -75.15 -6.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.071 0.938 . . . . 0.0 109.27 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.679 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -77.53 -32.57 54.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.913 174.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.644 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.4 p -99.55 159.38 30.17 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.87 -53.51 6.87 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.235 3.29 . . . . 0.0 114.835 -169.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.37 80.05 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.8 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.78 -39.84 54.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.307 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -56.75 -39.79 74.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.658 0.742 . . . . 0.0 110.044 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.98 -44.87 79.35 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.899 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -34.7 78.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -64.54 -38.34 90.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -83.62 -20.49 33.56 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.811 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -80.71 -48.92 11.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.591 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -86.44 -10.93 53.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.192 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 73.1 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.804 0.69 . . . . 0.0 109.977 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.04 86.42 58.14 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.626 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -103.15 122.57 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.673 2.916 . . . . 0.0 112.741 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.462 ' HA3' ' HE1' ' A' ' 99' ' ' PHE . . . 133.92 -74.58 0.43 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.412 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.57 HG21 ' HA ' ' A' ' 27' ' ' HIS . 23.7 m 73.23 141.97 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 123.704 0.297 . . . . 0.0 110.586 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 55.4 Cg_endo -69.08 153.99 91.36 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 124.426 -1.072 . . . . 0.0 113.32 1.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.1 m -138.94 123.82 18.77 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.432 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.57 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 1.5 m-85 -112.27 112.56 24.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.842 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.575 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 59.0 t -118.02 115.22 47.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HB2' HG23 ' A' ' 95' ' ' VAL . 49.2 m-85 -102.16 124.02 47.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.92 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 32.8 mt -117.59 132.46 56.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.531 HG22 ' SD ' ' A' ' 21' ' ' MET . 14.9 t -110.71 132.73 21.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.578 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.7 115.04 3.04 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.251 1.3 . . . . 0.0 110.748 170.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -169.13 141.52 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.99 11.41 8.33 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.66 0.6 . . . . 0.0 111.342 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.8 29.6 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.63 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.98 -177.12 3.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.0 111.076 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 67.1 m95 -105.74 130.74 53.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.011 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 31.3 tt0 -97.14 119.82 36.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.238 176.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.496 ' HA ' HD22 ' A' ' 85' ' ' LEU . 33.0 tt0 -75.24 96.56 3.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.933 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 13.7 m -73.91 -11.73 14.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.953 -173.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.79 141.82 3.23 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.763 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -116.16 128.24 55.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.229 0.537 . . . . 0.0 109.642 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.57 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.3 mt -108.03 131.39 54.63 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.462 ' HE1' ' HA3' ' A' ' 78' ' ' GLY . 79.1 t80 -130.9 124.1 30.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.81 178.26 15.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.412 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 8.0 m -112.91 126.29 55.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.468 ' HE ' ' HG2' ' A' ' 106' ' ' GLU . 24.4 mmm180 -128.05 151.02 75.3 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.779 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.07 158.94 41.05 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.254 1.969 . . . . 0.0 111.262 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.657 ' HB2' HG13 ' A' ' 41' ' ' VAL . 67.7 ttt180 -58.67 -34.83 71.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.386 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.64 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.086 0.469 . . . . 0.0 110.634 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.468 ' HG2' ' HE ' ' A' ' 102' ' ' ARG . 3.9 tp10 -67.02 -48.77 67.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.409 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -66.08 -37.36 85.6 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.843 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.53 HD22 HG23 ' A' ' 47' ' ' VAL . 60.6 mt -59.06 -44.51 91.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 0.0 110.73 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 46.7 mtmt -65.1 -48.07 74.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.32 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -59.36 -55.56 33.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.409 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.31 -32.39 72.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.32 0.581 . . . . 0.0 109.897 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -65.44 -37.85 88.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 175.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 109' ' ' LYS . 29.2 mm-40 -74.37 -43.19 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.553 0.215 . . . . 0.0 110.937 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.423 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . 79.5 t -62.67 -36.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.166 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.1 t -55.16 -29.73 58.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.576 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.9 t -85.42 -54.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.245 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.933 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -70.95 -11.53 61.02 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.107 -170.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.438 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -56.12 -41.09 85.14 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.167 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.823 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.855 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.459 ' HB3' ' NE1' ' A' ' 5' ' ' TRP . 11.3 tp . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 121.105 0.479 . . . . 0.0 111.436 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -102.17 103.8 14.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.68 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.459 ' NE1' ' HB3' ' A' ' 3' ' ' LEU . 13.2 m95 -104.35 139.78 38.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.539 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 86.1 m-85 -138.91 166.63 23.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.68 159.35 41.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.54 1.494 . . . . 0.0 110.884 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 60.4 t80 -50.84 -51.36 67.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.2 Cg_exo -60.85 -43.69 29.71 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.834 1.689 . . . . 0.0 112.386 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -65.71 -46.07 80.33 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 56' ' ' VAL . . . -55.15 -41.82 72.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.45 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.38 -38.78 91.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.044 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.47 -47.79 58.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.878 0.371 . . . . 0.0 110.399 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' HG12 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -54.21 -51.4 64.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.857 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.42 -43.96 95.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.357 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -62.39 -47.45 84.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.369 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.35 -15.45 57.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -112.58 -1.73 14.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.43 32.46 81.88 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.264 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.53 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 24.9 mmt180 -97.44 177.63 5.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.397 . . . . 0.0 110.675 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.653 ' HE3' HG22 ' A' ' 86' ' ' VAL . 88.1 mtp -104.5 156.25 18.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.474 176.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 49.9 t -105.95 124.69 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 ttt -104.39 103.47 13.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 37.5 t -84.5 104.54 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.896 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.9 t80 -102.33 108.84 20.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.077 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.977 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.7 m-85 -90.1 124.97 35.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.579 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 23.5 p80 -128.08 155.85 43.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.564 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.433 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 38.2 t -143.1 159.48 42.2 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -74.87 -9.05 58.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.57 0.7 . . . . 0.0 109.935 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -97.86 15.96 22.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.998 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 31.8 p -84.84 115.22 59.93 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.839 0.352 . . . . 0.0 110.562 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 79' ' ' THR . 38.0 Cg_endo -68.0 -69.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.497 2.132 . . . . 0.0 113.866 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.88 -17.19 36.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 44.5 t -55.46 -46.92 76.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.487 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -56.6 -38.25 71.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.38 . . . . 0.0 111.638 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -72.2 -38.93 68.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 50.8 ttm -65.32 -49.38 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.856 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 77.6 m-20 -52.36 -49.27 64.69 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.363 0.415 . . . . 0.0 111.018 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.9 m -59.86 -59.99 4.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.888 -175.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.05 -68.4 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 112.071 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 104' ' ' ARG . 68.6 t -58.9 -44.35 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.804 -170.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 21.1 tp -81.74 -34.68 30.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.334 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.4 t -85.74 -0.99 56.74 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -49.87 128.46 20.83 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.117 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.57 -35.63 57.16 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.222 2.614 . . . . 0.0 113.242 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.86 -48.22 28.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.962 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.695 HG21 HD21 ' A' ' 108' ' ' LEU . 59.6 t -61.36 -57.5 11.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.107 0.479 . . . . 0.0 110.762 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.661 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 54.9 m -52.23 -47.41 65.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.085 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -58.5 -36.56 73.98 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD12 HD13 ' A' ' 111' ' ' LEU . 76.7 mt -62.68 -40.38 96.92 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.0 110.593 176.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.5 mm? -74.53 -40.58 61.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.292 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.6 mt-10 -49.48 -50.21 42.32 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.204 0.526 . . . . 0.0 112.023 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.14 82.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -135.23 11.95 3.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 86.4 m-85 -121.38 145.64 47.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.353 0.597 . . . . 0.0 111.246 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.442 HG12 ' HB3' ' A' ' 14' ' ' LEU . 20.1 t -111.98 113.66 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.403 HG21 HD21 ' A' ' 3' ' ' LEU . 21.8 t -87.03 117.4 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 8' ' ' TYR . . . -90.31 117.27 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.45 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.1 p -85.14 101.41 12.44 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.9 125.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.565 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.612 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -100.48 108.52 20.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.057 0.456 . . . . 0.0 110.571 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.36 -11.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.054 0.93 . . . . 0.0 109.636 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.459 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 6.8 m-20 -77.68 -32.34 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.609 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.599 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -109.1 165.46 12.6 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.778 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.599 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.3 Cg_endo -49.73 -52.95 7.86 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.092 3.194 . . . . 0.0 114.491 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -43.37 79.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.34 -31.15 52.59 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.98 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -60.19 -41.32 92.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.724 0.297 . . . . 0.0 111.065 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.57 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.1 pt-20 -79.25 -30.64 43.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.882 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.83 -44.19 93.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 0.0 110.247 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 76' ' ' VAL . . . -60.06 -49.01 79.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.449 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.57 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.8 ptm180 -65.39 -30.68 71.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.111 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -66.51 -41.39 88.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 110.276 -179.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -92.33 -6.09 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.24 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 65.38 33.11 9.21 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.683 0.614 . . . . 0.0 111.439 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.413 ' O ' ' HB1' ' A' ' 71' ' ' ALA . 13.1 t -130.26 144.99 55.46 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.484 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 17.0 Cg_exo -69.63 -116.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.378 2.052 . . . . 0.0 111.282 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.497 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . 168.14 63.32 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 12.5 p -137.86 47.72 1.76 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 43.5 Cg_endo -93.08 174.38 16.62 Favored 'Cis proline' 0 C--N 1.356 0.949 0 CA-C-N 121.0 1.393 . . . . 0.0 112.507 -3.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.977 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 62.8 m -139.18 131.64 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 170.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -127.75 112.23 14.56 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.662 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 57.4 t -111.43 121.63 64.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.735 0.303 . . . . 0.0 110.199 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.49 116.62 30.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.668 0.27 . . . . 0.0 110.357 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 29.3 mt -112.93 137.04 51.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.213 0.53 . . . . 0.0 111.408 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.653 HG22 ' HE3' ' A' ' 21' ' ' MET . 58.8 t -109.98 123.33 36.46 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.03 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.558 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 59.5 Cg_endo -77.11 116.42 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.778 1.652 . . . . 0.0 111.193 173.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -147.85 135.33 20.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.684 0.278 . . . . 0.0 110.574 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.0 24.16 14.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.554 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.56 77.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.343 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.31 167.02 20.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 65.7 m95 -106.36 126.12 51.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.943 0.401 . . . . 0.0 110.026 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.8 tp10 -114.04 137.44 51.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.623 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 38.1 tt0 -88.29 112.91 23.35 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.521 HG23 ' HE2' ' A' ' 117' ' ' LYS . 8.7 p -98.93 7.46 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.499 0.666 . . . . 0.0 110.336 -175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.46 138.49 2.88 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.504 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -122.94 133.06 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.153 0.502 . . . . 0.0 110.508 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.98 128.39 56.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.923 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.514 ' HD1' ' HG1' ' A' ' 81' ' ' THR . 83.4 t80 -137.18 143.42 42.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.986 0.422 . . . . 0.0 110.965 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.02 -177.27 28.82 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.353 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.6 m -88.79 107.84 19.18 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.494 ' HB3' ' OE1' ' A' ' 106' ' ' GLU . 4.1 mmm180 -111.29 143.65 28.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.658 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.69 151.27 82.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.26 1.973 . . . . 0.0 110.925 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.687 ' HB2' HG12 ' A' ' 41' ' ' VAL . 22.6 ttp180 -59.21 -27.35 65.64 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.89 92.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.65 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' A' ' 102' ' ' ARG . 50.0 tt0 -82.84 -38.27 23.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 37.2 t80 -58.38 -51.4 69.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.675 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.695 HD21 HG21 ' A' ' 47' ' ' VAL . 57.8 mt -70.59 -28.23 64.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -56.7 -55.62 31.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.249 0.547 . . . . 0.0 109.879 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.471 ' O ' HG22 ' A' ' 114' ' ' VAL . 20.8 tp10 -73.74 -31.64 63.46 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.112 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.473 HD13 HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -60.31 -46.58 89.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -60.82 -38.06 84.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.83 -48.52 58.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 110' ' ' GLU . 55.5 t -58.36 -42.45 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.505 0.322 . . . . 0.0 111.75 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.0 p -63.05 -23.85 67.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 110.497 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -86.11 -50.12 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.661 173.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.521 ' HE2' HG23 ' A' ' 95' ' ' VAL . 38.2 mtpt -55.22 -34.3 63.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.236 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.496 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -68.41 -24.09 75.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.949 -0.644 . . . . 0.0 113.152 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.507 177.358 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.1 tp . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.403 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 23.0 mmt180 -88.3 106.38 18.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.646 -172.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -110.24 108.71 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 94.2 m-85 -133.17 154.26 81.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 34.6 Cg_exo -57.05 161.71 10.37 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.09 1.86 . . . . 0.0 111.504 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.56 ' O ' HD22 ' A' ' 12' ' ' LEU . 82.9 t80 -45.81 -53.66 19.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 20.9 Cg_exo -65.17 -40.68 18.91 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.485 1.457 . . . . 0.0 112.146 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.401 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 31.6 tt0 -71.08 -37.33 72.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.926 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.23 79.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.005 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 8' ' ' TYR . 4.6 mm? -61.18 -34.5 75.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.593 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -39.05 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.784 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HB3' HG12 ' A' ' 56' ' ' VAL . 11.5 tp -64.22 -47.31 80.19 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.008 0.432 . . . . 0.0 110.138 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.52 89.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.434 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -62.77 -51.65 66.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.226 178.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.72 -14.38 59.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.029 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -118.68 3.62 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.765 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.67 44.4 95.7 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.458 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.8 mmp_? -107.43 174.86 5.7 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.671 -0.311 . . . . 0.0 110.791 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.496 ' HE1' HG21 ' A' ' 86' ' ' VAL . 79.6 mtp -100.52 156.55 17.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 24.6 t -106.79 127.54 62.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.422 ' HE2' HD11 ' A' ' 42' ' ' LEU . 22.2 ttt -111.07 104.25 12.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.465 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -88.38 107.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -93.02 103.97 16.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 110.137 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.658 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 59.8 m-85 -87.41 122.48 31.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.302 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 62' ' ' VAL . 32.5 p80 -132.62 137.21 46.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.511 ' N ' ' HB3' ' A' ' 31' ' ' CYS . 50.6 m -60.81 167.01 3.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.751 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' N ' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -53.5 -38.22 63.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.285 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -102.05 -48.7 4.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p 41.19 78.45 0.37 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.467 1.107 . . . . 0.0 112.879 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.649 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 69.4 Cg_endo -79.24 -59.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 114.297 -174.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.447 ' HD2' ' HG ' ' A' ' 101' ' ' SER . 33.9 t80 -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 22.6 p -82.68 -21.64 34.85 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -173.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.649 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 8.3 pt20 -61.79 -30.84 71.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.64 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -66.02 -43.56 87.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.358 0.599 . . . . 0.0 109.551 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.426 ' SD ' ' HB3' ' A' ' 101' ' ' SER . 64.2 mmm -59.41 -44.4 92.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.704 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -62.79 -54.62 36.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.598 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 43' ' ' SER . 58.4 m -70.57 -37.65 74.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.27 -71.78 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.864 -0.523 . . . . 0.0 112.011 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.83 -45.53 94.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.285 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.422 HD11 ' HE2' ' A' ' 23' ' ' MET . 25.6 tp -80.93 -31.45 35.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.673 0.273 . . . . 0.0 111.451 -174.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 39' ' ' THR . 33.1 t -83.82 -4.48 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.934 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.81 129.15 14.42 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.351 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.33 -48.38 15.27 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.334 2.69 . . . . 0.0 113.547 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.12 -37.07 86.75 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.409 -176.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.512 ' HA ' HD23 ' A' ' 108' ' ' LEU . 34.8 t -66.63 -57.26 10.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.11 0.481 . . . . 0.0 109.882 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.656 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 50.1 m -52.35 -46.27 66.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.721 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.08 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.677 HD13 HD21 ' A' ' 108' ' ' LEU . 61.4 mt -61.51 -41.55 97.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.222 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.77 -40.66 65.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.2 mt-10 -57.68 -34.16 69.12 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . . . -67.67 -52.84 33.17 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.654 HH22 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.88 15.8 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -172.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -121.49 146.4 46.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.474 0.654 . . . . 0.0 111.871 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 14' ' ' LEU . 56.9 t -113.16 115.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 23' ' ' MET . 21.4 t -87.11 125.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.022 0.439 . . . . 0.0 110.582 -176.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.85 116.91 28.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.888 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -83.48 101.28 11.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.61 103.09 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.453 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 p -94.17 110.77 22.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.292 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.483 ' HB ' ' N ' ' A' ' 29' ' ' GLU . 97.1 t -70.28 -13.65 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.473 0.654 . . . . 0.0 110.367 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -73.94 -27.89 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.837 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.47 ' HB ' ' OE2' ' A' ' 66' ' ' GLU . 76.2 p -91.47 151.91 43.09 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.719 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 43.6 Cg_endo -61.58 -36.92 73.51 Favored 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 122.741 2.294 . . . . 0.0 113.565 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.504 ' O ' HD22 ' A' ' 70' ' ' LEU . 1.2 mp0 -57.3 -52.65 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.515 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.12 -29.77 66.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.825 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.719 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 2.1 pt20 -62.39 -47.46 84.07 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -72.62 -33.11 66.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.122 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.504 HD22 ' O ' ' A' ' 66' ' ' GLU . 1.9 mm? -59.19 -42.88 91.93 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . -62.19 -41.56 98.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.449 176.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 4.5 mtp180 -61.96 -43.81 98.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.12 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.45 -48.8 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.598 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.17 -6.65 58.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.458 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 57.45 46.74 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.738 0.649 . . . . 0.0 110.592 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.23 120.18 28.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.313 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -93.35 105.76 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.601 2.867 . . . . 0.0 110.61 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.47 92.28 1.5 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.362 -168.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.86 48.26 0.81 Allowed Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.699 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 Cg_endo -94.11 173.34 15.81 Favored 'Cis proline' 0 C--N 1.356 0.955 0 CA-C-N 120.541 1.229 . . . . 0.0 112.13 -4.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.658 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 18.0 m -142.67 137.95 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.833 167.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.21 118.19 21.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.755 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.492 HG22 ' HG2' ' A' ' 97' ' ' ARG . 86.6 t -115.27 126.89 72.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -104.72 122.97 46.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 35.4 mt -117.5 130.94 56.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG21 ' HE1' ' A' ' 21' ' ' MET . 39.9 t -109.87 127.95 26.23 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 58.4 Cg_endo -73.52 117.75 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 121.973 1.782 . . . . 0.0 110.432 171.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -164.04 143.78 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.716 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.06 -76.28 0.06 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.042 0.839 . . . . 0.0 111.187 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.47 22.43 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.852 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -161.9 -171.39 2.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.466 ' CE2' HD13 ' A' ' 12' ' ' LEU . 58.9 m95 -103.41 128.37 50.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.0 109.997 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 35.5 tt0 -94.81 115.2 27.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.453 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 34.9 tt0 -73.88 103.01 4.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 171.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' HD3' ' A' ' 117' ' ' LYS . 9.0 p -102.39 6.93 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.607 -167.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.8 146.54 4.54 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.468 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.492 ' HG2' HG22 ' A' ' 83' ' ' VAL . 77.7 mtt180 -123.42 126.58 47.05 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.512 HD21 ' HG3' ' A' ' 110' ' ' GLU . 83.4 mt -109.57 131.7 54.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.449 ' HD1' ' HG1' ' A' ' 81' ' ' THR . 86.7 t80 -137.15 142.14 42.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.44 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.98 136.86 7.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.391 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.447 ' HG ' ' HD2' ' A' ' 33' ' ' TYR . 11.8 m -66.18 122.37 17.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 110.595 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.442 ' NE ' ' HA ' ' A' ' 102' ' ' ARG . 4.0 mmp_? -124.01 157.2 64.42 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.776 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.87 154.87 30.07 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.373 2.049 . . . . 0.0 112.041 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -31.07 67.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.628 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.411 ' O ' ' HE3' ' A' ' 109' ' ' LYS . . . -67.81 -38.33 83.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.291 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.43 -32.81 48.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.538 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.69 -49.86 71.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.74 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.677 HD21 HD13 ' A' ' 50' ' ' LEU . 24.1 mt -70.5 -20.69 62.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 105' ' ' ALA . 1.0 OUTLIER -59.8 -61.2 2.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.512 ' HG3' HD21 ' A' ' 98' ' ' LEU . 2.1 tm-20 -67.85 -38.72 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.69 -44.34 90.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 110.551 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -64.65 -36.95 85.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 109.954 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 22.2 mt-30 -65.98 -38.96 89.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.52 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 72.4 t -61.51 -34.9 63.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.923 176.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.35 -34.99 71.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.326 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -84.24 -40.11 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.52 ' HD2' ' HA ' ' A' ' 114' ' ' VAL . 96.9 mttt -52.0 -57.2 10.18 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.027 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -51.68 -34.6 36.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.153 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.944 -178.062 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.553 HD21 HG23 ' A' ' 57' ' ' VAL . 27.7 tp . . . . . 0 C--O 1.236 0.382 0 N-CA-C 111.276 0.102 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.52 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.0 mmp_? -77.09 103.76 7.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.371 . . . . 0.0 111.297 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -105.64 115.08 29.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.754 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.5 m-85 -121.97 159.41 51.63 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.592 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 14.4 Cg_exo -67.88 157.91 59.69 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.964 1.776 . . . . 0.0 110.761 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.582 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 92.6 t80 -43.78 -53.14 13.18 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.2 Cg_exo -59.13 -52.02 5.68 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.787 1.658 . . . . 0.0 112.766 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.4 mm-40 -70.34 -30.6 67.6 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.32 -47.18 87.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.2 0.524 . . . . 0.0 110.259 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.45 -40.39 95.64 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.823 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.81 -36.51 65.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.04 0.448 . . . . 0.0 110.741 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -61.79 -37.92 86.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.191 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.12 -49.03 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.489 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 46.3 tt0 -57.52 -54.32 48.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 122.913 0.485 . . . . 0.0 112.308 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.84 60.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.612 -172.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 12.7 m-70 -110.35 -22.87 11.5 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.23 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.8 6.83 54.09 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.043 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 20' ' ' ARG . 4.0 mpt_? -85.9 -177.82 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.664 0.268 . . . . 0.0 111.402 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.77 158.74 17.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 38.8 t -106.36 135.62 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.67 0.272 . . . . 0.0 110.747 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.542 ' HG2' ' CD1' ' A' ' 84' ' ' PHE . 6.2 tmm? -125.69 104.74 8.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.528 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 35.2 t -91.16 120.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -175.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.477 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 44.0 t80 -108.74 124.33 50.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.081 0.467 . . . . 0.0 111.388 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.908 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.6 m-85 -104.22 132.55 50.36 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.393 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.9 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 30.4 p80 -135.84 161.69 34.9 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.491 0.494 . . . . 0.0 110.644 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.602 ' HG ' ' HB ' ' A' ' 62' ' ' VAL . 40.4 m -143.79 164.42 30.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.8 -32.89 20.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 109.995 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -76.54 -7.11 54.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.242 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.71 ' HB3' HG21 ' A' ' 79' ' ' THR . 5.0 t -113.89 87.52 12.73 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.24 27.11 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.047 2.498 . . . . 0.0 113.687 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -86.05 -48.43 8.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.025 0.441 . . . . 0.0 111.503 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.674 ' HG ' ' HB3' ' A' ' 80' ' ' PRO . 14.1 t -83.08 -20.45 34.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -171.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -53.21 -29.81 34.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -79.37 -32.24 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.451 0.643 . . . . 0.0 110.326 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -80.28 -49.88 10.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.994 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.524 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.0 p30 -64.65 -23.05 67.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.8 m -75.69 -60.42 2.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.499 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.65 -69.46 0.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.744 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.5 t -55.71 -43.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.9 tp -80.9 -23.93 38.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -105.69 9.06 33.25 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.068 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.97 135.24 21.43 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.766 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.02 -34.21 56.13 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 123.057 2.505 . . . . 0.0 113.561 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.61 -45.69 10.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.804 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG23 HD21 ' A' ' 108' ' ' LEU . 43.0 t -63.34 -51.96 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.292 0.568 . . . . 0.0 109.807 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 7.6 t -53.21 -41.33 65.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.525 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -61.84 -35.38 78.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.772 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD11 HD12 ' A' ' 111' ' ' LEU . 76.2 mt -69.28 -40.14 77.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.911 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.459 ' CB ' HD13 ' A' ' 3' ' ' LEU . 4.2 mm? -70.85 -48.72 52.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.846 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 48' ' ' SER . 12.0 mm-40 -53.0 -33.6 52.35 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.801 0.44 . . . . 0.0 112.182 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . . . -68.11 -57.99 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -173.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.508 ' HD3' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.91 18.88 3.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 76.2 m-85 -124.97 146.18 49.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.413 0.625 . . . . 0.0 111.245 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.522 HG12 ' HB3' ' A' ' 14' ' ' LEU . 39.7 t -115.12 120.09 63.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.553 HG23 HD21 ' A' ' 3' ' ' LEU . 19.0 t -91.58 124.6 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.77 -173.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -93.96 117.96 30.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.591 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 p -82.66 102.43 11.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.04 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -116.73 129.4 73.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.15 0.5 . . . . 0.0 110.485 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.589 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 2.2 m -112.97 114.45 26.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.811 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.602 ' HB ' ' HG ' ' A' ' 28' ' ' SER . 32.4 t -74.84 -7.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.015 0.912 . . . . 0.0 109.583 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.01 -29.37 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.012 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.603 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 2.9 p -109.11 158.51 34.14 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.603 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.0 Cg_endo -52.29 -50.4 14.15 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.301 3.334 . . . . 0.0 114.914 -167.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -38.62 84.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.991 0.424 . . . . 0.0 110.83 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.3 -31.02 53.28 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.606 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 64' ' ' THR . 92.4 mt-30 -62.36 -39.68 93.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.638 0.375 . . . . 0.0 111.117 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.541 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -77.9 -33.7 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.642 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.541 HD12 ' OE2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -61.27 -42.21 98.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 0.0 110.531 170.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.2 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.564 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.534 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.1 ptm180 -71.9 -21.46 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.969 0.414 . . . . 0.0 110.484 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 45.6 ttm105 -75.2 -52.42 10.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.45 -8.12 57.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.711 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 64.06 72.19 0.47 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.468 0.651 . . . . 0.0 109.698 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 56.0 t -123.6 136.96 27.85 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.959 -175.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.9 Cg_exo -73.62 -138.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.204 2.603 . . . . 0.0 111.553 173.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.12 -69.18 1.28 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.807 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.9 ' HB ' ' HA ' ' A' ' 27' ' ' HIS . 6.6 t 178.44 156.09 0.56 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.688 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 1.0 OUTLIER -84.29 132.75 18.39 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.354 -1.102 . . . . 0.0 112.701 0.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.908 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 31.4 m -126.41 121.13 31.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 110.584 174.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.64 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 8.8 m-85 -119.45 115.96 25.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 98.2 t -114.01 118.14 57.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.754 0.312 . . . . 0.0 110.548 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 23' ' ' MET . 26.2 m-85 -96.93 118.71 33.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.707 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 94' ' ' GLU . 42.0 mt -115.78 130.06 56.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.077 0.465 . . . . 0.0 110.516 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.01 135.14 20.52 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.6 116.64 4.64 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.574 1.516 . . . . 0.0 109.338 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -151.07 128.4 11.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.761 -171.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.12 -79.8 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.931 0.77 . . . . 0.0 111.341 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.67 21.09 0.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.07 -169.3 3.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 85.6 m95 -107.89 135.76 48.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.242 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -116.3 118.29 32.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.589 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 36.2 tt0 -77.62 108.17 10.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.832 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 31.1 m -88.35 12.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 111.329 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.09 155.02 6.31 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.301 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -130.76 135.5 47.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.64 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.9 mt -108.18 129.75 55.17 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.719 -177.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 80' ' ' PRO . 88.3 t80 -137.41 143.23 41.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.649 173.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.25 145.77 10.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.583 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m -70.09 125.76 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.607 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.613 ' HB3' ' HB2' ' A' ' 106' ' ' GLU . 92.9 mtt180 -137.89 142.75 37.28 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.789 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.464 ' HD2' ' HG2' ' A' ' 106' ' ' GLU . 24.5 Cg_exo -64.21 166.38 17.05 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.489 2.126 . . . . 0.0 111.518 173.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -55.54 -33.17 63.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.872 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -60.88 -47.25 87.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 17.4 mm-40 -72.3 -38.42 68.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.929 0.395 . . . . 0.0 110.602 -176.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -65.3 -39.37 92.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.345 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 47' ' ' VAL . 53.4 mt -67.35 -34.62 77.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.061 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 98.5 mttt -55.94 -53.3 58.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 109.871 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.496 ' O ' HG23 ' A' ' 114' ' ' VAL . 4.3 mm-40 -62.53 -44.16 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.432 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.444 HD12 HD11 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -57.71 -41.57 82.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.281 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 14.4 mmt180 -63.09 -49.55 74.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.852 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 6.9 pt20 -66.97 -23.04 65.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.066 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 110' ' ' GLU . 56.7 t -75.21 -41.92 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.838 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.4 m -56.75 -37.95 71.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 110.525 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.86 -32.39 56.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.832 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 54.2 mttp -71.19 -8.52 54.09 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.482 -176.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.46 -20.96 72.17 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.222 173.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 176.563 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 51' ' ' LEU . 26.6 tp . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.904 0.383 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.633 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -77.35 103.58 7.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.71 -174.641 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.415 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 43.7 m95 -114.0 102.67 10.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.7 m-85 -117.06 161.13 34.26 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 27.4 Cg_exo -60.02 162.04 17.49 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.934 1.756 . . . . 0.0 111.436 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.632 ' CD1' HD23 ' A' ' 70' ' ' LEU . 87.8 t80 -49.1 -52.89 43.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.1 Cg_exo -65.25 -40.51 19.2 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.632 1.555 . . . . 0.0 111.951 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 33.2 tt0 -69.46 -39.23 77.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 -177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.56 82.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.019 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.96 -34.6 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -38.45 64.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.682 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.424 ' HB3' HG12 ' A' ' 56' ' ' VAL . 11.1 tp -65.23 -44.6 87.69 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 109.71 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.14 87.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -50.85 71.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.77 -14.12 60.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.197 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -118.23 -9.9 10.36 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.2 89.71 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.714 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.72 ' HG3' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -73.07 169.75 16.33 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.466 0.306 . . . . 0.0 111.521 175.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.572 ' SD ' HG22 ' A' ' 86' ' ' VAL . 68.1 mtm -101.4 167.84 9.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.39 125.95 62.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.079 0.466 . . . . 0.0 111.242 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.762 ' HG3' HG11 ' A' ' 57' ' ' VAL . 5.4 tpt -103.67 102.77 12.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.19 108.53 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.954 0.407 . . . . 0.0 110.067 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.766 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 72.6 t80 -103.7 103.55 13.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.419 0.628 . . . . 0.0 110.743 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 70' ' ' LEU . 60.3 m-85 -77.29 105.38 8.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.24 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.766 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 24.4 p80 -104.15 138.29 40.85 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.618 175.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.664 ' OG ' ' HA2' ' A' ' 78' ' ' GLY . 49.3 m -122.67 144.06 49.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.627 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -42.81 62.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.303 0.573 . . . . 0.0 110.13 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.555 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 91.5 m-70 -101.87 42.74 1.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.263 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.633 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 28.3 p -93.58 100.91 5.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.617 176.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -88.41 -7.69 5.71 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.268 1.978 . . . . 0.0 114.152 -176.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -84.58 -34.51 23.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.697 ' HB3' ' HG3' ' A' ' 80' ' ' PRO . 29.2 p -80.96 -23.18 38.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -170.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -55.13 -32.41 62.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.18 -33.37 24.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.402 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.441 ' HE3' ' CZ ' ' A' ' 82' ' ' PHE . 46.0 ttp -80.73 -35.26 33.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.596 -173.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.575 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 38.3 p30 -72.14 -22.69 61.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 111.229 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.9 m -71.34 -59.94 2.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.609 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -91.48 -67.74 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.463 0.649 . . . . 0.0 111.482 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 104' ' ' ARG . 59.1 t -60.01 -58.95 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.98 -168.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 19.5 tp -78.84 -10.59 59.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.089 -169.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -101.05 -9.87 21.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.755 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.67 133.25 78.11 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.341 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.25 -48.74 20.41 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.191 2.594 . . . . 0.0 113.086 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.59 -43.14 99.27 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.37 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.733 HG22 HD23 ' A' ' 108' ' ' LEU . 50.0 t -60.07 -56.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 175.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 m -56.91 -36.53 70.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.579 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HA ' ' HB2' ' A' ' 52' ' ' GLU . 99.7 mtt180 -75.44 -21.16 58.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.442 HD11 HD21 ' A' ' 108' ' ' LEU . 69.1 mt -70.68 -36.52 73.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.163 169.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 1.5 mm? -70.45 -49.35 49.6 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.076 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 49' ' ' ARG . 17.1 mm-40 -45.88 -39.16 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.991 0.516 . . . . 0.0 112.124 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.501 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -68.13 -57.18 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.72 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.75 20.7 3.3 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -171.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.517 ' CE2' ' HE1' ' A' ' 21' ' ' MET . 96.2 m-85 -133.58 140.36 47.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.481 0.657 . . . . 0.0 111.674 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 14' ' ' LEU . 46.9 t -110.44 115.35 49.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.762 HG11 ' HG3' ' A' ' 23' ' ' MET . 20.8 t -86.76 126.35 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.523 . . . . 0.0 110.359 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.17 116.52 29.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.521 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 44.3 t -87.01 100.71 12.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.461 HG11 HD21 ' A' ' 70' ' ' LEU . 59.4 t -110.24 119.0 58.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.027 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.627 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.0 p -90.43 111.97 23.42 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.577 ' CG2' ' HG ' ' A' ' 28' ' ' SER . 21.6 m -74.29 -0.41 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.526 0.679 . . . . 0.0 110.346 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -29.49 31.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.086 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -95.63 166.73 14.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.977 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.5 Cg_endo -51.86 -55.85 3.52 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.511 2.807 . . . . 0.0 114.6 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.98 -35.66 80.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.353 . . . . 0.0 110.938 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.95 -40.88 62.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.724 174.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 5.9 mt-30 -62.29 -30.87 71.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.259 0.552 . . . . 0.0 110.594 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.459 ' CD ' HH21 ' A' ' 73' ' ' ARG . 5.3 tp10 -66.05 -53.43 38.49 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.631 173.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 8' ' ' TYR . 6.7 mp -58.62 -37.48 75.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 176.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.9 28.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.983 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -66.27 -23.34 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.459 HH21 ' CD ' ' A' ' 69' ' ' GLU . 14.2 ttm180 -83.49 -51.21 7.55 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.316 -175.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.26 4.12 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.637 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 68.67 22.13 7.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.793 0.437 . . . . 0.0 111.072 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.97 119.78 66.47 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.32 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.974 2.449 . . . . 0.0 112.589 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.664 ' HA2' ' OG ' ' A' ' 28' ' ' SER . . . -174.8 120.98 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.637 ' HB ' ' C ' ' A' ' 80' ' ' PRO . 31.2 m -146.56 -61.04 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -165.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HG3' ' HB3' ' A' ' 34' ' ' CYS . 17.8 Cg_endo -79.39 172.74 58.12 Favored 'Cis proline' 0 N--CA 1.492 1.414 0 CA-C-N 123.111 2.147 . . . . 0.0 115.915 4.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 m -125.97 143.12 51.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.254 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' HD1' ' HD1' ' A' ' 25' ' ' TYR . 1.2 m-85 -118.27 127.99 54.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.91 117.69 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.727 0.299 . . . . 0.0 110.716 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.86 125.77 42.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.78 0.324 . . . . 0.0 110.416 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.419 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 31.8 mt -117.1 142.23 47.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.577 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.572 HG22 ' SD ' ' A' ' 21' ' ' MET . 10.9 t -108.59 139.84 21.22 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.444 ' HD2' ' HG2' ' A' ' 21' ' ' MET . 41.2 Cg_endo -72.66 114.47 4.03 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 160.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.539 ' HZ3' HG13 ' A' ' 86' ' ' VAL . 17.5 mttp -142.21 113.36 7.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.35 15.77 9.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.669 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.4 37.83 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.985 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.04 178.29 4.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.629 0.252 . . . . 0.0 110.403 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -109.4 128.74 55.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.252 0.549 . . . . 0.0 110.319 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 23.7 tt0 -109.96 124.66 51.8 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.373 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.419 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 78.2 tt0 -77.08 100.15 5.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.4 ' HB ' HG23 ' A' ' 86' ' ' VAL . 14.8 p -94.4 -7.12 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.467 -169.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.84 125.71 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.939 -1.124 . . . . 0.0 112.89 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -114.87 128.5 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.112 0.482 . . . . 0.0 109.995 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 97.0 mt -117.24 141.46 48.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.882 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.488 ' CE1' HG21 ' A' ' 79' ' ' THR . 79.6 t80 -137.42 127.76 26.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.847 0.356 . . . . 0.0 110.608 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.96 154.02 30.22 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.843 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -66.23 142.39 57.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -123.82 132.95 24.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -56.94 140.86 93.27 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.928 1.752 . . . . 0.0 109.683 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 41' ' ' VAL . 16.7 ttp180 -51.23 -34.91 34.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.6 43.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 111.074 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.7 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 10.3 pt-20 -88.99 -20.04 24.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.851 -175.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 70.7 t80 -60.82 -43.25 98.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 171.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.733 HD23 HG22 ' A' ' 47' ' ' VAL . 89.1 mt -68.42 -34.26 75.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.881 174.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 14.8 ttpt -55.65 -52.77 62.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.211 171.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.7 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 28.9 mm-40 -57.03 -45.05 83.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.499 0.666 . . . . 0.0 109.694 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD21 HD12 ' A' ' 50' ' ' LEU . 20.9 tp -61.46 -41.37 97.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 26.7 mmt180 -62.35 -41.33 98.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.823 0.344 . . . . 0.0 110.298 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 10.5 mt-30 -56.4 -37.24 69.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.516 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.98 -37.35 26.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.758 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.9 m -54.92 -42.42 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.782 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.5 -47.56 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.289 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.7 ' HZ3' ' HB2' ' A' ' 117' ' ' LYS . 10.4 mtmp? -68.99 -13.25 62.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.576 -176.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.25 -33.12 69.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.827 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.854 175.76 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.708 HD22 HD23 ' A' ' 51' ' ' LEU . 6.7 tp . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.741 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 34.9 mmt180 -78.03 110.97 13.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.106 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -108.6 104.47 13.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.943 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.741 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 97.0 m-85 -110.49 160.27 29.15 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.936 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 20.0 Cg_exo -62.69 165.71 15.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.915 1.743 . . . . 0.0 110.552 170.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 93.5 t80 -49.87 -53.26 44.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.6 Cg_exo -64.42 -47.51 5.74 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.809 1.673 . . . . 0.0 112.198 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.506 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 31.2 tt0 -64.91 -35.39 81.01 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.437 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.84 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.37 . . . . 0.0 111.139 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.05 -30.88 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.021 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.33 -44.04 76.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.562 HD23 ' CE2' ' A' ' 6' ' ' TYR . 13.3 tp -61.72 -47.32 85.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.262 0.553 . . . . 0.0 110.247 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.91 89.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.246 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -68.1 -39.23 82.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.39 -18.88 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -116.02 -8.56 11.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 38.21 63.06 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.659 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -101.22 176.99 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.559 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 75.5 mtp -107.47 149.99 27.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.9 t -106.94 131.56 56.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.461 . . . . 0.0 111.536 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.46 ' SD ' HD21 ' A' ' 51' ' ' LEU . 20.5 ttt -107.93 107.25 17.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.829 172.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.499 HG12 HG21 ' A' ' 60' ' ' VAL . 40.9 t -84.75 103.1 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.531 ' OH ' ' HB3' ' A' ' 38' ' ' ASN . 92.7 t80 -97.67 108.02 20.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.74 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.938 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 74.8 m-85 -86.47 118.66 26.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.085 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.583 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 33.5 p80 -135.36 179.3 6.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.7 p -143.86 166.52 24.7 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -22.22 34.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.52 23.58 5.11 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 23.0 p -52.45 110.78 2.09 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 173.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.19 -81.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.289 2.659 . . . . 0.0 114.532 -167.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -77.78 -17.66 57.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.32 0.581 . . . . 0.0 110.499 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.642 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 37.3 t -62.94 -36.85 84.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -72.03 -17.15 62.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 111.212 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -81.79 -40.25 22.87 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.711 0.767 . . . . 0.0 109.716 171.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.575 ' SD ' ' HG3' ' A' ' 80' ' ' PRO . 75.9 mtp -69.39 -43.22 73.94 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.892 -170.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.531 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 30.1 p-10 -66.02 -35.08 79.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.863 0.363 . . . . 0.0 110.445 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 43' ' ' SER . 85.6 m -66.8 -55.94 12.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.585 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.97 -69.84 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.874 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.5 -51.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.788 -169.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 23.6 tp -76.87 -27.25 54.97 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.575 -173.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.7 m -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.748 0.309 . . . . 0.0 111.019 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.38 130.16 61.55 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.837 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.9 -43.09 24.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.508 2.805 . . . . 0.0 113.762 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.97 -43.45 65.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.453 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -65.68 -49.62 76.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 121.659 0.742 . . . . 0.0 109.831 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 32.4 m -59.58 -32.27 70.21 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.656 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.737 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.86 -42.07 97.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.814 ' HA ' HH21 ' A' ' 54' ' ' ARG . 64.8 mt -60.33 -45.03 94.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.654 0.264 . . . . 0.0 111.223 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.708 HD23 HD22 ' A' ' 3' ' ' LEU . 6.2 tp -72.34 -31.8 65.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.396 0.617 . . . . 0.0 111.051 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.577 ' HA ' HD12 ' A' ' 3' ' ' LEU . 8.3 tp10 -61.74 -35.95 79.59 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 113.741 -168.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -91.5 -31.17 16.06 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -168.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.814 HH21 ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -134.48 5.08 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -170.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.7 142.6 48.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.551 0.691 . . . . 0.0 111.956 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.8 t -107.87 115.21 48.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.51 126.71 40.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.852 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -94.95 116.98 29.39 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.717 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.7 p -82.42 101.06 10.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.499 HG21 HG12 ' A' ' 24' ' ' VAL . 99.8 t -115.17 123.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 -175.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.517 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 1.9 t -116.39 129.34 56.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.011 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.54 65.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.104 0.954 . . . . 0.0 110.0 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.67 -36.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.039 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 30.7 p -82.89 160.53 60.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.201 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 15.6 Cg_endo -52.92 -55.39 3.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.062 2.508 . . . . 0.0 113.415 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.463 ' O ' HD13 ' A' ' 70' ' ' LEU . 10.2 pt-20 -57.03 -44.85 83.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.983 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -68.91 -39.08 85.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.38 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -63.03 -48.68 77.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.049 0.54 . . . . 0.0 111.663 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.4 pt-20 -73.48 -29.05 62.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.588 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.661 ' HG ' ' HE2' ' A' ' 74' ' ' TYR . 5.3 mp -67.28 -40.61 86.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.809 173.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.55 78.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 9.3 ptm180 -83.48 -19.51 35.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.719 0.295 . . . . 0.0 111.371 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 48.0 ttt180 -72.69 -44.03 62.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.661 ' HE2' ' HG ' ' A' ' 70' ' ' LEU . 53.3 m-85 -102.45 -2.35 28.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 26.2 ptt180 45.95 71.19 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.526 1.13 . . . . 0.0 112.551 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.449 HG11 ' CG2' ' A' ' 81' ' ' THR . 13.5 t -137.74 94.65 11.53 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.882 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -97.83 128.08 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.415 2.743 . . . . 0.0 111.416 169.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.33 42.19 0.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.99 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.583 ' OG1' ' HA ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -47.03 152.36 1.0 Allowed Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 122.795 0.438 . . . . 0.0 110.741 173.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' A' ' 34' ' ' CYS . 58.6 Cg_endo -67.01 151.63 83.25 Favored 'Cis proline' 0 C--N 1.351 0.676 0 N-CA-C 114.841 1.054 . . . . 0.0 114.841 4.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.938 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.3 m -141.02 133.63 28.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.34 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 3.0 m-85 -123.14 111.88 17.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -175.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 39.5 t -119.12 112.49 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 110.146 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.5 122.33 38.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.394 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 94' ' ' GLU . 30.9 mt -113.55 135.76 53.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -109.12 130.74 22.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.81 116.89 4.09 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.633 1.556 . . . . 0.0 110.212 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.548 ' HZ1' ' CD ' ' A' ' 93' ' ' GLU . 35.8 ttpt -151.79 134.93 15.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.333 -175.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 71.14 -37.61 0.4 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.742 0.817 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 88' ' ' LYS . . . 149.7 -10.92 0.95 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.51 -179.13 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -108.16 136.71 47.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.042 0.449 . . . . 0.0 110.489 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.548 ' CD ' ' HZ1' ' A' ' 88' ' ' LYS . 33.0 tt0 -117.33 126.23 52.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.104 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.444 ' HA ' HD23 ' A' ' 85' ' ' LEU . 53.3 tt0 -77.3 99.69 5.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 117' ' ' LYS . 4.9 p -96.7 -10.43 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.176 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.15 126.79 1.48 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.449 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.41 127.53 49.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.972 0.415 . . . . 0.0 109.975 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 99.0 mt -117.72 139.17 51.41 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.278 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -137.26 142.87 41.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.798 0.332 . . . . 0.0 110.838 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.06 168.93 45.37 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.635 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.455 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 10.9 m -65.38 131.76 47.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.022 0.439 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.5 133.94 23.51 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HG2' ' HB2' ' A' ' 106' ' ' GLU . 12.4 Cg_endo -59.87 154.4 50.37 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.716 1.611 . . . . 0.0 110.991 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -30.69 64.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.839 0.352 . . . . 0.0 110.437 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.04 63.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.31 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.442 ' HB2' ' HG2' ' A' ' 103' ' ' PRO . 22.9 tp10 -73.19 -42.27 62.9 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.476 ' CE2' HD11 ' A' ' 111' ' ' LEU . 9.8 t80 -66.24 -44.85 82.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.405 -178.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.65 -47.88 78.78 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -52.26 -58.85 5.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.32 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 114' ' ' VAL . 2.3 tp10 -78.98 -28.43 43.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.519 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 50' ' ' LEU . 3.4 tt -61.22 -43.19 99.27 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.456 ' O ' HG21 ' A' ' 116' ' ' VAL . 22.6 tpt180 -61.43 -45.8 92.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.503 ' HB3' ' HZ2' ' A' ' 117' ' ' LYS . 34.4 mt-30 -64.73 -43.65 92.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.42 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.559 ' O ' ' HE2' ' A' ' 21' ' ' MET . 54.6 t -58.72 -40.87 80.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -56.43 -28.54 59.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 112' ' ' ARG . 59.2 t -83.88 -34.33 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.885 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.507 ' HB3' HG23 ' A' ' 95' ' ' VAL . 13.6 mptt -57.4 -28.5 63.29 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.615 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.85 -38.94 93.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.018 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.837 -179.018 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.794 0.33 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -107.36 117.31 33.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.435 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 36.8 m95 -111.24 123.14 49.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.215 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 37.0 m-85 -132.06 160.92 65.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.232 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 26.2 Cg_exo -61.22 162.16 20.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.003 1.802 . . . . 0.0 110.929 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.536 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 72.6 t80 -49.92 -50.24 69.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 34.7 Cg_exo -61.33 -46.61 14.41 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.808 1.672 . . . . 0.0 112.42 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -68.01 -40.61 82.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.219 -177.575 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.03 -35.92 82.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 177.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.0 -41.41 64.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.197 0.522 . . . . 0.0 110.228 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.515 ' HB3' HG12 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -57.23 -47.96 80.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.724 177.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.9 -41.92 67.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.455 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -61.05 -51.4 69.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 111.532 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.28 -15.35 58.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.927 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -112.86 -4.57 13.95 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.331 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.19 49.04 49.19 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.101 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -114.64 178.75 4.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.403 ' HE3' HG22 ' A' ' 86' ' ' VAL . 89.3 mtp -105.22 151.48 24.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.88 125.36 61.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.106 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.0 ttt -101.21 102.78 13.75 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 39.6 t -83.3 102.91 9.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.54 ' HH ' ' HB3' ' A' ' 38' ' ' ASN . 24.7 t80 -98.61 108.8 21.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.176 -175.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.595 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 96.4 m-85 -93.23 125.36 37.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.377 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 25.4 p80 -127.56 150.12 49.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.611 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 24.5 m -142.96 141.21 31.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.522 0.201 . . . . 0.0 110.825 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.505 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -75.89 -22.41 56.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 166.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -72.64 -11.99 60.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.047 175.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.542 ' SG ' ' HA2' ' A' ' 78' ' ' GLY . 10.9 t -137.61 77.55 39.45 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.483 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.53 17.71 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 122.975 2.45 . . . . 0.0 114.702 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.419 ' HB3' ' OG ' ' A' ' 101' ' ' SER . 57.3 m-85 -77.27 -18.28 57.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.541 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 13.2 t -83.43 -30.93 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.814 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 10.6 mm100 -52.2 -42.01 63.15 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -170.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.035 0.445 . . . . 0.0 110.925 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.466 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 45.2 ttm -77.61 -51.89 9.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.251 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.54 ' HB3' ' HH ' ' A' ' 25' ' ' TYR . 2.2 p-10 -65.49 -17.1 64.3 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 m -81.34 -62.33 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.679 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -92.88 -68.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.449 0.642 . . . . 0.0 112.116 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.466 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 89.6 t -52.67 -47.29 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.434 -168.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.4 tp -81.3 -18.43 45.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.982 0.42 . . . . 0.0 110.88 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 m -87.41 -10.99 50.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.58 130.01 10.74 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.083 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.13 -31.96 94.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.013 2.475 . . . . 0.0 113.181 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.36 -44.53 13.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.707 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.59 HG22 HD22 ' A' ' 108' ' ' LEU . 48.5 t -61.52 -52.88 55.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.548 0.69 . . . . 0.0 109.495 175.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.738 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 34.1 t -50.46 -44.37 55.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.316 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -57.39 -41.12 79.61 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.589 0.555 . . . . 0.0 111.763 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.692 HD11 HD23 ' A' ' 108' ' ' LEU . 76.2 mt -61.97 -35.87 79.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.598 0.237 . . . . 0.0 110.945 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.98 -38.7 57.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.43 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.738 ' HG3' ' O ' ' A' ' 48' ' ' SER . 55.9 mt-10 -55.55 -39.08 70.15 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.058 0.456 . . . . 0.0 111.436 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -62.74 -53.33 56.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -169.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.612 ' HE ' ' HE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.7 5.82 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.612 ' HE1' ' HE ' ' A' ' 54' ' ' ARG . 80.3 m-85 -110.44 143.17 41.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 112.525 -173.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 14' ' ' LEU . 49.0 t -110.76 115.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.7 t -86.54 123.58 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.1 0.476 . . . . 0.0 110.916 -173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -90.39 116.95 28.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -82.44 101.04 10.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.92 118.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 63' ' ' ASP . 2.6 m -102.11 110.82 22.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.278 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.611 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 6.1 t -82.67 28.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 122.574 1.178 . . . . 0.0 109.03 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.505 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 25.5 m-20 -113.42 -20.04 11.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.84 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.572 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 4.1 p -115.24 161.36 30.09 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.996 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.572 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.5 Cg_endo -51.96 -56.48 2.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.425 2.75 . . . . 0.0 114.025 -170.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -46.22 66.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.22 -36.46 63.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.879 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -63.75 -36.62 84.48 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.577 0.351 . . . . 0.0 111.018 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' OE1' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mm-40 -68.67 -39.06 80.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.177 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 70' ' ' LEU . 60.9 mt -67.96 -41.19 82.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.449 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.11 93.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.551 0.215 . . . . 0.0 111.321 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.5 ' HD3' ' OE1' ' A' ' 69' ' ' GLU . 9.3 ptm180 -73.38 -20.92 60.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 110.491 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -74.64 -56.27 4.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.287 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -75.7 -9.09 58.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.919 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.4 ttm105 68.79 42.63 1.37 Allowed 'General case' 0 CA--C 1.528 0.127 0 O-C-N 123.834 0.708 . . . . 0.0 110.793 170.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.499 HG11 HG23 ' A' ' 81' ' ' THR . 33.7 t -122.31 104.3 37.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.134 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -93.64 128.81 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.236 2.624 . . . . 0.0 111.765 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.542 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 108.88 150.96 14.45 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.255 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.605 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 39.8 p -141.74 162.76 44.81 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 72.4 Cg_endo -78.09 142.14 68.68 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 113.222 1.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 87.3 m -123.52 122.05 37.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.749 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 7.5 m-85 -115.82 112.27 21.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.184 -177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 46.8 t -106.77 118.41 54.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.593 ' HB2' HG23 ' A' ' 95' ' ' VAL . 79.3 m-85 -95.91 104.91 16.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.926 0.393 . . . . 0.0 110.593 -177.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 94' ' ' GLU . 78.5 mt -105.52 126.3 51.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.557 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.403 HG22 ' HE3' ' A' ' 21' ' ' MET . 11.2 t -110.25 132.47 21.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.09 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.56 116.45 2.6 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.153 1.902 . . . . 0.0 109.855 171.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.575 ' HZ3' ' CD ' ' A' ' 93' ' ' GLU . 9.6 ptmm? -161.73 141.36 10.11 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.207 -174.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.19 -72.13 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.13 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.15 25.82 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.759 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.97 165.12 25.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.601 0.239 . . . . 0.0 110.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.33 134.81 33.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.575 ' CD ' ' HZ3' ' A' ' 88' ' ' LYS . 30.0 tt0 -120.35 117.56 28.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.339 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.504 ' HA ' HD23 ' A' ' 85' ' ' LEU . 14.6 tt0 -77.05 112.05 13.28 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 84' ' ' PHE . 24.3 m -77.66 -18.08 14.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.422 0.629 . . . . 0.0 109.827 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.28 162.41 11.79 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.024 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 138.45 53.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.093 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.3 mt -111.87 130.72 55.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.775 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -137.19 133.99 35.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.0 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.73 159.97 8.42 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.074 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 33' ' ' TYR . 73.6 m -94.88 17.11 14.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.068 0.461 . . . . 0.0 111.585 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.482 ' HD2' ' OE1' ' A' ' 106' ' ' GLU . 14.1 mmt180 -57.87 140.71 81.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.78 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 102' ' ' ARG . 30.9 Cg_exo -62.29 172.3 4.38 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.344 2.696 . . . . 0.0 112.381 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.474 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 39.9 ptt180 -51.78 -26.13 9.04 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.839 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -53.34 -63.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.266 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.715 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 3.0 mp0 -70.07 -33.0 71.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 110.952 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.06 -47.05 87.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.692 HD23 HD11 ' A' ' 50' ' ' LEU . 75.7 mt -70.48 -33.31 71.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.715 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.7 mttt -57.06 -51.29 69.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.53 176.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 114' ' ' VAL . 11.6 mm-40 -68.91 -36.41 77.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.773 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.462 ' O ' HD22 ' A' ' 111' ' ' LEU . 4.1 tt -64.44 -34.88 79.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 116' ' ' VAL . 10.3 mmm180 -61.29 -41.33 96.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.471 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -67.62 -33.38 74.87 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.382 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.592 HG11 HG22 ' A' ' 95' ' ' VAL . 77.9 t -64.45 -45.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 p -65.39 -25.54 67.6 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.995 0.426 . . . . 0.0 110.7 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.6 t -77.19 -43.68 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.217 175.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.57 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 63.7 mttm -61.25 -37.0 81.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.281 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.87 70.12 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.056 -0.593 . . . . 0.0 113.092 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.928 -177.778 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.553 HD12 ' OE2' ' A' ' 52' ' ' GLU . 17.5 tp . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.698 0.285 . . . . 0.0 111.701 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -95.5 107.64 19.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.373 0.606 . . . . 0.0 112.086 -177.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.452 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.5 m95 -105.9 132.49 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.755 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -135.21 153.65 78.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 24.9 Cg_exo -59.8 164.38 11.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.006 1.804 . . . . 0.0 111.443 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.553 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 86.4 t80 -48.59 -53.37 36.48 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 18.5 Cg_exo -65.89 -44.08 8.36 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.573 1.515 . . . . 0.0 112.194 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 26.0 tt0 -67.5 -38.72 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.223 -176.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.38 77.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.076 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.17 -41.21 92.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.849 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.49 -38.58 74.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.39 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.483 ' HB3' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -58.43 -47.97 82.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.509 177.029 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -70.62 -43.43 69.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.93 -46.35 85.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.982 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.6 57.32 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -115.94 0.18 12.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.591 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.67 45.64 57.94 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.972 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 83.5 mmt-85 -117.57 177.63 4.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.085 0.469 . . . . 0.0 111.77 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.3 mtp -102.1 152.21 21.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.625 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.99 129.29 62.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.624 0.249 . . . . 0.0 111.316 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 ttp -109.77 104.25 13.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.555 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 24.4 t -81.05 107.33 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.019 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 52.9 t80 -94.97 104.77 16.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.606 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.449 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.3 m-85 -87.62 119.82 28.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.239 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 30.0 p80 -123.41 147.84 46.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.46 176.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.664 ' HG ' ' HB ' ' A' ' 62' ' ' VAL . 14.7 m -136.77 150.64 48.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.013 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.64 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.23 -26.72 52.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.278 0.561 . . . . 0.0 109.849 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -72.73 -16.7 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.053 173.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 56.8 m -124.15 60.69 23.53 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.702 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.65 23.81 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 114.132 -169.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.78 -36.54 78.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.216 0.531 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.593 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 7.2 t -68.22 -18.84 64.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.147 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -52.82 -26.11 13.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.2 -41.31 18.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.735 0.779 . . . . 0.0 109.738 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mmm -63.13 -39.24 94.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.193 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.9 p30 -77.97 -17.74 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.444 -175.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -74.01 -52.21 13.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 0.0 110.493 177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.86 -71.26 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.309 0.576 . . . . 0.0 111.564 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.428 ' O ' HG21 ' A' ' 47' ' ' VAL . 57.6 t -64.93 -54.34 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.675 -167.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 18.2 tp -79.76 -12.68 59.77 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.074 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 m -106.89 -3.09 20.64 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.11 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.9 133.33 38.63 Favored Pre-proline 0 C--O 1.235 0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.214 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.658 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 8.8 Cg_endo -51.87 -46.22 33.56 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.426 2.75 . . . . 0.0 113.106 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.58 93.85 Favored Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.113 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.839 HG22 HD21 ' A' ' 108' ' ' LEU . 57.4 t -61.73 -49.71 83.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.158 0.504 . . . . 0.0 109.795 174.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.513 ' HA ' HD13 ' A' ' 3' ' ' LEU . 35.3 m -56.05 -39.76 72.5 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.003 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 18.7 mtm180 -57.99 -40.76 81.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.075 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.836 HD12 HD22 ' A' ' 108' ' ' LEU . 76.3 mt -63.49 -39.83 95.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.548 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.36 -59.82 2.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.144 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.553 ' OE2' HD12 ' A' ' 3' ' ' LEU . 20.5 mm-40 -44.69 -40.17 5.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -171.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . . . -66.3 -42.41 88.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.01 6.18 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.95 149.8 43.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.281 0.563 . . . . 0.0 111.476 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' A' ' 14' ' ' LEU . 46.6 t -117.07 119.89 63.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 168.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.4 t -86.99 116.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.757 -173.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -90.86 117.11 29.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 p -88.15 102.23 14.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.765 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 8' ' ' TYR . 59.9 t -108.39 123.14 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 110.606 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.645 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.8 p -93.91 110.41 22.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.853 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.664 ' HB ' ' HG ' ' A' ' 28' ' ' SER . 28.0 t -82.83 0.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.318 1.056 . . . . 0.0 109.071 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.64 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -81.43 -33.86 31.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.528 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.625 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 33.4 p -92.63 160.84 33.62 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.625 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 25.6 Cg_endo -56.61 -53.95 4.48 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.3 2.667 . . . . 0.0 114.437 -171.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -37.02 85.7 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.277 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.19 -40.84 70.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.669 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 2.0 mt-30 -59.56 -35.16 73.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.317 0.58 . . . . 0.0 110.611 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.027 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.1 mt -64.38 -32.05 73.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.449 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -68.75 -30.68 69.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.846 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 51.9 mtp180 -71.69 -47.44 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 0.0 109.151 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -64.06 -50.2 69.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.055 -174.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.65 -0.02 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 55.71 81.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.778 0.674 . . . . 0.0 111.126 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -127.88 91.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.846 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -100.03 107.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.499 2.799 . . . . 0.0 111.994 170.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.87 169.19 12.61 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.918 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 80' ' ' PRO . 83.3 m -155.76 139.88 11.56 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 34' ' ' CYS . 64.1 Cg_endo -88.27 132.45 11.49 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.816 -1.327 . . . . 0.0 112.993 0.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 28.5 m -107.69 110.9 22.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.8 175.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 33.1 m-85 -99.87 113.19 25.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 95.0 t -102.95 115.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.542 ' CD2' HG11 ' A' ' 114' ' ' VAL . 90.5 m-85 -94.11 113.82 25.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.781 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 24.4 mt -111.54 128.13 55.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.183 0.516 . . . . 0.0 110.619 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.14 125.17 32.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.792 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.03 117.58 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.707 1.605 . . . . 0.0 110.814 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.789 ' HE2' ' HB2' ' A' ' 93' ' ' GLU . 65.2 pttt -133.83 128.55 34.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.06 -75.72 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.191 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.76 19.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.171 -0.537 . . . . 0.0 111.816 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.23 165.21 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -94.86 139.71 30.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.299 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.789 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 9.6 tp10 -117.49 136.0 53.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.554 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 34.8 tt0 -89.82 96.58 10.75 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -83.99 -4.67 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.323 -170.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.76 162.16 11.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.946 177.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 82' ' ' PHE . 87.3 mtt180 -127.57 136.74 52.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.38 150.97 37.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.799 0.333 . . . . 0.0 110.844 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -118.02 114.46 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.454 ' HA3' ' HG2' ' A' ' 80' ' ' PRO . . . -79.79 89.03 1.25 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.306 -172.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 p -135.7 -23.72 1.38 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.149 0.499 . . . . 0.0 110.547 175.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -70.03 155.54 93.29 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.691 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.8 167.08 9.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.669 2.246 . . . . 0.0 111.924 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -55.07 -38.01 67.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.512 -175.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -57.99 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.984 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.498 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 27.9 tt0 -75.08 -29.5 60.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.349 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.99 -47.88 84.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.873 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.839 HD21 HG22 ' A' ' 47' ' ' VAL . 47.1 mt -69.46 -27.12 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.238 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 106' ' ' GLU . 29.3 ttpp -61.2 -49.98 74.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 114' ' ' VAL . 5.8 mm-40 -68.03 -39.95 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.349 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.48 -40.65 92.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.046 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.23 -39.28 89.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.352 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -66.04 -28.67 69.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.542 HG11 ' CD2' ' A' ' 84' ' ' PHE . 97.8 t -69.95 -39.38 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.1 m -59.06 -41.0 86.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.172 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.74 -43.99 99.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.392 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -75.2 -7.41 53.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.52 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.99 -39.17 24.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.82 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.401 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 m -87.27 -75.16 0.41 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 51' ' ' LEU . 46.0 tp -75.1 150.06 38.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.071 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.657 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 1.9 mmt180 -90.66 104.31 16.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.52 0.2 . . . . 0.0 111.382 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -106.77 103.87 13.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.657 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.3 m-85 -111.28 166.67 10.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.443 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 17.4 Cg_exo -64.92 160.1 42.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.895 1.73 . . . . 0.0 110.836 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.541 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -49.2 -50.67 62.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.9 Cg_exo -58.55 -46.28 25.0 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 121.886 1.724 . . . . 0.0 112.685 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -67.47 -44.28 78.98 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.535 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HA ' HG13 ' A' ' 56' ' ' VAL . . . -55.42 -41.75 73.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.396 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.72 -36.12 75.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.744 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.79 60.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.576 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.6 tp -60.26 -43.81 95.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.996 0.426 . . . . 0.0 109.879 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.82 -46.94 82.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.896 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -65.93 -43.22 88.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.599 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.0 54.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -119.04 6.38 11.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.633 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.12 46.11 95.19 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.296 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.7 mmp_? -110.78 -173.74 2.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.836 0.35 . . . . 0.0 110.671 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.46 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 81.6 mtp -113.77 155.59 25.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 43.6 t -106.73 127.43 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.016 0.436 . . . . 0.0 111.585 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.4 ttt -109.42 103.69 12.65 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.508 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 31.7 t -85.75 108.87 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 82.6 t80 -104.28 103.18 12.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.526 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.884 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.0 m-85 -84.19 122.21 28.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.57 ' HE1' ' OG ' ' A' ' 61' ' ' SER . 8.3 p80 -132.37 145.89 51.57 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.6 0.562 . . . . 0.0 111.785 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.442 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 66.9 m -142.24 153.04 43.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.544 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -13.65 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.42 0.629 . . . . 0.0 109.828 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -82.89 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.603 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.06 83.01 37.51 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.63 26.3 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.043 2.495 . . . . 0.0 113.909 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -83.69 -23.52 31.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.177 0.513 . . . . 0.0 110.599 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 43.9 t -83.16 -30.85 27.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -55.93 -29.84 60.72 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -170.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.03 -46.59 67.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 110.724 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 42' ' ' LEU . 13.9 tmm? -79.46 -44.41 21.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.672 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 7.5 t30 -53.82 -45.98 70.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.781 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.3 m -60.54 -54.87 40.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.85 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -91.78 -69.39 0.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.558 0.694 . . . . 0.0 111.708 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.53 HG11 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -59.6 -44.57 93.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.829 -169.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HB2' ' SD ' ' A' ' 37' ' ' MET . 26.6 tp -79.09 -27.0 42.94 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.242 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 m -88.97 -2.33 58.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -47.79 128.76 11.31 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.546 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.1 -33.53 95.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.072 2.515 . . . . 0.0 112.686 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.23 -48.24 53.8 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.662 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.536 HG23 HD21 ' A' ' 108' ' ' LEU . 99.8 t -59.77 -53.51 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.12 0.486 . . . . 0.0 110.48 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -56.24 -32.21 64.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.625 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -67.11 -34.25 77.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.601 0.239 . . . . 0.0 111.066 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.565 HD11 HD22 ' A' ' 108' ' ' LEU . 53.8 mt -68.85 -37.37 79.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.713 175.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' HB3' HD11 ' A' ' 3' ' ' LEU . 3.0 mm? -67.74 -48.76 65.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.706 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' OE2' ' HA ' ' A' ' 3' ' ' LEU . 21.1 mm-40 -53.79 -32.32 52.06 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.972 0.415 . . . . 0.0 111.87 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.487 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -61.45 -54.6 41.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.495 HH12 HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -136.88 4.47 2.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.431 ' HE2' ' HE ' ' A' ' 54' ' ' ARG . 59.6 m-85 -112.3 149.96 31.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' A' ' 11' ' ' ALA . 47.1 t -115.39 115.98 51.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.775 167.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 29.8 t -89.05 129.03 40.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.871 -173.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -99.45 117.14 33.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.372 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -93.05 101.35 13.67 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.511 HG13 HD13 ' A' ' 70' ' ' LEU . 42.6 t -114.22 133.3 60.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.046 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.57 ' OG ' ' HE1' ' A' ' 27' ' ' HIS . 18.8 m -95.16 117.67 30.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.442 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 41.4 t -71.61 -23.57 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.074 0.464 . . . . 0.0 111.484 -174.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.38 -19.21 43.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.689 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.578 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.8 p -95.85 161.22 28.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -49.73 -49.96 14.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.765 2.977 . . . . 0.0 114.537 -168.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -60.41 -44.04 96.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -69.27 -39.24 82.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.695 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.659 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 55.1 mt-30 -57.67 -40.35 79.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.75 -45.56 74.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.511 HD13 HG13 ' A' ' 60' ' ' VAL . 78.9 mt -66.4 -29.47 69.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.485 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -68.81 -29.22 67.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.659 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 62.7 mtm180 -75.9 -45.7 33.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.478 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -65.5 -56.56 11.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.727 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -91.27 -12.51 34.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 71' ' ' ALA . 74.7 mtt180 62.28 87.21 0.1 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.678 0.751 . . . . 0.0 110.131 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG12 HG23 ' A' ' 81' ' ' THR . 56.1 t -128.1 137.96 31.95 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.529 -171.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.499 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 60.0 Cg_endo -74.29 -138.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.902 2.401 . . . . 0.0 111.361 170.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.499 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -91.31 -104.76 1.37 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.169 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.587 ' CG2' ' HA ' ' A' ' 80' ' ' PRO . 1.2 m -145.1 147.57 35.01 Favored Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.885 -0.185 . . . . 0.0 110.576 -169.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.622 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 36.7 Cg_endo -90.09 131.72 8.91 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.113 -1.203 . . . . 0.0 112.83 -1.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.884 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 22.5 m -114.51 108.22 16.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.484 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 23.8 m-85 -103.06 112.53 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.45 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.508 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -112.46 120.71 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.34 118.85 36.9 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.803 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 33.4 mt -114.86 132.58 56.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.704 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 40.2 t -109.73 127.56 26.92 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.414 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.415 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.2 Cg_endo -80.56 117.57 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.469 2.113 . . . . 0.0 110.383 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -142.58 124.53 15.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.426 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.46 -77.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.147 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.86 27.25 0.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.33 161.0 39.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 110.675 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.415 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 83.0 m95 -102.55 132.7 48.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.954 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 39.3 tt0 -117.87 120.51 38.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.509 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HA ' HD21 ' A' ' 85' ' ' LEU . 34.3 tt0 -84.34 115.0 22.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.723 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 32.8 m -100.76 8.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.32 166.6 11.03 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.239 -0.982 . . . . 0.0 112.888 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.47 ' HG2' HG23 ' A' ' 83' ' ' VAL . 92.5 mtt180 -133.78 135.74 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' A' ' 110' ' ' GLU . 69.1 mt -108.88 127.06 53.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.079 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -137.38 143.99 42.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.3 12.65 26.61 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.26 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.432 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 49.2 m 69.64 -73.29 0.09 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.109 0.564 . . . . 0.0 111.642 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 68.14 156.69 0.14 Allowed Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 123.316 0.646 . . . . 0.0 111.284 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.23 159.15 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.178 1.919 . . . . 0.0 110.557 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.53 ' HB3' HG11 ' A' ' 41' ' ' VAL . 32.1 ptt180 -59.89 -25.48 65.13 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.66 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -54.34 -53.82 48.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.734 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.576 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 22.2 mm-40 -72.81 -34.44 66.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 40.2 t80 -65.02 -43.6 91.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 50' ' ' LEU . 88.8 mt -69.83 -30.73 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.576 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.6 mttt -55.93 -53.56 55.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.494 ' HB3' HD12 ' A' ' 98' ' ' LEU . 9.5 tp10 -70.72 -38.03 73.55 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.557 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -60.09 -33.93 72.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.376 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 115' ' ' CYS . 7.7 tpt180 -80.25 -38.25 31.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.449 ' HG2' ' HE3' ' A' ' 117' ' ' LYS . 7.3 tt0 -62.9 -46.31 88.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.675 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.603 HG11 HG22 ' A' ' 95' ' ' VAL . 91.5 t -60.22 -37.05 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.5 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 112' ' ' ARG . 52.4 t -54.02 -36.7 63.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.32 -38.29 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.289 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.723 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 96.7 mttt -53.58 -28.59 32.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.22 -34.35 24.92 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.138 -0.554 . . . . 0.0 112.684 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -119.15 -15.46 5.59 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.338 177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.56 -15.17 25.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 34.6 t -72.46 127.9 33.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.86 0.3 19.69 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 124' ' ' GLY . 10.8 tp10 -73.17 165.16 25.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.157 -0.521 . . . . 0.0 109.768 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.422 ' H ' ' CD ' ' A' ' 123' ' ' GLU . . . 143.83 -3.05 1.5 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -169.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -68.92 -47.5 65.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -86.27 91.83 8.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.796 172.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -65.79 147.8 52.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.21 -174.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.5 ' HD1' ' C ' ' A' ' 130' ' ' HIS . 4.3 p80 -144.51 139.34 28.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.39 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -93.08 6.66 47.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.416 0.627 . . . . 0.0 109.913 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.5 ' C ' ' HD1' ' A' ' 128' ' ' HIS . 2.6 m170 . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.546 173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.1 tpp . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -145.48 41.96 1.25 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.715 HD23 HG23 ' A' ' 57' ' ' VAL . 22.2 tp -132.79 153.29 51.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.261 -169.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.611 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.3 mmt180 -88.44 104.52 16.87 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.984 0.421 . . . . 0.0 111.201 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -99.94 113.44 26.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.009 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.8 m-85 -122.93 160.48 49.15 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 20.4 Cg_exo -62.97 158.7 41.94 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.957 1.771 . . . . 0.0 111.343 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.564 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.7 t80 -47.1 -51.3 41.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 37.6 Cg_exo -60.79 -43.39 31.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.793 1.662 . . . . 0.0 112.266 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -68.49 -45.19 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 -177.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -54.71 -43.21 72.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.8 mp -66.97 -39.4 87.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.647 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.0 -44.19 66.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.214 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 56' ' ' VAL . 14.4 tp -59.06 -51.33 70.51 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.67 96.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.15 -41.46 99.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.474 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.1 -15.47 50.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.918 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -113.51 -0.55 14.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.09 37.84 95.6 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.158 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.739 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 2.1 mmp_? -107.15 -179.68 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.277 0.231 . . . . 0.0 110.47 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.646 ' HG3' HG21 ' A' ' 86' ' ' VAL . 41.2 ttm -102.12 156.08 17.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.8 t -105.79 122.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.798 0.333 . . . . 0.0 110.702 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.8 ttt -100.38 103.58 14.97 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 48.9 t -86.97 105.64 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.533 ' HE1' ' CE1' ' A' ' 82' ' ' PHE . 84.2 t80 -104.9 108.82 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.949 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 69.4 m-85 -81.02 111.25 17.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.579 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.512 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 22.4 p80 -119.76 156.41 30.64 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.949 0.781 . . . . 0.0 109.713 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.593 ' HA ' ' OD1' ' A' ' 63' ' ' ASP . 40.8 t -144.11 160.04 41.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HG3' ' OD2' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -89.16 -6.28 57.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.81 0.814 . . . . 0.0 108.927 169.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -103.24 10.68 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.485 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.593 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 20.2 p -69.12 154.63 94.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.7 -90.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.004 1.802 . . . . 0.0 113.482 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -79.59 -17.24 54.33 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.933 0.396 . . . . 0.0 111.434 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 8.1 t -56.42 -25.76 51.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.365 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -50.81 -41.63 57.49 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 111.108 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.3 -39.35 25.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 110.447 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.501 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 81.6 mtp -68.58 -48.46 64.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.62 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -63.33 -48.07 79.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.985 0.422 . . . . 0.0 111.053 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 43' ' ' SER . 10.6 m -72.68 -54.31 9.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.863 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -92.3 -68.34 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.996 0.427 . . . . 0.0 112.107 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 104' ' ' ARG . 95.8 t -51.66 -52.23 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -81.68 -16.33 51.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.4 m -93.59 -0.93 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.73 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -52.57 134.13 44.77 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.931 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.93 -39.57 85.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.024 2.483 . . . . 0.0 113.228 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.23 -41.1 54.28 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.67 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.759 HG23 HD22 ' A' ' 108' ' ' LEU . 29.0 t -63.56 -46.82 93.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -53.92 -44.24 70.42 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.92 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -62.67 -26.12 68.48 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -70.31 -45.12 66.87 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.659 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 1.6 mm? -71.78 -43.73 65.21 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.739 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.13 -32.1 9.41 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -79.31 -48.7 13.64 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.739 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -136.11 19.06 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 51' ' ' LEU . 77.8 m-85 -129.28 145.29 51.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 0.0 111.43 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 14' ' ' LEU . 47.3 t -116.3 120.5 65.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.715 HG23 HD23 ' A' ' 3' ' ' LEU . 35.5 t -91.89 123.36 43.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.15 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -92.31 117.44 29.9 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.235 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 p -80.81 101.6 9.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG23 HG11 ' A' ' 24' ' ' VAL . 58.7 t -110.05 119.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.165 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.56 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.9 OUTLIER -103.1 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -66.39 -15.4 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.724 0.773 . . . . 0.0 110.166 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.593 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 1.6 m-20 -71.58 -32.69 68.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.666 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -108.71 167.02 9.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.087 -173.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.7 Cg_endo -51.03 -48.33 21.55 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 124.174 3.249 . . . . 0.0 114.493 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.39 -35.57 80.86 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.912 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.3 -40.05 29.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.352 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -58.26 -35.57 71.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.437 0.637 . . . . 0.0 110.542 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.66 -51.18 61.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.439 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 9.3 mp -64.04 -33.71 76.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.956 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -63.42 -38.94 93.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.274 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.619 ' HA ' HH21 ' A' ' 75' ' ' ARG . 25.1 ptt180 -79.06 -34.81 43.39 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.23 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -68.97 -56.06 8.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.6 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.498 ' HE1' ' HG ' ' A' ' 70' ' ' LEU . 92.0 m-85 -85.89 -6.66 59.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.981 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.667 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 1.5 mmp_? 63.08 79.1 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.847 0.832 . . . . 0.0 110.127 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 71' ' ' ALA . 94.5 t -125.98 135.71 27.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.996 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.492 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 23.0 Cg_exo -65.56 -90.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.752 2.301 . . . . 0.0 112.067 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.492 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -143.14 -75.31 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.895 172.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -156.54 148.25 17.15 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.672 -0.311 . . . . 0.0 111.37 -170.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HA ' HG23 ' A' ' 79' ' ' THR . 5.1 Cg_endo -88.83 137.75 14.49 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.432 -1.07 . . . . 0.0 111.477 -3.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.949 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 6.3 m -122.71 123.93 42.23 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.924 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.685 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.7 m-85 -114.16 114.31 25.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.869 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -123.48 112.78 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.929 0.395 . . . . 0.0 110.316 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.81 120.43 39.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 35.4 mt -117.16 129.33 55.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.462 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.646 HG21 ' HG3' ' A' ' 21' ' ' MET . 21.6 t -108.61 122.87 38.92 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.203 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.3 118.07 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.188 1.925 . . . . 0.0 110.888 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.495 ' HZ1' ' CD ' ' A' ' 93' ' ' GLU . 13.7 ptmt -154.44 140.76 18.64 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.579 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.48 -76.13 0.06 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.084 0.865 . . . . 0.0 111.291 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.6 26.06 0.12 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.64 176.58 12.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 0.0 110.481 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -106.28 130.43 54.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.216 0.532 . . . . 0.0 110.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.495 ' CD ' ' HZ1' ' A' ' 88' ' ' LYS . 37.2 tt0 -101.47 112.29 24.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.853 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.647 ' CD ' ' HD2' ' A' ' 97' ' ' ARG . 33.2 tt0 -75.29 95.8 3.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.28 -14.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.532 -168.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -156.04 123.67 1.36 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.547 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.647 ' HD2' ' CD ' ' A' ' 94' ' ' GLU . 27.3 mtp180 -130.42 126.14 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.809 HD11 ' HG2' ' A' ' 110' ' ' GLU . 42.9 mt -136.03 135.57 39.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.785 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.01 143.2 40.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.19 -86.0 0.28 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.949 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.7 p 179.95 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.319 0.248 . . . . 0.0 111.056 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.685 ' HB3' ' HB3' ' A' ' 106' ' ' GLU . 54.0 mtm180 66.65 119.13 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 123.726 0.811 . . . . 0.0 110.495 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.69 171.05 3.84 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.198 2.599 . . . . 0.0 112.932 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.504 ' HB2' HG11 ' A' ' 41' ' ' VAL . 54.8 ttp180 -46.66 -41.41 14.8 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.828 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.76 86.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.016 0.436 . . . . 0.0 111.808 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.685 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 12.1 tp10 -80.77 -37.48 30.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.64 -37.28 87.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.103 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.759 HD22 HG23 ' A' ' 47' ' ' VAL . 42.6 mt -63.6 -44.78 92.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.286 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.48 ' HZ2' ' CD ' ' A' ' 106' ' ' GLU . 33.9 mtmm -61.17 -44.2 97.67 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.715 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.809 ' HG2' HD11 ' A' ' 98' ' ' LEU . 13.5 tp10 -59.05 -50.56 73.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.418 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -59.44 -34.59 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.614 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -60.54 -43.25 97.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.463 174.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -72.52 -38.74 67.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 110' ' ' GLU . 91.1 t -56.48 -38.77 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.805 0.335 . . . . 0.0 110.665 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.0 m -56.68 -35.01 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.3 t -84.66 -50.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -55.81 -40.76 73.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.932 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.509 ' CA ' HG23 ' A' ' 86' ' ' VAL . . . -66.54 -24.3 72.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.751 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -95.61 -56.88 1.22 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.101 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.29 114.76 18.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.893 0.378 . . . . 0.0 110.738 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.5 t -143.88 -55.72 0.37 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.447 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -119.51 49.47 0.87 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.224 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -90.13 -37.76 13.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.167 0.508 . . . . 0.0 110.311 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.42 25.81 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.597 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -46.96 -36.74 8.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.443 0.297 . . . . 0.0 111.747 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -163.34 66.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.721 0.772 . . . . 0.0 110.214 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -159.45 102.31 1.55 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.121 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -80.68 85.18 6.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.875 0.369 . . . . 0.0 110.539 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.4 ' O ' ' HB3' ' A' ' 130' ' ' HIS . 5.4 p80 -74.17 100.97 3.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.671 174.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' A' ' 129' ' ' HIS . 41.8 t-80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 117.825 -1.083 . . . . 0.0 109.607 -172.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.399 0.142 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -66.32 -42.48 88.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.111 0.481 . . . . 0.0 110.509 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.728 HD23 HG21 ' A' ' 57' ' ' VAL . 53.8 tp -64.59 150.83 46.18 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.88 177.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -82.28 104.88 12.91 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.273 0.559 . . . . 0.0 112.196 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.525 ' HZ2' ' HG ' ' A' ' 42' ' ' LEU . 43.0 m95 -107.9 131.37 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.669 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 89.8 m-85 -132.84 155.03 81.61 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 25.2 Cg_exo -58.09 160.85 14.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.003 1.802 . . . . 0.0 111.245 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.564 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 88.4 t80 -45.61 -53.95 17.47 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 19.7 Cg_exo -66.24 -42.19 11.02 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.668 1.579 . . . . 0.0 112.205 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.429 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 38.8 tt0 -69.4 -42.73 74.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.065 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.24 94.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.204 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 8' ' ' TYR . 9.1 mp -63.01 -35.82 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.77 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.6 69.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 110.203 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.51 ' HB3' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -60.12 -50.51 73.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.396 176.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -43.8 93.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.199 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -57.63 -52.15 66.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.493 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.96 59.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.756 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -115.91 2.9 13.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.499 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.3 44.58 96.42 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.626 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -108.7 -179.42 3.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.694 0.283 . . . . 0.0 110.919 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.673 ' HE2' HG22 ' A' ' 86' ' ' VAL . 87.3 mtp -100.92 158.48 15.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.2 125.84 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.008 0.432 . . . . 0.0 111.106 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.0 ttt -103.6 102.65 12.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 61.3 t -89.93 106.26 16.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.095 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.798 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 45.1 t80 -104.95 123.18 47.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.306 0.574 . . . . 0.0 111.36 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.903 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 67.1 m-85 -94.18 126.18 39.26 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.217 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.798 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 34.5 p80 -130.96 157.44 42.96 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.971 0.794 . . . . 0.0 110.679 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 79' ' ' THR . 30.3 t -143.01 159.12 42.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.565 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -6.6 58.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.42 0.629 . . . . 0.0 110.121 173.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -103.38 19.68 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.375 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.691 ' HB3' ' CG2' ' A' ' 79' ' ' THR . 26.9 p -74.68 131.32 79.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.567 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.11 -92.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.466 2.111 . . . . 0.0 114.031 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -74.43 -17.14 60.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.071 0.463 . . . . 0.0 111.433 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.4 t -58.49 -23.46 57.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.038 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -49.29 -47.81 46.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.218 0.532 . . . . 0.0 111.714 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.749 ' HA ' HE21 ' A' ' 36' ' ' GLN . 0.0 OUTLIER -75.26 -31.7 60.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -176.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.44 ' SD ' ' HA ' ' A' ' 101' ' ' SER . 83.5 mtp -67.11 -49.8 63.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.47 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 58.5 m-20 -64.55 -37.07 86.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.315 -174.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 m -64.77 -61.29 2.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.375 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.32 -70.6 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 104' ' ' ARG . 60.3 t -57.9 -44.64 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -170.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 15.1 tp -81.57 -11.1 59.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 -173.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -112.62 3.34 16.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.066 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.83 131.81 57.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.561 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -58.29 -28.57 84.98 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.933 2.422 . . . . 0.0 112.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.48 14.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.601 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.656 HG21 HD21 ' A' ' 108' ' ' LEU . 84.4 t -58.23 -53.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.161 0.505 . . . . 0.0 110.102 174.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.504 ' HA ' HD12 ' A' ' 3' ' ' LEU . 32.5 m -54.36 -38.29 65.92 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.234 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -60.86 -32.08 71.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.788 0.328 . . . . 0.0 111.387 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 108' ' ' LEU . 69.0 mt -71.83 -42.1 67.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.741 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -70.74 -53.19 16.47 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.195 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.555 ' OE2' HD11 ' A' ' 3' ' ' LEU . 32.9 mm-40 -45.33 -38.19 5.53 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.595 ' HB2' HH11 ' A' ' 54' ' ' ARG . . . -64.68 -51.51 62.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.595 HH11 ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.58 14.61 3.43 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -173.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -125.29 150.86 46.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.498 . . . . 0.0 111.251 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.51 HG13 ' HB3' ' A' ' 14' ' ' LEU . 61.0 t -119.02 122.06 68.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.728 HG21 HD23 ' A' ' 3' ' ' LEU . 33.1 t -89.11 124.31 41.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.994 -173.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.96 117.58 31.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.482 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -83.99 101.64 11.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.62 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.71 114.46 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 110.196 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.609 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -89.17 107.62 19.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.308 -178.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.463 HG11 ' HA2' ' A' ' 78' ' ' GLY . 44.3 t -80.7 -7.79 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 122.697 1.237 . . . . 0.0 107.694 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -33.78 76.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.826 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -124.64 167.14 16.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.204 -174.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -50.62 -50.77 12.69 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.312 3.341 . . . . 0.0 114.76 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -44.1 84.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.0 111.462 -174.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.61 -27.44 59.08 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.806 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -63.89 -37.69 88.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.7 -51.36 70.26 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.289 0.566 . . . . 0.0 109.874 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 4.0 mm? -56.91 -43.64 81.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.019 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.78 -54.68 44.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 72' ' ' ARG . 21.5 ptt85 -68.73 -23.36 64.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.102 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -72.64 -36.54 68.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.715 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -106.2 8.51 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.376 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 62.07 36.98 15.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.913 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.0 t -93.48 133.67 27.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.504 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 29.3 Cg_exo -61.56 -83.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.61 2.207 . . . . 0.0 111.552 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' HA2' HG11 ' A' ' 62' ' ' VAL . . . -145.5 -52.76 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.807 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.691 ' CG2' ' HB3' ' A' ' 31' ' ' CYS . 3.6 t 175.57 158.09 0.39 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.684 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 2.4 Cg_endo -79.75 126.61 13.21 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.29 0.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.903 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 29.3 m -129.77 119.67 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.115 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.16 110.72 20.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 60.8 t -113.99 114.21 46.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.862 0.363 . . . . 0.0 110.056 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.6 117.55 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.857 0.361 . . . . 0.0 110.754 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 26.5 mt -110.73 136.56 49.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.21 0.529 . . . . 0.0 111.303 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.673 HG22 ' HE2' ' A' ' 21' ' ' MET . 49.0 t -109.94 120.07 45.73 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 52.2 Cg_endo -74.95 117.49 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.72 1.614 . . . . 0.0 110.938 173.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.407 ' HE3' ' CB ' ' A' ' 93' ' ' GLU . 20.7 pttp -141.58 132.63 26.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.517 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.01 -76.8 0.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.008 0.818 . . . . 0.0 111.262 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.58 24.77 0.19 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -146.25 152.5 39.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.7 0.286 . . . . 0.0 110.695 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.479 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 32.8 m95 -92.95 120.77 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 7.6 tp10 -102.21 139.88 37.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.888 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.66 104.78 17.33 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.531 HG22 ' HD3' ' A' ' 117' ' ' LYS . 4.3 p -97.19 6.39 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 -172.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.85 134.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.488 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -122.84 135.88 54.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 110.441 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.48 136.77 52.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.737 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -137.13 136.67 38.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.856 0.36 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.14 -174.71 18.53 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.86 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.44 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.5 m -92.43 127.13 37.81 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.976 0.417 . . . . 0.0 110.566 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -127.87 137.61 31.15 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.88 157.18 58.01 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.911 1.741 . . . . 0.0 110.016 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB2' HG13 ' A' ' 41' ' ' VAL . 46.4 ttp180 -58.0 -26.82 62.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.89 -50.78 67.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.582 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -69.02 -42.67 76.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.979 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.18 -50.39 74.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 50' ' ' LEU . 56.8 mt -72.23 -19.16 61.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.512 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -73.16 -49.9 25.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.409 0.623 . . . . 0.0 109.946 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.448 ' O ' HG21 ' A' ' 114' ' ' VAL . 50.4 mt-10 -72.76 -35.33 67.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.213 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.54 -32.73 74.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.089 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -59.68 -47.29 86.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -56.31 -45.16 80.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.532 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.483 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 95.6 t -62.4 -45.58 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.922 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.434 ' HB2' HH21 ' A' ' 54' ' ' ARG . 21.0 p -67.12 -22.25 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 111.044 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 112' ' ' ARG . 80.3 t -79.23 -37.7 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 109.918 174.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.531 ' HD3' HG22 ' A' ' 95' ' ' VAL . 83.5 mttt -61.57 -27.49 68.67 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.635 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.462 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -65.0 -32.9 85.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.337 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.6 -41.21 4.51 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.078 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.27 37.36 1.26 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.911 0.386 . . . . 0.0 110.821 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.8 t -69.86 -24.24 63.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.52 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -167.28 119.37 0.84 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.099 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -123.81 -167.85 1.69 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 126.36 -16.56 6.67 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -92.87 7.06 45.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.402 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -113.04 96.04 5.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.062 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.23 132.26 18.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.801 0.334 . . . . 0.0 111.576 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -130.89 -41.91 1.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -108.19 147.47 31.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.937 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.347 -0.835 . . . . 0.0 108.75 171.186 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 tpt . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.295 0.569 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.5 m -155.22 62.69 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.445 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.2 tp -54.49 135.15 46.09 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.977 -174.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.627 ' NE ' ' HA ' ' A' ' 4' ' ' ARG . 3.1 mmp_? -109.05 123.1 48.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.246 -171.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -115.56 115.98 27.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.588 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 86.2 m-85 -133.69 160.88 66.86 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 31.7 Cg_exo -58.55 166.47 6.26 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.406 2.071 . . . . 0.0 111.483 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CD1' HD21 ' A' ' 70' ' ' LEU . 61.8 t80 -51.58 -51.43 69.76 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.5 Cg_exo -62.12 -45.69 15.11 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.866 1.71 . . . . 0.0 112.233 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.47 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 80.2 tt0 -67.09 -40.2 86.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.929 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.81 94.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.225 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.42 HD22 HG23 ' A' ' 22' ' ' VAL . 2.8 mt -63.25 -35.75 81.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.832 0.348 . . . . 0.0 110.332 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.73 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.229 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.2 tp -64.31 -44.6 91.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.612 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.75 -42.28 95.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.697 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.25 -44.74 90.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.54 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.76 -14.67 56.14 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -119.14 1.78 11.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.93 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.59 44.32 97.72 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.242 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.612 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 12.5 mmm180 -107.96 -178.04 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 111.342 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.589 ' HE2' HG21 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -101.22 165.06 11.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.546 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 84.1 t -122.53 133.6 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.737 0.303 . . . . 0.0 111.189 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 23' ' ' MET . 20.1 ptm -126.79 113.58 16.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.182 0.515 . . . . 0.0 109.645 170.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.534 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 46.5 t -87.22 109.62 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' HH ' ' HB2' ' A' ' 38' ' ' ASN . 88.6 t80 -97.49 103.6 15.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.378 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.944 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 77.0 m-85 -82.27 119.33 23.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.604 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 61' ' ' SER . 28.5 p80 -133.02 146.24 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.21 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 47.4 t -134.14 164.84 26.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 -17.87 30.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.114 0.483 . . . . 0.0 110.22 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.49 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 76.9 m-70 -89.56 -16.76 29.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.768 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.856 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 63.9 m -108.84 84.9 2.78 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.332 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.7 Cg_endo -92.08 -0.84 4.22 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.002 2.468 . . . . 0.0 114.896 -169.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -74.58 -21.7 59.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.837 -0.539 . . . . 0.0 111.409 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 17.5 p -72.52 -30.83 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 3.2 pt20 -67.9 -27.14 66.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.651 0.262 . . . . 0.0 110.97 -176.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.69 -50.49 66.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.638 ' HG3' ' HB3' ' A' ' 101' ' ' SER . 11.3 tmm? -67.95 -42.41 80.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.842 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.521 ' HB2' ' HH ' ' A' ' 25' ' ' TYR . 6.7 t30 -54.67 -47.2 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.504 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 m -61.59 -51.76 67.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.98 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.01 -70.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.258 0.551 . . . . 0.0 112.055 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.614 ' HB ' ' SD ' ' A' ' 37' ' ' MET . 96.9 t -63.37 -41.35 92.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.533 -168.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.3 tp -80.86 -30.61 35.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.2 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 m -87.6 -1.56 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.68 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.01 131.16 8.98 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.049 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.52 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 54.4 Cg_exo -52.99 -38.02 79.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.047 2.498 . . . . 0.0 113.305 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.7 -43.59 35.2 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.069 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.94 -51.09 73.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.436 0.636 . . . . 0.0 109.923 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.2 m -53.8 -39.21 65.27 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.128 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 17.7 mtp180 -60.61 -29.2 69.08 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.78 -39.11 67.0 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.599 174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.44 -43.62 72.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.584 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.23 -34.53 64.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.85 0.46 . . . . 0.0 111.327 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -54.22 47.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.205 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -11.39 2.07 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -90.48 151.63 21.29 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.9 t -115.41 122.73 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 163.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.414 HG22 ' SD ' ' A' ' 23' ' ' MET . 16.1 t -87.45 125.29 41.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.035 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -96.91 117.1 30.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.862 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.8 p -91.42 100.53 13.29 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.466 HG22 HG12 ' A' ' 24' ' ' VAL . 96.4 t -109.04 119.25 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.13 0.49 . . . . 0.0 110.985 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.618 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -96.53 119.56 35.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.467 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 16.4 t -81.24 66.31 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.876 0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.618 ' OD1' ' HB2' ' A' ' 61' ' ' SER . 3.1 p-10 -163.21 -33.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -94.9 164.02 20.6 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.454 175.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.6 Cg_endo -51.5 -55.03 4.37 Favored 'Trans proline' 0 N--CA 1.477 0.54 0 C-N-CA 123.497 2.798 . . . . 0.0 113.996 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.428 ' O ' HD11 ' A' ' 70' ' ' LEU . 10.7 pt-20 -57.68 -41.48 81.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.177 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.05 -34.23 64.96 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.642 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -68.79 -42.79 76.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.334 -0.433 . . . . 0.0 111.474 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.74 -33.82 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.883 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.611 HD21 ' CD1' ' A' ' 8' ' ' TYR . 5.5 mp -62.92 -36.06 82.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.435 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -65.14 -31.96 73.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.486 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -68.89 -41.82 77.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.481 0.658 . . . . 0.0 109.997 173.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -71.32 -57.38 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.601 ' HE1' ' HG ' ' A' ' 70' ' ' LEU . 96.9 m-85 -82.9 -18.44 40.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.022 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 74' ' ' TYR . 10.5 ptp180 44.85 73.19 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.357 1.035 . . . . 0.0 112.114 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.463 HG12 ' CG2' ' A' ' 81' ' ' THR . 35.0 t -135.92 100.65 10.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.636 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.6 130.11 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.991 2.461 . . . . 0.0 111.995 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' A' ' 99' ' ' PHE . . . 151.01 -77.41 0.23 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.44 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.856 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.2 m 71.62 138.94 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.919 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.693 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 51.5 Cg_endo -71.72 143.88 78.16 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 123.666 -1.389 . . . . 0.0 113.191 0.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.944 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 27.6 m -120.49 122.29 40.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.894 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.56 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 4.3 m-85 -114.35 110.95 20.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 74' ' ' TYR . 66.0 t -115.38 111.32 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.513 ' HB2' HG11 ' A' ' 95' ' ' VAL . 51.5 m-85 -93.1 135.83 33.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.473 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 37.2 mt -125.26 132.71 52.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.866 0.365 . . . . 0.0 110.184 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.589 HG21 ' HE2' ' A' ' 21' ' ' MET . 16.0 t -109.01 121.41 43.0 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.736 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.4 116.76 4.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.331 1.354 . . . . 0.0 110.124 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -137.19 126.73 25.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.642 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.72 -71.55 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.156 0.91 . . . . 0.0 111.024 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.13 23.81 0.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.027 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.96 157.1 44.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.673 0.273 . . . . 0.0 110.903 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -93.07 124.31 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.698 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -109.05 118.53 37.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.342 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 35.6 tt0 -69.78 98.93 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.634 0.731 . . . . 0.0 109.413 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 84' ' ' PHE . 1.8 p -80.05 -28.21 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.036 -170.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.18 152.02 10.76 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.388 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -120.05 127.33 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 85.9 mt -111.53 137.06 49.86 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CE1' ' HA3' ' A' ' 78' ' ' GLY . 91.0 t80 -137.87 143.09 40.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.84 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.75 23.92 59.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.745 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.638 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 43.1 m 68.15 174.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.422 ' O ' HG11 ' A' ' 41' ' ' VAL . 4.9 mmt180 -148.61 148.73 29.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 172.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.58 149.77 88.31 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 N-CA-C 108.626 -1.336 . . . . 0.0 108.626 164.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.635 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 10.9 ptt180 -59.8 -29.53 68.29 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.576 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.73 88.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.611 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 2.0 mt-10 -80.92 -35.44 32.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.342 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.38 -37.18 86.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 91.2 mt -62.77 -43.2 99.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.044 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.609 ' HD3' ' HA ' ' A' ' 106' ' ' GLU . 8.2 mtpm? -52.59 -56.57 14.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 175.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 3.7 mm-40 -61.23 -40.78 95.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.55 -20.9 66.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.345 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.4 mmt180 -78.54 -45.34 22.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.72 -38.4 78.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.383 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.488 HG11 HG12 ' A' ' 95' ' ' VAL . 78.7 t -74.66 -38.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.526 ' SG ' ' HA ' ' A' ' 112' ' ' ARG . 24.6 p -65.53 -31.77 73.0 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.506 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.2 t -71.26 -43.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.165 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.539 ' HA ' ' HB3' ' A' ' 121' ' ' CYS . 30.6 mtpt -68.92 -11.5 60.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 111.841 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.499 ' HA2' HG13 ' A' ' 86' ' ' VAL . . . -71.73 -33.48 63.29 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.405 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.15 -48.18 0.07 OUTLIER Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.147 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.45 26.74 1.39 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.052 0.453 . . . . 0.0 111.326 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.539 ' HB3' ' HA ' ' A' ' 117' ' ' LYS . 9.5 p -69.98 111.58 5.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.406 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.41 -76.74 1.64 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.012 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 68.87 -62.87 0.38 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.426 0.691 . . . . 0.0 110.825 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.65 -26.75 2.24 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.475 ' O ' ' HA ' ' A' ' 130' ' ' HIS . 5.3 m-70 -127.5 38.43 4.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.985 0.421 . . . . 0.0 111.293 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.5 m170 -110.3 83.64 1.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.453 ' C ' ' H ' ' A' ' 129' ' ' HIS . 40.5 t-80 -152.82 79.65 1.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.513 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.1 t60 72.28 -30.25 0.21 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.796 0.839 . . . . 0.0 111.405 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.453 ' H ' ' C ' ' A' ' 127' ' ' HIS . 23.2 p80 -145.95 174.55 11.16 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' A' ' 125' ' ' HIS . 22.2 t-80 . . . . . 0 C--O 1.246 0.904 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' H3 ' ' CD ' ' A' ' 52' ' ' GLU . 23.5 ttt . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 t 68.73 117.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.157 0.91 . . . . 0.0 108.59 -170.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 22.3 tp -55.34 120.85 7.72 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.4 0.619 . . . . 0.0 111.009 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.604 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.4 mmt180 -97.99 108.64 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.067 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -106.09 104.19 13.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.38 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 92.4 m-85 -116.23 168.9 7.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 12.4 Cg_exo -67.74 158.48 57.04 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.604 1.536 . . . . 0.0 110.094 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.534 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.7 t80 -47.11 -50.3 47.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 51.5 Cg_exo -56.57 -50.26 12.36 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.159 1.906 . . . . 0.0 112.981 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.04 -42.34 89.7 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.17 71.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.46 HD23 HG23 ' A' ' 22' ' ' VAL . 6.3 mt -70.81 -36.86 73.16 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.329 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.29 70.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.055 0.455 . . . . 0.0 110.065 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -59.75 -44.57 93.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.874 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.75 -53.42 33.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.446 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 7.7 tp60 -58.67 -53.14 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.069 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.22 60.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.999 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -116.72 -0.14 12.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.094 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.26 91.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.814 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.632 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 74.6 mmt-85 -112.79 179.59 3.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 111.653 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.602 ' HE3' HG21 ' A' ' 86' ' ' VAL . 90.2 mtp -101.69 159.06 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.285 -177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.689 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 47.8 t -105.8 119.53 55.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.508 ' HE3' ' HB2' ' A' ' 25' ' ' TYR . 10.2 tpt -99.6 103.3 14.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.235 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 16.4 t -94.88 106.28 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.508 ' HB2' ' HE3' ' A' ' 23' ' ' MET . 90.4 t80 -106.61 104.43 14.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.226 0.536 . . . . 0.0 111.143 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.918 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.5 m-85 -82.38 115.82 21.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.218 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -121.3 158.37 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.748 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.651 ' HG ' ' HB ' ' A' ' 62' ' ' VAL . 42.8 m -137.69 162.24 34.37 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -64.62 -60.77 2.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -94.42 48.72 1.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.314 0.578 . . . . 0.0 110.844 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.675 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 27.3 p -76.19 149.26 81.97 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.135 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.517 ' HB2' ' H ' ' A' ' 33' ' ' TYR . 39.0 Cg_exo -58.93 -98.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.076 2.518 . . . . 0.0 114.053 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.517 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 90.2 t80 -87.72 -17.83 30.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 0.0 111.565 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.488 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 1.6 t -51.4 -38.97 56.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.665 -174.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -56.85 -31.47 64.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.18 -48.16 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 110.084 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.488 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 15.1 ptm -68.96 -33.47 73.76 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.2 -27.73 65.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.208 0.527 . . . . 0.0 110.206 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.8 m -92.13 -61.58 1.59 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.378 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.45 -70.58 0.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.71 -47.03 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.223 -0.898 . . . . 0.0 113.305 -168.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 tp -81.89 -19.03 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.773 0.321 . . . . 0.0 110.984 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.2 m -92.92 -6.44 48.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.443 ' HB3' HG23 ' A' ' 47' ' ' VAL . 11.4 t70 -46.55 136.23 7.46 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.743 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 53.1 Cg_exo -56.86 -35.28 98.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.375 2.717 . . . . 0.0 113.698 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . -79.41 -24.35 61.09 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 44' ' ' ASP . 19.9 t -79.48 -43.56 23.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 109.003 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -62.77 -33.55 75.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.319 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 15.2 ptm180 -67.95 -24.49 65.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.798 0.333 . . . . 0.0 111.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -71.84 -46.43 58.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -62.45 -44.82 95.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.911 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.489 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 2.4 mm-40 -50.23 -31.34 13.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -174.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.537 ' HB1' ' HD3' ' A' ' 54' ' ' ARG . . . -82.91 -54.49 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -171.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.632 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.56 12.04 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -170.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 84.4 m-85 -118.84 138.41 52.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.529 0.68 . . . . 0.0 112.026 -176.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 14' ' ' LEU . 51.0 t -109.33 116.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.43 HG11 ' HG3' ' A' ' 23' ' ' MET . 15.5 t -89.21 127.36 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.215 0.531 . . . . 0.0 110.978 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.09 117.8 34.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.029 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.1 p -81.44 101.26 9.76 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.61 120.46 56.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.723 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.622 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 m -101.78 108.9 20.54 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.651 ' HB ' ' HG ' ' A' ' 28' ' ' SER . 24.0 t -68.19 -13.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.645 0.736 . . . . 0.0 110.439 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' OD2' ' HA ' ' A' ' 28' ' ' SER . 2.8 m-20 -79.72 -28.86 40.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.055 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.629 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -105.43 165.38 13.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.654 -175.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.6 Cg_endo -49.07 -52.35 8.9 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.035 3.157 . . . . 0.0 114.495 -171.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -59.49 -39.3 83.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -179.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.622 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.22 -35.74 47.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.839 175.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.39 -35.65 79.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.67 0.747 . . . . 0.0 110.089 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.59 -46.66 71.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.412 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.434 ' O ' ' HD1' ' A' ' 74' ' ' TYR . 45.1 mt -66.29 -31.44 72.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.33 -33.79 76.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.283 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -85.17 -28.45 25.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.632 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.49 -50.36 52.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD1' ' HZ ' ' A' ' 26' ' ' PHE . 89.3 m-85 -85.23 -20.91 29.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.312 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 58.4 62.26 2.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.834 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.4 t -137.37 101.47 9.09 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.791 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -96.58 128.2 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 111.292 168.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 107.85 1.65 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.72 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.675 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -92.64 147.83 34.98 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.203 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HA ' HG21 ' A' ' 79' ' ' THR . 10.3 Cg_endo -88.26 154.45 37.99 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.595 -1.002 . . . . 0.0 112.345 -0.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.918 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 23.9 m -120.01 115.02 22.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.319 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.532 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 11.8 m-85 -106.48 112.35 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 97' ' ' ARG . 46.5 t -118.13 129.6 74.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.472 ' CG ' HG12 ' A' ' 114' ' ' VAL . 68.1 m-85 -110.79 122.97 49.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.809 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.689 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 28.5 mt -112.86 131.36 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.472 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.602 HG21 ' HE3' ' A' ' 21' ' ' MET . 15.8 t -114.13 113.54 46.4 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.726 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.29 116.83 4.22 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.378 1.385 . . . . 0.0 110.326 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.517 ' HZ2' ' CD ' ' A' ' 93' ' ' GLU . 15.4 pttm -158.85 150.43 20.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.998 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.66 -65.49 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.038 0.836 . . . . 0.0 110.884 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.15 23.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.545 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.62 171.85 19.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 110.892 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.446 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 73.1 m95 -95.73 126.43 40.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.049 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.517 ' CD ' ' HZ2' ' A' ' 88' ' ' LYS . 35.6 tt0 -103.31 112.14 24.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.064 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HA ' HD21 ' A' ' 85' ' ' LEU . 39.4 tt0 -78.14 97.29 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' A' ' 84' ' ' PHE . 15.7 m -81.42 -6.63 9.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.63 171.49 15.24 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.077 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.64 ' HG2' HG22 ' A' ' 83' ' ' VAL . 89.8 mtt180 -133.37 137.99 46.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.815 -0.693 . . . . 0.0 109.752 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.5 mt -108.38 128.28 54.63 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -138.39 144.02 40.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.185 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.29 -2.73 7.75 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.367 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.9 m 71.44 128.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.414 0.626 . . . . 0.0 110.589 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -131.8 129.46 21.97 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.517 ' HD2' ' HG3' ' A' ' 106' ' ' GLU . 27.7 Cg_exo -62.44 166.19 13.79 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.394 2.062 . . . . 0.0 110.502 168.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.44 -44.75 76.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.0 111.39 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.18 85.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 120.966 0.412 . . . . 0.0 111.256 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.517 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 11.6 mm-40 -66.95 -54.64 19.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 111' ' ' LEU . 26.3 t80 -57.92 -42.77 85.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.863 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.412 ' O ' ' HG3' ' A' ' 112' ' ' ARG . 60.4 mt -58.4 -43.75 88.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.387 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.575 ' HZ2' ' HB2' ' A' ' 109' ' ' LYS . 10.3 mtmp? -63.95 -50.17 69.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 114' ' ' VAL . 3.1 pt-20 -75.31 -33.06 61.13 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 107' ' ' PHE . 4.7 tt -59.57 -43.37 93.63 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 45.1 mtm180 -65.13 -33.05 75.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.519 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.36 -37.74 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 110.499 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 110' ' ' GLU . 78.9 t -63.65 -34.53 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.592 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.9 m -57.25 -37.05 71.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.509 . . . . 0.0 110.209 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.2 -37.95 53.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.323 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.702 ' HB3' ' HZ2' ' A' ' 117' ' ' LYS . 9.1 mtpm? -68.11 -10.8 56.79 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.059 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 86' ' ' VAL . . . -63.75 -41.41 98.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.708 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.45 -55.05 0.91 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -97.87 87.32 3.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.53 -11.02 60.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.472 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.47 120.38 0.55 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.4 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -97.13 -51.35 4.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.003 0.43 . . . . 0.0 110.49 178.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' H ' ' CD ' ' A' ' 123' ' ' GLU . . . -77.17 92.16 1.04 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -80.74 19.6 0.82 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -178.29 -30.9 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.457 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -163.26 142.58 8.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.256 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -158.85 133.72 8.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -148.74 148.51 30.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 . . . . . 0 C--O 1.243 0.748 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.022 176.531 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 tpp . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.905 0.384 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -124.55 21.95 8.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' A' ' 52' ' ' GLU . 4.3 tp -55.52 132.66 49.1 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.995 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -103.34 116.77 33.06 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.496 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -108.88 127.13 53.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.754 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 30.1 m-85 -130.52 170.6 10.72 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.127 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.65 166.65 26.74 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.506 2.137 . . . . 0.0 110.566 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.594 ' CD1' HD22 ' A' ' 70' ' ' LEU . 63.0 t80 -44.97 -54.04 14.45 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.8 Cg_exo -59.36 -52.82 4.18 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.881 1.721 . . . . 0.0 113.089 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -66.18 -36.39 82.96 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.795 0.331 . . . . 0.0 110.452 -175.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.42 -43.42 93.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.81 -32.03 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.64 -46.24 32.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.871 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.454 ' HB3' HG11 ' A' ' 56' ' ' VAL . 12.0 tp -59.3 -46.37 88.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 110.305 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.428 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.64 -44.21 96.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 -14.58 59.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.141 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -117.92 5.44 12.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.548 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.22 37.18 94.11 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.472 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.783 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.7 mmp_? -108.19 175.66 5.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.522 ' SD ' HG23 ' A' ' 86' ' ' VAL . 69.5 mtm -102.62 162.67 12.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.97 121.2 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.832 0.348 . . . . 0.0 111.043 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.06 103.28 15.16 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 17.0 t -87.12 101.19 10.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 73.8 t80 -92.57 103.0 15.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.463 ' CB ' HG12 ' A' ' 76' ' ' VAL . 84.7 m-85 -81.83 112.23 18.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.254 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.634 ' HA ' HG21 ' A' ' 79' ' ' THR . 17.0 p80 -131.29 138.91 49.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.093 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.459 ' HG ' ' HB ' ' A' ' 62' ' ' VAL . 29.6 m -94.45 153.12 18.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 164.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 63' ' ' ASP . 1.1 pm0 -85.49 -13.11 50.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -105.52 24.39 12.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.684 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.853 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 14.8 p -73.03 161.62 78.52 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.927 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.25 -105.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.388 2.059 . . . . 0.0 114.415 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -70.37 -17.52 63.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.491 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 5.4 t -55.46 -30.89 61.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.015 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -55.03 -31.72 61.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.589 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.76 -50.78 8.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -63.43 -47.2 82.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.632 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.29 -42.48 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.291 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 m -68.98 -55.77 9.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.61 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -91.34 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.173 0.511 . . . . 0.0 112.102 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.02 -39.91 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.883 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -79.66 -28.45 40.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.763 0.315 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.6 m -88.2 -1.47 58.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -45.25 130.63 5.84 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.858 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.62 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 50.3 Cg_exo -55.66 -35.43 92.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.115 2.543 . . . . 0.0 113.259 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.41 ' HA2' ' NE ' ' A' ' 49' ' ' ARG . . . -75.6 -39.44 34.83 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.016 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' HA ' HD21 ' A' ' 108' ' ' LEU . 61.1 t -65.41 -44.57 94.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.36 0.6 . . . . 0.0 109.588 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.56 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 14.7 t -49.49 -46.91 48.79 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.297 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.62 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 77.5 mtm180 -50.31 -39.08 44.74 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.484 ' HB3' HD12 ' A' ' 111' ' ' LEU . 56.5 mt -73.26 -46.53 49.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.64 -35.7 73.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.105 0.478 . . . . 0.0 110.391 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -48.47 -48.5 37.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.304 1.041 . . . . 0.0 112.405 -177.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . . . -76.27 -43.18 42.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -167.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.783 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.26 17.94 3.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CE2' ' HE3' ' A' ' 21' ' ' MET . 94.7 m-85 -129.84 139.63 51.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.878 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.454 HG11 ' HB3' ' A' ' 14' ' ' LEU . 99.1 t -107.8 116.35 51.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.85 126.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.234 0.54 . . . . 0.0 110.973 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -95.46 117.32 30.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.901 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.3 p -86.41 101.36 13.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.1 t -103.88 113.55 41.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.702 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.514 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 3.0 p -91.22 114.31 26.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.237 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.491 HG13 ' HB3' ' A' ' 71' ' ' ALA . 99.4 t -74.16 -19.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.58 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 5.3 m-20 -82.55 -7.22 59.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.8 p -111.39 156.16 41.66 Favored Pre-proline 0 C--O 1.22 -0.472 0 O-C-N 122.36 -0.212 . . . . 0.0 111.078 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.2 Cg_endo -50.43 -55.3 4.22 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 124.062 3.175 . . . . 0.0 114.665 -167.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -35.48 76.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.97 -32.56 52.79 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.822 174.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 64' ' ' THR . 54.5 mt-30 -62.2 -42.91 99.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.142 0.577 . . . . 0.0 110.477 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.4 -41.55 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.274 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.594 HD22 ' CD1' ' A' ' 8' ' ' TYR . 3.9 mp -62.05 -34.88 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.234 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.491 ' HB3' HG13 ' A' ' 62' ' ' VAL . . . -63.78 -38.25 90.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.49 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -84.74 -27.92 26.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.891 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.88 -51.3 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.423 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.1 0.56 46.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.838 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 53.81 76.85 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.13 0.894 . . . . 0.0 111.161 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.463 HG12 ' CB ' ' A' ' 26' ' ' PHE . 61.6 t -128.48 84.01 64.44 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.035 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -102.5 105.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.638 2.892 . . . . 0.0 111.631 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.4 90.88 0.67 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.519 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.853 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 25.7 m -82.55 143.35 47.37 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.492 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 83.1 Cg_endo -88.76 151.0 30.17 Favored 'Cis proline' 0 C--N 1.35 0.609 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.734 0.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 91.0 m -128.05 129.16 46.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.907 171.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.736 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.2 m-85 -110.11 114.08 27.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.226 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.8 t -117.79 128.73 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.962 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.18 121.71 45.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.757 0.313 . . . . 0.0 110.733 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 94' ' ' GLU . 29.5 mt -110.39 136.16 49.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.522 HG23 ' SD ' ' A' ' 21' ' ' MET . 14.6 t -109.52 133.99 20.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.412 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 4.0 Cg_exo -79.58 118.11 3.81 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.47 2.113 . . . . 0.0 110.63 171.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -133.83 151.47 51.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.59 93.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.278 0.561 . . . . 0.0 111.134 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.54 -47.27 0.74 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.058 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.95 -168.36 0.21 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.855 0.36 . . . . 0.0 110.771 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -97.67 140.35 32.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.858 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.539 ' OE2' ' HB3' ' A' ' 121' ' ' CYS . 24.2 tt0 -124.61 129.38 50.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.449 -175.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.429 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 35.5 tt0 -80.33 108.63 14.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.473 HG21 ' HZ3' ' A' ' 117' ' ' LYS . 5.5 p -104.34 -13.16 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.986 -169.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.28 140.63 7.6 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.874 -1.155 . . . . 0.0 113.441 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.429 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 18.6 mmt180 -127.36 126.25 42.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.736 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 89.7 mt -131.71 135.7 47.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -137.47 142.78 41.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.559 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.93 138.42 9.96 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.895 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -76.44 124.41 27.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -141.33 160.57 56.78 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.94 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.81 161.3 22.1 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.54 2.16 . . . . 0.0 111.88 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.521 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 5.4 ptt180 -59.69 -28.92 67.71 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.976 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.2 91.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.945 0.402 . . . . 0.0 110.501 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.1 -47.04 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.776 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.06 -46.59 88.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.294 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 94.7 mt -57.46 -38.35 74.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.036 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -57.72 -63.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.521 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.6 mp0 -70.12 -34.61 73.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.538 -175.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 50' ' ' LEU . 2.1 tm? -63.12 -38.55 91.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -57.74 -47.76 81.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.633 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 13.1 mm100 -65.26 -36.26 83.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.086 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -61.84 -37.83 79.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.318 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.57 -34.38 74.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.537 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.06 -32.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.969 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HZ3' HG21 ' A' ' 95' ' ' VAL . 7.9 mtpm? -68.05 -8.62 39.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.28 88.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.148 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.46 13.24 54.52 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.364 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 123' ' ' GLU . . . -157.49 -55.99 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.866 0.365 . . . . 0.0 110.135 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.539 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 61.6 m 73.92 -56.41 0.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.861 173.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.46 58.84 0.38 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.483 ' HB3' ' HB3' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -88.32 104.49 16.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.278 0.561 . . . . 0.0 112.242 -172.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.2 60.52 8.7 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.003 171.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -118.68 93.18 4.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.111 0.482 . . . . 0.0 111.344 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -130.05 114.97 16.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.674 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.3 m170 60.79 -92.03 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.917 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 174.44 -173.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.66 0.784 . . . . 0.0 109.041 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -120.15 144.76 47.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.954 0.407 . . . . 0.0 111.097 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.224 168.289 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 p -155.54 -33.54 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.793 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.693 HD23 HD23 ' A' ' 51' ' ' LEU . 56.8 tp -133.6 156.52 47.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.62 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.41 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 2.7 mmp_? -80.66 102.76 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.976 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -107.85 104.56 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.48 . . . . 0.0 110.235 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -113.52 145.35 33.16 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.435 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 31.3 Cg_exo -59.41 166.93 6.93 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.975 1.783 . . . . 0.0 111.389 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.518 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 77.8 t80 -48.71 -50.03 62.62 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.9 Cg_exo -60.76 -55.63 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.702 1.601 . . . . 0.0 111.986 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.1 mp0 -54.14 -44.88 71.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.389 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.452 ' HA ' HG13 ' A' ' 56' ' ' VAL . . . -59.4 -47.45 85.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 0.0 111.279 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.9 -39.96 94.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.87 62.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.947 0.404 . . . . 0.0 110.484 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.84 -49.59 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.436 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.38 -46.98 68.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.238 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.25 -49.01 79.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.017 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -13.96 59.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.863 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -117.0 4.77 12.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.425 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.28 41.97 99.65 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.719 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.526 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.2 mmp_? -109.19 -179.93 3.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.764 0.316 . . . . 0.0 110.539 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.3 mtp -102.04 155.62 18.07 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 54.0 t -105.95 124.72 61.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.525 ' SD ' HD21 ' A' ' 51' ' ' LEU . 22.0 ttt -107.67 103.24 12.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 46.0 t -84.26 105.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -99.15 103.39 15.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.443 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.815 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 92.4 m-85 -81.67 115.9 21.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.606 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.458 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 27.8 p80 -120.12 150.42 40.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.543 0.527 . . . . 0.0 110.427 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 t -143.41 147.91 35.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.442 ' OE1' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -88.04 -26.99 22.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.111 0.481 . . . . 0.0 110.212 175.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -72.92 -21.71 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.903 ' HB3' HG21 ' A' ' 79' ' ' THR . 9.4 t -103.93 94.99 7.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.15 23.42 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.691 2.26 . . . . 0.0 113.453 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -86.65 -29.79 22.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.893 0.378 . . . . 0.0 111.092 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.549 ' HG ' HG23 ' A' ' 79' ' ' THR . 28.5 p -82.81 -32.79 27.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -55.54 -34.65 64.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -168.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.37 -48.2 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.891 0.377 . . . . 0.0 110.759 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.473 ' HE3' ' CZ ' ' A' ' 82' ' ' PHE . 26.3 ttp -74.51 -44.42 51.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -177.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -57.76 -45.67 85.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.751 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -64.17 -56.93 11.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.648 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.81 -70.13 0.7 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.171 0.51 . . . . 0.0 111.959 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.81 -41.97 76.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.797 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.3 tp -81.11 -27.05 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.25 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 t -92.55 1.11 57.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.356 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -50.82 134.63 27.85 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.074 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 75.0 Cg_exo -52.3 -40.58 69.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.139 2.559 . . . . 0.0 113.485 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.44 -46.84 18.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.098 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.9 -50.85 78.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.215 0.531 . . . . 0.0 110.392 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 64.0 m -59.84 -38.28 81.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.292 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -63.34 -39.95 95.96 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.711 HD21 HH22 ' A' ' 54' ' ' ARG . 64.7 mt -63.3 -38.05 89.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.953 0.406 . . . . 0.0 110.571 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.693 HD23 HD23 ' A' ' 3' ' ' LEU . 2.0 tp -70.08 -56.37 7.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.412 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.562 ' HG3' HH21 ' A' ' 49' ' ' ARG . 5.0 mm-40 -46.05 -40.59 10.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.414 0.686 . . . . 0.0 112.621 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB2' HH11 ' A' ' 54' ' ' ARG . . . -61.73 -49.7 75.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.711 HH22 HD21 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.79 9.05 3.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -174.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -119.28 138.94 52.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.572 . . . . 0.0 111.042 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 14' ' ' LEU . 46.2 t -109.32 116.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.6 HG21 HD23 ' A' ' 3' ' ' LEU . 19.6 t -87.26 119.49 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.554 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.685 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.21 117.48 28.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.852 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 p -83.2 100.33 10.51 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.622 HG11 HD22 ' A' ' 70' ' ' LEU . 59.0 t -111.33 124.3 67.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.696 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.455 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -95.41 118.14 31.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.62 -178.339 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.87 10.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 122.74 1.257 . . . . 0.0 108.328 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.442 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -97.37 -24.24 15.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.432 175.364 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 42.4 p -108.58 152.97 42.4 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.857 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 27.2 Cg_endo -55.86 -51.57 9.37 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.042 3.161 . . . . 0.0 114.778 -168.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -37.05 85.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.634 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -73.49 -37.3 53.45 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.335 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 64' ' ' THR . 93.4 mt-30 -61.91 -32.07 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 110.466 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 72' ' ' ARG . 6.0 tp10 -68.87 -43.45 75.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.802 175.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.622 HD22 HG11 ' A' ' 60' ' ' VAL . 23.5 tp -63.59 -31.18 72.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.807 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.14 81.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 69' ' ' GLU . 42.0 mtm180 -65.42 -32.46 74.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.117 0.484 . . . . 0.0 110.041 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -66.04 -53.29 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.227 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.82 2.07 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 61.7 56.22 2.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.497 0.665 . . . . 0.0 109.947 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 55.3 t -104.45 136.33 19.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.907 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.0 Cg_exo -73.97 -143.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.233 2.622 . . . . 0.0 111.265 171.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -80.16 -71.57 1.26 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.514 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.903 HG21 ' HB3' ' A' ' 31' ' ' CYS . 14.3 t 176.7 158.42 0.46 Allowed Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.715 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 12.4 Cg_endo -87.84 127.21 8.64 Favored 'Cis proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.21 -1.162 . . . . 0.0 112.385 -1.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.815 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 7.2 m -115.95 119.65 36.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.597 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.1 m-85 -108.14 112.11 24.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.032 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.55 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 80.4 t -113.81 107.36 22.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -93.98 123.2 37.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.1 mt -114.56 140.51 48.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 111.211 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.31 123.31 37.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.408 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 5.7 Cg_exo -77.7 118.0 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.398 2.066 . . . . 0.0 110.286 171.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' HZ2' ' HB2' ' A' ' 93' ' ' GLU . 24.2 pttm -128.18 112.62 14.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 0.0 111.05 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.75 -80.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.547 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 23.05 1.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.09 155.1 43.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.824 0.345 . . . . 0.0 110.452 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 91.6 m95 -90.94 163.62 14.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.551 ' HB2' ' HZ2' ' A' ' 88' ' ' LYS . 9.7 tp10 -148.1 140.85 24.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.681 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 37.2 tt0 -94.13 104.65 16.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.78 -12.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.616 -170.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.94 144.79 5.08 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.366 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 99.2 mtt180 -113.9 128.02 56.22 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 96.0 mt -121.72 141.83 50.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -137.66 143.93 41.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.326 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.21 141.37 11.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.403 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -70.21 122.45 19.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.595 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 23.4 mmt85 -108.03 142.11 24.57 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.92 158.25 25.63 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.022 1.815 . . . . 0.0 110.183 168.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -54.4 -49.05 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.567 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.48 72.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.39 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.542 ' OE1' ' HD2' ' A' ' 102' ' ' ARG . 4.5 tm-20 -76.05 -48.39 21.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.595 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 67.0 t80 -66.4 -36.76 83.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 108' ' ' LEU . 40.8 mt -62.64 -35.43 79.59 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.619 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -60.34 -49.17 78.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 114' ' ' VAL . 4.3 mm-40 -64.1 -47.2 80.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.19 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.62 -38.54 90.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -58.08 -41.91 84.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.11 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -66.1 -56.72 10.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.008 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -58.47 -39.92 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.252 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.44 ' CB ' HH21 ' A' ' 54' ' ' ARG . 22.8 p -63.07 -24.17 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 0.0 111.193 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.6 t -84.84 -33.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.352 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -62.94 -21.43 66.06 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.322 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.08 -17.58 77.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.58 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.17 -67.42 0.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.491 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.21 73.87 9.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.4 0.619 . . . . 0.0 109.725 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.7 t -70.5 -18.34 62.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.908 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 124' ' ' GLY . . . 118.26 3.61 14.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.525 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.472 ' CD ' ' HD1' ' A' ' 126' ' ' HIS . 54.6 mt-10 71.66 -34.51 0.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.37 0.668 . . . . 0.0 112.338 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 122' ' ' GLY . . . 88.61 -4.84 85.1 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.005 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -159.83 27.53 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.666 0.269 . . . . 0.0 110.947 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.472 ' HD1' ' CD ' ' A' ' 123' ' ' GLU . 52.8 t60 -72.21 94.17 1.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.831 0.348 . . . . 0.0 110.417 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -136.15 101.46 4.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.973 0.416 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -83.03 91.64 7.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.385 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -105.1 12.26 32.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.161 0.505 . . . . 0.0 110.009 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.834 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 t -76.05 77.25 2.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.444 HD13 ' CB ' ' A' ' 51' ' ' LEU . 30.1 tp -56.35 141.75 40.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.301 -173.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.421 HH21 ' CD ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -79.52 102.41 8.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.319 -178.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.482 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 75.2 m95 -106.73 125.92 51.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.115 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.3 m-85 -130.62 153.38 81.48 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 24.5 Cg_exo -61.6 161.47 24.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.789 1.659 . . . . 0.0 110.667 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.533 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 75.6 t80 -46.92 -51.11 41.66 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.4 Cg_exo -58.7 -52.5 5.22 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 121.694 1.596 . . . . 0.0 112.23 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 37.5 mt-10 -62.23 -38.89 90.93 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.455 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.17 78.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 0.0 111.6 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.4 mm? -62.88 -40.57 97.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.931 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.28 -37.28 63.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.23 0.538 . . . . 0.0 110.31 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.57 -50.11 74.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.822 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.47 88.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.427 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 24.2 tp60 -62.65 -46.28 88.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.21 -14.49 58.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.918 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -114.6 3.49 14.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.41 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.66 96.09 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.594 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.4 mmp_? -107.46 177.21 4.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.433 ' SD ' HG23 ' A' ' 86' ' ' VAL . 8.0 mmm -100.5 160.33 14.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.5 t -105.6 124.74 60.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 -174.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.578 ' SD ' HG13 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -113.4 103.65 11.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -92.33 109.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.093 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.694 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 84.0 t80 -103.86 103.62 13.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.462 0.649 . . . . 0.0 111.028 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.871 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 54.6 m-85 -84.64 116.1 23.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.082 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.694 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 24.3 p80 -124.54 138.3 54.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.526 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 39.2 t -100.46 141.47 33.27 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.026 168.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.65 -25.1 67.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -102.59 16.27 26.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.095 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.808 ' SG ' ' HA ' ' A' ' 79' ' ' THR . 50.6 t -70.81 112.02 11.77 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.06 -67.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.484 2.789 . . . . 0.0 114.905 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -86.69 -19.49 29.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -167.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 17.1 t -70.9 -22.85 62.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -30.06 59.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -71.29 -44.53 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.221 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.527 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 51.8 ttm -66.73 -49.18 66.83 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.358 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -54.09 -44.7 71.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.233 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.5 m -72.93 -59.77 2.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.659 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.45 -67.72 0.83 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.023 0.44 . . . . 0.0 112.153 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.527 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 98.9 t -55.14 -51.59 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.74 -21.9 37.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.769 0.319 . . . . 0.0 111.481 -170.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.6 m -92.55 -10.58 37.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.087 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -47.28 133.26 9.64 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.625 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.35 -33.77 57.61 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.573 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.56 -52.41 7.38 Favored Glycine 0 CA--C 1.51 -0.247 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.01 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 HD22 ' A' ' 108' ' ' LEU . 62.6 t -58.38 -51.3 73.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.642 0.734 . . . . 0.0 110.184 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -52.74 -44.11 66.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.711 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 49' ' ' ARG . 45.0 ttm180 -59.39 -38.45 80.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.256 0.347 . . . . 0.0 111.598 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.48 HD11 HD22 ' A' ' 111' ' ' LEU . 50.2 mt -64.0 -39.88 95.11 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.623 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.43 -52.9 13.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.094 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' OE1' ' HA ' ' A' ' 3' ' ' LEU . 6.1 mm-40 -48.84 -43.12 38.28 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.092 0.557 . . . . 0.0 112.32 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.09 -57.02 13.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.591 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.13 22.75 3.26 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -171.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.591 ' CE1' ' HD3' ' A' ' 54' ' ' ARG . 50.5 m-85 -133.23 142.02 48.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.417 0.627 . . . . 0.0 111.58 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' A' ' 14' ' ' LEU . 82.6 t -108.01 118.91 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.664 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.578 HG13 ' SD ' ' A' ' 23' ' ' MET . 17.9 t -92.23 120.63 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 -173.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.95 118.17 29.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.3 p -90.07 101.32 14.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 110.039 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG12 ' HG ' ' A' ' 70' ' ' LEU . 57.3 t -111.06 120.0 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.734 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 9.8 m -88.83 109.12 19.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 8.9 p -86.48 6.9 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.466 0.65 . . . . 0.0 111.262 -170.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 5.0 m-20 -90.2 -30.65 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.203 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.626 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -92.5 165.58 19.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.154 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.626 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.65 -50.24 14.6 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.565 2.844 . . . . 0.0 114.38 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -70.85 -30.08 66.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.734 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.6 -33.57 47.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.99 172.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.691 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 40.5 mm-40 -63.83 -36.74 84.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -55.05 -52.57 62.78 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.901 170.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.489 ' HG ' HG12 ' A' ' 60' ' ' VAL . 3.1 mm? -53.74 -38.36 64.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.121 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.427 ' HB2' ' CG2' ' A' ' 62' ' ' VAL . . . -71.32 -34.17 70.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.635 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.691 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -72.14 -40.88 67.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.188 0.518 . . . . 0.0 110.475 174.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -63.11 -55.49 24.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.238 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.66 -15.87 40.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.212 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 67.55 37.55 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -134.44 147.75 64.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.724 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.35 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.218 1.946 . . . . 0.0 111.185 165.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.427 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . -159.63 56.94 0.33 Allowed Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.808 ' HA ' ' SG ' ' A' ' 31' ' ' CYS . 11.5 p -130.12 46.14 2.1 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -167.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.742 ' HD3' ' HG ' ' A' ' 101' ' ' SER . 34.1 Cg_endo -94.4 172.79 15.78 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 120.731 1.297 . . . . 0.0 111.215 -5.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.871 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 36.1 m -132.83 129.26 38.25 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.613 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.489 ' CZ ' ' HG2' ' A' ' 80' ' ' PRO . 2.1 m-85 -124.66 114.56 19.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.14 119.17 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.883 0.373 . . . . 0.0 110.152 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -99.65 126.68 45.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.55 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.62 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 23.5 mt -117.04 144.87 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 0.0 111.239 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.433 HG23 ' SD ' ' A' ' 21' ' ' MET . 90.2 t -109.15 125.91 30.45 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.372 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.533 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 74.2 Cg_endo -79.04 117.93 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.043 1.829 . . . . 0.0 110.839 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.06 109.41 10.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.202 0.525 . . . . 0.0 110.849 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.02 -82.06 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.674 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.56 20.37 1.67 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.01 157.8 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.533 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 89.3 m95 -92.56 169.93 10.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.655 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.5 tp10 -145.21 139.1 26.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.21 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.455 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 33.8 tt0 -95.2 103.19 15.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.8 p -99.74 9.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.689 -168.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.94 146.21 4.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.505 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.408 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 77.5 mtt180 -120.94 127.37 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD23 ' NH1' ' A' ' 102' ' ' ARG . 84.3 mt -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -136.96 143.27 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.605 0.241 . . . . 0.0 110.398 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.66 146.05 19.22 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.477 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.742 ' HG ' ' HD3' ' A' ' 80' ' ' PRO . 5.9 m -83.33 107.46 15.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.604 0.716 . . . . 0.0 110.601 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.586 ' NH1' ' HG3' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -108.68 152.34 42.16 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.04 178.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.87 158.61 13.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.797 2.331 . . . . 0.0 111.974 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.469 ' HB2' HG12 ' A' ' 41' ' ' VAL . 16.1 ttt-85 -60.92 -31.66 71.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.51 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -45.1 94.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.147 0.499 . . . . 0.0 110.054 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.87 -42.92 94.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.902 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.31 -47.38 79.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.776 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 28.9 mt -61.72 -38.57 88.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.555 0.217 . . . . 0.0 110.795 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -56.06 -56.03 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.647 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.586 ' HG3' ' NH1' ' A' ' 102' ' ' ARG . 6.8 mm-40 -63.96 -44.96 91.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.48 HD22 HD11 ' A' ' 50' ' ' LEU . 35.0 tp -55.48 -47.87 75.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.425 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -64.46 -39.58 94.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.516 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.513 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 15.9 mm100 -70.49 -23.48 62.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.341 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 110' ' ' GLU . 73.8 t -73.41 -41.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 172.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.1 m -58.77 -37.73 76.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.493 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 112' ' ' ARG . 68.1 t -63.58 -40.0 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.977 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 121' ' ' CYS . 62.7 mttp -64.03 -41.77 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.162 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.29 -14.16 82.84 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.565 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.08 -35.51 4.48 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.874 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.9 -31.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.68 -0.306 . . . . 0.0 111.509 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.839 ' HA ' ' HA ' ' A' ' 117' ' ' LYS . 47.4 t 71.49 -63.1 0.44 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.368 0.667 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 117.42 39.39 0.79 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.597 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -57.25 164.69 1.66 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.477 0.656 . . . . 0.0 112.529 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.56 -43.92 3.23 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.141 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -68.86 -32.67 72.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 111.267 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -84.01 30.46 0.52 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.225 0.536 . . . . 0.0 111.146 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -85.15 -14.34 47.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.123 0.487 . . . . 0.0 109.691 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -126.66 14.57 7.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.259 0.552 . . . . 0.0 110.083 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -160.54 143.79 13.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.616 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 . . . . . 0 C--O 1.248 1.009 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.36 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tmm? . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 t -145.11 83.36 1.68 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.479 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 15.1 tp -56.11 123.5 14.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.898 -173.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -90.55 103.98 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.546 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -99.7 129.89 45.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.428 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.514 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 38.2 m-85 -131.49 167.12 23.31 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.083 171.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 15.0 Cg_exo -68.09 163.05 37.45 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.965 1.777 . . . . 0.0 110.974 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.569 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.9 t80 -47.53 -52.97 33.39 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 49.0 Cg_exo -57.62 -49.74 12.56 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.972 1.781 . . . . 0.0 112.935 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.14 -42.61 88.83 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.19 -42.03 72.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.0 111.528 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.47 -37.76 77.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.6 -43.67 63.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.638 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.97 0.415 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.13 -47.76 81.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.687 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.069 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.02 -14.59 55.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -118.43 6.61 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.564 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.4 39.42 97.73 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.76 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.3 mmp_? -110.53 -179.99 3.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.539 ' SD ' HG22 ' A' ' 86' ' ' VAL . 56.0 mtm -110.58 160.22 16.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 93.5 t -106.07 127.93 60.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.66 0.267 . . . . 0.0 111.52 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.2 ttt -105.69 103.15 12.6 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 171.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 41.1 t -86.79 107.53 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.505 ' HE1' ' HE2' ' A' ' 82' ' ' PHE . 65.4 t80 -98.99 103.65 15.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.546 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 88.3 m-85 -82.71 115.07 21.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.177 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.689 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 32.5 p80 -123.17 138.8 54.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.652 ' H ' HG23 ' A' ' 79' ' ' THR . 24.0 t -117.99 163.64 16.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.954 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -76.69 -2.43 32.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.586 0.708 . . . . 0.0 109.522 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -112.17 14.45 20.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 30.4 p -76.8 129.95 77.54 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.834 0.349 . . . . 0.0 111.457 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.62 -78.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.649 2.232 . . . . 0.0 113.829 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 37' ' ' MET . 89.3 t80 -86.08 -17.45 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.48 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 12.9 t -47.73 -44.36 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.133 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -57.35 -33.32 67.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.05 -45.97 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.902 0.382 . . . . 0.0 110.508 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.695 ' HG2' ' HB ' ' A' ' 41' ' ' VAL . 10.9 tmm? -65.42 -40.94 93.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.344 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.42 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 7.2 t30 -59.41 -41.24 89.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.32 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.3 m -77.17 -56.51 4.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -90.13 -64.65 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.146 0.498 . . . . 0.0 111.803 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.695 ' HB ' ' HG2' ' A' ' 37' ' ' MET . 77.8 t -55.71 -44.23 76.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.405 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.27 -13.96 57.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.861 0.362 . . . . 0.0 111.194 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -100.36 -6.78 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.684 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.19 135.55 8.94 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.746 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 80.8 Cg_exo -49.68 -45.45 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.351 2.701 . . . . 0.0 113.623 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.41 -45.64 67.69 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.111 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.684 HG21 HD23 ' A' ' 108' ' ' LEU . 43.4 t -59.41 -47.78 89.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 121.648 0.737 . . . . 0.0 109.778 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.539 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 23.5 t -52.86 -43.14 65.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.387 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 82.7 mtt180 -62.27 -21.38 65.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.41 HD12 HD21 ' A' ' 108' ' ' LEU . 23.3 mt -80.39 -38.11 30.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.756 174.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.32 -50.53 11.63 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 48' ' ' SER . 7.1 mm-40 -44.38 -47.69 9.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.715 ' HB2' HH11 ' A' ' 54' ' ' ARG . . . -67.98 -48.27 66.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -168.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.715 HH11 ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -134.44 16.45 3.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.501 ' CE2' ' HE3' ' A' ' 21' ' ' MET . 90.4 m-85 -125.18 141.01 52.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.393 0.616 . . . . 0.0 111.688 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.2 t -106.6 114.95 47.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.94 121.07 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.806 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -94.58 117.6 30.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.3 p -85.83 101.61 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.92 109.07 23.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.956 0.407 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.645 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -94.96 107.87 19.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.158 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.607 ' HB ' ' HA ' ' A' ' 28' ' ' SER . 38.3 t -75.04 -8.29 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.292 1.044 . . . . 0.0 108.549 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.041 176.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.609 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -125.11 163.51 37.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.069 -174.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.8 Cg_endo -50.75 -47.76 23.71 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.323 3.349 . . . . 0.0 114.85 -169.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.99 -36.44 81.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.082 -176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -82.47 -31.8 29.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.559 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 64' ' ' THR . 96.9 mt-30 -59.22 -38.0 78.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.514 0.673 . . . . 0.0 109.479 171.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 6.0 tp10 -61.51 -50.6 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.97 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.68 -40.25 83.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.686 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.62 -50.25 73.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.49 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.266 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 30.4 ttt85 -65.12 -56.02 15.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.221 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.55 3.29 55.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.565 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 58.47 64.75 1.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.623 0.577 . . . . 0.0 109.714 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.55 92.92 48.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -102.31 129.03 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.712 2.941 . . . . 0.0 112.052 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 140.23 -85.09 0.21 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.834 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.689 ' CG2' ' HA ' ' A' ' 27' ' ' HIS . 85.0 m 75.07 137.21 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 122.49 0.316 . . . . 0.0 111.325 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 79' ' ' THR . 70.1 Cg_endo -76.52 137.48 49.33 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.724 -1.365 . . . . 0.0 112.881 0.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.7 m -124.69 129.06 49.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.997 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.569 ' HE1' ' CA ' ' A' ' 100' ' ' GLY . 1.4 m-85 -115.27 122.07 44.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.044 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.8 t -121.47 108.31 22.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.881 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 59.1 m-85 -94.34 120.07 34.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.043 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 94' ' ' GLU . 32.4 mt -109.22 130.66 55.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.663 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.539 HG22 ' SD ' ' A' ' 21' ' ' MET . 22.6 t -108.56 123.91 35.94 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.378 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.5 117.69 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.901 1.734 . . . . 0.0 110.559 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 93' ' ' GLU . 18.0 ptmt -157.67 143.29 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.739 -175.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.18 -77.39 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.988 0.805 . . . . 0.0 111.43 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.18 24.38 0.13 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.797 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.42 -177.48 6.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.687 0.28 . . . . 0.0 110.453 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.07 132.62 51.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.427 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 88' ' ' LYS . 30.1 tt0 -107.11 119.71 40.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.266 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.501 ' HG3' HG12 ' A' ' 83' ' ' VAL . 39.9 tt0 -77.0 95.96 4.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.75 -7.46 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.094 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.74 118.3 0.6 Allowed Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.796 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.476 ' HG3' HG23 ' A' ' 83' ' ' VAL . 16.7 ttm180 -108.92 126.67 53.33 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.451 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 86.1 mt -124.41 139.03 54.28 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.032 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -102.58 117.13 34.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 164.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.569 ' CA ' ' HE1' ' A' ' 82' ' ' PHE . . . -90.78 -134.27 5.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.461 -167.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.0 m 75.67 -12.09 1.03 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.793 0.837 . . . . 0.0 110.578 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 100' ' ' GLY . 62.1 mtp180 -65.25 156.31 81.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.247 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.49 155.55 25.4 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 111.543 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.486 ' HB3' HG13 ' A' ' 41' ' ' VAL . 30.8 ptt180 -67.62 -25.12 65.59 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.083 -174.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.6 74.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.107 0.479 . . . . 0.0 109.956 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 21.7 mm-40 -75.25 -37.88 60.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.388 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.63 -47.95 83.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.638 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.684 HD23 HG21 ' A' ' 47' ' ' VAL . 88.6 mt -68.16 -31.43 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.732 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 109' ' ' LYS . 5.0 tmmm? -63.15 -47.9 80.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.951 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 5.4 mm-40 -69.92 -41.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 111' ' ' LEU . 4.1 tt -61.16 -36.32 79.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -63.46 -45.07 92.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.23 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 5.5 pt20 -62.81 -38.43 90.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.426 ' N ' ' HG3' ' A' ' 113' ' ' GLN . 69.9 t -66.78 -42.68 89.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.683 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 52.4 t -57.22 -30.48 64.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.864 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.15 -53.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.873 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -59.15 -28.13 66.29 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.445 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -62.46 -41.42 99.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.505 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.15 -36.42 5.2 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.755 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -130.52 98.12 4.58 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 2.6 p -84.74 -31.92 23.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.31 36.6 0.13 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.681 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.46 -72.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.47 43.35 77.24 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.669 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -144.29 151.15 38.98 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.554 -0.38 . . . . 0.0 110.8 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -159.05 160.4 35.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -59.78 119.19 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -82.3 93.74 7.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.567 -173.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -106.82 -5.82 18.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 164.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.7 t60 . . . . . 0 C--O 1.24 0.588 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.752 176.498 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -106.17 -30.69 9.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.283 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.45 HD21 HG23 ' A' ' 57' ' ' VAL . 24.6 tp -79.05 149.36 32.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.724 -172.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.656 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 5.4 mmt180 -88.34 104.64 16.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.328 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -106.38 104.63 14.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.656 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 96.8 m-85 -111.12 157.39 38.95 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 19.3 Cg_exo -63.48 162.02 29.14 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.957 1.771 . . . . 0.0 111.172 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.596 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.3 t80 -45.82 -55.73 12.03 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.8 Cg_exo -65.0 -41.52 16.89 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.654 1.569 . . . . 0.0 112.126 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 37.1 tt0 -70.13 -36.92 75.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.847 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.68 86.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.997 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.91 -39.67 92.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.653 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.08 70.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.778 0.323 . . . . 0.0 110.651 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -59.67 -50.08 75.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -65.52 -45.57 83.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.978 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -58.85 -46.63 87.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.729 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -14.32 58.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.933 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -115.29 0.37 13.46 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.686 -175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.72 41.36 97.7 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.355 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.824 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 76.6 mmt-85 -112.87 178.44 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 0.0 111.946 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.7 mtp -101.46 154.36 18.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.345 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 48.5 t -106.19 135.05 45.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.801 0.334 . . . . 0.0 110.786 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.491 ' HE2' HD12 ' A' ' 42' ' ' LEU . 24.1 ttt -118.17 103.21 9.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.683 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 38.9 t -89.58 111.18 22.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.4 t80 -102.92 109.15 20.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.435 0.636 . . . . 0.0 111.006 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.992 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.8 m-85 -85.49 118.87 25.28 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.563 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.551 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 29.3 p80 -133.89 163.93 28.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.943 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.52 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 22.6 m -143.36 149.68 38.08 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.555 174.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -39.53 86.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -84.26 4.61 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.397 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 9.0 t -134.83 65.73 66.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.83 31.98 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.004 2.469 . . . . 0.0 114.476 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -83.35 -58.11 2.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.865 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 46.6 t -74.6 -22.34 59.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -67.04 -19.75 65.74 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.296 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -69.7 -47.87 61.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 28.1 mtm -61.99 -35.76 79.48 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.299 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.534 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 7.3 t30 -56.24 -43.67 78.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' SER . 30.7 m -65.17 -49.73 68.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -90.87 -70.91 0.66 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.325 0.583 . . . . 0.0 111.375 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.481 HG13 ' CB ' ' A' ' 104' ' ' ARG . 71.1 t -56.04 -51.77 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.753 -173.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.6 tp -81.87 -22.57 36.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -170.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' THR . 62.1 m -93.95 -3.42 51.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.059 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 47' ' ' VAL . 9.6 t70 -48.59 129.13 13.76 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.544 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.99 -36.61 76.43 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.127 2.552 . . . . 0.0 113.212 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.43 -34.85 68.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.87 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 44' ' ' ASP . 20.6 t -74.9 -49.0 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.366 0.603 . . . . 0.0 109.598 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -54.49 -37.03 64.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.886 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -63.31 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 0.0 111.262 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.26 -46.01 68.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.476 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 2.4 mm? -67.29 -47.25 71.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.15 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -46.01 -41.79 12.35 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.723 ' HB1' HH11 ' A' ' 54' ' ' ARG . . . -70.84 -49.95 40.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -171.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.824 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.82 16.38 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.436 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 87.4 m-85 -127.18 143.67 51.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.334 0.588 . . . . 0.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 14' ' ' LEU . 61.6 t -115.72 117.28 55.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.45 HG23 HD21 ' A' ' 3' ' ' LEU . 15.2 t -91.07 131.76 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.855 -173.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -101.36 119.63 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -85.22 102.31 13.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.227 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.72 125.79 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.301 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -109.28 121.8 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.52 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 56.5 t -68.97 -16.03 20.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.219 0.533 . . . . 0.0 110.992 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.29 -34.49 77.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.909 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.539 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 61.5 p -97.04 158.29 33.59 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.024 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.545 ' HG2' ' OE2' ' A' ' 66' ' ' GLU . 15.1 Cg_endo -51.02 -41.55 56.26 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.636 2.891 . . . . 0.0 113.127 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' OE2' ' HG2' ' A' ' 65' ' ' PRO . 1.7 mp0 -52.0 -57.75 8.56 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.041 0.448 . . . . 0.0 110.036 175.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.11 -33.06 65.29 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.259 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 51.3 mt-30 -56.02 -51.14 68.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.606 0.362 . . . . 0.0 111.114 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.41 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -76.84 -29.41 55.87 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.777 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.586 HD23 ' CD1' ' A' ' 8' ' ' TYR . 1.7 mp -61.61 -42.23 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 0.0 110.549 170.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.26 77.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.799 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 86.5 mtt180 -71.64 -27.44 63.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -80.96 -52.58 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.28 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -85.47 -14.02 47.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.763 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 65.05 78.08 0.29 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 77' ' ' PRO . 54.5 t -135.35 142.01 39.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 -171.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.432 ' O ' HG11 ' A' ' 76' ' ' VAL . 9.0 Cg_exo -73.49 -143.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.262 2.641 . . . . 0.0 111.142 169.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.49 -49.31 3.02 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.239 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.705 ' OG1' ' HA ' ' A' ' 80' ' ' PRO . 1.1 t 179.89 160.38 0.83 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.806 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -88.96 126.75 7.67 Favored 'Cis proline' 0 N--CA 1.456 -0.711 0 C-N-CA 124.246 -1.147 . . . . 0.0 112.035 -1.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.992 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.4 m -125.24 108.17 11.47 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.98 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.487 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.6 m-85 -102.67 111.59 23.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.235 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.683 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.7 t -110.65 108.9 26.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.88 0.372 . . . . 0.0 110.775 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.27 118.44 32.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.891 0.377 . . . . 0.0 110.538 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 32.8 mt -114.25 131.75 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 95' ' ' VAL . 24.3 t -110.61 124.69 32.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.517 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.7 Cg_endo -80.38 117.2 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.166 1.911 . . . . 0.0 110.387 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -146.37 133.81 20.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.406 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.14 -75.67 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.029 0.831 . . . . 0.0 111.144 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.82 29.49 0.15 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.713 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.99 165.53 33.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.587 0.232 . . . . 0.0 110.528 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.517 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 80.0 m95 -98.99 126.47 44.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.972 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 26.5 tt0 -106.94 121.38 44.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.445 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.446 ' HA ' HD22 ' A' ' 85' ' ' LEU . 49.0 tt0 -76.25 96.46 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.436 ' HB ' HG23 ' A' ' 86' ' ' VAL . 9.7 p -82.62 -14.51 12.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.009 -169.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.16 129.58 1.26 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.304 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.479 ' HG3' HG23 ' A' ' 83' ' ' VAL . 27.7 ttm180 -115.61 127.45 55.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.487 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 99.0 mt -109.37 133.89 52.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.662 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -136.93 116.54 12.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.65 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.3 173.06 18.86 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.054 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 m -109.98 120.36 42.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.745 0.307 . . . . 0.0 110.327 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -146.23 147.44 31.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.39 163.09 13.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.809 2.34 . . . . 0.0 112.085 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.58 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -63.73 -25.97 68.44 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.778 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.49 95.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.022 0.439 . . . . 0.0 110.337 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.3 mm-40 -64.89 -44.98 87.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.464 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.441 ' CE2' HD11 ' A' ' 111' ' ' LEU . 44.7 t80 -62.58 -37.58 86.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.516 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 62.3 mt -61.68 -42.24 98.66 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 110.943 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -57.31 -54.23 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.165 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 2.7 mm-40 -65.91 -41.04 91.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.126 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 111' ' ' LEU . 3.8 tt -60.98 -39.51 89.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.667 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 116' ' ' VAL . 12.6 tpt180 -59.23 -41.05 87.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.95 -43.31 75.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.571 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 110' ' ' GLU . 90.1 t -59.46 -39.63 79.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.743 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.12 -40.1 88.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.666 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 112' ' ' ARG . 97.6 t -66.55 -37.58 79.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 109.997 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 121' ' ' CYS . 34.0 mtpt -72.74 -8.17 54.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.712 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.65 -27.09 11.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.259 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.99 -26.1 73.27 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 121' ' ' CYS . . . -151.14 -79.39 0.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 120' ' ' ALA . 48.5 t 157.55 -43.12 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.365 0 O-C-N 124.847 1.342 . . . . 0.0 109.065 172.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.9 30.79 3.57 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.98 -16.85 48.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.203 -0.499 . . . . 0.0 110.716 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.45 89.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.055 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -137.43 140.94 41.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.19 109.17 10.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.724 0.297 . . . . 0.0 110.447 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -93.12 100.61 12.98 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -74.54 91.61 2.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -156.91 145.62 19.9 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 80.6 t60 . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.845 178.264 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -140.03 133.81 30.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 51' ' ' LEU . 14.8 tp -133.22 141.64 48.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.58 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.7 mmm180 -91.13 103.12 15.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.782 0.325 . . . . 0.0 111.851 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.508 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 46.4 m95 -102.88 113.26 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.335 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 90.0 m-85 -118.14 161.8 33.0 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.021 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 16.7 Cg_exo -66.18 160.95 42.46 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.274 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.579 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 91.4 t80 -47.27 -53.84 25.68 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 35.3 Cg_exo -61.42 -46.96 12.93 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.83 1.687 . . . . 0.0 112.355 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -43.97 87.22 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HA ' HG12 ' A' ' 56' ' ' VAL . . . -54.97 -42.34 72.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.741 0.305 . . . . 0.0 111.478 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.8 mp -68.1 -38.69 82.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.81 63.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.755 0.312 . . . . 0.0 110.586 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -57.42 -40.62 78.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.564 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.09 -56.07 6.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.935 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.406 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 24.9 tt0 -60.46 -49.18 78.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.5 -175.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -14.02 59.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.535 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 15.7 m-70 -118.3 4.35 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.295 -175.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.64 34.06 72.43 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.261 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.564 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.6 mmp_? -108.64 178.87 4.35 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.589 -0.359 . . . . 0.0 110.108 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.532 ' HE2' ' CE2' ' A' ' 55' ' ' PHE . 48.3 mtm -108.06 165.49 11.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.4 t -105.69 125.04 61.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.818 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.543 ' SD ' HG11 ' A' ' 57' ' ' VAL . 1.4 tmt? -109.06 103.12 12.07 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.645 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 26.1 t -90.41 111.44 23.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.411 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 65.7 t80 -99.58 103.49 15.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.128 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.706 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 51.4 m-85 -81.39 121.67 26.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.639 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.566 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 25.4 p80 -135.28 138.54 43.6 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.165 0.915 . . . . 0.0 109.924 177.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.426 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 1.5 t -99.39 168.12 10.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.495 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -7.0 44.02 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -114.07 -80.12 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.382 -0.199 . . . . 0.0 111.027 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.667 ' SG ' HG22 ' A' ' 79' ' ' THR . 4.0 m 60.42 152.47 0.1 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.897 0.879 . . . . 0.0 112.915 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.22 -89.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.364 2.043 . . . . 0.0 113.08 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.02 -16.83 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 5.8 t -49.5 -52.57 28.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.241 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -57.8 -39.13 76.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.099 0.249 . . . . 0.0 111.613 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -66.84 -50.6 62.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.503 ' HE2' ' CZ ' ' A' ' 82' ' ' PHE . 30.3 ttp -62.25 -46.13 90.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.744 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.6 -43.07 84.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.498 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.7 m -66.44 -56.77 9.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.638 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -91.89 -70.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.563 0.697 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' A' ' 104' ' ' ARG . 94.0 t -52.89 -48.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.065 -171.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 tp -81.41 -15.24 55.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -173.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 1' ' ' MET . 70.6 m -95.79 -1.09 50.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.606 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 47' ' ' VAL . 13.0 t70 -47.03 129.17 9.08 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.658 171.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.89 -37.52 85.47 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.131 2.554 . . . . 0.0 113.229 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.87 -42.59 30.28 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.026 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.692 HG22 HD22 ' A' ' 108' ' ' LEU . 8.1 t -66.66 -44.3 89.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -55.24 -40.64 71.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.688 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -70.22 -21.37 63.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.85 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.419 ' CD1' ' HB2' ' A' ' 108' ' ' LEU . 72.5 mt -70.16 -44.56 68.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' HB2' HD12 ' A' ' 3' ' ' LEU . 3.1 mm? -66.54 -60.56 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.361 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' OE1' HD13 ' A' ' 3' ' ' LEU . 9.5 mm-40 -50.08 -34.73 22.77 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.623 ' HB1' HH11 ' A' ' 54' ' ' ARG . . . -64.61 -53.15 52.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.623 HH11 ' HB1' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.38 11.61 3.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.532 ' CE2' ' HE2' ' A' ' 21' ' ' MET . 91.4 m-85 -123.28 145.79 48.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.039 0.447 . . . . 0.0 110.959 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 11' ' ' ALA . 22.0 t -107.98 118.09 54.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.543 HG11 ' SD ' ' A' ' 23' ' ' MET . 21.3 t -86.93 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.044 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -92.68 117.28 29.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.159 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 42.9 t -88.15 100.57 13.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.522 HG12 HD22 ' A' ' 70' ' ' LEU . 61.2 t -113.57 122.79 68.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.295 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.528 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 4.4 p -85.84 109.4 18.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.374 0.606 . . . . 0.0 109.679 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.518 HG21 ' HB1' ' A' ' 71' ' ' ALA . 5.1 p -88.99 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 123.091 1.424 . . . . 0.0 109.008 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.14 -38.7 0.07 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.075 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.631 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 3.1 p -81.63 164.66 48.22 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.511 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.3 Cg_endo -51.39 -55.23 4.2 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.534 2.823 . . . . 0.0 114.524 -170.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -36.63 84.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.585 0.231 . . . . 0.0 111.182 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.38 -34.02 64.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.649 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -71.19 -28.51 64.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.306 0.574 . . . . 0.0 110.714 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.31 -44.83 93.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.217 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.522 HD22 HG12 ' A' ' 60' ' ' VAL . 9.0 mp -65.86 -30.9 71.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 174.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.518 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -67.14 -35.24 79.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.589 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.579 ' HA ' ' NH2' ' A' ' 75' ' ' ARG . 20.1 ptt180 -83.37 -33.17 25.86 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.314 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.519 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 28.4 ttm180 -73.18 -56.67 4.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.519 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 90.7 m-85 -91.38 -11.89 36.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.329 -174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.709 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 1.2 mmp_? 64.74 91.16 0.08 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.686 0.616 . . . . 0.0 110.247 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 HG11 ' CG ' ' A' ' 26' ' ' PHE . 39.1 t -129.51 85.85 57.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -105.29 125.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.512 2.808 . . . . 0.0 113.196 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.453 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 124.95 -68.31 0.51 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.422 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.667 HG22 ' SG ' ' A' ' 31' ' ' CYS . 60.3 m 72.26 138.58 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.463 0.305 . . . . 0.0 110.836 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.49 ' HA ' HG21 ' A' ' 79' ' ' THR . 73.0 Cg_endo -78.51 143.76 73.07 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.707 0.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.706 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 35.5 m -122.77 122.66 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.038 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.649 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 9.7 m-85 -106.51 122.9 47.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.053 -175.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.645 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 45.2 t -124.11 105.43 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.04 118.89 32.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.327 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 94' ' ' GLU . 38.6 mt -113.11 137.28 51.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.441 HG22 ' SD ' ' A' ' 21' ' ' MET . 13.5 t -108.28 135.87 19.9 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.968 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.21 115.39 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.405 1.403 . . . . 0.0 108.794 166.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.86 111.28 5.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.831 0.348 . . . . 0.0 110.572 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.22 18.25 11.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.142 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.05 -23.64 34.83 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.852 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.87 -175.53 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.693 0.283 . . . . 0.0 110.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.406 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 95.0 m95 -115.7 136.9 52.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.472 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 32.4 tt0 -122.37 125.22 45.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.508 ' HA ' HD22 ' A' ' 85' ' ' LEU . 35.5 tt0 -78.58 95.98 5.35 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.495 HG23 ' HD3' ' A' ' 117' ' ' LYS . 1.4 p -102.38 -11.9 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.836 -170.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.72 104.48 0.36 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.744 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.501 ' HD3' ' CD ' ' A' ' 94' ' ' GLU . 8.5 tpt180 -111.97 124.76 53.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.9 mt -137.62 143.54 41.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -137.82 133.16 33.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.71 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.02 149.2 15.65 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.586 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.477 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 49.2 m -76.02 151.12 37.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.586 0.231 . . . . 0.0 110.872 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.829 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 16.9 mmt-85 -130.96 165.66 33.27 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.633 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 106' ' ' GLU . 21.5 Cg_exo -67.96 154.68 72.16 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.272 1.981 . . . . 0.0 109.808 162.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -57.41 -42.95 83.28 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -170.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.624 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . . . -79.76 -27.2 40.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.384 -175.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.56 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.4 mm-40 -76.9 -38.46 53.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.829 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 86.8 t80 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.042 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.692 HD22 HG22 ' A' ' 47' ' ' VAL . 4.3 pp -68.12 -22.95 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.629 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.4 ' N ' HD13 ' A' ' 108' ' ' LEU . 37.6 ttmt -67.14 -53.81 27.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.856 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 8.3 pt-20 -71.56 -32.13 67.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.195 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD13 ' CE2' ' A' ' 107' ' ' PHE . 5.9 tt -59.21 -42.53 91.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.441 ' O ' HG21 ' A' ' 116' ' ' VAL . 43.9 ttt180 -59.92 -43.7 94.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.252 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.6 OUTLIER -67.97 -23.43 65.04 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.327 -179.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 110' ' ' GLU . 93.9 t -81.73 -36.75 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.2 t -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.026 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 112' ' ' ARG . 57.9 t -65.72 -30.18 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.495 ' HD3' HG23 ' A' ' 95' ' ' VAL . 63.2 mttp -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.274 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.5 -18.97 68.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.557 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -123.16 15.32 8.24 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -165.92 83.5 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.22 0.533 . . . . 0.0 110.05 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 10.7 p -124.04 15.39 9.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.251 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.05 26.03 17.7 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.958 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -83.93 -175.18 5.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.715 0.293 . . . . 0.0 110.441 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.17 52.29 2.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.334 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.83 -24.92 61.78 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.506 0.322 . . . . 0.0 110.412 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.4 m80 71.8 170.09 0.32 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.72 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -144.75 113.41 6.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.759 176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -80.54 -7.34 59.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.196 0.522 . . . . 0.0 110.202 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -134.64 143.71 47.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.17 176.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 . . . . . 0 C--O 1.243 0.74 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.216 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 m -88.05 167.64 13.5 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -55.75 155.01 6.26 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.596 0.712 . . . . 0.0 112.484 -173.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.52 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 36.7 mmt-85 -87.71 108.91 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.746 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.511 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.8 m95 -111.15 109.17 19.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 87.3 m-85 -124.31 156.36 67.03 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.53 159.75 19.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.935 1.757 . . . . 0.0 111.198 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.574 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.1 t80 -45.38 -54.02 16.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.7 Cg_exo -63.91 -39.74 31.46 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.643 1.562 . . . . 0.0 112.179 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.19 -36.97 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.832 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.37 -48.31 70.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.038 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 8' ' ' TYR . 4.3 mm? -56.45 -42.67 78.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.695 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.12 63.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.074 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.11 -51.04 70.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.18 -38.67 91.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.681 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.43 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 48.9 tt0 -65.86 -42.35 90.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.877 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.43 -16.04 44.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -112.06 2.11 16.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.753 -175.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.4 40.56 97.89 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.296 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.515 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -108.54 179.67 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 110.412 178.211 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.58 ' HE3' HG23 ' A' ' 86' ' ' VAL . 85.5 mtp -104.82 154.98 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 12' ' ' LEU . 85.0 t -106.15 130.54 57.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.412 . . . . 0.0 111.324 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.42 103.61 11.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.397 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.5 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 21.6 t -84.54 113.7 23.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CD2' ' HZ3' ' A' ' 5' ' ' TRP . 56.7 t80 -104.48 106.67 17.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.995 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.08 125.61 37.76 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.892 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -141.93 160.93 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.474 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' ' 31' ' ' CYS . 3.4 m -142.11 150.92 41.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.89 -40.77 83.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 172.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -82.16 1.53 35.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.8 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.649 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 86.0 m -132.86 68.05 78.47 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.175 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.39 38.49 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.076 2.517 . . . . 0.0 114.178 -167.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -73.61 -43.06 60.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.155 0.502 . . . . 0.0 111.124 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.694 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 16.1 t -77.46 -19.16 56.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.34 -176.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -54.81 -26.25 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.78 -32.16 31.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.424 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.2 ttm -78.97 -46.14 18.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.751 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 32.0 p30 -66.36 -21.07 66.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -78.68 -59.11 2.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.23 -70.19 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.932 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.52 HG11 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -54.98 -49.53 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.873 -170.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 25.0 tp -81.57 -21.48 38.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.465 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -95.34 -2.22 49.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 0.0 110.609 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -50.81 133.26 28.49 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.226 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.33 -44.27 39.78 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.246 2.631 . . . . 0.0 113.451 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.65 68.21 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.028 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG23 HD21 ' A' ' 108' ' ' LEU . 84.6 t -57.73 -48.18 84.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 109.845 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.411 ' HA ' HD22 ' A' ' 3' ' ' LEU . 66.4 m -53.53 -50.91 64.45 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.013 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -54.57 -29.42 51.28 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.817 HD11 HD22 ' A' ' 108' ' ' LEU . 74.9 mt -73.42 -54.02 9.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 111.313 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HB3' HD13 ' A' ' 3' ' ' LEU . 3.5 mm? -68.74 -39.62 80.26 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.12 -33.75 67.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.736 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . . . -71.56 -49.84 36.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.508 ' HD3' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.12 15.25 3.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -173.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 78.4 m-85 -121.2 143.46 49.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.424 0.63 . . . . 0.0 112.073 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.91 113.7 44.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.297 170.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.1 t -87.17 127.44 40.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.099 0.476 . . . . 0.0 110.881 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -93.4 117.09 29.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.986 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 p -83.82 102.09 12.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.098 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.04 126.03 74.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.028 0.442 . . . . 0.0 110.842 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.424 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.9 OUTLIER -113.09 132.64 55.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.464 HG12 ' CB ' ' A' ' 71' ' ' ALA . 46.3 t -79.68 -16.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.421 0.629 . . . . 0.0 111.244 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -76.21 -10.97 59.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.951 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.617 ' OG1' ' HD2' ' A' ' 65' ' ' PRO . 5.0 t -114.04 149.17 41.49 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.402 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.617 ' HD2' ' OG1' ' A' ' 64' ' ' THR . 19.0 Cg_endo -53.14 -50.91 12.36 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 123.523 2.815 . . . . 0.0 114.534 -169.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -31.88 62.75 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.138 -174.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -74.82 -30.42 59.61 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.653 174.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 64' ' ' THR . 4.6 tt0 -69.74 -36.89 76.22 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -54.34 -48.86 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.205 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.19 -43.42 92.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.297 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 62' ' ' VAL . . . -57.99 -49.19 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.257 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.88 -20.79 41.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.262 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -62.3 -48.84 78.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 110.009 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.48 -15.06 29.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.007 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 65.04 79.64 0.25 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.516 0.674 . . . . 0.0 110.245 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.3 t -123.1 97.55 43.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.382 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -101.29 130.42 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.387 2.725 . . . . 0.0 113.35 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.615 ' O ' ' HB3' ' A' ' 31' ' ' CYS . . . 104.04 -56.49 0.57 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.568 169.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.601 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 20.1 p 60.38 161.19 0.11 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.652 0.781 . . . . 0.0 111.638 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.694 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 45.3 Cg_endo -69.64 145.74 80.01 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 124.035 -1.235 . . . . 0.0 112.367 -0.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.528 ' HG1' ' HD1' ' A' ' 99' ' ' PHE . 40.3 m -134.21 116.58 15.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.185 0.517 . . . . 0.0 110.037 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 6.1 m-85 -106.27 112.34 25.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.666 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 47.0 t -108.88 113.46 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.788 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 18.0 m-85 -96.61 127.69 42.83 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.566 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.688 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.3 mt -116.52 131.13 57.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.972 0.415 . . . . 0.0 110.73 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.58 HG23 ' HE3' ' A' ' 21' ' ' MET . 91.7 t -109.64 129.8 23.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.774 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.39 117.88 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.841 1.694 . . . . 0.0 110.8 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.16 125.01 31.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.15 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.808 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -155.69 25.04 0.57 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.156 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.83 166.78 23.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.483 0.183 . . . . 0.0 110.852 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 91.3 m95 -103.25 153.21 20.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 59.0 mt-10 -119.74 133.56 55.57 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.387 167.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.461 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 34.1 tt0 -81.6 94.96 7.02 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.78 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 22.7 m -85.17 -5.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.943 -166.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.17 158.78 9.41 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.362 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -129.72 130.23 45.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 68.0 mt -108.49 134.47 51.22 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.528 ' HD1' ' HG1' ' A' ' 81' ' ' THR . 71.9 t80 -137.52 143.4 41.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.843 0.354 . . . . 0.0 111.044 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.84 162.35 25.85 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.281 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -74.55 116.26 15.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.118 0.485 . . . . 0.0 109.814 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -124.36 143.36 42.74 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.722 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.03 158.03 45.79 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.117 1.878 . . . . 0.0 110.268 169.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.52 ' HB3' HG11 ' A' ' 41' ' ' VAL . 33.5 ptt180 -62.55 -26.8 68.76 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.722 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.99 97.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.363 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.503 ' CD ' ' HZ1' ' A' ' 109' ' ' LYS . 26.2 mm-40 -69.18 -48.55 61.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.34 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.72 -52.4 65.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.883 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.817 HD22 HD11 ' A' ' 50' ' ' LEU . 71.0 mt -65.96 -30.23 70.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.258 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.503 ' HZ1' ' CD ' ' A' ' 106' ' ' GLU . 11.2 ttmt -55.57 -62.45 1.68 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.102 175.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.495 ' O ' HG22 ' A' ' 114' ' ' VAL . 1.1 mt-10 -70.76 -32.8 70.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.407 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD23 HD13 ' A' ' 51' ' ' LEU . 2.7 tm? -62.08 -41.29 98.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.209 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 42.7 mtm180 -68.5 -32.69 72.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.267 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 12.2 mm-40 -67.42 -35.46 79.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.043 0.449 . . . . 0.0 110.651 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 110' ' ' GLU . 95.6 t -66.75 -36.36 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.05 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.64 -34.55 71.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.35 -51.46 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.131 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.78 ' HE3' ' HB ' ' A' ' 95' ' ' VAL . 16.2 mtpp -59.79 -24.36 64.05 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -53.39 -31.58 43.34 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.44 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -122.45 20.27 7.91 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 117' ' ' LYS . . . -134.01 17.29 3.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.959 0.409 . . . . 0.0 111.046 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.466 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 19.2 m -74.98 109.24 8.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.246 0.546 . . . . 0.0 109.762 174.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.18 -25.62 21.42 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -170.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.798 ' HG3' ' H ' ' A' ' 124' ' ' GLY . 7.6 tp10 -89.38 -139.68 0.13 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.798 ' H ' ' HG3' ' A' ' 123' ' ' GLU . . . 91.22 2.88 70.38 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -95.83 117.57 30.81 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -58.49 -31.49 67.9 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.527 0.517 . . . . 0.0 112.338 -170.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -160.1 156.95 27.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.082 0.467 . . . . 0.0 110.721 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.525 ' CE1' ' HB3' ' A' ' 130' ' ' HIS . 0.2 OUTLIER -169.29 -169.28 0.92 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -75.84 74.52 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.741 0.781 . . . . 0.0 109.779 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.525 ' HB3' ' CE1' ' A' ' 128' ' ' HIS . 3.0 t-160 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.135 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m 65.88 -163.25 0.25 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -170.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.427 HD11 ' CB ' ' A' ' 51' ' ' LEU . 17.9 tp -133.82 145.85 50.12 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.696 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.481 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.4 mmt180 -86.81 103.07 14.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.971 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -105.59 103.95 13.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 85.6 m-85 -118.74 149.06 45.71 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.632 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.7 Cg_exo -59.67 166.26 8.46 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.423 2.082 . . . . 0.0 111.487 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.548 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -48.31 -50.99 53.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.1 Cg_exo -58.46 -49.25 12.56 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.823 1.682 . . . . 0.0 112.389 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 9.3 mt-10 -63.8 -42.94 97.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.704 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -59.99 -48.25 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.644 0.259 . . . . 0.0 111.54 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.6 mm? -63.29 -39.84 95.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.82 -37.69 48.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.08 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 56' ' ' VAL . 9.8 tp -64.15 -46.71 82.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.93 96.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -64.52 -45.66 86.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.516 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.8 -14.49 59.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -116.8 3.11 12.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.576 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.11 37.07 94.32 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.59 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.727 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.3 mmp_? -106.94 177.48 4.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.531 ' SD ' HG22 ' A' ' 86' ' ' VAL . 31.7 mtm -103.93 158.32 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG21 HD12 ' A' ' 12' ' ' LEU . 59.3 t -105.93 123.74 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.934 0.397 . . . . 0.0 111.17 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.506 ' HE2' HD11 ' A' ' 42' ' ' LEU . 21.1 ttt -103.4 103.58 13.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 173.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.575 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 40.6 t -85.42 108.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.416 ' HH ' ' HG3' ' A' ' 37' ' ' MET . 81.5 t80 -106.59 103.57 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 110.793 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.612 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.3 m-85 -80.63 120.76 24.98 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.197 176.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.57 ' HA ' HG21 ' A' ' 79' ' ' THR . 31.5 p80 -129.3 155.94 44.79 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.918 0.761 . . . . 0.0 109.316 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 31' ' ' CYS . 92.7 p -137.03 166.28 24.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.679 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -78.08 -5.89 52.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.761 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -119.58 -0.5 10.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.455 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 28' ' ' SER . 21.8 p -58.44 130.26 84.44 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.534 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 63.6 Cg_endo -76.91 -86.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.225 1.95 . . . . 0.0 114.045 -175.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.84 -18.77 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.578 . . . . 0.0 110.735 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.567 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 29.3 t -63.27 -42.06 99.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 4.3 pt20 -66.93 -23.49 65.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.402 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -79.3 -48.44 14.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.406 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.567 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 17.2 ptp -66.98 -39.15 87.12 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.781 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.07 -34.59 68.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.467 . . . . 0.0 110.672 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 43' ' ' SER . 26.0 m -83.25 -61.04 1.95 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.525 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -91.38 -70.6 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.657 HG13 ' HB2' ' A' ' 104' ' ' ARG . 70.8 t -49.31 -55.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.077 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD11 ' HE2' ' A' ' 23' ' ' MET . 21.2 tp -83.03 -27.07 30.59 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.738 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 39' ' ' THR . 31.2 t -88.39 -4.99 58.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.09 -175.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB3' HG21 ' A' ' 47' ' ' VAL . 13.3 t70 -51.26 130.88 32.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.644 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.706 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 27.5 Cg_exo -62.14 -20.94 71.54 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.854 2.37 . . . . 0.0 113.504 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.87 -34.52 38.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.174 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.53 HG23 HD22 ' A' ' 108' ' ' LEU . 14.8 t -76.89 -40.54 31.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 108.861 175.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 45' ' ' PRO . 36.8 p -59.08 -33.49 70.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.105 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.706 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 87.3 mtt180 -56.78 -35.54 68.8 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.743 0.306 . . . . 0.0 111.45 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.75 -43.42 84.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.735 0.302 . . . . 0.0 110.448 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.427 ' CB ' HD11 ' A' ' 3' ' ' LEU . 2.7 mm? -73.94 -45.78 48.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.762 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -44.79 -48.98 10.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.663 ' HB2' HH11 ' A' ' 54' ' ' ARG . . . -66.87 -48.54 68.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.727 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.67 16.3 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -170.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.463 ' CE2' ' HE3' ' A' ' 21' ' ' MET . 92.7 m-85 -130.05 145.71 51.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.407 0.623 . . . . 0.0 111.447 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 11' ' ' ALA . 60.4 t -114.86 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 21.6 t -86.95 121.31 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.193 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -89.62 117.1 28.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.868 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.0 p -84.65 100.14 11.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.5 t -104.28 106.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.995 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.639 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -90.04 109.16 20.22 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.944 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.477 HG12 ' HB2' ' A' ' 71' ' ' ALA . 25.9 t -75.15 -6.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.071 0.938 . . . . 0.0 109.27 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.679 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -77.53 -32.57 54.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.913 174.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.644 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.4 p -99.55 159.38 30.17 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.87 -53.51 6.87 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.235 3.29 . . . . 0.0 114.835 -169.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.37 80.05 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.8 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.78 -39.84 54.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.307 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -56.75 -39.79 74.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.658 0.742 . . . . 0.0 110.044 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.98 -44.87 79.35 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.899 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -34.7 78.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 62' ' ' VAL . . . -64.54 -38.34 90.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -83.62 -20.49 33.56 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.811 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -80.71 -48.92 11.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.591 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -86.44 -10.93 53.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.192 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 73.1 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.804 0.69 . . . . 0.0 109.977 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.04 86.42 58.14 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.626 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -103.15 122.57 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.673 2.916 . . . . 0.0 112.741 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.462 ' HA3' ' HE1' ' A' ' 99' ' ' PHE . . . 133.92 -74.58 0.43 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.412 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.57 HG21 ' HA ' ' A' ' 27' ' ' HIS . 23.7 m 73.23 141.97 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 123.704 0.297 . . . . 0.0 110.586 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 55.4 Cg_endo -69.08 153.99 91.36 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 124.426 -1.072 . . . . 0.0 113.32 1.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.1 m -138.94 123.82 18.77 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.432 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.57 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 1.5 m-85 -112.27 112.56 24.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.842 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.575 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 59.0 t -118.02 115.22 47.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HB2' HG23 ' A' ' 95' ' ' VAL . 49.2 m-85 -102.16 124.02 47.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.92 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 32.8 mt -117.59 132.46 56.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.531 HG22 ' SD ' ' A' ' 21' ' ' MET . 14.9 t -110.71 132.73 21.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.578 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.7 115.04 3.04 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.251 1.3 . . . . 0.0 110.748 170.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -169.13 141.52 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.99 11.41 8.33 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.66 0.6 . . . . 0.0 111.342 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.8 29.6 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.63 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.98 -177.12 3.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.0 111.076 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 67.1 m95 -105.74 130.74 53.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.011 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 31.3 tt0 -97.14 119.82 36.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.238 176.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.496 ' HA ' HD22 ' A' ' 85' ' ' LEU . 33.0 tt0 -75.24 96.56 3.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.933 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 13.7 m -73.91 -11.73 14.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.953 -173.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.79 141.82 3.23 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.763 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -116.16 128.24 55.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.229 0.537 . . . . 0.0 109.642 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.57 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.3 mt -108.03 131.39 54.63 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.462 ' HE1' ' HA3' ' A' ' 78' ' ' GLY . 79.1 t80 -130.9 124.1 30.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.81 178.26 15.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.412 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 8.0 m -112.91 126.29 55.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.468 ' HE ' ' HG2' ' A' ' 106' ' ' GLU . 24.4 mmm180 -128.05 151.02 75.3 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.779 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.07 158.94 41.05 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.254 1.969 . . . . 0.0 111.262 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.657 ' HB2' HG13 ' A' ' 41' ' ' VAL . 67.7 ttt180 -58.67 -34.83 71.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.386 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.64 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.086 0.469 . . . . 0.0 110.634 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.468 ' HG2' ' HE ' ' A' ' 102' ' ' ARG . 3.9 tp10 -67.02 -48.77 67.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.409 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -66.08 -37.36 85.6 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.843 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.53 HD22 HG23 ' A' ' 47' ' ' VAL . 60.6 mt -59.06 -44.51 91.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 0.0 110.73 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 46.7 mtmt -65.1 -48.07 74.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.32 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -59.36 -55.56 33.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.409 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.31 -32.39 72.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.32 0.581 . . . . 0.0 109.897 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -65.44 -37.85 88.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 175.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 109' ' ' LYS . 29.2 mm-40 -74.37 -43.19 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.553 0.215 . . . . 0.0 110.937 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.423 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . 79.5 t -62.67 -36.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.166 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.1 t -55.16 -29.73 58.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.576 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.9 t -85.42 -54.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.245 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.933 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -70.95 -11.53 61.02 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.107 -170.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.438 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -56.12 -41.09 85.14 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.167 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.06 -33.11 4.74 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.98 65.89 0.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.899 0.38 . . . . 0.0 111.213 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 7.7 p -71.6 122.59 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.44 41.26 0.89 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -166.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 123' ' ' GLU . 3.7 mp0 -43.54 104.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.165 1.386 . . . . 0.0 113.147 -170.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.51 -1.4 4.18 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.223 -0.898 . . . . 0.0 113.42 175.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.6 m80 59.19 25.28 13.8 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 121.09 0.471 . . . . 0.0 110.305 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -142.96 106.71 4.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.885 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -103.0 159.94 15.06 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -71.26 118.1 13.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.818 0.342 . . . . 0.0 110.934 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -63.38 147.25 51.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.455 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 . . . . . 0 C--O 1.244 0.785 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 169.778 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.47 ' H2 ' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 t 68.78 -171.35 0.18 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.459 ' HB3' ' NE1' ' A' ' 5' ' ' TRP . 11.3 tp -133.66 155.42 49.74 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.436 -176.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -102.17 103.8 14.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.68 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.459 ' NE1' ' HB3' ' A' ' 3' ' ' LEU . 13.2 m95 -104.35 139.78 38.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.539 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.421 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 86.1 m-85 -138.91 166.63 23.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.68 159.35 41.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.54 1.494 . . . . 0.0 110.884 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 60.4 t80 -50.84 -51.36 67.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.2 Cg_exo -60.85 -43.69 29.71 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.834 1.689 . . . . 0.0 112.386 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -65.71 -46.07 80.33 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HA ' HG12 ' A' ' 56' ' ' VAL . . . -55.15 -41.82 72.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.45 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.38 -38.78 91.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.044 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.47 -47.79 58.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.878 0.371 . . . . 0.0 110.399 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' HG12 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -54.21 -51.4 64.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.857 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.42 -43.96 95.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.357 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -62.39 -47.45 84.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.369 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.35 -15.45 57.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -112.58 -1.73 14.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.43 32.46 81.88 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.264 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.53 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 24.9 mmt180 -97.44 177.63 5.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.397 . . . . 0.0 110.675 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.653 ' HE3' HG22 ' A' ' 86' ' ' VAL . 88.1 mtp -104.5 156.25 18.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.474 176.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 49.9 t -105.95 124.69 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 ttt -104.39 103.47 13.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 37.5 t -84.5 104.54 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.896 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.9 t80 -102.33 108.84 20.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.077 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.977 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.7 m-85 -90.1 124.97 35.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.579 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 23.5 p80 -128.08 155.85 43.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.564 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.433 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 38.2 t -143.1 159.48 42.2 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -74.87 -9.05 58.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.57 0.7 . . . . 0.0 109.935 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -97.86 15.96 22.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.998 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 31.8 p -84.84 115.22 59.93 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.839 0.352 . . . . 0.0 110.562 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 79' ' ' THR . 38.0 Cg_endo -68.0 -69.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.497 2.132 . . . . 0.0 113.866 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.88 -17.19 36.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 44.5 t -55.46 -46.92 76.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.487 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -56.6 -38.25 71.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.38 . . . . 0.0 111.638 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -72.2 -38.93 68.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 50.8 ttm -65.32 -49.38 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.856 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 77.6 m-20 -52.36 -49.27 64.69 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.363 0.415 . . . . 0.0 111.018 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.9 m -59.86 -59.99 4.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.888 -175.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.05 -68.4 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 112.071 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 104' ' ' ARG . 68.6 t -58.9 -44.35 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.804 -170.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 21.1 tp -81.74 -34.68 30.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.334 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.4 t -85.74 -0.99 56.74 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -49.87 128.46 20.83 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.117 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.57 -35.63 57.16 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.222 2.614 . . . . 0.0 113.242 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.86 -48.22 28.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.962 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.695 HG21 HD21 ' A' ' 108' ' ' LEU . 59.6 t -61.36 -57.5 11.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.107 0.479 . . . . 0.0 110.762 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.661 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 54.9 m -52.23 -47.41 65.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.085 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -58.5 -36.56 73.98 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD12 HD13 ' A' ' 111' ' ' LEU . 76.7 mt -62.68 -40.38 96.92 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.0 110.593 176.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.5 mm? -74.53 -40.58 61.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.292 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.6 mt-10 -49.48 -50.21 42.32 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.204 0.526 . . . . 0.0 112.023 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.14 82.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -135.23 11.95 3.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 86.4 m-85 -121.38 145.64 47.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.353 0.597 . . . . 0.0 111.246 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.442 HG12 ' HB3' ' A' ' 14' ' ' LEU . 20.1 t -111.98 113.66 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.403 HG21 HD21 ' A' ' 3' ' ' LEU . 21.8 t -87.03 117.4 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 8' ' ' TYR . . . -90.31 117.27 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.45 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.1 p -85.14 101.41 12.44 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.9 125.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.565 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.612 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -100.48 108.52 20.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.057 0.456 . . . . 0.0 110.571 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.36 -11.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.054 0.93 . . . . 0.0 109.636 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 6.8 m-20 -77.68 -32.34 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.609 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.599 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -109.1 165.46 12.6 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.778 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.599 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.3 Cg_endo -49.73 -52.95 7.86 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.092 3.194 . . . . 0.0 114.491 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -43.37 79.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.34 -31.15 52.59 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.98 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -60.19 -41.32 92.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.724 0.297 . . . . 0.0 111.065 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.57 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.1 pt-20 -79.25 -30.64 43.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.882 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.83 -44.19 93.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 0.0 110.247 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 76' ' ' VAL . . . -60.06 -49.01 79.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.449 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.57 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.8 ptm180 -65.39 -30.68 71.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.111 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -66.51 -41.39 88.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 110.276 -179.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -92.33 -6.09 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.24 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 65.38 33.11 9.21 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.683 0.614 . . . . 0.0 111.439 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.413 ' O ' ' HB1' ' A' ' 71' ' ' ALA . 13.1 t -130.26 144.99 55.46 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.484 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 17.0 Cg_exo -69.63 -116.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.378 2.052 . . . . 0.0 111.282 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.497 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . 168.14 63.32 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 12.5 p -137.86 47.72 1.76 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 43.5 Cg_endo -93.08 174.38 16.62 Favored 'Cis proline' 0 C--N 1.356 0.949 0 CA-C-N 121.0 1.393 . . . . 0.0 112.507 -3.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.977 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 62.8 m -139.18 131.64 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 170.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -127.75 112.23 14.56 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.662 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 57.4 t -111.43 121.63 64.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.735 0.303 . . . . 0.0 110.199 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.49 116.62 30.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.668 0.27 . . . . 0.0 110.357 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 29.3 mt -112.93 137.04 51.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.213 0.53 . . . . 0.0 111.408 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.653 HG22 ' HE3' ' A' ' 21' ' ' MET . 58.8 t -109.98 123.33 36.46 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.03 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.558 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 59.5 Cg_endo -77.11 116.42 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.778 1.652 . . . . 0.0 111.193 173.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -147.85 135.33 20.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.684 0.278 . . . . 0.0 110.574 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.0 24.16 14.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.554 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.56 77.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.343 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.31 167.02 20.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 65.7 m95 -106.36 126.12 51.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.943 0.401 . . . . 0.0 110.026 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.8 tp10 -114.04 137.44 51.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.623 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 38.1 tt0 -88.29 112.91 23.35 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.521 HG23 ' HE2' ' A' ' 117' ' ' LYS . 8.7 p -98.93 7.46 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.499 0.666 . . . . 0.0 110.336 -175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.46 138.49 2.88 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.504 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -122.94 133.06 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.153 0.502 . . . . 0.0 110.508 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.98 128.39 56.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.923 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.514 ' HD1' ' HG1' ' A' ' 81' ' ' THR . 83.4 t80 -137.18 143.42 42.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.986 0.422 . . . . 0.0 110.965 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.02 -177.27 28.82 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.353 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.6 m -88.79 107.84 19.18 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.494 ' HB3' ' OE1' ' A' ' 106' ' ' GLU . 4.1 mmm180 -111.29 143.65 28.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.658 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.69 151.27 82.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.26 1.973 . . . . 0.0 110.925 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.687 ' HB2' HG12 ' A' ' 41' ' ' VAL . 22.6 ttp180 -59.21 -27.35 65.64 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.89 92.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.65 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' A' ' 102' ' ' ARG . 50.0 tt0 -82.84 -38.27 23.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 37.2 t80 -58.38 -51.4 69.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.675 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.695 HD21 HG21 ' A' ' 47' ' ' VAL . 57.8 mt -70.59 -28.23 64.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -56.7 -55.62 31.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.249 0.547 . . . . 0.0 109.879 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.471 ' O ' HG22 ' A' ' 114' ' ' VAL . 20.8 tp10 -73.74 -31.64 63.46 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.112 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.473 HD13 HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -60.31 -46.58 89.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -60.82 -38.06 84.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.83 -48.52 58.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 110' ' ' GLU . 55.5 t -58.36 -42.45 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.505 0.322 . . . . 0.0 111.75 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.0 p -63.05 -23.85 67.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 110.497 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -86.11 -50.12 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.661 173.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.521 ' HE2' HG23 ' A' ' 95' ' ' VAL . 38.2 mtpt -55.22 -34.3 63.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.236 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.496 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -68.41 -24.09 75.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.949 -0.644 . . . . 0.0 113.152 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.07 -39.55 3.06 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.507 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -158.96 99.9 1.55 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 117' ' ' LYS . 4.9 p -79.64 48.07 0.9 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.314 0.578 . . . . 0.0 111.308 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.36 25.79 69.72 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.902 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -61.64 158.94 14.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.072 0.463 . . . . 0.0 111.456 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 126' ' ' HIS . . . 69.85 52.43 19.68 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -167.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -70.26 13.54 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -168.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 124' ' ' GLY . 17.5 t-80 -129.26 13.05 6.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.005 0.431 . . . . 0.0 110.044 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.46 129.43 34.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.436 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 60.16 30.07 19.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.487 0.661 . . . . 0.0 109.993 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -155.07 105.99 2.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.893 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.4 p80 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.858 175.92 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -90.59 3.15 54.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.36 0.6 . . . . 0.0 110.322 173.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.1 tp -72.68 136.27 45.58 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.588 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.403 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 23.0 mmt180 -88.3 106.38 18.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.646 -172.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -110.24 108.71 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 94.2 m-85 -133.17 154.26 81.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 34.6 Cg_exo -57.05 161.71 10.37 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.09 1.86 . . . . 0.0 111.504 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.56 ' O ' HD22 ' A' ' 12' ' ' LEU . 82.9 t80 -45.81 -53.66 19.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 20.9 Cg_exo -65.17 -40.68 18.91 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.485 1.457 . . . . 0.0 112.146 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.401 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 31.6 tt0 -71.08 -37.33 72.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.926 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.23 79.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.005 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.56 HD22 ' O ' ' A' ' 8' ' ' TYR . 4.6 mm? -61.18 -34.5 75.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.593 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -39.05 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.784 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HB3' HG12 ' A' ' 56' ' ' VAL . 11.5 tp -64.22 -47.31 80.19 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.008 0.432 . . . . 0.0 110.138 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.52 89.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.434 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -62.77 -51.65 66.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.226 178.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.72 -14.38 59.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.029 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -118.68 3.62 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.765 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.67 44.4 95.7 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.458 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.8 mmp_? -107.43 174.86 5.7 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.671 -0.311 . . . . 0.0 110.791 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.496 ' HE1' HG21 ' A' ' 86' ' ' VAL . 79.6 mtp -100.52 156.55 17.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 24.6 t -106.79 127.54 62.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.422 ' HE2' HD11 ' A' ' 42' ' ' LEU . 22.2 ttt -111.07 104.25 12.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.465 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -88.38 107.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -93.02 103.97 16.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 110.137 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.658 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 59.8 m-85 -87.41 122.48 31.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.302 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 62' ' ' VAL . 32.5 p80 -132.62 137.21 46.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.511 ' N ' ' HB3' ' A' ' 31' ' ' CYS . 50.6 m -60.81 167.01 3.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.751 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' N ' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -53.5 -38.22 63.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.285 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -102.05 -48.7 4.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p 41.19 78.45 0.37 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.467 1.107 . . . . 0.0 112.879 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.649 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 69.4 Cg_endo -79.24 -59.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 114.297 -174.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.447 ' HD2' ' HG ' ' A' ' 101' ' ' SER . 33.9 t80 -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 22.6 p -82.68 -21.64 34.85 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -173.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.649 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 8.3 pt20 -61.79 -30.84 71.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.64 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -66.02 -43.56 87.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.358 0.599 . . . . 0.0 109.551 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.426 ' SD ' ' HB3' ' A' ' 101' ' ' SER . 64.2 mmm -59.41 -44.4 92.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.704 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -62.79 -54.62 36.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.598 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 43' ' ' SER . 58.4 m -70.57 -37.65 74.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.27 -71.78 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.864 -0.523 . . . . 0.0 112.011 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.83 -45.53 94.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.285 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.422 HD11 ' HE2' ' A' ' 23' ' ' MET . 25.6 tp -80.93 -31.45 35.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.673 0.273 . . . . 0.0 111.451 -174.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 39' ' ' THR . 33.1 t -83.82 -4.48 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.934 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.81 129.15 14.42 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.351 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.33 -48.38 15.27 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.334 2.69 . . . . 0.0 113.547 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.12 -37.07 86.75 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.409 -176.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.512 ' HA ' HD23 ' A' ' 108' ' ' LEU . 34.8 t -66.63 -57.26 10.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.11 0.481 . . . . 0.0 109.882 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.656 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 50.1 m -52.35 -46.27 66.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.721 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.08 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.677 HD13 HD21 ' A' ' 108' ' ' LEU . 61.4 mt -61.51 -41.55 97.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.222 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.77 -40.66 65.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.2 mt-10 -57.68 -34.16 69.12 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . . . -67.67 -52.84 33.17 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.654 HH22 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.88 15.8 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -172.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -121.49 146.4 46.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.474 0.654 . . . . 0.0 111.871 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 14' ' ' LEU . 56.9 t -113.16 115.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 23' ' ' MET . 21.4 t -87.11 125.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.022 0.439 . . . . 0.0 110.582 -176.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.85 116.91 28.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.888 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -83.48 101.28 11.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.61 103.09 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.453 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 p -94.17 110.77 22.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.292 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.483 ' HB ' ' N ' ' A' ' 29' ' ' GLU . 97.1 t -70.28 -13.65 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.473 0.654 . . . . 0.0 110.367 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -73.94 -27.89 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.837 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.47 ' HB ' ' OE2' ' A' ' 66' ' ' GLU . 76.2 p -91.47 151.91 43.09 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.719 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 43.6 Cg_endo -61.58 -36.92 73.51 Favored 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 122.741 2.294 . . . . 0.0 113.565 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.504 ' O ' HD22 ' A' ' 70' ' ' LEU . 1.2 mp0 -57.3 -52.65 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.515 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.12 -29.77 66.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.825 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.719 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 2.1 pt20 -62.39 -47.46 84.07 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -72.62 -33.11 66.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.122 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.504 HD22 ' O ' ' A' ' 66' ' ' GLU . 1.9 mm? -59.19 -42.88 91.93 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . -62.19 -41.56 98.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.449 176.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 4.5 mtp180 -61.96 -43.81 98.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.12 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.45 -48.8 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.598 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.17 -6.65 58.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.458 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 57.45 46.74 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.738 0.649 . . . . 0.0 110.592 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.23 120.18 28.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.313 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -93.35 105.76 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.601 2.867 . . . . 0.0 110.61 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.47 92.28 1.5 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.362 -168.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.86 48.26 0.81 Allowed Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.699 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 Cg_endo -94.11 173.34 15.81 Favored 'Cis proline' 0 C--N 1.356 0.955 0 CA-C-N 120.541 1.229 . . . . 0.0 112.13 -4.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.658 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 18.0 m -142.67 137.95 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.833 167.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.21 118.19 21.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.755 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.492 HG22 ' HG2' ' A' ' 97' ' ' ARG . 86.6 t -115.27 126.89 72.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -104.72 122.97 46.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 35.4 mt -117.5 130.94 56.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG21 ' HE1' ' A' ' 21' ' ' MET . 39.9 t -109.87 127.95 26.23 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.466 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 58.4 Cg_endo -73.52 117.75 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 121.973 1.782 . . . . 0.0 110.432 171.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -164.04 143.78 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.716 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.06 -76.28 0.06 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.042 0.839 . . . . 0.0 111.187 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.47 22.43 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.852 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -161.9 -171.39 2.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.466 ' CE2' HD13 ' A' ' 12' ' ' LEU . 58.9 m95 -103.41 128.37 50.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.0 109.997 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 35.5 tt0 -94.81 115.2 27.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.453 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 34.9 tt0 -73.88 103.01 4.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 171.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' HD3' ' A' ' 117' ' ' LYS . 9.0 p -102.39 6.93 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.607 -167.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.8 146.54 4.54 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.468 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.492 ' HG2' HG22 ' A' ' 83' ' ' VAL . 77.7 mtt180 -123.42 126.58 47.05 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.512 HD21 ' HG3' ' A' ' 110' ' ' GLU . 83.4 mt -109.57 131.7 54.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.449 ' HD1' ' HG1' ' A' ' 81' ' ' THR . 86.7 t80 -137.15 142.14 42.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.44 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.98 136.86 7.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.391 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.447 ' HG ' ' HD2' ' A' ' 33' ' ' TYR . 11.8 m -66.18 122.37 17.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 110.595 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.442 ' NE ' ' HA ' ' A' ' 102' ' ' ARG . 4.0 mmp_? -124.01 157.2 64.42 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.776 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.87 154.87 30.07 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.373 2.049 . . . . 0.0 112.041 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -31.07 67.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.628 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.411 ' O ' ' HE3' ' A' ' 109' ' ' LYS . . . -67.81 -38.33 83.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.291 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.43 -32.81 48.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.538 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.69 -49.86 71.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.74 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.677 HD21 HD13 ' A' ' 50' ' ' LEU . 24.1 mt -70.5 -20.69 62.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 105' ' ' ALA . 1.0 OUTLIER -59.8 -61.2 2.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.512 ' HG3' HD21 ' A' ' 98' ' ' LEU . 2.1 tm-20 -67.85 -38.72 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.69 -44.34 90.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 110.551 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -64.65 -36.95 85.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 109.954 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 22.2 mt-30 -65.98 -38.96 89.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.52 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 72.4 t -61.51 -34.9 63.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.923 176.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.35 -34.99 71.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.326 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -84.24 -40.11 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.52 ' HD2' ' HA ' ' A' ' 114' ' ' VAL . 96.9 mttt -52.0 -57.2 10.18 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.027 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -51.68 -34.6 36.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.153 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.09 -17.94 72.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.944 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.82 -83.89 0.22 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.752 -0.264 . . . . 0.0 111.447 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 90.7 m 57.82 24.73 11.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -168.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.04 -129.51 10.73 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -168.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.481 ' CD ' ' H ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -137.33 -51.09 0.64 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.274 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' H ' ' CD ' ' A' ' 123' ' ' GLU . . . -112.9 30.77 7.21 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.3 m170 57.97 43.45 21.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 122.911 0.484 . . . . 0.0 110.996 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -72.88 92.61 1.63 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -74.02 82.31 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.574 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.506 ' HB2' ' H ' ' A' ' 129' ' ' HIS . 1.2 m80 61.31 -89.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.055 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.506 ' H ' ' HB2' ' A' ' 128' ' ' HIS . 27.3 m80 -157.41 -30.61 0.08 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 . . . . . 0 C--O 1.242 0.672 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.788 167.151 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttp . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.64 0.257 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p -125.42 23.46 7.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.211 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.553 HD21 HG23 ' A' ' 57' ' ' VAL . 27.7 tp -120.39 146.13 46.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.276 -171.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.52 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.0 mmp_? -77.09 103.76 7.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.371 . . . . 0.0 111.297 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -105.64 115.08 29.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.754 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.5 m-85 -121.97 159.41 51.63 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.592 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 14.4 Cg_exo -67.88 157.91 59.69 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.964 1.776 . . . . 0.0 110.761 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.582 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 92.6 t80 -43.78 -53.14 13.18 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.2 Cg_exo -59.13 -52.02 5.68 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.787 1.658 . . . . 0.0 112.766 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.4 mm-40 -70.34 -30.6 67.6 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.32 -47.18 87.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.2 0.524 . . . . 0.0 110.259 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.45 -40.39 95.64 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.823 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.81 -36.51 65.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.04 0.448 . . . . 0.0 110.741 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -61.79 -37.92 86.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.191 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.12 -49.03 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.489 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 46.3 tt0 -57.52 -54.32 48.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 122.913 0.485 . . . . 0.0 112.308 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.84 60.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.612 -172.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 12.7 m-70 -110.35 -22.87 11.5 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.23 -174.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.8 6.83 54.09 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.043 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 20' ' ' ARG . 4.0 mpt_? -85.9 -177.82 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.664 0.268 . . . . 0.0 111.402 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.77 158.74 17.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 38.8 t -106.36 135.62 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.67 0.272 . . . . 0.0 110.747 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.542 ' HG2' ' CD1' ' A' ' 84' ' ' PHE . 6.2 tmm? -125.69 104.74 8.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.528 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 35.2 t -91.16 120.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -175.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.477 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 44.0 t80 -108.74 124.33 50.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.081 0.467 . . . . 0.0 111.388 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.908 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.6 m-85 -104.22 132.55 50.36 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.393 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.9 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 30.4 p80 -135.84 161.69 34.9 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.491 0.494 . . . . 0.0 110.644 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.602 ' HG ' ' HB ' ' A' ' 62' ' ' VAL . 40.4 m -143.79 164.42 30.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.8 -32.89 20.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 109.995 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -76.54 -7.11 54.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.242 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.71 ' HB3' HG21 ' A' ' 79' ' ' THR . 5.0 t -113.89 87.52 12.73 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.24 27.11 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.047 2.498 . . . . 0.0 113.687 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -86.05 -48.43 8.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.025 0.441 . . . . 0.0 111.503 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.674 ' HG ' ' HB3' ' A' ' 80' ' ' PRO . 14.1 t -83.08 -20.45 34.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -171.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -53.21 -29.81 34.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -79.37 -32.24 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.451 0.643 . . . . 0.0 110.326 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -80.28 -49.88 10.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.994 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.524 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.0 p30 -64.65 -23.05 67.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.8 m -75.69 -60.42 2.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.499 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.65 -69.46 0.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.744 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.5 t -55.71 -43.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.9 tp -80.9 -23.93 38.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -105.69 9.06 33.25 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.068 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.97 135.24 21.43 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.766 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.02 -34.21 56.13 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 123.057 2.505 . . . . 0.0 113.561 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.61 -45.69 10.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.804 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG23 HD21 ' A' ' 108' ' ' LEU . 43.0 t -63.34 -51.96 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.292 0.568 . . . . 0.0 109.807 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 7.6 t -53.21 -41.33 65.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.525 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -61.84 -35.38 78.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.772 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD11 HD12 ' A' ' 111' ' ' LEU . 76.2 mt -69.28 -40.14 77.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.911 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.459 ' CB ' HD13 ' A' ' 3' ' ' LEU . 4.2 mm? -70.85 -48.72 52.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.846 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 48' ' ' SER . 12.0 mm-40 -53.0 -33.6 52.35 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.801 0.44 . . . . 0.0 112.182 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . . . -68.11 -57.99 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -173.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.508 ' HD3' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.91 18.88 3.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 76.2 m-85 -124.97 146.18 49.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.413 0.625 . . . . 0.0 111.245 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.522 HG12 ' HB3' ' A' ' 14' ' ' LEU . 39.7 t -115.12 120.09 63.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.553 HG23 HD21 ' A' ' 3' ' ' LEU . 19.0 t -91.58 124.6 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.77 -173.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -93.96 117.96 30.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.591 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 p -82.66 102.43 11.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.04 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -116.73 129.4 73.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.15 0.5 . . . . 0.0 110.485 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.589 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 2.2 m -112.97 114.45 26.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.811 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.602 ' HB ' ' HG ' ' A' ' 28' ' ' SER . 32.4 t -74.84 -7.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.015 0.912 . . . . 0.0 109.583 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.01 -29.37 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.012 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.603 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 2.9 p -109.11 158.51 34.14 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.603 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.0 Cg_endo -52.29 -50.4 14.15 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.301 3.334 . . . . 0.0 114.914 -167.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -38.62 84.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.991 0.424 . . . . 0.0 110.83 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.3 -31.02 53.28 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.606 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 64' ' ' THR . 92.4 mt-30 -62.36 -39.68 93.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.638 0.375 . . . . 0.0 111.117 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.541 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -77.9 -33.7 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.642 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.541 HD12 ' OE2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -61.27 -42.21 98.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 0.0 110.531 170.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.2 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.564 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.534 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.1 ptm180 -71.9 -21.46 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.969 0.414 . . . . 0.0 110.484 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 45.6 ttm105 -75.2 -52.42 10.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.45 -8.12 57.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.711 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 64.06 72.19 0.47 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.468 0.651 . . . . 0.0 109.698 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 56.0 t -123.6 136.96 27.85 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.959 -175.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.9 Cg_exo -73.62 -138.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.204 2.603 . . . . 0.0 111.553 173.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.12 -69.18 1.28 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.807 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.9 ' HB ' ' HA ' ' A' ' 27' ' ' HIS . 6.6 t 178.44 156.09 0.56 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.688 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 1.0 OUTLIER -84.29 132.75 18.39 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.354 -1.102 . . . . 0.0 112.701 0.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.908 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 31.4 m -126.41 121.13 31.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 110.584 174.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.64 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 8.8 m-85 -119.45 115.96 25.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 98.2 t -114.01 118.14 57.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.754 0.312 . . . . 0.0 110.548 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.542 ' CD1' ' HG2' ' A' ' 23' ' ' MET . 26.2 m-85 -96.93 118.71 33.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.707 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 94' ' ' GLU . 42.0 mt -115.78 130.06 56.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.077 0.465 . . . . 0.0 110.516 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.01 135.14 20.52 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.6 116.64 4.64 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.574 1.516 . . . . 0.0 109.338 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -151.07 128.4 11.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.761 -171.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.12 -79.8 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.931 0.77 . . . . 0.0 111.341 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.67 21.09 0.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.07 -169.3 3.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 85.6 m95 -107.89 135.76 48.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.242 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -116.3 118.29 32.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.589 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 36.2 tt0 -77.62 108.17 10.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.832 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 31.1 m -88.35 12.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 111.329 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.09 155.02 6.31 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.301 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -130.76 135.5 47.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.64 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.9 mt -108.18 129.75 55.17 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.719 -177.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 80' ' ' PRO . 88.3 t80 -137.41 143.23 41.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.649 173.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.25 145.77 10.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.583 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m -70.09 125.76 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.607 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.613 ' HB3' ' HB2' ' A' ' 106' ' ' GLU . 92.9 mtt180 -137.89 142.75 37.28 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.789 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.464 ' HD2' ' HG2' ' A' ' 106' ' ' GLU . 24.5 Cg_exo -64.21 166.38 17.05 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.489 2.126 . . . . 0.0 111.518 173.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -55.54 -33.17 63.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.872 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -60.88 -47.25 87.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 17.4 mm-40 -72.3 -38.42 68.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.929 0.395 . . . . 0.0 110.602 -176.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -65.3 -39.37 92.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.345 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 47' ' ' VAL . 53.4 mt -67.35 -34.62 77.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.061 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 98.5 mttt -55.94 -53.3 58.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 109.871 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.496 ' O ' HG23 ' A' ' 114' ' ' VAL . 4.3 mm-40 -62.53 -44.16 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.432 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.444 HD12 HD11 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -57.71 -41.57 82.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.281 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 14.4 mmt180 -63.09 -49.55 74.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.852 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 6.9 pt20 -66.97 -23.04 65.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.066 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 110' ' ' GLU . 56.7 t -75.21 -41.92 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.838 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.4 m -56.75 -37.95 71.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 110.525 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.86 -32.39 56.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.832 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 54.2 mttp -71.19 -8.52 54.09 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.482 -176.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.46 -20.96 72.17 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.222 173.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.42 -58.53 0.49 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.704 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -99.94 119.31 38.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 177.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.7 p -145.88 96.59 2.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.268 0.556 . . . . 0.0 111.899 -171.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.62 -83.68 0.36 Allowed Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.11 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 56.3 -93.96 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.913 0.485 . . . . 0.0 111.024 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.58 33.53 26.13 Favored Glycine 0 C--N 1.335 0.522 0 O-C-N 123.486 0.491 . . . . 0.0 114.284 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -94.48 -6.09 44.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.244 0.522 . . . . 0.0 111.534 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -110.21 102.18 10.89 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 169.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -69.77 -17.76 63.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.286 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.402 ' HD1' ' C ' ' A' ' 130' ' ' HIS . 3.7 t-80 -78.94 108.7 12.6 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -62.72 -30.12 71.18 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.754 0.312 . . . . 0.0 111.41 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.402 ' C ' ' HD1' ' A' ' 128' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.004 174.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -85.95 140.22 30.53 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 51' ' ' LEU . 26.6 tp -58.5 137.79 57.15 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.379 0.424 . . . . 0.0 110.77 -177.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.633 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -77.35 103.58 7.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.71 -174.641 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.415 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 43.7 m95 -114.0 102.67 10.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.7 m-85 -117.06 161.13 34.26 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 27.4 Cg_exo -60.02 162.04 17.49 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.934 1.756 . . . . 0.0 111.436 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.632 ' CD1' HD23 ' A' ' 70' ' ' LEU . 87.8 t80 -49.1 -52.89 43.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.1 Cg_exo -65.25 -40.51 19.2 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.632 1.555 . . . . 0.0 111.951 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 33.2 tt0 -69.46 -39.23 77.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 -177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.56 82.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.019 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.96 -34.6 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -38.45 64.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.682 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.424 ' HB3' HG12 ' A' ' 56' ' ' VAL . 11.1 tp -65.23 -44.6 87.69 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 109.71 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.14 87.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -50.85 71.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.77 -14.12 60.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.197 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -118.23 -9.9 10.36 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.2 89.71 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.714 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.72 ' HG3' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -73.07 169.75 16.33 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.466 0.306 . . . . 0.0 111.521 175.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.572 ' SD ' HG22 ' A' ' 86' ' ' VAL . 68.1 mtm -101.4 167.84 9.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.39 125.95 62.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.079 0.466 . . . . 0.0 111.242 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.762 ' HG3' HG11 ' A' ' 57' ' ' VAL . 5.4 tpt -103.67 102.77 12.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.19 108.53 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.954 0.407 . . . . 0.0 110.067 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.766 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 72.6 t80 -103.7 103.55 13.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.419 0.628 . . . . 0.0 110.743 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 70' ' ' LEU . 60.3 m-85 -77.29 105.38 8.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.24 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.766 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 24.4 p80 -104.15 138.29 40.85 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.618 175.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.664 ' OG ' ' HA2' ' A' ' 78' ' ' GLY . 49.3 m -122.67 144.06 49.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.627 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -42.81 62.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.303 0.573 . . . . 0.0 110.13 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.555 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 91.5 m-70 -101.87 42.74 1.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.263 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.633 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 28.3 p -93.58 100.91 5.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.617 176.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -88.41 -7.69 5.71 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.268 1.978 . . . . 0.0 114.152 -176.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -84.58 -34.51 23.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.697 ' HB3' ' HG3' ' A' ' 80' ' ' PRO . 29.2 p -80.96 -23.18 38.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -170.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -55.13 -32.41 62.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.18 -33.37 24.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.402 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.441 ' HE3' ' CZ ' ' A' ' 82' ' ' PHE . 46.0 ttp -80.73 -35.26 33.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.596 -173.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.575 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 38.3 p30 -72.14 -22.69 61.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 111.229 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.9 m -71.34 -59.94 2.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.609 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -91.48 -67.74 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.463 0.649 . . . . 0.0 111.482 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 104' ' ' ARG . 59.1 t -60.01 -58.95 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.98 -168.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 19.5 tp -78.84 -10.59 59.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.089 -169.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -101.05 -9.87 21.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.755 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.67 133.25 78.11 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.341 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.25 -48.74 20.41 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.191 2.594 . . . . 0.0 113.086 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.59 -43.14 99.27 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.37 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.733 HG22 HD23 ' A' ' 108' ' ' LEU . 50.0 t -60.07 -56.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 175.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 m -56.91 -36.53 70.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.579 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HA ' ' HB2' ' A' ' 52' ' ' GLU . 99.7 mtt180 -75.44 -21.16 58.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.442 HD11 HD21 ' A' ' 108' ' ' LEU . 69.1 mt -70.68 -36.52 73.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.163 169.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 1.5 mm? -70.45 -49.35 49.6 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.076 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 49' ' ' ARG . 17.1 mm-40 -45.88 -39.16 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.991 0.516 . . . . 0.0 112.124 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.501 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -68.13 -57.18 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.72 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.75 20.7 3.3 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -171.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.517 ' CE2' ' HE1' ' A' ' 21' ' ' MET . 96.2 m-85 -133.58 140.36 47.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.481 0.657 . . . . 0.0 111.674 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 14' ' ' LEU . 46.9 t -110.44 115.35 49.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.762 HG11 ' HG3' ' A' ' 23' ' ' MET . 20.8 t -86.76 126.35 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.523 . . . . 0.0 110.359 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.17 116.52 29.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.521 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 44.3 t -87.01 100.71 12.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.461 HG11 HD21 ' A' ' 70' ' ' LEU . 59.4 t -110.24 119.0 58.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.027 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.627 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.0 p -90.43 111.97 23.42 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.577 ' CG2' ' HG ' ' A' ' 28' ' ' SER . 21.6 m -74.29 -0.41 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.526 0.679 . . . . 0.0 110.346 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -29.49 31.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.086 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -95.63 166.73 14.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.977 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.5 Cg_endo -51.86 -55.85 3.52 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.511 2.807 . . . . 0.0 114.6 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.98 -35.66 80.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.353 . . . . 0.0 110.938 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.95 -40.88 62.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.724 174.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 5.9 mt-30 -62.29 -30.87 71.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.259 0.552 . . . . 0.0 110.594 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.459 ' CD ' HH21 ' A' ' 73' ' ' ARG . 5.3 tp10 -66.05 -53.43 38.49 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.631 173.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 8' ' ' TYR . 6.7 mp -58.62 -37.48 75.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 176.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.9 28.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.983 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -66.27 -23.34 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.459 HH21 ' CD ' ' A' ' 69' ' ' GLU . 14.2 ttm180 -83.49 -51.21 7.55 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.316 -175.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.26 4.12 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.637 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 68.67 22.13 7.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.793 0.437 . . . . 0.0 111.072 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.97 119.78 66.47 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.32 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.974 2.449 . . . . 0.0 112.589 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.664 ' HA2' ' OG ' ' A' ' 28' ' ' SER . . . -174.8 120.98 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.637 ' HB ' ' C ' ' A' ' 80' ' ' PRO . 31.2 m -146.56 -61.04 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -165.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.697 ' HG3' ' HB3' ' A' ' 34' ' ' CYS . 17.8 Cg_endo -79.39 172.74 58.12 Favored 'Cis proline' 0 N--CA 1.492 1.414 0 CA-C-N 123.111 2.147 . . . . 0.0 115.915 4.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 m -125.97 143.12 51.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.254 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' HD1' ' HD1' ' A' ' 25' ' ' TYR . 1.2 m-85 -118.27 127.99 54.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.91 117.69 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.727 0.299 . . . . 0.0 110.716 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.86 125.77 42.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.78 0.324 . . . . 0.0 110.416 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.419 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 31.8 mt -117.1 142.23 47.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.577 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.572 HG22 ' SD ' ' A' ' 21' ' ' MET . 10.9 t -108.59 139.84 21.22 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.444 ' HD2' ' HG2' ' A' ' 21' ' ' MET . 41.2 Cg_endo -72.66 114.47 4.03 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 160.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.575 ' HE2' ' SG ' ' A' ' 121' ' ' CYS . 17.5 mttp -142.21 113.36 7.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.35 15.77 9.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.669 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.4 37.83 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.985 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.04 178.29 4.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.629 0.252 . . . . 0.0 110.403 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -109.4 128.74 55.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.252 0.549 . . . . 0.0 110.319 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 23.7 tt0 -109.96 124.66 51.8 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.373 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 78.2 tt0 -77.08 100.15 5.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.4 ' HB ' HG23 ' A' ' 86' ' ' VAL . 14.8 p -94.4 -7.12 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.467 -169.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.84 125.71 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.939 -1.124 . . . . 0.0 112.89 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -114.87 128.5 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.112 0.482 . . . . 0.0 109.995 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 97.0 mt -117.24 141.46 48.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.882 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.488 ' CE1' HG21 ' A' ' 79' ' ' THR . 79.6 t80 -137.42 127.76 26.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.847 0.356 . . . . 0.0 110.608 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.96 154.02 30.22 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.843 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -66.23 142.39 57.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -123.82 132.95 24.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -56.94 140.86 93.27 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.928 1.752 . . . . 0.0 109.683 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.513 ' HA ' HG12 ' A' ' 41' ' ' VAL . 16.7 ttp180 -51.23 -34.91 34.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.6 43.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 111.074 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.7 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 10.3 pt-20 -88.99 -20.04 24.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.851 -175.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 70.7 t80 -60.82 -43.25 98.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 171.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.733 HD23 HG22 ' A' ' 47' ' ' VAL . 89.1 mt -68.42 -34.26 75.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.881 174.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 14.8 ttpt -55.65 -52.77 62.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.211 171.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.7 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 28.9 mm-40 -57.03 -45.05 83.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.499 0.666 . . . . 0.0 109.694 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD21 HD12 ' A' ' 50' ' ' LEU . 20.9 tp -61.46 -41.37 97.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 26.7 mmt180 -62.35 -41.33 98.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.823 0.344 . . . . 0.0 110.298 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.45 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 10.5 mt-30 -56.4 -37.24 69.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.516 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.98 -37.35 26.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.758 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.9 m -54.92 -42.42 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.782 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.5 -47.56 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.289 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.7 ' HZ3' ' HB2' ' A' ' 117' ' ' LYS . 10.4 mtmp? -68.99 -13.25 62.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.576 -176.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.25 -33.12 69.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.73 -45.14 1.06 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.854 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -100.63 94.15 5.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.941 0.4 . . . . 0.0 111.219 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.575 ' SG ' ' HE2' ' A' ' 88' ' ' LYS . 25.7 p -127.04 -39.97 1.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 176.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -81.07 74.14 2.47 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.439 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -143.57 148.59 36.14 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.03 40.7 2.96 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.975 -174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 69.53 -57.01 0.55 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.444 0.698 . . . . 0.0 112.169 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -144.13 19.23 1.76 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.51 0.671 . . . . 0.0 109.359 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -96.69 27.97 3.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.731 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -73.58 86.38 1.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.191 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -124.4 27.12 7.11 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 . . . . . 0 C--O 1.242 0.682 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.597 -179.22 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.956 0.407 . . . . 0.0 110.77 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p -144.48 -51.5 0.29 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.708 HD22 HD23 ' A' ' 51' ' ' LEU . 6.7 tp -64.35 129.78 41.23 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.668 175.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.741 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 34.9 mmt180 -78.03 110.97 13.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.106 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -108.6 104.47 13.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.943 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.741 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 97.0 m-85 -110.49 160.27 29.15 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.936 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 20.0 Cg_exo -62.69 165.71 15.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.915 1.743 . . . . 0.0 110.552 170.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 93.5 t80 -49.87 -53.26 44.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.6 Cg_exo -64.42 -47.51 5.74 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.809 1.673 . . . . 0.0 112.198 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 31.2 tt0 -64.91 -35.39 81.01 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.437 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.84 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.37 . . . . 0.0 111.139 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.05 -30.88 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.021 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.33 -44.04 76.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.562 HD23 ' CE2' ' A' ' 6' ' ' TYR . 13.3 tp -61.72 -47.32 85.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.262 0.553 . . . . 0.0 110.247 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.91 89.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.246 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -68.1 -39.23 82.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.39 -18.88 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -116.02 -8.56 11.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 38.21 63.06 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.659 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -101.22 176.99 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.559 ' HE2' ' O ' ' A' ' 114' ' ' VAL . 75.5 mtp -107.47 149.99 27.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.9 t -106.94 131.56 56.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.461 . . . . 0.0 111.536 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.46 ' SD ' HD21 ' A' ' 51' ' ' LEU . 20.5 ttt -107.93 107.25 17.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.829 172.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.499 HG12 HG21 ' A' ' 60' ' ' VAL . 40.9 t -84.75 103.1 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.531 ' OH ' ' HB3' ' A' ' 38' ' ' ASN . 92.7 t80 -97.67 108.02 20.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.74 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.938 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 74.8 m-85 -86.47 118.66 26.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.085 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.583 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 33.5 p80 -135.36 179.3 6.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.7 p -143.86 166.52 24.7 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -22.22 34.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.52 23.58 5.11 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 23.0 p -52.45 110.78 2.09 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 173.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.19 -81.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.289 2.659 . . . . 0.0 114.532 -167.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -77.78 -17.66 57.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.32 0.581 . . . . 0.0 110.499 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.642 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 37.3 t -62.94 -36.85 84.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -72.03 -17.15 62.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 111.212 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -81.79 -40.25 22.87 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.711 0.767 . . . . 0.0 109.716 171.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.575 ' SD ' ' HG3' ' A' ' 80' ' ' PRO . 75.9 mtp -69.39 -43.22 73.94 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.892 -170.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.531 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 30.1 p-10 -66.02 -35.08 79.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.863 0.363 . . . . 0.0 110.445 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 43' ' ' SER . 85.6 m -66.8 -55.94 12.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.585 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.97 -69.84 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.874 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.5 -51.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.788 -169.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 23.6 tp -76.87 -27.25 54.97 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.575 -173.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.7 m -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.748 0.309 . . . . 0.0 111.019 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.38 130.16 61.55 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.837 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.9 -43.09 24.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.508 2.805 . . . . 0.0 113.762 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.97 -43.45 65.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.453 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -65.68 -49.62 76.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 121.659 0.742 . . . . 0.0 109.831 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 32.4 m -59.58 -32.27 70.21 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.656 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.737 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.86 -42.07 97.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.814 ' HA ' HH21 ' A' ' 54' ' ' ARG . 64.8 mt -60.33 -45.03 94.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.654 0.264 . . . . 0.0 111.223 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.708 HD23 HD22 ' A' ' 3' ' ' LEU . 6.2 tp -72.34 -31.8 65.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.396 0.617 . . . . 0.0 111.051 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.577 ' HA ' HD12 ' A' ' 3' ' ' LEU . 8.3 tp10 -61.74 -35.95 79.59 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 113.741 -168.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.497 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -91.5 -31.17 16.06 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -168.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.814 HH21 ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -134.48 5.08 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -170.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.7 142.6 48.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.551 0.691 . . . . 0.0 111.956 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.8 t -107.87 115.21 48.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.51 126.71 40.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.852 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 24' ' ' VAL . . . -94.95 116.98 29.39 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.717 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.7 p -82.42 101.06 10.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.499 HG21 HG12 ' A' ' 24' ' ' VAL . 99.8 t -115.17 123.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 -175.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.517 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 1.9 t -116.39 129.34 56.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.011 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.54 65.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.104 0.954 . . . . 0.0 110.0 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.67 -36.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.039 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 30.7 p -82.89 160.53 60.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.201 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 15.6 Cg_endo -52.92 -55.39 3.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.062 2.508 . . . . 0.0 113.415 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.463 ' O ' HD13 ' A' ' 70' ' ' LEU . 10.2 pt-20 -57.03 -44.85 83.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.983 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -68.91 -39.08 85.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.38 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -63.03 -48.68 77.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.049 0.54 . . . . 0.0 111.663 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.4 pt-20 -73.48 -29.05 62.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.588 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.661 ' HG ' ' HE2' ' A' ' 74' ' ' TYR . 5.3 mp -67.28 -40.61 86.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.809 173.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.55 78.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 9.3 ptm180 -83.48 -19.51 35.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.719 0.295 . . . . 0.0 111.371 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 48.0 ttt180 -72.69 -44.03 62.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.661 ' HE2' ' HG ' ' A' ' 70' ' ' LEU . 53.3 m-85 -102.45 -2.35 28.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 26.2 ptt180 45.95 71.19 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.526 1.13 . . . . 0.0 112.551 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.449 HG11 ' CG2' ' A' ' 81' ' ' THR . 13.5 t -137.74 94.65 11.53 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.882 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -97.83 128.08 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.415 2.743 . . . . 0.0 111.416 169.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.33 42.19 0.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.99 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.583 ' OG1' ' HA ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -47.03 152.36 1.0 Allowed Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 122.795 0.438 . . . . 0.0 110.741 173.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' A' ' 34' ' ' CYS . 58.6 Cg_endo -67.01 151.63 83.25 Favored 'Cis proline' 0 C--N 1.351 0.676 0 N-CA-C 114.841 1.054 . . . . 0.0 114.841 4.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.938 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.3 m -141.02 133.63 28.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.34 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.587 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 3.0 m-85 -123.14 111.88 17.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -175.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 39.5 t -119.12 112.49 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 110.146 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.5 122.33 38.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.394 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 94' ' ' GLU . 30.9 mt -113.55 135.76 53.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -109.12 130.74 22.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.81 116.89 4.09 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.633 1.556 . . . . 0.0 110.212 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.548 ' HZ1' ' CD ' ' A' ' 93' ' ' GLU . 35.8 ttpt -151.79 134.93 15.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.333 -175.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 71.14 -37.61 0.4 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.742 0.817 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 88' ' ' LYS . . . 149.7 -10.92 0.95 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.51 -179.13 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -108.16 136.71 47.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.042 0.449 . . . . 0.0 110.489 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.548 ' CD ' ' HZ1' ' A' ' 88' ' ' LYS . 33.0 tt0 -117.33 126.23 52.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.104 -178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 53.3 tt0 -77.3 99.69 5.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 117' ' ' LYS . 4.9 p -96.7 -10.43 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.176 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.15 126.79 1.48 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.449 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.41 127.53 49.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.972 0.415 . . . . 0.0 109.975 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 99.0 mt -117.72 139.17 51.41 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.278 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -137.26 142.87 41.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.798 0.332 . . . . 0.0 110.838 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.06 168.93 45.37 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.635 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.455 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 10.9 m -65.38 131.76 47.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.022 0.439 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.5 133.94 23.51 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HG2' ' HB2' ' A' ' 106' ' ' GLU . 12.4 Cg_endo -59.87 154.4 50.37 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.716 1.611 . . . . 0.0 110.991 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -30.69 64.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.839 0.352 . . . . 0.0 110.437 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.04 63.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.31 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.442 ' HB2' ' HG2' ' A' ' 103' ' ' PRO . 22.9 tp10 -73.19 -42.27 62.9 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.476 ' CE2' HD11 ' A' ' 111' ' ' LEU . 9.8 t80 -66.24 -44.85 82.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.405 -178.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.65 -47.88 78.78 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -52.26 -58.85 5.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.32 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 114' ' ' VAL . 2.3 tp10 -78.98 -28.43 43.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.519 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 50' ' ' LEU . 3.4 tt -61.22 -43.19 99.27 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.456 ' O ' HG21 ' A' ' 116' ' ' VAL . 22.6 tpt180 -61.43 -45.8 92.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.503 ' HB3' ' HZ2' ' A' ' 117' ' ' LYS . 34.4 mt-30 -64.73 -43.65 92.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.42 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.559 ' O ' ' HE2' ' A' ' 21' ' ' MET . 54.6 t -58.72 -40.87 80.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -56.43 -28.54 59.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 112' ' ' ARG . 59.2 t -83.88 -34.33 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.885 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.578 ' HA ' ' HB3' ' A' ' 121' ' ' CYS . 13.6 mptt -57.4 -28.5 63.29 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.615 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.85 -38.94 93.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.018 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.2 60.33 2.26 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.837 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.81 144.72 0.05 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.218 0.599 . . . . 0.0 110.363 -175.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 117' ' ' LYS . 20.7 p -171.0 -52.12 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.559 0.695 . . . . 0.0 109.437 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.62 -177.33 41.24 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.709 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -116.06 92.96 4.05 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.143 0.496 . . . . 0.0 109.891 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -100.39 34.98 5.12 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.395 -174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -70.82 81.97 0.63 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.499 0.666 . . . . 0.0 110.812 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.589 ' CE1' ' HB3' ' A' ' 94' ' ' GLU . 17.5 p-80 -87.37 97.29 10.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.71 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -81.92 73.09 8.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.875 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -166.14 122.6 1.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.936 -177.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -115.9 -37.83 3.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.113 0.482 . . . . 0.0 110.509 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.8 t60 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.471 -0.776 . . . . 0.0 109.146 177.527 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 tpp . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.755 0.312 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m -86.15 27.31 0.92 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.697 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.8 tp -65.55 133.0 50.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.4 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -107.36 117.31 33.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 36.8 m95 -111.24 123.14 49.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.215 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 37.0 m-85 -132.06 160.92 65.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.232 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 26.2 Cg_exo -61.22 162.16 20.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.003 1.802 . . . . 0.0 110.929 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.536 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 72.6 t80 -49.92 -50.24 69.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 34.7 Cg_exo -61.33 -46.61 14.41 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.808 1.672 . . . . 0.0 112.42 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -68.01 -40.61 82.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.219 -177.575 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.03 -35.92 82.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 177.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.0 -41.41 64.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.197 0.522 . . . . 0.0 110.228 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' HB3' HG12 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -57.23 -47.96 80.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.724 177.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.9 -41.92 67.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.455 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -61.05 -51.4 69.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 111.532 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.28 -15.35 58.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.927 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -112.86 -4.57 13.95 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.331 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.19 49.04 49.19 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.101 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -114.64 178.75 4.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.403 ' HE3' HG22 ' A' ' 86' ' ' VAL . 89.3 mtp -105.22 151.48 24.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.88 125.36 61.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.106 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.0 ttt -101.21 102.78 13.75 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 39.6 t -83.3 102.91 9.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.54 ' HH ' ' HB3' ' A' ' 38' ' ' ASN . 24.7 t80 -98.61 108.8 21.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.176 -175.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.595 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 96.4 m-85 -93.23 125.36 37.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.377 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 25.4 p80 -127.56 150.12 49.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.611 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 24.5 m -142.96 141.21 31.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.522 0.201 . . . . 0.0 110.825 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.505 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -75.89 -22.41 56.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 166.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -72.64 -11.99 60.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.047 175.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.542 ' SG ' ' HA2' ' A' ' 78' ' ' GLY . 10.9 t -137.61 77.55 39.45 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.483 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.53 17.71 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 122.975 2.45 . . . . 0.0 114.702 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.419 ' HB3' ' OG ' ' A' ' 101' ' ' SER . 57.3 m-85 -77.27 -18.28 57.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.541 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 13.2 t -83.43 -30.93 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.814 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 10.6 mm100 -52.2 -42.01 63.15 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -170.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.035 0.445 . . . . 0.0 110.925 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.466 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 45.2 ttm -77.61 -51.89 9.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.251 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.54 ' HB3' ' HH ' ' A' ' 25' ' ' TYR . 2.2 p-10 -65.49 -17.1 64.3 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 m -81.34 -62.33 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.679 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -92.88 -68.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.449 0.642 . . . . 0.0 112.116 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.466 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 89.6 t -52.67 -47.29 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.434 -168.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.4 tp -81.3 -18.43 45.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.982 0.42 . . . . 0.0 110.88 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 m -87.41 -10.99 50.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.58 130.01 10.74 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.083 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.13 -31.96 94.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.013 2.475 . . . . 0.0 113.181 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.36 -44.53 13.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.707 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.59 HG22 HD22 ' A' ' 108' ' ' LEU . 48.5 t -61.52 -52.88 55.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.548 0.69 . . . . 0.0 109.495 175.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.738 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 34.1 t -50.46 -44.37 55.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.316 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -57.39 -41.12 79.61 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.589 0.555 . . . . 0.0 111.763 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.692 HD11 HD23 ' A' ' 108' ' ' LEU . 76.2 mt -61.97 -35.87 79.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.598 0.237 . . . . 0.0 110.945 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.98 -38.7 57.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.43 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.738 ' HG3' ' O ' ' A' ' 48' ' ' SER . 55.9 mt-10 -55.55 -39.08 70.15 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.058 0.456 . . . . 0.0 111.436 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.508 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -62.74 -53.33 56.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -169.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.612 ' HE ' ' HE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.7 5.82 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.612 ' HE1' ' HE ' ' A' ' 54' ' ' ARG . 80.3 m-85 -110.44 143.17 41.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 112.525 -173.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 14' ' ' LEU . 49.0 t -110.76 115.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.7 t -86.54 123.58 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.1 0.476 . . . . 0.0 110.916 -173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -90.39 116.95 28.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -82.44 101.04 10.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.92 118.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 63' ' ' ASP . 2.6 m -102.11 110.82 22.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.278 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.611 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 6.1 t -82.67 28.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 122.574 1.178 . . . . 0.0 109.03 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.505 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 25.5 m-20 -113.42 -20.04 11.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.84 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.572 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 4.1 p -115.24 161.36 30.09 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.996 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.572 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.5 Cg_endo -51.96 -56.48 2.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.425 2.75 . . . . 0.0 114.025 -170.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -46.22 66.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.22 -36.46 63.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.879 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -63.75 -36.62 84.48 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.577 0.351 . . . . 0.0 111.018 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' OE1' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mm-40 -68.67 -39.06 80.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.177 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 70' ' ' LEU . 60.9 mt -67.96 -41.19 82.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.449 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.11 93.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.551 0.215 . . . . 0.0 111.321 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.5 ' HD3' ' OE1' ' A' ' 69' ' ' GLU . 9.3 ptm180 -73.38 -20.92 60.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 110.491 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -74.64 -56.27 4.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.287 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -75.7 -9.09 58.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.919 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.4 ttm105 68.79 42.63 1.37 Allowed 'General case' 0 CA--C 1.528 0.127 0 O-C-N 123.834 0.708 . . . . 0.0 110.793 170.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.499 HG11 HG23 ' A' ' 81' ' ' THR . 33.7 t -122.31 104.3 37.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.134 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -93.64 128.81 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.236 2.624 . . . . 0.0 111.765 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.542 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 108.88 150.96 14.45 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.255 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.605 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 39.8 p -141.74 162.76 44.81 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 72.4 Cg_endo -78.09 142.14 68.68 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 113.222 1.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 87.3 m -123.52 122.05 37.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.749 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 7.5 m-85 -115.82 112.27 21.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.184 -177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 46.8 t -106.77 118.41 54.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.593 ' HB2' HG23 ' A' ' 95' ' ' VAL . 79.3 m-85 -95.91 104.91 16.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.926 0.393 . . . . 0.0 110.593 -177.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 94' ' ' GLU . 78.5 mt -105.52 126.3 51.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.557 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.403 HG22 ' HE3' ' A' ' 21' ' ' MET . 11.2 t -110.25 132.47 21.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.09 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.56 116.45 2.6 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.153 1.902 . . . . 0.0 109.855 171.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.575 ' HZ3' ' CD ' ' A' ' 93' ' ' GLU . 9.6 ptmm? -161.73 141.36 10.11 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.207 -174.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.19 -72.13 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.13 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.15 25.82 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.759 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.97 165.12 25.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.601 0.239 . . . . 0.0 110.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.33 134.81 33.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.575 ' CD ' ' HZ3' ' A' ' 88' ' ' LYS . 30.0 tt0 -120.35 117.56 28.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.339 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.504 ' HA ' HD23 ' A' ' 85' ' ' LEU . 14.6 tt0 -77.05 112.05 13.28 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.593 HG23 ' HB2' ' A' ' 84' ' ' PHE . 24.3 m -77.66 -18.08 14.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.422 0.629 . . . . 0.0 109.827 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.28 162.41 11.79 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.024 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 138.45 53.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.093 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.3 mt -111.87 130.72 55.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.775 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -137.19 133.99 35.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.0 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.73 159.97 8.42 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.074 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 33' ' ' TYR . 73.6 m -94.88 17.11 14.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.068 0.461 . . . . 0.0 111.585 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.482 ' HD2' ' OE1' ' A' ' 106' ' ' GLU . 14.1 mmt180 -57.87 140.71 81.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.78 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 102' ' ' ARG . 30.9 Cg_exo -62.29 172.3 4.38 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.344 2.696 . . . . 0.0 112.381 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.474 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 39.9 ptt180 -51.78 -26.13 9.04 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.839 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -53.34 -63.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.266 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.715 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 3.0 mp0 -70.07 -33.0 71.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 110.952 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.06 -47.05 87.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.692 HD23 HD11 ' A' ' 50' ' ' LEU . 75.7 mt -70.48 -33.31 71.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.715 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.7 mttt -57.06 -51.29 69.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.53 176.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 114' ' ' VAL . 11.6 mm-40 -68.91 -36.41 77.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.773 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.462 ' O ' HD22 ' A' ' 111' ' ' LEU . 4.1 tt -64.44 -34.88 79.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 116' ' ' VAL . 10.3 mmm180 -61.29 -41.33 96.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.471 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -67.62 -33.38 74.87 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.382 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.592 HG11 HG22 ' A' ' 95' ' ' VAL . 77.9 t -64.45 -45.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 p -65.39 -25.54 67.6 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.995 0.426 . . . . 0.0 110.7 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.6 t -77.19 -43.68 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.217 175.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.57 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 63.7 mttm -61.25 -37.0 81.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.281 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.87 70.12 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.056 -0.593 . . . . 0.0 113.092 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.94 11.47 32.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.928 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.18 -72.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.767 0.284 . . . . 0.0 110.724 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 42.2 t 64.0 -87.87 0.03 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.287 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.2 -48.38 80.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.236 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -96.04 41.93 1.1 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.332 0.587 . . . . 0.0 110.315 179.139 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.61 29.21 3.32 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.407 ' H ' ' C ' ' A' ' 123' ' ' GLU . 88.5 m-70 -122.42 -64.01 1.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.6 m80 57.01 -150.6 0.44 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -171.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -155.84 -25.46 0.11 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.568 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -77.77 35.58 0.2 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -110.27 5.83 22.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 171.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 . . . . . 0 C--O 1.243 0.713 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.7 177.429 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -127.32 -26.28 3.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.553 HD12 ' OE2' ' A' ' 52' ' ' GLU . 17.5 tp -116.21 148.42 40.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.698 0.285 . . . . 0.0 111.701 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -95.5 107.64 19.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.373 0.606 . . . . 0.0 112.086 -177.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.452 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.5 m95 -105.9 132.49 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.755 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -135.21 153.65 78.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 24.9 Cg_exo -59.8 164.38 11.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.006 1.804 . . . . 0.0 111.443 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.553 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 86.4 t80 -48.59 -53.37 36.48 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 18.5 Cg_exo -65.89 -44.08 8.36 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.573 1.515 . . . . 0.0 112.194 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 26.0 tt0 -67.5 -38.72 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.223 -176.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.38 77.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.076 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.17 -41.21 92.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.849 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.49 -38.58 74.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.39 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.483 ' HB3' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -58.43 -47.97 82.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.509 177.029 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -70.62 -43.43 69.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.93 -46.35 85.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.982 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.6 57.32 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -115.94 0.18 12.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.591 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.67 45.64 57.94 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.972 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 83.5 mmt-85 -117.57 177.63 4.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.085 0.469 . . . . 0.0 111.77 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.3 mtp -102.1 152.21 21.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.625 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.99 129.29 62.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.624 0.249 . . . . 0.0 111.316 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 ttp -109.77 104.25 13.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.555 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 24.4 t -81.05 107.33 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.019 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 52.9 t80 -94.97 104.77 16.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.606 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.449 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.3 m-85 -87.62 119.82 28.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.239 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 30.0 p80 -123.41 147.84 46.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.46 176.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.664 ' HG ' ' HB ' ' A' ' 62' ' ' VAL . 14.7 m -136.77 150.64 48.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.013 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.64 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.23 -26.72 52.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.278 0.561 . . . . 0.0 109.849 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -72.73 -16.7 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.053 173.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 56.8 m -124.15 60.69 23.53 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.702 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.65 23.81 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 114.132 -169.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.78 -36.54 78.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.216 0.531 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.593 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 7.2 t -68.22 -18.84 64.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.147 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -52.82 -26.11 13.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.2 -41.31 18.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.735 0.779 . . . . 0.0 109.738 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mmm -63.13 -39.24 94.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.193 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.9 p30 -77.97 -17.74 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.444 -175.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -74.01 -52.21 13.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 0.0 110.493 177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.86 -71.26 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.309 0.576 . . . . 0.0 111.564 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.428 ' O ' HG21 ' A' ' 47' ' ' VAL . 57.6 t -64.93 -54.34 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.675 -167.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 18.2 tp -79.76 -12.68 59.77 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.074 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 m -106.89 -3.09 20.64 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.11 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.9 133.33 38.63 Favored Pre-proline 0 C--O 1.235 0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.214 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.658 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 8.8 Cg_endo -51.87 -46.22 33.56 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.426 2.75 . . . . 0.0 113.106 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.58 93.85 Favored Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.113 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.839 HG22 HD21 ' A' ' 108' ' ' LEU . 57.4 t -61.73 -49.71 83.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.158 0.504 . . . . 0.0 109.795 174.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.513 ' HA ' HD13 ' A' ' 3' ' ' LEU . 35.3 m -56.05 -39.76 72.5 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.003 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 18.7 mtm180 -57.99 -40.76 81.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.075 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.836 HD12 HD22 ' A' ' 108' ' ' LEU . 76.3 mt -63.49 -39.83 95.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.548 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.36 -59.82 2.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.144 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.553 ' OE2' HD12 ' A' ' 3' ' ' LEU . 20.5 mm-40 -44.69 -40.17 5.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -171.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.476 ' HB2' ' HD3' ' A' ' 54' ' ' ARG . . . -66.3 -42.41 88.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.01 6.18 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.95 149.8 43.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.281 0.563 . . . . 0.0 111.476 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' A' ' 14' ' ' LEU . 46.6 t -117.07 119.89 63.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 168.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.4 t -86.99 116.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.757 -173.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 24' ' ' VAL . . . -90.86 117.11 29.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 p -88.15 102.23 14.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.765 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 8' ' ' TYR . 59.9 t -108.39 123.14 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 110.606 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.645 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.8 p -93.91 110.41 22.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.853 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.664 ' HB ' ' HG ' ' A' ' 28' ' ' SER . 28.0 t -82.83 0.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.318 1.056 . . . . 0.0 109.071 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.64 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -81.43 -33.86 31.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.528 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.625 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 33.4 p -92.63 160.84 33.62 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.625 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 25.6 Cg_endo -56.61 -53.95 4.48 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.3 2.667 . . . . 0.0 114.437 -171.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -37.02 85.7 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.277 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.19 -40.84 70.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.669 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 2.0 mt-30 -59.56 -35.16 73.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.317 0.58 . . . . 0.0 110.611 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.027 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.1 mt -64.38 -32.05 73.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.449 ' HB1' HG11 ' A' ' 62' ' ' VAL . . . -68.75 -30.68 69.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.846 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 51.9 mtp180 -71.69 -47.44 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 0.0 109.151 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -64.06 -50.2 69.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.055 -174.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.65 -0.02 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 55.71 81.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.778 0.674 . . . . 0.0 111.126 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -127.88 91.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.846 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -100.03 107.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.499 2.799 . . . . 0.0 111.994 170.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.87 169.19 12.61 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.918 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 80' ' ' PRO . 83.3 m -155.76 139.88 11.56 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 34' ' ' CYS . 64.1 Cg_endo -88.27 132.45 11.49 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.816 -1.327 . . . . 0.0 112.993 0.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 28.5 m -107.69 110.9 22.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.8 175.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 33.1 m-85 -99.87 113.19 25.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 95.0 t -102.95 115.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.542 ' CD2' HG11 ' A' ' 114' ' ' VAL . 90.5 m-85 -94.11 113.82 25.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.781 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 24.4 mt -111.54 128.13 55.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.183 0.516 . . . . 0.0 110.619 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.14 125.17 32.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.792 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.03 117.58 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.707 1.605 . . . . 0.0 110.814 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.789 ' HE2' ' HB2' ' A' ' 93' ' ' GLU . 65.2 pttt -133.83 128.55 34.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.06 -75.72 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.191 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.76 19.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.171 -0.537 . . . . 0.0 111.816 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.23 165.21 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -94.86 139.71 30.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.299 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.789 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 9.6 tp10 -117.49 136.0 53.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.554 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.45 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 34.8 tt0 -89.82 96.58 10.75 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -83.99 -4.67 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.323 -170.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.76 162.16 11.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.946 177.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 82' ' ' PHE . 87.3 mtt180 -127.57 136.74 52.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.38 150.97 37.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.799 0.333 . . . . 0.0 110.844 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -118.02 114.46 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.454 ' HA3' ' HG2' ' A' ' 80' ' ' PRO . . . -79.79 89.03 1.25 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.306 -172.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 p -135.7 -23.72 1.38 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.149 0.499 . . . . 0.0 110.547 175.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -70.03 155.54 93.29 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.691 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.8 167.08 9.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.669 2.246 . . . . 0.0 111.924 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -55.07 -38.01 67.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.512 -175.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -57.99 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.984 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.498 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 27.9 tt0 -75.08 -29.5 60.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.349 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.99 -47.88 84.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.873 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.839 HD21 HG22 ' A' ' 47' ' ' VAL . 47.1 mt -69.46 -27.12 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.238 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.498 ' HE3' ' HG3' ' A' ' 106' ' ' GLU . 29.3 ttpp -61.2 -49.98 74.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 114' ' ' VAL . 5.8 mm-40 -68.03 -39.95 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.349 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.48 -40.65 92.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.046 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.23 -39.28 89.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.352 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -66.04 -28.67 69.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.542 HG11 ' CD2' ' A' ' 84' ' ' PHE . 97.8 t -69.95 -39.38 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.1 m -59.06 -41.0 86.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.172 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.74 -43.99 99.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.392 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 121' ' ' CYS . 35.6 mtmm -75.2 -7.41 53.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.52 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.99 -39.17 24.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.82 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.51 -43.19 6.24 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.401 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.33 -31.88 22.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.478 0.18 . . . . 0.0 111.101 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 117' ' ' LYS . 17.2 t 68.98 -57.59 0.51 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.069 0.856 . . . . 0.0 111.334 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.42 27.27 5.33 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.93 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -67.17 -66.26 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.067 0.461 . . . . 0.0 110.116 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.99 175.4 47.96 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.532 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -172.39 23.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 0.0 110.295 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -83.74 135.21 34.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.236 0.541 . . . . 0.0 110.898 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -136.88 87.52 2.29 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.532 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -127.67 93.4 3.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.784 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -119.76 -40.27 2.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 66.3 t60 . . . . . 0 C--O 1.241 0.645 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.911 175.109 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 51' ' ' LEU . 46.0 tp . . . . . 0 C--O 1.236 0.374 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.68 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 1.9 mmt180 -90.66 104.31 16.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.52 0.2 . . . . 0.0 111.382 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -106.77 103.87 13.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.68 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.3 m-85 -111.28 166.67 10.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 17.4 Cg_exo -64.92 160.1 42.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.895 1.73 . . . . 0.0 110.836 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.553 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -49.2 -50.67 62.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.9 Cg_exo -58.55 -46.28 25.0 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 121.886 1.724 . . . . 0.0 112.685 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -67.47 -44.28 78.98 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.535 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.42 -41.75 73.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.396 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.72 -36.12 75.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.744 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.79 60.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.576 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.429 HD23 HG22 ' A' ' 56' ' ' VAL . 6.6 tp -60.26 -43.81 95.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.996 0.426 . . . . 0.0 109.879 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.82 -46.94 82.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.896 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -65.93 -43.22 88.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.599 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.0 54.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -119.04 6.38 11.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.633 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.12 46.11 95.19 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.296 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.7 mmp_? -110.78 -173.74 2.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.836 0.35 . . . . 0.0 110.671 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.463 ' HE1' ' O ' ' A' ' 114' ' ' VAL . 81.6 mtp -113.77 155.59 25.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 43.6 t -106.73 127.43 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.016 0.436 . . . . 0.0 111.585 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.4 ttt -109.42 103.69 12.65 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 31.7 t -85.75 108.87 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.486 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 82.6 t80 -104.28 103.18 12.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.526 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.89 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.0 m-85 -84.19 122.21 28.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.612 ' HA ' HG23 ' A' ' 79' ' ' THR . 8.3 p80 -132.37 145.89 51.57 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.6 0.562 . . . . 0.0 111.785 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.449 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 66.9 m -142.24 153.04 43.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.544 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -13.65 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.42 0.629 . . . . 0.0 109.828 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -82.89 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.603 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.06 83.01 37.51 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.63 26.3 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.043 2.495 . . . . 0.0 113.909 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -83.69 -23.52 31.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.177 0.513 . . . . 0.0 110.599 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 43.9 t -83.16 -30.85 27.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -55.93 -29.84 60.72 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -170.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.03 -46.59 67.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 110.724 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 42' ' ' LEU . 13.9 tmm? -79.46 -44.41 21.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.672 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.475 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 7.5 t30 -53.82 -45.98 70.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.781 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.3 m -60.54 -54.87 40.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.85 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -91.78 -69.39 0.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.558 0.694 . . . . 0.0 111.708 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.564 HG13 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -59.6 -44.57 93.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.829 -169.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HB2' ' SD ' ' A' ' 37' ' ' MET . 26.6 tp -79.09 -27.0 42.94 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.242 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 m -88.97 -2.33 58.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 28.4 t70 -47.79 128.76 11.31 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.546 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 46.7 Cg_exo -57.1 -33.53 95.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.072 2.515 . . . . 0.0 112.686 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.23 -48.24 53.8 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.662 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.569 HG22 HD21 ' A' ' 108' ' ' LEU . 99.8 t -59.77 -53.51 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.12 0.486 . . . . 0.0 110.48 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -56.24 -32.21 64.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.625 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -67.11 -34.25 77.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.601 0.239 . . . . 0.0 111.066 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.613 HD12 HD22 ' A' ' 108' ' ' LEU . 53.8 mt -68.85 -37.37 79.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.713 175.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.508 ' HB3' HD11 ' A' ' 3' ' ' LEU . 3.0 mm? -67.74 -48.76 65.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.706 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 3' ' ' LEU . 21.1 mm-40 -53.79 -32.32 52.06 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.972 0.415 . . . . 0.0 111.87 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -61.45 -54.6 41.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.502 HH12 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -136.88 4.47 2.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.45 ' HE2' ' HE ' ' A' ' 54' ' ' ARG . 59.6 m-85 -112.3 149.96 31.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.429 HG22 HD23 ' A' ' 14' ' ' LEU . 47.1 t -115.39 115.98 51.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.775 167.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 29.8 t -89.05 129.03 40.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.871 -173.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -99.45 117.14 33.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.372 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -93.05 101.35 13.67 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 70' ' ' LEU . 42.6 t -114.22 133.3 60.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.046 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.567 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 18.8 m -95.16 117.67 30.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.449 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 41.4 t -71.61 -23.57 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.074 0.464 . . . . 0.0 111.484 -174.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.38 -19.21 43.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.689 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.8 p -95.85 161.22 28.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.598 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -49.73 -49.96 14.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.765 2.977 . . . . 0.0 114.537 -168.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -60.41 -44.04 96.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -69.27 -39.24 82.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.695 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.678 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 55.1 mt-30 -57.67 -40.35 79.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.75 -45.56 74.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.552 HD12 HG11 ' A' ' 60' ' ' VAL . 78.9 mt -66.4 -29.47 69.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.485 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -68.81 -29.22 67.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 62.7 mtm180 -75.9 -45.7 33.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.478 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -65.5 -56.56 11.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.727 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -91.27 -12.51 34.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 71' ' ' ALA . 74.7 mtt180 62.28 87.21 0.1 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.678 0.751 . . . . 0.0 110.131 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 81' ' ' THR . 56.1 t -128.1 137.96 31.95 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.529 -171.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 60.0 Cg_endo -74.29 -138.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.902 2.401 . . . . 0.0 111.361 170.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -91.31 -104.76 1.37 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.169 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' HIS . 1.2 m -145.1 147.57 35.01 Favored Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.885 -0.185 . . . . 0.0 110.576 -169.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 36.7 Cg_endo -90.09 131.72 8.91 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.113 -1.203 . . . . 0.0 112.83 -1.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.89 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 22.5 m -114.51 108.22 16.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.484 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 23.8 m-85 -103.06 112.53 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.45 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -112.46 120.71 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.34 118.85 36.9 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.803 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 33.4 mt -114.86 132.58 56.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.704 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 40.2 t -109.73 127.56 26.92 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.414 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.2 Cg_endo -80.56 117.57 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.469 2.113 . . . . 0.0 110.383 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -142.58 124.53 15.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.426 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.46 -77.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.147 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.86 27.25 0.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.33 161.0 39.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 110.675 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.407 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 83.0 m95 -102.55 132.7 48.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.954 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 39.3 tt0 -117.87 120.51 38.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.509 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.3 tt0 -84.34 115.0 22.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.743 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 32.8 m -100.76 8.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.32 166.6 11.03 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.239 -0.982 . . . . 0.0 112.888 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 83' ' ' VAL . 92.5 mtt180 -133.78 135.74 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 110' ' ' GLU . 69.1 mt -108.88 127.06 53.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.079 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -137.38 143.99 42.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.3 12.65 26.61 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.26 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.436 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 49.2 m 69.64 -73.29 0.09 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.109 0.564 . . . . 0.0 111.642 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 68.14 156.69 0.14 Allowed Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 123.316 0.646 . . . . 0.0 111.284 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.23 159.15 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.178 1.919 . . . . 0.0 110.557 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.564 ' HB3' HG13 ' A' ' 41' ' ' VAL . 32.1 ptt180 -59.89 -25.48 65.13 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.66 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -54.34 -53.82 48.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.734 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.583 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 22.2 mm-40 -72.81 -34.44 66.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 40.2 t80 -65.02 -43.6 91.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 50' ' ' LEU . 88.8 mt -69.83 -30.73 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.6 mttt -55.93 -53.56 55.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.51 ' HB3' HD11 ' A' ' 98' ' ' LEU . 9.5 tp10 -70.72 -38.03 73.55 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.557 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -60.09 -33.93 72.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.376 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 115' ' ' CYS . 7.7 tpt180 -80.25 -38.25 31.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.454 ' HG2' ' HE3' ' A' ' 117' ' ' LYS . 7.3 tt0 -62.9 -46.31 88.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.675 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.619 HG13 HG21 ' A' ' 95' ' ' VAL . 91.5 t -60.22 -37.05 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.5 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 112' ' ' ARG . 52.4 t -54.02 -36.7 63.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.32 -38.29 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.289 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.743 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 96.7 mttt -53.58 -28.59 32.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.22 -34.35 24.92 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.138 -0.554 . . . . 0.0 112.684 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.338 177.086 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 57' ' ' VAL . 22.2 tp . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.43 0.157 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.633 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.3 mmt180 -88.44 104.52 16.87 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.984 0.421 . . . . 0.0 111.201 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -99.94 113.44 26.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.009 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.8 m-85 -122.93 160.48 49.15 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 20.4 Cg_exo -62.97 158.7 41.94 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.957 1.771 . . . . 0.0 111.343 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.573 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.7 t80 -47.1 -51.3 41.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 37.6 Cg_exo -60.79 -43.39 31.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.793 1.662 . . . . 0.0 112.266 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -68.49 -45.19 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 -177.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -54.71 -43.21 72.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.8 mp -66.97 -39.4 87.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.647 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.0 -44.19 66.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.214 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.468 ' HB3' HG11 ' A' ' 56' ' ' VAL . 14.4 tp -59.06 -51.33 70.51 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.67 96.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -63.15 -41.46 99.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.474 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.1 -15.47 50.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.918 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -113.51 -0.55 14.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.09 37.84 95.6 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.158 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.764 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 2.1 mmp_? -107.15 -179.68 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.277 0.231 . . . . 0.0 110.47 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.655 ' HG3' HG22 ' A' ' 86' ' ' VAL . 41.2 ttm -102.12 156.08 17.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.424 HG11 HD12 ' A' ' 12' ' ' LEU . 84.8 t -105.79 122.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.798 0.333 . . . . 0.0 110.702 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.8 ttt -100.38 103.58 14.97 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 48.9 t -86.97 105.64 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.533 ' HE1' ' CE1' ' A' ' 82' ' ' PHE . 84.2 t80 -104.9 108.82 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.96 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 69.4 m-85 -81.02 111.25 17.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.579 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.513 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 9.1 p-80 -119.76 156.41 30.64 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.949 0.781 . . . . 0.0 109.713 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.617 ' HA ' ' OD1' ' A' ' 63' ' ' ASP . 40.8 t -144.11 160.04 41.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.517 ' HG3' ' OD2' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -89.16 -6.28 57.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.81 0.814 . . . . 0.0 108.927 169.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -103.24 10.68 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.485 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 20.2 p -69.12 154.63 94.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.7 -90.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.004 1.802 . . . . 0.0 113.482 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -79.59 -17.24 54.33 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.933 0.396 . . . . 0.0 111.434 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 8.1 t -56.42 -25.76 51.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.365 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -50.81 -41.63 57.49 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 111.108 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.3 -39.35 25.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 110.447 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.511 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 81.6 mtp -68.58 -48.46 64.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.62 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -63.33 -48.07 79.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.985 0.422 . . . . 0.0 111.053 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 43' ' ' SER . 10.6 m -72.68 -54.31 9.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.863 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -92.3 -68.34 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.996 0.427 . . . . 0.0 112.107 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 37' ' ' MET . 95.8 t -51.66 -52.23 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -81.68 -16.33 51.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.4 m -93.59 -0.93 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.73 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -52.57 134.13 44.77 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.931 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.93 -39.57 85.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.024 2.483 . . . . 0.0 113.228 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.23 -41.1 54.28 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.67 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.785 HG22 HD21 ' A' ' 108' ' ' LEU . 29.0 t -63.56 -46.82 93.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -53.92 -44.24 70.42 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.92 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -62.67 -26.12 68.48 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -70.31 -45.12 66.87 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.659 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 47' ' ' VAL . 1.6 mm? -71.78 -43.73 65.21 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.739 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.13 -32.1 9.41 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.521 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -79.31 -48.7 13.64 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.764 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -136.11 19.06 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 51' ' ' LEU . 77.8 m-85 -129.28 145.29 51.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 0.0 111.43 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 14' ' ' LEU . 47.3 t -116.3 120.5 65.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 3' ' ' LEU . 35.5 t -91.89 123.36 43.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.15 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -92.31 117.44 29.9 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.235 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 p -80.81 101.6 9.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.435 HG21 HG13 ' A' ' 24' ' ' VAL . 58.7 t -110.05 119.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.165 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.563 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 0.9 OUTLIER -103.1 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -66.39 -15.4 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.724 0.773 . . . . 0.0 110.166 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.617 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 1.6 m-20 -71.58 -32.69 68.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.666 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.635 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -108.71 167.02 9.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.087 -173.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.635 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.7 Cg_endo -51.03 -48.33 21.55 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 124.174 3.249 . . . . 0.0 114.493 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.39 -35.57 80.86 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.912 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.3 -40.05 29.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.352 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -58.26 -35.57 71.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.437 0.637 . . . . 0.0 110.542 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.66 -51.18 61.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.439 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 9.3 mp -64.04 -33.71 76.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.956 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -63.42 -38.94 93.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.274 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.642 ' HA ' HH21 ' A' ' 75' ' ' ARG . 25.1 ptt180 -79.06 -34.81 43.39 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.23 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -68.97 -56.06 8.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.6 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.502 ' HE1' ' HG ' ' A' ' 70' ' ' LEU . 92.0 m-85 -85.89 -6.66 59.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.981 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.695 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 1.5 mmp_? 63.08 79.1 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.847 0.832 . . . . 0.0 110.127 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 71' ' ' ALA . 94.5 t -125.98 135.71 27.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.996 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 23.0 Cg_exo -65.56 -90.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.752 2.301 . . . . 0.0 112.067 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -143.14 -75.31 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.895 172.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -156.54 148.25 17.15 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.672 -0.311 . . . . 0.0 111.37 -170.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.674 ' HA ' HG22 ' A' ' 79' ' ' THR . 5.1 Cg_endo -88.83 137.75 14.49 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.432 -1.07 . . . . 0.0 111.477 -3.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.96 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 6.3 m -122.71 123.93 42.23 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.924 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.696 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.7 m-85 -114.16 114.31 25.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.869 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -123.48 112.78 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.929 0.395 . . . . 0.0 110.316 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.81 120.43 39.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 94' ' ' GLU . 35.4 mt -117.16 129.33 55.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.462 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.655 HG22 ' HG3' ' A' ' 21' ' ' MET . 21.6 t -108.61 122.87 38.92 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.203 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.3 118.07 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.188 1.925 . . . . 0.0 110.888 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -154.44 140.76 18.64 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.579 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.48 -76.13 0.06 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.084 0.865 . . . . 0.0 111.291 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.6 26.06 0.12 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.64 176.58 12.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 0.0 110.481 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -106.28 130.43 54.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.216 0.532 . . . . 0.0 110.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 37.2 tt0 -101.47 112.29 24.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.853 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.655 ' OE1' ' HD2' ' A' ' 97' ' ' ARG . 33.2 tt0 -75.29 95.8 3.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.28 -14.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.532 -168.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -156.04 123.67 1.36 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.547 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.655 ' HD2' ' OE1' ' A' ' 94' ' ' GLU . 27.3 mtp180 -130.42 126.14 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.831 HD11 ' HG2' ' A' ' 110' ' ' GLU . 42.9 mt -136.03 135.57 39.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.785 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.01 143.2 40.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.19 -86.0 0.28 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.949 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.7 p 179.95 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.319 0.248 . . . . 0.0 111.056 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.711 ' HB3' ' HB3' ' A' ' 106' ' ' GLU . 54.0 mtm180 66.65 119.13 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 123.726 0.811 . . . . 0.0 110.495 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.69 171.05 3.84 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.198 2.599 . . . . 0.0 112.932 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.486 ' HB2' HG13 ' A' ' 41' ' ' VAL . 54.8 ttp180 -46.66 -41.41 14.8 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.828 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.76 86.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.016 0.436 . . . . 0.0 111.808 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 12.1 tp10 -80.77 -37.48 30.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.64 -37.28 87.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.103 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.785 HD21 HG22 ' A' ' 47' ' ' VAL . 42.6 mt -63.6 -44.78 92.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.286 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HZ3' ' HA ' ' A' ' 106' ' ' GLU . 33.9 mtmm -61.17 -44.2 97.67 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.715 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.831 ' HG2' HD11 ' A' ' 98' ' ' LEU . 13.5 tp10 -59.05 -50.56 73.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.418 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -59.44 -34.59 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.614 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 112' ' ' ARG . 9.3 mmm180 -60.54 -43.25 97.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.463 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -72.52 -38.74 67.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 110' ' ' GLU . 91.1 t -56.48 -38.77 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.805 0.335 . . . . 0.0 110.665 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.0 m -56.68 -35.01 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.3 t -84.66 -50.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -55.81 -40.76 73.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.932 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.52 ' CA ' HG21 ' A' ' 86' ' ' VAL . . . -66.54 -24.3 72.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.751 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.734 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.101 -179.797 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.74 HD21 HG21 ' A' ' 57' ' ' VAL . 53.8 tp . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.543 0.211 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -82.28 104.88 12.91 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.273 0.559 . . . . 0.0 112.196 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.512 ' HZ2' ' HG ' ' A' ' 42' ' ' LEU . 43.0 m95 -107.9 131.37 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.669 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 89.8 m-85 -132.84 155.03 81.61 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 25.2 Cg_exo -58.09 160.85 14.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.003 1.802 . . . . 0.0 111.245 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.566 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 88.4 t80 -45.61 -53.95 17.47 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 19.7 Cg_exo -66.24 -42.19 11.02 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.668 1.579 . . . . 0.0 112.205 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 38.8 tt0 -69.4 -42.73 74.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.065 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.24 94.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.204 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 8' ' ' TYR . 9.1 mp -63.01 -35.82 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.77 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.6 69.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 110.203 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.547 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -60.12 -50.51 73.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.396 176.115 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -43.8 93.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.199 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -57.63 -52.15 66.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.493 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.96 59.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.756 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -115.91 2.9 13.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.499 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.3 44.58 96.42 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.626 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -108.7 -179.42 3.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.694 0.283 . . . . 0.0 110.919 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.478 ' SD ' ' HA3' ' A' ' 118' ' ' GLY . 87.3 mtp -100.92 158.48 15.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.2 125.84 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.008 0.432 . . . . 0.0 111.106 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.0 ttt -103.6 102.65 12.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 61.3 t -89.93 106.26 16.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.095 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.803 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 45.1 t80 -104.95 123.18 47.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.306 0.574 . . . . 0.0 111.36 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.914 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 67.1 m-85 -94.18 126.18 39.26 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.217 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.803 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 34.5 p80 -130.96 157.44 42.96 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.971 0.794 . . . . 0.0 110.679 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.557 ' H ' HG21 ' A' ' 79' ' ' THR . 30.3 t -143.01 159.12 42.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.565 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -6.6 58.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.42 0.629 . . . . 0.0 110.121 173.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -103.38 19.68 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.375 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.712 ' HB3' ' CG2' ' A' ' 79' ' ' THR . 26.9 p -74.68 131.32 79.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.567 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.11 -92.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.466 2.111 . . . . 0.0 114.031 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -74.43 -17.14 60.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.071 0.463 . . . . 0.0 111.433 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.4 t -58.49 -23.46 57.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.038 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -49.29 -47.81 46.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.218 0.532 . . . . 0.0 111.714 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -75.26 -31.7 60.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 101' ' ' SER . 83.5 mtp -67.11 -49.8 63.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.47 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 58.5 m-20 -64.55 -37.07 86.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.315 -174.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 m -64.77 -61.29 2.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.375 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.32 -70.6 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 104' ' ' ARG . 60.3 t -57.9 -44.64 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -170.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 15.1 tp -81.57 -11.1 59.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 -173.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -112.62 3.34 16.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.066 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' CG ' HH11 ' A' ' 104' ' ' ARG . 26.5 t70 -53.83 131.81 57.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.561 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -58.29 -28.57 84.98 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.933 2.422 . . . . 0.0 112.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.48 14.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.601 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.659 HG22 HD21 ' A' ' 108' ' ' LEU . 84.4 t -58.23 -53.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.161 0.505 . . . . 0.0 110.102 174.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.525 ' HA ' HD13 ' A' ' 3' ' ' LEU . 32.5 m -54.36 -38.29 65.92 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.234 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -60.86 -32.08 71.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.788 0.328 . . . . 0.0 111.387 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.763 HD12 HD22 ' A' ' 108' ' ' LEU . 69.0 mt -71.83 -42.1 67.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.741 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.419 ' HB2' HD11 ' A' ' 3' ' ' LEU . 2.4 mm? -70.74 -53.19 16.47 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.195 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.566 ' OE2' HD12 ' A' ' 3' ' ' LEU . 32.9 mm-40 -45.33 -38.19 5.53 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.644 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -64.68 -51.51 62.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.644 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.58 14.61 3.43 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -173.527 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.409 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 74.4 m-85 -125.29 150.86 46.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.498 . . . . 0.0 111.251 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 14' ' ' LEU . 61.0 t -119.02 122.06 68.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.74 HG21 HD21 ' A' ' 3' ' ' LEU . 33.1 t -89.11 124.31 41.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.994 -173.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.96 117.58 31.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.482 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -83.99 101.64 11.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.62 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.71 114.46 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 110.196 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.603 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -89.17 107.62 19.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.308 -178.292 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.501 HG11 ' HA2' ' A' ' 78' ' ' GLY . 44.3 t -80.7 -7.79 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 122.697 1.237 . . . . 0.0 107.694 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -33.78 76.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.826 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -124.64 167.14 16.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.204 -174.028 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -50.62 -50.77 12.69 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.312 3.341 . . . . 0.0 114.76 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -44.1 84.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.0 111.462 -174.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.61 -27.44 59.08 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.806 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -63.89 -37.69 88.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.7 -51.36 70.26 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.289 0.566 . . . . 0.0 109.874 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 4.0 mm? -56.91 -43.64 81.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.019 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.78 -54.68 44.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 72' ' ' ARG . 21.5 ptt85 -68.73 -23.36 64.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.102 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -72.64 -36.54 68.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.715 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -106.2 8.51 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.376 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 62.07 36.98 15.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.913 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.0 t -93.48 133.67 27.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.504 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.439 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 29.3 Cg_exo -61.56 -83.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.61 2.207 . . . . 0.0 111.552 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' HA2' HG11 ' A' ' 62' ' ' VAL . . . -145.5 -52.76 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.807 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.712 ' CG2' ' HB3' ' A' ' 31' ' ' CYS . 3.6 t 175.57 158.09 0.39 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.682 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 2.4 Cg_endo -79.75 126.61 13.21 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.29 0.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.914 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 29.3 m -129.77 119.67 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.115 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.16 110.72 20.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 60.8 t -113.99 114.21 46.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.862 0.363 . . . . 0.0 110.056 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.6 117.55 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.857 0.361 . . . . 0.0 110.754 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 26.5 mt -110.73 136.56 49.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.21 0.529 . . . . 0.0 111.303 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.0 t -109.94 120.07 45.73 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.49 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 52.2 Cg_endo -74.95 117.49 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.72 1.614 . . . . 0.0 110.938 173.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.409 ' HE3' ' CB ' ' A' ' 93' ' ' GLU . 20.7 pttp -141.58 132.63 26.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.517 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.01 -76.8 0.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.008 0.818 . . . . 0.0 111.262 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.58 24.77 0.19 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -146.25 152.5 39.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.7 0.286 . . . . 0.0 110.695 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.49 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 32.8 m95 -92.95 120.77 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 7.6 tp10 -102.21 139.88 37.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.888 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.66 104.78 17.33 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.608 HG22 ' HD3' ' A' ' 117' ' ' LYS . 4.3 p -97.19 6.39 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 -172.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.85 134.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.488 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -122.84 135.88 54.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 110.441 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.48 136.77 52.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.737 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -137.13 136.67 38.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.856 0.36 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.14 -174.71 18.53 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.86 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.448 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.5 m -92.43 127.13 37.81 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.976 0.417 . . . . 0.0 110.566 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 102' ' ' ARG . 8.6 mmm180 -127.87 137.61 31.15 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.88 157.18 58.01 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.911 1.741 . . . . 0.0 110.016 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB2' HG13 ' A' ' 41' ' ' VAL . 46.4 ttp180 -58.0 -26.82 62.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.89 -50.78 67.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.582 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -69.02 -42.67 76.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.979 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.18 -50.39 74.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.763 HD22 HD12 ' A' ' 50' ' ' LEU . 56.8 mt -72.23 -19.16 61.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.512 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -73.16 -49.9 25.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.409 0.623 . . . . 0.0 109.946 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 114' ' ' VAL . 50.4 mt-10 -72.76 -35.33 67.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.213 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.54 -32.73 74.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.089 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -59.68 -47.29 86.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.343 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -56.31 -45.16 80.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.532 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 95.6 t -62.4 -45.58 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.922 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.444 ' HB2' HH21 ' A' ' 54' ' ' ARG . 21.0 p -67.12 -22.25 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 111.044 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 112' ' ' ARG . 80.3 t -79.23 -37.7 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 109.918 174.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.608 ' HD3' HG22 ' A' ' 95' ' ' VAL . 83.5 mttt -61.57 -27.49 68.67 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.635 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.478 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -65.0 -32.9 85.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.337 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.078 179.575 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.2 tp . . . . . 0 C--O 1.237 0.412 0 CA-C-O 121.154 0.502 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.613 ' HA ' ' NE ' ' A' ' 4' ' ' ARG . 3.1 mmp_? -109.05 123.1 48.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.246 -171.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -115.56 115.98 27.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.588 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 86.2 m-85 -133.69 160.88 66.86 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.497 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 31.7 Cg_exo -58.55 166.47 6.26 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.406 2.071 . . . . 0.0 111.483 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.615 ' CD1' HD21 ' A' ' 70' ' ' LEU . 61.8 t80 -51.58 -51.43 69.76 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.5 Cg_exo -62.12 -45.69 15.11 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.866 1.71 . . . . 0.0 112.233 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 80.2 tt0 -67.09 -40.2 86.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.929 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.81 94.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.225 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 22' ' ' VAL . 2.8 mt -63.25 -35.75 81.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.832 0.348 . . . . 0.0 110.332 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.73 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.229 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.2 tp -64.31 -44.6 91.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.628 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.75 -42.28 95.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.697 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.25 -44.74 90.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.54 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.76 -14.67 56.14 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -119.14 1.78 11.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.93 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.59 44.32 97.72 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.242 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.628 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 12.5 mmm180 -107.96 -178.04 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 111.342 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -101.22 165.06 11.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.546 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 84.1 t -122.53 133.6 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.737 0.303 . . . . 0.0 111.189 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 23' ' ' MET . 20.1 ptm -126.79 113.58 16.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.182 0.515 . . . . 0.0 109.645 170.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.548 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 46.5 t -87.22 109.62 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 88.6 t80 -97.49 103.6 15.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.378 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.964 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 77.0 m-85 -82.27 119.33 23.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.604 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.496 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 48.5 p-80 -133.02 146.24 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.21 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 47.4 t -134.14 164.84 26.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 -17.87 30.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.114 0.483 . . . . 0.0 110.22 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.505 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 76.9 m-70 -89.56 -16.76 29.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.768 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.873 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 63.9 m -108.84 84.9 2.78 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.332 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.566 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.7 Cg_endo -92.08 -0.84 4.22 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.002 2.468 . . . . 0.0 114.896 -169.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -74.58 -21.7 59.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.837 -0.539 . . . . 0.0 111.409 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 17.5 p -72.52 -30.83 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 13.6 pt20 -67.9 -27.14 66.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.651 0.262 . . . . 0.0 110.97 -176.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.69 -50.49 66.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.646 ' HG3' ' HB3' ' A' ' 101' ' ' SER . 11.3 tmm? -67.95 -42.41 80.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.842 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -54.67 -47.2 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.504 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 m -61.59 -51.76 67.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.98 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.01 -70.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.258 0.551 . . . . 0.0 112.055 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.623 ' HB ' ' SD ' ' A' ' 37' ' ' MET . 96.9 t -63.37 -41.35 92.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.533 -168.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.3 tp -80.86 -30.61 35.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.2 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 m -87.6 -1.56 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.68 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.01 131.16 8.98 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.049 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.52 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 54.4 Cg_exo -52.99 -38.02 79.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.047 2.498 . . . . 0.0 113.305 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.7 -43.59 35.2 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.069 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.94 -51.09 73.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.436 0.636 . . . . 0.0 109.923 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.2 m -53.8 -39.21 65.27 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.128 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 17.7 mtp180 -60.61 -29.2 69.08 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.78 -39.11 67.0 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.599 174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.44 -43.62 72.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.584 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.23 -34.53 64.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.85 0.46 . . . . 0.0 111.327 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -54.22 47.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.205 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -11.39 2.07 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -90.48 151.63 21.29 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 14' ' ' LEU . 90.9 t -115.41 122.73 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 163.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.421 HG22 ' SD ' ' A' ' 23' ' ' MET . 16.1 t -87.45 125.29 41.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.035 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -96.91 117.1 30.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.862 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.8 p -91.42 100.53 13.29 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.469 HG21 HG13 ' A' ' 24' ' ' VAL . 96.4 t -109.04 119.25 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.13 0.49 . . . . 0.0 110.985 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.629 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -96.53 119.56 35.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.467 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.623 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 16.4 t -81.24 66.31 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.876 0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.629 ' OD1' ' HB2' ' A' ' 61' ' ' SER . 3.1 p-10 -163.21 -33.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -94.9 164.02 20.6 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.454 175.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.6 Cg_endo -51.5 -55.03 4.37 Favored 'Trans proline' 0 N--CA 1.477 0.54 0 C-N-CA 123.497 2.798 . . . . 0.0 113.996 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 70' ' ' LEU . 10.7 pt-20 -57.68 -41.48 81.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.177 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.05 -34.23 64.96 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.642 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -68.79 -42.79 76.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.334 -0.433 . . . . 0.0 111.474 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' A' ' 72' ' ' ARG . 12.0 pt-20 -73.74 -33.82 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.883 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.615 HD21 ' CD1' ' A' ' 8' ' ' TYR . 5.5 mp -62.92 -36.06 82.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.435 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -65.14 -31.96 73.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.486 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.43 HH21 ' HB2' ' A' ' 69' ' ' GLU . 56.0 mtm180 -68.89 -41.82 77.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.481 0.658 . . . . 0.0 109.997 173.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -71.32 -57.38 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.609 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 96.9 m-85 -82.9 -18.44 40.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.022 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 74' ' ' TYR . 10.5 ptp180 44.85 73.19 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.357 1.035 . . . . 0.0 112.114 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.49 HG11 ' CG2' ' A' ' 81' ' ' THR . 35.0 t -135.92 100.65 10.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.636 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.6 130.11 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.991 2.461 . . . . 0.0 111.995 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 151.01 -77.41 0.23 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.44 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.873 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.2 m 71.62 138.94 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.919 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.718 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 51.5 Cg_endo -71.72 143.88 78.16 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 123.666 -1.389 . . . . 0.0 113.191 0.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.964 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 27.6 m -120.49 122.29 40.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.894 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 4.3 m-85 -114.35 110.95 20.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 74' ' ' TYR . 66.0 t -115.38 111.32 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.543 ' HB2' HG13 ' A' ' 95' ' ' VAL . 51.5 m-85 -93.1 135.83 33.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 37.2 mt -125.26 132.71 52.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.866 0.365 . . . . 0.0 110.184 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.574 HG11 ' HA2' ' A' ' 118' ' ' GLY . 16.0 t -109.01 121.41 43.0 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.736 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.4 116.76 4.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.331 1.354 . . . . 0.0 110.124 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -137.19 126.73 25.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.642 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.72 -71.55 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.156 0.91 . . . . 0.0 111.024 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.13 23.81 0.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.027 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.96 157.1 44.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.673 0.273 . . . . 0.0 110.903 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -93.07 124.31 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.698 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -109.05 118.53 37.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.342 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 35.6 tt0 -69.78 98.93 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.634 0.731 . . . . 0.0 109.413 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 84' ' ' PHE . 1.8 p -80.05 -28.21 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.036 -170.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.18 152.02 10.76 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.388 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -120.05 127.33 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 85.9 mt -111.53 137.06 49.86 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.417 ' CE1' ' HA3' ' A' ' 78' ' ' GLY . 91.0 t80 -137.87 143.09 40.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.84 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.75 23.92 59.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.745 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.646 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 43.1 m 68.15 174.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.429 ' O ' HG11 ' A' ' 41' ' ' VAL . 4.9 mmt180 -148.61 148.73 29.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 172.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.58 149.77 88.31 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 N-CA-C 108.626 -1.336 . . . . 0.0 108.626 164.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.648 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 10.9 ptt180 -59.8 -29.53 68.29 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.576 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.73 88.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.611 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.681 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 2.0 mt-10 -80.92 -35.44 32.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.342 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.38 -37.18 86.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 91.2 mt -62.77 -43.2 99.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.044 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.618 ' HD3' ' HA ' ' A' ' 106' ' ' GLU . 8.2 mtpm? -52.59 -56.57 14.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 175.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 3.7 mm-40 -61.23 -40.78 95.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.55 -20.9 66.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.345 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.4 mmt180 -78.54 -45.34 22.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.72 -38.4 78.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.383 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.498 HG13 HG11 ' A' ' 95' ' ' VAL . 78.7 t -74.66 -38.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 112' ' ' ARG . 24.6 p -65.53 -31.77 73.0 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.506 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.2 t -71.26 -43.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.165 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.51 ' HD3' HG23 ' A' ' 95' ' ' VAL . 30.6 mtpt -68.92 -11.5 60.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 111.841 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.574 ' HA2' HG11 ' A' ' 86' ' ' VAL . . . -71.73 -33.48 63.29 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.405 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.251 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.147 -177.349 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 22.3 tp . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.4 0.619 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.4 mmt180 -97.99 108.64 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.067 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -106.09 104.19 13.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.38 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 92.4 m-85 -116.23 168.9 7.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 12.4 Cg_exo -67.74 158.48 57.04 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.604 1.536 . . . . 0.0 110.094 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.542 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.7 t80 -47.11 -50.3 47.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 51.5 Cg_exo -56.57 -50.26 12.36 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.159 1.906 . . . . 0.0 112.981 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.04 -42.34 89.7 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.17 71.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 22' ' ' VAL . 6.3 mt -70.81 -36.86 73.16 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.329 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.29 70.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.055 0.455 . . . . 0.0 110.065 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.548 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -59.75 -44.57 93.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.874 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.75 -53.42 33.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.455 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 7.7 tp60 -58.67 -53.14 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.069 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.22 60.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.999 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -116.72 -0.14 12.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.094 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.26 91.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.814 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.667 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 74.6 mmt-85 -112.79 179.59 3.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 111.653 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.2 mtp -101.69 159.06 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.285 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 47.8 t -105.8 119.53 55.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 57' ' ' VAL . 10.2 tpt -99.6 103.3 14.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.235 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 16.4 t -94.88 106.28 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.445 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 90.4 t80 -106.61 104.43 14.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.226 0.536 . . . . 0.0 111.143 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.926 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.5 m-85 -82.38 115.82 21.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.218 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -121.3 158.37 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.748 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 42.8 m -137.69 162.24 34.37 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -64.62 -60.77 2.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -94.42 48.72 1.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.314 0.578 . . . . 0.0 110.844 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 27.3 p -76.19 149.26 81.97 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.135 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 33' ' ' TYR . 39.0 Cg_exo -58.93 -98.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.076 2.518 . . . . 0.0 114.053 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.433 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 90.2 t80 -87.72 -17.83 30.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 0.0 111.565 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 1.6 t -51.4 -38.97 56.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.665 -174.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 2.1 pp0? -56.85 -31.47 64.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.18 -48.16 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 110.084 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.53 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 15.1 ptm -68.96 -33.47 73.76 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.2 -27.73 65.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.208 0.527 . . . . 0.0 110.206 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.8 m -92.13 -61.58 1.59 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.378 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.45 -70.58 0.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.71 -47.03 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.223 -0.898 . . . . 0.0 113.305 -168.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 tp -81.89 -19.03 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.773 0.321 . . . . 0.0 110.984 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.2 m -92.92 -6.44 48.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.459 ' HB3' HG23 ' A' ' 47' ' ' VAL . 11.4 t70 -46.55 136.23 7.46 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.743 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 53.1 Cg_exo -56.86 -35.28 98.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.375 2.717 . . . . 0.0 113.698 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.589 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . -79.41 -24.35 61.09 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 44' ' ' ASP . 19.9 t -79.48 -43.56 23.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 109.003 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -62.77 -33.55 75.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.319 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 15.2 ptm180 -67.95 -24.49 65.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.798 0.333 . . . . 0.0 111.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -71.84 -46.43 58.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -62.45 -44.82 95.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.911 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -50.23 -31.34 13.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.548 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -82.91 -54.49 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -171.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.667 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.56 12.04 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -170.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 84.4 m-85 -118.84 138.41 52.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.529 0.68 . . . . 0.0 112.026 -176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 14' ' ' LEU . 51.0 t -109.33 116.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.46 HG13 ' HG3' ' A' ' 23' ' ' MET . 15.5 t -89.21 127.36 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.215 0.531 . . . . 0.0 110.978 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.09 117.8 34.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.029 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.1 p -81.44 101.26 9.76 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.61 120.46 56.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.723 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.625 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 m -101.78 108.9 20.54 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.0 t -68.19 -13.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.645 0.736 . . . . 0.0 110.439 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 28' ' ' SER . 2.8 m-20 -79.72 -28.86 40.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.055 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.644 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -105.43 165.38 13.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.654 -175.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.6 Cg_endo -49.07 -52.35 8.9 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.035 3.157 . . . . 0.0 114.495 -171.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -59.49 -39.3 83.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -179.238 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.22 -35.74 47.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.839 175.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.39 -35.65 79.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.67 0.747 . . . . 0.0 110.089 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.59 -46.66 71.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.412 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.431 ' O ' ' HD1' ' A' ' 74' ' ' TYR . 45.1 mt -66.29 -31.44 72.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.33 -33.79 76.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.283 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -85.17 -28.45 25.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.632 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.49 -50.36 52.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.488 ' CD1' ' HZ ' ' A' ' 26' ' ' PHE . 89.3 m-85 -85.23 -20.91 29.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.312 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 58.4 62.26 2.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.834 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.4 t -137.37 101.47 9.09 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.791 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -96.58 128.2 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 111.292 168.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 107.85 1.65 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.72 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -92.64 147.83 34.98 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.203 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.69 ' HA ' HG22 ' A' ' 79' ' ' THR . 10.3 Cg_endo -88.26 154.45 37.99 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.595 -1.002 . . . . 0.0 112.345 -0.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.926 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 23.9 m -120.01 115.02 22.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.319 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 11.8 m-85 -106.48 112.35 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.606 HG22 ' HG2' ' A' ' 97' ' ' ARG . 46.5 t -118.13 129.6 74.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.463 ' CG ' HG11 ' A' ' 114' ' ' VAL . 68.1 m-85 -110.79 122.97 49.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.809 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.694 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 28.5 mt -112.86 131.36 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.472 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.552 HG21 ' HA2' ' A' ' 118' ' ' GLY . 15.8 t -114.13 113.54 46.4 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.726 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.29 116.83 4.22 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.378 1.385 . . . . 0.0 110.326 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -158.85 150.43 20.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.66 -65.49 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.038 0.836 . . . . 0.0 110.884 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.15 23.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.545 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.62 171.85 19.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 110.892 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 73.1 m95 -95.73 126.43 40.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.049 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 35.6 tt0 -103.31 112.14 24.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.064 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.429 ' HA ' HD23 ' A' ' 85' ' ' LEU . 39.4 tt0 -78.14 97.29 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 84' ' ' PHE . 15.7 m -81.42 -6.63 9.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.63 171.49 15.24 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.077 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.606 ' HG2' HG22 ' A' ' 83' ' ' VAL . 89.8 mtt180 -133.37 137.99 46.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.815 -0.693 . . . . 0.0 109.752 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.5 mt -108.38 128.28 54.63 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -138.39 144.02 40.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.185 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.29 -2.73 7.75 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.367 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.9 m 71.44 128.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.414 0.626 . . . . 0.0 110.589 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -131.8 129.46 21.97 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD2' ' HG3' ' A' ' 106' ' ' GLU . 27.7 Cg_exo -62.44 166.19 13.79 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.394 2.062 . . . . 0.0 110.502 168.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.44 -44.75 76.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.0 111.39 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.18 85.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 120.966 0.412 . . . . 0.0 111.256 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.551 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 11.6 mm-40 -66.95 -54.64 19.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 111' ' ' LEU . 26.3 t80 -57.92 -42.77 85.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.863 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 47' ' ' VAL . 60.4 mt -58.4 -43.75 88.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.387 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.483 ' HZ2' ' HA ' ' A' ' 106' ' ' GLU . 10.3 mtmp? -63.95 -50.17 69.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 114' ' ' VAL . 3.1 pt-20 -75.31 -33.06 61.13 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 107' ' ' PHE . 4.7 tt -59.57 -43.37 93.63 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 45.1 mtm180 -65.13 -33.05 75.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.519 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.36 -37.74 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 110.499 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 110' ' ' GLU . 78.9 t -63.65 -34.53 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.592 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.9 m -57.25 -37.05 71.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.509 . . . . 0.0 110.209 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.2 -37.95 53.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.323 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HZ2' ' HB3' ' A' ' 117' ' ' LYS . 9.1 mtpm? -68.11 -10.8 56.79 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.059 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.552 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -63.75 -41.41 98.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.708 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 176.44 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 52' ' ' GLU . 4.3 tp . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.216 0.531 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 6' ' ' TYR . 17.1 tpt180 -103.34 116.77 33.06 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.496 -169.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -108.88 127.13 53.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.754 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.56 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 30.1 m-85 -130.52 170.6 10.72 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.127 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 15.1 Cg_exo -69.65 166.65 26.74 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.506 2.137 . . . . 0.0 110.566 171.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.602 ' CD1' HD21 ' A' ' 70' ' ' LEU . 63.0 t80 -44.97 -54.04 14.45 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.8 Cg_exo -59.36 -52.82 4.18 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.881 1.721 . . . . 0.0 113.089 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -66.18 -36.39 82.96 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.795 0.331 . . . . 0.0 110.452 -175.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.42 -43.42 93.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.81 -32.03 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.64 -46.24 32.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.871 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 56' ' ' VAL . 12.0 tp -59.3 -46.37 88.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 110.305 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.428 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -60.64 -44.21 96.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 -14.58 59.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.141 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -117.92 5.44 12.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.548 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.22 37.18 94.11 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.472 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.7 mmp_? -108.19 175.66 5.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.549 ' SD ' HG22 ' A' ' 86' ' ' VAL . 69.5 mtm -102.62 162.67 12.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.97 121.2 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.832 0.348 . . . . 0.0 111.043 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.06 103.28 15.16 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 17.0 t -87.12 101.19 10.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 73.8 t80 -92.57 103.0 15.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 84.7 m-85 -81.83 112.23 18.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.254 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.609 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 17.0 p80 -131.29 138.91 49.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.093 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.6 m -94.45 153.12 18.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 164.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 63' ' ' ASP . 1.1 pm0 -85.49 -13.11 50.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -105.52 24.39 12.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.684 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.873 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 14.8 p -73.03 161.62 78.52 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.927 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.25 -105.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.388 2.059 . . . . 0.0 114.415 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -70.37 -17.52 63.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 5.4 t -55.46 -30.89 61.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.015 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -55.03 -31.72 61.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.589 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.76 -50.78 8.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -63.43 -47.2 82.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.632 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.29 -42.48 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.291 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 m -68.98 -55.77 9.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.61 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -91.34 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.173 0.511 . . . . 0.0 112.102 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.02 -39.91 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.883 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -79.66 -28.45 40.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.763 0.315 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.6 m -88.2 -1.47 58.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -45.25 130.63 5.84 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.858 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.629 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 50.3 Cg_exo -55.66 -35.43 92.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.115 2.543 . . . . 0.0 113.259 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' NE ' ' A' ' 49' ' ' ARG . . . -75.6 -39.44 34.83 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.016 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.455 ' HA ' HD21 ' A' ' 108' ' ' LEU . 61.1 t -65.41 -44.57 94.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.36 0.6 . . . . 0.0 109.588 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 14.7 t -49.49 -46.91 48.79 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.297 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 77.5 mtm180 -50.31 -39.08 44.74 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.501 ' HB3' HD12 ' A' ' 111' ' ' LEU . 56.5 mt -73.26 -46.53 49.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.64 -35.7 73.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.105 0.478 . . . . 0.0 110.391 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -48.47 -48.5 37.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.304 1.041 . . . . 0.0 112.405 -177.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -76.27 -43.18 42.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -167.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.809 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.26 17.94 3.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -129.84 139.63 51.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.878 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 14' ' ' LEU . 99.1 t -107.8 116.35 51.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.85 126.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.234 0.54 . . . . 0.0 110.973 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -95.46 117.32 30.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.901 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.3 p -86.41 101.36 13.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.1 t -103.88 113.55 41.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.702 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.515 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 3.0 p -91.22 114.31 26.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.237 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 71' ' ' ALA . 99.4 t -74.16 -19.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.58 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 5.3 m-20 -82.55 -7.22 59.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.588 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.8 p -111.39 156.16 41.66 Favored Pre-proline 0 C--O 1.22 -0.472 0 O-C-N 122.36 -0.212 . . . . 0.0 111.078 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.588 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.2 Cg_endo -50.43 -55.3 4.22 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 124.062 3.175 . . . . 0.0 114.665 -167.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -35.48 76.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.97 -32.56 52.79 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.822 174.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 64' ' ' THR . 54.5 mt-30 -62.2 -42.91 99.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.142 0.577 . . . . 0.0 110.477 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.4 -41.55 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.274 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.602 HD21 ' CD1' ' A' ' 8' ' ' TYR . 3.9 mp -62.05 -34.88 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.234 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.539 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -63.78 -38.25 90.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.49 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -84.74 -27.92 26.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.891 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.88 -51.3 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.423 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.1 0.56 46.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.838 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 53.81 76.85 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.13 0.894 . . . . 0.0 111.161 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG11 ' CB ' ' A' ' 26' ' ' PHE . 61.6 t -128.48 84.01 64.44 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.035 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -102.5 105.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.638 2.892 . . . . 0.0 111.631 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.4 90.88 0.67 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.519 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.873 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 25.7 m -82.55 143.35 47.37 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 83.1 Cg_endo -88.76 151.0 30.17 Favored 'Cis proline' 0 C--N 1.35 0.609 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.734 0.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 91.0 m -128.05 129.16 46.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.907 171.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.739 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.2 m-85 -110.11 114.08 27.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.226 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.405 HG22 ' HD3' ' A' ' 97' ' ' ARG . 91.8 t -117.79 128.73 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.962 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.18 121.71 45.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.757 0.313 . . . . 0.0 110.733 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 94' ' ' GLU . 29.5 mt -110.39 136.16 49.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.549 HG22 ' SD ' ' A' ' 21' ' ' MET . 14.6 t -109.52 133.99 20.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.412 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 4.0 Cg_exo -79.58 118.11 3.81 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.47 2.113 . . . . 0.0 110.63 171.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -133.83 151.47 51.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.59 93.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.278 0.561 . . . . 0.0 111.134 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.54 -47.27 0.74 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.058 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.95 -168.36 0.21 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.855 0.36 . . . . 0.0 110.771 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -97.67 140.35 32.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.858 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -124.61 129.38 50.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.449 -175.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 35.5 tt0 -80.33 108.63 14.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.465 HG22 ' HZ2' ' A' ' 117' ' ' LYS . 5.5 p -104.34 -13.16 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.986 -169.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.28 140.63 7.6 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.874 -1.155 . . . . 0.0 113.441 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.451 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 18.6 mmt180 -127.36 126.25 42.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 89.7 mt -131.71 135.7 47.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -137.47 142.78 41.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.559 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.93 138.42 9.96 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.895 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -76.44 124.41 27.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -141.33 160.57 56.78 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.94 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.81 161.3 22.1 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.54 2.16 . . . . 0.0 111.88 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.537 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 5.4 ptt180 -59.69 -28.92 67.71 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.976 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.2 91.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.945 0.402 . . . . 0.0 110.501 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.1 -47.04 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.776 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.06 -46.59 88.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.294 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 94.7 mt -57.46 -38.35 74.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.036 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -57.72 -63.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 114' ' ' VAL . 1.6 mp0 -70.12 -34.61 73.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.538 -175.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 50' ' ' LEU . 2.1 tm? -63.12 -38.55 91.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -57.74 -47.76 81.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.633 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 13.1 mm100 -65.26 -36.26 83.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.086 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -61.84 -37.83 79.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.318 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.57 -34.38 74.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.537 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.06 -32.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.969 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.465 ' HZ2' HG22 ' A' ' 95' ' ' VAL . 7.9 mtpm? -68.05 -8.62 39.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.28 88.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.148 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.364 178.829 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.705 HD21 HD23 ' A' ' 51' ' ' LEU . 56.8 tp . . . . . 0 C--O 1.236 0.363 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.419 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 2.7 mmp_? -80.66 102.76 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.976 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.406 ' HE1' ' HB3' ' A' ' 3' ' ' LEU . 74.4 m95 -107.85 104.56 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.48 . . . . 0.0 110.235 175.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -113.52 145.35 33.16 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 31.3 Cg_exo -59.41 166.93 6.93 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.975 1.783 . . . . 0.0 111.389 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 77.8 t80 -48.71 -50.03 62.62 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.9 Cg_exo -60.76 -55.63 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.702 1.601 . . . . 0.0 111.986 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.1 mp0 -54.14 -44.88 71.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.389 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -59.4 -47.45 85.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 0.0 111.279 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.9 -39.96 94.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.87 62.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.947 0.404 . . . . 0.0 110.484 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.84 -49.59 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.436 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.38 -46.98 68.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.238 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -59.25 -49.01 79.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.017 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -13.96 59.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.863 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -117.0 4.77 12.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.425 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.28 41.97 99.65 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.719 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.2 mmp_? -109.19 -179.93 3.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.764 0.316 . . . . 0.0 110.539 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.3 mtp -102.04 155.62 18.07 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 54.0 t -105.95 124.72 61.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.535 ' SD ' HD21 ' A' ' 51' ' ' LEU . 22.0 ttt -107.67 103.24 12.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 46.0 t -84.26 105.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -99.15 103.39 15.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.443 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.81 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 92.4 m-85 -81.67 115.9 21.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.606 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.467 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 27.8 p80 -120.12 150.42 40.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.543 0.527 . . . . 0.0 110.427 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.426 ' H ' HG21 ' A' ' 79' ' ' THR . 47.0 t -143.41 147.91 35.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' OE1' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -88.04 -26.99 22.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.111 0.481 . . . . 0.0 110.212 175.278 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -72.92 -21.71 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.912 ' HB3' HG22 ' A' ' 79' ' ' THR . 9.4 t -103.93 94.99 7.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.15 23.42 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.691 2.26 . . . . 0.0 113.453 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.417 ' HD2' ' HD3' ' A' ' 80' ' ' PRO . 2.7 t80 -86.65 -29.79 22.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.893 0.378 . . . . 0.0 111.092 -174.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.407 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . 28.5 p -82.81 -32.79 27.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -55.54 -34.65 64.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -168.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.37 -48.2 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.891 0.377 . . . . 0.0 110.759 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.4 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 26.3 ttp -74.51 -44.42 51.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -177.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -57.76 -45.67 85.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.751 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -64.17 -56.93 11.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.648 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.81 -70.13 0.7 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.171 0.51 . . . . 0.0 111.959 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.81 -41.97 76.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.797 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.3 tp -81.11 -27.05 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.25 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 t -92.55 1.11 57.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.356 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -50.82 134.63 27.85 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.074 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.578 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 75.0 Cg_exo -52.3 -40.58 69.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.139 2.559 . . . . 0.0 113.485 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.44 -46.84 18.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.098 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.9 -50.85 78.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.215 0.531 . . . . 0.0 110.392 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 64.0 m -59.84 -38.28 81.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.292 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -63.34 -39.95 95.96 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.71 HD22 HH22 ' A' ' 54' ' ' ARG . 64.7 mt -63.3 -38.05 89.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.953 0.406 . . . . 0.0 110.571 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.705 HD23 HD21 ' A' ' 3' ' ' LEU . 2.0 tp -70.08 -56.37 7.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.412 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HG3' HH21 ' A' ' 49' ' ' ARG . 5.0 mm-40 -46.05 -40.59 10.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.414 0.686 . . . . 0.0 112.621 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.477 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -61.73 -49.7 75.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.71 HH22 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.79 9.05 3.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -174.129 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -119.28 138.94 52.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.572 . . . . 0.0 111.042 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.2 t -109.32 116.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.621 HG21 HD21 ' A' ' 3' ' ' LEU . 19.6 t -87.26 119.49 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.554 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.21 117.48 28.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.852 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 p -83.2 100.33 10.51 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.644 HG11 HD23 ' A' ' 70' ' ' LEU . 59.0 t -111.33 124.3 67.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.696 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.462 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -95.41 118.14 31.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.62 -178.339 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.87 10.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 122.74 1.257 . . . . 0.0 108.328 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.474 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -97.37 -24.24 15.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.432 175.364 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.578 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 42.4 p -108.58 152.97 42.4 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.857 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 27.2 Cg_endo -55.86 -51.57 9.37 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.042 3.161 . . . . 0.0 114.778 -168.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.4 -37.05 85.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.634 -177.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -73.49 -37.3 53.45 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.335 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 64' ' ' THR . 93.4 mt-30 -61.91 -32.07 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 110.466 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 72' ' ' ARG . 6.0 tp10 -68.87 -43.45 75.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.802 175.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.644 HD23 HG11 ' A' ' 60' ' ' VAL . 23.5 tp -63.59 -31.18 72.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.807 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.14 81.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.425 HH21 ' CD ' ' A' ' 69' ' ' GLU . 42.0 mtm180 -65.42 -32.46 74.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.117 0.484 . . . . 0.0 110.041 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -66.04 -53.29 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.227 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.82 2.07 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 61.7 56.22 2.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.497 0.665 . . . . 0.0 109.947 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 55.3 t -104.45 136.33 19.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.907 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.0 Cg_exo -73.97 -143.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.233 2.622 . . . . 0.0 111.265 171.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -80.16 -71.57 1.26 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.514 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.912 HG22 ' HB3' ' A' ' 31' ' ' CYS . 14.3 t 176.7 158.42 0.46 Allowed Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.692 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 12.4 Cg_endo -87.84 127.21 8.64 Favored 'Cis proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.21 -1.162 . . . . 0.0 112.385 -1.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.81 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 7.2 m -115.95 119.65 36.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.609 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.1 m-85 -108.14 112.11 24.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.032 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.576 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 80.4 t -113.81 107.36 22.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HE1' HD12 ' A' ' 98' ' ' LEU . 96.3 m-85 -93.98 123.2 37.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.1 mt -114.56 140.51 48.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 111.211 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.31 123.31 37.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.408 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 5.7 Cg_exo -77.7 118.0 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.398 2.066 . . . . 0.0 110.286 171.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 93' ' ' GLU . 24.2 pttm -128.18 112.62 14.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 0.0 111.05 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.75 -80.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.547 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 23.05 1.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.09 155.1 43.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.824 0.345 . . . . 0.0 110.452 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.44 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 91.6 m95 -90.94 163.62 14.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 9.7 tp10 -148.1 140.85 24.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.681 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.465 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 37.2 tt0 -94.13 104.65 16.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.78 -12.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.616 -170.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.94 144.79 5.08 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.366 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 99.2 mtt180 -113.9 128.02 56.22 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 96.0 mt -121.72 141.83 50.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -137.66 143.93 41.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.326 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.21 141.37 11.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.403 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 37' ' ' MET . 3.3 p -70.21 122.45 19.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 23.4 mmt85 -108.03 142.11 24.57 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.92 158.25 25.63 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.022 1.815 . . . . 0.0 110.183 168.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -54.4 -49.05 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.567 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.48 72.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.39 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.535 ' OE1' ' HD2' ' A' ' 102' ' ' ARG . 4.5 tm-20 -76.05 -48.39 21.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 67.0 t80 -66.4 -36.76 83.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 108' ' ' LEU . 40.8 mt -62.64 -35.43 79.59 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.619 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 24.0 ttpp -60.34 -49.17 78.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 114' ' ' VAL . 4.3 mm-40 -64.1 -47.2 80.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.19 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.62 -38.54 90.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -58.08 -41.91 84.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.11 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.403 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 30.3 tt0 -66.1 -56.72 10.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.008 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -58.47 -39.92 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.252 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.457 ' CB ' HH21 ' A' ' 54' ' ' ARG . 22.8 p -63.07 -24.17 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 0.0 111.193 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.6 t -84.84 -33.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.352 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 113' ' ' GLN . 32.7 mmmt -62.94 -21.43 66.06 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.322 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.08 -17.58 77.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.58 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.491 178.618 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.452 HD11 ' CB ' ' A' ' 51' ' ' LEU . 30.1 tp . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.007 0.432 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -79.52 102.41 8.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.319 -178.424 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 75.2 m95 -106.73 125.92 51.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.115 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.3 m-85 -130.62 153.38 81.48 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 24.5 Cg_exo -61.6 161.47 24.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.789 1.659 . . . . 0.0 110.667 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.543 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 75.6 t80 -46.92 -51.11 41.66 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.4 Cg_exo -58.7 -52.5 5.22 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 121.694 1.596 . . . . 0.0 112.23 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 37.5 mt-10 -62.23 -38.89 90.93 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.455 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.17 78.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 0.0 111.6 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.437 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.4 mm? -62.88 -40.57 97.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.931 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.28 -37.28 63.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.23 0.538 . . . . 0.0 110.31 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.57 -50.11 74.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.822 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.47 88.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.432 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 24.2 tp60 -62.65 -46.28 88.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.21 -14.49 58.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.918 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -114.6 3.49 14.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.41 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.66 96.09 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.594 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.4 mmp_? -107.46 177.21 4.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.443 ' SD ' HG22 ' A' ' 86' ' ' VAL . 8.0 mmm -100.5 160.33 14.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.5 t -105.6 124.74 60.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 -174.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.588 ' SD ' HG13 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -113.4 103.65 11.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -92.33 109.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.093 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 84.0 t80 -103.86 103.62 13.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.462 0.649 . . . . 0.0 111.028 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.865 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 54.6 m-85 -84.64 116.1 23.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.082 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.702 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 9.2 p-80 -124.54 138.3 54.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 39.2 t -100.46 141.47 33.27 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.026 168.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.65 -25.1 67.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -102.59 16.27 26.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.095 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 79' ' ' THR . 50.6 t -70.81 112.02 11.77 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.06 -67.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.484 2.789 . . . . 0.0 114.905 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -86.69 -19.49 29.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -167.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.574 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 17.1 t -70.9 -22.85 62.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -30.06 59.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -71.29 -44.53 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.221 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.547 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 51.8 ttm -66.73 -49.18 66.83 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.358 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -54.09 -44.7 71.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.233 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.5 m -72.93 -59.77 2.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.659 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.45 -67.72 0.83 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.023 0.44 . . . . 0.0 112.153 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.547 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 98.9 t -55.14 -51.59 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.74 -21.9 37.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.769 0.319 . . . . 0.0 111.481 -170.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.6 m -92.55 -10.58 37.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.087 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -47.28 133.26 9.64 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.625 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.35 -33.77 57.61 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.573 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.56 -52.41 7.38 Favored Glycine 0 CA--C 1.51 -0.247 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.01 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.445 HG22 HD21 ' A' ' 108' ' ' LEU . 62.6 t -58.38 -51.3 73.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.642 0.734 . . . . 0.0 110.184 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -52.74 -44.11 66.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.711 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 49' ' ' ARG . 45.0 ttm180 -59.39 -38.45 80.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.256 0.347 . . . . 0.0 111.598 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.53 HD12 HD23 ' A' ' 111' ' ' LEU . 50.2 mt -64.0 -39.88 95.11 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.623 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.43 -52.9 13.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.094 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 3' ' ' LEU . 6.1 mm-40 -48.84 -43.12 38.28 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.092 0.557 . . . . 0.0 112.32 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.09 -57.02 13.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.615 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.13 22.75 3.26 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -171.428 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.615 ' CE1' ' HD3' ' A' ' 54' ' ' ARG . 50.5 m-85 -133.23 142.02 48.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.417 0.627 . . . . 0.0 111.58 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' A' ' 14' ' ' LEU . 82.6 t -108.01 118.91 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.664 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.588 HG13 ' SD ' ' A' ' 23' ' ' MET . 17.9 t -92.23 120.63 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 -173.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -89.95 118.17 29.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.3 p -90.07 101.32 14.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 110.039 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.534 HG11 ' HG ' ' A' ' 70' ' ' LEU . 57.3 t -111.06 120.0 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.739 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 9.8 m -88.83 109.12 19.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 8.9 p -86.48 6.9 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.466 0.65 . . . . 0.0 111.262 -170.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.524 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 5.0 m-20 -90.2 -30.65 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.203 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.647 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -92.5 165.58 19.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.154 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.647 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.65 -50.24 14.6 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.565 2.844 . . . . 0.0 114.38 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.477 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -70.85 -30.08 66.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.6 -33.57 47.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.99 172.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.701 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 40.5 mm-40 -63.83 -36.74 84.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -55.05 -52.57 62.78 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.901 170.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.534 ' HG ' HG11 ' A' ' 60' ' ' VAL . 3.1 mm? -53.74 -38.36 64.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.121 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' ' CG2' ' A' ' 62' ' ' VAL . . . -71.32 -34.17 70.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.635 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.701 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -72.14 -40.88 67.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.188 0.518 . . . . 0.0 110.475 174.278 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -63.11 -55.49 24.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.238 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.66 -15.87 40.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.212 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 67.55 37.55 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -134.44 147.75 64.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.724 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.35 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.218 1.946 . . . . 0.0 111.185 165.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.426 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . -159.63 56.94 0.33 Allowed Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.806 ' HA ' ' SG ' ' A' ' 31' ' ' CYS . 11.5 p -130.12 46.14 2.1 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -167.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 34.1 Cg_endo -94.4 172.79 15.78 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 120.731 1.297 . . . . 0.0 111.215 -5.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.865 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 36.1 m -132.83 129.26 38.25 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.613 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CZ ' ' HG2' ' A' ' 80' ' ' PRO . 2.1 m-85 -124.66 114.56 19.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.14 119.17 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.883 0.373 . . . . 0.0 110.152 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -99.65 126.68 45.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.55 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 23.5 mt -117.04 144.87 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 0.0 111.239 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.443 HG22 ' SD ' ' A' ' 21' ' ' MET . 90.2 t -109.15 125.91 30.45 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.372 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 74.2 Cg_endo -79.04 117.93 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.043 1.829 . . . . 0.0 110.839 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.06 109.41 10.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.202 0.525 . . . . 0.0 110.849 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.02 -82.06 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.674 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.56 20.37 1.67 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.01 157.8 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 89.3 m95 -92.56 169.93 10.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.655 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.5 tp10 -145.21 139.1 26.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.21 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.475 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 33.8 tt0 -95.2 103.19 15.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.8 p -99.74 9.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.689 -168.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.94 146.21 4.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.505 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.432 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 77.5 mtt180 -120.94 127.37 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.471 HD22 ' NH1' ' A' ' 102' ' ' ARG . 84.3 mt -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -136.96 143.27 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.605 0.241 . . . . 0.0 110.398 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.66 146.05 19.22 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.477 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 m -83.33 107.46 15.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.604 0.716 . . . . 0.0 110.601 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.591 ' NH1' ' HG3' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -108.68 152.34 42.16 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.04 178.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.87 158.61 13.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.797 2.331 . . . . 0.0 111.974 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.453 ' HB2' HG13 ' A' ' 41' ' ' VAL . 16.1 ttt-85 -60.92 -31.66 71.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.51 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -45.1 94.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.147 0.499 . . . . 0.0 110.054 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.87 -42.92 94.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.902 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.31 -47.38 79.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.776 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 28.9 mt -61.72 -38.57 88.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.555 0.217 . . . . 0.0 110.795 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 20.8 tttm -56.06 -56.03 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.647 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.591 ' HG3' ' NH1' ' A' ' 102' ' ' ARG . 6.8 mm-40 -63.96 -44.96 91.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 50' ' ' LEU . 35.0 tp -55.48 -47.87 75.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.425 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -64.46 -39.58 94.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.516 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 15.9 mm100 -70.49 -23.48 62.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.341 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 110' ' ' GLU . 73.8 t -73.41 -41.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 172.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.1 m -58.77 -37.73 76.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.493 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 112' ' ' ARG . 68.1 t -63.58 -40.0 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.977 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 113' ' ' GLN . 62.7 mttp -64.03 -41.77 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.162 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.29 -14.16 82.84 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.565 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.874 -178.538 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.475 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 15.1 tp . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.289 0.566 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -90.55 103.98 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.546 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.407 ' HE3' ' HB3' ' A' ' 59' ' ' SER . 52.5 m95 -99.7 129.89 45.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.428 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 38.2 m-85 -131.49 167.12 23.31 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.083 171.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 15.0 Cg_exo -68.09 163.05 37.45 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.965 1.777 . . . . 0.0 110.974 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.584 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.9 t80 -47.53 -52.97 33.39 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 49.0 Cg_exo -57.62 -49.74 12.56 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.972 1.781 . . . . 0.0 112.935 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.14 -42.61 88.83 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.19 -42.03 72.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.0 111.528 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.47 -37.76 77.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.6 -43.67 63.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.638 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.97 0.415 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.13 -47.76 81.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.687 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.069 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.02 -14.59 55.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -118.43 6.61 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.564 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.4 39.42 97.73 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.76 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.3 mmp_? -110.53 -179.99 3.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.582 ' SD ' HG22 ' A' ' 86' ' ' VAL . 56.0 mtm -110.58 160.22 16.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 93.5 t -106.07 127.93 60.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.66 0.267 . . . . 0.0 111.52 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.2 ttt -105.69 103.15 12.6 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 171.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.553 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 41.1 t -86.79 107.53 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.499 ' HE1' ' HE2' ' A' ' 82' ' ' PHE . 65.4 t80 -98.99 103.65 15.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 88.3 m-85 -82.71 115.07 21.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.177 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.692 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 29.0 p-80 -123.17 138.8 54.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.646 ' H ' HG21 ' A' ' 79' ' ' THR . 24.0 t -117.99 163.64 16.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.954 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -76.69 -2.43 32.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.586 0.708 . . . . 0.0 109.522 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -112.17 14.45 20.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 30.4 p -76.8 129.95 77.54 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.834 0.349 . . . . 0.0 111.457 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.62 -78.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.649 2.232 . . . . 0.0 113.829 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.541 ' CE2' ' HB2' ' A' ' 37' ' ' MET . 89.3 t80 -86.08 -17.45 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.48 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.638 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 12.9 t -47.73 -44.36 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.133 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -57.35 -33.32 67.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.05 -45.97 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.902 0.382 . . . . 0.0 110.508 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.697 ' HG2' ' HB ' ' A' ' 41' ' ' VAL . 10.9 tmm? -65.42 -40.94 93.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.344 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 7.2 t30 -59.41 -41.24 89.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.32 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.3 m -77.17 -56.51 4.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -90.13 -64.65 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.146 0.498 . . . . 0.0 111.803 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.697 ' HB ' ' HG2' ' A' ' 37' ' ' MET . 77.8 t -55.71 -44.23 76.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.405 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.27 -13.96 57.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.861 0.362 . . . . 0.0 111.194 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -100.36 -6.78 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.684 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.19 135.55 8.94 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.746 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 80.8 Cg_exo -49.68 -45.45 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.351 2.701 . . . . 0.0 113.623 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.41 -45.64 67.69 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.111 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.707 HG22 HD21 ' A' ' 108' ' ' LEU . 43.4 t -59.41 -47.78 89.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 121.648 0.737 . . . . 0.0 109.778 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.557 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 23.5 t -52.86 -43.14 65.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.387 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 82.7 mtt180 -62.27 -21.38 65.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.447 HD12 HD22 ' A' ' 108' ' ' LEU . 23.3 mt -80.39 -38.11 30.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.756 174.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.32 -50.53 11.63 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 48' ' ' SER . 7.1 mm-40 -44.38 -47.69 9.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.783 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -67.98 -48.27 66.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -168.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.783 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -134.44 16.45 3.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -125.18 141.01 52.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.393 0.616 . . . . 0.0 111.688 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.2 t -106.6 114.95 47.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.94 121.07 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.806 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -94.58 117.6 30.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.407 ' HB3' ' HE3' ' A' ' 5' ' ' TRP . 22.3 p -85.83 101.61 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.92 109.07 23.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.956 0.407 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.641 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -94.96 107.87 19.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.158 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 28' ' ' SER . 38.3 t -75.04 -8.29 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.292 1.044 . . . . 0.0 108.549 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.041 176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -125.11 163.51 37.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.069 -174.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.8 Cg_endo -50.75 -47.76 23.71 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.323 3.349 . . . . 0.0 114.85 -169.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.416 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -61.99 -36.44 81.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.082 -176.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -82.47 -31.8 29.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.559 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 64' ' ' THR . 96.9 mt-30 -59.22 -38.0 78.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.514 0.673 . . . . 0.0 109.479 171.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 6.0 tp10 -61.51 -50.6 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.97 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 66' ' ' GLU . 3.5 mm? -58.68 -40.25 83.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.686 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.62 -50.25 73.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.49 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.266 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 30.4 ttt85 -65.12 -56.02 15.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.221 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.55 3.29 55.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.565 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 58.47 64.75 1.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.623 0.577 . . . . 0.0 109.714 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.55 92.92 48.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -102.31 129.03 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.712 2.941 . . . . 0.0 112.052 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 140.23 -85.09 0.21 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.834 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.692 ' CG2' ' HA ' ' A' ' 27' ' ' HIS . 85.0 m 75.07 137.21 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 122.49 0.316 . . . . 0.0 111.325 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HA ' HG23 ' A' ' 79' ' ' THR . 70.1 Cg_endo -76.52 137.48 49.33 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.724 -1.365 . . . . 0.0 112.881 0.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.7 m -124.69 129.06 49.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.997 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' HE1' ' CA ' ' A' ' 100' ' ' GLY . 1.4 m-85 -115.27 122.07 44.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.044 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.8 t -121.47 108.31 22.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.881 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HE1' HD12 ' A' ' 98' ' ' LEU . 59.1 m-85 -94.34 120.07 34.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.043 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 94' ' ' GLU . 32.4 mt -109.22 130.66 55.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.663 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.582 HG22 ' SD ' ' A' ' 21' ' ' MET . 22.6 t -108.56 123.91 35.94 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.378 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.5 117.69 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.901 1.734 . . . . 0.0 110.559 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -157.67 143.29 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.739 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.18 -77.39 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.988 0.805 . . . . 0.0 111.43 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.18 24.38 0.13 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.797 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.42 -177.48 6.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.687 0.28 . . . . 0.0 110.453 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.07 132.62 51.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.427 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.11 119.71 40.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.266 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.525 ' HA ' HD23 ' A' ' 85' ' ' LEU . 39.9 tt0 -77.0 95.96 4.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.75 -7.46 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.094 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.74 118.3 0.6 Allowed Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.796 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.479 ' HG3' HG22 ' A' ' 83' ' ' VAL . 16.7 ttm180 -108.92 126.67 53.33 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 86.1 mt -124.41 139.03 54.28 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.032 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -102.58 117.13 34.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 164.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.568 ' CA ' ' HE1' ' A' ' 82' ' ' PHE . . . -90.78 -134.27 5.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.461 -167.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 33' ' ' TYR . 23.0 m 75.67 -12.09 1.03 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.793 0.837 . . . . 0.0 110.578 -173.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 100' ' ' GLY . 62.1 mtp180 -65.25 156.31 81.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.247 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.49 155.55 25.4 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 111.543 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.51 ' HB3' HG13 ' A' ' 41' ' ' VAL . 30.8 ptt180 -67.62 -25.12 65.59 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.083 -174.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.6 74.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.107 0.479 . . . . 0.0 109.956 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 21.7 mm-40 -75.25 -37.88 60.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.388 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.63 -47.95 83.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.638 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.707 HD21 HG22 ' A' ' 47' ' ' VAL . 88.6 mt -68.16 -31.43 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.732 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' HB3' ' A' ' 109' ' ' LYS . 5.0 tmmm? -63.15 -47.9 80.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.951 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 5.4 mm-40 -69.92 -41.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.446 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.1 tt -61.16 -36.32 79.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -63.46 -45.07 92.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.23 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 5.5 pt20 -62.81 -38.43 90.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.437 ' N ' ' HG3' ' A' ' 113' ' ' GLN . 69.9 t -66.78 -42.68 89.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.683 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 52.4 t -57.22 -30.48 64.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.864 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.15 -53.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.873 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -59.15 -28.13 66.29 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.463 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -62.46 -41.42 99.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.505 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.755 179.721 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 57' ' ' VAL . 24.6 tp . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.869 0.366 . . . . 0.0 111.724 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.678 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 5.4 mmt180 -88.34 104.64 16.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.328 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -106.38 104.63 14.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.678 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 96.8 m-85 -111.12 157.39 38.95 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 19.3 Cg_exo -63.48 162.02 29.14 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.957 1.771 . . . . 0.0 111.172 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.607 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.3 t80 -45.82 -55.73 12.03 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.8 Cg_exo -65.0 -41.52 16.89 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.654 1.569 . . . . 0.0 112.126 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 37.1 tt0 -70.13 -36.92 75.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.847 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.68 86.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.997 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.91 -39.67 92.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.653 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.08 70.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.778 0.323 . . . . 0.0 110.651 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.557 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -59.67 -50.08 75.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -65.52 -45.57 83.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.978 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -58.85 -46.63 87.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.729 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -14.32 58.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.933 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -115.29 0.37 13.46 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.686 -175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.72 41.36 97.7 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.355 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.873 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 76.6 mmt-85 -112.87 178.44 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 0.0 111.946 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.7 mtp -101.46 154.36 18.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.345 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 48.5 t -106.19 135.05 45.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.801 0.334 . . . . 0.0 110.786 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.1 ttt -118.17 103.21 9.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 38.9 t -89.58 111.18 22.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.4 t80 -102.92 109.15 20.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.435 0.636 . . . . 0.0 111.006 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 1.023 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.8 m-85 -85.49 118.87 25.28 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.563 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.554 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 29.3 p80 -133.89 163.93 28.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.943 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 22.6 m -143.36 149.68 38.08 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.555 174.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -39.53 86.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -84.26 4.61 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.397 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 9.0 t -134.83 65.73 66.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.83 31.98 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.004 2.469 . . . . 0.0 114.476 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -83.35 -58.11 2.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.865 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.821 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 46.6 t -74.6 -22.34 59.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -67.04 -19.75 65.74 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.296 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -69.7 -47.87 61.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 28.1 mtm -61.99 -35.76 79.48 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.299 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 7.3 t30 -56.24 -43.67 78.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' SER . 30.7 m -65.17 -49.73 68.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -90.87 -70.91 0.66 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.325 0.583 . . . . 0.0 111.375 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' A' ' 104' ' ' ARG . 71.1 t -56.04 -51.77 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.753 -173.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.6 tp -81.87 -22.57 36.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -170.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' THR . 62.1 m -93.95 -3.42 51.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.059 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 47' ' ' VAL . 9.6 t70 -48.59 129.13 13.76 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.544 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.99 -36.61 76.43 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.127 2.552 . . . . 0.0 113.212 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.43 -34.85 68.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.87 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 44' ' ' ASP . 20.6 t -74.9 -49.0 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.366 0.603 . . . . 0.0 109.598 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -54.49 -37.03 64.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.886 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -63.31 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 0.0 111.262 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.26 -46.01 68.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.476 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 2.4 mm? -67.29 -47.25 71.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.15 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -46.01 -41.79 12.35 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.777 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -70.84 -49.95 40.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -171.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.873 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.82 16.38 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.151 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.42 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 87.4 m-85 -127.18 143.67 51.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.334 0.588 . . . . 0.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 14' ' ' LEU . 61.6 t -115.72 117.28 55.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 3' ' ' LEU . 15.2 t -91.07 131.76 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.855 -173.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -101.36 119.63 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -85.22 102.31 13.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.227 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.72 125.79 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.301 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -109.28 121.8 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.519 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 56.5 t -68.97 -16.03 20.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.219 0.533 . . . . 0.0 110.992 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 2.1 m-20 -67.29 -34.49 77.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.909 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 61.5 p -97.04 158.29 33.59 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.024 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 15.1 Cg_endo -51.02 -41.55 56.26 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.636 2.891 . . . . 0.0 113.127 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.538 ' OE2' ' HG2' ' A' ' 65' ' ' PRO . 1.7 mp0 -52.0 -57.75 8.56 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.041 0.448 . . . . 0.0 110.036 175.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.11 -33.06 65.29 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.259 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.615 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 51.3 mt-30 -56.02 -51.14 68.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.606 0.362 . . . . 0.0 111.114 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.419 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -76.84 -29.41 55.87 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.777 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.595 HD21 ' CD1' ' A' ' 8' ' ' TYR . 1.7 mp -61.61 -42.23 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 0.0 110.549 170.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.26 77.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.799 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 86.5 mtt180 -71.64 -27.44 63.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -80.96 -52.58 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.28 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -85.47 -14.02 47.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.763 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 65.05 78.08 0.29 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 77' ' ' PRO . 54.5 t -135.35 142.01 39.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 -171.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.446 ' O ' HG12 ' A' ' 76' ' ' VAL . 9.0 Cg_exo -73.49 -143.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.262 2.641 . . . . 0.0 111.142 169.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.49 -49.31 3.02 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.239 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.692 ' OG1' ' HA ' ' A' ' 80' ' ' PRO . 1.1 t 179.89 160.38 0.83 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.821 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -88.96 126.75 7.67 Favored 'Cis proline' 0 N--CA 1.456 -0.711 0 C-N-CA 124.246 -1.147 . . . . 0.0 112.035 -1.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 1.023 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.4 m -125.24 108.17 11.47 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.98 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.498 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.6 m-85 -102.67 111.59 23.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.235 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.7 t -110.65 108.9 26.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.88 0.372 . . . . 0.0 110.775 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.27 118.44 32.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.891 0.377 . . . . 0.0 110.538 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 32.8 mt -114.25 131.75 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 t -110.61 124.69 32.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.516 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.7 Cg_endo -80.38 117.2 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.166 1.911 . . . . 0.0 110.387 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -146.37 133.81 20.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.406 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.14 -75.67 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.029 0.831 . . . . 0.0 111.144 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.82 29.49 0.15 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.713 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.99 165.53 33.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.587 0.232 . . . . 0.0 110.528 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.516 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 80.0 m95 -98.99 126.47 44.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.972 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 26.5 tt0 -106.94 121.38 44.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.445 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.522 ' HA ' HD23 ' A' ' 85' ' ' LEU . 49.0 tt0 -76.25 96.46 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 117' ' ' LYS . 9.7 p -82.62 -14.51 12.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.009 -169.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.16 129.58 1.26 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.304 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.484 ' HG3' HG22 ' A' ' 83' ' ' VAL . 27.7 ttm180 -115.61 127.45 55.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 99.0 mt -109.37 133.89 52.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.662 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -136.93 116.54 12.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.65 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.3 173.06 18.86 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.054 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 m -109.98 120.36 42.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.745 0.307 . . . . 0.0 110.327 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 65.0 mtp180 -146.23 147.44 31.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HD2' ' HG3' ' A' ' 106' ' ' GLU . 31.4 Cg_exo -59.39 163.09 13.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.809 2.34 . . . . 0.0 112.085 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.592 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -63.73 -25.97 68.44 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.778 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.49 95.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.022 0.439 . . . . 0.0 110.337 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.3 mm-40 -64.89 -44.98 87.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.464 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.447 ' CE2' HD12 ' A' ' 111' ' ' LEU . 44.7 t80 -62.58 -37.58 86.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.516 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 62.3 mt -61.68 -42.24 98.66 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 110.943 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -57.31 -54.23 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.165 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 2.7 mm-40 -65.91 -41.04 91.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.126 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.45 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.8 tt -60.98 -39.51 89.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.667 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 116' ' ' VAL . 12.6 tpt180 -59.23 -41.05 87.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.95 -43.31 75.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.571 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 110' ' ' GLU . 90.1 t -59.46 -39.63 79.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.743 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.12 -40.1 88.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.666 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 112' ' ' ARG . 97.6 t -66.55 -37.58 79.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 109.997 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HB3' ' CG2' ' A' ' 95' ' ' VAL . 34.0 mtpt -72.74 -8.17 54.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.712 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.65 -27.09 11.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.259 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.325 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 174.52 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 51' ' ' LEU . 14.8 tp . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.591 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.7 mmm180 -91.13 103.12 15.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.782 0.325 . . . . 0.0 111.851 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.497 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 46.4 m95 -102.88 113.26 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.335 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 90.0 m-85 -118.14 161.8 33.0 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.021 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 16.7 Cg_exo -66.18 160.95 42.46 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.274 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.589 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 91.4 t80 -47.27 -53.84 25.68 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 35.3 Cg_exo -61.42 -46.96 12.93 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.83 1.687 . . . . 0.0 112.355 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -43.97 87.22 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -54.97 -42.34 72.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.741 0.305 . . . . 0.0 111.478 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.1 -38.69 82.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.81 63.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.755 0.312 . . . . 0.0 110.586 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -57.42 -40.62 78.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.09 -56.07 6.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.935 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 24.9 tt0 -60.46 -49.18 78.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.5 -175.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -14.02 59.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 15.7 m-70 -118.3 4.35 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.295 -175.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.64 34.06 72.43 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.261 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.6 mmp_? -108.64 178.87 4.35 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.589 -0.359 . . . . 0.0 110.108 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.475 ' SD ' HG22 ' A' ' 86' ' ' VAL . 48.3 mtm -108.06 165.49 11.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.4 t -105.69 125.04 61.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.818 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.551 ' SD ' HG13 ' A' ' 57' ' ' VAL . 1.4 tmt? -109.06 103.12 12.07 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.664 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 26.1 t -90.41 111.44 23.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.407 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 65.7 t80 -99.58 103.49 15.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.128 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.723 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 51.4 m-85 -81.39 121.67 26.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.639 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 25.4 p80 -135.28 138.54 43.6 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.165 0.915 . . . . 0.0 109.924 177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.426 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 1.5 t -99.39 168.12 10.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.495 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -7.0 44.02 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -114.07 -80.12 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.382 -0.199 . . . . 0.0 111.027 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 79' ' ' THR . 4.0 m 60.42 152.47 0.1 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.897 0.879 . . . . 0.0 112.915 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.22 -89.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.364 2.043 . . . . 0.0 113.08 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.02 -16.83 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 5.8 t -49.5 -52.57 28.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.241 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -57.8 -39.13 76.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.099 0.249 . . . . 0.0 111.613 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -66.84 -50.6 62.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 101' ' ' SER . 30.3 ttp -62.25 -46.13 90.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.744 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.6 -43.07 84.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.498 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.7 m -66.44 -56.77 9.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.638 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -91.89 -70.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.563 0.697 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.599 HG13 ' HA ' ' A' ' 104' ' ' ARG . 94.0 t -52.89 -48.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.065 -171.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 tp -81.41 -15.24 55.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -173.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.6 m -95.79 -1.09 50.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.606 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 47' ' ' VAL . 13.0 t70 -47.03 129.17 9.08 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.658 171.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.89 -37.52 85.47 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.131 2.554 . . . . 0.0 113.229 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.87 -42.59 30.28 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.026 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.698 HG22 HD23 ' A' ' 108' ' ' LEU . 8.1 t -66.66 -44.3 89.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -55.24 -40.64 71.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.688 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -70.22 -21.37 63.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.85 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 108' ' ' LEU . 72.5 mt -70.16 -44.56 68.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 3' ' ' LEU . 3.1 mm? -66.54 -60.56 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.361 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.456 ' OE1' HD12 ' A' ' 3' ' ' LEU . 9.5 mm-40 -50.08 -34.73 22.77 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.649 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -64.61 -53.15 52.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.649 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.38 11.61 3.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -123.28 145.79 48.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.039 0.447 . . . . 0.0 110.959 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 11' ' ' ALA . 22.0 t -107.98 118.09 54.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.551 HG13 ' SD ' ' A' ' 23' ' ' MET . 21.3 t -86.93 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.044 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -92.68 117.28 29.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.159 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 42.9 t -88.15 100.57 13.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.538 HG11 HD22 ' A' ' 70' ' ' LEU . 61.2 t -113.57 122.79 68.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.295 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.539 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 4.4 p -85.84 109.4 18.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.374 0.606 . . . . 0.0 109.679 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' A' ' 71' ' ' ALA . 5.1 p -88.99 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 123.091 1.424 . . . . 0.0 109.008 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.14 -38.7 0.07 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.075 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.653 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 3.1 p -81.63 164.66 48.22 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.511 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.3 Cg_endo -51.39 -55.23 4.2 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.534 2.823 . . . . 0.0 114.524 -170.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.1 -36.63 84.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.585 0.231 . . . . 0.0 111.182 -178.428 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.38 -34.02 64.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.649 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -71.19 -28.51 64.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.306 0.574 . . . . 0.0 110.714 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.31 -44.83 93.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.217 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.538 HD22 HG11 ' A' ' 60' ' ' VAL . 9.0 mp -65.86 -30.9 71.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 174.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB2' HG23 ' A' ' 62' ' ' VAL . . . -67.14 -35.24 79.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.589 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HA ' ' NH2' ' A' ' 75' ' ' ARG . 20.1 ptt180 -83.37 -33.17 25.86 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.314 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 28.4 ttm180 -73.18 -56.67 4.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.526 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 90.7 m-85 -91.38 -11.89 36.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.329 -174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.741 ' HE ' ' HA ' ' A' ' 75' ' ' ARG . 1.2 mmp_? 64.74 91.16 0.08 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.686 0.616 . . . . 0.0 110.247 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.457 HG11 ' CG ' ' A' ' 26' ' ' PHE . 39.1 t -129.51 85.85 57.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -105.29 125.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.512 2.808 . . . . 0.0 113.196 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 124.95 -68.31 0.51 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.422 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.651 HG21 ' SG ' ' A' ' 31' ' ' CYS . 60.3 m 72.26 138.58 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.463 0.305 . . . . 0.0 110.836 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HA ' HG23 ' A' ' 79' ' ' THR . 73.0 Cg_endo -78.51 143.76 73.07 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.707 0.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 35.5 m -122.77 122.66 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.038 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.648 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 9.7 m-85 -106.51 122.9 47.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.053 -175.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.664 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 45.2 t -124.11 105.43 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.04 118.89 32.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.327 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 94' ' ' GLU . 38.6 mt -113.11 137.28 51.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.475 HG22 ' SD ' ' A' ' 21' ' ' MET . 13.5 t -108.28 135.87 19.9 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.968 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.21 115.39 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.405 1.403 . . . . 0.0 108.794 166.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.86 111.28 5.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.831 0.348 . . . . 0.0 110.572 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.22 18.25 11.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.142 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.05 -23.64 34.83 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.852 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.87 -175.53 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.693 0.283 . . . . 0.0 110.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 95.0 m95 -115.7 136.9 52.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.472 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 32.4 tt0 -122.37 125.22 45.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.548 ' HA ' HD23 ' A' ' 85' ' ' LEU . 35.5 tt0 -78.58 95.98 5.35 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.538 HG22 ' HD3' ' A' ' 117' ' ' LYS . 1.4 p -102.38 -11.9 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.836 -170.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.72 104.48 0.36 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.744 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.517 ' HD3' ' CD ' ' A' ' 94' ' ' GLU . 8.5 tpt180 -111.97 124.76 53.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.9 mt -137.62 143.54 41.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -137.82 133.16 33.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.71 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.02 149.2 15.65 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.586 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.493 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 49.2 m -76.02 151.12 37.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.586 0.231 . . . . 0.0 110.872 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.843 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 16.9 mmt-85 -130.96 165.66 33.27 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.633 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 106' ' ' GLU . 21.5 Cg_exo -67.96 154.68 72.16 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.272 1.981 . . . . 0.0 109.808 162.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.599 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -57.41 -42.95 83.28 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -170.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.616 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . . . -79.76 -27.2 40.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.384 -175.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.4 mm-40 -76.9 -38.46 53.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.843 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 86.8 t80 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.042 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.698 HD23 HG22 ' A' ' 47' ' ' VAL . 4.3 pp -68.12 -22.95 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.629 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.409 ' N ' HD12 ' A' ' 108' ' ' LEU . 37.6 ttmt -67.14 -53.81 27.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.856 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.619 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 8.3 pt-20 -71.56 -32.13 67.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.195 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.419 HD12 ' CE2' ' A' ' 107' ' ' PHE . 5.9 tt -59.21 -42.53 91.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 116' ' ' VAL . 43.9 ttt180 -59.92 -43.7 94.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.252 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 10.2 pt20 -67.97 -23.43 65.04 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.327 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 110' ' ' GLU . 93.9 t -81.73 -36.75 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.2 t -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.026 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 112' ' ' ARG . 57.9 t -65.72 -30.18 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.538 ' HD3' HG22 ' A' ' 95' ' ' VAL . 63.2 mttp -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.274 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.5 -18.97 68.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.557 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 175.776 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.238 0.455 0 CA-C-O 121.596 0.712 . . . . 0.0 112.484 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 36.7 mmt-85 -87.71 108.91 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.746 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.51 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.8 m95 -111.15 109.17 19.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 87.3 m-85 -124.31 156.36 67.03 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.53 159.75 19.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.935 1.757 . . . . 0.0 111.198 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.582 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.1 t80 -45.38 -54.02 16.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.7 Cg_exo -63.91 -39.74 31.46 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.643 1.562 . . . . 0.0 112.179 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.19 -36.97 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.832 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.37 -48.31 70.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.038 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.532 HD13 HG21 ' A' ' 22' ' ' VAL . 4.3 mm? -56.45 -42.67 78.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.695 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.12 63.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.074 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' HB3' HG11 ' A' ' 56' ' ' VAL . 9.4 tp -61.11 -51.04 70.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.18 -38.67 91.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.681 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 48.9 tt0 -65.86 -42.35 90.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.877 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.43 -16.04 44.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -112.06 2.11 16.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.753 -175.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.4 40.56 97.89 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.296 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -108.54 179.67 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 110.412 178.211 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 85.5 mtp -104.82 154.98 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 12' ' ' LEU . 85.0 t -106.15 130.54 57.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.412 . . . . 0.0 111.324 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.42 103.61 11.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.397 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 21.6 t -84.54 113.7 23.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CD2' ' HZ3' ' A' ' 5' ' ' TRP . 56.7 t80 -104.48 106.67 17.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.995 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.08 125.61 37.76 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.892 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -141.93 160.93 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.474 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.645 ' HB2' ' HB2' ' A' ' 31' ' ' CYS . 3.4 m -142.11 150.92 41.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.89 -40.77 83.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 172.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -82.16 1.53 35.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.8 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 86.0 m -132.86 68.05 78.47 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.175 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 35' ' ' GLN . 91.4 Cg_endo -81.39 38.49 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.076 2.517 . . . . 0.0 114.178 -167.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -73.61 -43.06 60.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.155 0.502 . . . . 0.0 111.124 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 16.1 t -77.46 -19.16 56.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.34 -176.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 32' ' ' PRO . 82.5 mm-40 -54.81 -26.25 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -81.78 -32.16 31.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.424 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.2 ttm -78.97 -46.14 18.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.751 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.589 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 32.0 p30 -66.36 -21.07 66.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -78.68 -59.11 2.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.23 -70.19 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.932 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -54.98 -49.53 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.873 -170.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 25.0 tp -81.57 -21.48 38.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.465 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -95.34 -2.22 49.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 0.0 110.609 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -50.81 133.26 28.49 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.226 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.33 -44.27 39.78 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.246 2.631 . . . . 0.0 113.451 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.65 68.21 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.028 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 108' ' ' LEU . 84.6 t -57.73 -48.18 84.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 109.845 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.4 m -53.53 -50.91 64.45 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.013 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -54.57 -29.42 51.28 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.839 HD12 HD22 ' A' ' 108' ' ' LEU . 74.9 mt -73.42 -54.02 9.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 111.313 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.557 ' HB2' HD21 ' A' ' 3' ' ' LEU . 3.5 mm? -68.74 -39.62 80.26 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.12 -33.75 67.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.736 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -71.56 -49.84 36.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.529 ' HD3' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.12 15.25 3.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -173.525 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 78.4 m-85 -121.2 143.46 49.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.424 0.63 . . . . 0.0 112.073 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 14' ' ' LEU . 47.7 t -111.91 113.7 44.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.297 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.1 t -87.17 127.44 40.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.099 0.476 . . . . 0.0 110.881 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -93.4 117.09 29.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.986 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 p -83.82 102.09 12.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.098 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.04 126.03 74.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.028 0.442 . . . . 0.0 110.842 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 64' ' ' THR . 0.9 OUTLIER -113.09 132.64 55.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.468 HG13 ' CB ' ' A' ' 71' ' ' ALA . 46.3 t -79.68 -16.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.421 0.629 . . . . 0.0 111.244 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -76.21 -10.97 59.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.951 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.608 ' OG1' ' HD2' ' A' ' 65' ' ' PRO . 5.0 t -114.04 149.17 41.49 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.402 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.608 ' HD2' ' OG1' ' A' ' 64' ' ' THR . 19.0 Cg_endo -53.14 -50.91 12.36 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 123.523 2.815 . . . . 0.0 114.534 -169.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -31.88 62.75 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.138 -174.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -74.82 -30.42 59.61 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.653 174.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 64' ' ' THR . 16.1 tt0 -69.74 -36.89 76.22 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -54.34 -48.86 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.205 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.19 -43.42 92.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.297 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.468 ' CB ' HG13 ' A' ' 62' ' ' VAL . . . -57.99 -49.19 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.257 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.88 -20.79 41.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.262 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -62.3 -48.84 78.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 110.009 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.48 -15.06 29.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.007 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 65.04 79.64 0.25 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.516 0.674 . . . . 0.0 110.245 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.3 t -123.1 97.55 43.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.382 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -101.29 130.42 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.387 2.725 . . . . 0.0 113.35 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 31' ' ' CYS . . . 104.04 -56.49 0.57 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.568 169.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.68 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 20.1 p 60.38 161.19 0.11 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.652 0.781 . . . . 0.0 111.638 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.68 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 45.3 Cg_endo -69.64 145.74 80.01 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 124.035 -1.235 . . . . 0.0 112.367 -0.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.3 m -134.21 116.58 15.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.185 0.517 . . . . 0.0 110.037 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 6.1 m-85 -106.27 112.34 25.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.666 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 47.0 t -108.88 113.46 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.788 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.416 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 18.0 m-85 -96.61 127.69 42.83 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.566 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.3 mt -116.52 131.13 57.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.972 0.415 . . . . 0.0 110.73 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.507 ' CG2' HG11 ' A' ' 95' ' ' VAL . 91.7 t -109.64 129.8 23.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.774 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.39 117.88 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.841 1.694 . . . . 0.0 110.8 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' CE ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -131.16 125.01 31.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.631 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.15 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.808 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -155.69 25.04 0.57 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.156 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.83 166.78 23.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.483 0.183 . . . . 0.0 110.852 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 91.3 m95 -103.25 153.21 20.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.697 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 59.0 mt-10 -119.74 133.56 55.57 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.387 167.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.1 tt0 -81.6 94.96 7.02 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.805 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 22.7 m -85.17 -5.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.943 -166.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.17 158.78 9.41 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.362 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.4 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 82.5 mtt180 -129.72 130.23 45.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 68.0 mt -108.49 134.47 51.22 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -137.52 143.4 41.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.843 0.354 . . . . 0.0 111.044 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.84 162.35 25.85 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.281 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -74.55 116.26 15.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.118 0.485 . . . . 0.0 109.814 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -124.36 143.36 42.74 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.722 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.03 158.03 45.79 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.117 1.878 . . . . 0.0 110.268 169.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.536 ' HB3' HG13 ' A' ' 41' ' ' VAL . 33.5 ptt180 -62.55 -26.8 68.76 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.722 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.99 97.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.363 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -69.18 -48.55 61.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.34 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.72 -52.4 65.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.883 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.839 HD22 HD12 ' A' ' 50' ' ' LEU . 71.0 mt -65.96 -30.23 70.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.258 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -55.57 -62.45 1.68 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.102 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 114' ' ' VAL . 1.1 mt-10 -70.76 -32.8 70.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.407 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 51' ' ' LEU . 2.7 tm? -62.08 -41.29 98.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.209 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 42.7 mtm180 -68.5 -32.69 72.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.267 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.483 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 12.2 mm-40 -67.42 -35.46 79.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.043 0.449 . . . . 0.0 110.651 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 110' ' ' GLU . 95.6 t -66.75 -36.36 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.05 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.64 -34.55 71.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.35 -51.46 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.131 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.805 ' HE3' ' HB ' ' A' ' 95' ' ' VAL . 16.2 mtpp -59.79 -24.36 64.05 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -53.39 -31.58 43.34 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.44 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.217 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 51' ' ' LEU . 17.9 tp . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.4 0.143 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.491 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.4 mmt180 -86.81 103.07 14.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.971 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -105.59 103.95 13.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 85.6 m-85 -118.74 149.06 45.71 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.632 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.477 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.7 Cg_exo -59.67 166.26 8.46 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.423 2.082 . . . . 0.0 111.487 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.558 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -48.31 -50.99 53.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.1 Cg_exo -58.46 -49.25 12.56 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.823 1.682 . . . . 0.0 112.389 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 9.3 mt-10 -63.8 -42.94 97.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.704 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -59.99 -48.25 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.644 0.259 . . . . 0.0 111.54 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.508 HD13 HG21 ' A' ' 22' ' ' VAL . 4.6 mm? -63.29 -39.84 95.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.82 -37.69 48.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.08 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.454 ' HB3' HG11 ' A' ' 56' ' ' VAL . 9.8 tp -64.15 -46.71 82.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.93 96.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -64.52 -45.66 86.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.516 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.8 -14.49 59.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -116.8 3.11 12.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.576 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' C ' ' HE ' ' A' ' 20' ' ' ARG . . . 63.11 37.07 94.32 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.59 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.754 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.3 mmp_? -106.94 177.48 4.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.586 ' SD ' HG22 ' A' ' 86' ' ' VAL . 31.7 mtm -103.93 158.32 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG21 HD13 ' A' ' 12' ' ' LEU . 59.3 t -105.93 123.74 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.934 0.397 . . . . 0.0 111.17 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.416 ' HE1' HD11 ' A' ' 42' ' ' LEU . 21.1 ttt -103.4 103.58 13.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 173.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 40.6 t -85.42 108.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -106.59 103.57 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 110.793 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.3 m-85 -80.63 120.76 24.98 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.197 176.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.563 ' HA ' HG21 ' A' ' 79' ' ' THR . 31.5 p80 -129.3 155.94 44.79 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.918 0.761 . . . . 0.0 109.316 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 31' ' ' CYS . 92.7 p -137.03 166.28 24.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.722 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -78.08 -5.89 52.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.761 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -119.58 -0.5 10.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.455 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 28' ' ' SER . 21.8 p -58.44 130.26 84.44 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.534 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.6 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 63.6 Cg_endo -76.91 -86.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.225 1.95 . . . . 0.0 114.045 -175.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.84 -18.77 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.578 . . . . 0.0 110.735 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 29.3 t -63.27 -42.06 99.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 29.9 pt20 -66.93 -23.49 65.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.402 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -79.3 -48.44 14.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.406 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.596 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 17.2 ptp -66.98 -39.15 87.12 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.781 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.07 -34.59 68.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.467 . . . . 0.0 110.672 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 43' ' ' SER . 26.0 m -83.25 -61.04 1.95 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.525 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -91.38 -70.6 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 104' ' ' ARG . 70.8 t -49.31 -55.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.077 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.416 HD11 ' HE1' ' A' ' 23' ' ' MET . 21.2 tp -83.03 -27.07 30.59 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.738 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 39' ' ' THR . 31.2 t -88.39 -4.99 58.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.09 -175.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' A' ' 47' ' ' VAL . 13.3 t70 -51.26 130.88 32.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.644 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.709 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 27.5 Cg_exo -62.14 -20.94 71.54 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.854 2.37 . . . . 0.0 113.504 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.87 -34.52 38.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.174 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.54 HG22 HD21 ' A' ' 108' ' ' LEU . 14.8 t -76.89 -40.54 31.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 108.861 175.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.582 ' OG ' ' HA ' ' A' ' 45' ' ' PRO . 36.8 p -59.08 -33.49 70.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.105 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.709 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 87.3 mtt180 -56.78 -35.54 68.8 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.743 0.306 . . . . 0.0 111.45 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.75 -43.42 84.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.735 0.302 . . . . 0.0 110.448 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB2' HD11 ' A' ' 3' ' ' LEU . 2.7 mm? -73.94 -45.78 48.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.762 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -44.79 -48.98 10.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.731 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -66.87 -48.54 68.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.754 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.67 16.3 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -170.372 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.05 145.71 51.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.407 0.623 . . . . 0.0 111.447 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 11' ' ' ALA . 60.4 t -114.86 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 21.6 t -86.95 121.31 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.193 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -89.62 117.1 28.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.868 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.0 p -84.65 100.14 11.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.5 t -104.28 106.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.995 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.641 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -90.04 109.16 20.22 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.944 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 71' ' ' ALA . 25.9 t -75.15 -6.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.071 0.938 . . . . 0.0 109.27 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.722 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -77.53 -32.57 54.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.913 174.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.659 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.4 p -99.55 159.38 30.17 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.659 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.87 -53.51 6.87 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.235 3.29 . . . . 0.0 114.835 -169.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.37 80.05 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.8 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.78 -39.84 54.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.307 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -56.75 -39.79 74.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.658 0.742 . . . . 0.0 110.044 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.98 -44.87 79.35 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.899 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -34.7 78.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -64.54 -38.34 90.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -83.62 -20.49 33.56 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.811 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -80.71 -48.92 11.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.591 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -86.44 -10.93 53.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.192 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 73.1 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.804 0.69 . . . . 0.0 109.977 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.04 86.42 58.14 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.626 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -103.15 122.57 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.673 2.916 . . . . 0.0 112.741 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.46 ' HA3' ' HE1' ' A' ' 99' ' ' PHE . . . 133.92 -74.58 0.43 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.412 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 27' ' ' HIS . 23.7 m 73.23 141.97 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 123.704 0.297 . . . . 0.0 110.586 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.551 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 55.4 Cg_endo -69.08 153.99 91.36 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 124.426 -1.072 . . . . 0.0 113.32 1.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.1 m -138.94 123.82 18.77 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.432 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 1.5 m-85 -112.27 112.56 24.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.842 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 59.0 t -118.02 115.22 47.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HB2' HG22 ' A' ' 95' ' ' VAL . 49.2 m-85 -102.16 124.02 47.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.92 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 94' ' ' GLU . 32.8 mt -117.59 132.46 56.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.586 HG22 ' SD ' ' A' ' 21' ' ' MET . 14.9 t -110.71 132.73 21.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.578 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.7 115.04 3.04 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.251 1.3 . . . . 0.0 110.748 170.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -169.13 141.52 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.99 11.41 8.33 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.66 0.6 . . . . 0.0 111.342 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.8 29.6 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.63 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.98 -177.12 3.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.0 111.076 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 67.1 m95 -105.74 130.74 53.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.011 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.507 ' OE2' HG12 ' A' ' 95' ' ' VAL . 31.3 tt0 -97.14 119.82 36.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.238 176.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.533 ' HA ' HD23 ' A' ' 85' ' ' LEU . 33.0 tt0 -75.24 96.56 3.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.94 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 13.7 m -73.91 -11.73 14.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.953 -173.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.79 141.82 3.23 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.763 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -116.16 128.24 55.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.229 0.537 . . . . 0.0 109.642 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.579 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.3 mt -108.03 131.39 54.63 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.46 ' HE1' ' HA3' ' A' ' 78' ' ' GLY . 79.1 t80 -130.9 124.1 30.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.81 178.26 15.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.419 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 8.0 m -112.91 126.29 55.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.502 ' HE ' ' HG2' ' A' ' 106' ' ' GLU . 24.4 mmm180 -128.05 151.02 75.3 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.779 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.07 158.94 41.05 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.254 1.969 . . . . 0.0 111.262 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.655 ' HB2' HG13 ' A' ' 41' ' ' VAL . 67.7 ttt180 -58.67 -34.83 71.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.386 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.64 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.086 0.469 . . . . 0.0 110.634 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HG2' ' HE ' ' A' ' 102' ' ' ARG . 3.9 tp10 -67.02 -48.77 67.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.409 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -66.08 -37.36 85.6 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.843 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.54 HD21 HG22 ' A' ' 47' ' ' VAL . 60.6 mt -59.06 -44.51 91.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 0.0 110.73 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 46.7 mtmt -65.1 -48.07 74.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.32 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -59.36 -55.56 33.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.409 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' LEU . 1.9 tm? -61.31 -32.39 72.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.32 0.581 . . . . 0.0 109.897 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 116' ' ' VAL . 3.6 tpm_? -65.44 -37.85 88.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 109' ' ' LYS . 29.2 mm-40 -74.37 -43.19 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.553 0.215 . . . . 0.0 110.937 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.458 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . 79.5 t -62.67 -36.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.166 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.1 t -55.16 -29.73 58.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.576 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 112' ' ' ARG . 85.9 t -85.42 -54.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.245 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.94 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -70.95 -11.53 61.02 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.107 -170.452 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.448 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -56.12 -41.09 85.14 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.167 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.823 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.855 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.466 ' HB3' ' NE1' ' A' ' 5' ' ' TRP . 11.3 tp . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 121.105 0.479 . . . . 0.0 111.436 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -102.17 103.8 14.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.68 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.466 ' NE1' ' HB3' ' A' ' 3' ' ' LEU . 13.2 m95 -104.35 139.78 38.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.539 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 86.1 m-85 -138.91 166.63 23.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.68 159.35 41.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.54 1.494 . . . . 0.0 110.884 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.544 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 60.4 t80 -50.84 -51.36 67.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.2 Cg_exo -60.85 -43.69 29.71 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.834 1.689 . . . . 0.0 112.386 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -65.71 -46.07 80.33 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.35 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.491 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.15 -41.82 72.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.45 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.38 -38.78 91.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.044 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.47 -47.79 58.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.878 0.371 . . . . 0.0 110.399 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.446 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -54.21 -51.4 64.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.857 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.42 -43.96 95.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.357 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -62.39 -47.45 84.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.369 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.35 -15.45 57.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -112.58 -1.73 14.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.43 32.46 81.88 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.264 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 24.9 mmt180 -97.44 177.63 5.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.397 . . . . 0.0 110.675 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 88.1 mtp -104.5 156.25 18.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.474 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 49.9 t -105.95 124.69 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 ttt -104.39 103.47 13.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.684 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 37.5 t -84.5 104.54 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.896 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.9 t80 -102.33 108.84 20.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.077 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 1.004 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.7 m-85 -90.1 124.97 35.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 23.5 p80 -128.08 155.85 43.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.564 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.437 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 38.2 t -143.1 159.48 42.2 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -74.87 -9.05 58.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.57 0.7 . . . . 0.0 109.935 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -97.86 15.96 22.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.998 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.586 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 31.8 p -84.84 115.22 59.93 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.839 0.352 . . . . 0.0 110.562 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 79' ' ' THR . 38.0 Cg_endo -68.0 -69.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.497 2.132 . . . . 0.0 113.866 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.88 -17.19 36.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 44.5 t -55.46 -46.92 76.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.487 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -56.6 -38.25 71.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.38 . . . . 0.0 111.638 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -72.2 -38.93 68.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.42 ' HE1' ' H ' ' A' ' 102' ' ' ARG . 50.8 ttm -65.32 -49.38 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.856 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 77.6 m-20 -52.36 -49.27 64.69 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.363 0.415 . . . . 0.0 111.018 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' SER . 21.9 m -59.86 -59.99 4.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.888 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.05 -68.4 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 112.071 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 104' ' ' ARG . 68.6 t -58.9 -44.35 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.804 -170.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 21.1 tp -81.74 -34.68 30.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.334 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 39' ' ' THR . 33.4 t -85.74 -0.99 56.74 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.406 ' OD2' HG23 ' A' ' 47' ' ' VAL . 22.1 t70 -49.87 128.46 20.83 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.117 174.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.57 -35.63 57.16 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.222 2.614 . . . . 0.0 113.242 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.86 -48.22 28.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.962 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.712 HG22 HD21 ' A' ' 108' ' ' LEU . 59.6 t -61.36 -57.5 11.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.107 0.479 . . . . 0.0 110.762 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.68 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 54.9 m -52.23 -47.41 65.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.085 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -58.5 -36.56 73.98 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.471 HD13 HD12 ' A' ' 111' ' ' LEU . 76.7 mt -62.68 -40.38 96.92 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.0 110.593 176.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.5 mm? -74.53 -40.58 61.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.292 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.6 mt-10 -49.48 -50.21 42.32 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.204 0.526 . . . . 0.0 112.023 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.14 82.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -135.23 11.95 3.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 86.4 m-85 -121.38 145.64 47.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.353 0.597 . . . . 0.0 111.246 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 11' ' ' ALA . 20.1 t -111.98 113.66 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 3' ' ' LEU . 21.8 t -87.03 117.4 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 8' ' ' TYR . . . -90.31 117.27 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.45 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.1 p -85.14 101.41 12.44 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.9 125.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.565 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.606 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -100.48 108.52 20.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.057 0.456 . . . . 0.0 110.571 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.36 -11.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.054 0.93 . . . . 0.0 109.636 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.474 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 6.8 m-20 -77.68 -32.34 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.609 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.616 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -109.1 165.46 12.6 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.778 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.3 Cg_endo -49.73 -52.95 7.86 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.092 3.194 . . . . 0.0 114.491 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -56.43 -43.37 79.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.34 -31.15 52.59 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.98 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -60.19 -41.32 92.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.724 0.297 . . . . 0.0 111.065 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.1 pt-20 -79.25 -30.64 43.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.882 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.408 ' HB3' ' HE1' ' A' ' 26' ' ' PHE . 1.9 mm? -63.83 -44.19 93.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 0.0 110.247 172.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.01 79.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.449 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.8 ptm180 -65.39 -30.68 71.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.111 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -66.51 -41.39 88.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 110.276 -179.531 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -92.33 -6.09 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.24 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 65.38 33.11 9.21 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.683 0.614 . . . . 0.0 111.439 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 t -130.26 144.99 55.46 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 17.0 Cg_exo -69.63 -116.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.378 2.052 . . . . 0.0 111.282 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.496 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . 168.14 63.32 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 12.5 p -137.86 47.72 1.76 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.657 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 43.5 Cg_endo -93.08 174.38 16.62 Favored 'Cis proline' 0 C--N 1.356 0.949 0 CA-C-N 121.0 1.393 . . . . 0.0 112.507 -3.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 1.004 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 62.8 m -139.18 131.64 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 170.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -127.75 112.23 14.56 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.684 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 57.4 t -111.43 121.63 64.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.735 0.303 . . . . 0.0 110.199 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.49 116.62 30.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.668 0.27 . . . . 0.0 110.357 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 29.3 mt -112.93 137.04 51.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.213 0.53 . . . . 0.0 111.408 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.522 HG21 ' HA2' ' A' ' 118' ' ' GLY . 58.8 t -109.98 123.33 36.46 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.03 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 59.5 Cg_endo -77.11 116.42 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.778 1.652 . . . . 0.0 111.193 173.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -147.85 135.33 20.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.684 0.278 . . . . 0.0 110.574 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.0 24.16 14.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.554 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.56 77.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.343 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.31 167.02 20.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 65.7 m95 -106.36 126.12 51.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.943 0.401 . . . . 0.0 110.026 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.8 tp10 -114.04 137.44 51.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.623 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 38.1 tt0 -88.29 112.91 23.35 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.537 HG22 ' HE2' ' A' ' 117' ' ' LYS . 8.7 p -98.93 7.46 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.499 0.666 . . . . 0.0 110.336 -175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.46 138.49 2.88 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.504 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -122.94 133.06 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.153 0.502 . . . . 0.0 110.508 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.98 128.39 56.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.923 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -137.18 143.42 42.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.986 0.422 . . . . 0.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.02 -177.27 28.82 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.353 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.6 m -88.79 107.84 19.18 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.497 ' HB3' ' OE1' ' A' ' 106' ' ' GLU . 4.1 mmm180 -111.29 143.65 28.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.658 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.69 151.27 82.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.26 1.973 . . . . 0.0 110.925 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.689 ' HB2' HG13 ' A' ' 41' ' ' VAL . 22.6 ttp180 -59.21 -27.35 65.64 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.89 92.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.65 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.497 ' OE1' ' HB3' ' A' ' 102' ' ' ARG . 50.0 tt0 -82.84 -38.27 23.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 37.2 t80 -58.38 -51.4 69.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.675 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 47' ' ' VAL . 57.8 mt -70.59 -28.23 64.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -56.7 -55.62 31.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.249 0.547 . . . . 0.0 109.879 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 114' ' ' VAL . 20.8 tp10 -73.74 -31.64 63.46 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.112 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -60.31 -46.58 89.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -60.82 -38.06 84.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.83 -48.52 58.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 110' ' ' GLU . 55.5 t -58.36 -42.45 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.505 0.322 . . . . 0.0 111.75 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.0 p -63.05 -23.85 67.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 110.497 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -86.11 -50.12 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.661 173.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HE2' HG22 ' A' ' 95' ' ' VAL . 38.2 mtpt -55.22 -34.3 63.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.236 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -68.41 -24.09 75.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.949 -0.644 . . . . 0.0 113.152 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.507 177.358 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.1 tp . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 23.0 mmt180 -88.3 106.38 18.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.646 -172.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -110.24 108.71 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 94.2 m-85 -133.17 154.26 81.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.43 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 34.6 Cg_exo -57.05 161.71 10.37 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.09 1.86 . . . . 0.0 111.504 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.569 ' O ' HD23 ' A' ' 12' ' ' LEU . 82.9 t80 -45.81 -53.66 19.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 20.9 Cg_exo -65.17 -40.68 18.91 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.485 1.457 . . . . 0.0 112.146 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.43 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 31.6 tt0 -71.08 -37.33 72.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.926 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.23 79.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.005 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.569 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.6 mm? -61.18 -34.5 75.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.593 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -39.05 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.784 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.5 tp -64.22 -47.31 80.19 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.008 0.432 . . . . 0.0 110.138 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.52 89.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.434 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -62.77 -51.65 66.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.226 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.72 -14.38 59.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.029 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -118.68 3.62 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.765 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.67 44.4 95.7 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.458 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.8 mmp_? -107.43 174.86 5.7 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.671 -0.311 . . . . 0.0 110.791 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 79.6 mtp -100.52 156.55 17.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 24.6 t -106.79 127.54 62.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.2 ttt -111.07 104.25 12.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -88.38 107.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -93.02 103.97 16.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 110.137 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.692 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 59.8 m-85 -87.41 122.48 31.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.302 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 62' ' ' VAL . 32.5 p80 -132.62 137.21 46.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.527 ' N ' ' HB3' ' A' ' 31' ' ' CYS . 50.6 m -60.81 167.01 3.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.751 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.502 ' N ' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -53.5 -38.22 63.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.285 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -102.05 -48.7 4.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p 41.19 78.45 0.37 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.467 1.107 . . . . 0.0 112.879 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.663 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 69.4 Cg_endo -79.24 -59.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 114.297 -174.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HD2' ' HG ' ' A' ' 101' ' ' SER . 33.9 t80 -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.698 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 22.6 p -82.68 -21.64 34.85 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -173.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 8.3 pt20 -61.79 -30.84 71.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.64 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -66.02 -43.56 87.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.358 0.599 . . . . 0.0 109.551 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.42 ' SD ' ' HB3' ' A' ' 101' ' ' SER . 64.2 mmm -59.41 -44.4 92.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.704 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -62.79 -54.62 36.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.598 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 43' ' ' SER . 58.4 m -70.57 -37.65 74.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.27 -71.78 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.864 -0.523 . . . . 0.0 112.011 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.83 -45.53 94.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.285 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.6 tp -80.93 -31.45 35.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.673 0.273 . . . . 0.0 111.451 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 39' ' ' THR . 33.1 t -83.82 -4.48 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.934 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.81 129.15 14.42 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.351 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.33 -48.38 15.27 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.334 2.69 . . . . 0.0 113.547 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.12 -37.07 86.75 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.409 -176.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.558 ' HA ' HD21 ' A' ' 108' ' ' LEU . 34.8 t -66.63 -57.26 10.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.11 0.481 . . . . 0.0 109.882 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.673 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 50.1 m -52.35 -46.27 66.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.721 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.08 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.665 HD22 HH22 ' A' ' 54' ' ' ARG . 61.4 mt -61.51 -41.55 97.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.222 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.77 -40.66 65.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.673 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.2 mt-10 -57.68 -34.16 69.12 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.459 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -67.67 -52.84 33.17 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.665 HH22 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.88 15.8 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -172.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -121.49 146.4 46.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.474 0.654 . . . . 0.0 111.871 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.475 HG11 ' HB3' ' A' ' 14' ' ' LEU . 56.9 t -113.16 115.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.11 125.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.022 0.439 . . . . 0.0 110.582 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.85 116.91 28.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.888 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -83.48 101.28 11.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.61 103.09 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.453 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 p -94.17 110.77 22.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.292 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.502 ' HB ' ' N ' ' A' ' 29' ' ' GLU . 97.1 t -70.28 -13.65 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.473 0.654 . . . . 0.0 110.367 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -73.94 -27.89 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.837 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.478 ' HB ' ' OE2' ' A' ' 66' ' ' GLU . 76.2 p -91.47 151.91 43.09 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.741 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 43.6 Cg_endo -61.58 -36.92 73.51 Favored 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 122.741 2.294 . . . . 0.0 113.565 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.2 mp0 -57.3 -52.65 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.515 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.12 -29.77 66.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.825 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.741 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 7.9 pt20 -62.39 -47.46 84.07 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.432 ' HA ' ' CD ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -72.62 -33.11 66.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.122 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 66' ' ' GLU . 1.9 mm? -59.19 -42.88 91.93 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . -62.19 -41.56 98.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.449 176.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.432 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 4.5 mtp180 -61.96 -43.81 98.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.12 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.45 -48.8 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.598 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.17 -6.65 58.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.458 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 57.45 46.74 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.738 0.649 . . . . 0.0 110.592 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.23 120.18 28.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.313 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -93.35 105.76 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.601 2.867 . . . . 0.0 110.61 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' HIS . . . -81.47 92.28 1.5 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.362 -168.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.86 48.26 0.81 Allowed Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.698 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 Cg_endo -94.11 173.34 15.81 Favored 'Cis proline' 0 C--N 1.356 0.955 0 CA-C-N 120.541 1.229 . . . . 0.0 112.13 -4.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 18.0 m -142.67 137.95 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.833 167.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.21 118.19 21.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.755 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' A' ' 97' ' ' ARG . 86.6 t -115.27 126.89 72.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -104.72 122.97 46.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 35.4 mt -117.5 130.94 56.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.87 127.95 26.23 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.963 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.478 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 58.4 Cg_endo -73.52 117.75 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 121.973 1.782 . . . . 0.0 110.432 171.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -164.04 143.78 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.716 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.06 -76.28 0.06 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.042 0.839 . . . . 0.0 111.187 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.47 22.43 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.852 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -161.9 -171.39 2.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.48 ' CE2' HD12 ' A' ' 12' ' ' LEU . 58.9 m95 -103.41 128.37 50.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.0 109.997 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 35.5 tt0 -94.81 115.2 27.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.453 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.9 tt0 -73.88 103.01 4.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 171.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.545 HG22 ' HD3' ' A' ' 117' ' ' LYS . 9.0 p -102.39 6.93 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.607 -167.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.8 146.54 4.54 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.468 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HG2' HG22 ' A' ' 83' ' ' VAL . 77.7 mtt180 -123.42 126.58 47.05 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.527 HD21 ' HG3' ' A' ' 110' ' ' GLU . 83.4 mt -109.57 131.7 54.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -137.15 142.14 42.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.44 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.98 136.86 7.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.391 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.44 ' HG ' ' HD2' ' A' ' 33' ' ' TYR . 11.8 m -66.18 122.37 17.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 110.595 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 4.0 mmp_? -124.01 157.2 64.42 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.776 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.87 154.87 30.07 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.373 2.049 . . . . 0.0 112.041 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -31.07 67.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.628 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.421 ' O ' ' HE3' ' A' ' 109' ' ' LYS . . . -67.81 -38.33 83.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.291 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.43 -32.81 48.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.538 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.69 -49.86 71.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.74 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.651 HD22 HD12 ' A' ' 50' ' ' LEU . 24.1 mt -70.5 -20.69 62.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 105' ' ' ALA . 1.0 OUTLIER -59.8 -61.2 2.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.611 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.527 ' HG3' HD21 ' A' ' 98' ' ' LEU . 2.1 tm-20 -67.85 -38.72 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 50' ' ' LEU . 3.0 tm? -58.69 -44.34 90.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 110.551 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -64.65 -36.95 85.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 109.954 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 61.4 mt-30 -65.98 -38.96 89.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.539 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 72.4 t -61.51 -34.9 63.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.923 176.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.35 -34.99 71.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.326 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -84.24 -40.11 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.545 ' HD3' HG22 ' A' ' 95' ' ' VAL . 96.9 mttt -52.0 -57.2 10.18 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.027 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -51.68 -34.6 36.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.153 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.944 -178.062 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 57' ' ' VAL . 27.7 tp . . . . . 0 C--O 1.236 0.382 0 N-CA-C 111.276 0.102 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.0 mmp_? -77.09 103.76 7.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.371 . . . . 0.0 111.297 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -105.64 115.08 29.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.754 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.531 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.5 m-85 -121.97 159.41 51.63 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.592 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 14.4 Cg_exo -67.88 157.91 59.69 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.964 1.776 . . . . 0.0 110.761 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.59 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 92.6 t80 -43.78 -53.14 13.18 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.2 Cg_exo -59.13 -52.02 5.68 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.787 1.658 . . . . 0.0 112.766 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.4 mm-40 -70.34 -30.6 67.6 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.32 -47.18 87.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.2 0.524 . . . . 0.0 110.259 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 8' ' ' TYR . 11.0 mp -64.45 -40.39 95.64 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.823 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.81 -36.51 65.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.04 0.448 . . . . 0.0 110.741 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -61.79 -37.92 86.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.191 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.12 -49.03 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 46.3 tt0 -57.52 -54.32 48.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 122.913 0.485 . . . . 0.0 112.308 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.84 60.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.612 -172.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -110.35 -22.87 11.5 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.23 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.8 6.83 54.09 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.043 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 20' ' ' ARG . 4.0 mpt_? -85.9 -177.82 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.664 0.268 . . . . 0.0 111.402 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.77 158.74 17.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 38.8 t -106.36 135.62 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.67 0.272 . . . . 0.0 110.747 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.559 ' HG2' ' CD1' ' A' ' 84' ' ' PHE . 6.2 tmm? -125.69 104.74 8.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.581 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 35.2 t -91.16 120.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -175.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 44.0 t80 -108.74 124.33 50.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.081 0.467 . . . . 0.0 111.388 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.911 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.6 m-85 -104.22 132.55 50.36 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.393 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.902 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 30.4 p80 -135.84 161.69 34.9 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.491 0.494 . . . . 0.0 110.644 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.583 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 40.4 m -143.79 164.42 30.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.8 -32.89 20.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 109.995 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -76.54 -7.11 54.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.242 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.716 ' HB3' HG22 ' A' ' 79' ' ' THR . 5.0 t -113.89 87.52 12.73 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.24 27.11 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.047 2.498 . . . . 0.0 113.687 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -86.05 -48.43 8.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.025 0.441 . . . . 0.0 111.503 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.59 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 14.1 t -83.08 -20.45 34.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -171.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -53.21 -29.81 34.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -79.37 -32.24 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.451 0.643 . . . . 0.0 110.326 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -80.28 -49.88 10.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.994 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.0 p30 -64.65 -23.05 67.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.8 m -75.69 -60.42 2.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.499 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.65 -69.46 0.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.744 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.5 t -55.71 -43.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.9 tp -80.9 -23.93 38.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -105.69 9.06 33.25 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.068 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.97 135.24 21.43 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.766 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 10.1 Cg_endo -52.02 -34.21 56.13 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 123.057 2.505 . . . . 0.0 113.561 -177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.61 -45.69 10.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.804 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.613 HG22 HD21 ' A' ' 108' ' ' LEU . 43.0 t -63.34 -51.96 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.292 0.568 . . . . 0.0 109.807 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.442 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 7.6 t -53.21 -41.33 65.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.525 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HE ' ' HB2' ' A' ' 49' ' ' ARG . 14.2 ttm180 -61.84 -35.38 78.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.772 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD13 HD12 ' A' ' 111' ' ' LEU . 76.2 mt -69.28 -40.14 77.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.911 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HB3' HD11 ' A' ' 3' ' ' LEU . 4.2 mm? -70.85 -48.72 52.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.846 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 48' ' ' SER . 12.0 mm-40 -53.0 -33.6 52.35 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.801 0.44 . . . . 0.0 112.182 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -68.11 -57.99 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -173.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.484 ' HD3' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.91 18.88 3.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.312 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 76.2 m-85 -124.97 146.18 49.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.413 0.625 . . . . 0.0 111.245 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 14' ' ' LEU . 39.7 t -115.12 120.09 63.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.569 HG21 HD21 ' A' ' 3' ' ' LEU . 19.0 t -91.58 124.6 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.77 -173.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.581 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -93.96 117.96 30.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.591 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 p -82.66 102.43 11.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.04 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -116.73 129.4 73.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.15 0.5 . . . . 0.0 110.485 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.605 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 2.2 m -112.97 114.45 26.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.811 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.583 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 32.4 t -74.84 -7.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.015 0.912 . . . . 0.0 109.583 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.01 -29.37 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.012 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.614 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 2.9 p -109.11 158.51 34.14 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.614 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.0 Cg_endo -52.29 -50.4 14.15 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.301 3.334 . . . . 0.0 114.914 -167.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -38.62 84.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.991 0.424 . . . . 0.0 110.83 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.3 -31.02 53.28 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.606 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 64' ' ' THR . 92.4 mt-30 -62.36 -39.68 93.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.638 0.375 . . . . 0.0 111.117 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.55 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -77.9 -33.7 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.642 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.55 HD12 ' OE2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -61.27 -42.21 98.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 0.0 110.531 170.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.2 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.564 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.1 ptm180 -71.9 -21.46 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.969 0.414 . . . . 0.0 110.484 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 73' ' ' ARG . 45.6 ttm105 -75.2 -52.42 10.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.45 -8.12 57.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.711 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 64.06 72.19 0.47 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.468 0.651 . . . . 0.0 109.698 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 56.0 t -123.6 136.96 27.85 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.959 -175.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.9 Cg_exo -73.62 -138.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.204 2.603 . . . . 0.0 111.553 173.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -88.12 -69.18 1.28 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.807 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' A' ' 27' ' ' HIS . 6.6 t 178.44 156.09 0.56 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.69 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 1.0 OUTLIER -84.29 132.75 18.39 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.354 -1.102 . . . . 0.0 112.701 0.052 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.911 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 31.4 m -126.41 121.13 31.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 110.584 174.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.652 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 8.8 m-85 -119.45 115.96 25.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 98.2 t -114.01 118.14 57.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.754 0.312 . . . . 0.0 110.548 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.559 ' CD1' ' HG2' ' A' ' 23' ' ' MET . 26.2 m-85 -96.93 118.71 33.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.707 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 94' ' ' GLU . 42.0 mt -115.78 130.06 56.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.077 0.465 . . . . 0.0 110.516 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.01 135.14 20.52 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.6 116.64 4.64 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.574 1.516 . . . . 0.0 109.338 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -151.07 128.4 11.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.761 -171.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.12 -79.8 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.931 0.77 . . . . 0.0 111.341 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.67 21.09 0.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.07 -169.3 3.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 85.6 m95 -107.89 135.76 48.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.242 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -116.3 118.29 32.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.589 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 36.2 tt0 -77.62 108.17 10.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.87 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 31.1 m -88.35 12.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 111.329 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 94' ' ' GLU . . . 142.09 155.02 6.31 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.301 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -130.76 135.5 47.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.652 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.9 mt -108.18 129.75 55.17 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.719 -177.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 80' ' ' PRO . 88.3 t80 -137.41 143.23 41.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.649 173.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.25 145.77 10.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.583 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m -70.09 125.76 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.607 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.636 ' HB3' ' HB2' ' A' ' 106' ' ' GLU . 92.9 mtt180 -137.89 142.75 37.28 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.789 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.473 ' HD2' ' HG2' ' A' ' 106' ' ' GLU . 24.5 Cg_exo -64.21 166.38 17.05 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.489 2.126 . . . . 0.0 111.518 173.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -55.54 -33.17 63.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.872 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -60.88 -47.25 87.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 17.4 mm-40 -72.3 -38.42 68.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.929 0.395 . . . . 0.0 110.602 -176.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -65.3 -39.37 92.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.345 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.613 HD21 HG22 ' A' ' 47' ' ' VAL . 53.4 mt -67.35 -34.62 77.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.061 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 98.5 mttt -55.94 -53.3 58.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 109.871 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.516 ' O ' HG23 ' A' ' 114' ' ' VAL . 4.3 mm-40 -62.53 -44.16 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.432 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.461 HD12 HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -57.71 -41.57 82.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.281 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 14.4 mmt180 -63.09 -49.55 74.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.852 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 6.9 pt20 -66.97 -23.04 65.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.066 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 110' ' ' GLU . 56.7 t -75.21 -41.92 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.838 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.4 m -56.75 -37.95 71.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 110.525 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.86 -32.39 56.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.87 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 54.2 mttp -71.19 -8.52 54.09 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.482 -176.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.46 -20.96 72.17 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.222 173.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 176.563 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 51' ' ' LEU . 26.6 tp . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.904 0.383 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.642 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -77.35 103.58 7.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.71 -174.641 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HH2' HD21 ' A' ' 42' ' ' LEU . 43.7 m95 -114.0 102.67 10.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.7 m-85 -117.06 161.13 34.26 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 27.4 Cg_exo -60.02 162.04 17.49 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.934 1.756 . . . . 0.0 111.436 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.651 ' CD1' HD21 ' A' ' 70' ' ' LEU . 87.8 t80 -49.1 -52.89 43.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.1 Cg_exo -65.25 -40.51 19.2 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.632 1.555 . . . . 0.0 111.951 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.431 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 33.2 tt0 -69.46 -39.23 77.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 -177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.56 82.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.019 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.96 -34.6 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -38.45 64.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.682 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.463 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.1 tp -65.23 -44.6 87.69 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 109.71 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.14 87.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -50.85 71.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.77 -14.12 60.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.197 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -118.23 -9.9 10.36 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.2 89.71 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.714 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.773 ' HG3' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -73.07 169.75 16.33 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.466 0.306 . . . . 0.0 111.521 175.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.559 ' SD ' HG22 ' A' ' 86' ' ' VAL . 68.1 mtm -101.4 167.84 9.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.39 125.95 62.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.079 0.466 . . . . 0.0 111.242 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.79 ' HG3' HG13 ' A' ' 57' ' ' VAL . 5.4 tpt -103.67 102.77 12.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.19 108.53 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.954 0.407 . . . . 0.0 110.067 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.776 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 72.6 t80 -103.7 103.55 13.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.419 0.628 . . . . 0.0 110.743 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 70' ' ' LEU . 60.3 m-85 -77.29 105.38 8.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.24 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.776 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 24.4 p80 -104.15 138.29 40.85 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.618 175.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.685 ' OG ' ' HA2' ' A' ' 78' ' ' GLY . 49.3 m -122.67 144.06 49.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.627 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -42.81 62.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.303 0.573 . . . . 0.0 110.13 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.564 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 91.5 m-70 -101.87 42.74 1.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.263 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 28.3 p -93.58 100.91 5.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.617 176.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -88.41 -7.69 5.71 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.268 1.978 . . . . 0.0 114.152 -176.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -84.58 -34.51 23.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.709 ' HB3' ' HG3' ' A' ' 80' ' ' PRO . 29.2 p -80.96 -23.18 38.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -170.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -55.13 -32.41 62.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.18 -33.37 24.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.402 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.0 ttp -80.73 -35.26 33.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.596 -173.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 38.3 p30 -72.14 -22.69 61.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 111.229 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.9 m -71.34 -59.94 2.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.609 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -91.48 -67.74 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.463 0.649 . . . . 0.0 111.482 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.578 HG13 ' HA ' ' A' ' 104' ' ' ARG . 59.1 t -60.01 -58.95 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.98 -168.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.606 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 19.5 tp -78.84 -10.59 59.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.089 -169.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -101.05 -9.87 21.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.755 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 31.6 t70 -56.67 133.25 78.11 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.341 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 66.4 Cg_exo -53.25 -48.74 20.41 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.191 2.594 . . . . 0.0 113.086 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.59 -43.14 99.27 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.37 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.769 HG22 HD21 ' A' ' 108' ' ' LEU . 50.0 t -60.07 -56.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 175.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 m -56.91 -36.53 70.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.579 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.476 ' HA ' ' HB2' ' A' ' 52' ' ' GLU . 99.7 mtt180 -75.44 -21.16 58.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.457 HD12 HD22 ' A' ' 108' ' ' LEU . 69.1 mt -70.68 -36.52 73.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.163 169.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB2' HD11 ' A' ' 3' ' ' LEU . 1.5 mm? -70.45 -49.35 49.6 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.076 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 49' ' ' ARG . 17.1 mm-40 -45.88 -39.16 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.991 0.516 . . . . 0.0 112.124 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.503 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -68.13 -57.18 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.773 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.75 20.7 3.3 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -171.755 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.472 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 96.2 m-85 -133.58 140.36 47.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.481 0.657 . . . . 0.0 111.674 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 14' ' ' LEU . 46.9 t -110.44 115.35 49.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.79 HG13 ' HG3' ' A' ' 23' ' ' MET . 20.8 t -86.76 126.35 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.523 . . . . 0.0 110.359 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.17 116.52 29.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.521 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 44.3 t -87.01 100.71 12.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.509 HG11 HD22 ' A' ' 70' ' ' LEU . 59.4 t -110.24 119.0 58.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.027 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.633 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.0 p -90.43 111.97 23.42 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 21.6 m -74.29 -0.41 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.526 0.679 . . . . 0.0 110.346 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -29.49 31.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.086 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.655 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -95.63 166.73 14.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.977 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.655 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.5 Cg_endo -51.86 -55.85 3.52 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.511 2.807 . . . . 0.0 114.6 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -62.98 -35.66 80.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.353 . . . . 0.0 110.938 -178.454 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.95 -40.88 62.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.724 174.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 5.9 mt-30 -62.29 -30.87 71.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.259 0.552 . . . . 0.0 110.594 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' CD ' HH21 ' A' ' 73' ' ' ARG . 5.3 tp10 -66.05 -53.43 38.49 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.631 173.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.651 HD21 ' CD1' ' A' ' 8' ' ' TYR . 6.7 mp -58.62 -37.48 75.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 176.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.9 28.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.983 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 69' ' ' GLU . 36.4 ptt180 -66.27 -23.34 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.462 HH21 ' CD ' ' A' ' 69' ' ' GLU . 14.2 ttm180 -83.49 -51.21 7.55 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.316 -175.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.26 4.12 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.637 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 68.67 22.13 7.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.793 0.437 . . . . 0.0 111.072 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.97 119.78 66.47 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.32 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.974 2.449 . . . . 0.0 112.589 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.685 ' HA2' ' OG ' ' A' ' 28' ' ' SER . . . -174.8 120.98 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.632 ' HB ' ' C ' ' A' ' 80' ' ' PRO . 31.2 m -146.56 -61.04 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -165.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.709 ' HG3' ' HB3' ' A' ' 34' ' ' CYS . 17.8 Cg_endo -79.39 172.74 58.12 Favored 'Cis proline' 0 N--CA 1.492 1.414 0 CA-C-N 123.111 2.147 . . . . 0.0 115.915 4.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 m -125.97 143.12 51.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.254 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' HD1' ' HD1' ' A' ' 25' ' ' TYR . 1.2 m-85 -118.27 127.99 54.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.91 117.69 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.727 0.299 . . . . 0.0 110.716 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.86 125.77 42.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.78 0.324 . . . . 0.0 110.416 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 31.8 mt -117.1 142.23 47.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.577 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.559 HG22 ' SD ' ' A' ' 21' ' ' MET . 10.9 t -108.59 139.84 21.22 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 21' ' ' MET . 41.2 Cg_endo -72.66 114.47 4.03 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 160.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HG3' ' CG1' ' A' ' 86' ' ' VAL . 17.5 mttp -142.21 113.36 7.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.35 15.77 9.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.669 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.4 37.83 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.985 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.04 178.29 4.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.629 0.252 . . . . 0.0 110.403 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -109.4 128.74 55.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.252 0.549 . . . . 0.0 110.319 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 23.7 tt0 -109.96 124.66 51.8 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.373 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 78.2 tt0 -77.08 100.15 5.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 86' ' ' VAL . 14.8 p -94.4 -7.12 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.467 -169.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.84 125.71 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.939 -1.124 . . . . 0.0 112.89 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -114.87 128.5 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.112 0.482 . . . . 0.0 109.995 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 97.0 mt -117.24 141.46 48.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.882 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 79' ' ' THR . 79.6 t80 -137.42 127.76 26.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.847 0.356 . . . . 0.0 110.608 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.96 154.02 30.22 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.843 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -66.23 142.39 57.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -123.82 132.95 24.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -56.94 140.86 93.27 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.928 1.752 . . . . 0.0 109.683 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.578 ' HA ' HG13 ' A' ' 41' ' ' VAL . 16.7 ttp180 -51.23 -34.91 34.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.6 43.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 111.074 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.71 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 10.3 pt-20 -88.99 -20.04 24.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.851 -175.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 70.7 t80 -60.82 -43.25 98.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 171.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.769 HD21 HG22 ' A' ' 47' ' ' VAL . 89.1 mt -68.42 -34.26 75.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.881 174.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 14.8 ttpt -55.65 -52.77 62.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.211 171.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.71 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 28.9 mm-40 -57.03 -45.05 83.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.499 0.666 . . . . 0.0 109.694 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 50' ' ' LEU . 20.9 tp -61.46 -41.37 97.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 26.7 mmt180 -62.35 -41.33 98.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.823 0.344 . . . . 0.0 110.298 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 10.5 mt-30 -56.4 -37.24 69.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.516 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.513 ' HA ' ' HZ2' ' A' ' 117' ' ' LYS . 61.7 t -76.98 -37.35 26.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.758 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.9 m -54.92 -42.42 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.782 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.5 -47.56 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.289 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HB2' ' HZ2' ' A' ' 117' ' ' LYS . 10.4 mtmp? -68.99 -13.25 62.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.576 -176.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.25 -33.12 69.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.827 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.854 175.76 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.718 HD21 HD23 ' A' ' 51' ' ' LEU . 6.7 tp . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.756 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 34.9 mmt180 -78.03 110.97 13.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.106 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -108.6 104.47 13.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.943 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.756 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 97.0 m-85 -110.49 160.27 29.15 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.936 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 20.0 Cg_exo -62.69 165.71 15.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.915 1.743 . . . . 0.0 110.552 170.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.568 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 93.5 t80 -49.87 -53.26 44.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.6 Cg_exo -64.42 -47.51 5.74 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.809 1.673 . . . . 0.0 112.198 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 31.2 tt0 -64.91 -35.39 81.01 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.437 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.84 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.37 . . . . 0.0 111.139 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.7 mp -62.05 -30.88 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.021 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.33 -44.04 76.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.573 HD22 ' CE2' ' A' ' 6' ' ' TYR . 13.3 tp -61.72 -47.32 85.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.262 0.553 . . . . 0.0 110.247 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.91 89.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.246 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -68.1 -39.23 82.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.39 -18.88 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -116.02 -8.56 11.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 38.21 63.06 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.659 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -101.22 176.99 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.5 mtp -107.47 149.99 27.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.9 t -106.94 131.56 56.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.461 . . . . 0.0 111.536 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.465 ' SD ' HD21 ' A' ' 51' ' ' LEU . 20.5 ttt -107.93 107.25 17.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.829 172.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 60' ' ' VAL . 40.9 t -84.75 103.1 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.54 ' OH ' ' HB3' ' A' ' 38' ' ' ASN . 92.7 t80 -97.67 108.02 20.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.74 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.935 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 74.8 m-85 -86.47 118.66 26.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.085 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.591 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 33.5 p80 -135.36 179.3 6.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 31' ' ' CYS . 93.7 p -143.86 166.52 24.7 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -56.76 -22.22 34.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.575 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.52 23.58 5.11 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 23.0 p -52.45 110.78 2.09 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 173.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 12.9 Cg_endo -56.19 -81.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.289 2.659 . . . . 0.0 114.532 -167.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -77.78 -17.66 57.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.32 0.581 . . . . 0.0 110.499 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 37.3 t -62.94 -36.85 84.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 26.5 pt20 -72.03 -17.15 62.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 111.212 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -81.79 -40.25 22.87 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.711 0.767 . . . . 0.0 109.716 171.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.592 ' SD ' ' HG3' ' A' ' 80' ' ' PRO . 75.9 mtp -69.39 -43.22 73.94 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.892 -170.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.54 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 30.1 p-10 -66.02 -35.08 79.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.863 0.363 . . . . 0.0 110.445 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 43' ' ' SER . 85.6 m -66.8 -55.94 12.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.585 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.97 -69.84 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.874 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.5 -51.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.788 -169.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 23.6 tp -76.87 -27.25 54.97 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.575 -173.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.7 m -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.748 0.309 . . . . 0.0 111.019 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.38 130.16 61.55 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.837 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.9 -43.09 24.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.508 2.805 . . . . 0.0 113.762 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.97 -43.45 65.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.453 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -65.68 -49.62 76.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 121.659 0.742 . . . . 0.0 109.831 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 32.4 m -59.58 -32.27 70.21 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.656 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.765 ' HE ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.86 -42.07 97.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.833 ' HA ' HH21 ' A' ' 54' ' ' ARG . 64.8 mt -60.33 -45.03 94.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.654 0.264 . . . . 0.0 111.223 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.718 HD23 HD21 ' A' ' 3' ' ' LEU . 6.2 tp -72.34 -31.8 65.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.396 0.617 . . . . 0.0 111.051 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.595 ' HA ' HD13 ' A' ' 3' ' ' LEU . 8.3 tp10 -61.74 -35.95 79.59 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 113.741 -168.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -91.5 -31.17 16.06 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -168.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.833 HH21 ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -134.48 5.08 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -170.635 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.7 142.6 48.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.551 0.691 . . . . 0.0 111.956 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 14' ' ' LEU . 43.8 t -107.87 115.21 48.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.51 126.71 40.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.852 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -94.95 116.98 29.39 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.717 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.7 p -82.42 101.06 10.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG13 ' HA2' ' A' ' 67' ' ' GLY . 99.8 t -115.17 123.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 -175.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.525 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 1.9 t -116.39 129.34 56.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.011 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.54 65.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.104 0.954 . . . . 0.0 110.0 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.67 -36.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.039 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.569 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 30.7 p -82.89 160.53 60.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.201 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 15.6 Cg_endo -52.92 -55.39 3.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.062 2.508 . . . . 0.0 113.415 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' HD13 ' A' ' 70' ' ' LEU . 10.2 pt-20 -57.03 -44.85 83.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.983 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -68.91 -39.08 85.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.38 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -63.03 -48.68 77.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.049 0.54 . . . . 0.0 111.663 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.4 pt-20 -73.48 -29.05 62.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.588 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.672 ' HG ' ' HE2' ' A' ' 74' ' ' TYR . 5.3 mp -67.28 -40.61 86.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.809 173.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.55 78.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 9.3 ptm180 -83.48 -19.51 35.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.719 0.295 . . . . 0.0 111.371 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 48.0 ttt180 -72.69 -44.03 62.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.672 ' HE2' ' HG ' ' A' ' 70' ' ' LEU . 53.3 m-85 -102.45 -2.35 28.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 26.2 ptt180 45.95 71.19 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.526 1.13 . . . . 0.0 112.551 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG11 HG21 ' A' ' 81' ' ' THR . 13.5 t -137.74 94.65 11.53 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.882 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -97.83 128.08 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.415 2.743 . . . . 0.0 111.416 169.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.33 42.19 0.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.99 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -47.03 152.36 1.0 Allowed Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 122.795 0.438 . . . . 0.0 110.741 173.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 34' ' ' CYS . 58.6 Cg_endo -67.01 151.63 83.25 Favored 'Cis proline' 0 C--N 1.351 0.676 0 N-CA-C 114.841 1.054 . . . . 0.0 114.841 4.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.935 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.3 m -141.02 133.63 28.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.34 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 3.0 m-85 -123.14 111.88 17.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -175.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 39.5 t -119.12 112.49 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 110.146 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.5 122.33 38.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.394 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 94' ' ' GLU . 30.9 mt -113.55 135.76 53.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -109.12 130.74 22.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.81 116.89 4.09 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.633 1.556 . . . . 0.0 110.212 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 90' ' ' GLY . 35.8 ttpt -151.79 134.93 15.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.333 -175.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 71.14 -37.61 0.4 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.742 0.817 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 88' ' ' LYS . . . 149.7 -10.92 0.95 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.51 -179.13 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -108.16 136.71 47.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.042 0.449 . . . . 0.0 110.489 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -117.33 126.23 52.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.104 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.467 ' HA ' HD23 ' A' ' 85' ' ' LEU . 53.3 tt0 -77.3 99.69 5.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 117' ' ' LYS . 4.9 p -96.7 -10.43 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.176 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.15 126.79 1.48 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.449 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.41 127.53 49.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.972 0.415 . . . . 0.0 109.975 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 99.0 mt -117.72 139.17 51.41 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.278 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -137.26 142.87 41.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.798 0.332 . . . . 0.0 110.838 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.06 168.93 45.37 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.635 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.463 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 10.9 m -65.38 131.76 47.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.022 0.439 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.5 133.94 23.51 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 106' ' ' GLU . 12.4 Cg_endo -59.87 154.4 50.37 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.716 1.611 . . . . 0.0 110.991 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -30.69 64.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.839 0.352 . . . . 0.0 110.437 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.04 63.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.31 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 103' ' ' PRO . 22.9 tp10 -73.19 -42.27 62.9 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CE2' HD12 ' A' ' 111' ' ' LEU . 9.8 t80 -66.24 -44.85 82.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.405 -178.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.65 -47.88 78.78 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -52.26 -58.85 5.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.32 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 114' ' ' VAL . 2.3 tp10 -78.98 -28.43 43.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.519 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 50' ' ' LEU . 3.4 tt -61.22 -43.19 99.27 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 116' ' ' VAL . 22.6 tpt180 -61.43 -45.8 92.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.471 ' HB3' ' NZ ' ' A' ' 117' ' ' LYS . 34.4 mt-30 -64.73 -43.65 92.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.42 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 110' ' ' GLU . 54.6 t -58.72 -40.87 80.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -56.43 -28.54 59.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 112' ' ' ARG . 59.2 t -83.88 -34.33 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.885 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.55 ' HB3' HG21 ' A' ' 95' ' ' VAL . 13.6 mptt -57.4 -28.5 63.29 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.615 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.85 -38.94 93.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.018 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.837 -179.018 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.794 0.33 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -107.36 117.31 33.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.435 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 36.8 m95 -111.24 123.14 49.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.215 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.555 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 37.0 m-85 -132.06 160.92 65.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.232 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 26.2 Cg_exo -61.22 162.16 20.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.003 1.802 . . . . 0.0 110.929 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.545 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 72.6 t80 -49.92 -50.24 69.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 34.7 Cg_exo -61.33 -46.61 14.41 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.808 1.672 . . . . 0.0 112.42 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -68.01 -40.61 82.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.219 -177.575 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.03 -35.92 82.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 177.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.0 -41.41 64.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.197 0.522 . . . . 0.0 110.228 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -57.23 -47.96 80.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.724 177.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.9 -41.92 67.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.455 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -61.05 -51.4 69.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 111.532 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.28 -15.35 58.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.927 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -112.86 -4.57 13.95 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.331 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.19 49.04 49.19 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.101 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -114.64 178.75 4.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 89.3 mtp -105.22 151.48 24.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.88 125.36 61.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.106 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.0 ttt -101.21 102.78 13.75 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 39.6 t -83.3 102.91 9.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.435 ' CD2' ' HZ3' ' A' ' 5' ' ' TRP . 24.7 t80 -98.61 108.8 21.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.176 -175.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.614 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 96.4 m-85 -93.23 125.36 37.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.377 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 25.4 p80 -127.56 150.12 49.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.621 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 24.5 m -142.96 141.21 31.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.522 0.201 . . . . 0.0 110.825 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -75.89 -22.41 56.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 166.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.416 ' HE1' ' HA ' ' A' ' 63' ' ' ASP . 29.1 m80 -72.64 -11.99 60.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.047 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.552 ' SG ' ' HA2' ' A' ' 78' ' ' GLY . 10.9 t -137.61 77.55 39.45 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.483 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.53 17.71 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 122.975 2.45 . . . . 0.0 114.702 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' HB3' ' OG ' ' A' ' 101' ' ' SER . 57.3 m-85 -77.27 -18.28 57.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.545 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 13.2 t -83.43 -30.93 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.814 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.448 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 10.6 mm100 -52.2 -42.01 63.15 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -170.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.035 0.445 . . . . 0.0 110.925 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.49 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 45.2 ttm -77.61 -51.89 9.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.251 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 35' ' ' GLN . 2.2 p-10 -65.49 -17.1 64.3 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 m -81.34 -62.33 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.679 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -92.88 -68.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.449 0.642 . . . . 0.0 112.116 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 89.6 t -52.67 -47.29 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.434 -168.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 21.4 tp -81.3 -18.43 45.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.982 0.42 . . . . 0.0 110.88 -173.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 m -87.41 -10.99 50.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.58 130.01 10.74 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.083 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.13 -31.96 94.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.013 2.475 . . . . 0.0 113.181 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.36 -44.53 13.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.707 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 HD21 ' A' ' 108' ' ' LEU . 48.5 t -61.52 -52.88 55.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.548 0.69 . . . . 0.0 109.495 175.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.753 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 34.1 t -50.46 -44.37 55.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.316 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -57.39 -41.12 79.61 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.589 0.555 . . . . 0.0 111.763 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.709 HD12 HD22 ' A' ' 108' ' ' LEU . 76.2 mt -61.97 -35.87 79.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.598 0.237 . . . . 0.0 110.945 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.98 -38.7 57.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.43 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.753 ' HG3' ' O ' ' A' ' 48' ' ' SER . 55.9 mt-10 -55.55 -39.08 70.15 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.058 0.456 . . . . 0.0 111.436 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -62.74 -53.33 56.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -169.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.647 ' HE ' ' HE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.7 5.82 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.647 ' HE1' ' HE ' ' A' ' 54' ' ' ARG . 80.3 m-85 -110.44 143.17 41.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 112.525 -173.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' A' ' 14' ' ' LEU . 49.0 t -110.76 115.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.7 t -86.54 123.58 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.1 0.476 . . . . 0.0 110.916 -173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -90.39 116.95 28.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -82.44 101.04 10.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.92 118.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 63' ' ' ASP . 2.6 m -102.11 110.82 22.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.278 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.621 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 6.1 t -82.67 28.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 122.574 1.178 . . . . 0.0 109.03 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.511 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 25.5 m-20 -113.42 -20.04 11.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.84 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 4.1 p -115.24 161.36 30.09 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.996 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.5 Cg_endo -51.96 -56.48 2.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.425 2.75 . . . . 0.0 114.025 -170.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -46.22 66.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.22 -36.46 63.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.879 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -63.75 -36.62 84.48 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.577 0.351 . . . . 0.0 111.018 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' OE1' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mm-40 -68.67 -39.06 80.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.177 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.9 mt -67.96 -41.19 82.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.449 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.11 93.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.551 0.215 . . . . 0.0 111.321 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HD3' ' OE1' ' A' ' 69' ' ' GLU . 9.3 ptm180 -73.38 -20.92 60.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 110.491 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -74.64 -56.27 4.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.287 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -75.7 -9.09 58.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.919 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.4 ttm105 68.79 42.63 1.37 Allowed 'General case' 0 CA--C 1.528 0.127 0 O-C-N 123.834 0.708 . . . . 0.0 110.793 170.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.635 HG11 HG21 ' A' ' 81' ' ' THR . 33.7 t -122.31 104.3 37.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.134 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -93.64 128.81 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.236 2.624 . . . . 0.0 111.765 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.552 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 108.88 150.96 14.45 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.255 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.626 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 39.8 p -141.74 162.76 44.81 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 72.4 Cg_endo -78.09 142.14 68.68 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 113.222 1.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.635 HG21 HG11 ' A' ' 76' ' ' VAL . 87.3 m -123.52 122.05 37.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.749 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 7.5 m-85 -115.82 112.27 21.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.184 -177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 46.8 t -106.77 118.41 54.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.616 ' HB2' HG22 ' A' ' 95' ' ' VAL . 79.3 m-85 -95.91 104.91 16.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.926 0.393 . . . . 0.0 110.593 -177.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 94' ' ' GLU . 78.5 mt -105.52 126.3 51.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.557 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 t -110.25 132.47 21.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.09 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.56 116.45 2.6 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.153 1.902 . . . . 0.0 109.855 171.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -161.73 141.36 10.11 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.207 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.19 -72.13 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.13 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.15 25.82 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.759 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.97 165.12 25.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.601 0.239 . . . . 0.0 110.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.33 134.81 33.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -120.35 117.56 28.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.339 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.535 ' HA ' HD23 ' A' ' 85' ' ' LEU . 14.6 tt0 -77.05 112.05 13.28 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 84' ' ' PHE . 24.3 m -77.66 -18.08 14.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.422 0.629 . . . . 0.0 109.827 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.28 162.41 11.79 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.024 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 138.45 53.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.093 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 77.3 mt -111.87 130.72 55.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.775 -175.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -137.19 133.99 35.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.0 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.73 159.97 8.42 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.074 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 33' ' ' TYR . 73.6 m -94.88 17.11 14.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.068 0.461 . . . . 0.0 111.585 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 106' ' ' GLU . 14.1 mmt180 -57.87 140.71 81.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.78 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 102' ' ' ARG . 30.9 Cg_exo -62.29 172.3 4.38 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.344 2.696 . . . . 0.0 112.381 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 39.9 ptt180 -51.78 -26.13 9.04 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.839 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -53.34 -63.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.266 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.726 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 3.0 mp0 -70.07 -33.0 71.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 110.952 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.06 -47.05 87.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.709 HD22 HD12 ' A' ' 50' ' ' LEU . 75.7 mt -70.48 -33.31 71.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.726 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.7 mttt -57.06 -51.29 69.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.53 176.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 114' ' ' VAL . 11.6 mm-40 -68.91 -36.41 77.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.773 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.467 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.1 tt -64.44 -34.88 79.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 116' ' ' VAL . 10.3 mmm180 -61.29 -41.33 96.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.471 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -67.62 -33.38 74.87 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.382 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.597 HG13 HG21 ' A' ' 95' ' ' VAL . 77.9 t -64.45 -45.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 p -65.39 -25.54 67.6 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.995 0.426 . . . . 0.0 110.7 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.6 t -77.19 -43.68 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.217 175.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.601 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 63.7 mttm -61.25 -37.0 81.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.281 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.87 70.12 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.056 -0.593 . . . . 0.0 113.092 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.928 -177.778 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.564 HD12 ' OE2' ' A' ' 52' ' ' GLU . 17.5 tp . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.698 0.285 . . . . 0.0 111.701 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -95.5 107.64 19.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.373 0.606 . . . . 0.0 112.086 -177.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.45 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.5 m95 -105.9 132.49 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.755 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -135.21 153.65 78.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 24.9 Cg_exo -59.8 164.38 11.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.006 1.804 . . . . 0.0 111.443 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.558 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 86.4 t80 -48.59 -53.37 36.48 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 18.5 Cg_exo -65.89 -44.08 8.36 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.573 1.515 . . . . 0.0 112.194 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 26.0 tt0 -67.5 -38.72 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.223 -176.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.38 77.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.076 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 8' ' ' TYR . 7.9 mp -60.17 -41.21 92.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.849 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.49 -38.58 74.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.39 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -58.43 -47.97 82.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.509 177.029 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -70.62 -43.43 69.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.93 -46.35 85.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.982 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.6 57.32 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -115.94 0.18 12.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.591 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.67 45.64 57.94 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.972 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 83.5 mmt-85 -117.57 177.63 4.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.085 0.469 . . . . 0.0 111.77 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.3 mtp -102.1 152.21 21.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.625 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.99 129.29 62.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.624 0.249 . . . . 0.0 111.316 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 ttp -109.77 104.25 13.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 24.4 t -81.05 107.33 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.019 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 52.9 t80 -94.97 104.77 16.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.606 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.463 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.3 m-85 -87.62 119.82 28.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.239 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 30.0 p80 -123.41 147.84 46.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.46 176.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 31' ' ' CYS . 14.7 m -136.77 150.64 48.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.013 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.677 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.23 -26.72 52.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.278 0.561 . . . . 0.0 109.849 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -72.73 -16.7 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.053 173.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 56.8 m -124.15 60.69 23.53 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.702 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.65 23.81 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 114.132 -169.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.78 -36.54 78.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.216 0.531 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.576 ' HB2' ' CD ' ' A' ' 80' ' ' PRO . 7.2 t -68.22 -18.84 64.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.147 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -52.82 -26.11 13.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -83.2 -41.31 18.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.735 0.779 . . . . 0.0 109.738 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mmm -63.13 -39.24 94.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.193 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.9 p30 -77.97 -17.74 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.444 -175.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -74.01 -52.21 13.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 0.0 110.493 177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.86 -71.26 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.309 0.576 . . . . 0.0 111.564 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.445 ' O ' HG21 ' A' ' 47' ' ' VAL . 57.6 t -64.93 -54.34 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.675 -167.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.599 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 18.2 tp -79.76 -12.68 59.77 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.074 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 m -106.89 -3.09 20.64 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.11 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.9 133.33 38.63 Favored Pre-proline 0 C--O 1.235 0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.214 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.668 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 8.8 Cg_endo -51.87 -46.22 33.56 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.426 2.75 . . . . 0.0 113.106 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.58 93.85 Favored Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.113 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.85 HG22 HD21 ' A' ' 108' ' ' LEU . 57.4 t -61.73 -49.71 83.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.158 0.504 . . . . 0.0 109.795 174.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.532 ' HA ' HD13 ' A' ' 3' ' ' LEU . 35.3 m -56.05 -39.76 72.5 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.003 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.668 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 18.7 mtm180 -57.99 -40.76 81.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.075 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.855 HD12 HD22 ' A' ' 108' ' ' LEU . 76.3 mt -63.49 -39.83 95.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.548 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.36 -59.82 2.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.144 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.564 ' OE2' HD12 ' A' ' 3' ' ' LEU . 20.5 mm-40 -44.69 -40.17 5.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -171.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.3 -42.41 88.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.422 HH21 ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -136.01 6.18 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.95 149.8 43.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.281 0.563 . . . . 0.0 111.476 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 14' ' ' LEU . 46.6 t -117.07 119.89 63.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 168.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 3' ' ' LEU . 19.4 t -86.99 116.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.757 -173.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -90.86 117.11 29.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 p -88.15 102.23 14.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.765 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 8' ' ' TYR . 59.9 t -108.39 123.14 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 110.606 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.648 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.8 p -93.91 110.41 22.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.853 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.644 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 28.0 t -82.83 0.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.318 1.056 . . . . 0.0 109.071 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.677 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -81.43 -33.86 31.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.528 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 33.4 p -92.63 160.84 33.62 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 25.6 Cg_endo -56.61 -53.95 4.48 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.3 2.667 . . . . 0.0 114.437 -171.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -37.02 85.7 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.277 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.19 -40.84 70.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.669 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 2.0 mt-30 -59.56 -35.16 73.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.317 0.58 . . . . 0.0 110.611 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.027 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.1 mt -64.38 -32.05 73.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -68.75 -30.68 69.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.846 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 51.9 mtp180 -71.69 -47.44 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 0.0 109.151 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -64.06 -50.2 69.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.055 -174.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.65 -0.02 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 55.71 81.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.778 0.674 . . . . 0.0 111.126 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -127.88 91.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.846 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -100.03 107.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.499 2.799 . . . . 0.0 111.994 170.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.87 169.19 12.61 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.918 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 31' ' ' CYS . 83.3 m -155.76 139.88 11.56 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.576 ' CD ' ' HB2' ' A' ' 34' ' ' CYS . 64.1 Cg_endo -88.27 132.45 11.49 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.816 -1.327 . . . . 0.0 112.993 0.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 28.5 m -107.69 110.9 22.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.8 175.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 33.1 m-85 -99.87 113.19 25.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 95.0 t -102.95 115.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.552 ' CD2' HG11 ' A' ' 114' ' ' VAL . 90.5 m-85 -94.11 113.82 25.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.781 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 24.4 mt -111.54 128.13 55.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.183 0.516 . . . . 0.0 110.619 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.14 125.17 32.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.792 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.03 117.58 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.707 1.605 . . . . 0.0 110.814 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.801 ' HE2' ' HB2' ' A' ' 93' ' ' GLU . 65.2 pttt -133.83 128.55 34.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.06 -75.72 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.191 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.76 19.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.171 -0.537 . . . . 0.0 111.816 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.23 165.21 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -94.86 139.71 30.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.299 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.801 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 9.6 tp10 -117.49 136.0 53.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.554 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 34.8 tt0 -89.82 96.58 10.75 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -83.99 -4.67 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.323 -170.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.76 162.16 11.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.946 177.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.481 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 87.3 mtt180 -127.57 136.74 52.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.38 150.97 37.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.799 0.333 . . . . 0.0 110.844 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -118.02 114.46 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA3' ' HG2' ' A' ' 80' ' ' PRO . . . -79.79 89.03 1.25 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.306 -172.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 p -135.7 -23.72 1.38 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.149 0.499 . . . . 0.0 110.547 175.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -70.03 155.54 93.29 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.691 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.8 167.08 9.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.669 2.246 . . . . 0.0 111.924 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -55.07 -38.01 67.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.512 -175.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -57.99 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.984 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.541 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 27.9 tt0 -75.08 -29.5 60.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.349 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.99 -47.88 84.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.873 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.855 HD22 HD12 ' A' ' 50' ' ' LEU . 47.1 mt -69.46 -27.12 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.238 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.541 ' HE3' ' HG3' ' A' ' 106' ' ' GLU . 29.3 ttpp -61.2 -49.98 74.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.475 ' O ' HG23 ' A' ' 114' ' ' VAL . 5.8 mm-40 -68.03 -39.95 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.349 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.48 -40.65 92.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.046 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.23 -39.28 89.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.352 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -66.04 -28.67 69.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.552 HG11 ' CD2' ' A' ' 84' ' ' PHE . 97.8 t -69.95 -39.38 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.1 m -59.06 -41.0 86.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.172 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.74 -43.99 99.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.392 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -75.2 -7.41 53.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.52 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.99 -39.17 24.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.82 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.401 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 m -87.27 -75.16 0.41 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 51' ' ' LEU . 46.0 tp -75.1 150.06 38.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.071 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.68 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 1.9 mmt180 -90.66 104.31 16.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.52 0.2 . . . . 0.0 111.382 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -106.77 103.87 13.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.68 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.3 m-85 -111.28 166.67 10.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 17.4 Cg_exo -64.92 160.1 42.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.895 1.73 . . . . 0.0 110.836 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.553 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -49.2 -50.67 62.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.9 Cg_exo -58.55 -46.28 25.0 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 121.886 1.724 . . . . 0.0 112.685 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -67.47 -44.28 78.98 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.535 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.42 -41.75 73.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.396 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.72 -36.12 75.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.744 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.79 60.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.576 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.429 HD23 HG22 ' A' ' 56' ' ' VAL . 6.6 tp -60.26 -43.81 95.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.996 0.426 . . . . 0.0 109.879 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.82 -46.94 82.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.896 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -65.93 -43.22 88.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.599 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.0 54.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -119.04 6.38 11.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.633 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.12 46.11 95.19 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.296 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.7 mmp_? -110.78 -173.74 2.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.836 0.35 . . . . 0.0 110.671 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.463 ' HE1' ' O ' ' A' ' 114' ' ' VAL . 81.6 mtp -113.77 155.59 25.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 43.6 t -106.73 127.43 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.016 0.436 . . . . 0.0 111.585 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.4 ttt -109.42 103.69 12.65 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 31.7 t -85.75 108.87 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.486 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 82.6 t80 -104.28 103.18 12.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.526 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.89 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.0 m-85 -84.19 122.21 28.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.612 ' HA ' HG23 ' A' ' 79' ' ' THR . 8.3 p80 -132.37 145.89 51.57 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.6 0.562 . . . . 0.0 111.785 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.449 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 66.9 m -142.24 153.04 43.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.544 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -13.65 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.42 0.629 . . . . 0.0 109.828 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -82.89 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.603 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.06 83.01 37.51 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.63 26.3 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.043 2.495 . . . . 0.0 113.909 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -83.69 -23.52 31.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.177 0.513 . . . . 0.0 110.599 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 43.9 t -83.16 -30.85 27.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -55.93 -29.84 60.72 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -170.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.03 -46.59 67.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 110.724 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 42' ' ' LEU . 13.9 tmm? -79.46 -44.41 21.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.672 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.475 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 7.5 t30 -53.82 -45.98 70.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.781 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.3 m -60.54 -54.87 40.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.85 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -91.78 -69.39 0.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.558 0.694 . . . . 0.0 111.708 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.564 HG13 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -59.6 -44.57 93.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.829 -169.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HB2' ' SD ' ' A' ' 37' ' ' MET . 26.6 tp -79.09 -27.0 42.94 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.242 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 m -88.97 -2.33 58.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 28.4 t70 -47.79 128.76 11.31 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.546 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 46.7 Cg_exo -57.1 -33.53 95.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.072 2.515 . . . . 0.0 112.686 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.23 -48.24 53.8 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.662 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.569 HG22 HD21 ' A' ' 108' ' ' LEU . 99.8 t -59.77 -53.51 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.12 0.486 . . . . 0.0 110.48 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -56.24 -32.21 64.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.625 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -67.11 -34.25 77.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.601 0.239 . . . . 0.0 111.066 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.613 HD12 HD22 ' A' ' 108' ' ' LEU . 53.8 mt -68.85 -37.37 79.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.713 175.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.508 ' HB3' HD11 ' A' ' 3' ' ' LEU . 3.0 mm? -67.74 -48.76 65.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.706 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 3' ' ' LEU . 21.1 mm-40 -53.79 -32.32 52.06 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.972 0.415 . . . . 0.0 111.87 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -61.45 -54.6 41.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.502 HH12 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -136.88 4.47 2.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.45 ' HE2' ' HE ' ' A' ' 54' ' ' ARG . 59.6 m-85 -112.3 149.96 31.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.429 HG22 HD23 ' A' ' 14' ' ' LEU . 47.1 t -115.39 115.98 51.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.775 167.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 29.8 t -89.05 129.03 40.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.871 -173.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -99.45 117.14 33.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.372 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -93.05 101.35 13.67 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 70' ' ' LEU . 42.6 t -114.22 133.3 60.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.046 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.567 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 18.8 m -95.16 117.67 30.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.449 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 41.4 t -71.61 -23.57 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.074 0.464 . . . . 0.0 111.484 -174.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.38 -19.21 43.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.689 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.8 p -95.85 161.22 28.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.598 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -49.73 -49.96 14.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.765 2.977 . . . . 0.0 114.537 -168.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -60.41 -44.04 96.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -69.27 -39.24 82.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.695 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.678 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 55.1 mt-30 -57.67 -40.35 79.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.75 -45.56 74.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.552 HD12 HG11 ' A' ' 60' ' ' VAL . 78.9 mt -66.4 -29.47 69.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.485 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -68.81 -29.22 67.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 62.7 mtm180 -75.9 -45.7 33.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.478 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -65.5 -56.56 11.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.727 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -91.27 -12.51 34.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 71' ' ' ALA . 74.7 mtt180 62.28 87.21 0.1 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.678 0.751 . . . . 0.0 110.131 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 81' ' ' THR . 56.1 t -128.1 137.96 31.95 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.529 -171.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 60.0 Cg_endo -74.29 -138.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.902 2.401 . . . . 0.0 111.361 170.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -91.31 -104.76 1.37 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.169 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' HIS . 1.2 m -145.1 147.57 35.01 Favored Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.885 -0.185 . . . . 0.0 110.576 -169.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 36.7 Cg_endo -90.09 131.72 8.91 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.113 -1.203 . . . . 0.0 112.83 -1.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.89 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 22.5 m -114.51 108.22 16.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.484 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 23.8 m-85 -103.06 112.53 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.45 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -112.46 120.71 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.34 118.85 36.9 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.803 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 33.4 mt -114.86 132.58 56.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.704 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 40.2 t -109.73 127.56 26.92 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.414 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.2 Cg_endo -80.56 117.57 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.469 2.113 . . . . 0.0 110.383 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -142.58 124.53 15.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.426 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.46 -77.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.147 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.86 27.25 0.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.33 161.0 39.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 110.675 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.407 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 83.0 m95 -102.55 132.7 48.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.954 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 39.3 tt0 -117.87 120.51 38.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.509 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.3 tt0 -84.34 115.0 22.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.743 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 32.8 m -100.76 8.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.32 166.6 11.03 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.239 -0.982 . . . . 0.0 112.888 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 83' ' ' VAL . 92.5 mtt180 -133.78 135.74 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 110' ' ' GLU . 69.1 mt -108.88 127.06 53.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.079 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -137.38 143.99 42.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.3 12.65 26.61 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.26 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.436 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 49.2 m 69.64 -73.29 0.09 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.109 0.564 . . . . 0.0 111.642 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 68.14 156.69 0.14 Allowed Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 123.316 0.646 . . . . 0.0 111.284 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.23 159.15 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.178 1.919 . . . . 0.0 110.557 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.564 ' HB3' HG13 ' A' ' 41' ' ' VAL . 32.1 ptt180 -59.89 -25.48 65.13 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.66 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -54.34 -53.82 48.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.734 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.583 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 22.2 mm-40 -72.81 -34.44 66.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 40.2 t80 -65.02 -43.6 91.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 50' ' ' LEU . 88.8 mt -69.83 -30.73 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.6 mttt -55.93 -53.56 55.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.51 ' HB3' HD11 ' A' ' 98' ' ' LEU . 9.5 tp10 -70.72 -38.03 73.55 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.557 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -60.09 -33.93 72.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.376 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 115' ' ' CYS . 7.7 tpt180 -80.25 -38.25 31.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.454 ' HG2' ' HE3' ' A' ' 117' ' ' LYS . 7.3 tt0 -62.9 -46.31 88.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.675 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.619 HG13 HG21 ' A' ' 95' ' ' VAL . 91.5 t -60.22 -37.05 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.5 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 112' ' ' ARG . 52.4 t -54.02 -36.7 63.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.32 -38.29 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.289 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.743 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 96.7 mttt -53.58 -28.59 32.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.22 -34.35 24.92 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.138 -0.554 . . . . 0.0 112.684 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -119.15 -15.46 5.59 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.338 177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.56 -15.17 25.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 34.6 t -72.46 127.9 33.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.86 0.3 19.69 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 124' ' ' GLY . 10.8 tp10 -73.17 165.16 25.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.157 -0.521 . . . . 0.0 109.768 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.402 ' H ' ' CD ' ' A' ' 123' ' ' GLU . . . 143.83 -3.05 1.5 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -169.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -68.92 -47.5 65.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -86.27 91.83 8.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.796 172.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -65.79 147.8 52.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.21 -174.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -144.51 139.34 28.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.39 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -93.08 6.66 47.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.416 0.627 . . . . 0.0 109.913 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.6 m170 . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.546 173.935 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.1 tpp . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -145.48 41.96 1.25 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 57' ' ' VAL . 22.2 tp -132.79 153.29 51.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.261 -169.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.633 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.3 mmt180 -88.44 104.52 16.87 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.984 0.421 . . . . 0.0 111.201 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -99.94 113.44 26.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.009 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.8 m-85 -122.93 160.48 49.15 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 20.4 Cg_exo -62.97 158.7 41.94 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.957 1.771 . . . . 0.0 111.343 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.573 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.7 t80 -47.1 -51.3 41.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 37.6 Cg_exo -60.79 -43.39 31.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.793 1.662 . . . . 0.0 112.266 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -68.49 -45.19 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 -177.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -54.71 -43.21 72.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.8 mp -66.97 -39.4 87.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.647 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.0 -44.19 66.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.214 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.468 ' HB3' HG11 ' A' ' 56' ' ' VAL . 14.4 tp -59.06 -51.33 70.51 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.67 96.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -63.15 -41.46 99.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.474 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.1 -15.47 50.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.918 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -113.51 -0.55 14.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.09 37.84 95.6 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.158 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.764 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 2.1 mmp_? -107.15 -179.68 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.277 0.231 . . . . 0.0 110.47 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.655 ' HG3' HG22 ' A' ' 86' ' ' VAL . 41.2 ttm -102.12 156.08 17.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.424 HG11 HD12 ' A' ' 12' ' ' LEU . 84.8 t -105.79 122.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.798 0.333 . . . . 0.0 110.702 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.8 ttt -100.38 103.58 14.97 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 48.9 t -86.97 105.64 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.533 ' HE1' ' CE1' ' A' ' 82' ' ' PHE . 84.2 t80 -104.9 108.82 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.96 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 69.4 m-85 -81.02 111.25 17.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.579 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.513 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 9.1 p-80 -119.76 156.41 30.64 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.949 0.781 . . . . 0.0 109.713 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.617 ' HA ' ' OD1' ' A' ' 63' ' ' ASP . 40.8 t -144.11 160.04 41.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' HG3' ' OD2' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -89.16 -6.28 57.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.81 0.814 . . . . 0.0 108.927 169.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -103.24 10.68 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.485 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 20.2 p -69.12 154.63 94.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.7 -90.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.004 1.802 . . . . 0.0 113.482 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -79.59 -17.24 54.33 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.933 0.396 . . . . 0.0 111.434 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 8.1 t -56.42 -25.76 51.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.365 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -50.81 -41.63 57.49 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 111.108 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.3 -39.35 25.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 110.447 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.511 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 81.6 mtp -68.58 -48.46 64.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.62 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -63.33 -48.07 79.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.985 0.422 . . . . 0.0 111.053 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 43' ' ' SER . 10.6 m -72.68 -54.31 9.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.863 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -92.3 -68.34 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.996 0.427 . . . . 0.0 112.107 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 37' ' ' MET . 95.8 t -51.66 -52.23 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -81.68 -16.33 51.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.4 m -93.59 -0.93 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.73 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -52.57 134.13 44.77 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.931 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.93 -39.57 85.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.024 2.483 . . . . 0.0 113.228 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.23 -41.1 54.28 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.67 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.785 HG22 HD21 ' A' ' 108' ' ' LEU . 29.0 t -63.56 -46.82 93.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -53.92 -44.24 70.42 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.92 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -62.67 -26.12 68.48 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -70.31 -45.12 66.87 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.659 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 47' ' ' VAL . 1.6 mm? -71.78 -43.73 65.21 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.739 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.13 -32.1 9.41 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.521 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -79.31 -48.7 13.64 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.764 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -136.11 19.06 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 51' ' ' LEU . 77.8 m-85 -129.28 145.29 51.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 0.0 111.43 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 14' ' ' LEU . 47.3 t -116.3 120.5 65.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 3' ' ' LEU . 35.5 t -91.89 123.36 43.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.15 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -92.31 117.44 29.9 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.235 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 p -80.81 101.6 9.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.435 HG21 HG13 ' A' ' 24' ' ' VAL . 58.7 t -110.05 119.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.165 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.563 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 0.9 OUTLIER -103.1 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -66.39 -15.4 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.724 0.773 . . . . 0.0 110.166 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.617 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 1.6 m-20 -71.58 -32.69 68.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.666 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.635 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -108.71 167.02 9.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.087 -173.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.635 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.7 Cg_endo -51.03 -48.33 21.55 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 124.174 3.249 . . . . 0.0 114.493 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.39 -35.57 80.86 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.912 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.3 -40.05 29.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.352 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -58.26 -35.57 71.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.437 0.637 . . . . 0.0 110.542 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.66 -51.18 61.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.439 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 9.3 mp -64.04 -33.71 76.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.956 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -63.42 -38.94 93.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.274 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.642 ' HA ' HH21 ' A' ' 75' ' ' ARG . 25.1 ptt180 -79.06 -34.81 43.39 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.23 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -68.97 -56.06 8.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.6 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.502 ' HE1' ' HG ' ' A' ' 70' ' ' LEU . 92.0 m-85 -85.89 -6.66 59.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.981 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.695 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 1.5 mmp_? 63.08 79.1 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.847 0.832 . . . . 0.0 110.127 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 71' ' ' ALA . 94.5 t -125.98 135.71 27.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.996 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 23.0 Cg_exo -65.56 -90.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.752 2.301 . . . . 0.0 112.067 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -143.14 -75.31 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.895 172.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -156.54 148.25 17.15 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.672 -0.311 . . . . 0.0 111.37 -170.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.674 ' HA ' HG22 ' A' ' 79' ' ' THR . 5.1 Cg_endo -88.83 137.75 14.49 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.432 -1.07 . . . . 0.0 111.477 -3.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.96 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 6.3 m -122.71 123.93 42.23 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.924 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.696 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.7 m-85 -114.16 114.31 25.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.869 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -123.48 112.78 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.929 0.395 . . . . 0.0 110.316 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.81 120.43 39.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 94' ' ' GLU . 35.4 mt -117.16 129.33 55.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.462 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.655 HG22 ' HG3' ' A' ' 21' ' ' MET . 21.6 t -108.61 122.87 38.92 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.203 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.3 118.07 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.188 1.925 . . . . 0.0 110.888 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -154.44 140.76 18.64 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.579 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.48 -76.13 0.06 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.084 0.865 . . . . 0.0 111.291 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.6 26.06 0.12 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.64 176.58 12.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 0.0 110.481 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -106.28 130.43 54.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.216 0.532 . . . . 0.0 110.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 37.2 tt0 -101.47 112.29 24.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.853 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.655 ' OE1' ' HD2' ' A' ' 97' ' ' ARG . 33.2 tt0 -75.29 95.8 3.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.28 -14.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.532 -168.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -156.04 123.67 1.36 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.547 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.655 ' HD2' ' OE1' ' A' ' 94' ' ' GLU . 27.3 mtp180 -130.42 126.14 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.831 HD11 ' HG2' ' A' ' 110' ' ' GLU . 42.9 mt -136.03 135.57 39.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.785 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.01 143.2 40.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.19 -86.0 0.28 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.949 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.7 p 179.95 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.319 0.248 . . . . 0.0 111.056 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.711 ' HB3' ' HB3' ' A' ' 106' ' ' GLU . 54.0 mtm180 66.65 119.13 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 123.726 0.811 . . . . 0.0 110.495 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.69 171.05 3.84 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.198 2.599 . . . . 0.0 112.932 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.486 ' HB2' HG13 ' A' ' 41' ' ' VAL . 54.8 ttp180 -46.66 -41.41 14.8 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.828 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.76 86.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.016 0.436 . . . . 0.0 111.808 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 12.1 tp10 -80.77 -37.48 30.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.64 -37.28 87.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.103 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.785 HD21 HG22 ' A' ' 47' ' ' VAL . 42.6 mt -63.6 -44.78 92.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.286 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HZ3' ' HA ' ' A' ' 106' ' ' GLU . 33.9 mtmm -61.17 -44.2 97.67 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.715 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.831 ' HG2' HD11 ' A' ' 98' ' ' LEU . 13.5 tp10 -59.05 -50.56 73.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.418 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -59.44 -34.59 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.614 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 112' ' ' ARG . 9.3 mmm180 -60.54 -43.25 97.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.463 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -72.52 -38.74 67.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 110' ' ' GLU . 91.1 t -56.48 -38.77 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.805 0.335 . . . . 0.0 110.665 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.0 m -56.68 -35.01 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.3 t -84.66 -50.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -55.81 -40.76 73.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.932 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.52 ' CA ' HG21 ' A' ' 86' ' ' VAL . . . -66.54 -24.3 72.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.751 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -95.61 -56.88 1.22 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.101 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.29 114.76 18.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.893 0.378 . . . . 0.0 110.738 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.5 t -143.88 -55.72 0.37 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.447 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -119.51 49.47 0.87 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.224 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -90.13 -37.76 13.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.167 0.508 . . . . 0.0 110.311 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.42 25.81 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.597 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -46.96 -36.74 8.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.443 0.297 . . . . 0.0 111.747 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -163.34 66.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.721 0.772 . . . . 0.0 110.214 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -159.45 102.31 1.55 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.121 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -80.68 85.18 6.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.875 0.369 . . . . 0.0 110.539 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 130' ' ' HIS . 5.4 p80 -74.17 100.97 3.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.671 174.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.415 ' HB3' ' O ' ' A' ' 129' ' ' HIS . 41.8 t-80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 117.825 -1.083 . . . . 0.0 109.607 -172.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.399 0.142 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -66.32 -42.48 88.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.111 0.481 . . . . 0.0 110.509 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.74 HD21 HG21 ' A' ' 57' ' ' VAL . 53.8 tp -64.59 150.83 46.18 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.88 177.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -82.28 104.88 12.91 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.273 0.559 . . . . 0.0 112.196 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.512 ' HZ2' ' HG ' ' A' ' 42' ' ' LEU . 43.0 m95 -107.9 131.37 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.669 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 89.8 m-85 -132.84 155.03 81.61 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 25.2 Cg_exo -58.09 160.85 14.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.003 1.802 . . . . 0.0 111.245 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.566 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 88.4 t80 -45.61 -53.95 17.47 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 19.7 Cg_exo -66.24 -42.19 11.02 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.668 1.579 . . . . 0.0 112.205 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 38.8 tt0 -69.4 -42.73 74.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.065 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.24 94.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.204 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 8' ' ' TYR . 9.1 mp -63.01 -35.82 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.77 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.6 69.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 110.203 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.547 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -60.12 -50.51 73.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.396 176.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -43.8 93.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.199 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -57.63 -52.15 66.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.493 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.96 59.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.756 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -115.91 2.9 13.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.499 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.3 44.58 96.42 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.626 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -108.7 -179.42 3.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.694 0.283 . . . . 0.0 110.919 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.478 ' SD ' ' HA3' ' A' ' 118' ' ' GLY . 87.3 mtp -100.92 158.48 15.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.2 125.84 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.008 0.432 . . . . 0.0 111.106 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.0 ttt -103.6 102.65 12.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 61.3 t -89.93 106.26 16.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.095 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.803 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 45.1 t80 -104.95 123.18 47.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.306 0.574 . . . . 0.0 111.36 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.914 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 67.1 m-85 -94.18 126.18 39.26 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.217 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.803 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 34.5 p80 -130.96 157.44 42.96 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.971 0.794 . . . . 0.0 110.679 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.557 ' H ' HG21 ' A' ' 79' ' ' THR . 30.3 t -143.01 159.12 42.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.565 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -6.6 58.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.42 0.629 . . . . 0.0 110.121 173.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -103.38 19.68 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.375 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.712 ' HB3' ' CG2' ' A' ' 79' ' ' THR . 26.9 p -74.68 131.32 79.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.567 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.11 -92.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.466 2.111 . . . . 0.0 114.031 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -74.43 -17.14 60.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.071 0.463 . . . . 0.0 111.433 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.4 t -58.49 -23.46 57.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.038 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -49.29 -47.81 46.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.218 0.532 . . . . 0.0 111.714 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -75.26 -31.7 60.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 101' ' ' SER . 83.5 mtp -67.11 -49.8 63.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.47 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 58.5 m-20 -64.55 -37.07 86.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.315 -174.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 m -64.77 -61.29 2.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.375 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.32 -70.6 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 104' ' ' ARG . 60.3 t -57.9 -44.64 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -170.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 15.1 tp -81.57 -11.1 59.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 -173.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -112.62 3.34 16.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.066 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' CG ' HH11 ' A' ' 104' ' ' ARG . 26.5 t70 -53.83 131.81 57.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.561 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -58.29 -28.57 84.98 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.933 2.422 . . . . 0.0 112.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.48 14.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.601 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG22 HD21 ' A' ' 108' ' ' LEU . 84.4 t -58.23 -53.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.161 0.505 . . . . 0.0 110.102 174.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.525 ' HA ' HD13 ' A' ' 3' ' ' LEU . 32.5 m -54.36 -38.29 65.92 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.234 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -60.86 -32.08 71.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.788 0.328 . . . . 0.0 111.387 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.763 HD12 HD22 ' A' ' 108' ' ' LEU . 69.0 mt -71.83 -42.1 67.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.741 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.419 ' HB2' HD11 ' A' ' 3' ' ' LEU . 2.4 mm? -70.74 -53.19 16.47 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.195 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' OE2' HD12 ' A' ' 3' ' ' LEU . 32.9 mm-40 -45.33 -38.19 5.53 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.644 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -64.68 -51.51 62.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.644 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.58 14.61 3.43 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -173.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.409 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 74.4 m-85 -125.29 150.86 46.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.498 . . . . 0.0 111.251 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 14' ' ' LEU . 61.0 t -119.02 122.06 68.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.74 HG21 HD21 ' A' ' 3' ' ' LEU . 33.1 t -89.11 124.31 41.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.994 -173.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.96 117.58 31.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.482 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -83.99 101.64 11.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.62 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.71 114.46 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 110.196 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.603 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -89.17 107.62 19.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.308 -178.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.501 HG11 ' HA2' ' A' ' 78' ' ' GLY . 44.3 t -80.7 -7.79 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 122.697 1.237 . . . . 0.0 107.694 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -33.78 76.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.826 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -124.64 167.14 16.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.204 -174.028 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -50.62 -50.77 12.69 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.312 3.341 . . . . 0.0 114.76 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -44.1 84.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.0 111.462 -174.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.61 -27.44 59.08 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.806 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -63.89 -37.69 88.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.7 -51.36 70.26 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.289 0.566 . . . . 0.0 109.874 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 4.0 mm? -56.91 -43.64 81.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.019 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.78 -54.68 44.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 72' ' ' ARG . 21.5 ptt85 -68.73 -23.36 64.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.102 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -72.64 -36.54 68.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.715 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -106.2 8.51 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.376 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 62.07 36.98 15.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.913 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.0 t -93.48 133.67 27.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.504 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.439 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 29.3 Cg_exo -61.56 -83.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.61 2.207 . . . . 0.0 111.552 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' HA2' HG11 ' A' ' 62' ' ' VAL . . . -145.5 -52.76 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.807 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.712 ' CG2' ' HB3' ' A' ' 31' ' ' CYS . 3.6 t 175.57 158.09 0.39 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.682 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 2.4 Cg_endo -79.75 126.61 13.21 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.29 0.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.914 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 29.3 m -129.77 119.67 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.115 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.16 110.72 20.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 60.8 t -113.99 114.21 46.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.862 0.363 . . . . 0.0 110.056 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.6 117.55 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.857 0.361 . . . . 0.0 110.754 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 26.5 mt -110.73 136.56 49.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.21 0.529 . . . . 0.0 111.303 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.0 t -109.94 120.07 45.73 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.49 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 52.2 Cg_endo -74.95 117.49 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.72 1.614 . . . . 0.0 110.938 173.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.409 ' HE3' ' CB ' ' A' ' 93' ' ' GLU . 20.7 pttp -141.58 132.63 26.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.517 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.01 -76.8 0.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.008 0.818 . . . . 0.0 111.262 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.58 24.77 0.19 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -146.25 152.5 39.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.7 0.286 . . . . 0.0 110.695 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.49 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 32.8 m95 -92.95 120.77 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 7.6 tp10 -102.21 139.88 37.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.888 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.66 104.78 17.33 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.608 HG22 ' HD3' ' A' ' 117' ' ' LYS . 4.3 p -97.19 6.39 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 -172.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.85 134.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.488 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -122.84 135.88 54.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 110.441 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.48 136.77 52.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.737 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -137.13 136.67 38.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.856 0.36 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.14 -174.71 18.53 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.86 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.448 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.5 m -92.43 127.13 37.81 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.976 0.417 . . . . 0.0 110.566 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 102' ' ' ARG . 8.6 mmm180 -127.87 137.61 31.15 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.88 157.18 58.01 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.911 1.741 . . . . 0.0 110.016 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB2' HG13 ' A' ' 41' ' ' VAL . 46.4 ttp180 -58.0 -26.82 62.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.89 -50.78 67.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.582 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -69.02 -42.67 76.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.979 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.18 -50.39 74.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.763 HD22 HD12 ' A' ' 50' ' ' LEU . 56.8 mt -72.23 -19.16 61.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.512 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -73.16 -49.9 25.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.409 0.623 . . . . 0.0 109.946 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 114' ' ' VAL . 50.4 mt-10 -72.76 -35.33 67.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.213 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.54 -32.73 74.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.089 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -59.68 -47.29 86.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.343 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -56.31 -45.16 80.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.532 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 95.6 t -62.4 -45.58 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.922 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.444 ' HB2' HH21 ' A' ' 54' ' ' ARG . 21.0 p -67.12 -22.25 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 111.044 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 112' ' ' ARG . 80.3 t -79.23 -37.7 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 109.918 174.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.608 ' HD3' HG22 ' A' ' 95' ' ' VAL . 83.5 mttt -61.57 -27.49 68.67 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.635 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.478 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -65.0 -32.9 85.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.337 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.6 -41.21 4.51 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.078 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.27 37.36 1.26 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.911 0.386 . . . . 0.0 110.821 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.8 t -69.86 -24.24 63.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.52 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -167.28 119.37 0.84 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.099 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -123.81 -167.85 1.69 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 126.36 -16.56 6.67 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -92.87 7.06 45.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.402 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -113.04 96.04 5.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.062 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.23 132.26 18.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.801 0.334 . . . . 0.0 111.576 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -130.89 -41.91 1.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -108.19 147.47 31.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.937 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.347 -0.835 . . . . 0.0 108.75 171.186 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 tpt . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.295 0.569 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.5 m -155.22 62.69 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.445 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.2 tp -54.49 135.15 46.09 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.977 -174.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.613 ' HA ' ' NE ' ' A' ' 4' ' ' ARG . 3.1 mmp_? -109.05 123.1 48.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.246 -171.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -115.56 115.98 27.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.588 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 86.2 m-85 -133.69 160.88 66.86 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.497 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 31.7 Cg_exo -58.55 166.47 6.26 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.406 2.071 . . . . 0.0 111.483 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.615 ' CD1' HD21 ' A' ' 70' ' ' LEU . 61.8 t80 -51.58 -51.43 69.76 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.5 Cg_exo -62.12 -45.69 15.11 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.866 1.71 . . . . 0.0 112.233 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 80.2 tt0 -67.09 -40.2 86.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.929 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.81 94.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.225 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 22' ' ' VAL . 2.8 mt -63.25 -35.75 81.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.832 0.348 . . . . 0.0 110.332 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.73 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.229 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.2 tp -64.31 -44.6 91.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.628 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.75 -42.28 95.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.697 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.25 -44.74 90.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.54 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.76 -14.67 56.14 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -119.14 1.78 11.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.93 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.59 44.32 97.72 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.242 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.628 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 12.5 mmm180 -107.96 -178.04 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 111.342 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -101.22 165.06 11.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.546 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 84.1 t -122.53 133.6 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.737 0.303 . . . . 0.0 111.189 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 23' ' ' MET . 20.1 ptm -126.79 113.58 16.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.182 0.515 . . . . 0.0 109.645 170.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.548 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 46.5 t -87.22 109.62 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 88.6 t80 -97.49 103.6 15.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.378 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.964 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 77.0 m-85 -82.27 119.33 23.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.604 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.496 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 48.5 p-80 -133.02 146.24 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.21 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 47.4 t -134.14 164.84 26.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 -17.87 30.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.114 0.483 . . . . 0.0 110.22 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.505 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 76.9 m-70 -89.56 -16.76 29.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.768 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.873 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 63.9 m -108.84 84.9 2.78 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.332 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.566 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.7 Cg_endo -92.08 -0.84 4.22 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.002 2.468 . . . . 0.0 114.896 -169.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -74.58 -21.7 59.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.837 -0.539 . . . . 0.0 111.409 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 17.5 p -72.52 -30.83 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 13.6 pt20 -67.9 -27.14 66.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.651 0.262 . . . . 0.0 110.97 -176.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.69 -50.49 66.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.646 ' HG3' ' HB3' ' A' ' 101' ' ' SER . 11.3 tmm? -67.95 -42.41 80.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.842 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -54.67 -47.2 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.504 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 m -61.59 -51.76 67.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.98 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.01 -70.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.258 0.551 . . . . 0.0 112.055 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.623 ' HB ' ' SD ' ' A' ' 37' ' ' MET . 96.9 t -63.37 -41.35 92.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.533 -168.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.3 tp -80.86 -30.61 35.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.2 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 m -87.6 -1.56 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.68 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.01 131.16 8.98 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.049 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.52 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 54.4 Cg_exo -52.99 -38.02 79.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.047 2.498 . . . . 0.0 113.305 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.7 -43.59 35.2 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.069 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.94 -51.09 73.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.436 0.636 . . . . 0.0 109.923 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.2 m -53.8 -39.21 65.27 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.128 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 17.7 mtp180 -60.61 -29.2 69.08 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.78 -39.11 67.0 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.599 174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.44 -43.62 72.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.584 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.23 -34.53 64.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.85 0.46 . . . . 0.0 111.327 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -54.22 47.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.205 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -11.39 2.07 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -90.48 151.63 21.29 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 14' ' ' LEU . 90.9 t -115.41 122.73 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 163.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG22 ' SD ' ' A' ' 23' ' ' MET . 16.1 t -87.45 125.29 41.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.035 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -96.91 117.1 30.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.862 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.8 p -91.42 100.53 13.29 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.469 HG21 HG13 ' A' ' 24' ' ' VAL . 96.4 t -109.04 119.25 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.13 0.49 . . . . 0.0 110.985 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.629 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -96.53 119.56 35.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.467 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.623 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 16.4 t -81.24 66.31 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.876 0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.629 ' OD1' ' HB2' ' A' ' 61' ' ' SER . 3.1 p-10 -163.21 -33.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -94.9 164.02 20.6 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.454 175.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.6 Cg_endo -51.5 -55.03 4.37 Favored 'Trans proline' 0 N--CA 1.477 0.54 0 C-N-CA 123.497 2.798 . . . . 0.0 113.996 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 70' ' ' LEU . 10.7 pt-20 -57.68 -41.48 81.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.177 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.05 -34.23 64.96 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.642 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -68.79 -42.79 76.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.334 -0.433 . . . . 0.0 111.474 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' A' ' 72' ' ' ARG . 12.0 pt-20 -73.74 -33.82 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.883 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.615 HD21 ' CD1' ' A' ' 8' ' ' TYR . 5.5 mp -62.92 -36.06 82.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.435 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -65.14 -31.96 73.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.486 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.43 HH21 ' HB2' ' A' ' 69' ' ' GLU . 56.0 mtm180 -68.89 -41.82 77.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.481 0.658 . . . . 0.0 109.997 173.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -71.32 -57.38 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.609 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 96.9 m-85 -82.9 -18.44 40.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.022 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 74' ' ' TYR . 10.5 ptp180 44.85 73.19 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.357 1.035 . . . . 0.0 112.114 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.49 HG11 ' CG2' ' A' ' 81' ' ' THR . 35.0 t -135.92 100.65 10.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.636 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.6 130.11 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.991 2.461 . . . . 0.0 111.995 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 151.01 -77.41 0.23 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.44 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.873 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.2 m 71.62 138.94 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.919 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.718 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 51.5 Cg_endo -71.72 143.88 78.16 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 123.666 -1.389 . . . . 0.0 113.191 0.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.964 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 27.6 m -120.49 122.29 40.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.894 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 4.3 m-85 -114.35 110.95 20.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 74' ' ' TYR . 66.0 t -115.38 111.32 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.543 ' HB2' HG13 ' A' ' 95' ' ' VAL . 51.5 m-85 -93.1 135.83 33.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 37.2 mt -125.26 132.71 52.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.866 0.365 . . . . 0.0 110.184 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.574 HG11 ' HA2' ' A' ' 118' ' ' GLY . 16.0 t -109.01 121.41 43.0 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.736 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.4 116.76 4.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.331 1.354 . . . . 0.0 110.124 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.402 ' HE2' ' SG ' ' A' ' 121' ' ' CYS . 1.9 ptpp? -137.19 126.73 25.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.642 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.72 -71.55 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.156 0.91 . . . . 0.0 111.024 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.13 23.81 0.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.027 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.96 157.1 44.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.673 0.273 . . . . 0.0 110.903 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -93.07 124.31 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.698 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -109.05 118.53 37.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.342 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 35.6 tt0 -69.78 98.93 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.634 0.731 . . . . 0.0 109.413 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 84' ' ' PHE . 1.8 p -80.05 -28.21 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.036 -170.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.18 152.02 10.76 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.388 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -120.05 127.33 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 85.9 mt -111.53 137.06 49.86 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.417 ' CE1' ' HA3' ' A' ' 78' ' ' GLY . 91.0 t80 -137.87 143.09 40.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.84 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.75 23.92 59.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.745 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.646 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 43.1 m 68.15 174.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.429 ' O ' HG11 ' A' ' 41' ' ' VAL . 4.9 mmt180 -148.61 148.73 29.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 172.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.58 149.77 88.31 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 N-CA-C 108.626 -1.336 . . . . 0.0 108.626 164.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.648 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 10.9 ptt180 -59.8 -29.53 68.29 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.576 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.73 88.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.611 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.681 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 2.0 mt-10 -80.92 -35.44 32.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.342 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.38 -37.18 86.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 91.2 mt -62.77 -43.2 99.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.044 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.618 ' HD3' ' HA ' ' A' ' 106' ' ' GLU . 8.2 mtpm? -52.59 -56.57 14.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 175.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 3.7 mm-40 -61.23 -40.78 95.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.55 -20.9 66.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.345 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.4 mmt180 -78.54 -45.34 22.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.72 -38.4 78.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.383 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.498 HG13 HG11 ' A' ' 95' ' ' VAL . 78.7 t -74.66 -38.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 112' ' ' ARG . 24.6 p -65.53 -31.77 73.0 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.506 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.2 t -71.26 -43.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.165 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 121' ' ' CYS . 30.6 mtpt -68.92 -11.5 60.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 111.841 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.574 ' HA2' HG11 ' A' ' 86' ' ' VAL . . . -71.73 -33.48 63.29 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.405 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.15 -48.18 0.07 OUTLIER Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.147 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.45 26.74 1.39 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.052 0.453 . . . . 0.0 111.326 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 117' ' ' LYS . 9.5 p -69.98 111.58 5.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.406 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.41 -76.74 1.64 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.012 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 68.87 -62.87 0.38 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.426 0.691 . . . . 0.0 110.825 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.65 -26.75 2.24 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 130' ' ' HIS . 5.3 m-70 -127.5 38.43 4.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.985 0.421 . . . . 0.0 111.293 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.5 m170 -110.3 83.64 1.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.426 ' C ' ' H ' ' A' ' 129' ' ' HIS . 40.5 t-80 -152.82 79.65 1.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.513 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.1 t60 72.28 -30.25 0.21 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.796 0.839 . . . . 0.0 111.405 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 127' ' ' HIS . 23.2 p80 -145.95 174.55 11.16 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' A' ' 125' ' ' HIS . 22.2 t-80 . . . . . 0 C--O 1.246 0.904 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ttt . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 t 68.73 117.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.157 0.91 . . . . 0.0 108.59 -170.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 22.3 tp -55.34 120.85 7.72 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.4 0.619 . . . . 0.0 111.009 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.4 mmt180 -97.99 108.64 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.067 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -106.09 104.19 13.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.38 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 92.4 m-85 -116.23 168.9 7.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 12.4 Cg_exo -67.74 158.48 57.04 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.604 1.536 . . . . 0.0 110.094 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.542 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.7 t80 -47.11 -50.3 47.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 51.5 Cg_exo -56.57 -50.26 12.36 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.159 1.906 . . . . 0.0 112.981 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.04 -42.34 89.7 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.17 71.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 22' ' ' VAL . 6.3 mt -70.81 -36.86 73.16 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.329 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.29 70.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.055 0.455 . . . . 0.0 110.065 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.548 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -59.75 -44.57 93.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.874 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.75 -53.42 33.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.455 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 7.7 tp60 -58.67 -53.14 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.069 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.22 60.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.999 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -116.72 -0.14 12.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.094 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.26 91.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.814 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.667 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 74.6 mmt-85 -112.79 179.59 3.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 111.653 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.2 mtp -101.69 159.06 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.285 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 47.8 t -105.8 119.53 55.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 57' ' ' VAL . 10.2 tpt -99.6 103.3 14.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.235 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 16.4 t -94.88 106.28 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.445 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 90.4 t80 -106.61 104.43 14.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.226 0.536 . . . . 0.0 111.143 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.926 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.5 m-85 -82.38 115.82 21.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.218 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -121.3 158.37 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.748 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 42.8 m -137.69 162.24 34.37 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -64.62 -60.77 2.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -94.42 48.72 1.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.314 0.578 . . . . 0.0 110.844 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 27.3 p -76.19 149.26 81.97 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.135 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 33' ' ' TYR . 39.0 Cg_exo -58.93 -98.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.076 2.518 . . . . 0.0 114.053 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.433 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 90.2 t80 -87.72 -17.83 30.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 0.0 111.565 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 1.6 t -51.4 -38.97 56.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.665 -174.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 2.1 pp0? -56.85 -31.47 64.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.18 -48.16 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 110.084 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.53 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 15.1 ptm -68.96 -33.47 73.76 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.2 -27.73 65.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.208 0.527 . . . . 0.0 110.206 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.8 m -92.13 -61.58 1.59 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.378 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.45 -70.58 0.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.71 -47.03 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.223 -0.898 . . . . 0.0 113.305 -168.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 tp -81.89 -19.03 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.773 0.321 . . . . 0.0 110.984 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.2 m -92.92 -6.44 48.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.459 ' HB3' HG23 ' A' ' 47' ' ' VAL . 11.4 t70 -46.55 136.23 7.46 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.743 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 53.1 Cg_exo -56.86 -35.28 98.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.375 2.717 . . . . 0.0 113.698 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.589 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . -79.41 -24.35 61.09 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 44' ' ' ASP . 19.9 t -79.48 -43.56 23.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 109.003 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -62.77 -33.55 75.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.319 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 15.2 ptm180 -67.95 -24.49 65.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.798 0.333 . . . . 0.0 111.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -71.84 -46.43 58.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -62.45 -44.82 95.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.911 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -50.23 -31.34 13.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.548 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -82.91 -54.49 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -171.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.667 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.56 12.04 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -170.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 84.4 m-85 -118.84 138.41 52.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.529 0.68 . . . . 0.0 112.026 -176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 14' ' ' LEU . 51.0 t -109.33 116.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.46 HG13 ' HG3' ' A' ' 23' ' ' MET . 15.5 t -89.21 127.36 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.215 0.531 . . . . 0.0 110.978 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.09 117.8 34.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.029 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.1 p -81.44 101.26 9.76 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.61 120.46 56.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.723 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.625 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 m -101.78 108.9 20.54 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.0 t -68.19 -13.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.645 0.736 . . . . 0.0 110.439 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 28' ' ' SER . 2.8 m-20 -79.72 -28.86 40.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.055 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.644 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -105.43 165.38 13.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.654 -175.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.6 Cg_endo -49.07 -52.35 8.9 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.035 3.157 . . . . 0.0 114.495 -171.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -59.49 -39.3 83.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -179.238 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.22 -35.74 47.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.839 175.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.39 -35.65 79.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.67 0.747 . . . . 0.0 110.089 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.59 -46.66 71.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.412 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.431 ' O ' ' HD1' ' A' ' 74' ' ' TYR . 45.1 mt -66.29 -31.44 72.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.33 -33.79 76.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.283 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -85.17 -28.45 25.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.632 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.49 -50.36 52.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' CD1' ' HZ ' ' A' ' 26' ' ' PHE . 89.3 m-85 -85.23 -20.91 29.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.312 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 58.4 62.26 2.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.834 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.4 t -137.37 101.47 9.09 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.791 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -96.58 128.2 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 111.292 168.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 107.85 1.65 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.72 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -92.64 147.83 34.98 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.203 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.69 ' HA ' HG22 ' A' ' 79' ' ' THR . 10.3 Cg_endo -88.26 154.45 37.99 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.595 -1.002 . . . . 0.0 112.345 -0.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.926 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 23.9 m -120.01 115.02 22.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.319 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 11.8 m-85 -106.48 112.35 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.606 HG22 ' HG2' ' A' ' 97' ' ' ARG . 46.5 t -118.13 129.6 74.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.463 ' CG ' HG11 ' A' ' 114' ' ' VAL . 68.1 m-85 -110.79 122.97 49.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.809 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.694 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 28.5 mt -112.86 131.36 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.472 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.552 HG21 ' HA2' ' A' ' 118' ' ' GLY . 15.8 t -114.13 113.54 46.4 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.726 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.29 116.83 4.22 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.378 1.385 . . . . 0.0 110.326 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -158.85 150.43 20.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.66 -65.49 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.038 0.836 . . . . 0.0 110.884 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.15 23.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.545 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.62 171.85 19.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 110.892 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 73.1 m95 -95.73 126.43 40.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.049 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 35.6 tt0 -103.31 112.14 24.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.064 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.429 ' HA ' HD23 ' A' ' 85' ' ' LEU . 39.4 tt0 -78.14 97.29 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 84' ' ' PHE . 15.7 m -81.42 -6.63 9.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.63 171.49 15.24 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.077 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.606 ' HG2' HG22 ' A' ' 83' ' ' VAL . 89.8 mtt180 -133.37 137.99 46.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.815 -0.693 . . . . 0.0 109.752 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.5 mt -108.38 128.28 54.63 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -138.39 144.02 40.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.185 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.29 -2.73 7.75 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.367 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.9 m 71.44 128.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.414 0.626 . . . . 0.0 110.589 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -131.8 129.46 21.97 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD2' ' HG3' ' A' ' 106' ' ' GLU . 27.7 Cg_exo -62.44 166.19 13.79 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.394 2.062 . . . . 0.0 110.502 168.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.44 -44.75 76.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.0 111.39 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.18 85.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 120.966 0.412 . . . . 0.0 111.256 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.551 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 11.6 mm-40 -66.95 -54.64 19.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 111' ' ' LEU . 26.3 t80 -57.92 -42.77 85.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.863 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 47' ' ' VAL . 60.4 mt -58.4 -43.75 88.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.387 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.483 ' HZ2' ' HA ' ' A' ' 106' ' ' GLU . 10.3 mtmp? -63.95 -50.17 69.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 114' ' ' VAL . 3.1 pt-20 -75.31 -33.06 61.13 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 107' ' ' PHE . 4.7 tt -59.57 -43.37 93.63 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 45.1 mtm180 -65.13 -33.05 75.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.519 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.36 -37.74 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 110.499 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 110' ' ' GLU . 78.9 t -63.65 -34.53 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.592 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.9 m -57.25 -37.05 71.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.509 . . . . 0.0 110.209 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.2 -37.95 53.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.323 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 9.1 mtpm? -68.11 -10.8 56.79 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.059 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.552 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -63.75 -41.41 98.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.708 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.45 -55.05 0.91 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -97.87 87.32 3.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.53 -11.02 60.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.472 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.47 120.38 0.55 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.4 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -97.13 -51.35 4.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.003 0.43 . . . . 0.0 110.49 178.219 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.402 ' H ' ' CD ' ' A' ' 123' ' ' GLU . . . -77.17 92.16 1.04 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -80.74 19.6 0.82 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -178.29 -30.9 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.457 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -163.26 142.58 8.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.256 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -158.85 133.72 8.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -148.74 148.51 30.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 . . . . . 0 C--O 1.243 0.748 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.022 176.531 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 tpp . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.905 0.384 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -124.55 21.95 8.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 52' ' ' GLU . 4.3 tp -55.52 132.66 49.1 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.995 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 6' ' ' TYR . 17.1 tpt180 -103.34 116.77 33.06 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.496 -169.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -108.88 127.13 53.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.754 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.56 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 30.1 m-85 -130.52 170.6 10.72 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.127 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 15.1 Cg_exo -69.65 166.65 26.74 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.506 2.137 . . . . 0.0 110.566 171.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.602 ' CD1' HD21 ' A' ' 70' ' ' LEU . 63.0 t80 -44.97 -54.04 14.45 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.8 Cg_exo -59.36 -52.82 4.18 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.881 1.721 . . . . 0.0 113.089 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -66.18 -36.39 82.96 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.795 0.331 . . . . 0.0 110.452 -175.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.42 -43.42 93.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.81 -32.03 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.64 -46.24 32.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.871 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 56' ' ' VAL . 12.0 tp -59.3 -46.37 88.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 110.305 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.428 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -60.64 -44.21 96.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 -14.58 59.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.141 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -117.92 5.44 12.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.548 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.22 37.18 94.11 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.472 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.7 mmp_? -108.19 175.66 5.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.549 ' SD ' HG22 ' A' ' 86' ' ' VAL . 69.5 mtm -102.62 162.67 12.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.97 121.2 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.832 0.348 . . . . 0.0 111.043 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.06 103.28 15.16 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 17.0 t -87.12 101.19 10.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.485 ' HH ' ' HG ' ' A' ' 34' ' ' CYS . 73.8 t80 -92.57 103.0 15.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 84.7 m-85 -81.83 112.23 18.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.254 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.609 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 17.0 p80 -131.29 138.91 49.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.093 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.6 m -94.45 153.12 18.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 164.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 63' ' ' ASP . 1.1 pm0 -85.49 -13.11 50.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -105.52 24.39 12.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.684 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.873 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 14.8 p -73.03 161.62 78.52 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.927 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.25 -105.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.388 2.059 . . . . 0.0 114.415 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -70.37 -17.52 63.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 5.4 t -55.46 -30.89 61.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.015 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -55.03 -31.72 61.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.589 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.76 -50.78 8.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -63.43 -47.2 82.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.632 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.29 -42.48 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.291 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 m -68.98 -55.77 9.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.61 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -91.34 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.173 0.511 . . . . 0.0 112.102 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.02 -39.91 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.883 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -79.66 -28.45 40.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.763 0.315 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.6 m -88.2 -1.47 58.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -45.25 130.63 5.84 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.858 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.629 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 50.3 Cg_exo -55.66 -35.43 92.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.115 2.543 . . . . 0.0 113.259 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' NE ' ' A' ' 49' ' ' ARG . . . -75.6 -39.44 34.83 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.016 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.455 ' HA ' HD21 ' A' ' 108' ' ' LEU . 61.1 t -65.41 -44.57 94.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.36 0.6 . . . . 0.0 109.588 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 14.7 t -49.49 -46.91 48.79 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.297 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 77.5 mtm180 -50.31 -39.08 44.74 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.501 ' HB3' HD12 ' A' ' 111' ' ' LEU . 56.5 mt -73.26 -46.53 49.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.64 -35.7 73.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.105 0.478 . . . . 0.0 110.391 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -48.47 -48.5 37.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.304 1.041 . . . . 0.0 112.405 -177.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -76.27 -43.18 42.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -167.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.809 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.26 17.94 3.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -129.84 139.63 51.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.878 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 14' ' ' LEU . 99.1 t -107.8 116.35 51.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.85 126.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.234 0.54 . . . . 0.0 110.973 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -95.46 117.32 30.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.901 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.3 p -86.41 101.36 13.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.1 t -103.88 113.55 41.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.702 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.515 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 3.0 p -91.22 114.31 26.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.237 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 71' ' ' ALA . 99.4 t -74.16 -19.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.58 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 5.3 m-20 -82.55 -7.22 59.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.588 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.8 p -111.39 156.16 41.66 Favored Pre-proline 0 C--O 1.22 -0.472 0 O-C-N 122.36 -0.212 . . . . 0.0 111.078 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.588 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.2 Cg_endo -50.43 -55.3 4.22 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 124.062 3.175 . . . . 0.0 114.665 -167.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -35.48 76.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.97 -32.56 52.79 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.822 174.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 64' ' ' THR . 54.5 mt-30 -62.2 -42.91 99.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.142 0.577 . . . . 0.0 110.477 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.4 -41.55 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.274 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.602 HD21 ' CD1' ' A' ' 8' ' ' TYR . 3.9 mp -62.05 -34.88 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.234 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.539 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -63.78 -38.25 90.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.49 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -84.74 -27.92 26.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.891 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.88 -51.3 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.423 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.1 0.56 46.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.838 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 53.81 76.85 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.13 0.894 . . . . 0.0 111.161 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG11 ' CB ' ' A' ' 26' ' ' PHE . 61.6 t -128.48 84.01 64.44 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.035 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -102.5 105.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.638 2.892 . . . . 0.0 111.631 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.4 90.88 0.67 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.519 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.873 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 25.7 m -82.55 143.35 47.37 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 83.1 Cg_endo -88.76 151.0 30.17 Favored 'Cis proline' 0 C--N 1.35 0.609 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.734 0.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 91.0 m -128.05 129.16 46.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.907 171.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.739 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.2 m-85 -110.11 114.08 27.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.226 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.405 HG22 ' HD3' ' A' ' 97' ' ' ARG . 91.8 t -117.79 128.73 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.962 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.18 121.71 45.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.757 0.313 . . . . 0.0 110.733 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 94' ' ' GLU . 29.5 mt -110.39 136.16 49.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.549 HG22 ' SD ' ' A' ' 21' ' ' MET . 14.6 t -109.52 133.99 20.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.412 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 4.0 Cg_exo -79.58 118.11 3.81 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.47 2.113 . . . . 0.0 110.63 171.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -133.83 151.47 51.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.59 93.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.278 0.561 . . . . 0.0 111.134 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.54 -47.27 0.74 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.058 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.95 -168.36 0.21 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.855 0.36 . . . . 0.0 110.771 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -97.67 140.35 32.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.858 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.561 ' OE2' ' HB3' ' A' ' 121' ' ' CYS . 24.2 tt0 -124.61 129.38 50.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.449 -175.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 35.5 tt0 -80.33 108.63 14.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG22 ' HZ2' ' A' ' 117' ' ' LYS . 5.5 p -104.34 -13.16 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.986 -169.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.28 140.63 7.6 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.874 -1.155 . . . . 0.0 113.441 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.451 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 18.6 mmt180 -127.36 126.25 42.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 89.7 mt -131.71 135.7 47.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -137.47 142.78 41.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.559 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.93 138.42 9.96 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.895 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -76.44 124.41 27.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -141.33 160.57 56.78 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.94 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.81 161.3 22.1 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.54 2.16 . . . . 0.0 111.88 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.537 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 5.4 ptt180 -59.69 -28.92 67.71 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.976 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.2 91.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.945 0.402 . . . . 0.0 110.501 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.1 -47.04 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.776 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.06 -46.59 88.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.294 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 94.7 mt -57.46 -38.35 74.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.036 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -57.72 -63.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 114' ' ' VAL . 1.6 mp0 -70.12 -34.61 73.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.538 -175.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 50' ' ' LEU . 2.1 tm? -63.12 -38.55 91.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -57.74 -47.76 81.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.633 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 13.1 mm100 -65.26 -36.26 83.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.086 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -61.84 -37.83 79.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.318 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.57 -34.38 74.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.537 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.06 -32.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.969 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 113' ' ' GLN . 7.9 mtpm? -68.05 -8.62 39.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.28 88.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.148 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.46 13.24 54.52 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.364 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 123' ' ' GLU . . . -157.49 -55.99 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.866 0.365 . . . . 0.0 110.135 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.561 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 61.6 m 73.92 -56.41 0.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.861 173.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.46 58.84 0.38 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.517 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -88.32 104.49 16.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.278 0.561 . . . . 0.0 112.242 -172.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.2 60.52 8.7 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.003 171.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -118.68 93.18 4.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.111 0.482 . . . . 0.0 111.344 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -130.05 114.97 16.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.674 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.3 m170 60.79 -92.03 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.917 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 174.44 -173.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.66 0.784 . . . . 0.0 109.041 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -120.15 144.76 47.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.954 0.407 . . . . 0.0 111.097 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.224 168.289 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 p -155.54 -33.54 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.793 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.705 HD21 HD23 ' A' ' 51' ' ' LEU . 56.8 tp -133.6 156.52 47.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.62 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 2.7 mmp_? -80.66 102.76 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.976 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.406 ' HE1' ' HB3' ' A' ' 3' ' ' LEU . 74.4 m95 -107.85 104.56 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.48 . . . . 0.0 110.235 175.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -113.52 145.35 33.16 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 31.3 Cg_exo -59.41 166.93 6.93 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.975 1.783 . . . . 0.0 111.389 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 77.8 t80 -48.71 -50.03 62.62 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.9 Cg_exo -60.76 -55.63 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.702 1.601 . . . . 0.0 111.986 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.1 mp0 -54.14 -44.88 71.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.389 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -59.4 -47.45 85.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 0.0 111.279 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.9 -39.96 94.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.87 62.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.947 0.404 . . . . 0.0 110.484 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.84 -49.59 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.436 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.38 -46.98 68.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.238 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -59.25 -49.01 79.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.017 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -13.96 59.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.863 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -117.0 4.77 12.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.425 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.28 41.97 99.65 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.719 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.2 mmp_? -109.19 -179.93 3.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.764 0.316 . . . . 0.0 110.539 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.3 mtp -102.04 155.62 18.07 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 54.0 t -105.95 124.72 61.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.535 ' SD ' HD21 ' A' ' 51' ' ' LEU . 22.0 ttt -107.67 103.24 12.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 46.0 t -84.26 105.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -99.15 103.39 15.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.443 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.81 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 92.4 m-85 -81.67 115.9 21.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.606 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.467 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 27.8 p80 -120.12 150.42 40.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.543 0.527 . . . . 0.0 110.427 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.426 ' H ' HG21 ' A' ' 79' ' ' THR . 47.0 t -143.41 147.91 35.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' OE1' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -88.04 -26.99 22.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.111 0.481 . . . . 0.0 110.212 175.278 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -72.92 -21.71 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.912 ' HB3' HG22 ' A' ' 79' ' ' THR . 9.4 t -103.93 94.99 7.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.15 23.42 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.691 2.26 . . . . 0.0 113.453 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.417 ' HD2' ' HD3' ' A' ' 80' ' ' PRO . 2.7 t80 -86.65 -29.79 22.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.893 0.378 . . . . 0.0 111.092 -174.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.407 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . 28.5 p -82.81 -32.79 27.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -55.54 -34.65 64.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -168.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.37 -48.2 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.891 0.377 . . . . 0.0 110.759 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.4 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 26.3 ttp -74.51 -44.42 51.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -177.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -57.76 -45.67 85.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.751 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -64.17 -56.93 11.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.648 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.81 -70.13 0.7 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.171 0.51 . . . . 0.0 111.959 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.81 -41.97 76.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.797 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.3 tp -81.11 -27.05 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.25 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 t -92.55 1.11 57.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.356 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -50.82 134.63 27.85 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.074 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.578 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 75.0 Cg_exo -52.3 -40.58 69.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.139 2.559 . . . . 0.0 113.485 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.44 -46.84 18.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.098 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.9 -50.85 78.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.215 0.531 . . . . 0.0 110.392 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 64.0 m -59.84 -38.28 81.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.292 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -63.34 -39.95 95.96 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.71 HD22 HH22 ' A' ' 54' ' ' ARG . 64.7 mt -63.3 -38.05 89.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.953 0.406 . . . . 0.0 110.571 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.705 HD23 HD21 ' A' ' 3' ' ' LEU . 2.0 tp -70.08 -56.37 7.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.412 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HG3' HH21 ' A' ' 49' ' ' ARG . 5.0 mm-40 -46.05 -40.59 10.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.414 0.686 . . . . 0.0 112.621 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -61.73 -49.7 75.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.71 HH22 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.79 9.05 3.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -174.129 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -119.28 138.94 52.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.572 . . . . 0.0 111.042 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.2 t -109.32 116.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.621 HG21 HD21 ' A' ' 3' ' ' LEU . 19.6 t -87.26 119.49 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.554 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.21 117.48 28.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.852 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 p -83.2 100.33 10.51 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.644 HG11 HD23 ' A' ' 70' ' ' LEU . 59.0 t -111.33 124.3 67.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.696 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.462 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -95.41 118.14 31.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.62 -178.339 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.87 10.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 122.74 1.257 . . . . 0.0 108.328 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.474 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -97.37 -24.24 15.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.432 175.364 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.578 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 42.4 p -108.58 152.97 42.4 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.857 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 27.2 Cg_endo -55.86 -51.57 9.37 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.042 3.161 . . . . 0.0 114.778 -168.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.4 -37.05 85.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.634 -177.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -73.49 -37.3 53.45 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.335 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 64' ' ' THR . 93.4 mt-30 -61.91 -32.07 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 110.466 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 72' ' ' ARG . 6.0 tp10 -68.87 -43.45 75.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.802 175.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.644 HD23 HG11 ' A' ' 60' ' ' VAL . 23.5 tp -63.59 -31.18 72.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.807 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.14 81.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.425 HH21 ' CD ' ' A' ' 69' ' ' GLU . 42.0 mtm180 -65.42 -32.46 74.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.117 0.484 . . . . 0.0 110.041 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -66.04 -53.29 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.227 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.82 2.07 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 61.7 56.22 2.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.497 0.665 . . . . 0.0 109.947 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 55.3 t -104.45 136.33 19.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.907 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.0 Cg_exo -73.97 -143.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.233 2.622 . . . . 0.0 111.265 171.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -80.16 -71.57 1.26 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.514 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.912 HG22 ' HB3' ' A' ' 31' ' ' CYS . 14.3 t 176.7 158.42 0.46 Allowed Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.692 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 12.4 Cg_endo -87.84 127.21 8.64 Favored 'Cis proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.21 -1.162 . . . . 0.0 112.385 -1.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.81 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 7.2 m -115.95 119.65 36.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.609 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.1 m-85 -108.14 112.11 24.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.032 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.576 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 80.4 t -113.81 107.36 22.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HE1' HD12 ' A' ' 98' ' ' LEU . 96.3 m-85 -93.98 123.2 37.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.1 mt -114.56 140.51 48.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 111.211 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.31 123.31 37.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.408 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 5.7 Cg_exo -77.7 118.0 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.398 2.066 . . . . 0.0 110.286 171.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 93' ' ' GLU . 24.2 pttm -128.18 112.62 14.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 0.0 111.05 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.75 -80.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.547 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 23.05 1.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.09 155.1 43.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.824 0.345 . . . . 0.0 110.452 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.44 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 91.6 m95 -90.94 163.62 14.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 9.7 tp10 -148.1 140.85 24.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.681 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.465 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 37.2 tt0 -94.13 104.65 16.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.78 -12.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.616 -170.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.94 144.79 5.08 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.366 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 99.2 mtt180 -113.9 128.02 56.22 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 96.0 mt -121.72 141.83 50.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -137.66 143.93 41.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.326 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.21 141.37 11.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.403 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 37' ' ' MET . 3.3 p -70.21 122.45 19.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 23.4 mmt85 -108.03 142.11 24.57 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.92 158.25 25.63 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.022 1.815 . . . . 0.0 110.183 168.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -54.4 -49.05 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.567 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.48 72.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.39 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.535 ' OE1' ' HD2' ' A' ' 102' ' ' ARG . 4.5 tm-20 -76.05 -48.39 21.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 67.0 t80 -66.4 -36.76 83.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 108' ' ' LEU . 40.8 mt -62.64 -35.43 79.59 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.619 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 24.0 ttpp -60.34 -49.17 78.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 114' ' ' VAL . 4.3 mm-40 -64.1 -47.2 80.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.19 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.62 -38.54 90.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -58.08 -41.91 84.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.11 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.403 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 30.3 tt0 -66.1 -56.72 10.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.008 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -58.47 -39.92 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.252 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.457 ' CB ' HH21 ' A' ' 54' ' ' ARG . 22.8 p -63.07 -24.17 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 0.0 111.193 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.6 t -84.84 -33.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.352 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 113' ' ' GLN . 32.7 mmmt -62.94 -21.43 66.06 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.322 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.08 -17.58 77.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.58 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.17 -67.42 0.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.491 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.21 73.87 9.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.4 0.619 . . . . 0.0 109.725 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.7 t -70.5 -18.34 62.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.908 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 124' ' ' GLY . . . 118.26 3.61 14.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.525 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 71.66 -34.51 0.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.37 0.668 . . . . 0.0 112.338 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 122' ' ' GLY . . . 88.61 -4.84 85.1 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.005 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -159.83 27.53 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.666 0.269 . . . . 0.0 110.947 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -72.21 94.17 1.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.831 0.348 . . . . 0.0 110.417 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -136.15 101.46 4.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.973 0.416 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -83.03 91.64 7.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.385 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -105.1 12.26 32.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.161 0.505 . . . . 0.0 110.009 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.834 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 t -76.05 77.25 2.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.452 HD11 ' CB ' ' A' ' 51' ' ' LEU . 30.1 tp -56.35 141.75 40.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.301 -173.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -79.52 102.41 8.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.319 -178.424 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 75.2 m95 -106.73 125.92 51.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.115 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.3 m-85 -130.62 153.38 81.48 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 24.5 Cg_exo -61.6 161.47 24.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.789 1.659 . . . . 0.0 110.667 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.543 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 75.6 t80 -46.92 -51.11 41.66 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.4 Cg_exo -58.7 -52.5 5.22 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 121.694 1.596 . . . . 0.0 112.23 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 37.5 mt-10 -62.23 -38.89 90.93 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.455 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.17 78.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 0.0 111.6 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.437 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.4 mm? -62.88 -40.57 97.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.931 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.28 -37.28 63.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.23 0.538 . . . . 0.0 110.31 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.57 -50.11 74.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.822 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.47 88.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.432 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 24.2 tp60 -62.65 -46.28 88.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.21 -14.49 58.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.918 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -114.6 3.49 14.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.41 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.66 96.09 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.594 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.4 mmp_? -107.46 177.21 4.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.443 ' SD ' HG22 ' A' ' 86' ' ' VAL . 8.0 mmm -100.5 160.33 14.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.5 t -105.6 124.74 60.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 -174.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.588 ' SD ' HG13 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -113.4 103.65 11.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -92.33 109.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.093 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 84.0 t80 -103.86 103.62 13.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.462 0.649 . . . . 0.0 111.028 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.865 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 54.6 m-85 -84.64 116.1 23.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.082 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.702 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 9.2 p-80 -124.54 138.3 54.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 39.2 t -100.46 141.47 33.27 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.026 168.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.65 -25.1 67.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -102.59 16.27 26.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.095 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 79' ' ' THR . 50.6 t -70.81 112.02 11.77 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.06 -67.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.484 2.789 . . . . 0.0 114.905 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -86.69 -19.49 29.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -167.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.574 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 17.1 t -70.9 -22.85 62.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -30.06 59.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -71.29 -44.53 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.221 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.547 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 51.8 ttm -66.73 -49.18 66.83 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.358 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -54.09 -44.7 71.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.233 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.5 m -72.93 -59.77 2.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.659 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.45 -67.72 0.83 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.023 0.44 . . . . 0.0 112.153 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.547 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 98.9 t -55.14 -51.59 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.74 -21.9 37.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.769 0.319 . . . . 0.0 111.481 -170.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.6 m -92.55 -10.58 37.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.087 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -47.28 133.26 9.64 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.625 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.35 -33.77 57.61 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.573 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.56 -52.41 7.38 Favored Glycine 0 CA--C 1.51 -0.247 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.01 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.445 HG22 HD21 ' A' ' 108' ' ' LEU . 62.6 t -58.38 -51.3 73.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.642 0.734 . . . . 0.0 110.184 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -52.74 -44.11 66.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.711 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 49' ' ' ARG . 45.0 ttm180 -59.39 -38.45 80.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.256 0.347 . . . . 0.0 111.598 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.53 HD12 HD23 ' A' ' 111' ' ' LEU . 50.2 mt -64.0 -39.88 95.11 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.623 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.43 -52.9 13.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.094 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 3' ' ' LEU . 6.1 mm-40 -48.84 -43.12 38.28 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.092 0.557 . . . . 0.0 112.32 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.09 -57.02 13.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.615 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.13 22.75 3.26 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -171.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.615 ' CE1' ' HD3' ' A' ' 54' ' ' ARG . 50.5 m-85 -133.23 142.02 48.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.417 0.627 . . . . 0.0 111.58 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' A' ' 14' ' ' LEU . 82.6 t -108.01 118.91 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.664 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.588 HG13 ' SD ' ' A' ' 23' ' ' MET . 17.9 t -92.23 120.63 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 -173.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -89.95 118.17 29.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.3 p -90.07 101.32 14.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 110.039 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.534 HG11 ' HG ' ' A' ' 70' ' ' LEU . 57.3 t -111.06 120.0 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.739 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 9.8 m -88.83 109.12 19.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 8.9 p -86.48 6.9 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.466 0.65 . . . . 0.0 111.262 -170.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.524 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 5.0 m-20 -90.2 -30.65 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.203 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.647 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -92.5 165.58 19.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.154 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.647 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.65 -50.24 14.6 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.565 2.844 . . . . 0.0 114.38 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.477 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -70.85 -30.08 66.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.6 -33.57 47.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.99 172.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.701 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 40.5 mm-40 -63.83 -36.74 84.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -55.05 -52.57 62.78 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.901 170.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.534 ' HG ' HG11 ' A' ' 60' ' ' VAL . 3.1 mm? -53.74 -38.36 64.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.121 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' ' CG2' ' A' ' 62' ' ' VAL . . . -71.32 -34.17 70.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.635 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.701 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -72.14 -40.88 67.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.188 0.518 . . . . 0.0 110.475 174.278 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -63.11 -55.49 24.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.238 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.66 -15.87 40.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.212 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 67.55 37.55 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -134.44 147.75 64.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.724 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.35 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.218 1.946 . . . . 0.0 111.185 165.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.426 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . -159.63 56.94 0.33 Allowed Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.806 ' HA ' ' SG ' ' A' ' 31' ' ' CYS . 11.5 p -130.12 46.14 2.1 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -167.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 34.1 Cg_endo -94.4 172.79 15.78 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 120.731 1.297 . . . . 0.0 111.215 -5.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.865 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 36.1 m -132.83 129.26 38.25 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.613 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CZ ' ' HG2' ' A' ' 80' ' ' PRO . 2.1 m-85 -124.66 114.56 19.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.14 119.17 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.883 0.373 . . . . 0.0 110.152 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -99.65 126.68 45.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.55 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 23.5 mt -117.04 144.87 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 0.0 111.239 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.443 HG22 ' SD ' ' A' ' 21' ' ' MET . 90.2 t -109.15 125.91 30.45 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.372 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 74.2 Cg_endo -79.04 117.93 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.043 1.829 . . . . 0.0 110.839 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.06 109.41 10.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.202 0.525 . . . . 0.0 110.849 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.02 -82.06 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.674 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.56 20.37 1.67 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.01 157.8 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 89.3 m95 -92.56 169.93 10.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.655 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.5 tp10 -145.21 139.1 26.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.21 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.475 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 33.8 tt0 -95.2 103.19 15.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.8 p -99.74 9.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.689 -168.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.94 146.21 4.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.505 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.432 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 77.5 mtt180 -120.94 127.37 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.471 HD22 ' NH1' ' A' ' 102' ' ' ARG . 84.3 mt -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -136.96 143.27 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.605 0.241 . . . . 0.0 110.398 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.66 146.05 19.22 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.477 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 m -83.33 107.46 15.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.604 0.716 . . . . 0.0 110.601 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.591 ' NH1' ' HG3' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -108.68 152.34 42.16 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.04 178.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.87 158.61 13.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.797 2.331 . . . . 0.0 111.974 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.453 ' HB2' HG13 ' A' ' 41' ' ' VAL . 16.1 ttt-85 -60.92 -31.66 71.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.51 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -45.1 94.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.147 0.499 . . . . 0.0 110.054 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.87 -42.92 94.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.902 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.31 -47.38 79.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.776 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 28.9 mt -61.72 -38.57 88.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.555 0.217 . . . . 0.0 110.795 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 20.8 tttm -56.06 -56.03 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.647 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.591 ' HG3' ' NH1' ' A' ' 102' ' ' ARG . 6.8 mm-40 -63.96 -44.96 91.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 50' ' ' LEU . 35.0 tp -55.48 -47.87 75.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.425 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -64.46 -39.58 94.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.516 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 15.9 mm100 -70.49 -23.48 62.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.341 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 110' ' ' GLU . 73.8 t -73.41 -41.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 172.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.1 m -58.77 -37.73 76.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.493 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 112' ' ' ARG . 68.1 t -63.58 -40.0 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.977 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.852 ' HA ' ' HA ' ' A' ' 121' ' ' CYS . 62.7 mttp -64.03 -41.77 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.162 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.29 -14.16 82.84 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.565 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.08 -35.51 4.48 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.874 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.9 -31.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.68 -0.306 . . . . 0.0 111.509 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.852 ' HA ' ' HA ' ' A' ' 117' ' ' LYS . 47.4 t 71.49 -63.1 0.44 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.368 0.667 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 117.42 39.39 0.79 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.597 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -57.25 164.69 1.66 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.477 0.656 . . . . 0.0 112.529 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.56 -43.92 3.23 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.141 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -68.86 -32.67 72.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 111.267 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -84.01 30.46 0.52 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.225 0.536 . . . . 0.0 111.146 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -85.15 -14.34 47.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.123 0.487 . . . . 0.0 109.691 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -126.66 14.57 7.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.259 0.552 . . . . 0.0 110.083 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -160.54 143.79 13.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.616 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 . . . . . 0 C--O 1.248 1.009 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.36 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tmm? . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 t -145.11 83.36 1.68 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.475 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 15.1 tp -56.11 123.5 14.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.898 -173.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -90.55 103.98 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.546 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.407 ' HE3' ' HB3' ' A' ' 59' ' ' SER . 52.5 m95 -99.7 129.89 45.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.428 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 38.2 m-85 -131.49 167.12 23.31 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.083 171.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 15.0 Cg_exo -68.09 163.05 37.45 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.965 1.777 . . . . 0.0 110.974 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.584 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.9 t80 -47.53 -52.97 33.39 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 49.0 Cg_exo -57.62 -49.74 12.56 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.972 1.781 . . . . 0.0 112.935 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.14 -42.61 88.83 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.19 -42.03 72.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.0 111.528 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.47 -37.76 77.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.6 -43.67 63.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.638 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.97 0.415 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.13 -47.76 81.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.687 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.069 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.02 -14.59 55.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -118.43 6.61 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.564 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.4 39.42 97.73 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.76 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.3 mmp_? -110.53 -179.99 3.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.582 ' SD ' HG22 ' A' ' 86' ' ' VAL . 56.0 mtm -110.58 160.22 16.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 93.5 t -106.07 127.93 60.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.66 0.267 . . . . 0.0 111.52 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.2 ttt -105.69 103.15 12.6 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 171.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.553 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 41.1 t -86.79 107.53 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.499 ' HE1' ' HE2' ' A' ' 82' ' ' PHE . 65.4 t80 -98.99 103.65 15.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 88.3 m-85 -82.71 115.07 21.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.177 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.692 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 29.0 p-80 -123.17 138.8 54.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.646 ' H ' HG21 ' A' ' 79' ' ' THR . 24.0 t -117.99 163.64 16.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.954 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -76.69 -2.43 32.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.586 0.708 . . . . 0.0 109.522 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -112.17 14.45 20.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 30.4 p -76.8 129.95 77.54 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.834 0.349 . . . . 0.0 111.457 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.62 -78.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.649 2.232 . . . . 0.0 113.829 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.541 ' CE2' ' HB2' ' A' ' 37' ' ' MET . 89.3 t80 -86.08 -17.45 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.48 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.638 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 12.9 t -47.73 -44.36 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.133 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -57.35 -33.32 67.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.05 -45.97 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.902 0.382 . . . . 0.0 110.508 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.697 ' HG2' ' HB ' ' A' ' 41' ' ' VAL . 10.9 tmm? -65.42 -40.94 93.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.344 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 7.2 t30 -59.41 -41.24 89.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.32 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.3 m -77.17 -56.51 4.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -90.13 -64.65 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.146 0.498 . . . . 0.0 111.803 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.697 ' HB ' ' HG2' ' A' ' 37' ' ' MET . 77.8 t -55.71 -44.23 76.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.405 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.27 -13.96 57.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.861 0.362 . . . . 0.0 111.194 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -100.36 -6.78 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.684 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.19 135.55 8.94 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.746 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 80.8 Cg_exo -49.68 -45.45 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.351 2.701 . . . . 0.0 113.623 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.41 -45.64 67.69 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.111 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.707 HG22 HD21 ' A' ' 108' ' ' LEU . 43.4 t -59.41 -47.78 89.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 121.648 0.737 . . . . 0.0 109.778 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.557 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 23.5 t -52.86 -43.14 65.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.387 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 82.7 mtt180 -62.27 -21.38 65.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.447 HD12 HD22 ' A' ' 108' ' ' LEU . 23.3 mt -80.39 -38.11 30.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.756 174.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.32 -50.53 11.63 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 48' ' ' SER . 7.1 mm-40 -44.38 -47.69 9.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.783 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -67.98 -48.27 66.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -168.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.783 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -134.44 16.45 3.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -125.18 141.01 52.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.393 0.616 . . . . 0.0 111.688 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.2 t -106.6 114.95 47.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.94 121.07 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.806 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -94.58 117.6 30.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.407 ' HB3' ' HE3' ' A' ' 5' ' ' TRP . 22.3 p -85.83 101.61 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.92 109.07 23.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.956 0.407 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.641 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -94.96 107.87 19.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.158 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 28' ' ' SER . 38.3 t -75.04 -8.29 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.292 1.044 . . . . 0.0 108.549 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.041 176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -125.11 163.51 37.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.069 -174.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.8 Cg_endo -50.75 -47.76 23.71 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.323 3.349 . . . . 0.0 114.85 -169.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.416 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -61.99 -36.44 81.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.082 -176.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -82.47 -31.8 29.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.559 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 64' ' ' THR . 96.9 mt-30 -59.22 -38.0 78.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.514 0.673 . . . . 0.0 109.479 171.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 6.0 tp10 -61.51 -50.6 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.97 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 66' ' ' GLU . 3.5 mm? -58.68 -40.25 83.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.686 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.62 -50.25 73.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.49 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.266 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 30.4 ttt85 -65.12 -56.02 15.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.221 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.55 3.29 55.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.565 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 58.47 64.75 1.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.623 0.577 . . . . 0.0 109.714 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.55 92.92 48.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -102.31 129.03 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.712 2.941 . . . . 0.0 112.052 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 140.23 -85.09 0.21 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.834 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.692 ' CG2' ' HA ' ' A' ' 27' ' ' HIS . 85.0 m 75.07 137.21 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 122.49 0.316 . . . . 0.0 111.325 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HA ' HG23 ' A' ' 79' ' ' THR . 70.1 Cg_endo -76.52 137.48 49.33 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.724 -1.365 . . . . 0.0 112.881 0.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.7 m -124.69 129.06 49.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.997 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' HE1' ' CA ' ' A' ' 100' ' ' GLY . 1.4 m-85 -115.27 122.07 44.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.044 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.8 t -121.47 108.31 22.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.881 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HE1' HD12 ' A' ' 98' ' ' LEU . 59.1 m-85 -94.34 120.07 34.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.043 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 94' ' ' GLU . 32.4 mt -109.22 130.66 55.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.663 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.582 HG22 ' SD ' ' A' ' 21' ' ' MET . 22.6 t -108.56 123.91 35.94 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.378 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.5 117.69 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.901 1.734 . . . . 0.0 110.559 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -157.67 143.29 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.739 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.18 -77.39 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.988 0.805 . . . . 0.0 111.43 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.18 24.38 0.13 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.797 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.42 -177.48 6.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.687 0.28 . . . . 0.0 110.453 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.07 132.62 51.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.427 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.11 119.71 40.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.266 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.525 ' HA ' HD23 ' A' ' 85' ' ' LEU . 39.9 tt0 -77.0 95.96 4.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.75 -7.46 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.094 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.74 118.3 0.6 Allowed Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.796 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.479 ' HG3' HG22 ' A' ' 83' ' ' VAL . 16.7 ttm180 -108.92 126.67 53.33 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 86.1 mt -124.41 139.03 54.28 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.032 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -102.58 117.13 34.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 164.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.568 ' CA ' ' HE1' ' A' ' 82' ' ' PHE . . . -90.78 -134.27 5.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.461 -167.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 33' ' ' TYR . 23.0 m 75.67 -12.09 1.03 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.793 0.837 . . . . 0.0 110.578 -173.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 100' ' ' GLY . 62.1 mtp180 -65.25 156.31 81.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.247 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.49 155.55 25.4 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 111.543 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.51 ' HB3' HG13 ' A' ' 41' ' ' VAL . 30.8 ptt180 -67.62 -25.12 65.59 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.083 -174.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.6 74.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.107 0.479 . . . . 0.0 109.956 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 21.7 mm-40 -75.25 -37.88 60.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.388 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.63 -47.95 83.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.638 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.707 HD21 HG22 ' A' ' 47' ' ' VAL . 88.6 mt -68.16 -31.43 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.732 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' HB3' ' A' ' 109' ' ' LYS . 5.0 tmmm? -63.15 -47.9 80.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.951 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 5.4 mm-40 -69.92 -41.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.446 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.1 tt -61.16 -36.32 79.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -63.46 -45.07 92.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.23 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 5.5 pt20 -62.81 -38.43 90.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.437 ' N ' ' HG3' ' A' ' 113' ' ' GLN . 69.9 t -66.78 -42.68 89.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.683 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 52.4 t -57.22 -30.48 64.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.864 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.15 -53.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.873 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -59.15 -28.13 66.29 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.463 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -62.46 -41.42 99.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.505 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.15 -36.42 5.2 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.755 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -130.52 98.12 4.58 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 2.6 p -84.74 -31.92 23.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.31 36.6 0.13 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.681 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.46 -72.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.47 43.35 77.24 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.669 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -144.29 151.15 38.98 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.554 -0.38 . . . . 0.0 110.8 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -159.05 160.4 35.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -59.78 119.19 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -82.3 93.74 7.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.567 -173.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -106.82 -5.82 18.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 164.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.7 t60 . . . . . 0 C--O 1.24 0.588 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.752 176.498 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -106.17 -30.69 9.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.283 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 57' ' ' VAL . 24.6 tp -79.05 149.36 32.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.724 -172.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.678 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 5.4 mmt180 -88.34 104.64 16.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.328 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -106.38 104.63 14.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.678 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 96.8 m-85 -111.12 157.39 38.95 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 19.3 Cg_exo -63.48 162.02 29.14 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.957 1.771 . . . . 0.0 111.172 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.607 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.3 t80 -45.82 -55.73 12.03 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.8 Cg_exo -65.0 -41.52 16.89 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.654 1.569 . . . . 0.0 112.126 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 37.1 tt0 -70.13 -36.92 75.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.847 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.68 86.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.997 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.91 -39.67 92.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.653 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.08 70.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.778 0.323 . . . . 0.0 110.651 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.557 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -59.67 -50.08 75.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -65.52 -45.57 83.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.978 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -58.85 -46.63 87.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.729 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -14.32 58.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.933 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -115.29 0.37 13.46 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.686 -175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.72 41.36 97.7 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.355 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.873 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 76.6 mmt-85 -112.87 178.44 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 0.0 111.946 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.7 mtp -101.46 154.36 18.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.345 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 48.5 t -106.19 135.05 45.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.801 0.334 . . . . 0.0 110.786 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.1 ttt -118.17 103.21 9.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 38.9 t -89.58 111.18 22.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.4 t80 -102.92 109.15 20.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.435 0.636 . . . . 0.0 111.006 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 1.023 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.8 m-85 -85.49 118.87 25.28 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.563 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.554 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 29.3 p80 -133.89 163.93 28.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.943 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 22.6 m -143.36 149.68 38.08 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.555 174.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -39.53 86.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -84.26 4.61 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.397 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 9.0 t -134.83 65.73 66.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.83 31.98 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.004 2.469 . . . . 0.0 114.476 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -83.35 -58.11 2.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.865 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.821 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 46.6 t -74.6 -22.34 59.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -67.04 -19.75 65.74 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.296 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -69.7 -47.87 61.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 28.1 mtm -61.99 -35.76 79.48 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.299 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 7.3 t30 -56.24 -43.67 78.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' SER . 30.7 m -65.17 -49.73 68.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -90.87 -70.91 0.66 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.325 0.583 . . . . 0.0 111.375 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' A' ' 104' ' ' ARG . 71.1 t -56.04 -51.77 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.753 -173.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.6 tp -81.87 -22.57 36.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -170.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' THR . 62.1 m -93.95 -3.42 51.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.059 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 47' ' ' VAL . 9.6 t70 -48.59 129.13 13.76 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.544 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.99 -36.61 76.43 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.127 2.552 . . . . 0.0 113.212 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.43 -34.85 68.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.87 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 44' ' ' ASP . 20.6 t -74.9 -49.0 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.366 0.603 . . . . 0.0 109.598 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -54.49 -37.03 64.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.886 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -63.31 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 0.0 111.262 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.26 -46.01 68.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.476 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 2.4 mm? -67.29 -47.25 71.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.15 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -46.01 -41.79 12.35 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.777 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -70.84 -49.95 40.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -171.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.873 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.82 16.38 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.151 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.42 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 87.4 m-85 -127.18 143.67 51.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.334 0.588 . . . . 0.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 14' ' ' LEU . 61.6 t -115.72 117.28 55.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 3' ' ' LEU . 15.2 t -91.07 131.76 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.855 -173.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -101.36 119.63 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -85.22 102.31 13.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.227 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.72 125.79 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.301 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -109.28 121.8 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.519 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 56.5 t -68.97 -16.03 20.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.219 0.533 . . . . 0.0 110.992 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 2.1 m-20 -67.29 -34.49 77.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.909 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 61.5 p -97.04 158.29 33.59 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.024 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 15.1 Cg_endo -51.02 -41.55 56.26 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.636 2.891 . . . . 0.0 113.127 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.538 ' OE2' ' HG2' ' A' ' 65' ' ' PRO . 1.7 mp0 -52.0 -57.75 8.56 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.041 0.448 . . . . 0.0 110.036 175.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.11 -33.06 65.29 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.259 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.615 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 51.3 mt-30 -56.02 -51.14 68.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.606 0.362 . . . . 0.0 111.114 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -76.84 -29.41 55.87 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.777 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.595 HD21 ' CD1' ' A' ' 8' ' ' TYR . 1.7 mp -61.61 -42.23 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 0.0 110.549 170.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.26 77.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.799 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 86.5 mtt180 -71.64 -27.44 63.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -80.96 -52.58 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.28 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -85.47 -14.02 47.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.763 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 65.05 78.08 0.29 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 77' ' ' PRO . 54.5 t -135.35 142.01 39.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 -171.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.446 ' O ' HG12 ' A' ' 76' ' ' VAL . 9.0 Cg_exo -73.49 -143.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.262 2.641 . . . . 0.0 111.142 169.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.49 -49.31 3.02 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.239 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.692 ' OG1' ' HA ' ' A' ' 80' ' ' PRO . 1.1 t 179.89 160.38 0.83 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.821 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -88.96 126.75 7.67 Favored 'Cis proline' 0 N--CA 1.456 -0.711 0 C-N-CA 124.246 -1.147 . . . . 0.0 112.035 -1.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 1.023 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.4 m -125.24 108.17 11.47 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.98 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.498 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.6 m-85 -102.67 111.59 23.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.235 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.7 t -110.65 108.9 26.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.88 0.372 . . . . 0.0 110.775 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.27 118.44 32.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.891 0.377 . . . . 0.0 110.538 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 32.8 mt -114.25 131.75 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 t -110.61 124.69 32.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.516 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.7 Cg_endo -80.38 117.2 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.166 1.911 . . . . 0.0 110.387 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -146.37 133.81 20.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.406 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.14 -75.67 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.029 0.831 . . . . 0.0 111.144 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.82 29.49 0.15 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.713 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.99 165.53 33.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.587 0.232 . . . . 0.0 110.528 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.516 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 80.0 m95 -98.99 126.47 44.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.972 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 26.5 tt0 -106.94 121.38 44.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.445 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.522 ' HA ' HD23 ' A' ' 85' ' ' LEU . 49.0 tt0 -76.25 96.46 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 117' ' ' LYS . 9.7 p -82.62 -14.51 12.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.009 -169.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.16 129.58 1.26 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.304 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.484 ' HG3' HG22 ' A' ' 83' ' ' VAL . 27.7 ttm180 -115.61 127.45 55.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 99.0 mt -109.37 133.89 52.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.662 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -136.93 116.54 12.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.65 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.3 173.06 18.86 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.054 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 m -109.98 120.36 42.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.745 0.307 . . . . 0.0 110.327 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 65.0 mtp180 -146.23 147.44 31.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HD2' ' HG3' ' A' ' 106' ' ' GLU . 31.4 Cg_exo -59.39 163.09 13.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.809 2.34 . . . . 0.0 112.085 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.592 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -63.73 -25.97 68.44 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.778 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.49 95.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.022 0.439 . . . . 0.0 110.337 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.3 mm-40 -64.89 -44.98 87.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.464 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.447 ' CE2' HD12 ' A' ' 111' ' ' LEU . 44.7 t80 -62.58 -37.58 86.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.516 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 62.3 mt -61.68 -42.24 98.66 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 110.943 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -57.31 -54.23 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.165 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 2.7 mm-40 -65.91 -41.04 91.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.126 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.45 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.8 tt -60.98 -39.51 89.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.667 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 116' ' ' VAL . 12.6 tpt180 -59.23 -41.05 87.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.95 -43.31 75.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.571 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 110' ' ' GLU . 90.1 t -59.46 -39.63 79.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.743 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.12 -40.1 88.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.666 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 112' ' ' ARG . 97.6 t -66.55 -37.58 79.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 109.997 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 121' ' ' CYS . 34.0 mtpt -72.74 -8.17 54.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.712 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.65 -27.09 11.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.259 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.99 -26.1 73.27 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 121' ' ' CYS . . . -151.14 -79.39 0.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 120' ' ' ALA . 48.5 t 157.55 -43.12 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.365 0 O-C-N 124.847 1.342 . . . . 0.0 109.065 172.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.9 30.79 3.57 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -81.98 -16.85 48.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.203 -0.499 . . . . 0.0 110.716 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.45 89.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.055 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -137.43 140.94 41.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.19 109.17 10.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.724 0.297 . . . . 0.0 110.447 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -93.12 100.61 12.98 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -74.54 91.61 2.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -156.91 145.62 19.9 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 80.6 t60 . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.845 178.264 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' HG3' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -140.03 133.81 30.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 51' ' ' LEU . 14.8 tp -133.22 141.64 48.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.591 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.7 mmm180 -91.13 103.12 15.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.782 0.325 . . . . 0.0 111.851 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.497 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 46.4 m95 -102.88 113.26 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.335 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 90.0 m-85 -118.14 161.8 33.0 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.021 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 16.7 Cg_exo -66.18 160.95 42.46 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.274 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.589 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 91.4 t80 -47.27 -53.84 25.68 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 35.3 Cg_exo -61.42 -46.96 12.93 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.83 1.687 . . . . 0.0 112.355 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -43.97 87.22 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -54.97 -42.34 72.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.741 0.305 . . . . 0.0 111.478 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.1 -38.69 82.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.81 63.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.755 0.312 . . . . 0.0 110.586 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -57.42 -40.62 78.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.09 -56.07 6.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.935 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 24.9 tt0 -60.46 -49.18 78.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.5 -175.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -14.02 59.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 15.7 m-70 -118.3 4.35 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.295 -175.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.64 34.06 72.43 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.261 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.6 mmp_? -108.64 178.87 4.35 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.589 -0.359 . . . . 0.0 110.108 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.475 ' SD ' HG22 ' A' ' 86' ' ' VAL . 48.3 mtm -108.06 165.49 11.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.4 t -105.69 125.04 61.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.818 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.551 ' SD ' HG13 ' A' ' 57' ' ' VAL . 1.4 tmt? -109.06 103.12 12.07 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.664 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 26.1 t -90.41 111.44 23.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.407 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 65.7 t80 -99.58 103.49 15.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.128 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.723 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 51.4 m-85 -81.39 121.67 26.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.639 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 25.4 p80 -135.28 138.54 43.6 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.165 0.915 . . . . 0.0 109.924 177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.426 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 1.5 t -99.39 168.12 10.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.495 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -7.0 44.02 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -114.07 -80.12 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.382 -0.199 . . . . 0.0 111.027 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 79' ' ' THR . 4.0 m 60.42 152.47 0.1 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.897 0.879 . . . . 0.0 112.915 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.22 -89.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.364 2.043 . . . . 0.0 113.08 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.02 -16.83 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 5.8 t -49.5 -52.57 28.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.241 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -57.8 -39.13 76.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.099 0.249 . . . . 0.0 111.613 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -66.84 -50.6 62.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 101' ' ' SER . 30.3 ttp -62.25 -46.13 90.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.744 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.6 -43.07 84.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.498 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.7 m -66.44 -56.77 9.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.638 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -91.89 -70.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.563 0.697 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.599 HG13 ' HA ' ' A' ' 104' ' ' ARG . 94.0 t -52.89 -48.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.065 -171.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 tp -81.41 -15.24 55.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -173.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.496 ' O ' ' HG3' ' A' ' 1' ' ' MET . 70.6 m -95.79 -1.09 50.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.606 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 47' ' ' VAL . 13.0 t70 -47.03 129.17 9.08 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.658 171.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.89 -37.52 85.47 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.131 2.554 . . . . 0.0 113.229 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.87 -42.59 30.28 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.026 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.698 HG22 HD23 ' A' ' 108' ' ' LEU . 8.1 t -66.66 -44.3 89.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -55.24 -40.64 71.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.688 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -70.22 -21.37 63.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.85 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 108' ' ' LEU . 72.5 mt -70.16 -44.56 68.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 3' ' ' LEU . 3.1 mm? -66.54 -60.56 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.361 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' OE1' HD12 ' A' ' 3' ' ' LEU . 9.5 mm-40 -50.08 -34.73 22.77 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.649 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -64.61 -53.15 52.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.649 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.38 11.61 3.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -123.28 145.79 48.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.039 0.447 . . . . 0.0 110.959 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 11' ' ' ALA . 22.0 t -107.98 118.09 54.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.551 HG13 ' SD ' ' A' ' 23' ' ' MET . 21.3 t -86.93 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.044 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -92.68 117.28 29.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.159 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 42.9 t -88.15 100.57 13.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.538 HG11 HD22 ' A' ' 70' ' ' LEU . 61.2 t -113.57 122.79 68.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.295 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.539 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 4.4 p -85.84 109.4 18.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.374 0.606 . . . . 0.0 109.679 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' A' ' 71' ' ' ALA . 5.1 p -88.99 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 123.091 1.424 . . . . 0.0 109.008 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.14 -38.7 0.07 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.075 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.653 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 3.1 p -81.63 164.66 48.22 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.511 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.3 Cg_endo -51.39 -55.23 4.2 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.534 2.823 . . . . 0.0 114.524 -170.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.1 -36.63 84.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.585 0.231 . . . . 0.0 111.182 -178.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.38 -34.02 64.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.649 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -71.19 -28.51 64.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.306 0.574 . . . . 0.0 110.714 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.31 -44.83 93.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.217 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.538 HD22 HG11 ' A' ' 60' ' ' VAL . 9.0 mp -65.86 -30.9 71.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 174.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB2' HG23 ' A' ' 62' ' ' VAL . . . -67.14 -35.24 79.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.589 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HA ' ' NH2' ' A' ' 75' ' ' ARG . 20.1 ptt180 -83.37 -33.17 25.86 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.314 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 28.4 ttm180 -73.18 -56.67 4.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.526 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 90.7 m-85 -91.38 -11.89 36.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.329 -174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.741 ' HE ' ' HA ' ' A' ' 75' ' ' ARG . 1.2 mmp_? 64.74 91.16 0.08 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.686 0.616 . . . . 0.0 110.247 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.457 HG11 ' CG ' ' A' ' 26' ' ' PHE . 39.1 t -129.51 85.85 57.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -105.29 125.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.512 2.808 . . . . 0.0 113.196 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 124.95 -68.31 0.51 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.422 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.651 HG21 ' SG ' ' A' ' 31' ' ' CYS . 60.3 m 72.26 138.58 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.463 0.305 . . . . 0.0 110.836 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HA ' HG23 ' A' ' 79' ' ' THR . 73.0 Cg_endo -78.51 143.76 73.07 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.707 0.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 35.5 m -122.77 122.66 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.038 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.648 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 9.7 m-85 -106.51 122.9 47.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.053 -175.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.664 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 45.2 t -124.11 105.43 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.04 118.89 32.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.327 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 94' ' ' GLU . 38.6 mt -113.11 137.28 51.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.475 HG22 ' SD ' ' A' ' 21' ' ' MET . 13.5 t -108.28 135.87 19.9 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.968 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.21 115.39 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.405 1.403 . . . . 0.0 108.794 166.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.86 111.28 5.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.831 0.348 . . . . 0.0 110.572 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.22 18.25 11.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.142 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.05 -23.64 34.83 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.852 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.87 -175.53 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.693 0.283 . . . . 0.0 110.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 95.0 m95 -115.7 136.9 52.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.472 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 32.4 tt0 -122.37 125.22 45.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.548 ' HA ' HD23 ' A' ' 85' ' ' LEU . 35.5 tt0 -78.58 95.98 5.35 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.538 HG22 ' HD3' ' A' ' 117' ' ' LYS . 1.4 p -102.38 -11.9 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.836 -170.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.72 104.48 0.36 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.744 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.517 ' HD3' ' CD ' ' A' ' 94' ' ' GLU . 8.5 tpt180 -111.97 124.76 53.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.9 mt -137.62 143.54 41.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -137.82 133.16 33.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.71 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.02 149.2 15.65 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.586 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.493 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 49.2 m -76.02 151.12 37.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.586 0.231 . . . . 0.0 110.872 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.843 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 16.9 mmt-85 -130.96 165.66 33.27 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.633 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 106' ' ' GLU . 21.5 Cg_exo -67.96 154.68 72.16 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.272 1.981 . . . . 0.0 109.808 162.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.599 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -57.41 -42.95 83.28 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -170.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.616 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . . . -79.76 -27.2 40.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.384 -175.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.4 mm-40 -76.9 -38.46 53.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.843 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 86.8 t80 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.042 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.698 HD23 HG22 ' A' ' 47' ' ' VAL . 4.3 pp -68.12 -22.95 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.629 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.409 ' N ' HD12 ' A' ' 108' ' ' LEU . 37.6 ttmt -67.14 -53.81 27.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.856 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.619 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 8.3 pt-20 -71.56 -32.13 67.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.195 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD12 ' CE2' ' A' ' 107' ' ' PHE . 5.9 tt -59.21 -42.53 91.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 116' ' ' VAL . 43.9 ttt180 -59.92 -43.7 94.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.252 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 10.2 pt20 -67.97 -23.43 65.04 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.327 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 110' ' ' GLU . 93.9 t -81.73 -36.75 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.2 t -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.026 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 112' ' ' ARG . 57.9 t -65.72 -30.18 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.538 ' HD3' HG22 ' A' ' 95' ' ' VAL . 63.2 mttp -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.274 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.5 -18.97 68.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.557 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -123.16 15.32 8.24 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -165.92 83.5 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.22 0.533 . . . . 0.0 110.05 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 10.7 p -124.04 15.39 9.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.251 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.05 26.03 17.7 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.958 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -83.93 -175.18 5.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.715 0.293 . . . . 0.0 110.441 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.17 52.29 2.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.334 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.83 -24.92 61.78 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.506 0.322 . . . . 0.0 110.412 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.4 m80 71.8 170.09 0.32 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.72 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -144.75 113.41 6.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.759 176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -80.54 -7.34 59.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.196 0.522 . . . . 0.0 110.202 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -134.64 143.71 47.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.17 176.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 . . . . . 0 C--O 1.243 0.74 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.216 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 m -88.05 167.64 13.5 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -55.75 155.01 6.26 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.596 0.712 . . . . 0.0 112.484 -173.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 36.7 mmt-85 -87.71 108.91 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.746 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.51 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.8 m95 -111.15 109.17 19.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 87.3 m-85 -124.31 156.36 67.03 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.53 159.75 19.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.935 1.757 . . . . 0.0 111.198 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.582 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.1 t80 -45.38 -54.02 16.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.7 Cg_exo -63.91 -39.74 31.46 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.643 1.562 . . . . 0.0 112.179 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.19 -36.97 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.832 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.37 -48.31 70.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.038 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.532 HD13 HG21 ' A' ' 22' ' ' VAL . 4.3 mm? -56.45 -42.67 78.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.695 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.12 63.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.074 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' HB3' HG11 ' A' ' 56' ' ' VAL . 9.4 tp -61.11 -51.04 70.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.18 -38.67 91.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.681 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 48.9 tt0 -65.86 -42.35 90.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.877 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.43 -16.04 44.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -112.06 2.11 16.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.753 -175.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.4 40.56 97.89 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.296 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -108.54 179.67 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 110.412 178.211 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 85.5 mtp -104.82 154.98 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 12' ' ' LEU . 85.0 t -106.15 130.54 57.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.412 . . . . 0.0 111.324 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.42 103.61 11.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.397 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 21.6 t -84.54 113.7 23.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CD2' ' HZ3' ' A' ' 5' ' ' TRP . 56.7 t80 -104.48 106.67 17.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.995 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.08 125.61 37.76 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.892 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -141.93 160.93 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.474 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.645 ' HB2' ' HB2' ' A' ' 31' ' ' CYS . 3.4 m -142.11 150.92 41.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.89 -40.77 83.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 172.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -82.16 1.53 35.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.8 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 86.0 m -132.86 68.05 78.47 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.175 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 35' ' ' GLN . 91.4 Cg_endo -81.39 38.49 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.076 2.517 . . . . 0.0 114.178 -167.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -73.61 -43.06 60.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.155 0.502 . . . . 0.0 111.124 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 16.1 t -77.46 -19.16 56.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.34 -176.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 32' ' ' PRO . 82.5 mm-40 -54.81 -26.25 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -81.78 -32.16 31.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.424 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.2 ttm -78.97 -46.14 18.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.751 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.589 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 32.0 p30 -66.36 -21.07 66.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -78.68 -59.11 2.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.23 -70.19 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.932 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -54.98 -49.53 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.873 -170.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 25.0 tp -81.57 -21.48 38.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.465 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -95.34 -2.22 49.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 0.0 110.609 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -50.81 133.26 28.49 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.226 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.33 -44.27 39.78 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.246 2.631 . . . . 0.0 113.451 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.65 68.21 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.028 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 108' ' ' LEU . 84.6 t -57.73 -48.18 84.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 109.845 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.4 m -53.53 -50.91 64.45 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.013 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -54.57 -29.42 51.28 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.839 HD12 HD22 ' A' ' 108' ' ' LEU . 74.9 mt -73.42 -54.02 9.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 111.313 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.557 ' HB2' HD21 ' A' ' 3' ' ' LEU . 3.5 mm? -68.74 -39.62 80.26 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.12 -33.75 67.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.736 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -71.56 -49.84 36.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.529 ' HD3' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.12 15.25 3.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -173.525 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 78.4 m-85 -121.2 143.46 49.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.424 0.63 . . . . 0.0 112.073 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 14' ' ' LEU . 47.7 t -111.91 113.7 44.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.297 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.1 t -87.17 127.44 40.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.099 0.476 . . . . 0.0 110.881 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -93.4 117.09 29.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.986 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 p -83.82 102.09 12.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.098 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.04 126.03 74.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.028 0.442 . . . . 0.0 110.842 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 64' ' ' THR . 0.9 OUTLIER -113.09 132.64 55.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.468 HG13 ' CB ' ' A' ' 71' ' ' ALA . 46.3 t -79.68 -16.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.421 0.629 . . . . 0.0 111.244 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -76.21 -10.97 59.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.951 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.608 ' OG1' ' HD2' ' A' ' 65' ' ' PRO . 5.0 t -114.04 149.17 41.49 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.402 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.608 ' HD2' ' OG1' ' A' ' 64' ' ' THR . 19.0 Cg_endo -53.14 -50.91 12.36 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 123.523 2.815 . . . . 0.0 114.534 -169.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -31.88 62.75 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.138 -174.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -74.82 -30.42 59.61 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.653 174.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 64' ' ' THR . 16.1 tt0 -69.74 -36.89 76.22 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -54.34 -48.86 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.205 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.19 -43.42 92.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.297 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.468 ' CB ' HG13 ' A' ' 62' ' ' VAL . . . -57.99 -49.19 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.257 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.88 -20.79 41.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.262 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -62.3 -48.84 78.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 110.009 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.48 -15.06 29.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.007 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 65.04 79.64 0.25 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.516 0.674 . . . . 0.0 110.245 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.3 t -123.1 97.55 43.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.382 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -101.29 130.42 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.387 2.725 . . . . 0.0 113.35 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 31' ' ' CYS . . . 104.04 -56.49 0.57 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.568 169.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.68 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 20.1 p 60.38 161.19 0.11 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.652 0.781 . . . . 0.0 111.638 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.68 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 45.3 Cg_endo -69.64 145.74 80.01 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 124.035 -1.235 . . . . 0.0 112.367 -0.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.3 m -134.21 116.58 15.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.185 0.517 . . . . 0.0 110.037 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 6.1 m-85 -106.27 112.34 25.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.666 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 47.0 t -108.88 113.46 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.788 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.416 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 18.0 m-85 -96.61 127.69 42.83 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.566 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.3 mt -116.52 131.13 57.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.972 0.415 . . . . 0.0 110.73 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.507 ' CG2' HG11 ' A' ' 95' ' ' VAL . 91.7 t -109.64 129.8 23.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.774 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.39 117.88 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.841 1.694 . . . . 0.0 110.8 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' CE ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -131.16 125.01 31.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.15 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.808 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -155.69 25.04 0.57 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.156 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.83 166.78 23.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.483 0.183 . . . . 0.0 110.852 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 91.3 m95 -103.25 153.21 20.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.697 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 59.0 mt-10 -119.74 133.56 55.57 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.387 167.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.1 tt0 -81.6 94.96 7.02 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.805 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 22.7 m -85.17 -5.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.943 -166.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.17 158.78 9.41 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.362 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.4 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 82.5 mtt180 -129.72 130.23 45.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 68.0 mt -108.49 134.47 51.22 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -137.52 143.4 41.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.843 0.354 . . . . 0.0 111.044 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.84 162.35 25.85 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.281 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -74.55 116.26 15.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.118 0.485 . . . . 0.0 109.814 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -124.36 143.36 42.74 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.722 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.03 158.03 45.79 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.117 1.878 . . . . 0.0 110.268 169.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.536 ' HB3' HG13 ' A' ' 41' ' ' VAL . 33.5 ptt180 -62.55 -26.8 68.76 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.722 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.99 97.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.363 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -69.18 -48.55 61.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.34 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.72 -52.4 65.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.883 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.839 HD22 HD12 ' A' ' 50' ' ' LEU . 71.0 mt -65.96 -30.23 70.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.258 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -55.57 -62.45 1.68 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.102 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 114' ' ' VAL . 1.1 mt-10 -70.76 -32.8 70.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.407 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 51' ' ' LEU . 2.7 tm? -62.08 -41.29 98.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.209 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 42.7 mtm180 -68.5 -32.69 72.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.267 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.483 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 12.2 mm-40 -67.42 -35.46 79.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.043 0.449 . . . . 0.0 110.651 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 110' ' ' GLU . 95.6 t -66.75 -36.36 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.05 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.64 -34.55 71.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.35 -51.46 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.131 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.805 ' HE3' ' HB ' ' A' ' 95' ' ' VAL . 16.2 mtpp -59.79 -24.36 64.05 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -53.39 -31.58 43.34 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.44 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -122.45 20.27 7.91 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' A' ' 117' ' ' LYS . . . -134.01 17.29 3.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.959 0.409 . . . . 0.0 111.046 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.469 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 19.2 m -74.98 109.24 8.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.246 0.546 . . . . 0.0 109.762 174.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.18 -25.62 21.42 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -170.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.811 ' HG3' ' H ' ' A' ' 124' ' ' GLY . 7.6 tp10 -89.38 -139.68 0.13 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.811 ' H ' ' HG3' ' A' ' 123' ' ' GLU . . . 91.22 2.88 70.38 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -95.83 117.57 30.81 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -58.49 -31.49 67.9 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.527 0.517 . . . . 0.0 112.338 -170.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -160.1 156.95 27.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.082 0.467 . . . . 0.0 110.721 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.529 ' CE1' ' HB3' ' A' ' 130' ' ' HIS . 0.2 OUTLIER -169.29 -169.28 0.92 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -75.84 74.52 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.741 0.781 . . . . 0.0 109.779 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.529 ' HB3' ' CE1' ' A' ' 128' ' ' HIS . 6.8 t-80 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.135 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m 65.88 -163.25 0.25 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -170.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 51' ' ' LEU . 17.9 tp -133.82 145.85 50.12 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.696 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.491 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.4 mmt180 -86.81 103.07 14.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.971 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -105.59 103.95 13.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 85.6 m-85 -118.74 149.06 45.71 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.632 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.477 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.7 Cg_exo -59.67 166.26 8.46 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.423 2.082 . . . . 0.0 111.487 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.558 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -48.31 -50.99 53.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.1 Cg_exo -58.46 -49.25 12.56 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.823 1.682 . . . . 0.0 112.389 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 9.3 mt-10 -63.8 -42.94 97.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.704 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -59.99 -48.25 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.644 0.259 . . . . 0.0 111.54 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.508 HD13 HG21 ' A' ' 22' ' ' VAL . 4.6 mm? -63.29 -39.84 95.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.82 -37.69 48.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.08 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.454 ' HB3' HG11 ' A' ' 56' ' ' VAL . 9.8 tp -64.15 -46.71 82.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.93 96.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -64.52 -45.66 86.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.516 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.8 -14.49 59.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -116.8 3.11 12.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.576 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' C ' ' HE ' ' A' ' 20' ' ' ARG . . . 63.11 37.07 94.32 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.59 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.754 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.3 mmp_? -106.94 177.48 4.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.586 ' SD ' HG22 ' A' ' 86' ' ' VAL . 31.7 mtm -103.93 158.32 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG21 HD13 ' A' ' 12' ' ' LEU . 59.3 t -105.93 123.74 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.934 0.397 . . . . 0.0 111.17 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.416 ' HE1' HD11 ' A' ' 42' ' ' LEU . 21.1 ttt -103.4 103.58 13.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 173.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 40.6 t -85.42 108.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -106.59 103.57 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 110.793 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.3 m-85 -80.63 120.76 24.98 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.197 176.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.563 ' HA ' HG21 ' A' ' 79' ' ' THR . 31.5 p80 -129.3 155.94 44.79 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.918 0.761 . . . . 0.0 109.316 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 31' ' ' CYS . 92.7 p -137.03 166.28 24.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.722 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -78.08 -5.89 52.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.761 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -119.58 -0.5 10.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.455 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 28' ' ' SER . 21.8 p -58.44 130.26 84.44 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.534 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.6 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 63.6 Cg_endo -76.91 -86.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.225 1.95 . . . . 0.0 114.045 -175.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.84 -18.77 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.578 . . . . 0.0 110.735 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 29.3 t -63.27 -42.06 99.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 29.9 pt20 -66.93 -23.49 65.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.402 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -79.3 -48.44 14.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.406 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.596 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 17.2 ptp -66.98 -39.15 87.12 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.781 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.07 -34.59 68.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.467 . . . . 0.0 110.672 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 43' ' ' SER . 26.0 m -83.25 -61.04 1.95 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.525 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -91.38 -70.6 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 104' ' ' ARG . 70.8 t -49.31 -55.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.077 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.416 HD11 ' HE1' ' A' ' 23' ' ' MET . 21.2 tp -83.03 -27.07 30.59 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.738 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 39' ' ' THR . 31.2 t -88.39 -4.99 58.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.09 -175.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' A' ' 47' ' ' VAL . 13.3 t70 -51.26 130.88 32.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.644 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.709 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 27.5 Cg_exo -62.14 -20.94 71.54 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.854 2.37 . . . . 0.0 113.504 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.87 -34.52 38.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.174 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.54 HG22 HD21 ' A' ' 108' ' ' LEU . 14.8 t -76.89 -40.54 31.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 108.861 175.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.582 ' OG ' ' HA ' ' A' ' 45' ' ' PRO . 36.8 p -59.08 -33.49 70.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.105 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.709 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 87.3 mtt180 -56.78 -35.54 68.8 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.743 0.306 . . . . 0.0 111.45 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.75 -43.42 84.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.735 0.302 . . . . 0.0 110.448 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB2' HD11 ' A' ' 3' ' ' LEU . 2.7 mm? -73.94 -45.78 48.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.762 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -44.79 -48.98 10.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.731 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -66.87 -48.54 68.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.754 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.67 16.3 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -170.372 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.05 145.71 51.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.407 0.623 . . . . 0.0 111.447 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 11' ' ' ALA . 60.4 t -114.86 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 21.6 t -86.95 121.31 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.193 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -89.62 117.1 28.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.868 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.0 p -84.65 100.14 11.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.5 t -104.28 106.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.995 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.641 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -90.04 109.16 20.22 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.944 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 71' ' ' ALA . 25.9 t -75.15 -6.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.071 0.938 . . . . 0.0 109.27 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.722 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -77.53 -32.57 54.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.913 174.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.659 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.4 p -99.55 159.38 30.17 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.659 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.87 -53.51 6.87 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.235 3.29 . . . . 0.0 114.835 -169.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.37 80.05 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.8 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.78 -39.84 54.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.307 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -56.75 -39.79 74.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.658 0.742 . . . . 0.0 110.044 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.98 -44.87 79.35 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.899 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -34.7 78.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -64.54 -38.34 90.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -83.62 -20.49 33.56 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.811 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -80.71 -48.92 11.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.591 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -86.44 -10.93 53.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.192 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 73.1 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.804 0.69 . . . . 0.0 109.977 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.04 86.42 58.14 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.626 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -103.15 122.57 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.673 2.916 . . . . 0.0 112.741 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.46 ' HA3' ' HE1' ' A' ' 99' ' ' PHE . . . 133.92 -74.58 0.43 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.412 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 27' ' ' HIS . 23.7 m 73.23 141.97 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 123.704 0.297 . . . . 0.0 110.586 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.551 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 55.4 Cg_endo -69.08 153.99 91.36 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 124.426 -1.072 . . . . 0.0 113.32 1.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.1 m -138.94 123.82 18.77 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.432 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 1.5 m-85 -112.27 112.56 24.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.842 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 59.0 t -118.02 115.22 47.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HB2' HG22 ' A' ' 95' ' ' VAL . 49.2 m-85 -102.16 124.02 47.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.92 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 94' ' ' GLU . 32.8 mt -117.59 132.46 56.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.586 HG22 ' SD ' ' A' ' 21' ' ' MET . 14.9 t -110.71 132.73 21.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.578 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.7 115.04 3.04 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.251 1.3 . . . . 0.0 110.748 170.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -169.13 141.52 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.99 11.41 8.33 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.66 0.6 . . . . 0.0 111.342 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.8 29.6 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.63 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.98 -177.12 3.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.0 111.076 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 67.1 m95 -105.74 130.74 53.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.011 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.507 ' OE2' HG12 ' A' ' 95' ' ' VAL . 31.3 tt0 -97.14 119.82 36.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.238 176.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.533 ' HA ' HD23 ' A' ' 85' ' ' LEU . 33.0 tt0 -75.24 96.56 3.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.94 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 13.7 m -73.91 -11.73 14.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.953 -173.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.79 141.82 3.23 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.763 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -116.16 128.24 55.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.229 0.537 . . . . 0.0 109.642 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.579 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.3 mt -108.03 131.39 54.63 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.46 ' HE1' ' HA3' ' A' ' 78' ' ' GLY . 79.1 t80 -130.9 124.1 30.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.81 178.26 15.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.419 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 8.0 m -112.91 126.29 55.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.502 ' HE ' ' HG2' ' A' ' 106' ' ' GLU . 24.4 mmm180 -128.05 151.02 75.3 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.779 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.07 158.94 41.05 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.254 1.969 . . . . 0.0 111.262 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.655 ' HB2' HG13 ' A' ' 41' ' ' VAL . 67.7 ttt180 -58.67 -34.83 71.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.386 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.64 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.086 0.469 . . . . 0.0 110.634 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HG2' ' HE ' ' A' ' 102' ' ' ARG . 3.9 tp10 -67.02 -48.77 67.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.409 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -66.08 -37.36 85.6 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.843 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.54 HD21 HG22 ' A' ' 47' ' ' VAL . 60.6 mt -59.06 -44.51 91.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 0.0 110.73 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 46.7 mtmt -65.1 -48.07 74.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.32 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -59.36 -55.56 33.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.409 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' LEU . 1.9 tm? -61.31 -32.39 72.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.32 0.581 . . . . 0.0 109.897 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 116' ' ' VAL . 3.6 tpm_? -65.44 -37.85 88.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 109' ' ' LYS . 29.2 mm-40 -74.37 -43.19 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.553 0.215 . . . . 0.0 110.937 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.458 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . 79.5 t -62.67 -36.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.166 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.1 t -55.16 -29.73 58.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.576 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 112' ' ' ARG . 85.9 t -85.42 -54.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.245 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.94 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -70.95 -11.53 61.02 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.107 -170.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.448 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -56.12 -41.09 85.14 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.167 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.06 -33.11 4.74 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -102.98 65.89 0.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.899 0.38 . . . . 0.0 111.213 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 7.7 p -71.6 122.59 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.44 41.26 0.89 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -166.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.64 ' H ' ' CD ' ' A' ' 123' ' ' GLU . 3.7 mp0 -43.54 104.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.165 1.386 . . . . 0.0 113.147 -170.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.51 -1.4 4.18 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.223 -0.898 . . . . 0.0 113.42 175.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.6 m80 59.19 25.28 13.8 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 121.09 0.471 . . . . 0.0 110.305 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -142.96 106.71 4.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.885 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -103.0 159.94 15.06 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -71.26 118.1 13.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.818 0.342 . . . . 0.0 110.934 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -63.38 147.25 51.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.455 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 . . . . . 0 C--O 1.244 0.785 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 169.778 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 t 68.78 -171.35 0.18 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.466 ' HB3' ' NE1' ' A' ' 5' ' ' TRP . 11.3 tp -133.66 155.42 49.74 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.436 -176.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -102.17 103.8 14.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.68 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.466 ' NE1' ' HB3' ' A' ' 3' ' ' LEU . 13.2 m95 -104.35 139.78 38.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.539 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 86.1 m-85 -138.91 166.63 23.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.68 159.35 41.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.54 1.494 . . . . 0.0 110.884 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.544 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 60.4 t80 -50.84 -51.36 67.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.2 Cg_exo -60.85 -43.69 29.71 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.834 1.689 . . . . 0.0 112.386 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -65.71 -46.07 80.33 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.35 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.491 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.15 -41.82 72.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.45 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.38 -38.78 91.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.044 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.47 -47.79 58.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.878 0.371 . . . . 0.0 110.399 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.446 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -54.21 -51.4 64.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.857 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.42 -43.96 95.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.357 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -62.39 -47.45 84.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.369 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.35 -15.45 57.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -112.58 -1.73 14.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.43 32.46 81.88 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.264 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 24.9 mmt180 -97.44 177.63 5.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.397 . . . . 0.0 110.675 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 88.1 mtp -104.5 156.25 18.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.474 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 49.9 t -105.95 124.69 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 ttt -104.39 103.47 13.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.684 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 37.5 t -84.5 104.54 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.896 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.9 t80 -102.33 108.84 20.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.077 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 1.004 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.7 m-85 -90.1 124.97 35.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 23.5 p80 -128.08 155.85 43.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.564 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.437 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 38.2 t -143.1 159.48 42.2 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -74.87 -9.05 58.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.57 0.7 . . . . 0.0 109.935 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -97.86 15.96 22.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.998 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.586 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 31.8 p -84.84 115.22 59.93 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.839 0.352 . . . . 0.0 110.562 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 79' ' ' THR . 38.0 Cg_endo -68.0 -69.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.497 2.132 . . . . 0.0 113.866 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.88 -17.19 36.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 44.5 t -55.46 -46.92 76.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.487 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -56.6 -38.25 71.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.38 . . . . 0.0 111.638 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -72.2 -38.93 68.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.42 ' HE1' ' H ' ' A' ' 102' ' ' ARG . 50.8 ttm -65.32 -49.38 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.856 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 77.6 m-20 -52.36 -49.27 64.69 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.363 0.415 . . . . 0.0 111.018 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' SER . 21.9 m -59.86 -59.99 4.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.888 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.05 -68.4 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 112.071 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 104' ' ' ARG . 68.6 t -58.9 -44.35 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.804 -170.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 21.1 tp -81.74 -34.68 30.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.334 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 39' ' ' THR . 33.4 t -85.74 -0.99 56.74 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.406 ' OD2' HG23 ' A' ' 47' ' ' VAL . 22.1 t70 -49.87 128.46 20.83 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.117 174.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.57 -35.63 57.16 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.222 2.614 . . . . 0.0 113.242 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.86 -48.22 28.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.962 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.712 HG22 HD21 ' A' ' 108' ' ' LEU . 59.6 t -61.36 -57.5 11.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.107 0.479 . . . . 0.0 110.762 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.68 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 54.9 m -52.23 -47.41 65.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.085 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -58.5 -36.56 73.98 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.471 HD13 HD12 ' A' ' 111' ' ' LEU . 76.7 mt -62.68 -40.38 96.92 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.0 110.593 176.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.5 mm? -74.53 -40.58 61.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.292 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.6 mt-10 -49.48 -50.21 42.32 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.204 0.526 . . . . 0.0 112.023 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.14 82.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -135.23 11.95 3.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 86.4 m-85 -121.38 145.64 47.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.353 0.597 . . . . 0.0 111.246 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 11' ' ' ALA . 20.1 t -111.98 113.66 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 3' ' ' LEU . 21.8 t -87.03 117.4 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 8' ' ' TYR . . . -90.31 117.27 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.45 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.1 p -85.14 101.41 12.44 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.9 125.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.565 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.606 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -100.48 108.52 20.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.057 0.456 . . . . 0.0 110.571 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.36 -11.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.054 0.93 . . . . 0.0 109.636 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.474 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 6.8 m-20 -77.68 -32.34 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.609 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.616 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -109.1 165.46 12.6 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.778 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.3 Cg_endo -49.73 -52.95 7.86 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.092 3.194 . . . . 0.0 114.491 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -56.43 -43.37 79.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.34 -31.15 52.59 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.98 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -60.19 -41.32 92.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.724 0.297 . . . . 0.0 111.065 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.1 pt-20 -79.25 -30.64 43.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.882 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.408 ' HB3' ' HE1' ' A' ' 26' ' ' PHE . 1.9 mm? -63.83 -44.19 93.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 0.0 110.247 172.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.01 79.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.449 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.8 ptm180 -65.39 -30.68 71.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.111 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -66.51 -41.39 88.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 110.276 -179.531 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -92.33 -6.09 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.24 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 65.38 33.11 9.21 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.683 0.614 . . . . 0.0 111.439 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 t -130.26 144.99 55.46 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 17.0 Cg_exo -69.63 -116.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.378 2.052 . . . . 0.0 111.282 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.496 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . 168.14 63.32 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 12.5 p -137.86 47.72 1.76 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.657 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 43.5 Cg_endo -93.08 174.38 16.62 Favored 'Cis proline' 0 C--N 1.356 0.949 0 CA-C-N 121.0 1.393 . . . . 0.0 112.507 -3.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 1.004 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 62.8 m -139.18 131.64 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 170.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -127.75 112.23 14.56 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.684 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 57.4 t -111.43 121.63 64.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.735 0.303 . . . . 0.0 110.199 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.49 116.62 30.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.668 0.27 . . . . 0.0 110.357 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 29.3 mt -112.93 137.04 51.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.213 0.53 . . . . 0.0 111.408 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.522 HG21 ' HA2' ' A' ' 118' ' ' GLY . 58.8 t -109.98 123.33 36.46 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.03 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 59.5 Cg_endo -77.11 116.42 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.778 1.652 . . . . 0.0 111.193 173.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -147.85 135.33 20.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.684 0.278 . . . . 0.0 110.574 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.0 24.16 14.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.554 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.56 77.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.343 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.31 167.02 20.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 65.7 m95 -106.36 126.12 51.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.943 0.401 . . . . 0.0 110.026 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.8 tp10 -114.04 137.44 51.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.623 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 38.1 tt0 -88.29 112.91 23.35 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.537 HG22 ' HE2' ' A' ' 117' ' ' LYS . 8.7 p -98.93 7.46 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.499 0.666 . . . . 0.0 110.336 -175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.46 138.49 2.88 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.504 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -122.94 133.06 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.153 0.502 . . . . 0.0 110.508 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.98 128.39 56.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.923 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -137.18 143.42 42.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.986 0.422 . . . . 0.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.02 -177.27 28.82 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.353 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.6 m -88.79 107.84 19.18 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.497 ' HB3' ' OE1' ' A' ' 106' ' ' GLU . 4.1 mmm180 -111.29 143.65 28.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.658 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.69 151.27 82.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.26 1.973 . . . . 0.0 110.925 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.689 ' HB2' HG13 ' A' ' 41' ' ' VAL . 22.6 ttp180 -59.21 -27.35 65.64 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.89 92.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.65 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.497 ' OE1' ' HB3' ' A' ' 102' ' ' ARG . 50.0 tt0 -82.84 -38.27 23.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 37.2 t80 -58.38 -51.4 69.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.675 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 47' ' ' VAL . 57.8 mt -70.59 -28.23 64.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -56.7 -55.62 31.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.249 0.547 . . . . 0.0 109.879 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 114' ' ' VAL . 20.8 tp10 -73.74 -31.64 63.46 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.112 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -60.31 -46.58 89.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -60.82 -38.06 84.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.83 -48.52 58.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 110' ' ' GLU . 55.5 t -58.36 -42.45 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.505 0.322 . . . . 0.0 111.75 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.0 p -63.05 -23.85 67.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 110.497 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -86.11 -50.12 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.661 173.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HE2' HG22 ' A' ' 95' ' ' VAL . 38.2 mtpt -55.22 -34.3 63.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.236 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -68.41 -24.09 75.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.949 -0.644 . . . . 0.0 113.152 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.07 -39.55 3.06 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.507 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -158.96 99.9 1.55 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 117' ' ' LYS . 4.9 p -79.64 48.07 0.9 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.314 0.578 . . . . 0.0 111.308 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.36 25.79 69.72 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.902 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -61.64 158.94 14.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.072 0.463 . . . . 0.0 111.456 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.85 52.43 19.68 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -167.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -70.26 13.54 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -168.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -129.26 13.05 6.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.005 0.431 . . . . 0.0 110.044 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -79.46 129.43 34.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.436 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 60.16 30.07 19.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.487 0.661 . . . . 0.0 109.993 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -155.07 105.99 2.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.893 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.4 p80 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.858 175.92 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -90.59 3.15 54.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.36 0.6 . . . . 0.0 110.322 173.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.1 tp -72.68 136.27 45.58 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.588 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 23.0 mmt180 -88.3 106.38 18.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.646 -172.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -110.24 108.71 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 94.2 m-85 -133.17 154.26 81.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.43 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 34.6 Cg_exo -57.05 161.71 10.37 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.09 1.86 . . . . 0.0 111.504 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.569 ' O ' HD23 ' A' ' 12' ' ' LEU . 82.9 t80 -45.81 -53.66 19.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 20.9 Cg_exo -65.17 -40.68 18.91 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.485 1.457 . . . . 0.0 112.146 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.43 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 31.6 tt0 -71.08 -37.33 72.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.926 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.23 79.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.005 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.569 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.6 mm? -61.18 -34.5 75.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.593 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -39.05 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.784 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.5 tp -64.22 -47.31 80.19 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.008 0.432 . . . . 0.0 110.138 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.52 89.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.434 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.7 tm0? -62.77 -51.65 66.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.226 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.72 -14.38 59.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.029 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -118.68 3.62 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.765 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.67 44.4 95.7 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.458 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.8 mmp_? -107.43 174.86 5.7 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.671 -0.311 . . . . 0.0 110.791 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 79.6 mtp -100.52 156.55 17.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 24.6 t -106.79 127.54 62.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.2 ttt -111.07 104.25 12.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -88.38 107.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -93.02 103.97 16.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 110.137 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.692 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 59.8 m-85 -87.41 122.48 31.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.302 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 62' ' ' VAL . 32.5 p80 -132.62 137.21 46.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.527 ' N ' ' HB3' ' A' ' 31' ' ' CYS . 50.6 m -60.81 167.01 3.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.751 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.502 ' N ' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -53.5 -38.22 63.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.285 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -102.05 -48.7 4.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p 41.19 78.45 0.37 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.467 1.107 . . . . 0.0 112.879 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.663 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 69.4 Cg_endo -79.24 -59.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 114.297 -174.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HD2' ' HG ' ' A' ' 101' ' ' SER . 33.9 t80 -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.698 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 22.6 p -82.68 -21.64 34.85 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -173.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 8.3 pt20 -61.79 -30.84 71.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.64 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -66.02 -43.56 87.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.358 0.599 . . . . 0.0 109.551 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.42 ' SD ' ' HB3' ' A' ' 101' ' ' SER . 64.2 mmm -59.41 -44.4 92.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.704 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -62.79 -54.62 36.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.598 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 43' ' ' SER . 58.4 m -70.57 -37.65 74.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.27 -71.78 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.864 -0.523 . . . . 0.0 112.011 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.83 -45.53 94.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.285 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.6 tp -80.93 -31.45 35.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.673 0.273 . . . . 0.0 111.451 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 39' ' ' THR . 33.1 t -83.82 -4.48 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.934 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.81 129.15 14.42 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.351 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.33 -48.38 15.27 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.334 2.69 . . . . 0.0 113.547 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.12 -37.07 86.75 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.409 -176.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.558 ' HA ' HD21 ' A' ' 108' ' ' LEU . 34.8 t -66.63 -57.26 10.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.11 0.481 . . . . 0.0 109.882 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.673 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 50.1 m -52.35 -46.27 66.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.721 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.08 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.665 HD22 HH22 ' A' ' 54' ' ' ARG . 61.4 mt -61.51 -41.55 97.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.222 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.77 -40.66 65.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.673 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.2 mt-10 -57.68 -34.16 69.12 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.459 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -67.67 -52.84 33.17 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.665 HH22 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.88 15.8 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -172.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -121.49 146.4 46.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.474 0.654 . . . . 0.0 111.871 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.475 HG11 ' HB3' ' A' ' 14' ' ' LEU . 56.9 t -113.16 115.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.11 125.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.022 0.439 . . . . 0.0 110.582 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.85 116.91 28.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.888 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -83.48 101.28 11.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.61 103.09 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.453 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 p -94.17 110.77 22.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.292 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.502 ' HB ' ' N ' ' A' ' 29' ' ' GLU . 97.1 t -70.28 -13.65 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.473 0.654 . . . . 0.0 110.367 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -73.94 -27.89 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.837 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.478 ' HB ' ' OE2' ' A' ' 66' ' ' GLU . 76.2 p -91.47 151.91 43.09 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.741 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 43.6 Cg_endo -61.58 -36.92 73.51 Favored 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 122.741 2.294 . . . . 0.0 113.565 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.2 mp0 -57.3 -52.65 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.515 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.12 -29.77 66.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.825 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.741 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 7.9 pt20 -62.39 -47.46 84.07 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.432 ' HA ' ' CD ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -72.62 -33.11 66.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.122 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 66' ' ' GLU . 1.9 mm? -59.19 -42.88 91.93 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . -62.19 -41.56 98.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.449 176.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.432 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 4.5 mtp180 -61.96 -43.81 98.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.12 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.45 -48.8 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.598 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.17 -6.65 58.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.458 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 57.45 46.74 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.738 0.649 . . . . 0.0 110.592 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.23 120.18 28.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.313 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -93.35 105.76 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.601 2.867 . . . . 0.0 110.61 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' HIS . . . -81.47 92.28 1.5 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.362 -168.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.86 48.26 0.81 Allowed Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.698 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 Cg_endo -94.11 173.34 15.81 Favored 'Cis proline' 0 C--N 1.356 0.955 0 CA-C-N 120.541 1.229 . . . . 0.0 112.13 -4.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 18.0 m -142.67 137.95 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.833 167.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.21 118.19 21.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.755 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' A' ' 97' ' ' ARG . 86.6 t -115.27 126.89 72.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -104.72 122.97 46.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 35.4 mt -117.5 130.94 56.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.87 127.95 26.23 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.963 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.478 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 58.4 Cg_endo -73.52 117.75 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 121.973 1.782 . . . . 0.0 110.432 171.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -164.04 143.78 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.716 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.06 -76.28 0.06 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.042 0.839 . . . . 0.0 111.187 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.47 22.43 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.852 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -161.9 -171.39 2.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.48 ' CE2' HD12 ' A' ' 12' ' ' LEU . 58.9 m95 -103.41 128.37 50.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.0 109.997 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 35.5 tt0 -94.81 115.2 27.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.453 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.9 tt0 -73.88 103.01 4.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 171.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.545 HG22 ' HD3' ' A' ' 117' ' ' LYS . 9.0 p -102.39 6.93 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.607 -167.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.8 146.54 4.54 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.468 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HG2' HG22 ' A' ' 83' ' ' VAL . 77.7 mtt180 -123.42 126.58 47.05 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.527 HD21 ' HG3' ' A' ' 110' ' ' GLU . 83.4 mt -109.57 131.7 54.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -137.15 142.14 42.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.44 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.98 136.86 7.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.391 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.44 ' HG ' ' HD2' ' A' ' 33' ' ' TYR . 11.8 m -66.18 122.37 17.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 110.595 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 102' ' ' ARG . 4.0 mmp_? -124.01 157.2 64.42 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.776 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.87 154.87 30.07 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.373 2.049 . . . . 0.0 112.041 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -31.07 67.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.628 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.421 ' O ' ' HE3' ' A' ' 109' ' ' LYS . . . -67.81 -38.33 83.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.291 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.43 -32.81 48.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.538 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.69 -49.86 71.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.74 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.651 HD22 HD12 ' A' ' 50' ' ' LEU . 24.1 mt -70.5 -20.69 62.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 105' ' ' ALA . 1.0 OUTLIER -59.8 -61.2 2.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.611 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.527 ' HG3' HD21 ' A' ' 98' ' ' LEU . 2.1 tm-20 -67.85 -38.72 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 50' ' ' LEU . 3.0 tm? -58.69 -44.34 90.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 110.551 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -64.65 -36.95 85.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 109.954 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 61.4 mt-30 -65.98 -38.96 89.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.539 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 72.4 t -61.51 -34.9 63.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.923 176.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.35 -34.99 71.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.326 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -84.24 -40.11 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.545 ' HD3' HG22 ' A' ' 95' ' ' VAL . 96.9 mttt -52.0 -57.2 10.18 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.027 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -51.68 -34.6 36.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.153 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.09 -17.94 72.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.944 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.82 -83.89 0.22 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.752 -0.264 . . . . 0.0 111.447 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 90.7 m 57.82 24.73 11.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -168.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.04 -129.51 10.73 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -168.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -137.33 -51.09 0.64 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.274 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.466 ' H ' ' CD ' ' A' ' 123' ' ' GLU . . . -112.9 30.77 7.21 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.3 m170 57.97 43.45 21.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 122.911 0.484 . . . . 0.0 110.996 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -72.88 92.61 1.63 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -74.02 82.31 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.574 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.448 ' HB2' ' H ' ' A' ' 129' ' ' HIS . 1.2 m80 61.31 -89.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.055 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.448 ' H ' ' HB2' ' A' ' 128' ' ' HIS . 27.3 m80 -157.41 -30.61 0.08 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 . . . . . 0 C--O 1.242 0.672 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.788 167.151 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttp . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.64 0.257 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p -125.42 23.46 7.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.211 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 57' ' ' VAL . 27.7 tp -120.39 146.13 46.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.276 -171.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.0 mmp_? -77.09 103.76 7.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.371 . . . . 0.0 111.297 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -105.64 115.08 29.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.754 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.531 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.5 m-85 -121.97 159.41 51.63 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.592 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 14.4 Cg_exo -67.88 157.91 59.69 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.964 1.776 . . . . 0.0 110.761 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.59 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 92.6 t80 -43.78 -53.14 13.18 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.2 Cg_exo -59.13 -52.02 5.68 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.787 1.658 . . . . 0.0 112.766 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.4 mm-40 -70.34 -30.6 67.6 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.32 -47.18 87.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.2 0.524 . . . . 0.0 110.259 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 8' ' ' TYR . 11.0 mp -64.45 -40.39 95.64 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.823 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.81 -36.51 65.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.04 0.448 . . . . 0.0 110.741 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -61.79 -37.92 86.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.191 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.12 -49.03 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 46.3 tt0 -57.52 -54.32 48.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 122.913 0.485 . . . . 0.0 112.308 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.84 60.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.612 -172.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -110.35 -22.87 11.5 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.23 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.8 6.83 54.09 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.043 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 20' ' ' ARG . 4.0 mpt_? -85.9 -177.82 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.664 0.268 . . . . 0.0 111.402 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.77 158.74 17.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 38.8 t -106.36 135.62 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.67 0.272 . . . . 0.0 110.747 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.559 ' HG2' ' CD1' ' A' ' 84' ' ' PHE . 6.2 tmm? -125.69 104.74 8.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.581 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 35.2 t -91.16 120.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -175.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 44.0 t80 -108.74 124.33 50.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.081 0.467 . . . . 0.0 111.388 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.911 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.6 m-85 -104.22 132.55 50.36 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.393 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.902 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 30.4 p80 -135.84 161.69 34.9 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.491 0.494 . . . . 0.0 110.644 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.583 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 40.4 m -143.79 164.42 30.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.8 -32.89 20.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 109.995 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -76.54 -7.11 54.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.242 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.716 ' HB3' HG22 ' A' ' 79' ' ' THR . 5.0 t -113.89 87.52 12.73 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.24 27.11 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.047 2.498 . . . . 0.0 113.687 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -86.05 -48.43 8.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.025 0.441 . . . . 0.0 111.503 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.59 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 14.1 t -83.08 -20.45 34.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -171.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -53.21 -29.81 34.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -79.37 -32.24 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.451 0.643 . . . . 0.0 110.326 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -80.28 -49.88 10.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.994 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.0 p30 -64.65 -23.05 67.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.8 m -75.69 -60.42 2.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.499 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.65 -69.46 0.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.744 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.5 t -55.71 -43.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.9 tp -80.9 -23.93 38.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -105.69 9.06 33.25 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.068 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.97 135.24 21.43 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.766 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 10.1 Cg_endo -52.02 -34.21 56.13 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 123.057 2.505 . . . . 0.0 113.561 -177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.61 -45.69 10.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.804 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.613 HG22 HD21 ' A' ' 108' ' ' LEU . 43.0 t -63.34 -51.96 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.292 0.568 . . . . 0.0 109.807 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.442 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 7.6 t -53.21 -41.33 65.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.525 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HE ' ' HB2' ' A' ' 49' ' ' ARG . 14.2 ttm180 -61.84 -35.38 78.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.772 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD13 HD12 ' A' ' 111' ' ' LEU . 76.2 mt -69.28 -40.14 77.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.911 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HB3' HD11 ' A' ' 3' ' ' LEU . 4.2 mm? -70.85 -48.72 52.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.846 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 48' ' ' SER . 12.0 mm-40 -53.0 -33.6 52.35 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.801 0.44 . . . . 0.0 112.182 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -68.11 -57.99 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -173.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.484 ' HD3' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.91 18.88 3.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.312 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 76.2 m-85 -124.97 146.18 49.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.413 0.625 . . . . 0.0 111.245 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 14' ' ' LEU . 39.7 t -115.12 120.09 63.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.569 HG21 HD21 ' A' ' 3' ' ' LEU . 19.0 t -91.58 124.6 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.77 -173.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.581 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -93.96 117.96 30.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.591 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 p -82.66 102.43 11.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.04 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -116.73 129.4 73.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.15 0.5 . . . . 0.0 110.485 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.605 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 2.2 m -112.97 114.45 26.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.811 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.583 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 32.4 t -74.84 -7.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.015 0.912 . . . . 0.0 109.583 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.01 -29.37 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.012 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.614 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 2.9 p -109.11 158.51 34.14 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.614 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.0 Cg_endo -52.29 -50.4 14.15 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.301 3.334 . . . . 0.0 114.914 -167.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -38.62 84.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.991 0.424 . . . . 0.0 110.83 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.3 -31.02 53.28 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.606 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 64' ' ' THR . 92.4 mt-30 -62.36 -39.68 93.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.638 0.375 . . . . 0.0 111.117 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.55 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -77.9 -33.7 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.642 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.55 HD12 ' OE2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -61.27 -42.21 98.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 0.0 110.531 170.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.2 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.564 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.1 ptm180 -71.9 -21.46 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.969 0.414 . . . . 0.0 110.484 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 73' ' ' ARG . 45.6 ttm105 -75.2 -52.42 10.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.45 -8.12 57.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.711 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 64.06 72.19 0.47 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.468 0.651 . . . . 0.0 109.698 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 56.0 t -123.6 136.96 27.85 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.959 -175.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.9 Cg_exo -73.62 -138.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.204 2.603 . . . . 0.0 111.553 173.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -88.12 -69.18 1.28 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.807 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' A' ' 27' ' ' HIS . 6.6 t 178.44 156.09 0.56 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.69 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 1.0 OUTLIER -84.29 132.75 18.39 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.354 -1.102 . . . . 0.0 112.701 0.052 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.911 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 31.4 m -126.41 121.13 31.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 110.584 174.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.652 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 8.8 m-85 -119.45 115.96 25.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 98.2 t -114.01 118.14 57.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.754 0.312 . . . . 0.0 110.548 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.559 ' CD1' ' HG2' ' A' ' 23' ' ' MET . 26.2 m-85 -96.93 118.71 33.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.707 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 94' ' ' GLU . 42.0 mt -115.78 130.06 56.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.077 0.465 . . . . 0.0 110.516 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.01 135.14 20.52 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.6 116.64 4.64 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.574 1.516 . . . . 0.0 109.338 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -151.07 128.4 11.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.761 -171.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.12 -79.8 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.931 0.77 . . . . 0.0 111.341 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.67 21.09 0.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.07 -169.3 3.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 85.6 m95 -107.89 135.76 48.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.242 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -116.3 118.29 32.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.589 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 36.2 tt0 -77.62 108.17 10.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.87 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 31.1 m -88.35 12.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 111.329 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 94' ' ' GLU . . . 142.09 155.02 6.31 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.301 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -130.76 135.5 47.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.652 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.9 mt -108.18 129.75 55.17 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.719 -177.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 80' ' ' PRO . 88.3 t80 -137.41 143.23 41.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.649 173.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.25 145.77 10.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.583 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m -70.09 125.76 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.607 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.636 ' HB3' ' HB2' ' A' ' 106' ' ' GLU . 92.9 mtt180 -137.89 142.75 37.28 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.789 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.473 ' HD2' ' HG2' ' A' ' 106' ' ' GLU . 24.5 Cg_exo -64.21 166.38 17.05 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.489 2.126 . . . . 0.0 111.518 173.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -55.54 -33.17 63.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.872 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -60.88 -47.25 87.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 17.4 mm-40 -72.3 -38.42 68.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.929 0.395 . . . . 0.0 110.602 -176.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -65.3 -39.37 92.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.345 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.613 HD21 HG22 ' A' ' 47' ' ' VAL . 53.4 mt -67.35 -34.62 77.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.061 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 98.5 mttt -55.94 -53.3 58.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 109.871 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.516 ' O ' HG23 ' A' ' 114' ' ' VAL . 4.3 mm-40 -62.53 -44.16 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.432 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.461 HD12 HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -57.71 -41.57 82.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.281 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 14.4 mmt180 -63.09 -49.55 74.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.852 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 6.9 pt20 -66.97 -23.04 65.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.066 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 110' ' ' GLU . 56.7 t -75.21 -41.92 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.838 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.4 m -56.75 -37.95 71.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 110.525 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.86 -32.39 56.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.87 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 54.2 mttp -71.19 -8.52 54.09 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.482 -176.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.46 -20.96 72.17 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.222 173.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.42 -58.53 0.49 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.711 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -99.94 119.31 38.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.7 p -145.88 96.59 2.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.268 0.556 . . . . 0.0 111.899 -171.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.62 -83.68 0.36 Allowed Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.11 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 56.3 -93.96 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.913 0.485 . . . . 0.0 111.024 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.58 33.53 26.13 Favored Glycine 0 C--N 1.335 0.522 0 O-C-N 123.486 0.491 . . . . 0.0 114.284 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -94.48 -6.09 44.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.244 0.522 . . . . 0.0 111.534 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -110.21 102.18 10.89 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 169.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -69.77 -17.76 63.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.286 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -78.94 108.7 12.6 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -62.72 -30.12 71.18 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.754 0.312 . . . . 0.0 111.41 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.004 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -85.95 140.22 30.53 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 51' ' ' LEU . 26.6 tp -58.5 137.79 57.15 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.379 0.424 . . . . 0.0 110.77 -177.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.642 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -77.35 103.58 7.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.71 -174.641 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HH2' HD21 ' A' ' 42' ' ' LEU . 43.7 m95 -114.0 102.67 10.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.7 m-85 -117.06 161.13 34.26 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 27.4 Cg_exo -60.02 162.04 17.49 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.934 1.756 . . . . 0.0 111.436 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.651 ' CD1' HD21 ' A' ' 70' ' ' LEU . 87.8 t80 -49.1 -52.89 43.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.1 Cg_exo -65.25 -40.51 19.2 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.632 1.555 . . . . 0.0 111.951 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.431 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 33.2 tt0 -69.46 -39.23 77.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 -177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.56 82.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.019 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.96 -34.6 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -38.45 64.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.682 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.463 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.1 tp -65.23 -44.6 87.69 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 109.71 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.14 87.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -50.85 71.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.77 -14.12 60.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.197 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -118.23 -9.9 10.36 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.2 89.71 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.714 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.773 ' HG3' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -73.07 169.75 16.33 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.466 0.306 . . . . 0.0 111.521 175.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.559 ' SD ' HG22 ' A' ' 86' ' ' VAL . 68.1 mtm -101.4 167.84 9.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.39 125.95 62.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.079 0.466 . . . . 0.0 111.242 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.79 ' HG3' HG13 ' A' ' 57' ' ' VAL . 5.4 tpt -103.67 102.77 12.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.19 108.53 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.954 0.407 . . . . 0.0 110.067 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.776 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 72.6 t80 -103.7 103.55 13.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.419 0.628 . . . . 0.0 110.743 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 70' ' ' LEU . 60.3 m-85 -77.29 105.38 8.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.24 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.776 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 24.4 p80 -104.15 138.29 40.85 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.618 175.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.685 ' OG ' ' HA2' ' A' ' 78' ' ' GLY . 49.3 m -122.67 144.06 49.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.627 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -42.81 62.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.303 0.573 . . . . 0.0 110.13 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.564 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 91.5 m-70 -101.87 42.74 1.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.263 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 28.3 p -93.58 100.91 5.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.617 176.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -88.41 -7.69 5.71 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.268 1.978 . . . . 0.0 114.152 -176.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -84.58 -34.51 23.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.709 ' HB3' ' HG3' ' A' ' 80' ' ' PRO . 29.2 p -80.96 -23.18 38.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -170.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -55.13 -32.41 62.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.18 -33.37 24.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.402 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.0 ttp -80.73 -35.26 33.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.596 -173.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 38.3 p30 -72.14 -22.69 61.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 111.229 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.9 m -71.34 -59.94 2.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.609 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -91.48 -67.74 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.463 0.649 . . . . 0.0 111.482 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.578 HG13 ' HA ' ' A' ' 104' ' ' ARG . 59.1 t -60.01 -58.95 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.98 -168.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.606 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 19.5 tp -78.84 -10.59 59.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.089 -169.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -101.05 -9.87 21.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.755 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 31.6 t70 -56.67 133.25 78.11 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.341 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 66.4 Cg_exo -53.25 -48.74 20.41 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.191 2.594 . . . . 0.0 113.086 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.59 -43.14 99.27 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.37 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.769 HG22 HD21 ' A' ' 108' ' ' LEU . 50.0 t -60.07 -56.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 175.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 m -56.91 -36.53 70.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.579 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.476 ' HA ' ' HB2' ' A' ' 52' ' ' GLU . 99.7 mtt180 -75.44 -21.16 58.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.457 HD12 HD22 ' A' ' 108' ' ' LEU . 69.1 mt -70.68 -36.52 73.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.163 169.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB2' HD11 ' A' ' 3' ' ' LEU . 1.5 mm? -70.45 -49.35 49.6 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.076 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 49' ' ' ARG . 17.1 mm-40 -45.88 -39.16 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.991 0.516 . . . . 0.0 112.124 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.503 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -68.13 -57.18 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.773 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.75 20.7 3.3 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -171.755 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.472 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 96.2 m-85 -133.58 140.36 47.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.481 0.657 . . . . 0.0 111.674 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 14' ' ' LEU . 46.9 t -110.44 115.35 49.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.79 HG13 ' HG3' ' A' ' 23' ' ' MET . 20.8 t -86.76 126.35 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.523 . . . . 0.0 110.359 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.17 116.52 29.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.521 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 44.3 t -87.01 100.71 12.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.509 HG11 HD22 ' A' ' 70' ' ' LEU . 59.4 t -110.24 119.0 58.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.027 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.633 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.0 p -90.43 111.97 23.42 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 21.6 m -74.29 -0.41 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.526 0.679 . . . . 0.0 110.346 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -29.49 31.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.086 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.655 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -95.63 166.73 14.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.977 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.655 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.5 Cg_endo -51.86 -55.85 3.52 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.511 2.807 . . . . 0.0 114.6 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -62.98 -35.66 80.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.353 . . . . 0.0 110.938 -178.454 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.95 -40.88 62.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.724 174.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 5.9 mt-30 -62.29 -30.87 71.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.259 0.552 . . . . 0.0 110.594 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' CD ' HH21 ' A' ' 73' ' ' ARG . 5.3 tp10 -66.05 -53.43 38.49 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.631 173.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.651 HD21 ' CD1' ' A' ' 8' ' ' TYR . 6.7 mp -58.62 -37.48 75.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 176.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.9 28.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.983 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 69' ' ' GLU . 36.4 ptt180 -66.27 -23.34 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.462 HH21 ' CD ' ' A' ' 69' ' ' GLU . 14.2 ttm180 -83.49 -51.21 7.55 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.316 -175.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.26 4.12 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.637 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 68.67 22.13 7.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.793 0.437 . . . . 0.0 111.072 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.97 119.78 66.47 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.32 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.974 2.449 . . . . 0.0 112.589 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.685 ' HA2' ' OG ' ' A' ' 28' ' ' SER . . . -174.8 120.98 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.632 ' HB ' ' C ' ' A' ' 80' ' ' PRO . 31.2 m -146.56 -61.04 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -165.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.709 ' HG3' ' HB3' ' A' ' 34' ' ' CYS . 17.8 Cg_endo -79.39 172.74 58.12 Favored 'Cis proline' 0 N--CA 1.492 1.414 0 CA-C-N 123.111 2.147 . . . . 0.0 115.915 4.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 m -125.97 143.12 51.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.254 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' HD1' ' HD1' ' A' ' 25' ' ' TYR . 1.2 m-85 -118.27 127.99 54.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.91 117.69 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.727 0.299 . . . . 0.0 110.716 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.86 125.77 42.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.78 0.324 . . . . 0.0 110.416 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 31.8 mt -117.1 142.23 47.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.577 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.559 HG22 ' SD ' ' A' ' 21' ' ' MET . 10.9 t -108.59 139.84 21.22 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 21' ' ' MET . 41.2 Cg_endo -72.66 114.47 4.03 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 160.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' HE2' ' SG ' ' A' ' 121' ' ' CYS . 17.5 mttp -142.21 113.36 7.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.35 15.77 9.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.669 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.4 37.83 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.985 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.04 178.29 4.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.629 0.252 . . . . 0.0 110.403 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -109.4 128.74 55.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.252 0.549 . . . . 0.0 110.319 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 23.7 tt0 -109.96 124.66 51.8 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.373 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 78.2 tt0 -77.08 100.15 5.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 86' ' ' VAL . 14.8 p -94.4 -7.12 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.467 -169.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.84 125.71 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.939 -1.124 . . . . 0.0 112.89 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -114.87 128.5 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.112 0.482 . . . . 0.0 109.995 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 97.0 mt -117.24 141.46 48.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.882 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 79' ' ' THR . 79.6 t80 -137.42 127.76 26.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.847 0.356 . . . . 0.0 110.608 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.96 154.02 30.22 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.843 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -66.23 142.39 57.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -123.82 132.95 24.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -56.94 140.86 93.27 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.928 1.752 . . . . 0.0 109.683 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.578 ' HA ' HG13 ' A' ' 41' ' ' VAL . 16.7 ttp180 -51.23 -34.91 34.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.6 43.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 111.074 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.71 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 10.3 pt-20 -88.99 -20.04 24.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.851 -175.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 70.7 t80 -60.82 -43.25 98.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 171.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.769 HD21 HG22 ' A' ' 47' ' ' VAL . 89.1 mt -68.42 -34.26 75.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.881 174.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 14.8 ttpt -55.65 -52.77 62.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.211 171.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.71 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 28.9 mm-40 -57.03 -45.05 83.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.499 0.666 . . . . 0.0 109.694 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 50' ' ' LEU . 20.9 tp -61.46 -41.37 97.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 26.7 mmt180 -62.35 -41.33 98.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.823 0.344 . . . . 0.0 110.298 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 10.5 mt-30 -56.4 -37.24 69.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.516 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.513 ' HA ' ' HZ2' ' A' ' 117' ' ' LYS . 61.7 t -76.98 -37.35 26.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.758 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.9 m -54.92 -42.42 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.782 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.5 -47.56 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.289 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HB2' ' HZ2' ' A' ' 117' ' ' LYS . 10.4 mtmp? -68.99 -13.25 62.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.576 -176.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.25 -33.12 69.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.73 -45.14 1.06 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.854 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -100.63 94.15 5.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.941 0.4 . . . . 0.0 111.219 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.569 ' SG ' ' HE2' ' A' ' 88' ' ' LYS . 25.7 p -127.04 -39.97 1.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 176.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -81.07 74.14 2.47 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.439 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -143.57 148.59 36.14 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.03 40.7 2.96 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.975 -174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 69.53 -57.01 0.55 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.444 0.698 . . . . 0.0 112.169 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -144.13 19.23 1.76 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.51 0.671 . . . . 0.0 109.359 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -96.69 27.97 3.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.731 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -73.58 86.38 1.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.191 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -124.4 27.12 7.11 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 . . . . . 0 C--O 1.242 0.682 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.597 -179.22 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.956 0.407 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p -144.48 -51.5 0.29 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.718 HD21 HD23 ' A' ' 51' ' ' LEU . 6.7 tp -64.35 129.78 41.23 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.668 175.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.756 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 34.9 mmt180 -78.03 110.97 13.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.106 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -108.6 104.47 13.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.943 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.756 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 97.0 m-85 -110.49 160.27 29.15 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.936 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 20.0 Cg_exo -62.69 165.71 15.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.915 1.743 . . . . 0.0 110.552 170.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.568 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 93.5 t80 -49.87 -53.26 44.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.6 Cg_exo -64.42 -47.51 5.74 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.809 1.673 . . . . 0.0 112.198 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 31.2 tt0 -64.91 -35.39 81.01 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.437 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.84 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.37 . . . . 0.0 111.139 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.7 mp -62.05 -30.88 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.021 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.33 -44.04 76.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.573 HD22 ' CE2' ' A' ' 6' ' ' TYR . 13.3 tp -61.72 -47.32 85.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.262 0.553 . . . . 0.0 110.247 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.91 89.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.246 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -68.1 -39.23 82.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.39 -18.88 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -116.02 -8.56 11.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 38.21 63.06 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.659 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -101.22 176.99 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.5 mtp -107.47 149.99 27.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.9 t -106.94 131.56 56.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.461 . . . . 0.0 111.536 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.465 ' SD ' HD21 ' A' ' 51' ' ' LEU . 20.5 ttt -107.93 107.25 17.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.829 172.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 60' ' ' VAL . 40.9 t -84.75 103.1 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.54 ' OH ' ' HB3' ' A' ' 38' ' ' ASN . 92.7 t80 -97.67 108.02 20.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.74 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.935 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 74.8 m-85 -86.47 118.66 26.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.085 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.591 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 33.5 p80 -135.36 179.3 6.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 31' ' ' CYS . 93.7 p -143.86 166.52 24.7 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -56.76 -22.22 34.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.575 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.52 23.58 5.11 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 23.0 p -52.45 110.78 2.09 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 173.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 12.9 Cg_endo -56.19 -81.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.289 2.659 . . . . 0.0 114.532 -167.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -77.78 -17.66 57.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.32 0.581 . . . . 0.0 110.499 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 37.3 t -62.94 -36.85 84.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 26.5 pt20 -72.03 -17.15 62.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 111.212 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -81.79 -40.25 22.87 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.711 0.767 . . . . 0.0 109.716 171.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.592 ' SD ' ' HG3' ' A' ' 80' ' ' PRO . 75.9 mtp -69.39 -43.22 73.94 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.892 -170.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.54 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 30.1 p-10 -66.02 -35.08 79.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.863 0.363 . . . . 0.0 110.445 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 43' ' ' SER . 85.6 m -66.8 -55.94 12.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.585 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.97 -69.84 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.874 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.5 -51.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.788 -169.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 23.6 tp -76.87 -27.25 54.97 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.575 -173.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.7 m -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.748 0.309 . . . . 0.0 111.019 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.38 130.16 61.55 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.837 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.9 -43.09 24.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.508 2.805 . . . . 0.0 113.762 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.97 -43.45 65.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.453 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -65.68 -49.62 76.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 121.659 0.742 . . . . 0.0 109.831 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 32.4 m -59.58 -32.27 70.21 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.656 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.765 ' HE ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.86 -42.07 97.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.833 ' HA ' HH21 ' A' ' 54' ' ' ARG . 64.8 mt -60.33 -45.03 94.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.654 0.264 . . . . 0.0 111.223 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.718 HD23 HD21 ' A' ' 3' ' ' LEU . 6.2 tp -72.34 -31.8 65.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.396 0.617 . . . . 0.0 111.051 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.595 ' HA ' HD13 ' A' ' 3' ' ' LEU . 8.3 tp10 -61.74 -35.95 79.59 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 113.741 -168.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -91.5 -31.17 16.06 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -168.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.833 HH21 ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -134.48 5.08 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -170.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.7 142.6 48.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.551 0.691 . . . . 0.0 111.956 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 14' ' ' LEU . 43.8 t -107.87 115.21 48.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.51 126.71 40.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.852 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -94.95 116.98 29.39 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.717 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.7 p -82.42 101.06 10.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG13 ' HA2' ' A' ' 67' ' ' GLY . 99.8 t -115.17 123.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 -175.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.525 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 1.9 t -116.39 129.34 56.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.011 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.54 65.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.104 0.954 . . . . 0.0 110.0 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.67 -36.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.039 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.569 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 30.7 p -82.89 160.53 60.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.201 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 15.6 Cg_endo -52.92 -55.39 3.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.062 2.508 . . . . 0.0 113.415 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' HD13 ' A' ' 70' ' ' LEU . 10.2 pt-20 -57.03 -44.85 83.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.983 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -68.91 -39.08 85.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.38 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -63.03 -48.68 77.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.049 0.54 . . . . 0.0 111.663 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.4 pt-20 -73.48 -29.05 62.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.588 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.672 ' HG ' ' HE2' ' A' ' 74' ' ' TYR . 5.3 mp -67.28 -40.61 86.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.809 173.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.55 78.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 9.3 ptm180 -83.48 -19.51 35.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.719 0.295 . . . . 0.0 111.371 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 48.0 ttt180 -72.69 -44.03 62.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.672 ' HE2' ' HG ' ' A' ' 70' ' ' LEU . 53.3 m-85 -102.45 -2.35 28.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 26.2 ptt180 45.95 71.19 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.526 1.13 . . . . 0.0 112.551 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG11 HG21 ' A' ' 81' ' ' THR . 13.5 t -137.74 94.65 11.53 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.882 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -97.83 128.08 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.415 2.743 . . . . 0.0 111.416 169.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.33 42.19 0.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.99 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -47.03 152.36 1.0 Allowed Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 122.795 0.438 . . . . 0.0 110.741 173.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 34' ' ' CYS . 58.6 Cg_endo -67.01 151.63 83.25 Favored 'Cis proline' 0 C--N 1.351 0.676 0 N-CA-C 114.841 1.054 . . . . 0.0 114.841 4.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.935 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.3 m -141.02 133.63 28.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.34 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 3.0 m-85 -123.14 111.88 17.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -175.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 39.5 t -119.12 112.49 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 110.146 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.5 122.33 38.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.394 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 94' ' ' GLU . 30.9 mt -113.55 135.76 53.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -109.12 130.74 22.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.81 116.89 4.09 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.633 1.556 . . . . 0.0 110.212 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 90' ' ' GLY . 35.8 ttpt -151.79 134.93 15.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.333 -175.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 71.14 -37.61 0.4 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.742 0.817 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 88' ' ' LYS . . . 149.7 -10.92 0.95 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.51 -179.13 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -108.16 136.71 47.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.042 0.449 . . . . 0.0 110.489 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -117.33 126.23 52.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.104 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.596 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 53.3 tt0 -77.3 99.69 5.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 117' ' ' LYS . 4.9 p -96.7 -10.43 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.176 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.15 126.79 1.48 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.449 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.41 127.53 49.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.972 0.415 . . . . 0.0 109.975 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 99.0 mt -117.72 139.17 51.41 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.278 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -137.26 142.87 41.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.798 0.332 . . . . 0.0 110.838 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.06 168.93 45.37 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.635 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.463 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 10.9 m -65.38 131.76 47.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.022 0.439 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.5 133.94 23.51 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 106' ' ' GLU . 12.4 Cg_endo -59.87 154.4 50.37 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.716 1.611 . . . . 0.0 110.991 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -30.69 64.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.839 0.352 . . . . 0.0 110.437 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.04 63.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.31 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 103' ' ' PRO . 22.9 tp10 -73.19 -42.27 62.9 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CE2' HD12 ' A' ' 111' ' ' LEU . 9.8 t80 -66.24 -44.85 82.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.405 -178.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.65 -47.88 78.78 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -52.26 -58.85 5.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.32 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 114' ' ' VAL . 2.3 tp10 -78.98 -28.43 43.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.519 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 50' ' ' LEU . 3.4 tt -61.22 -43.19 99.27 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 116' ' ' VAL . 22.6 tpt180 -61.43 -45.8 92.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.471 ' HB3' ' NZ ' ' A' ' 117' ' ' LYS . 34.4 mt-30 -64.73 -43.65 92.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.42 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 110' ' ' GLU . 54.6 t -58.72 -40.87 80.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -56.43 -28.54 59.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 112' ' ' ARG . 59.2 t -83.88 -34.33 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.885 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 121' ' ' CYS . 13.6 mptt -57.4 -28.5 63.29 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.615 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.85 -38.94 93.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.018 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.2 60.33 2.26 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.837 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.81 144.72 0.05 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.218 0.599 . . . . 0.0 110.363 -175.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 117' ' ' LYS . 20.7 p -171.0 -52.12 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.559 0.695 . . . . 0.0 109.437 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.62 -177.33 41.24 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.709 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -116.06 92.96 4.05 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.143 0.496 . . . . 0.0 109.891 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -100.39 34.98 5.12 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.395 -174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -70.82 81.97 0.63 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.499 0.666 . . . . 0.0 110.812 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.596 ' CE1' ' HB3' ' A' ' 94' ' ' GLU . 17.5 p-80 -87.37 97.29 10.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.71 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -81.92 73.09 8.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.875 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -166.14 122.6 1.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.936 -177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -115.9 -37.83 3.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.113 0.482 . . . . 0.0 110.509 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.8 t60 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.471 -0.776 . . . . 0.0 109.146 177.527 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 tpp . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.755 0.312 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m -86.15 27.31 0.92 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.697 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.8 tp -65.55 133.0 50.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.4 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -107.36 117.31 33.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 36.8 m95 -111.24 123.14 49.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.215 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.555 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 37.0 m-85 -132.06 160.92 65.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.232 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 26.2 Cg_exo -61.22 162.16 20.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.003 1.802 . . . . 0.0 110.929 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.545 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 72.6 t80 -49.92 -50.24 69.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 34.7 Cg_exo -61.33 -46.61 14.41 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.808 1.672 . . . . 0.0 112.42 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -68.01 -40.61 82.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.219 -177.575 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.03 -35.92 82.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 177.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.0 -41.41 64.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.197 0.522 . . . . 0.0 110.228 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -57.23 -47.96 80.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.724 177.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.9 -41.92 67.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.455 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -61.05 -51.4 69.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 111.532 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.28 -15.35 58.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.927 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -112.86 -4.57 13.95 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.331 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.19 49.04 49.19 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.101 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -114.64 178.75 4.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 89.3 mtp -105.22 151.48 24.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.88 125.36 61.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.106 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.0 ttt -101.21 102.78 13.75 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 39.6 t -83.3 102.91 9.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.435 ' CD2' ' HZ3' ' A' ' 5' ' ' TRP . 24.7 t80 -98.61 108.8 21.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.176 -175.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.614 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 96.4 m-85 -93.23 125.36 37.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.377 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 25.4 p80 -127.56 150.12 49.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.621 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 24.5 m -142.96 141.21 31.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.522 0.201 . . . . 0.0 110.825 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -75.89 -22.41 56.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 166.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.416 ' HE1' ' HA ' ' A' ' 63' ' ' ASP . 29.1 m80 -72.64 -11.99 60.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.047 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.552 ' SG ' ' HA2' ' A' ' 78' ' ' GLY . 10.9 t -137.61 77.55 39.45 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.483 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.53 17.71 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 122.975 2.45 . . . . 0.0 114.702 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' HB3' ' OG ' ' A' ' 101' ' ' SER . 57.3 m-85 -77.27 -18.28 57.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.545 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 13.2 t -83.43 -30.93 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.814 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.448 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 10.6 mm100 -52.2 -42.01 63.15 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -170.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.035 0.445 . . . . 0.0 110.925 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.49 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 45.2 ttm -77.61 -51.89 9.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.251 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 35' ' ' GLN . 2.2 p-10 -65.49 -17.1 64.3 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 m -81.34 -62.33 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.679 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -92.88 -68.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.449 0.642 . . . . 0.0 112.116 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 89.6 t -52.67 -47.29 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.434 -168.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 21.4 tp -81.3 -18.43 45.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.982 0.42 . . . . 0.0 110.88 -173.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 m -87.41 -10.99 50.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.58 130.01 10.74 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.083 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.13 -31.96 94.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.013 2.475 . . . . 0.0 113.181 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.36 -44.53 13.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.707 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 HD21 ' A' ' 108' ' ' LEU . 48.5 t -61.52 -52.88 55.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.548 0.69 . . . . 0.0 109.495 175.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.753 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 34.1 t -50.46 -44.37 55.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.316 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -57.39 -41.12 79.61 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.589 0.555 . . . . 0.0 111.763 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.709 HD12 HD22 ' A' ' 108' ' ' LEU . 76.2 mt -61.97 -35.87 79.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.598 0.237 . . . . 0.0 110.945 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.98 -38.7 57.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.43 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.753 ' HG3' ' O ' ' A' ' 48' ' ' SER . 55.9 mt-10 -55.55 -39.08 70.15 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.058 0.456 . . . . 0.0 111.436 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -62.74 -53.33 56.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -169.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.647 ' HE ' ' HE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.7 5.82 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.647 ' HE1' ' HE ' ' A' ' 54' ' ' ARG . 80.3 m-85 -110.44 143.17 41.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 112.525 -173.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' A' ' 14' ' ' LEU . 49.0 t -110.76 115.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.7 t -86.54 123.58 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.1 0.476 . . . . 0.0 110.916 -173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -90.39 116.95 28.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -82.44 101.04 10.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.92 118.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 63' ' ' ASP . 2.6 m -102.11 110.82 22.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.278 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.621 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 6.1 t -82.67 28.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 122.574 1.178 . . . . 0.0 109.03 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.511 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 25.5 m-20 -113.42 -20.04 11.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.84 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 4.1 p -115.24 161.36 30.09 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.996 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.5 Cg_endo -51.96 -56.48 2.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.425 2.75 . . . . 0.0 114.025 -170.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -46.22 66.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.22 -36.46 63.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.879 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -63.75 -36.62 84.48 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.577 0.351 . . . . 0.0 111.018 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' OE1' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mm-40 -68.67 -39.06 80.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.177 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.9 mt -67.96 -41.19 82.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.449 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.11 93.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.551 0.215 . . . . 0.0 111.321 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HD3' ' OE1' ' A' ' 69' ' ' GLU . 9.3 ptm180 -73.38 -20.92 60.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 110.491 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -74.64 -56.27 4.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.287 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -75.7 -9.09 58.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.919 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.4 ttm105 68.79 42.63 1.37 Allowed 'General case' 0 CA--C 1.528 0.127 0 O-C-N 123.834 0.708 . . . . 0.0 110.793 170.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.635 HG11 HG21 ' A' ' 81' ' ' THR . 33.7 t -122.31 104.3 37.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.134 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -93.64 128.81 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.236 2.624 . . . . 0.0 111.765 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.552 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 108.88 150.96 14.45 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.255 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.626 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 39.8 p -141.74 162.76 44.81 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 72.4 Cg_endo -78.09 142.14 68.68 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 113.222 1.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.635 HG21 HG11 ' A' ' 76' ' ' VAL . 87.3 m -123.52 122.05 37.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.749 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 7.5 m-85 -115.82 112.27 21.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.184 -177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 46.8 t -106.77 118.41 54.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.616 ' HB2' HG22 ' A' ' 95' ' ' VAL . 79.3 m-85 -95.91 104.91 16.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.926 0.393 . . . . 0.0 110.593 -177.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 94' ' ' GLU . 78.5 mt -105.52 126.3 51.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.557 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 t -110.25 132.47 21.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.09 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.56 116.45 2.6 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.153 1.902 . . . . 0.0 109.855 171.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -161.73 141.36 10.11 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.207 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.19 -72.13 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.13 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.15 25.82 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.759 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.97 165.12 25.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.601 0.239 . . . . 0.0 110.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.33 134.81 33.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -120.35 117.56 28.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.339 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.535 ' HA ' HD23 ' A' ' 85' ' ' LEU . 14.6 tt0 -77.05 112.05 13.28 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 84' ' ' PHE . 24.3 m -77.66 -18.08 14.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.422 0.629 . . . . 0.0 109.827 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.28 162.41 11.79 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.024 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 138.45 53.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.093 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 77.3 mt -111.87 130.72 55.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.775 -175.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -137.19 133.99 35.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.0 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.73 159.97 8.42 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.074 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 33' ' ' TYR . 73.6 m -94.88 17.11 14.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.068 0.461 . . . . 0.0 111.585 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 106' ' ' GLU . 14.1 mmt180 -57.87 140.71 81.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.78 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 102' ' ' ARG . 30.9 Cg_exo -62.29 172.3 4.38 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.344 2.696 . . . . 0.0 112.381 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 39.9 ptt180 -51.78 -26.13 9.04 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.839 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -53.34 -63.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.266 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.726 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 3.0 mp0 -70.07 -33.0 71.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 110.952 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.06 -47.05 87.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.709 HD22 HD12 ' A' ' 50' ' ' LEU . 75.7 mt -70.48 -33.31 71.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.726 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.7 mttt -57.06 -51.29 69.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.53 176.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 114' ' ' VAL . 11.6 mm-40 -68.91 -36.41 77.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.773 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.467 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.1 tt -64.44 -34.88 79.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 116' ' ' VAL . 10.3 mmm180 -61.29 -41.33 96.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.471 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -67.62 -33.38 74.87 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.382 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.597 HG13 HG21 ' A' ' 95' ' ' VAL . 77.9 t -64.45 -45.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 p -65.39 -25.54 67.6 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.995 0.426 . . . . 0.0 110.7 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.6 t -77.19 -43.68 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.217 175.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.601 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 63.7 mttm -61.25 -37.0 81.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.281 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.87 70.12 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.056 -0.593 . . . . 0.0 113.092 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.94 11.47 32.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.928 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.18 -72.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.767 0.284 . . . . 0.0 110.724 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 42.2 t 64.0 -87.87 0.03 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.287 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.2 -48.38 80.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.236 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.04 41.93 1.1 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.332 0.587 . . . . 0.0 110.315 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.61 29.21 3.32 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -122.42 -64.01 1.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.6 m80 57.01 -150.6 0.44 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -171.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -155.84 -25.46 0.11 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.568 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -77.77 35.58 0.2 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -110.27 5.83 22.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 171.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 . . . . . 0 C--O 1.243 0.713 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.7 177.429 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -127.32 -26.28 3.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.564 HD12 ' OE2' ' A' ' 52' ' ' GLU . 17.5 tp -116.21 148.42 40.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.698 0.285 . . . . 0.0 111.701 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -95.5 107.64 19.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.373 0.606 . . . . 0.0 112.086 -177.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.45 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.5 m95 -105.9 132.49 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.755 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -135.21 153.65 78.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 24.9 Cg_exo -59.8 164.38 11.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.006 1.804 . . . . 0.0 111.443 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.558 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 86.4 t80 -48.59 -53.37 36.48 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 18.5 Cg_exo -65.89 -44.08 8.36 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.573 1.515 . . . . 0.0 112.194 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 26.0 tt0 -67.5 -38.72 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.223 -176.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.38 77.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.076 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 8' ' ' TYR . 7.9 mp -60.17 -41.21 92.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.849 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.49 -38.58 74.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.39 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -58.43 -47.97 82.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.509 177.029 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -70.62 -43.43 69.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.93 -46.35 85.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.982 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.6 57.32 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -115.94 0.18 12.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.591 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.67 45.64 57.94 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.972 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 83.5 mmt-85 -117.57 177.63 4.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.085 0.469 . . . . 0.0 111.77 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.3 mtp -102.1 152.21 21.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.625 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.99 129.29 62.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.624 0.249 . . . . 0.0 111.316 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 ttp -109.77 104.25 13.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 24.4 t -81.05 107.33 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.019 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 52.9 t80 -94.97 104.77 16.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.606 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.463 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.3 m-85 -87.62 119.82 28.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.239 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 30.0 p80 -123.41 147.84 46.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.46 176.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 31' ' ' CYS . 14.7 m -136.77 150.64 48.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.013 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.677 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.23 -26.72 52.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.278 0.561 . . . . 0.0 109.849 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -72.73 -16.7 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.053 173.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 56.8 m -124.15 60.69 23.53 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.702 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.65 23.81 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 114.132 -169.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.78 -36.54 78.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.216 0.531 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.576 ' HB2' ' CD ' ' A' ' 80' ' ' PRO . 7.2 t -68.22 -18.84 64.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.147 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -52.82 -26.11 13.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -83.2 -41.31 18.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.735 0.779 . . . . 0.0 109.738 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mmm -63.13 -39.24 94.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.193 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.9 p30 -77.97 -17.74 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.444 -175.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -74.01 -52.21 13.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 0.0 110.493 177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.86 -71.26 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.309 0.576 . . . . 0.0 111.564 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.445 ' O ' HG21 ' A' ' 47' ' ' VAL . 57.6 t -64.93 -54.34 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.675 -167.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.599 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 18.2 tp -79.76 -12.68 59.77 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.074 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 m -106.89 -3.09 20.64 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.11 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.9 133.33 38.63 Favored Pre-proline 0 C--O 1.235 0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.214 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.668 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 8.8 Cg_endo -51.87 -46.22 33.56 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.426 2.75 . . . . 0.0 113.106 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.58 93.85 Favored Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.113 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.85 HG22 HD21 ' A' ' 108' ' ' LEU . 57.4 t -61.73 -49.71 83.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.158 0.504 . . . . 0.0 109.795 174.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.532 ' HA ' HD13 ' A' ' 3' ' ' LEU . 35.3 m -56.05 -39.76 72.5 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.003 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.668 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 18.7 mtm180 -57.99 -40.76 81.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.075 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.855 HD12 HD22 ' A' ' 108' ' ' LEU . 76.3 mt -63.49 -39.83 95.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.548 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.36 -59.82 2.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.144 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.564 ' OE2' HD12 ' A' ' 3' ' ' LEU . 20.5 mm-40 -44.69 -40.17 5.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -171.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.3 -42.41 88.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.422 HH21 ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -136.01 6.18 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.95 149.8 43.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.281 0.563 . . . . 0.0 111.476 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 14' ' ' LEU . 46.6 t -117.07 119.89 63.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 168.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 3' ' ' LEU . 19.4 t -86.99 116.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.757 -173.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -90.86 117.11 29.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 p -88.15 102.23 14.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.765 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 8' ' ' TYR . 59.9 t -108.39 123.14 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 110.606 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.648 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.8 p -93.91 110.41 22.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.853 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.644 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 28.0 t -82.83 0.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.318 1.056 . . . . 0.0 109.071 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.677 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -81.43 -33.86 31.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.528 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 33.4 p -92.63 160.84 33.62 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 25.6 Cg_endo -56.61 -53.95 4.48 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.3 2.667 . . . . 0.0 114.437 -171.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -37.02 85.7 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.277 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.19 -40.84 70.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.669 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 2.0 mt-30 -59.56 -35.16 73.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.317 0.58 . . . . 0.0 110.611 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.027 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.1 mt -64.38 -32.05 73.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -68.75 -30.68 69.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.846 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 51.9 mtp180 -71.69 -47.44 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 0.0 109.151 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -64.06 -50.2 69.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.055 -174.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.65 -0.02 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 55.71 81.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.778 0.674 . . . . 0.0 111.126 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -127.88 91.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.846 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -100.03 107.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.499 2.799 . . . . 0.0 111.994 170.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.87 169.19 12.61 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.918 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 31' ' ' CYS . 83.3 m -155.76 139.88 11.56 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.576 ' CD ' ' HB2' ' A' ' 34' ' ' CYS . 64.1 Cg_endo -88.27 132.45 11.49 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.816 -1.327 . . . . 0.0 112.993 0.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 28.5 m -107.69 110.9 22.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.8 175.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 33.1 m-85 -99.87 113.19 25.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 95.0 t -102.95 115.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.552 ' CD2' HG11 ' A' ' 114' ' ' VAL . 90.5 m-85 -94.11 113.82 25.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.781 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 24.4 mt -111.54 128.13 55.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.183 0.516 . . . . 0.0 110.619 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.14 125.17 32.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.792 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.03 117.58 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.707 1.605 . . . . 0.0 110.814 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.801 ' HE2' ' HB2' ' A' ' 93' ' ' GLU . 65.2 pttt -133.83 128.55 34.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.06 -75.72 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.191 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.76 19.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.171 -0.537 . . . . 0.0 111.816 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.23 165.21 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -94.86 139.71 30.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.299 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.801 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 9.6 tp10 -117.49 136.0 53.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.554 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 34.8 tt0 -89.82 96.58 10.75 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -83.99 -4.67 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.323 -170.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.76 162.16 11.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.946 177.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.481 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 87.3 mtt180 -127.57 136.74 52.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.38 150.97 37.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.799 0.333 . . . . 0.0 110.844 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -118.02 114.46 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA3' ' HG2' ' A' ' 80' ' ' PRO . . . -79.79 89.03 1.25 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.306 -172.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 p -135.7 -23.72 1.38 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.149 0.499 . . . . 0.0 110.547 175.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -70.03 155.54 93.29 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.691 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.8 167.08 9.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.669 2.246 . . . . 0.0 111.924 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -55.07 -38.01 67.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.512 -175.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -57.99 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.984 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.541 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 27.9 tt0 -75.08 -29.5 60.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.349 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.99 -47.88 84.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.873 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.855 HD22 HD12 ' A' ' 50' ' ' LEU . 47.1 mt -69.46 -27.12 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.238 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.541 ' HE3' ' HG3' ' A' ' 106' ' ' GLU . 29.3 ttpp -61.2 -49.98 74.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.475 ' O ' HG23 ' A' ' 114' ' ' VAL . 5.8 mm-40 -68.03 -39.95 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.349 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.48 -40.65 92.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.046 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.23 -39.28 89.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.352 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -66.04 -28.67 69.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.552 HG11 ' CD2' ' A' ' 84' ' ' PHE . 97.8 t -69.95 -39.38 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.1 m -59.06 -41.0 86.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.172 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.74 -43.99 99.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.392 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 121' ' ' CYS . 35.6 mtmm -75.2 -7.41 53.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.52 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.99 -39.17 24.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.82 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.51 -43.19 6.24 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.401 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.33 -31.88 22.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.478 0.18 . . . . 0.0 111.101 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' LYS . 17.2 t 68.98 -57.59 0.51 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.069 0.856 . . . . 0.0 111.334 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.42 27.27 5.33 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.93 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -67.17 -66.26 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.067 0.461 . . . . 0.0 110.116 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.99 175.4 47.96 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.532 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -172.39 23.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 0.0 110.295 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -83.74 135.21 34.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.236 0.541 . . . . 0.0 110.898 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -136.88 87.52 2.29 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.532 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -127.67 93.4 3.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.784 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -119.76 -40.27 2.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 66.3 t60 . . . . . 0 C--O 1.241 0.645 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.911 175.109 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 51' ' ' LEU . 46.0 tp . . . . . 0 C--O 1.236 0.374 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.68 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 1.9 mmt180 -90.66 104.31 16.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.52 0.2 . . . . 0.0 111.382 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -106.77 103.87 13.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.68 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.3 m-85 -111.28 166.67 10.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 17.4 Cg_exo -64.92 160.1 42.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.895 1.73 . . . . 0.0 110.836 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.553 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -49.2 -50.67 62.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.9 Cg_exo -58.55 -46.28 25.0 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 121.886 1.724 . . . . 0.0 112.685 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -67.47 -44.28 78.98 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.535 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.42 -41.75 73.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.396 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.72 -36.12 75.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.744 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.79 60.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.576 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.429 HD23 HG22 ' A' ' 56' ' ' VAL . 6.6 tp -60.26 -43.81 95.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.996 0.426 . . . . 0.0 109.879 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.82 -46.94 82.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.896 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -65.93 -43.22 88.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.599 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.0 54.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -119.04 6.38 11.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.633 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.12 46.11 95.19 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.296 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.7 mmp_? -110.78 -173.74 2.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.836 0.35 . . . . 0.0 110.671 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.463 ' HE1' ' O ' ' A' ' 114' ' ' VAL . 81.6 mtp -113.77 155.59 25.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 43.6 t -106.73 127.43 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.016 0.436 . . . . 0.0 111.585 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.4 ttt -109.42 103.69 12.65 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 31.7 t -85.75 108.87 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.486 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 82.6 t80 -104.28 103.18 12.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.526 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.89 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.0 m-85 -84.19 122.21 28.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.612 ' HA ' HG23 ' A' ' 79' ' ' THR . 8.3 p80 -132.37 145.89 51.57 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.6 0.562 . . . . 0.0 111.785 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.449 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 66.9 m -142.24 153.04 43.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.544 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -13.65 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.42 0.629 . . . . 0.0 109.828 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -82.89 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.603 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.06 83.01 37.51 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.63 26.3 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.043 2.495 . . . . 0.0 113.909 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -83.69 -23.52 31.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.177 0.513 . . . . 0.0 110.599 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 43.9 t -83.16 -30.85 27.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -55.93 -29.84 60.72 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -170.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.03 -46.59 67.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 110.724 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 42' ' ' LEU . 13.9 tmm? -79.46 -44.41 21.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.672 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.475 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 7.5 t30 -53.82 -45.98 70.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.781 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.3 m -60.54 -54.87 40.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.85 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -91.78 -69.39 0.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.558 0.694 . . . . 0.0 111.708 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.564 HG13 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -59.6 -44.57 93.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.829 -169.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HB2' ' SD ' ' A' ' 37' ' ' MET . 26.6 tp -79.09 -27.0 42.94 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.242 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 m -88.97 -2.33 58.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 28.4 t70 -47.79 128.76 11.31 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.546 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 46.7 Cg_exo -57.1 -33.53 95.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.072 2.515 . . . . 0.0 112.686 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.23 -48.24 53.8 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.662 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.569 HG22 HD21 ' A' ' 108' ' ' LEU . 99.8 t -59.77 -53.51 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.12 0.486 . . . . 0.0 110.48 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -56.24 -32.21 64.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.625 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -67.11 -34.25 77.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.601 0.239 . . . . 0.0 111.066 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.613 HD12 HD22 ' A' ' 108' ' ' LEU . 53.8 mt -68.85 -37.37 79.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.713 175.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.508 ' HB3' HD11 ' A' ' 3' ' ' LEU . 3.0 mm? -67.74 -48.76 65.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.706 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 3' ' ' LEU . 21.1 mm-40 -53.79 -32.32 52.06 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.972 0.415 . . . . 0.0 111.87 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -61.45 -54.6 41.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.502 HH12 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -136.88 4.47 2.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.45 ' HE2' ' HE ' ' A' ' 54' ' ' ARG . 59.6 m-85 -112.3 149.96 31.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.429 HG22 HD23 ' A' ' 14' ' ' LEU . 47.1 t -115.39 115.98 51.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.775 167.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 29.8 t -89.05 129.03 40.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.871 -173.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -99.45 117.14 33.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.372 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -93.05 101.35 13.67 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 70' ' ' LEU . 42.6 t -114.22 133.3 60.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.046 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.567 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 18.8 m -95.16 117.67 30.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.449 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 41.4 t -71.61 -23.57 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.074 0.464 . . . . 0.0 111.484 -174.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.38 -19.21 43.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.689 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.8 p -95.85 161.22 28.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.598 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -49.73 -49.96 14.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.765 2.977 . . . . 0.0 114.537 -168.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -60.41 -44.04 96.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -69.27 -39.24 82.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.695 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.678 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 55.1 mt-30 -57.67 -40.35 79.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.75 -45.56 74.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.552 HD12 HG11 ' A' ' 60' ' ' VAL . 78.9 mt -66.4 -29.47 69.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.485 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -68.81 -29.22 67.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 62.7 mtm180 -75.9 -45.7 33.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.478 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -65.5 -56.56 11.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.727 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -91.27 -12.51 34.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 71' ' ' ALA . 74.7 mtt180 62.28 87.21 0.1 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.678 0.751 . . . . 0.0 110.131 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 81' ' ' THR . 56.1 t -128.1 137.96 31.95 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.529 -171.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 60.0 Cg_endo -74.29 -138.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.902 2.401 . . . . 0.0 111.361 170.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -91.31 -104.76 1.37 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.169 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' HIS . 1.2 m -145.1 147.57 35.01 Favored Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.885 -0.185 . . . . 0.0 110.576 -169.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 36.7 Cg_endo -90.09 131.72 8.91 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.113 -1.203 . . . . 0.0 112.83 -1.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.89 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 22.5 m -114.51 108.22 16.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.484 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 23.8 m-85 -103.06 112.53 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.45 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -112.46 120.71 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.34 118.85 36.9 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.803 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 33.4 mt -114.86 132.58 56.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.704 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 40.2 t -109.73 127.56 26.92 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.414 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.2 Cg_endo -80.56 117.57 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.469 2.113 . . . . 0.0 110.383 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -142.58 124.53 15.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.426 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.46 -77.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.147 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.86 27.25 0.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.33 161.0 39.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 110.675 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.407 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 83.0 m95 -102.55 132.7 48.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.954 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 39.3 tt0 -117.87 120.51 38.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.509 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.3 tt0 -84.34 115.0 22.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.743 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 32.8 m -100.76 8.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.32 166.6 11.03 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.239 -0.982 . . . . 0.0 112.888 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 83' ' ' VAL . 92.5 mtt180 -133.78 135.74 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 110' ' ' GLU . 69.1 mt -108.88 127.06 53.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.079 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -137.38 143.99 42.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.3 12.65 26.61 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.26 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.436 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 49.2 m 69.64 -73.29 0.09 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.109 0.564 . . . . 0.0 111.642 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 68.14 156.69 0.14 Allowed Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 123.316 0.646 . . . . 0.0 111.284 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.23 159.15 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.178 1.919 . . . . 0.0 110.557 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.564 ' HB3' HG13 ' A' ' 41' ' ' VAL . 32.1 ptt180 -59.89 -25.48 65.13 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.66 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -54.34 -53.82 48.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.734 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.583 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 22.2 mm-40 -72.81 -34.44 66.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 40.2 t80 -65.02 -43.6 91.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 50' ' ' LEU . 88.8 mt -69.83 -30.73 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.6 mttt -55.93 -53.56 55.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.51 ' HB3' HD11 ' A' ' 98' ' ' LEU . 9.5 tp10 -70.72 -38.03 73.55 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.557 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -60.09 -33.93 72.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.376 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 115' ' ' CYS . 7.7 tpt180 -80.25 -38.25 31.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.454 ' HG2' ' HE3' ' A' ' 117' ' ' LYS . 7.3 tt0 -62.9 -46.31 88.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.675 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.619 HG13 HG21 ' A' ' 95' ' ' VAL . 91.5 t -60.22 -37.05 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.5 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 112' ' ' ARG . 52.4 t -54.02 -36.7 63.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.32 -38.29 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.289 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.743 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 96.7 mttt -53.58 -28.59 32.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.22 -34.35 24.92 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.138 -0.554 . . . . 0.0 112.684 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.338 177.086 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 57' ' ' VAL . 22.2 tp . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.43 0.157 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.633 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.3 mmt180 -88.44 104.52 16.87 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.984 0.421 . . . . 0.0 111.201 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -99.94 113.44 26.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.009 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.8 m-85 -122.93 160.48 49.15 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 20.4 Cg_exo -62.97 158.7 41.94 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.957 1.771 . . . . 0.0 111.343 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.573 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.7 t80 -47.1 -51.3 41.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 37.6 Cg_exo -60.79 -43.39 31.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.793 1.662 . . . . 0.0 112.266 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -68.49 -45.19 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 -177.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -54.71 -43.21 72.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.8 mp -66.97 -39.4 87.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.647 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.0 -44.19 66.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.214 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.468 ' HB3' HG11 ' A' ' 56' ' ' VAL . 14.4 tp -59.06 -51.33 70.51 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.67 96.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.15 -41.46 99.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.474 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.1 -15.47 50.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.918 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -113.51 -0.55 14.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.09 37.84 95.6 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.158 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.764 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 2.1 mmp_? -107.15 -179.68 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.277 0.231 . . . . 0.0 110.47 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.655 ' HG3' HG22 ' A' ' 86' ' ' VAL . 41.2 ttm -102.12 156.08 17.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.424 HG11 HD12 ' A' ' 12' ' ' LEU . 84.8 t -105.79 122.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.798 0.333 . . . . 0.0 110.702 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.8 ttt -100.38 103.58 14.97 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 48.9 t -86.97 105.64 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.533 ' HE1' ' CE1' ' A' ' 82' ' ' PHE . 84.2 t80 -104.9 108.82 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.96 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 69.4 m-85 -81.02 111.25 17.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.579 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.513 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 22.4 p80 -119.76 156.41 30.64 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.949 0.781 . . . . 0.0 109.713 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.617 ' HA ' ' OD1' ' A' ' 63' ' ' ASP . 40.8 t -144.11 160.04 41.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.517 ' HG3' ' OD2' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -89.16 -6.28 57.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.81 0.814 . . . . 0.0 108.927 169.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -103.24 10.68 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.485 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 20.2 p -69.12 154.63 94.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.7 -90.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.004 1.802 . . . . 0.0 113.482 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -79.59 -17.24 54.33 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.933 0.396 . . . . 0.0 111.434 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 8.1 t -56.42 -25.76 51.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.365 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -50.81 -41.63 57.49 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 111.108 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.3 -39.35 25.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 110.447 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.511 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 81.6 mtp -68.58 -48.46 64.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.62 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -63.33 -48.07 79.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.985 0.422 . . . . 0.0 111.053 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 43' ' ' SER . 10.6 m -72.68 -54.31 9.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.863 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -92.3 -68.34 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.996 0.427 . . . . 0.0 112.107 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 37' ' ' MET . 95.8 t -51.66 -52.23 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -81.68 -16.33 51.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.4 m -93.59 -0.93 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.73 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -52.57 134.13 44.77 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.931 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.93 -39.57 85.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.024 2.483 . . . . 0.0 113.228 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.23 -41.1 54.28 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.67 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.785 HG22 HD21 ' A' ' 108' ' ' LEU . 29.0 t -63.56 -46.82 93.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -53.92 -44.24 70.42 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.92 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -62.67 -26.12 68.48 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -70.31 -45.12 66.87 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.659 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 47' ' ' VAL . 1.6 mm? -71.78 -43.73 65.21 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.739 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.13 -32.1 9.41 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.521 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -79.31 -48.7 13.64 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.764 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -136.11 19.06 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 51' ' ' LEU . 77.8 m-85 -129.28 145.29 51.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 0.0 111.43 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 14' ' ' LEU . 47.3 t -116.3 120.5 65.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 3' ' ' LEU . 35.5 t -91.89 123.36 43.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.15 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -92.31 117.44 29.9 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.235 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 p -80.81 101.6 9.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.435 HG21 HG13 ' A' ' 24' ' ' VAL . 58.7 t -110.05 119.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.165 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.563 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 0.9 OUTLIER -103.1 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -66.39 -15.4 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.724 0.773 . . . . 0.0 110.166 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.617 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 1.6 m-20 -71.58 -32.69 68.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.666 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.635 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -108.71 167.02 9.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.087 -173.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.635 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.7 Cg_endo -51.03 -48.33 21.55 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 124.174 3.249 . . . . 0.0 114.493 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.39 -35.57 80.86 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.912 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.3 -40.05 29.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.352 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -58.26 -35.57 71.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.437 0.637 . . . . 0.0 110.542 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.66 -51.18 61.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.439 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 9.3 mp -64.04 -33.71 76.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.956 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -63.42 -38.94 93.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.274 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.642 ' HA ' HH21 ' A' ' 75' ' ' ARG . 25.1 ptt180 -79.06 -34.81 43.39 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.23 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -68.97 -56.06 8.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.6 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.502 ' HE1' ' HG ' ' A' ' 70' ' ' LEU . 92.0 m-85 -85.89 -6.66 59.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.981 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.695 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 1.5 mmp_? 63.08 79.1 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.847 0.832 . . . . 0.0 110.127 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 71' ' ' ALA . 94.5 t -125.98 135.71 27.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.996 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 23.0 Cg_exo -65.56 -90.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.752 2.301 . . . . 0.0 112.067 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -143.14 -75.31 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.895 172.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -156.54 148.25 17.15 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.672 -0.311 . . . . 0.0 111.37 -170.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.674 ' HA ' HG22 ' A' ' 79' ' ' THR . 5.1 Cg_endo -88.83 137.75 14.49 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.432 -1.07 . . . . 0.0 111.477 -3.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.96 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 6.3 m -122.71 123.93 42.23 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.924 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.696 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.7 m-85 -114.16 114.31 25.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.869 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -123.48 112.78 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.929 0.395 . . . . 0.0 110.316 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.81 120.43 39.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 94' ' ' GLU . 35.4 mt -117.16 129.33 55.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.462 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.655 HG22 ' HG3' ' A' ' 21' ' ' MET . 21.6 t -108.61 122.87 38.92 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.203 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.3 118.07 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.188 1.925 . . . . 0.0 110.888 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -154.44 140.76 18.64 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.579 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.48 -76.13 0.06 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.084 0.865 . . . . 0.0 111.291 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.6 26.06 0.12 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.64 176.58 12.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 0.0 110.481 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -106.28 130.43 54.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.216 0.532 . . . . 0.0 110.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 37.2 tt0 -101.47 112.29 24.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.853 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.655 ' OE1' ' HD2' ' A' ' 97' ' ' ARG . 33.2 tt0 -75.29 95.8 3.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.28 -14.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.532 -168.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -156.04 123.67 1.36 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.547 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.655 ' HD2' ' OE1' ' A' ' 94' ' ' GLU . 27.3 mtp180 -130.42 126.14 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.831 HD11 ' HG2' ' A' ' 110' ' ' GLU . 42.9 mt -136.03 135.57 39.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.785 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.01 143.2 40.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.19 -86.0 0.28 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.949 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.7 p 179.95 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.319 0.248 . . . . 0.0 111.056 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.711 ' HB3' ' HB3' ' A' ' 106' ' ' GLU . 54.0 mtm180 66.65 119.13 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 123.726 0.811 . . . . 0.0 110.495 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.69 171.05 3.84 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.198 2.599 . . . . 0.0 112.932 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.486 ' HB2' HG13 ' A' ' 41' ' ' VAL . 54.8 ttp180 -46.66 -41.41 14.8 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.828 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.76 86.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.016 0.436 . . . . 0.0 111.808 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 12.1 tp10 -80.77 -37.48 30.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.64 -37.28 87.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.103 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.785 HD21 HG22 ' A' ' 47' ' ' VAL . 42.6 mt -63.6 -44.78 92.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.286 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HZ3' ' HA ' ' A' ' 106' ' ' GLU . 33.9 mtmm -61.17 -44.2 97.67 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.715 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.831 ' HG2' HD11 ' A' ' 98' ' ' LEU . 13.5 tp10 -59.05 -50.56 73.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.418 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -59.44 -34.59 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.614 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 112' ' ' ARG . 9.3 mmm180 -60.54 -43.25 97.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.463 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -72.52 -38.74 67.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 110' ' ' GLU . 91.1 t -56.48 -38.77 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.805 0.335 . . . . 0.0 110.665 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.0 m -56.68 -35.01 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.3 t -84.66 -50.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -55.81 -40.76 73.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.932 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.52 ' CA ' HG21 ' A' ' 86' ' ' VAL . . . -66.54 -24.3 72.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.751 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.734 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.101 -179.797 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.74 HD21 HG21 ' A' ' 57' ' ' VAL . 53.8 tp . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.543 0.211 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -82.28 104.88 12.91 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.273 0.559 . . . . 0.0 112.196 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.512 ' HZ2' ' HG ' ' A' ' 42' ' ' LEU . 43.0 m95 -107.9 131.37 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.669 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 89.8 m-85 -132.84 155.03 81.61 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 25.2 Cg_exo -58.09 160.85 14.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.003 1.802 . . . . 0.0 111.245 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.566 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 88.4 t80 -45.61 -53.95 17.47 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 19.7 Cg_exo -66.24 -42.19 11.02 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.668 1.579 . . . . 0.0 112.205 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 38.8 tt0 -69.4 -42.73 74.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.065 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.24 94.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.204 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 8' ' ' TYR . 9.1 mp -63.01 -35.82 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.77 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.6 69.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 110.203 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.547 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -60.12 -50.51 73.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.396 176.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -43.8 93.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.199 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -57.63 -52.15 66.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.493 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.96 59.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.756 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -115.91 2.9 13.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.499 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.3 44.58 96.42 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.626 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -108.7 -179.42 3.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.694 0.283 . . . . 0.0 110.919 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.478 ' SD ' ' HA3' ' A' ' 118' ' ' GLY . 87.3 mtp -100.92 158.48 15.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.2 125.84 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.008 0.432 . . . . 0.0 111.106 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.0 ttt -103.6 102.65 12.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 61.3 t -89.93 106.26 16.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.095 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.803 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 45.1 t80 -104.95 123.18 47.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.306 0.574 . . . . 0.0 111.36 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.914 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 67.1 m-85 -94.18 126.18 39.26 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.217 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.803 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 34.5 p80 -130.96 157.44 42.96 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.971 0.794 . . . . 0.0 110.679 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.557 ' H ' HG21 ' A' ' 79' ' ' THR . 30.3 t -143.01 159.12 42.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.565 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -6.6 58.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.42 0.629 . . . . 0.0 110.121 173.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -103.38 19.68 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.375 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.712 ' HB3' ' CG2' ' A' ' 79' ' ' THR . 26.9 p -74.68 131.32 79.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.567 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.11 -92.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.466 2.111 . . . . 0.0 114.031 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -74.43 -17.14 60.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.071 0.463 . . . . 0.0 111.433 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.4 t -58.49 -23.46 57.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.038 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -49.29 -47.81 46.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.218 0.532 . . . . 0.0 111.714 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.783 ' HA ' HE21 ' A' ' 36' ' ' GLN . 0.0 OUTLIER -75.26 -31.7 60.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -176.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 101' ' ' SER . 83.5 mtp -67.11 -49.8 63.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.47 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 58.5 m-20 -64.55 -37.07 86.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.315 -174.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 m -64.77 -61.29 2.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.375 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.32 -70.6 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 104' ' ' ARG . 60.3 t -57.9 -44.64 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -170.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 15.1 tp -81.57 -11.1 59.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 -173.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -112.62 3.34 16.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.066 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' CG ' HH11 ' A' ' 104' ' ' ARG . 26.5 t70 -53.83 131.81 57.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.561 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -58.29 -28.57 84.98 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.933 2.422 . . . . 0.0 112.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.48 14.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.601 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.659 HG22 HD21 ' A' ' 108' ' ' LEU . 84.4 t -58.23 -53.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.161 0.505 . . . . 0.0 110.102 174.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.525 ' HA ' HD13 ' A' ' 3' ' ' LEU . 32.5 m -54.36 -38.29 65.92 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.234 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -60.86 -32.08 71.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.788 0.328 . . . . 0.0 111.387 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.763 HD12 HD22 ' A' ' 108' ' ' LEU . 69.0 mt -71.83 -42.1 67.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.741 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.419 ' HB2' HD11 ' A' ' 3' ' ' LEU . 2.4 mm? -70.74 -53.19 16.47 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.195 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.566 ' OE2' HD12 ' A' ' 3' ' ' LEU . 32.9 mm-40 -45.33 -38.19 5.53 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.644 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -64.68 -51.51 62.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.644 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.58 14.61 3.43 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -173.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.409 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 74.4 m-85 -125.29 150.86 46.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.498 . . . . 0.0 111.251 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 14' ' ' LEU . 61.0 t -119.02 122.06 68.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.74 HG21 HD21 ' A' ' 3' ' ' LEU . 33.1 t -89.11 124.31 41.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.994 -173.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.96 117.58 31.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.482 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -83.99 101.64 11.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.62 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.71 114.46 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 110.196 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.603 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -89.17 107.62 19.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.308 -178.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.501 HG11 ' HA2' ' A' ' 78' ' ' GLY . 44.3 t -80.7 -7.79 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 122.697 1.237 . . . . 0.0 107.694 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -33.78 76.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.826 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -124.64 167.14 16.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.204 -174.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -50.62 -50.77 12.69 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.312 3.341 . . . . 0.0 114.76 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -44.1 84.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.0 111.462 -174.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.61 -27.44 59.08 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.806 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -63.89 -37.69 88.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.7 -51.36 70.26 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.289 0.566 . . . . 0.0 109.874 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 4.0 mm? -56.91 -43.64 81.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.019 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.78 -54.68 44.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 72' ' ' ARG . 21.5 ptt85 -68.73 -23.36 64.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.102 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -72.64 -36.54 68.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.715 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -106.2 8.51 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.376 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 62.07 36.98 15.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.913 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.0 t -93.48 133.67 27.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.504 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.439 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 29.3 Cg_exo -61.56 -83.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.61 2.207 . . . . 0.0 111.552 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' HA2' HG11 ' A' ' 62' ' ' VAL . . . -145.5 -52.76 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.807 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.712 ' CG2' ' HB3' ' A' ' 31' ' ' CYS . 3.6 t 175.57 158.09 0.39 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.682 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 2.4 Cg_endo -79.75 126.61 13.21 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.29 0.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.914 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 29.3 m -129.77 119.67 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.115 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.16 110.72 20.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 60.8 t -113.99 114.21 46.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.862 0.363 . . . . 0.0 110.056 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.6 117.55 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.857 0.361 . . . . 0.0 110.754 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 26.5 mt -110.73 136.56 49.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.21 0.529 . . . . 0.0 111.303 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.0 t -109.94 120.07 45.73 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.49 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 52.2 Cg_endo -74.95 117.49 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.72 1.614 . . . . 0.0 110.938 173.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.409 ' HE3' ' CB ' ' A' ' 93' ' ' GLU . 20.7 pttp -141.58 132.63 26.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.517 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.01 -76.8 0.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.008 0.818 . . . . 0.0 111.262 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.58 24.77 0.19 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -146.25 152.5 39.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.7 0.286 . . . . 0.0 110.695 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.49 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 32.8 m95 -92.95 120.77 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 7.6 tp10 -102.21 139.88 37.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.888 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.66 104.78 17.33 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.608 HG22 ' HD3' ' A' ' 117' ' ' LYS . 4.3 p -97.19 6.39 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 -172.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.85 134.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.488 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -122.84 135.88 54.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 110.441 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.48 136.77 52.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.737 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -137.13 136.67 38.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.856 0.36 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.14 -174.71 18.53 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.86 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.448 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.5 m -92.43 127.13 37.81 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.976 0.417 . . . . 0.0 110.566 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 102' ' ' ARG . 8.6 mmm180 -127.87 137.61 31.15 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.88 157.18 58.01 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.911 1.741 . . . . 0.0 110.016 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB2' HG13 ' A' ' 41' ' ' VAL . 46.4 ttp180 -58.0 -26.82 62.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.89 -50.78 67.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.582 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -69.02 -42.67 76.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.979 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.18 -50.39 74.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.763 HD22 HD12 ' A' ' 50' ' ' LEU . 56.8 mt -72.23 -19.16 61.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.512 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -73.16 -49.9 25.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.409 0.623 . . . . 0.0 109.946 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 114' ' ' VAL . 50.4 mt-10 -72.76 -35.33 67.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.213 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.54 -32.73 74.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.089 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -59.68 -47.29 86.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -56.31 -45.16 80.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.532 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 95.6 t -62.4 -45.58 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.922 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.444 ' HB2' HH21 ' A' ' 54' ' ' ARG . 21.0 p -67.12 -22.25 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 111.044 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 112' ' ' ARG . 80.3 t -79.23 -37.7 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 109.918 174.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.608 ' HD3' HG22 ' A' ' 95' ' ' VAL . 83.5 mttt -61.57 -27.49 68.67 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.635 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.478 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -65.0 -32.9 85.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.337 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.078 179.575 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.2 tp . . . . . 0 C--O 1.237 0.412 0 CA-C-O 121.154 0.502 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.613 ' NE ' ' HA ' ' A' ' 4' ' ' ARG . 3.1 mmp_? -109.05 123.1 48.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.246 -171.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -115.56 115.98 27.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.588 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 86.2 m-85 -133.69 160.88 66.86 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.497 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 31.7 Cg_exo -58.55 166.47 6.26 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.406 2.071 . . . . 0.0 111.483 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.615 ' CD1' HD21 ' A' ' 70' ' ' LEU . 61.8 t80 -51.58 -51.43 69.76 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.5 Cg_exo -62.12 -45.69 15.11 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.866 1.71 . . . . 0.0 112.233 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 80.2 tt0 -67.09 -40.2 86.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.929 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.81 94.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.225 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 22' ' ' VAL . 2.8 mt -63.25 -35.75 81.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.832 0.348 . . . . 0.0 110.332 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.73 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.229 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.2 tp -64.31 -44.6 91.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.628 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.75 -42.28 95.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.697 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.25 -44.74 90.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.54 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.76 -14.67 56.14 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -119.14 1.78 11.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.93 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.59 44.32 97.72 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.242 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.628 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 12.5 mmm180 -107.96 -178.04 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 111.342 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -101.22 165.06 11.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.546 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 84.1 t -122.53 133.6 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.737 0.303 . . . . 0.0 111.189 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 23' ' ' MET . 20.1 ptm -126.79 113.58 16.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.182 0.515 . . . . 0.0 109.645 170.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.548 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 46.5 t -87.22 109.62 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 88.6 t80 -97.49 103.6 15.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.378 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.964 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 77.0 m-85 -82.27 119.33 23.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.604 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 61' ' ' SER . 28.5 p80 -133.02 146.24 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.21 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 47.4 t -134.14 164.84 26.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 -17.87 30.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.114 0.483 . . . . 0.0 110.22 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.505 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 76.9 m-70 -89.56 -16.76 29.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.768 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.873 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 63.9 m -108.84 84.9 2.78 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.332 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.566 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.7 Cg_endo -92.08 -0.84 4.22 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.002 2.468 . . . . 0.0 114.896 -169.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -74.58 -21.7 59.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.837 -0.539 . . . . 0.0 111.409 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 17.5 p -72.52 -30.83 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 3.2 pt20 -67.9 -27.14 66.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.651 0.262 . . . . 0.0 110.97 -176.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.69 -50.49 66.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.646 ' HG3' ' HB3' ' A' ' 101' ' ' SER . 11.3 tmm? -67.95 -42.41 80.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.842 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -54.67 -47.2 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.504 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 m -61.59 -51.76 67.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.98 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.01 -70.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.258 0.551 . . . . 0.0 112.055 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.623 ' HB ' ' SD ' ' A' ' 37' ' ' MET . 96.9 t -63.37 -41.35 92.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.533 -168.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.3 tp -80.86 -30.61 35.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.2 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 m -87.6 -1.56 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.68 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.01 131.16 8.98 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.049 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.52 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 54.4 Cg_exo -52.99 -38.02 79.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.047 2.498 . . . . 0.0 113.305 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.7 -43.59 35.2 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.069 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.94 -51.09 73.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.436 0.636 . . . . 0.0 109.923 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.2 m -53.8 -39.21 65.27 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.128 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 17.7 mtp180 -60.61 -29.2 69.08 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.78 -39.11 67.0 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.599 174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.44 -43.62 72.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.584 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.23 -34.53 64.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.85 0.46 . . . . 0.0 111.327 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -54.22 47.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.205 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -11.39 2.07 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -90.48 151.63 21.29 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 14' ' ' LEU . 90.9 t -115.41 122.73 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 163.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.421 HG22 ' SD ' ' A' ' 23' ' ' MET . 16.1 t -87.45 125.29 41.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.035 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -96.91 117.1 30.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.862 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.8 p -91.42 100.53 13.29 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.469 HG21 HG13 ' A' ' 24' ' ' VAL . 96.4 t -109.04 119.25 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.13 0.49 . . . . 0.0 110.985 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.629 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -96.53 119.56 35.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.467 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.623 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 16.4 t -81.24 66.31 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.876 0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.629 ' OD1' ' HB2' ' A' ' 61' ' ' SER . 3.1 p-10 -163.21 -33.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -94.9 164.02 20.6 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.454 175.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.6 Cg_endo -51.5 -55.03 4.37 Favored 'Trans proline' 0 N--CA 1.477 0.54 0 C-N-CA 123.497 2.798 . . . . 0.0 113.996 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 70' ' ' LEU . 10.7 pt-20 -57.68 -41.48 81.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.177 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.05 -34.23 64.96 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.642 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -68.79 -42.79 76.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.334 -0.433 . . . . 0.0 111.474 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' A' ' 72' ' ' ARG . 12.0 pt-20 -73.74 -33.82 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.883 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.615 HD21 ' CD1' ' A' ' 8' ' ' TYR . 5.5 mp -62.92 -36.06 82.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.435 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -65.14 -31.96 73.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.486 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.43 HH21 ' HB2' ' A' ' 69' ' ' GLU . 56.0 mtm180 -68.89 -41.82 77.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.481 0.658 . . . . 0.0 109.997 173.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -71.32 -57.38 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.609 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 96.9 m-85 -82.9 -18.44 40.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.022 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 74' ' ' TYR . 10.5 ptp180 44.85 73.19 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.357 1.035 . . . . 0.0 112.114 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.49 HG11 ' CG2' ' A' ' 81' ' ' THR . 35.0 t -135.92 100.65 10.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.636 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.6 130.11 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.991 2.461 . . . . 0.0 111.995 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 151.01 -77.41 0.23 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.44 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.873 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.2 m 71.62 138.94 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.919 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.718 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 51.5 Cg_endo -71.72 143.88 78.16 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 123.666 -1.389 . . . . 0.0 113.191 0.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.964 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 27.6 m -120.49 122.29 40.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.894 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 4.3 m-85 -114.35 110.95 20.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 74' ' ' TYR . 66.0 t -115.38 111.32 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.543 ' HB2' HG13 ' A' ' 95' ' ' VAL . 51.5 m-85 -93.1 135.83 33.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 37.2 mt -125.26 132.71 52.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.866 0.365 . . . . 0.0 110.184 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.574 HG11 ' HA2' ' A' ' 118' ' ' GLY . 16.0 t -109.01 121.41 43.0 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.736 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.4 116.76 4.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.331 1.354 . . . . 0.0 110.124 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -137.19 126.73 25.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.642 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.72 -71.55 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.156 0.91 . . . . 0.0 111.024 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.13 23.81 0.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.027 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.96 157.1 44.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.673 0.273 . . . . 0.0 110.903 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -93.07 124.31 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.698 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -109.05 118.53 37.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.342 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 35.6 tt0 -69.78 98.93 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.634 0.731 . . . . 0.0 109.413 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 84' ' ' PHE . 1.8 p -80.05 -28.21 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.036 -170.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.18 152.02 10.76 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.388 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -120.05 127.33 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 85.9 mt -111.53 137.06 49.86 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.417 ' CE1' ' HA3' ' A' ' 78' ' ' GLY . 91.0 t80 -137.87 143.09 40.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.84 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.75 23.92 59.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.745 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.646 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 43.1 m 68.15 174.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.429 ' O ' HG11 ' A' ' 41' ' ' VAL . 4.9 mmt180 -148.61 148.73 29.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 172.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.58 149.77 88.31 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 N-CA-C 108.626 -1.336 . . . . 0.0 108.626 164.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.648 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 10.9 ptt180 -59.8 -29.53 68.29 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.576 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.73 88.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.611 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.681 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 2.0 mt-10 -80.92 -35.44 32.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.342 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.38 -37.18 86.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 91.2 mt -62.77 -43.2 99.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.044 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.618 ' HD3' ' HA ' ' A' ' 106' ' ' GLU . 8.2 mtpm? -52.59 -56.57 14.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 175.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 3.7 mm-40 -61.23 -40.78 95.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.55 -20.9 66.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.345 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.4 mmt180 -78.54 -45.34 22.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.72 -38.4 78.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.383 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.498 HG13 HG11 ' A' ' 95' ' ' VAL . 78.7 t -74.66 -38.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 112' ' ' ARG . 24.6 p -65.53 -31.77 73.0 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.506 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.2 t -71.26 -43.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.165 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.51 ' HD3' HG23 ' A' ' 95' ' ' VAL . 30.6 mtpt -68.92 -11.5 60.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 111.841 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.574 ' HA2' HG11 ' A' ' 86' ' ' VAL . . . -71.73 -33.48 63.29 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.405 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.251 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.147 -177.349 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 22.3 tp . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.4 0.619 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.4 mmt180 -97.99 108.64 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.067 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -106.09 104.19 13.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.38 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 92.4 m-85 -116.23 168.9 7.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 12.4 Cg_exo -67.74 158.48 57.04 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.604 1.536 . . . . 0.0 110.094 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.542 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.7 t80 -47.11 -50.3 47.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 51.5 Cg_exo -56.57 -50.26 12.36 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.159 1.906 . . . . 0.0 112.981 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.04 -42.34 89.7 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.17 71.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 22' ' ' VAL . 6.3 mt -70.81 -36.86 73.16 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.329 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.29 70.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.055 0.455 . . . . 0.0 110.065 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.548 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -59.75 -44.57 93.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.874 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.75 -53.42 33.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.455 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 7.7 tp60 -58.67 -53.14 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.069 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.22 60.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.999 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -116.72 -0.14 12.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.094 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.26 91.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.814 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.667 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 74.6 mmt-85 -112.79 179.59 3.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 111.653 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.2 mtp -101.69 159.06 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.285 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 47.8 t -105.8 119.53 55.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 57' ' ' VAL . 10.2 tpt -99.6 103.3 14.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.235 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 16.4 t -94.88 106.28 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.445 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 90.4 t80 -106.61 104.43 14.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.226 0.536 . . . . 0.0 111.143 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.926 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.5 m-85 -82.38 115.82 21.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.218 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -121.3 158.37 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.748 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 42.8 m -137.69 162.24 34.37 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -64.62 -60.77 2.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -94.42 48.72 1.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.314 0.578 . . . . 0.0 110.844 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 27.3 p -76.19 149.26 81.97 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.135 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 33' ' ' TYR . 39.0 Cg_exo -58.93 -98.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.076 2.518 . . . . 0.0 114.053 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.433 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 90.2 t80 -87.72 -17.83 30.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 0.0 111.565 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 1.6 t -51.4 -38.97 56.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.665 -174.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 2.1 pp0? -56.85 -31.47 64.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.18 -48.16 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 110.084 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.53 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 15.1 ptm -68.96 -33.47 73.76 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.2 -27.73 65.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.208 0.527 . . . . 0.0 110.206 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.8 m -92.13 -61.58 1.59 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.378 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.45 -70.58 0.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.71 -47.03 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.223 -0.898 . . . . 0.0 113.305 -168.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 tp -81.89 -19.03 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.773 0.321 . . . . 0.0 110.984 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.2 m -92.92 -6.44 48.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.459 ' HB3' HG23 ' A' ' 47' ' ' VAL . 11.4 t70 -46.55 136.23 7.46 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.743 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 53.1 Cg_exo -56.86 -35.28 98.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.375 2.717 . . . . 0.0 113.698 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.589 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . -79.41 -24.35 61.09 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 44' ' ' ASP . 19.9 t -79.48 -43.56 23.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 109.003 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -62.77 -33.55 75.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.319 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 15.2 ptm180 -67.95 -24.49 65.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.798 0.333 . . . . 0.0 111.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -71.84 -46.43 58.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -62.45 -44.82 95.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.911 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -50.23 -31.34 13.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.548 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -82.91 -54.49 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -171.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.667 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.56 12.04 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -170.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 84.4 m-85 -118.84 138.41 52.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.529 0.68 . . . . 0.0 112.026 -176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 14' ' ' LEU . 51.0 t -109.33 116.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.46 HG13 ' HG3' ' A' ' 23' ' ' MET . 15.5 t -89.21 127.36 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.215 0.531 . . . . 0.0 110.978 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.09 117.8 34.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.029 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.1 p -81.44 101.26 9.76 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.61 120.46 56.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.723 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.625 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 m -101.78 108.9 20.54 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.0 t -68.19 -13.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.645 0.736 . . . . 0.0 110.439 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 28' ' ' SER . 2.8 m-20 -79.72 -28.86 40.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.055 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.644 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -105.43 165.38 13.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.654 -175.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.6 Cg_endo -49.07 -52.35 8.9 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.035 3.157 . . . . 0.0 114.495 -171.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -59.49 -39.3 83.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -179.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.22 -35.74 47.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.839 175.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.39 -35.65 79.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.67 0.747 . . . . 0.0 110.089 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.59 -46.66 71.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.412 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.431 ' O ' ' HD1' ' A' ' 74' ' ' TYR . 45.1 mt -66.29 -31.44 72.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.33 -33.79 76.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.283 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -85.17 -28.45 25.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.632 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.49 -50.36 52.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.488 ' CD1' ' HZ ' ' A' ' 26' ' ' PHE . 89.3 m-85 -85.23 -20.91 29.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.312 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 58.4 62.26 2.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.834 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.4 t -137.37 101.47 9.09 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.791 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -96.58 128.2 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 111.292 168.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 107.85 1.65 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.72 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -92.64 147.83 34.98 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.203 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.69 ' HA ' HG22 ' A' ' 79' ' ' THR . 10.3 Cg_endo -88.26 154.45 37.99 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.595 -1.002 . . . . 0.0 112.345 -0.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.926 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 23.9 m -120.01 115.02 22.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.319 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 11.8 m-85 -106.48 112.35 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.606 HG22 ' HG2' ' A' ' 97' ' ' ARG . 46.5 t -118.13 129.6 74.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.463 ' CG ' HG11 ' A' ' 114' ' ' VAL . 68.1 m-85 -110.79 122.97 49.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.809 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.694 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 28.5 mt -112.86 131.36 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.472 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.552 HG21 ' HA2' ' A' ' 118' ' ' GLY . 15.8 t -114.13 113.54 46.4 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.726 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.29 116.83 4.22 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.378 1.385 . . . . 0.0 110.326 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -158.85 150.43 20.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.66 -65.49 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.038 0.836 . . . . 0.0 110.884 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.15 23.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.545 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.62 171.85 19.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 110.892 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 73.1 m95 -95.73 126.43 40.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.049 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 35.6 tt0 -103.31 112.14 24.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.064 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.429 ' HA ' HD23 ' A' ' 85' ' ' LEU . 39.4 tt0 -78.14 97.29 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 84' ' ' PHE . 15.7 m -81.42 -6.63 9.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.63 171.49 15.24 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.077 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.606 ' HG2' HG22 ' A' ' 83' ' ' VAL . 89.8 mtt180 -133.37 137.99 46.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.815 -0.693 . . . . 0.0 109.752 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.5 mt -108.38 128.28 54.63 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -138.39 144.02 40.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.185 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.29 -2.73 7.75 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.367 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.9 m 71.44 128.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.414 0.626 . . . . 0.0 110.589 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -131.8 129.46 21.97 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD2' ' HG3' ' A' ' 106' ' ' GLU . 27.7 Cg_exo -62.44 166.19 13.79 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.394 2.062 . . . . 0.0 110.502 168.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.44 -44.75 76.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.0 111.39 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.18 85.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 120.966 0.412 . . . . 0.0 111.256 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.551 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 11.6 mm-40 -66.95 -54.64 19.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 111' ' ' LEU . 26.3 t80 -57.92 -42.77 85.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.863 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 47' ' ' VAL . 60.4 mt -58.4 -43.75 88.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.387 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.483 ' HZ2' ' HA ' ' A' ' 106' ' ' GLU . 10.3 mtmp? -63.95 -50.17 69.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 114' ' ' VAL . 3.1 pt-20 -75.31 -33.06 61.13 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 107' ' ' PHE . 4.7 tt -59.57 -43.37 93.63 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 45.1 mtm180 -65.13 -33.05 75.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.519 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.36 -37.74 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 110.499 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 110' ' ' GLU . 78.9 t -63.65 -34.53 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.592 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.9 m -57.25 -37.05 71.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.509 . . . . 0.0 110.209 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.2 -37.95 53.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.323 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HB3' ' HZ2' ' A' ' 117' ' ' LYS . 9.1 mtpm? -68.11 -10.8 56.79 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.059 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.552 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -63.75 -41.41 98.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.708 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 176.44 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 52' ' ' GLU . 4.3 tp . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.216 0.531 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 6' ' ' TYR . 17.1 tpt180 -103.34 116.77 33.06 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.496 -169.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -108.88 127.13 53.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.754 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.56 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 30.1 m-85 -130.52 170.6 10.72 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.127 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 15.1 Cg_exo -69.65 166.65 26.74 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.506 2.137 . . . . 0.0 110.566 171.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.602 ' CD1' HD21 ' A' ' 70' ' ' LEU . 63.0 t80 -44.97 -54.04 14.45 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.8 Cg_exo -59.36 -52.82 4.18 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.881 1.721 . . . . 0.0 113.089 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -66.18 -36.39 82.96 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.795 0.331 . . . . 0.0 110.452 -175.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.42 -43.42 93.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.81 -32.03 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.64 -46.24 32.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.871 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 56' ' ' VAL . 12.0 tp -59.3 -46.37 88.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 110.305 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.428 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.64 -44.21 96.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 -14.58 59.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.141 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -117.92 5.44 12.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.548 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.22 37.18 94.11 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.472 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.7 mmp_? -108.19 175.66 5.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.549 ' SD ' HG22 ' A' ' 86' ' ' VAL . 69.5 mtm -102.62 162.67 12.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.97 121.2 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.832 0.348 . . . . 0.0 111.043 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.06 103.28 15.16 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 17.0 t -87.12 101.19 10.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 73.8 t80 -92.57 103.0 15.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 84.7 m-85 -81.83 112.23 18.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.254 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.609 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 17.0 p80 -131.29 138.91 49.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.093 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.6 m -94.45 153.12 18.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 164.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 63' ' ' ASP . 1.1 pm0 -85.49 -13.11 50.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -105.52 24.39 12.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.684 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.873 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 14.8 p -73.03 161.62 78.52 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.927 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.25 -105.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.388 2.059 . . . . 0.0 114.415 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -70.37 -17.52 63.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 5.4 t -55.46 -30.89 61.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.015 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -55.03 -31.72 61.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.589 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.76 -50.78 8.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -63.43 -47.2 82.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.632 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.29 -42.48 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.291 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 m -68.98 -55.77 9.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.61 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -91.34 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.173 0.511 . . . . 0.0 112.102 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.02 -39.91 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.883 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -79.66 -28.45 40.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.763 0.315 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.6 m -88.2 -1.47 58.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -45.25 130.63 5.84 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.858 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.629 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 50.3 Cg_exo -55.66 -35.43 92.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.115 2.543 . . . . 0.0 113.259 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' NE ' ' A' ' 49' ' ' ARG . . . -75.6 -39.44 34.83 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.016 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.455 ' HA ' HD21 ' A' ' 108' ' ' LEU . 61.1 t -65.41 -44.57 94.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.36 0.6 . . . . 0.0 109.588 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 14.7 t -49.49 -46.91 48.79 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.297 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 77.5 mtm180 -50.31 -39.08 44.74 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.501 ' HB3' HD12 ' A' ' 111' ' ' LEU . 56.5 mt -73.26 -46.53 49.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.64 -35.7 73.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.105 0.478 . . . . 0.0 110.391 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -48.47 -48.5 37.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.304 1.041 . . . . 0.0 112.405 -177.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -76.27 -43.18 42.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -167.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.809 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.26 17.94 3.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -129.84 139.63 51.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.878 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 14' ' ' LEU . 99.1 t -107.8 116.35 51.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.85 126.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.234 0.54 . . . . 0.0 110.973 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -95.46 117.32 30.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.901 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.3 p -86.41 101.36 13.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.1 t -103.88 113.55 41.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.702 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.515 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 3.0 p -91.22 114.31 26.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.237 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 71' ' ' ALA . 99.4 t -74.16 -19.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.58 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 5.3 m-20 -82.55 -7.22 59.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.588 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.8 p -111.39 156.16 41.66 Favored Pre-proline 0 C--O 1.22 -0.472 0 O-C-N 122.36 -0.212 . . . . 0.0 111.078 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.588 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.2 Cg_endo -50.43 -55.3 4.22 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 124.062 3.175 . . . . 0.0 114.665 -167.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -35.48 76.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.97 -32.56 52.79 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.822 174.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 64' ' ' THR . 54.5 mt-30 -62.2 -42.91 99.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.142 0.577 . . . . 0.0 110.477 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.4 -41.55 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.274 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.602 HD21 ' CD1' ' A' ' 8' ' ' TYR . 3.9 mp -62.05 -34.88 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.234 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.539 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -63.78 -38.25 90.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.49 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -84.74 -27.92 26.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.891 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.88 -51.3 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.423 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.1 0.56 46.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.838 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 53.81 76.85 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.13 0.894 . . . . 0.0 111.161 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG11 ' CB ' ' A' ' 26' ' ' PHE . 61.6 t -128.48 84.01 64.44 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.035 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -102.5 105.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.638 2.892 . . . . 0.0 111.631 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.4 90.88 0.67 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.519 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.873 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 25.7 m -82.55 143.35 47.37 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 83.1 Cg_endo -88.76 151.0 30.17 Favored 'Cis proline' 0 C--N 1.35 0.609 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.734 0.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 91.0 m -128.05 129.16 46.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.907 171.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.739 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.2 m-85 -110.11 114.08 27.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.226 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.405 HG22 ' HD3' ' A' ' 97' ' ' ARG . 91.8 t -117.79 128.73 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.962 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.18 121.71 45.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.757 0.313 . . . . 0.0 110.733 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 94' ' ' GLU . 29.5 mt -110.39 136.16 49.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.549 HG22 ' SD ' ' A' ' 21' ' ' MET . 14.6 t -109.52 133.99 20.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.412 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 4.0 Cg_exo -79.58 118.11 3.81 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.47 2.113 . . . . 0.0 110.63 171.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -133.83 151.47 51.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.59 93.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.278 0.561 . . . . 0.0 111.134 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.54 -47.27 0.74 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.058 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.95 -168.36 0.21 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.855 0.36 . . . . 0.0 110.771 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -97.67 140.35 32.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.858 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -124.61 129.38 50.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.449 -175.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 35.5 tt0 -80.33 108.63 14.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.465 HG22 ' HZ2' ' A' ' 117' ' ' LYS . 5.5 p -104.34 -13.16 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.986 -169.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.28 140.63 7.6 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.874 -1.155 . . . . 0.0 113.441 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.451 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 18.6 mmt180 -127.36 126.25 42.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 89.7 mt -131.71 135.7 47.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -137.47 142.78 41.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.559 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.93 138.42 9.96 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.895 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -76.44 124.41 27.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -141.33 160.57 56.78 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.94 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.81 161.3 22.1 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.54 2.16 . . . . 0.0 111.88 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.537 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 5.4 ptt180 -59.69 -28.92 67.71 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.976 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.2 91.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.945 0.402 . . . . 0.0 110.501 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.1 -47.04 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.776 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.06 -46.59 88.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.294 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 94.7 mt -57.46 -38.35 74.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.036 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -57.72 -63.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 114' ' ' VAL . 1.6 mp0 -70.12 -34.61 73.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.538 -175.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 50' ' ' LEU . 2.1 tm? -63.12 -38.55 91.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -57.74 -47.76 81.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.633 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 13.1 mm100 -65.26 -36.26 83.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.086 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -61.84 -37.83 79.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.318 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.57 -34.38 74.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.537 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.06 -32.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.969 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.465 ' HZ2' HG22 ' A' ' 95' ' ' VAL . 7.9 mtpm? -68.05 -8.62 39.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.28 88.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.148 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.364 178.829 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.705 HD21 HD23 ' A' ' 51' ' ' LEU . 56.8 tp . . . . . 0 C--O 1.236 0.363 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.419 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 2.7 mmp_? -80.66 102.76 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.976 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.406 ' HE1' ' HB3' ' A' ' 3' ' ' LEU . 74.4 m95 -107.85 104.56 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.48 . . . . 0.0 110.235 175.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -113.52 145.35 33.16 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 31.3 Cg_exo -59.41 166.93 6.93 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.975 1.783 . . . . 0.0 111.389 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 77.8 t80 -48.71 -50.03 62.62 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.9 Cg_exo -60.76 -55.63 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.702 1.601 . . . . 0.0 111.986 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.1 mp0 -54.14 -44.88 71.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.389 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -59.4 -47.45 85.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 0.0 111.279 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.9 -39.96 94.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.87 62.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.947 0.404 . . . . 0.0 110.484 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.84 -49.59 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.436 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.38 -46.98 68.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.238 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.25 -49.01 79.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.017 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -13.96 59.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.863 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -117.0 4.77 12.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.425 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.28 41.97 99.65 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.719 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.2 mmp_? -109.19 -179.93 3.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.764 0.316 . . . . 0.0 110.539 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.3 mtp -102.04 155.62 18.07 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 54.0 t -105.95 124.72 61.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.535 ' SD ' HD21 ' A' ' 51' ' ' LEU . 22.0 ttt -107.67 103.24 12.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 46.0 t -84.26 105.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -99.15 103.39 15.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.443 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.81 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 92.4 m-85 -81.67 115.9 21.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.606 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.467 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 27.8 p80 -120.12 150.42 40.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.543 0.527 . . . . 0.0 110.427 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.426 ' H ' HG21 ' A' ' 79' ' ' THR . 47.0 t -143.41 147.91 35.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' OE1' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -88.04 -26.99 22.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.111 0.481 . . . . 0.0 110.212 175.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -72.92 -21.71 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.912 ' HB3' HG22 ' A' ' 79' ' ' THR . 9.4 t -103.93 94.99 7.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.15 23.42 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.691 2.26 . . . . 0.0 113.453 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.417 ' HD2' ' HD3' ' A' ' 80' ' ' PRO . 2.7 t80 -86.65 -29.79 22.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.893 0.378 . . . . 0.0 111.092 -174.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.407 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . 28.5 p -82.81 -32.79 27.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -55.54 -34.65 64.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -168.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.37 -48.2 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.891 0.377 . . . . 0.0 110.759 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.4 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 26.3 ttp -74.51 -44.42 51.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -177.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -57.76 -45.67 85.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.751 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -64.17 -56.93 11.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.648 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.81 -70.13 0.7 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.171 0.51 . . . . 0.0 111.959 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.81 -41.97 76.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.797 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.3 tp -81.11 -27.05 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.25 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 t -92.55 1.11 57.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.356 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -50.82 134.63 27.85 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.074 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.578 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 75.0 Cg_exo -52.3 -40.58 69.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.139 2.559 . . . . 0.0 113.485 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.44 -46.84 18.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.098 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.9 -50.85 78.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.215 0.531 . . . . 0.0 110.392 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 64.0 m -59.84 -38.28 81.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.292 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -63.34 -39.95 95.96 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.71 HD22 HH22 ' A' ' 54' ' ' ARG . 64.7 mt -63.3 -38.05 89.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.953 0.406 . . . . 0.0 110.571 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.705 HD23 HD21 ' A' ' 3' ' ' LEU . 2.0 tp -70.08 -56.37 7.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.412 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HG3' HH21 ' A' ' 49' ' ' ARG . 5.0 mm-40 -46.05 -40.59 10.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.414 0.686 . . . . 0.0 112.621 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.477 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -61.73 -49.7 75.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.71 HH22 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.79 9.05 3.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -174.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -119.28 138.94 52.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.572 . . . . 0.0 111.042 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.2 t -109.32 116.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.621 HG21 HD21 ' A' ' 3' ' ' LEU . 19.6 t -87.26 119.49 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.554 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.21 117.48 28.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.852 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 p -83.2 100.33 10.51 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.644 HG11 HD23 ' A' ' 70' ' ' LEU . 59.0 t -111.33 124.3 67.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.696 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.462 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -95.41 118.14 31.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.62 -178.339 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.87 10.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 122.74 1.257 . . . . 0.0 108.328 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.474 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -97.37 -24.24 15.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.432 175.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.578 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 42.4 p -108.58 152.97 42.4 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.857 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 27.2 Cg_endo -55.86 -51.57 9.37 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.042 3.161 . . . . 0.0 114.778 -168.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.4 -37.05 85.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.634 -177.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -73.49 -37.3 53.45 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.335 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 64' ' ' THR . 93.4 mt-30 -61.91 -32.07 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 110.466 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 72' ' ' ARG . 6.0 tp10 -68.87 -43.45 75.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.802 175.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.644 HD23 HG11 ' A' ' 60' ' ' VAL . 23.5 tp -63.59 -31.18 72.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.807 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.14 81.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.425 HH21 ' CD ' ' A' ' 69' ' ' GLU . 42.0 mtm180 -65.42 -32.46 74.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.117 0.484 . . . . 0.0 110.041 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -66.04 -53.29 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.227 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.82 2.07 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 61.7 56.22 2.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.497 0.665 . . . . 0.0 109.947 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 55.3 t -104.45 136.33 19.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.907 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.0 Cg_exo -73.97 -143.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.233 2.622 . . . . 0.0 111.265 171.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -80.16 -71.57 1.26 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.514 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.912 HG22 ' HB3' ' A' ' 31' ' ' CYS . 14.3 t 176.7 158.42 0.46 Allowed Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.692 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 12.4 Cg_endo -87.84 127.21 8.64 Favored 'Cis proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.21 -1.162 . . . . 0.0 112.385 -1.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.81 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 7.2 m -115.95 119.65 36.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.609 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.1 m-85 -108.14 112.11 24.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.032 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.576 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 80.4 t -113.81 107.36 22.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HE1' HD12 ' A' ' 98' ' ' LEU . 96.3 m-85 -93.98 123.2 37.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.1 mt -114.56 140.51 48.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 111.211 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.31 123.31 37.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.408 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 5.7 Cg_exo -77.7 118.0 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.398 2.066 . . . . 0.0 110.286 171.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 93' ' ' GLU . 24.2 pttm -128.18 112.62 14.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 0.0 111.05 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.75 -80.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.547 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 23.05 1.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.09 155.1 43.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.824 0.345 . . . . 0.0 110.452 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.44 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 91.6 m95 -90.94 163.62 14.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 9.7 tp10 -148.1 140.85 24.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.681 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.465 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 37.2 tt0 -94.13 104.65 16.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.78 -12.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.616 -170.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.94 144.79 5.08 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.366 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 99.2 mtt180 -113.9 128.02 56.22 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 96.0 mt -121.72 141.83 50.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -137.66 143.93 41.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.326 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.21 141.37 11.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.403 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 37' ' ' MET . 3.3 p -70.21 122.45 19.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 23.4 mmt85 -108.03 142.11 24.57 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.92 158.25 25.63 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.022 1.815 . . . . 0.0 110.183 168.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -54.4 -49.05 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.567 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.48 72.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.39 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.535 ' OE1' ' HD2' ' A' ' 102' ' ' ARG . 4.5 tm-20 -76.05 -48.39 21.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 67.0 t80 -66.4 -36.76 83.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 108' ' ' LEU . 40.8 mt -62.64 -35.43 79.59 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.619 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 24.0 ttpp -60.34 -49.17 78.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 114' ' ' VAL . 4.3 mm-40 -64.1 -47.2 80.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.19 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.62 -38.54 90.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -58.08 -41.91 84.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.11 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.403 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 5.9 tt0 -66.1 -56.72 10.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.008 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -58.47 -39.92 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.252 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.457 ' CB ' HH21 ' A' ' 54' ' ' ARG . 22.8 p -63.07 -24.17 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 0.0 111.193 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.6 t -84.84 -33.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.352 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 113' ' ' GLN . 32.7 mmmt -62.94 -21.43 66.06 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.322 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.08 -17.58 77.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.58 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.491 178.618 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.452 HD11 ' CB ' ' A' ' 51' ' ' LEU . 30.1 tp . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.007 0.432 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -79.52 102.41 8.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.319 -178.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 75.2 m95 -106.73 125.92 51.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.115 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.3 m-85 -130.62 153.38 81.48 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 24.5 Cg_exo -61.6 161.47 24.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.789 1.659 . . . . 0.0 110.667 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.543 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 75.6 t80 -46.92 -51.11 41.66 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.4 Cg_exo -58.7 -52.5 5.22 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 121.694 1.596 . . . . 0.0 112.23 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 37.5 mt-10 -62.23 -38.89 90.93 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.455 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.17 78.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 0.0 111.6 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.437 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.4 mm? -62.88 -40.57 97.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.931 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.28 -37.28 63.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.23 0.538 . . . . 0.0 110.31 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.57 -50.11 74.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.822 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.47 88.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.432 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 24.2 tp60 -62.65 -46.28 88.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.21 -14.49 58.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.918 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -114.6 3.49 14.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.41 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.66 96.09 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.594 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.4 mmp_? -107.46 177.21 4.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.443 ' SD ' HG22 ' A' ' 86' ' ' VAL . 8.0 mmm -100.5 160.33 14.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.5 t -105.6 124.74 60.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 -174.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.588 ' SD ' HG13 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -113.4 103.65 11.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -92.33 109.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.093 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 84.0 t80 -103.86 103.62 13.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.462 0.649 . . . . 0.0 111.028 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.865 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 54.6 m-85 -84.64 116.1 23.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.082 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.702 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 24.3 p80 -124.54 138.3 54.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 39.2 t -100.46 141.47 33.27 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.026 168.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.65 -25.1 67.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -102.59 16.27 26.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.095 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 79' ' ' THR . 50.6 t -70.81 112.02 11.77 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.06 -67.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.484 2.789 . . . . 0.0 114.905 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -86.69 -19.49 29.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -167.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.574 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 17.1 t -70.9 -22.85 62.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -30.06 59.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -71.29 -44.53 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.221 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.547 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 51.8 ttm -66.73 -49.18 66.83 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.358 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -54.09 -44.7 71.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.233 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.5 m -72.93 -59.77 2.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.659 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.45 -67.72 0.83 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.023 0.44 . . . . 0.0 112.153 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.547 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 98.9 t -55.14 -51.59 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.74 -21.9 37.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.769 0.319 . . . . 0.0 111.481 -170.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.6 m -92.55 -10.58 37.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.087 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -47.28 133.26 9.64 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.625 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.35 -33.77 57.61 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.573 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.56 -52.41 7.38 Favored Glycine 0 CA--C 1.51 -0.247 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.01 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.445 HG22 HD21 ' A' ' 108' ' ' LEU . 62.6 t -58.38 -51.3 73.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.642 0.734 . . . . 0.0 110.184 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -52.74 -44.11 66.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.711 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 49' ' ' ARG . 45.0 ttm180 -59.39 -38.45 80.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.256 0.347 . . . . 0.0 111.598 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.53 HD12 HD23 ' A' ' 111' ' ' LEU . 50.2 mt -64.0 -39.88 95.11 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.623 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.43 -52.9 13.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.094 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 3' ' ' LEU . 6.1 mm-40 -48.84 -43.12 38.28 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.092 0.557 . . . . 0.0 112.32 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.09 -57.02 13.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.615 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.13 22.75 3.26 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -171.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.615 ' CE1' ' HD3' ' A' ' 54' ' ' ARG . 50.5 m-85 -133.23 142.02 48.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.417 0.627 . . . . 0.0 111.58 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' A' ' 14' ' ' LEU . 82.6 t -108.01 118.91 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.664 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.588 HG13 ' SD ' ' A' ' 23' ' ' MET . 17.9 t -92.23 120.63 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 -173.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -89.95 118.17 29.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.3 p -90.07 101.32 14.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 110.039 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.534 HG11 ' HG ' ' A' ' 70' ' ' LEU . 57.3 t -111.06 120.0 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.739 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 9.8 m -88.83 109.12 19.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 8.9 p -86.48 6.9 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.466 0.65 . . . . 0.0 111.262 -170.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.524 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 5.0 m-20 -90.2 -30.65 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.203 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.647 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -92.5 165.58 19.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.154 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.647 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.65 -50.24 14.6 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.565 2.844 . . . . 0.0 114.38 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.477 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -70.85 -30.08 66.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.6 -33.57 47.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.99 172.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.701 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 40.5 mm-40 -63.83 -36.74 84.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -55.05 -52.57 62.78 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.901 170.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.534 ' HG ' HG11 ' A' ' 60' ' ' VAL . 3.1 mm? -53.74 -38.36 64.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.121 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' ' CG2' ' A' ' 62' ' ' VAL . . . -71.32 -34.17 70.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.635 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.701 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -72.14 -40.88 67.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.188 0.518 . . . . 0.0 110.475 174.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -63.11 -55.49 24.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.238 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.66 -15.87 40.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.212 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 67.55 37.55 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -134.44 147.75 64.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.724 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.35 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.218 1.946 . . . . 0.0 111.185 165.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.426 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . -159.63 56.94 0.33 Allowed Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.806 ' HA ' ' SG ' ' A' ' 31' ' ' CYS . 11.5 p -130.12 46.14 2.1 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -167.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 34.1 Cg_endo -94.4 172.79 15.78 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 120.731 1.297 . . . . 0.0 111.215 -5.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.865 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 36.1 m -132.83 129.26 38.25 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.613 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CZ ' ' HG2' ' A' ' 80' ' ' PRO . 2.1 m-85 -124.66 114.56 19.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.14 119.17 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.883 0.373 . . . . 0.0 110.152 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -99.65 126.68 45.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.55 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 23.5 mt -117.04 144.87 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 0.0 111.239 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.443 HG22 ' SD ' ' A' ' 21' ' ' MET . 90.2 t -109.15 125.91 30.45 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.372 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 74.2 Cg_endo -79.04 117.93 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.043 1.829 . . . . 0.0 110.839 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.06 109.41 10.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.202 0.525 . . . . 0.0 110.849 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.02 -82.06 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.674 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.56 20.37 1.67 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.01 157.8 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 89.3 m95 -92.56 169.93 10.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.655 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.5 tp10 -145.21 139.1 26.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.21 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.475 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 33.8 tt0 -95.2 103.19 15.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.8 p -99.74 9.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.689 -168.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.94 146.21 4.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.505 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.432 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 77.5 mtt180 -120.94 127.37 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.471 HD22 ' NH1' ' A' ' 102' ' ' ARG . 84.3 mt -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -136.96 143.27 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.605 0.241 . . . . 0.0 110.398 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.66 146.05 19.22 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.477 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 m -83.33 107.46 15.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.604 0.716 . . . . 0.0 110.601 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.591 ' NH1' ' HG3' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -108.68 152.34 42.16 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.04 178.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.87 158.61 13.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.797 2.331 . . . . 0.0 111.974 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.453 ' HB2' HG13 ' A' ' 41' ' ' VAL . 16.1 ttt-85 -60.92 -31.66 71.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.51 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -45.1 94.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.147 0.499 . . . . 0.0 110.054 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.87 -42.92 94.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.902 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.31 -47.38 79.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.776 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 28.9 mt -61.72 -38.57 88.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.555 0.217 . . . . 0.0 110.795 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 20.8 tttm -56.06 -56.03 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.647 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.591 ' HG3' ' NH1' ' A' ' 102' ' ' ARG . 6.8 mm-40 -63.96 -44.96 91.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 50' ' ' LEU . 35.0 tp -55.48 -47.87 75.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.425 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -64.46 -39.58 94.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.516 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 15.9 mm100 -70.49 -23.48 62.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.341 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 110' ' ' GLU . 73.8 t -73.41 -41.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 172.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.1 m -58.77 -37.73 76.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.493 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 112' ' ' ARG . 68.1 t -63.58 -40.0 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.977 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 113' ' ' GLN . 62.7 mttp -64.03 -41.77 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.162 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.29 -14.16 82.84 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.565 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.874 -178.538 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.475 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 15.1 tp . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.289 0.566 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -90.55 103.98 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.546 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.407 ' HE3' ' HB3' ' A' ' 59' ' ' SER . 52.5 m95 -99.7 129.89 45.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.428 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 38.2 m-85 -131.49 167.12 23.31 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.083 171.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 15.0 Cg_exo -68.09 163.05 37.45 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.965 1.777 . . . . 0.0 110.974 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.584 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.9 t80 -47.53 -52.97 33.39 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 49.0 Cg_exo -57.62 -49.74 12.56 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.972 1.781 . . . . 0.0 112.935 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.14 -42.61 88.83 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.19 -42.03 72.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.0 111.528 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.47 -37.76 77.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.6 -43.67 63.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.638 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.97 0.415 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.13 -47.76 81.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.687 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.069 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.02 -14.59 55.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -118.43 6.61 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.564 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.4 39.42 97.73 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.76 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.3 mmp_? -110.53 -179.99 3.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.582 ' SD ' HG22 ' A' ' 86' ' ' VAL . 56.0 mtm -110.58 160.22 16.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 93.5 t -106.07 127.93 60.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.66 0.267 . . . . 0.0 111.52 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.2 ttt -105.69 103.15 12.6 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 171.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.553 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 41.1 t -86.79 107.53 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.499 ' HE1' ' HE2' ' A' ' 82' ' ' PHE . 65.4 t80 -98.99 103.65 15.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 88.3 m-85 -82.71 115.07 21.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.177 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.692 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 32.5 p80 -123.17 138.8 54.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.646 ' H ' HG21 ' A' ' 79' ' ' THR . 24.0 t -117.99 163.64 16.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.954 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -76.69 -2.43 32.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.586 0.708 . . . . 0.0 109.522 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -112.17 14.45 20.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 30.4 p -76.8 129.95 77.54 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.834 0.349 . . . . 0.0 111.457 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.62 -78.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.649 2.232 . . . . 0.0 113.829 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.541 ' CE2' ' HB2' ' A' ' 37' ' ' MET . 89.3 t80 -86.08 -17.45 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.48 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.638 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 12.9 t -47.73 -44.36 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.133 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -57.35 -33.32 67.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.05 -45.97 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.902 0.382 . . . . 0.0 110.508 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.697 ' HG2' ' HB ' ' A' ' 41' ' ' VAL . 10.9 tmm? -65.42 -40.94 93.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.344 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 7.2 t30 -59.41 -41.24 89.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.32 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.3 m -77.17 -56.51 4.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -90.13 -64.65 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.146 0.498 . . . . 0.0 111.803 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.697 ' HB ' ' HG2' ' A' ' 37' ' ' MET . 77.8 t -55.71 -44.23 76.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.405 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.27 -13.96 57.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.861 0.362 . . . . 0.0 111.194 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -100.36 -6.78 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.684 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.19 135.55 8.94 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.746 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 80.8 Cg_exo -49.68 -45.45 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.351 2.701 . . . . 0.0 113.623 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.41 -45.64 67.69 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.111 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.707 HG22 HD21 ' A' ' 108' ' ' LEU . 43.4 t -59.41 -47.78 89.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 121.648 0.737 . . . . 0.0 109.778 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.557 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 23.5 t -52.86 -43.14 65.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.387 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 82.7 mtt180 -62.27 -21.38 65.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.447 HD12 HD22 ' A' ' 108' ' ' LEU . 23.3 mt -80.39 -38.11 30.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.756 174.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.32 -50.53 11.63 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 48' ' ' SER . 7.1 mm-40 -44.38 -47.69 9.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.783 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -67.98 -48.27 66.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -168.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.783 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -134.44 16.45 3.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -125.18 141.01 52.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.393 0.616 . . . . 0.0 111.688 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.2 t -106.6 114.95 47.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.94 121.07 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.806 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -94.58 117.6 30.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.407 ' HB3' ' HE3' ' A' ' 5' ' ' TRP . 22.3 p -85.83 101.61 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.92 109.07 23.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.956 0.407 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.641 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -94.96 107.87 19.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.158 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 28' ' ' SER . 38.3 t -75.04 -8.29 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.292 1.044 . . . . 0.0 108.549 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.041 176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -125.11 163.51 37.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.069 -174.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.8 Cg_endo -50.75 -47.76 23.71 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.323 3.349 . . . . 0.0 114.85 -169.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.416 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -61.99 -36.44 81.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.082 -176.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -82.47 -31.8 29.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.559 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 64' ' ' THR . 96.9 mt-30 -59.22 -38.0 78.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.514 0.673 . . . . 0.0 109.479 171.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 6.0 tp10 -61.51 -50.6 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.97 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 66' ' ' GLU . 3.5 mm? -58.68 -40.25 83.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.686 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.62 -50.25 73.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.49 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.266 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 30.4 ttt85 -65.12 -56.02 15.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.221 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.55 3.29 55.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.565 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 58.47 64.75 1.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.623 0.577 . . . . 0.0 109.714 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.55 92.92 48.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -102.31 129.03 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.712 2.941 . . . . 0.0 112.052 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 140.23 -85.09 0.21 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.834 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.692 ' CG2' ' HA ' ' A' ' 27' ' ' HIS . 85.0 m 75.07 137.21 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 122.49 0.316 . . . . 0.0 111.325 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HA ' HG23 ' A' ' 79' ' ' THR . 70.1 Cg_endo -76.52 137.48 49.33 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.724 -1.365 . . . . 0.0 112.881 0.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.7 m -124.69 129.06 49.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.997 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' HE1' ' CA ' ' A' ' 100' ' ' GLY . 1.4 m-85 -115.27 122.07 44.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.044 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.8 t -121.47 108.31 22.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.881 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HE1' HD12 ' A' ' 98' ' ' LEU . 59.1 m-85 -94.34 120.07 34.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.043 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 94' ' ' GLU . 32.4 mt -109.22 130.66 55.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.663 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.582 HG22 ' SD ' ' A' ' 21' ' ' MET . 22.6 t -108.56 123.91 35.94 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.378 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.5 117.69 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.901 1.734 . . . . 0.0 110.559 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -157.67 143.29 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.739 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.18 -77.39 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.988 0.805 . . . . 0.0 111.43 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.18 24.38 0.13 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.797 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.42 -177.48 6.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.687 0.28 . . . . 0.0 110.453 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.07 132.62 51.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.427 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.11 119.71 40.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.266 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.525 ' HA ' HD23 ' A' ' 85' ' ' LEU . 39.9 tt0 -77.0 95.96 4.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.75 -7.46 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.094 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.74 118.3 0.6 Allowed Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.796 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.479 ' HG3' HG22 ' A' ' 83' ' ' VAL . 16.7 ttm180 -108.92 126.67 53.33 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 86.1 mt -124.41 139.03 54.28 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.032 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -102.58 117.13 34.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 164.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.568 ' CA ' ' HE1' ' A' ' 82' ' ' PHE . . . -90.78 -134.27 5.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.461 -167.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 33' ' ' TYR . 23.0 m 75.67 -12.09 1.03 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.793 0.837 . . . . 0.0 110.578 -173.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 100' ' ' GLY . 62.1 mtp180 -65.25 156.31 81.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.247 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.49 155.55 25.4 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 111.543 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.51 ' HB3' HG13 ' A' ' 41' ' ' VAL . 30.8 ptt180 -67.62 -25.12 65.59 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.083 -174.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.6 74.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.107 0.479 . . . . 0.0 109.956 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 21.7 mm-40 -75.25 -37.88 60.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.388 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.63 -47.95 83.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.638 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.707 HD21 HG22 ' A' ' 47' ' ' VAL . 88.6 mt -68.16 -31.43 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.732 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' HB3' ' A' ' 109' ' ' LYS . 5.0 tmmm? -63.15 -47.9 80.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.951 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 5.4 mm-40 -69.92 -41.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 111' ' ' LEU . 4.1 tt -61.16 -36.32 79.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -63.46 -45.07 92.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.23 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 5.5 pt20 -62.81 -38.43 90.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.437 ' N ' ' HG3' ' A' ' 113' ' ' GLN . 69.9 t -66.78 -42.68 89.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.683 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 52.4 t -57.22 -30.48 64.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.864 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.15 -53.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.873 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -59.15 -28.13 66.29 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.463 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -62.46 -41.42 99.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.505 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.482 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.755 179.721 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 57' ' ' VAL . 24.6 tp . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.869 0.366 . . . . 0.0 111.724 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.678 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 5.4 mmt180 -88.34 104.64 16.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.328 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -106.38 104.63 14.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.678 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 96.8 m-85 -111.12 157.39 38.95 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 19.3 Cg_exo -63.48 162.02 29.14 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.957 1.771 . . . . 0.0 111.172 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.607 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.3 t80 -45.82 -55.73 12.03 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.8 Cg_exo -65.0 -41.52 16.89 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.654 1.569 . . . . 0.0 112.126 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 37.1 tt0 -70.13 -36.92 75.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.847 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.68 86.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.997 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.91 -39.67 92.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.653 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.08 70.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.778 0.323 . . . . 0.0 110.651 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.557 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -59.67 -50.08 75.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -65.52 -45.57 83.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.978 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -58.85 -46.63 87.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.729 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -14.32 58.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.933 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -115.29 0.37 13.46 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.686 -175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.72 41.36 97.7 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.355 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.873 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 76.6 mmt-85 -112.87 178.44 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 0.0 111.946 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.7 mtp -101.46 154.36 18.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.345 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 48.5 t -106.19 135.05 45.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.801 0.334 . . . . 0.0 110.786 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.1 ttt -118.17 103.21 9.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 38.9 t -89.58 111.18 22.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.4 t80 -102.92 109.15 20.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.435 0.636 . . . . 0.0 111.006 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 1.023 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.8 m-85 -85.49 118.87 25.28 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.563 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.554 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 29.3 p80 -133.89 163.93 28.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.943 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 22.6 m -143.36 149.68 38.08 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.555 174.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -39.53 86.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -84.26 4.61 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.397 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 9.0 t -134.83 65.73 66.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.83 31.98 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.004 2.469 . . . . 0.0 114.476 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -83.35 -58.11 2.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.865 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.821 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 46.6 t -74.6 -22.34 59.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -67.04 -19.75 65.74 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.296 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -69.7 -47.87 61.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 28.1 mtm -61.99 -35.76 79.48 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.299 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 7.3 t30 -56.24 -43.67 78.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' SER . 30.7 m -65.17 -49.73 68.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -90.87 -70.91 0.66 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.325 0.583 . . . . 0.0 111.375 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' A' ' 104' ' ' ARG . 71.1 t -56.04 -51.77 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.753 -173.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.6 tp -81.87 -22.57 36.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -170.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' THR . 62.1 m -93.95 -3.42 51.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.059 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 47' ' ' VAL . 9.6 t70 -48.59 129.13 13.76 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.544 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.99 -36.61 76.43 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.127 2.552 . . . . 0.0 113.212 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.43 -34.85 68.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.87 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 44' ' ' ASP . 20.6 t -74.9 -49.0 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.366 0.603 . . . . 0.0 109.598 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -54.49 -37.03 64.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.886 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -63.31 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 0.0 111.262 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.26 -46.01 68.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.476 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 2.4 mm? -67.29 -47.25 71.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.15 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -46.01 -41.79 12.35 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.777 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -70.84 -49.95 40.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -171.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.873 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.82 16.38 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.42 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 87.4 m-85 -127.18 143.67 51.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.334 0.588 . . . . 0.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 14' ' ' LEU . 61.6 t -115.72 117.28 55.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 3' ' ' LEU . 15.2 t -91.07 131.76 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.855 -173.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -101.36 119.63 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -85.22 102.31 13.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.227 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.72 125.79 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.301 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -109.28 121.8 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.519 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 56.5 t -68.97 -16.03 20.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.219 0.533 . . . . 0.0 110.992 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 2.1 m-20 -67.29 -34.49 77.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.909 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 61.5 p -97.04 158.29 33.59 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.024 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 15.1 Cg_endo -51.02 -41.55 56.26 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.636 2.891 . . . . 0.0 113.127 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.538 ' OE2' ' HG2' ' A' ' 65' ' ' PRO . 1.7 mp0 -52.0 -57.75 8.56 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.041 0.448 . . . . 0.0 110.036 175.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.11 -33.06 65.29 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.259 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.615 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 51.3 mt-30 -56.02 -51.14 68.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.606 0.362 . . . . 0.0 111.114 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.419 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -76.84 -29.41 55.87 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.777 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.595 HD21 ' CD1' ' A' ' 8' ' ' TYR . 1.7 mp -61.61 -42.23 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 0.0 110.549 170.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.26 77.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.799 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 86.5 mtt180 -71.64 -27.44 63.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -80.96 -52.58 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.28 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -85.47 -14.02 47.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.763 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 65.05 78.08 0.29 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 77' ' ' PRO . 54.5 t -135.35 142.01 39.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 -171.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.446 ' O ' HG12 ' A' ' 76' ' ' VAL . 9.0 Cg_exo -73.49 -143.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.262 2.641 . . . . 0.0 111.142 169.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.49 -49.31 3.02 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.239 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.692 ' OG1' ' HA ' ' A' ' 80' ' ' PRO . 1.1 t 179.89 160.38 0.83 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.821 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -88.96 126.75 7.67 Favored 'Cis proline' 0 N--CA 1.456 -0.711 0 C-N-CA 124.246 -1.147 . . . . 0.0 112.035 -1.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 1.023 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.4 m -125.24 108.17 11.47 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.98 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.498 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.6 m-85 -102.67 111.59 23.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.235 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.7 t -110.65 108.9 26.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.88 0.372 . . . . 0.0 110.775 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.27 118.44 32.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.891 0.377 . . . . 0.0 110.538 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 32.8 mt -114.25 131.75 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 t -110.61 124.69 32.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.516 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.7 Cg_endo -80.38 117.2 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.166 1.911 . . . . 0.0 110.387 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -146.37 133.81 20.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.406 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.14 -75.67 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.029 0.831 . . . . 0.0 111.144 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.82 29.49 0.15 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.713 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.99 165.53 33.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.587 0.232 . . . . 0.0 110.528 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.516 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 80.0 m95 -98.99 126.47 44.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.972 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 26.5 tt0 -106.94 121.38 44.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.445 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.522 ' HA ' HD23 ' A' ' 85' ' ' LEU . 49.0 tt0 -76.25 96.46 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 117' ' ' LYS . 9.7 p -82.62 -14.51 12.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.009 -169.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.16 129.58 1.26 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.304 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.484 ' HG3' HG22 ' A' ' 83' ' ' VAL . 27.7 ttm180 -115.61 127.45 55.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 99.0 mt -109.37 133.89 52.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.662 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -136.93 116.54 12.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.65 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.3 173.06 18.86 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.054 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 m -109.98 120.36 42.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.745 0.307 . . . . 0.0 110.327 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 65.0 mtp180 -146.23 147.44 31.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HD2' ' HG3' ' A' ' 106' ' ' GLU . 31.4 Cg_exo -59.39 163.09 13.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.809 2.34 . . . . 0.0 112.085 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.592 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -63.73 -25.97 68.44 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.778 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.49 95.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.022 0.439 . . . . 0.0 110.337 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.3 mm-40 -64.89 -44.98 87.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.464 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.447 ' CE2' HD12 ' A' ' 111' ' ' LEU . 44.7 t80 -62.58 -37.58 86.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.516 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 62.3 mt -61.68 -42.24 98.66 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 110.943 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -57.31 -54.23 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.165 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 2.7 mm-40 -65.91 -41.04 91.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.126 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 111' ' ' LEU . 3.8 tt -60.98 -39.51 89.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.667 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 116' ' ' VAL . 12.6 tpt180 -59.23 -41.05 87.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.95 -43.31 75.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.571 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 110' ' ' GLU . 90.1 t -59.46 -39.63 79.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.743 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.12 -40.1 88.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.666 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 112' ' ' ARG . 97.6 t -66.55 -37.58 79.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 109.997 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HB3' ' CG2' ' A' ' 95' ' ' VAL . 34.0 mtpt -72.74 -8.17 54.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.712 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.65 -27.09 11.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.259 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.325 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 174.52 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 51' ' ' LEU . 14.8 tp . . . . . 0 C--O 1.238 0.469 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.591 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.7 mmm180 -91.13 103.12 15.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.782 0.325 . . . . 0.0 111.851 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.497 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 46.4 m95 -102.88 113.26 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.335 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 90.0 m-85 -118.14 161.8 33.0 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.021 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 16.7 Cg_exo -66.18 160.95 42.46 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.274 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.589 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 91.4 t80 -47.27 -53.84 25.68 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 35.3 Cg_exo -61.42 -46.96 12.93 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.83 1.687 . . . . 0.0 112.355 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -43.97 87.22 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -54.97 -42.34 72.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.741 0.305 . . . . 0.0 111.478 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.1 -38.69 82.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.81 63.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.755 0.312 . . . . 0.0 110.586 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -57.42 -40.62 78.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.09 -56.07 6.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.935 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 24.9 tt0 -60.46 -49.18 78.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.5 -175.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -14.02 59.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 15.7 m-70 -118.3 4.35 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.295 -175.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.64 34.06 72.43 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.261 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.6 mmp_? -108.64 178.87 4.35 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.589 -0.359 . . . . 0.0 110.108 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.475 ' SD ' HG22 ' A' ' 86' ' ' VAL . 48.3 mtm -108.06 165.49 11.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.4 t -105.69 125.04 61.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.818 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.551 ' SD ' HG13 ' A' ' 57' ' ' VAL . 1.4 tmt? -109.06 103.12 12.07 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.664 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 26.1 t -90.41 111.44 23.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.407 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 65.7 t80 -99.58 103.49 15.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.128 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.723 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 51.4 m-85 -81.39 121.67 26.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.639 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 25.4 p80 -135.28 138.54 43.6 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.165 0.915 . . . . 0.0 109.924 177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.426 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 1.5 t -99.39 168.12 10.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.495 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -7.0 44.02 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -114.07 -80.12 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.382 -0.199 . . . . 0.0 111.027 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 79' ' ' THR . 4.0 m 60.42 152.47 0.1 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.897 0.879 . . . . 0.0 112.915 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.22 -89.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.364 2.043 . . . . 0.0 113.08 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.02 -16.83 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 5.8 t -49.5 -52.57 28.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.241 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -57.8 -39.13 76.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.099 0.249 . . . . 0.0 111.613 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -66.84 -50.6 62.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 101' ' ' SER . 30.3 ttp -62.25 -46.13 90.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.744 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.6 -43.07 84.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.498 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.7 m -66.44 -56.77 9.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.638 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -91.89 -70.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.563 0.697 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.599 HG13 ' HA ' ' A' ' 104' ' ' ARG . 94.0 t -52.89 -48.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.065 -171.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 tp -81.41 -15.24 55.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -173.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.6 m -95.79 -1.09 50.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.606 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 47' ' ' VAL . 13.0 t70 -47.03 129.17 9.08 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.658 171.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.89 -37.52 85.47 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.131 2.554 . . . . 0.0 113.229 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.87 -42.59 30.28 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.026 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.698 HG22 HD23 ' A' ' 108' ' ' LEU . 8.1 t -66.66 -44.3 89.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -55.24 -40.64 71.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.688 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -70.22 -21.37 63.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.85 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 108' ' ' LEU . 72.5 mt -70.16 -44.56 68.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 3' ' ' LEU . 3.1 mm? -66.54 -60.56 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.361 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.456 ' OE1' HD12 ' A' ' 3' ' ' LEU . 9.5 mm-40 -50.08 -34.73 22.77 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.649 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -64.61 -53.15 52.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.649 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.38 11.61 3.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -123.28 145.79 48.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.039 0.447 . . . . 0.0 110.959 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 11' ' ' ALA . 22.0 t -107.98 118.09 54.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.551 HG13 ' SD ' ' A' ' 23' ' ' MET . 21.3 t -86.93 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.044 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -92.68 117.28 29.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.159 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 42.9 t -88.15 100.57 13.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.538 HG11 HD22 ' A' ' 70' ' ' LEU . 61.2 t -113.57 122.79 68.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.295 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.539 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 4.4 p -85.84 109.4 18.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.374 0.606 . . . . 0.0 109.679 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' A' ' 71' ' ' ALA . 5.1 p -88.99 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 123.091 1.424 . . . . 0.0 109.008 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.14 -38.7 0.07 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.075 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.653 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 3.1 p -81.63 164.66 48.22 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.511 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.3 Cg_endo -51.39 -55.23 4.2 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.534 2.823 . . . . 0.0 114.524 -170.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.1 -36.63 84.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.585 0.231 . . . . 0.0 111.182 -178.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.38 -34.02 64.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.649 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -71.19 -28.51 64.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.306 0.574 . . . . 0.0 110.714 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.31 -44.83 93.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.217 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.538 HD22 HG11 ' A' ' 60' ' ' VAL . 9.0 mp -65.86 -30.9 71.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 174.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB2' HG23 ' A' ' 62' ' ' VAL . . . -67.14 -35.24 79.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.589 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HA ' ' NH2' ' A' ' 75' ' ' ARG . 20.1 ptt180 -83.37 -33.17 25.86 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.314 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 28.4 ttm180 -73.18 -56.67 4.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.526 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 90.7 m-85 -91.38 -11.89 36.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.329 -174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.741 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 1.2 mmp_? 64.74 91.16 0.08 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.686 0.616 . . . . 0.0 110.247 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.457 HG11 ' CG ' ' A' ' 26' ' ' PHE . 39.1 t -129.51 85.85 57.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -105.29 125.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.512 2.808 . . . . 0.0 113.196 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 124.95 -68.31 0.51 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.422 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.651 HG21 ' SG ' ' A' ' 31' ' ' CYS . 60.3 m 72.26 138.58 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.463 0.305 . . . . 0.0 110.836 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HA ' HG23 ' A' ' 79' ' ' THR . 73.0 Cg_endo -78.51 143.76 73.07 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.707 0.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 35.5 m -122.77 122.66 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.038 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.648 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 9.7 m-85 -106.51 122.9 47.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.053 -175.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.664 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 45.2 t -124.11 105.43 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.04 118.89 32.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.327 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 94' ' ' GLU . 38.6 mt -113.11 137.28 51.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.475 HG22 ' SD ' ' A' ' 21' ' ' MET . 13.5 t -108.28 135.87 19.9 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.968 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.21 115.39 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.405 1.403 . . . . 0.0 108.794 166.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.86 111.28 5.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.831 0.348 . . . . 0.0 110.572 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.22 18.25 11.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.142 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.05 -23.64 34.83 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.852 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.87 -175.53 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.693 0.283 . . . . 0.0 110.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 95.0 m95 -115.7 136.9 52.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.472 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 32.4 tt0 -122.37 125.22 45.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.548 ' HA ' HD23 ' A' ' 85' ' ' LEU . 35.5 tt0 -78.58 95.98 5.35 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.538 HG22 ' HD3' ' A' ' 117' ' ' LYS . 1.4 p -102.38 -11.9 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.836 -170.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.72 104.48 0.36 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.744 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.517 ' HD3' ' CD ' ' A' ' 94' ' ' GLU . 8.5 tpt180 -111.97 124.76 53.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.9 mt -137.62 143.54 41.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -137.82 133.16 33.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.71 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.02 149.2 15.65 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.586 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.493 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 49.2 m -76.02 151.12 37.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.586 0.231 . . . . 0.0 110.872 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.843 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 16.9 mmt-85 -130.96 165.66 33.27 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.633 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 106' ' ' GLU . 21.5 Cg_exo -67.96 154.68 72.16 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.272 1.981 . . . . 0.0 109.808 162.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.599 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -57.41 -42.95 83.28 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -170.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.616 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . . . -79.76 -27.2 40.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.384 -175.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.4 mm-40 -76.9 -38.46 53.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.843 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 86.8 t80 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.042 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.698 HD23 HG22 ' A' ' 47' ' ' VAL . 4.3 pp -68.12 -22.95 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.629 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.409 ' N ' HD12 ' A' ' 108' ' ' LEU . 37.6 ttmt -67.14 -53.81 27.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.856 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.619 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 8.3 pt-20 -71.56 -32.13 67.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.195 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.419 HD12 ' CE2' ' A' ' 107' ' ' PHE . 5.9 tt -59.21 -42.53 91.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 116' ' ' VAL . 43.9 ttt180 -59.92 -43.7 94.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.252 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.6 OUTLIER -67.97 -23.43 65.04 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.327 -179.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 110' ' ' GLU . 93.9 t -81.73 -36.75 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.2 t -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.026 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 112' ' ' ARG . 57.9 t -65.72 -30.18 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.538 ' HD3' HG22 ' A' ' 95' ' ' VAL . 63.2 mttp -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.274 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.5 -18.97 68.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.557 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 175.776 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.238 0.455 0 CA-C-O 121.596 0.712 . . . . 0.0 112.484 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 36.7 mmt-85 -87.71 108.91 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.746 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.51 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.8 m95 -111.15 109.17 19.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 87.3 m-85 -124.31 156.36 67.03 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.53 159.75 19.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.935 1.757 . . . . 0.0 111.198 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.582 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.1 t80 -45.38 -54.02 16.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.7 Cg_exo -63.91 -39.74 31.46 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.643 1.562 . . . . 0.0 112.179 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.19 -36.97 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.832 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.37 -48.31 70.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.038 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.532 HD13 HG21 ' A' ' 22' ' ' VAL . 4.3 mm? -56.45 -42.67 78.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.695 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.12 63.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.074 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' HB3' HG11 ' A' ' 56' ' ' VAL . 9.4 tp -61.11 -51.04 70.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.18 -38.67 91.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.681 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 48.9 tt0 -65.86 -42.35 90.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.877 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.43 -16.04 44.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -112.06 2.11 16.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.753 -175.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.4 40.56 97.89 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.296 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -108.54 179.67 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 110.412 178.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 85.5 mtp -104.82 154.98 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 12' ' ' LEU . 85.0 t -106.15 130.54 57.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.412 . . . . 0.0 111.324 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.42 103.61 11.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.397 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 21.6 t -84.54 113.7 23.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CD2' ' HZ3' ' A' ' 5' ' ' TRP . 56.7 t80 -104.48 106.67 17.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.995 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.08 125.61 37.76 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.892 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -141.93 160.93 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.474 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.645 ' HB2' ' HB2' ' A' ' 31' ' ' CYS . 3.4 m -142.11 150.92 41.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.89 -40.77 83.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 172.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -82.16 1.53 35.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.8 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 86.0 m -132.86 68.05 78.47 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.175 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 35' ' ' GLN . 91.4 Cg_endo -81.39 38.49 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.076 2.517 . . . . 0.0 114.178 -167.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -73.61 -43.06 60.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.155 0.502 . . . . 0.0 111.124 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 16.1 t -77.46 -19.16 56.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.34 -176.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 32' ' ' PRO . 15.8 mm100 -54.81 -26.25 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.78 -32.16 31.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.424 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.2 ttm -78.97 -46.14 18.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.751 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.589 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 32.0 p30 -66.36 -21.07 66.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -78.68 -59.11 2.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.23 -70.19 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.932 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -54.98 -49.53 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.873 -170.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 25.0 tp -81.57 -21.48 38.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.465 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -95.34 -2.22 49.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 0.0 110.609 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -50.81 133.26 28.49 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.226 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.33 -44.27 39.78 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.246 2.631 . . . . 0.0 113.451 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.65 68.21 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.028 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 108' ' ' LEU . 84.6 t -57.73 -48.18 84.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 109.845 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.4 m -53.53 -50.91 64.45 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.013 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -54.57 -29.42 51.28 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.839 HD12 HD22 ' A' ' 108' ' ' LEU . 74.9 mt -73.42 -54.02 9.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 111.313 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.557 ' HB2' HD21 ' A' ' 3' ' ' LEU . 3.5 mm? -68.74 -39.62 80.26 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.12 -33.75 67.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.736 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -71.56 -49.84 36.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.529 ' HD3' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.12 15.25 3.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -173.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 78.4 m-85 -121.2 143.46 49.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.424 0.63 . . . . 0.0 112.073 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 14' ' ' LEU . 47.7 t -111.91 113.7 44.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.297 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.1 t -87.17 127.44 40.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.099 0.476 . . . . 0.0 110.881 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -93.4 117.09 29.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.986 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 p -83.82 102.09 12.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.098 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.04 126.03 74.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.028 0.442 . . . . 0.0 110.842 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 64' ' ' THR . 0.9 OUTLIER -113.09 132.64 55.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.468 HG13 ' CB ' ' A' ' 71' ' ' ALA . 46.3 t -79.68 -16.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.421 0.629 . . . . 0.0 111.244 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -76.21 -10.97 59.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.951 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.608 ' OG1' ' HD2' ' A' ' 65' ' ' PRO . 5.0 t -114.04 149.17 41.49 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.402 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.608 ' HD2' ' OG1' ' A' ' 64' ' ' THR . 19.0 Cg_endo -53.14 -50.91 12.36 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 123.523 2.815 . . . . 0.0 114.534 -169.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -31.88 62.75 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.138 -174.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -74.82 -30.42 59.61 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.653 174.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 64' ' ' THR . 4.6 tt0 -69.74 -36.89 76.22 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -54.34 -48.86 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.205 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.19 -43.42 92.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.297 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.468 ' CB ' HG13 ' A' ' 62' ' ' VAL . . . -57.99 -49.19 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.257 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.88 -20.79 41.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.262 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -62.3 -48.84 78.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 110.009 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.48 -15.06 29.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.007 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 65.04 79.64 0.25 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.516 0.674 . . . . 0.0 110.245 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.3 t -123.1 97.55 43.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.382 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -101.29 130.42 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.387 2.725 . . . . 0.0 113.35 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 31' ' ' CYS . . . 104.04 -56.49 0.57 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.568 169.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.68 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 20.1 p 60.38 161.19 0.11 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.652 0.781 . . . . 0.0 111.638 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.68 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 45.3 Cg_endo -69.64 145.74 80.01 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 124.035 -1.235 . . . . 0.0 112.367 -0.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.3 m -134.21 116.58 15.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.185 0.517 . . . . 0.0 110.037 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 6.1 m-85 -106.27 112.34 25.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.666 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 47.0 t -108.88 113.46 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.788 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.416 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 18.0 m-85 -96.61 127.69 42.83 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.566 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.3 mt -116.52 131.13 57.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.972 0.415 . . . . 0.0 110.73 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.507 ' CG2' HG11 ' A' ' 95' ' ' VAL . 91.7 t -109.64 129.8 23.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.774 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.39 117.88 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.841 1.694 . . . . 0.0 110.8 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' CE ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -131.16 125.01 31.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.15 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.808 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -155.69 25.04 0.57 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.156 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.83 166.78 23.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.483 0.183 . . . . 0.0 110.852 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 91.3 m95 -103.25 153.21 20.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.697 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 59.0 mt-10 -119.74 133.56 55.57 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.387 167.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.1 tt0 -81.6 94.96 7.02 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.805 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 22.7 m -85.17 -5.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.943 -166.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.17 158.78 9.41 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.362 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.4 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 82.5 mtt180 -129.72 130.23 45.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 68.0 mt -108.49 134.47 51.22 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -137.52 143.4 41.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.843 0.354 . . . . 0.0 111.044 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.84 162.35 25.85 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.281 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -74.55 116.26 15.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.118 0.485 . . . . 0.0 109.814 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -124.36 143.36 42.74 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.722 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.03 158.03 45.79 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.117 1.878 . . . . 0.0 110.268 169.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.536 ' HB3' HG13 ' A' ' 41' ' ' VAL . 33.5 ptt180 -62.55 -26.8 68.76 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.722 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.99 97.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.363 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -69.18 -48.55 61.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.34 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.72 -52.4 65.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.883 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.839 HD22 HD12 ' A' ' 50' ' ' LEU . 71.0 mt -65.96 -30.23 70.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.258 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -55.57 -62.45 1.68 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.102 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 114' ' ' VAL . 1.1 mt-10 -70.76 -32.8 70.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.407 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 51' ' ' LEU . 2.7 tm? -62.08 -41.29 98.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.209 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 42.7 mtm180 -68.5 -32.69 72.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.267 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.483 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 12.2 mm-40 -67.42 -35.46 79.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.043 0.449 . . . . 0.0 110.651 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 110' ' ' GLU . 95.6 t -66.75 -36.36 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.05 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.64 -34.55 71.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.35 -51.46 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.131 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.805 ' HE3' ' HB ' ' A' ' 95' ' ' VAL . 16.2 mtpp -59.79 -24.36 64.05 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -53.39 -31.58 43.34 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.44 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.217 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 51' ' ' LEU . 17.9 tp . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.4 0.143 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.491 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.4 mmt180 -86.81 103.07 14.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.971 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -105.59 103.95 13.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 85.6 m-85 -118.74 149.06 45.71 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.632 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.477 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.7 Cg_exo -59.67 166.26 8.46 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.423 2.082 . . . . 0.0 111.487 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.558 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -48.31 -50.99 53.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.1 Cg_exo -58.46 -49.25 12.56 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.823 1.682 . . . . 0.0 112.389 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 9.3 mt-10 -63.8 -42.94 97.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.704 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -59.99 -48.25 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.644 0.259 . . . . 0.0 111.54 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.508 HD13 HG21 ' A' ' 22' ' ' VAL . 4.6 mm? -63.29 -39.84 95.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.82 -37.69 48.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.08 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.454 ' HB3' HG11 ' A' ' 56' ' ' VAL . 9.8 tp -64.15 -46.71 82.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.93 96.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -64.52 -45.66 86.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.516 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.8 -14.49 59.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -116.8 3.11 12.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.576 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' C ' ' HE ' ' A' ' 20' ' ' ARG . . . 63.11 37.07 94.32 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.59 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.754 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.3 mmp_? -106.94 177.48 4.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.586 ' SD ' HG22 ' A' ' 86' ' ' VAL . 31.7 mtm -103.93 158.32 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG21 HD13 ' A' ' 12' ' ' LEU . 59.3 t -105.93 123.74 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.934 0.397 . . . . 0.0 111.17 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.416 ' HE1' HD11 ' A' ' 42' ' ' LEU . 21.1 ttt -103.4 103.58 13.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 173.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 40.6 t -85.42 108.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -106.59 103.57 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 110.793 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.3 m-85 -80.63 120.76 24.98 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.197 176.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.563 ' HA ' HG21 ' A' ' 79' ' ' THR . 31.5 p80 -129.3 155.94 44.79 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.918 0.761 . . . . 0.0 109.316 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 31' ' ' CYS . 92.7 p -137.03 166.28 24.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.722 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -78.08 -5.89 52.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.761 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -119.58 -0.5 10.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.455 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 28' ' ' SER . 21.8 p -58.44 130.26 84.44 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.534 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.6 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 63.6 Cg_endo -76.91 -86.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.225 1.95 . . . . 0.0 114.045 -175.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.84 -18.77 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.578 . . . . 0.0 110.735 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 29.3 t -63.27 -42.06 99.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 4.3 pt20 -66.93 -23.49 65.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.402 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -79.3 -48.44 14.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.406 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.596 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 17.2 ptp -66.98 -39.15 87.12 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.781 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.07 -34.59 68.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.467 . . . . 0.0 110.672 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 43' ' ' SER . 26.0 m -83.25 -61.04 1.95 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.525 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -91.38 -70.6 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 104' ' ' ARG . 70.8 t -49.31 -55.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.077 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.416 HD11 ' HE1' ' A' ' 23' ' ' MET . 21.2 tp -83.03 -27.07 30.59 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.738 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 39' ' ' THR . 31.2 t -88.39 -4.99 58.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.09 -175.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' A' ' 47' ' ' VAL . 13.3 t70 -51.26 130.88 32.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.644 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.709 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 27.5 Cg_exo -62.14 -20.94 71.54 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.854 2.37 . . . . 0.0 113.504 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.87 -34.52 38.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.174 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.54 HG22 HD21 ' A' ' 108' ' ' LEU . 14.8 t -76.89 -40.54 31.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 108.861 175.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.582 ' OG ' ' HA ' ' A' ' 45' ' ' PRO . 36.8 p -59.08 -33.49 70.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.105 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.709 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 87.3 mtt180 -56.78 -35.54 68.8 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.743 0.306 . . . . 0.0 111.45 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.75 -43.42 84.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.735 0.302 . . . . 0.0 110.448 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB2' HD11 ' A' ' 3' ' ' LEU . 2.7 mm? -73.94 -45.78 48.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.762 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -44.79 -48.98 10.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.731 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -66.87 -48.54 68.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.754 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.67 16.3 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -170.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.05 145.71 51.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.407 0.623 . . . . 0.0 111.447 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 11' ' ' ALA . 60.4 t -114.86 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 21.6 t -86.95 121.31 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.193 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -89.62 117.1 28.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.868 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.0 p -84.65 100.14 11.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.5 t -104.28 106.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.995 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.641 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -90.04 109.16 20.22 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.944 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 71' ' ' ALA . 25.9 t -75.15 -6.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.071 0.938 . . . . 0.0 109.27 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.722 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -77.53 -32.57 54.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.913 174.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.659 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.4 p -99.55 159.38 30.17 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.659 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.87 -53.51 6.87 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.235 3.29 . . . . 0.0 114.835 -169.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.37 80.05 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.8 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.78 -39.84 54.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.307 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -56.75 -39.79 74.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.658 0.742 . . . . 0.0 110.044 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.98 -44.87 79.35 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.899 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -34.7 78.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -64.54 -38.34 90.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -83.62 -20.49 33.56 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.811 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -80.71 -48.92 11.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.591 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -86.44 -10.93 53.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.192 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 73.1 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.804 0.69 . . . . 0.0 109.977 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.04 86.42 58.14 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.626 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -103.15 122.57 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.673 2.916 . . . . 0.0 112.741 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.46 ' HA3' ' HE1' ' A' ' 99' ' ' PHE . . . 133.92 -74.58 0.43 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.412 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 27' ' ' HIS . 23.7 m 73.23 141.97 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 123.704 0.297 . . . . 0.0 110.586 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.551 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 55.4 Cg_endo -69.08 153.99 91.36 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 124.426 -1.072 . . . . 0.0 113.32 1.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.1 m -138.94 123.82 18.77 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.432 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 1.5 m-85 -112.27 112.56 24.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.842 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 59.0 t -118.02 115.22 47.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HB2' HG22 ' A' ' 95' ' ' VAL . 49.2 m-85 -102.16 124.02 47.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.92 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 94' ' ' GLU . 32.8 mt -117.59 132.46 56.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.586 HG22 ' SD ' ' A' ' 21' ' ' MET . 14.9 t -110.71 132.73 21.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.578 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.7 115.04 3.04 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.251 1.3 . . . . 0.0 110.748 170.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -169.13 141.52 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.99 11.41 8.33 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.66 0.6 . . . . 0.0 111.342 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.8 29.6 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.63 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.98 -177.12 3.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.0 111.076 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 67.1 m95 -105.74 130.74 53.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.011 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.507 ' OE2' HG12 ' A' ' 95' ' ' VAL . 31.3 tt0 -97.14 119.82 36.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.238 176.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.533 ' HA ' HD23 ' A' ' 85' ' ' LEU . 33.0 tt0 -75.24 96.56 3.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.94 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 13.7 m -73.91 -11.73 14.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.953 -173.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.79 141.82 3.23 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.763 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -116.16 128.24 55.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.229 0.537 . . . . 0.0 109.642 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.579 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.3 mt -108.03 131.39 54.63 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.46 ' HE1' ' HA3' ' A' ' 78' ' ' GLY . 79.1 t80 -130.9 124.1 30.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.81 178.26 15.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.419 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 8.0 m -112.91 126.29 55.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.502 ' HE ' ' HG2' ' A' ' 106' ' ' GLU . 24.4 mmm180 -128.05 151.02 75.3 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.779 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.07 158.94 41.05 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.254 1.969 . . . . 0.0 111.262 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.655 ' HB2' HG13 ' A' ' 41' ' ' VAL . 67.7 ttt180 -58.67 -34.83 71.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.386 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.64 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.086 0.469 . . . . 0.0 110.634 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HG2' ' HE ' ' A' ' 102' ' ' ARG . 3.9 tp10 -67.02 -48.77 67.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.409 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -66.08 -37.36 85.6 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.843 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.54 HD21 HG22 ' A' ' 47' ' ' VAL . 60.6 mt -59.06 -44.51 91.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 0.0 110.73 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 46.7 mtmt -65.1 -48.07 74.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.32 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -59.36 -55.56 33.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.409 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' LEU . 1.9 tm? -61.31 -32.39 72.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.32 0.581 . . . . 0.0 109.897 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 116' ' ' VAL . 3.6 tpm_? -65.44 -37.85 88.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 109' ' ' LYS . 29.2 mm-40 -74.37 -43.19 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.553 0.215 . . . . 0.0 110.937 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.458 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . 79.5 t -62.67 -36.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.166 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.1 t -55.16 -29.73 58.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.576 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 112' ' ' ARG . 85.9 t -85.42 -54.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.245 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.94 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -70.95 -11.53 61.02 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.107 -170.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.448 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -56.12 -41.09 85.14 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.167 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.823 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.855 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.466 ' HB3' ' NE1' ' A' ' 5' ' ' TRP . 11.3 tp . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 121.105 0.479 . . . . 0.0 111.436 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -102.17 103.8 14.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.68 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.466 ' NE1' ' HB3' ' A' ' 3' ' ' LEU . 13.2 m95 -104.35 139.78 38.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.539 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 86.1 m-85 -138.91 166.63 23.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.68 159.35 41.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.54 1.494 . . . . 0.0 110.884 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.544 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 60.4 t80 -50.84 -51.36 67.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.2 Cg_exo -60.85 -43.69 29.71 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.834 1.689 . . . . 0.0 112.386 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -65.71 -46.07 80.33 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.491 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.15 -41.82 72.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.45 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.38 -38.78 91.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.044 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.47 -47.79 58.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.878 0.371 . . . . 0.0 110.399 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.446 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -54.21 -51.4 64.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.857 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.42 -43.96 95.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.357 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -62.39 -47.45 84.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.369 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.35 -15.45 57.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -112.58 -1.73 14.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.43 32.46 81.88 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.264 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 24.9 mmt180 -97.44 177.63 5.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.397 . . . . 0.0 110.675 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 88.1 mtp -104.5 156.25 18.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.474 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 49.9 t -105.95 124.69 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 ttt -104.39 103.47 13.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.684 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 37.5 t -84.5 104.54 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.896 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.9 t80 -102.33 108.84 20.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.077 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 1.004 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.7 m-85 -90.1 124.97 35.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 23.5 p80 -128.08 155.85 43.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.564 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.437 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 38.2 t -143.1 159.48 42.2 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -74.87 -9.05 58.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.57 0.7 . . . . 0.0 109.935 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -97.86 15.96 22.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.998 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.586 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 31.8 p -84.84 115.22 59.93 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.839 0.352 . . . . 0.0 110.562 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 79' ' ' THR . 38.0 Cg_endo -68.0 -69.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.497 2.132 . . . . 0.0 113.866 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.88 -17.19 36.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 44.5 t -55.46 -46.92 76.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.487 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -56.6 -38.25 71.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.38 . . . . 0.0 111.638 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -72.2 -38.93 68.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.42 ' HE1' ' H ' ' A' ' 102' ' ' ARG . 50.8 ttm -65.32 -49.38 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.856 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 77.6 m-20 -52.36 -49.27 64.69 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.363 0.415 . . . . 0.0 111.018 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' SER . 21.9 m -59.86 -59.99 4.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.888 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.05 -68.4 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 112.071 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 104' ' ' ARG . 68.6 t -58.9 -44.35 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.804 -170.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 21.1 tp -81.74 -34.68 30.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.334 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 39' ' ' THR . 33.4 t -85.74 -0.99 56.74 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.406 ' OD2' HG23 ' A' ' 47' ' ' VAL . 22.1 t70 -49.87 128.46 20.83 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.117 174.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.57 -35.63 57.16 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.222 2.614 . . . . 0.0 113.242 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.86 -48.22 28.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.962 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.712 HG22 HD21 ' A' ' 108' ' ' LEU . 59.6 t -61.36 -57.5 11.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.107 0.479 . . . . 0.0 110.762 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.68 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 54.9 m -52.23 -47.41 65.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.085 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -58.5 -36.56 73.98 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.471 HD13 HD12 ' A' ' 111' ' ' LEU . 76.7 mt -62.68 -40.38 96.92 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.0 110.593 176.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.5 mm? -74.53 -40.58 61.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.292 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.6 mt-10 -49.48 -50.21 42.32 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.204 0.526 . . . . 0.0 112.023 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.14 82.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -135.23 11.95 3.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 86.4 m-85 -121.38 145.64 47.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.353 0.597 . . . . 0.0 111.246 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 11' ' ' ALA . 20.1 t -111.98 113.66 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 3' ' ' LEU . 21.8 t -87.03 117.4 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 8' ' ' TYR . . . -90.31 117.27 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.45 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.1 p -85.14 101.41 12.44 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.9 125.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.565 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.606 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -100.48 108.52 20.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.057 0.456 . . . . 0.0 110.571 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.36 -11.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.054 0.93 . . . . 0.0 109.636 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.474 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 6.8 m-20 -77.68 -32.34 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.609 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.616 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -109.1 165.46 12.6 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.778 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.3 Cg_endo -49.73 -52.95 7.86 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.092 3.194 . . . . 0.0 114.491 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -56.43 -43.37 79.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.34 -31.15 52.59 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.98 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -60.19 -41.32 92.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.724 0.297 . . . . 0.0 111.065 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.1 pt-20 -79.25 -30.64 43.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.882 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.408 ' HB3' ' HE1' ' A' ' 26' ' ' PHE . 1.9 mm? -63.83 -44.19 93.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 0.0 110.247 172.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.01 79.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.449 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.8 ptm180 -65.39 -30.68 71.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.111 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -66.51 -41.39 88.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 110.276 -179.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -92.33 -6.09 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.24 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 65.38 33.11 9.21 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.683 0.614 . . . . 0.0 111.439 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 t -130.26 144.99 55.46 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 17.0 Cg_exo -69.63 -116.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.378 2.052 . . . . 0.0 111.282 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.496 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . 168.14 63.32 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 12.5 p -137.86 47.72 1.76 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.657 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 43.5 Cg_endo -93.08 174.38 16.62 Favored 'Cis proline' 0 C--N 1.356 0.949 0 CA-C-N 121.0 1.393 . . . . 0.0 112.507 -3.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 1.004 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 62.8 m -139.18 131.64 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 170.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -127.75 112.23 14.56 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.684 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 57.4 t -111.43 121.63 64.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.735 0.303 . . . . 0.0 110.199 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.49 116.62 30.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.668 0.27 . . . . 0.0 110.357 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 29.3 mt -112.93 137.04 51.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.213 0.53 . . . . 0.0 111.408 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.522 HG21 ' HA2' ' A' ' 118' ' ' GLY . 58.8 t -109.98 123.33 36.46 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.03 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 59.5 Cg_endo -77.11 116.42 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.778 1.652 . . . . 0.0 111.193 173.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -147.85 135.33 20.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.684 0.278 . . . . 0.0 110.574 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.0 24.16 14.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.554 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.56 77.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.343 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.31 167.02 20.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 65.7 m95 -106.36 126.12 51.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.943 0.401 . . . . 0.0 110.026 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.8 tp10 -114.04 137.44 51.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.623 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 38.1 tt0 -88.29 112.91 23.35 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.537 HG22 ' HE2' ' A' ' 117' ' ' LYS . 8.7 p -98.93 7.46 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.499 0.666 . . . . 0.0 110.336 -175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.46 138.49 2.88 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.504 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -122.94 133.06 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.153 0.502 . . . . 0.0 110.508 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.98 128.39 56.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.923 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -137.18 143.42 42.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.986 0.422 . . . . 0.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.02 -177.27 28.82 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.353 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.6 m -88.79 107.84 19.18 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.497 ' HB3' ' OE1' ' A' ' 106' ' ' GLU . 4.1 mmm180 -111.29 143.65 28.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.658 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.69 151.27 82.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.26 1.973 . . . . 0.0 110.925 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.689 ' HB2' HG13 ' A' ' 41' ' ' VAL . 22.6 ttp180 -59.21 -27.35 65.64 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.89 92.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.65 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.497 ' OE1' ' HB3' ' A' ' 102' ' ' ARG . 50.0 tt0 -82.84 -38.27 23.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 37.2 t80 -58.38 -51.4 69.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.675 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 47' ' ' VAL . 57.8 mt -70.59 -28.23 64.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -56.7 -55.62 31.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.249 0.547 . . . . 0.0 109.879 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 114' ' ' VAL . 20.8 tp10 -73.74 -31.64 63.46 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.112 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -60.31 -46.58 89.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -60.82 -38.06 84.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.83 -48.52 58.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 110' ' ' GLU . 55.5 t -58.36 -42.45 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.505 0.322 . . . . 0.0 111.75 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.0 p -63.05 -23.85 67.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 110.497 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -86.11 -50.12 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.661 173.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HE2' HG22 ' A' ' 95' ' ' VAL . 38.2 mtpt -55.22 -34.3 63.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.236 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -68.41 -24.09 75.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.949 -0.644 . . . . 0.0 113.152 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.507 177.358 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.1 tp . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 23.0 mmt180 -88.3 106.38 18.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.646 -172.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -110.24 108.71 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 94.2 m-85 -133.17 154.26 81.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.43 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 34.6 Cg_exo -57.05 161.71 10.37 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.09 1.86 . . . . 0.0 111.504 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.569 ' O ' HD23 ' A' ' 12' ' ' LEU . 82.9 t80 -45.81 -53.66 19.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 20.9 Cg_exo -65.17 -40.68 18.91 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.485 1.457 . . . . 0.0 112.146 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.43 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 31.6 tt0 -71.08 -37.33 72.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.926 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.23 79.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.005 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.569 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.6 mm? -61.18 -34.5 75.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.593 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -39.05 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.784 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.5 tp -64.22 -47.31 80.19 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.008 0.432 . . . . 0.0 110.138 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.52 89.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.434 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -62.77 -51.65 66.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.226 178.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.72 -14.38 59.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.029 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -118.68 3.62 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.765 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.67 44.4 95.7 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.458 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.8 mmp_? -107.43 174.86 5.7 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.671 -0.311 . . . . 0.0 110.791 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 79.6 mtp -100.52 156.55 17.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 24.6 t -106.79 127.54 62.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.2 ttt -111.07 104.25 12.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -88.38 107.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -93.02 103.97 16.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 110.137 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.692 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 59.8 m-85 -87.41 122.48 31.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.302 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 62' ' ' VAL . 32.5 p80 -132.62 137.21 46.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.527 ' N ' ' HB3' ' A' ' 31' ' ' CYS . 50.6 m -60.81 167.01 3.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.751 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.502 ' N ' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -53.5 -38.22 63.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.285 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -102.05 -48.7 4.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p 41.19 78.45 0.37 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.467 1.107 . . . . 0.0 112.879 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.663 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 69.4 Cg_endo -79.24 -59.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 114.297 -174.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HD2' ' HG ' ' A' ' 101' ' ' SER . 33.9 t80 -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.698 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 22.6 p -82.68 -21.64 34.85 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -173.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 8.3 pt20 -61.79 -30.84 71.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.64 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -66.02 -43.56 87.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.358 0.599 . . . . 0.0 109.551 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.42 ' SD ' ' HB3' ' A' ' 101' ' ' SER . 64.2 mmm -59.41 -44.4 92.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.704 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -62.79 -54.62 36.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.598 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 43' ' ' SER . 58.4 m -70.57 -37.65 74.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.27 -71.78 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.864 -0.523 . . . . 0.0 112.011 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.83 -45.53 94.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.285 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.6 tp -80.93 -31.45 35.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.673 0.273 . . . . 0.0 111.451 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 39' ' ' THR . 33.1 t -83.82 -4.48 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.934 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.81 129.15 14.42 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.351 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.33 -48.38 15.27 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.334 2.69 . . . . 0.0 113.547 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.12 -37.07 86.75 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.409 -176.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.558 ' HA ' HD21 ' A' ' 108' ' ' LEU . 34.8 t -66.63 -57.26 10.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.11 0.481 . . . . 0.0 109.882 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.673 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 50.1 m -52.35 -46.27 66.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.721 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.08 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.665 HD22 HH22 ' A' ' 54' ' ' ARG . 61.4 mt -61.51 -41.55 97.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.222 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.77 -40.66 65.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.673 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.2 mt-10 -57.68 -34.16 69.12 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.459 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -67.67 -52.84 33.17 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.665 HH22 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.88 15.8 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -172.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -121.49 146.4 46.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.474 0.654 . . . . 0.0 111.871 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.475 HG11 ' HB3' ' A' ' 14' ' ' LEU . 56.9 t -113.16 115.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.11 125.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.022 0.439 . . . . 0.0 110.582 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.85 116.91 28.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.888 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -83.48 101.28 11.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.61 103.09 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.453 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 p -94.17 110.77 22.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.292 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.502 ' HB ' ' N ' ' A' ' 29' ' ' GLU . 97.1 t -70.28 -13.65 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.473 0.654 . . . . 0.0 110.367 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -73.94 -27.89 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.837 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.478 ' HB ' ' OE2' ' A' ' 66' ' ' GLU . 76.2 p -91.47 151.91 43.09 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.741 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 43.6 Cg_endo -61.58 -36.92 73.51 Favored 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 122.741 2.294 . . . . 0.0 113.565 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.2 mp0 -57.3 -52.65 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.515 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.12 -29.77 66.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.825 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.741 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 2.1 pt20 -62.39 -47.46 84.07 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.432 ' HA ' ' CD ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -72.62 -33.11 66.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.122 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 66' ' ' GLU . 1.9 mm? -59.19 -42.88 91.93 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . -62.19 -41.56 98.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.449 176.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.432 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 4.5 mtp180 -61.96 -43.81 98.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.12 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.45 -48.8 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.598 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.17 -6.65 58.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.458 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 57.45 46.74 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.738 0.649 . . . . 0.0 110.592 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.23 120.18 28.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.313 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -93.35 105.76 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.601 2.867 . . . . 0.0 110.61 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' HIS . . . -81.47 92.28 1.5 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.362 -168.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.86 48.26 0.81 Allowed Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.698 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 Cg_endo -94.11 173.34 15.81 Favored 'Cis proline' 0 C--N 1.356 0.955 0 CA-C-N 120.541 1.229 . . . . 0.0 112.13 -4.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 18.0 m -142.67 137.95 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.833 167.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.21 118.19 21.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.755 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' A' ' 97' ' ' ARG . 86.6 t -115.27 126.89 72.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -104.72 122.97 46.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 35.4 mt -117.5 130.94 56.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.87 127.95 26.23 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.963 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.478 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 58.4 Cg_endo -73.52 117.75 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 121.973 1.782 . . . . 0.0 110.432 171.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -164.04 143.78 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.716 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.06 -76.28 0.06 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.042 0.839 . . . . 0.0 111.187 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.47 22.43 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.852 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -161.9 -171.39 2.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.48 ' CE2' HD12 ' A' ' 12' ' ' LEU . 58.9 m95 -103.41 128.37 50.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.0 109.997 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 35.5 tt0 -94.81 115.2 27.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.453 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.9 tt0 -73.88 103.01 4.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 171.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.545 HG22 ' HD3' ' A' ' 117' ' ' LYS . 9.0 p -102.39 6.93 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.607 -167.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.8 146.54 4.54 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.468 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HG2' HG22 ' A' ' 83' ' ' VAL . 77.7 mtt180 -123.42 126.58 47.05 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.527 HD21 ' HG3' ' A' ' 110' ' ' GLU . 83.4 mt -109.57 131.7 54.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -137.15 142.14 42.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.44 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.98 136.86 7.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.391 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.44 ' HG ' ' HD2' ' A' ' 33' ' ' TYR . 11.8 m -66.18 122.37 17.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 110.595 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 102' ' ' ARG . 4.0 mmp_? -124.01 157.2 64.42 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.776 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.87 154.87 30.07 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.373 2.049 . . . . 0.0 112.041 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -31.07 67.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.628 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.421 ' O ' ' HE3' ' A' ' 109' ' ' LYS . . . -67.81 -38.33 83.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.291 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.43 -32.81 48.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.538 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.69 -49.86 71.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.74 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.651 HD22 HD12 ' A' ' 50' ' ' LEU . 24.1 mt -70.5 -20.69 62.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 105' ' ' ALA . 1.0 OUTLIER -59.8 -61.2 2.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.527 ' HG3' HD21 ' A' ' 98' ' ' LEU . 2.1 tm-20 -67.85 -38.72 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 50' ' ' LEU . 3.0 tm? -58.69 -44.34 90.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 110.551 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -64.65 -36.95 85.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 109.954 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 22.2 mt-30 -65.98 -38.96 89.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.539 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 72.4 t -61.51 -34.9 63.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.923 176.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.35 -34.99 71.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.326 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -84.24 -40.11 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.545 ' HD3' HG22 ' A' ' 95' ' ' VAL . 96.9 mttt -52.0 -57.2 10.18 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.027 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -51.68 -34.6 36.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.153 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.944 -178.062 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 57' ' ' VAL . 27.7 tp . . . . . 0 C--O 1.236 0.382 0 N-CA-C 111.276 0.102 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.0 mmp_? -77.09 103.76 7.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.371 . . . . 0.0 111.297 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -105.64 115.08 29.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.754 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.531 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.5 m-85 -121.97 159.41 51.63 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.592 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 14.4 Cg_exo -67.88 157.91 59.69 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.964 1.776 . . . . 0.0 110.761 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.59 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 92.6 t80 -43.78 -53.14 13.18 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.2 Cg_exo -59.13 -52.02 5.68 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.787 1.658 . . . . 0.0 112.766 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.4 mm-40 -70.34 -30.6 67.6 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.32 -47.18 87.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.2 0.524 . . . . 0.0 110.259 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 8' ' ' TYR . 11.0 mp -64.45 -40.39 95.64 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.823 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.81 -36.51 65.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.04 0.448 . . . . 0.0 110.741 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -61.79 -37.92 86.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.191 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.12 -49.03 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 46.3 tt0 -57.52 -54.32 48.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 122.913 0.485 . . . . 0.0 112.308 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.84 60.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.612 -172.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -110.35 -22.87 11.5 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.23 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.8 6.83 54.09 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.043 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 20' ' ' ARG . 4.0 mpt_? -85.9 -177.82 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.664 0.268 . . . . 0.0 111.402 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.77 158.74 17.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 38.8 t -106.36 135.62 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.67 0.272 . . . . 0.0 110.747 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.559 ' HG2' ' CD1' ' A' ' 84' ' ' PHE . 6.2 tmm? -125.69 104.74 8.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.581 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 35.2 t -91.16 120.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -175.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 44.0 t80 -108.74 124.33 50.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.081 0.467 . . . . 0.0 111.388 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.911 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.6 m-85 -104.22 132.55 50.36 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.393 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.902 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 30.4 p80 -135.84 161.69 34.9 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.491 0.494 . . . . 0.0 110.644 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.583 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 40.4 m -143.79 164.42 30.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.8 -32.89 20.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 109.995 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -76.54 -7.11 54.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.242 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.716 ' HB3' HG22 ' A' ' 79' ' ' THR . 5.0 t -113.89 87.52 12.73 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.24 27.11 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.047 2.498 . . . . 0.0 113.687 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -86.05 -48.43 8.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.025 0.441 . . . . 0.0 111.503 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.59 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 14.1 t -83.08 -20.45 34.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -171.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -53.21 -29.81 34.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -79.37 -32.24 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.451 0.643 . . . . 0.0 110.326 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -80.28 -49.88 10.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.994 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.0 p30 -64.65 -23.05 67.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.8 m -75.69 -60.42 2.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.499 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.65 -69.46 0.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.744 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.5 t -55.71 -43.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.9 tp -80.9 -23.93 38.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -105.69 9.06 33.25 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.068 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.97 135.24 21.43 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.766 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 10.1 Cg_endo -52.02 -34.21 56.13 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 123.057 2.505 . . . . 0.0 113.561 -177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.61 -45.69 10.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.804 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.613 HG22 HD21 ' A' ' 108' ' ' LEU . 43.0 t -63.34 -51.96 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.292 0.568 . . . . 0.0 109.807 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.442 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 7.6 t -53.21 -41.33 65.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.525 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HE ' ' HB2' ' A' ' 49' ' ' ARG . 14.2 ttm180 -61.84 -35.38 78.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.772 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD13 HD12 ' A' ' 111' ' ' LEU . 76.2 mt -69.28 -40.14 77.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.911 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HB3' HD11 ' A' ' 3' ' ' LEU . 4.2 mm? -70.85 -48.72 52.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.846 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 48' ' ' SER . 12.0 mm-40 -53.0 -33.6 52.35 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.801 0.44 . . . . 0.0 112.182 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -68.11 -57.99 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -173.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.484 ' HD3' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.91 18.88 3.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 76.2 m-85 -124.97 146.18 49.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.413 0.625 . . . . 0.0 111.245 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 14' ' ' LEU . 39.7 t -115.12 120.09 63.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.569 HG21 HD21 ' A' ' 3' ' ' LEU . 19.0 t -91.58 124.6 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.77 -173.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.581 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -93.96 117.96 30.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.591 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 p -82.66 102.43 11.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.04 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -116.73 129.4 73.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.15 0.5 . . . . 0.0 110.485 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.605 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 2.2 m -112.97 114.45 26.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.811 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.583 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 32.4 t -74.84 -7.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.015 0.912 . . . . 0.0 109.583 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.01 -29.37 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.012 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.614 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 2.9 p -109.11 158.51 34.14 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.614 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.0 Cg_endo -52.29 -50.4 14.15 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.301 3.334 . . . . 0.0 114.914 -167.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -38.62 84.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.991 0.424 . . . . 0.0 110.83 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.3 -31.02 53.28 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.606 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 64' ' ' THR . 92.4 mt-30 -62.36 -39.68 93.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.638 0.375 . . . . 0.0 111.117 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.55 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -77.9 -33.7 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.642 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.55 HD12 ' OE2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -61.27 -42.21 98.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 0.0 110.531 170.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.2 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.564 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.1 ptm180 -71.9 -21.46 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.969 0.414 . . . . 0.0 110.484 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 73' ' ' ARG . 45.6 ttm105 -75.2 -52.42 10.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.45 -8.12 57.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.711 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 64.06 72.19 0.47 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.468 0.651 . . . . 0.0 109.698 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 56.0 t -123.6 136.96 27.85 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.959 -175.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.9 Cg_exo -73.62 -138.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.204 2.603 . . . . 0.0 111.553 173.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -88.12 -69.18 1.28 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.807 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' A' ' 27' ' ' HIS . 6.6 t 178.44 156.09 0.56 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.69 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 1.0 OUTLIER -84.29 132.75 18.39 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.354 -1.102 . . . . 0.0 112.701 0.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.911 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 31.4 m -126.41 121.13 31.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 110.584 174.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.652 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 8.8 m-85 -119.45 115.96 25.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 98.2 t -114.01 118.14 57.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.754 0.312 . . . . 0.0 110.548 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.559 ' CD1' ' HG2' ' A' ' 23' ' ' MET . 26.2 m-85 -96.93 118.71 33.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.707 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 94' ' ' GLU . 42.0 mt -115.78 130.06 56.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.077 0.465 . . . . 0.0 110.516 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.01 135.14 20.52 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.6 116.64 4.64 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.574 1.516 . . . . 0.0 109.338 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -151.07 128.4 11.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.761 -171.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.12 -79.8 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.931 0.77 . . . . 0.0 111.341 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.67 21.09 0.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.07 -169.3 3.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 85.6 m95 -107.89 135.76 48.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.242 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -116.3 118.29 32.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.589 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 36.2 tt0 -77.62 108.17 10.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.87 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 31.1 m -88.35 12.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 111.329 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 94' ' ' GLU . . . 142.09 155.02 6.31 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.301 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -130.76 135.5 47.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.652 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.9 mt -108.18 129.75 55.17 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.719 -177.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 80' ' ' PRO . 88.3 t80 -137.41 143.23 41.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.649 173.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.25 145.77 10.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.583 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m -70.09 125.76 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.607 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.636 ' HB3' ' HB2' ' A' ' 106' ' ' GLU . 92.9 mtt180 -137.89 142.75 37.28 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.789 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.473 ' HD2' ' HG2' ' A' ' 106' ' ' GLU . 24.5 Cg_exo -64.21 166.38 17.05 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.489 2.126 . . . . 0.0 111.518 173.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -55.54 -33.17 63.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.872 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -60.88 -47.25 87.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 17.4 mm-40 -72.3 -38.42 68.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.929 0.395 . . . . 0.0 110.602 -176.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -65.3 -39.37 92.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.345 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.613 HD21 HG22 ' A' ' 47' ' ' VAL . 53.4 mt -67.35 -34.62 77.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.061 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 98.5 mttt -55.94 -53.3 58.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 109.871 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.516 ' O ' HG23 ' A' ' 114' ' ' VAL . 4.3 mm-40 -62.53 -44.16 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.432 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.461 HD12 HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -57.71 -41.57 82.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.281 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 14.4 mmt180 -63.09 -49.55 74.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.852 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 6.9 pt20 -66.97 -23.04 65.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.066 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 110' ' ' GLU . 56.7 t -75.21 -41.92 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.838 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.4 m -56.75 -37.95 71.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 110.525 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.86 -32.39 56.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.87 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 54.2 mttp -71.19 -8.52 54.09 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.482 -176.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.46 -20.96 72.17 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.222 173.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 176.563 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 51' ' ' LEU . 26.6 tp . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.904 0.383 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.642 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -77.35 103.58 7.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.71 -174.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HH2' HD21 ' A' ' 42' ' ' LEU . 43.7 m95 -114.0 102.67 10.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.7 m-85 -117.06 161.13 34.26 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 27.4 Cg_exo -60.02 162.04 17.49 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.934 1.756 . . . . 0.0 111.436 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.651 ' CD1' HD21 ' A' ' 70' ' ' LEU . 87.8 t80 -49.1 -52.89 43.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.1 Cg_exo -65.25 -40.51 19.2 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.632 1.555 . . . . 0.0 111.951 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.431 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 33.2 tt0 -69.46 -39.23 77.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 -177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.56 82.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.019 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.96 -34.6 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -38.45 64.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.682 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.463 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.1 tp -65.23 -44.6 87.69 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 109.71 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.14 87.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -50.85 71.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.77 -14.12 60.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.197 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -118.23 -9.9 10.36 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.2 89.71 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.714 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.773 ' HG3' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -73.07 169.75 16.33 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.466 0.306 . . . . 0.0 111.521 175.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.559 ' SD ' HG22 ' A' ' 86' ' ' VAL . 68.1 mtm -101.4 167.84 9.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.39 125.95 62.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.079 0.466 . . . . 0.0 111.242 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.79 ' HG3' HG13 ' A' ' 57' ' ' VAL . 5.4 tpt -103.67 102.77 12.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.19 108.53 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.954 0.407 . . . . 0.0 110.067 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.776 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 72.6 t80 -103.7 103.55 13.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.419 0.628 . . . . 0.0 110.743 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 70' ' ' LEU . 60.3 m-85 -77.29 105.38 8.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.24 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.776 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 24.4 p80 -104.15 138.29 40.85 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.618 175.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.685 ' OG ' ' HA2' ' A' ' 78' ' ' GLY . 49.3 m -122.67 144.06 49.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.627 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -42.81 62.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.303 0.573 . . . . 0.0 110.13 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.564 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 91.5 m-70 -101.87 42.74 1.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.263 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 28.3 p -93.58 100.91 5.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.617 176.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -88.41 -7.69 5.71 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.268 1.978 . . . . 0.0 114.152 -176.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -84.58 -34.51 23.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.709 ' HB3' ' HG3' ' A' ' 80' ' ' PRO . 29.2 p -80.96 -23.18 38.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -170.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -55.13 -32.41 62.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.18 -33.37 24.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.402 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.0 ttp -80.73 -35.26 33.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.596 -173.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 38.3 p30 -72.14 -22.69 61.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 111.229 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.9 m -71.34 -59.94 2.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.609 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -91.48 -67.74 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.463 0.649 . . . . 0.0 111.482 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.578 HG13 ' HA ' ' A' ' 104' ' ' ARG . 59.1 t -60.01 -58.95 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.98 -168.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.606 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 19.5 tp -78.84 -10.59 59.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.089 -169.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -101.05 -9.87 21.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.755 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 31.6 t70 -56.67 133.25 78.11 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.341 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 66.4 Cg_exo -53.25 -48.74 20.41 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.191 2.594 . . . . 0.0 113.086 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.59 -43.14 99.27 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.37 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.769 HG22 HD21 ' A' ' 108' ' ' LEU . 50.0 t -60.07 -56.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 175.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 m -56.91 -36.53 70.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.579 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.476 ' HA ' ' HB2' ' A' ' 52' ' ' GLU . 99.7 mtt180 -75.44 -21.16 58.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.457 HD12 HD22 ' A' ' 108' ' ' LEU . 69.1 mt -70.68 -36.52 73.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.163 169.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB2' HD11 ' A' ' 3' ' ' LEU . 1.5 mm? -70.45 -49.35 49.6 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.076 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 49' ' ' ARG . 17.1 mm-40 -45.88 -39.16 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.991 0.516 . . . . 0.0 112.124 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.503 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -68.13 -57.18 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.773 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.75 20.7 3.3 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -171.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.472 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 96.2 m-85 -133.58 140.36 47.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.481 0.657 . . . . 0.0 111.674 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 14' ' ' LEU . 46.9 t -110.44 115.35 49.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.79 HG13 ' HG3' ' A' ' 23' ' ' MET . 20.8 t -86.76 126.35 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.523 . . . . 0.0 110.359 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.17 116.52 29.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.521 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 44.3 t -87.01 100.71 12.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.509 HG11 HD22 ' A' ' 70' ' ' LEU . 59.4 t -110.24 119.0 58.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.027 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.633 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.0 p -90.43 111.97 23.42 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 21.6 m -74.29 -0.41 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.526 0.679 . . . . 0.0 110.346 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -29.49 31.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.086 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.655 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -95.63 166.73 14.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.977 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.655 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.5 Cg_endo -51.86 -55.85 3.52 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.511 2.807 . . . . 0.0 114.6 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -62.98 -35.66 80.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.353 . . . . 0.0 110.938 -178.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.95 -40.88 62.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.724 174.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 5.9 mt-30 -62.29 -30.87 71.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.259 0.552 . . . . 0.0 110.594 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' CD ' HH21 ' A' ' 73' ' ' ARG . 5.3 tp10 -66.05 -53.43 38.49 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.631 173.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.651 HD21 ' CD1' ' A' ' 8' ' ' TYR . 6.7 mp -58.62 -37.48 75.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 176.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.9 28.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.983 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 69' ' ' GLU . 36.4 ptt180 -66.27 -23.34 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.462 HH21 ' CD ' ' A' ' 69' ' ' GLU . 14.2 ttm180 -83.49 -51.21 7.55 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.316 -175.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.26 4.12 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.637 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 68.67 22.13 7.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.793 0.437 . . . . 0.0 111.072 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.97 119.78 66.47 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.32 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.974 2.449 . . . . 0.0 112.589 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.685 ' HA2' ' OG ' ' A' ' 28' ' ' SER . . . -174.8 120.98 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.632 ' HB ' ' C ' ' A' ' 80' ' ' PRO . 31.2 m -146.56 -61.04 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -165.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.709 ' HG3' ' HB3' ' A' ' 34' ' ' CYS . 17.8 Cg_endo -79.39 172.74 58.12 Favored 'Cis proline' 0 N--CA 1.492 1.414 0 CA-C-N 123.111 2.147 . . . . 0.0 115.915 4.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 m -125.97 143.12 51.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.254 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' HD1' ' HD1' ' A' ' 25' ' ' TYR . 1.2 m-85 -118.27 127.99 54.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.91 117.69 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.727 0.299 . . . . 0.0 110.716 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.86 125.77 42.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.78 0.324 . . . . 0.0 110.416 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 31.8 mt -117.1 142.23 47.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.577 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.559 HG22 ' SD ' ' A' ' 21' ' ' MET . 10.9 t -108.59 139.84 21.22 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 21' ' ' MET . 41.2 Cg_endo -72.66 114.47 4.03 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 160.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HG3' ' CG1' ' A' ' 86' ' ' VAL . 17.5 mttp -142.21 113.36 7.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.35 15.77 9.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.669 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.4 37.83 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.985 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.04 178.29 4.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.629 0.252 . . . . 0.0 110.403 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -109.4 128.74 55.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.252 0.549 . . . . 0.0 110.319 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 23.7 tt0 -109.96 124.66 51.8 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.373 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 78.2 tt0 -77.08 100.15 5.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 86' ' ' VAL . 14.8 p -94.4 -7.12 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.467 -169.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.84 125.71 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.939 -1.124 . . . . 0.0 112.89 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -114.87 128.5 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.112 0.482 . . . . 0.0 109.995 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 97.0 mt -117.24 141.46 48.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.882 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 79' ' ' THR . 79.6 t80 -137.42 127.76 26.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.847 0.356 . . . . 0.0 110.608 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.96 154.02 30.22 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.843 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -66.23 142.39 57.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -123.82 132.95 24.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -56.94 140.86 93.27 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.928 1.752 . . . . 0.0 109.683 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.578 ' HA ' HG13 ' A' ' 41' ' ' VAL . 16.7 ttp180 -51.23 -34.91 34.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.6 43.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 111.074 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.71 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 10.3 pt-20 -88.99 -20.04 24.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.851 -175.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 70.7 t80 -60.82 -43.25 98.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 171.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.769 HD21 HG22 ' A' ' 47' ' ' VAL . 89.1 mt -68.42 -34.26 75.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.881 174.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 14.8 ttpt -55.65 -52.77 62.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.211 171.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.71 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 28.9 mm-40 -57.03 -45.05 83.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.499 0.666 . . . . 0.0 109.694 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 50' ' ' LEU . 20.9 tp -61.46 -41.37 97.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 26.7 mmt180 -62.35 -41.33 98.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.823 0.344 . . . . 0.0 110.298 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 10.5 mt-30 -56.4 -37.24 69.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.516 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.513 ' HA ' ' HZ2' ' A' ' 117' ' ' LYS . 61.7 t -76.98 -37.35 26.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.758 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.9 m -54.92 -42.42 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.782 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.5 -47.56 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.289 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HZ2' ' HB2' ' A' ' 117' ' ' LYS . 10.4 mtmp? -68.99 -13.25 62.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.576 -176.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.25 -33.12 69.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.827 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.854 175.76 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.718 HD21 HD23 ' A' ' 51' ' ' LEU . 6.7 tp . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.756 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 34.9 mmt180 -78.03 110.97 13.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.106 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -108.6 104.47 13.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.943 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.756 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 97.0 m-85 -110.49 160.27 29.15 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.936 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 20.0 Cg_exo -62.69 165.71 15.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.915 1.743 . . . . 0.0 110.552 170.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.568 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 93.5 t80 -49.87 -53.26 44.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.6 Cg_exo -64.42 -47.51 5.74 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.809 1.673 . . . . 0.0 112.198 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 31.2 tt0 -64.91 -35.39 81.01 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.437 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.84 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.37 . . . . 0.0 111.139 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.7 mp -62.05 -30.88 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.021 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.33 -44.04 76.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.573 HD22 ' CE2' ' A' ' 6' ' ' TYR . 13.3 tp -61.72 -47.32 85.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.262 0.553 . . . . 0.0 110.247 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.91 89.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.246 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -68.1 -39.23 82.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.39 -18.88 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -116.02 -8.56 11.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 38.21 63.06 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.659 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -101.22 176.99 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.5 mtp -107.47 149.99 27.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.9 t -106.94 131.56 56.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.461 . . . . 0.0 111.536 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.465 ' SD ' HD21 ' A' ' 51' ' ' LEU . 20.5 ttt -107.93 107.25 17.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.829 172.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 60' ' ' VAL . 40.9 t -84.75 103.1 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.54 ' OH ' ' HB3' ' A' ' 38' ' ' ASN . 92.7 t80 -97.67 108.02 20.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.74 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.935 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 74.8 m-85 -86.47 118.66 26.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.085 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.591 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 33.5 p80 -135.36 179.3 6.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 31' ' ' CYS . 93.7 p -143.86 166.52 24.7 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -56.76 -22.22 34.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.52 23.58 5.11 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 23.0 p -52.45 110.78 2.09 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 173.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 12.9 Cg_endo -56.19 -81.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.289 2.659 . . . . 0.0 114.532 -167.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -77.78 -17.66 57.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.32 0.581 . . . . 0.0 110.499 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 37.3 t -62.94 -36.85 84.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 4.3 pt20 -72.03 -17.15 62.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 111.212 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -81.79 -40.25 22.87 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.711 0.767 . . . . 0.0 109.716 171.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.592 ' SD ' ' HG3' ' A' ' 80' ' ' PRO . 75.9 mtp -69.39 -43.22 73.94 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.892 -170.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.54 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 30.1 p-10 -66.02 -35.08 79.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.863 0.363 . . . . 0.0 110.445 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 43' ' ' SER . 85.6 m -66.8 -55.94 12.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.585 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.97 -69.84 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.874 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.5 -51.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.788 -169.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 23.6 tp -76.87 -27.25 54.97 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.575 -173.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.7 m -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.748 0.309 . . . . 0.0 111.019 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.38 130.16 61.55 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.837 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.9 -43.09 24.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.508 2.805 . . . . 0.0 113.762 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.97 -43.45 65.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.453 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -65.68 -49.62 76.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 121.659 0.742 . . . . 0.0 109.831 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 32.4 m -59.58 -32.27 70.21 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.656 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.765 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.86 -42.07 97.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.833 ' HA ' HH21 ' A' ' 54' ' ' ARG . 64.8 mt -60.33 -45.03 94.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.654 0.264 . . . . 0.0 111.223 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.718 HD23 HD21 ' A' ' 3' ' ' LEU . 6.2 tp -72.34 -31.8 65.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.396 0.617 . . . . 0.0 111.051 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.595 ' HA ' HD13 ' A' ' 3' ' ' LEU . 8.3 tp10 -61.74 -35.95 79.59 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 113.741 -168.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -91.5 -31.17 16.06 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -168.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.833 HH21 ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -134.48 5.08 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -170.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.7 142.6 48.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.551 0.691 . . . . 0.0 111.956 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 14' ' ' LEU . 43.8 t -107.87 115.21 48.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.51 126.71 40.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.852 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -94.95 116.98 29.39 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.717 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.7 p -82.42 101.06 10.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG13 ' HA2' ' A' ' 67' ' ' GLY . 99.8 t -115.17 123.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 -175.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.525 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 1.9 t -116.39 129.34 56.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.011 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.54 65.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.104 0.954 . . . . 0.0 110.0 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.67 -36.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.039 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.569 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 30.7 p -82.89 160.53 60.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.201 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 15.6 Cg_endo -52.92 -55.39 3.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.062 2.508 . . . . 0.0 113.415 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' HD13 ' A' ' 70' ' ' LEU . 10.2 pt-20 -57.03 -44.85 83.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.983 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -68.91 -39.08 85.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.38 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -63.03 -48.68 77.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.049 0.54 . . . . 0.0 111.663 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.4 pt-20 -73.48 -29.05 62.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.588 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.672 ' HG ' ' HE2' ' A' ' 74' ' ' TYR . 5.3 mp -67.28 -40.61 86.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.809 173.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.55 78.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 9.3 ptm180 -83.48 -19.51 35.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.719 0.295 . . . . 0.0 111.371 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 48.0 ttt180 -72.69 -44.03 62.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.672 ' HE2' ' HG ' ' A' ' 70' ' ' LEU . 53.3 m-85 -102.45 -2.35 28.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 26.2 ptt180 45.95 71.19 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.526 1.13 . . . . 0.0 112.551 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG11 HG21 ' A' ' 81' ' ' THR . 13.5 t -137.74 94.65 11.53 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.882 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -97.83 128.08 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.415 2.743 . . . . 0.0 111.416 169.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.33 42.19 0.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.99 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -47.03 152.36 1.0 Allowed Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 122.795 0.438 . . . . 0.0 110.741 173.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 34' ' ' CYS . 58.6 Cg_endo -67.01 151.63 83.25 Favored 'Cis proline' 0 C--N 1.351 0.676 0 N-CA-C 114.841 1.054 . . . . 0.0 114.841 4.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.935 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.3 m -141.02 133.63 28.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.34 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 3.0 m-85 -123.14 111.88 17.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -175.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 39.5 t -119.12 112.49 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 110.146 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.5 122.33 38.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.394 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 94' ' ' GLU . 30.9 mt -113.55 135.76 53.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -109.12 130.74 22.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.81 116.89 4.09 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.633 1.556 . . . . 0.0 110.212 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 90' ' ' GLY . 35.8 ttpt -151.79 134.93 15.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.333 -175.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 71.14 -37.61 0.4 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.742 0.817 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 88' ' ' LYS . . . 149.7 -10.92 0.95 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.51 -179.13 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -108.16 136.71 47.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.042 0.449 . . . . 0.0 110.489 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -117.33 126.23 52.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.104 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.467 ' HA ' HD23 ' A' ' 85' ' ' LEU . 53.3 tt0 -77.3 99.69 5.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 117' ' ' LYS . 4.9 p -96.7 -10.43 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.176 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.15 126.79 1.48 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.449 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.41 127.53 49.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.972 0.415 . . . . 0.0 109.975 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 99.0 mt -117.72 139.17 51.41 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.278 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -137.26 142.87 41.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.798 0.332 . . . . 0.0 110.838 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.06 168.93 45.37 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.635 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.463 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 10.9 m -65.38 131.76 47.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.022 0.439 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.5 133.94 23.51 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 106' ' ' GLU . 12.4 Cg_endo -59.87 154.4 50.37 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.716 1.611 . . . . 0.0 110.991 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -30.69 64.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.839 0.352 . . . . 0.0 110.437 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.04 63.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.31 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 103' ' ' PRO . 22.9 tp10 -73.19 -42.27 62.9 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CE2' HD12 ' A' ' 111' ' ' LEU . 9.8 t80 -66.24 -44.85 82.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.405 -178.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.65 -47.88 78.78 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -52.26 -58.85 5.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.32 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 114' ' ' VAL . 2.3 tp10 -78.98 -28.43 43.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.519 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 50' ' ' LEU . 3.4 tt -61.22 -43.19 99.27 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 116' ' ' VAL . 22.6 tpt180 -61.43 -45.8 92.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.471 ' HB3' ' NZ ' ' A' ' 117' ' ' LYS . 34.4 mt-30 -64.73 -43.65 92.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.42 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 110' ' ' GLU . 54.6 t -58.72 -40.87 80.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -56.43 -28.54 59.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 112' ' ' ARG . 59.2 t -83.88 -34.33 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.885 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.55 ' HB3' HG21 ' A' ' 95' ' ' VAL . 13.6 mptt -57.4 -28.5 63.29 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.615 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.85 -38.94 93.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.018 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.837 -179.018 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.794 0.33 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -107.36 117.31 33.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.435 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 36.8 m95 -111.24 123.14 49.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.215 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.555 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 37.0 m-85 -132.06 160.92 65.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.232 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 26.2 Cg_exo -61.22 162.16 20.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.003 1.802 . . . . 0.0 110.929 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.545 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 72.6 t80 -49.92 -50.24 69.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 34.7 Cg_exo -61.33 -46.61 14.41 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.808 1.672 . . . . 0.0 112.42 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -68.01 -40.61 82.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.219 -177.575 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.03 -35.92 82.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 177.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.0 -41.41 64.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.197 0.522 . . . . 0.0 110.228 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -57.23 -47.96 80.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.724 177.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.9 -41.92 67.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.455 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -61.05 -51.4 69.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 111.532 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.28 -15.35 58.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.927 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -112.86 -4.57 13.95 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.331 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.19 49.04 49.19 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.101 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -114.64 178.75 4.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 89.3 mtp -105.22 151.48 24.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.88 125.36 61.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.106 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.0 ttt -101.21 102.78 13.75 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 39.6 t -83.3 102.91 9.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.435 ' CD2' ' HZ3' ' A' ' 5' ' ' TRP . 24.7 t80 -98.61 108.8 21.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.176 -175.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.614 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 96.4 m-85 -93.23 125.36 37.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.377 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 25.4 p80 -127.56 150.12 49.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.621 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 24.5 m -142.96 141.21 31.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.522 0.201 . . . . 0.0 110.825 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -75.89 -22.41 56.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 166.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.416 ' HE1' ' HA ' ' A' ' 63' ' ' ASP . 29.1 m80 -72.64 -11.99 60.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.047 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.552 ' SG ' ' HA2' ' A' ' 78' ' ' GLY . 10.9 t -137.61 77.55 39.45 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.483 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.53 17.71 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 122.975 2.45 . . . . 0.0 114.702 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' HB3' ' OG ' ' A' ' 101' ' ' SER . 57.3 m-85 -77.27 -18.28 57.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.545 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 13.2 t -83.43 -30.93 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.814 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.448 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 10.6 mm100 -52.2 -42.01 63.15 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -170.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.035 0.445 . . . . 0.0 110.925 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.49 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 45.2 ttm -77.61 -51.89 9.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.251 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 35' ' ' GLN . 2.2 p-10 -65.49 -17.1 64.3 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 m -81.34 -62.33 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.679 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -92.88 -68.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.449 0.642 . . . . 0.0 112.116 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 89.6 t -52.67 -47.29 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.434 -168.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 21.4 tp -81.3 -18.43 45.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.982 0.42 . . . . 0.0 110.88 -173.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 m -87.41 -10.99 50.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.58 130.01 10.74 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.083 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.13 -31.96 94.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.013 2.475 . . . . 0.0 113.181 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.36 -44.53 13.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.707 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 HD21 ' A' ' 108' ' ' LEU . 48.5 t -61.52 -52.88 55.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.548 0.69 . . . . 0.0 109.495 175.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.753 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 34.1 t -50.46 -44.37 55.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.316 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -57.39 -41.12 79.61 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.589 0.555 . . . . 0.0 111.763 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.709 HD12 HD22 ' A' ' 108' ' ' LEU . 76.2 mt -61.97 -35.87 79.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.598 0.237 . . . . 0.0 110.945 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.98 -38.7 57.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.43 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.753 ' HG3' ' O ' ' A' ' 48' ' ' SER . 55.9 mt-10 -55.55 -39.08 70.15 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.058 0.456 . . . . 0.0 111.436 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -62.74 -53.33 56.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -169.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.647 ' HE ' ' HE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.7 5.82 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.647 ' HE1' ' HE ' ' A' ' 54' ' ' ARG . 80.3 m-85 -110.44 143.17 41.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 112.525 -173.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' A' ' 14' ' ' LEU . 49.0 t -110.76 115.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.7 t -86.54 123.58 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.1 0.476 . . . . 0.0 110.916 -173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -90.39 116.95 28.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -82.44 101.04 10.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.92 118.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 63' ' ' ASP . 2.6 m -102.11 110.82 22.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.278 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.621 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 6.1 t -82.67 28.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 122.574 1.178 . . . . 0.0 109.03 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.511 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 25.5 m-20 -113.42 -20.04 11.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.84 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 4.1 p -115.24 161.36 30.09 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.996 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.5 Cg_endo -51.96 -56.48 2.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.425 2.75 . . . . 0.0 114.025 -170.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -46.22 66.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.22 -36.46 63.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.879 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -63.75 -36.62 84.48 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.577 0.351 . . . . 0.0 111.018 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' OE1' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mm-40 -68.67 -39.06 80.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.177 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.9 mt -67.96 -41.19 82.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.449 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.11 93.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.551 0.215 . . . . 0.0 111.321 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HD3' ' OE1' ' A' ' 69' ' ' GLU . 9.3 ptm180 -73.38 -20.92 60.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 110.491 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -74.64 -56.27 4.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.287 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -75.7 -9.09 58.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.919 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.4 ttm105 68.79 42.63 1.37 Allowed 'General case' 0 CA--C 1.528 0.127 0 O-C-N 123.834 0.708 . . . . 0.0 110.793 170.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.635 HG11 HG21 ' A' ' 81' ' ' THR . 33.7 t -122.31 104.3 37.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.134 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -93.64 128.81 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.236 2.624 . . . . 0.0 111.765 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.552 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 108.88 150.96 14.45 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.255 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.626 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 39.8 p -141.74 162.76 44.81 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 72.4 Cg_endo -78.09 142.14 68.68 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 113.222 1.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.635 HG21 HG11 ' A' ' 76' ' ' VAL . 87.3 m -123.52 122.05 37.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.749 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 7.5 m-85 -115.82 112.27 21.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.184 -177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 46.8 t -106.77 118.41 54.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.616 ' HB2' HG22 ' A' ' 95' ' ' VAL . 79.3 m-85 -95.91 104.91 16.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.926 0.393 . . . . 0.0 110.593 -177.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 94' ' ' GLU . 78.5 mt -105.52 126.3 51.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.557 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 t -110.25 132.47 21.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.09 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.56 116.45 2.6 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.153 1.902 . . . . 0.0 109.855 171.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -161.73 141.36 10.11 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.207 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.19 -72.13 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.13 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.15 25.82 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.759 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.97 165.12 25.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.601 0.239 . . . . 0.0 110.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.33 134.81 33.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -120.35 117.56 28.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.339 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.535 ' HA ' HD23 ' A' ' 85' ' ' LEU . 14.6 tt0 -77.05 112.05 13.28 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 84' ' ' PHE . 24.3 m -77.66 -18.08 14.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.422 0.629 . . . . 0.0 109.827 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.28 162.41 11.79 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.024 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 138.45 53.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.093 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 77.3 mt -111.87 130.72 55.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.775 -175.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -137.19 133.99 35.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.0 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.73 159.97 8.42 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.074 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 33' ' ' TYR . 73.6 m -94.88 17.11 14.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.068 0.461 . . . . 0.0 111.585 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 106' ' ' GLU . 14.1 mmt180 -57.87 140.71 81.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.78 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 102' ' ' ARG . 30.9 Cg_exo -62.29 172.3 4.38 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.344 2.696 . . . . 0.0 112.381 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 39.9 ptt180 -51.78 -26.13 9.04 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.839 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -53.34 -63.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.266 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.726 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 3.0 mp0 -70.07 -33.0 71.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 110.952 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.06 -47.05 87.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.709 HD22 HD12 ' A' ' 50' ' ' LEU . 75.7 mt -70.48 -33.31 71.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.726 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.7 mttt -57.06 -51.29 69.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.53 176.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 114' ' ' VAL . 11.6 mm-40 -68.91 -36.41 77.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.773 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 111' ' ' LEU . 4.1 tt -64.44 -34.88 79.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 116' ' ' VAL . 10.3 mmm180 -61.29 -41.33 96.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.471 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -67.62 -33.38 74.87 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.382 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.597 HG13 HG21 ' A' ' 95' ' ' VAL . 77.9 t -64.45 -45.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 p -65.39 -25.54 67.6 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.995 0.426 . . . . 0.0 110.7 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.6 t -77.19 -43.68 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.217 175.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.601 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 63.7 mttm -61.25 -37.0 81.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.281 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.87 70.12 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.056 -0.593 . . . . 0.0 113.092 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.928 -177.778 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.564 HD12 ' OE2' ' A' ' 52' ' ' GLU . 17.5 tp . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.698 0.285 . . . . 0.0 111.701 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -95.5 107.64 19.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.373 0.606 . . . . 0.0 112.086 -177.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.45 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.5 m95 -105.9 132.49 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.755 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -135.21 153.65 78.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 24.9 Cg_exo -59.8 164.38 11.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.006 1.804 . . . . 0.0 111.443 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.558 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 86.4 t80 -48.59 -53.37 36.48 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 18.5 Cg_exo -65.89 -44.08 8.36 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.573 1.515 . . . . 0.0 112.194 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 26.0 tt0 -67.5 -38.72 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.223 -176.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.38 77.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.076 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 8' ' ' TYR . 7.9 mp -60.17 -41.21 92.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.849 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.49 -38.58 74.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.39 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -58.43 -47.97 82.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.509 177.029 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -70.62 -43.43 69.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.93 -46.35 85.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.982 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.6 57.32 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -115.94 0.18 12.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.591 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.67 45.64 57.94 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.972 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 83.5 mmt-85 -117.57 177.63 4.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.085 0.469 . . . . 0.0 111.77 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.3 mtp -102.1 152.21 21.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.625 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.99 129.29 62.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.624 0.249 . . . . 0.0 111.316 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 ttp -109.77 104.25 13.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 24.4 t -81.05 107.33 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.019 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 52.9 t80 -94.97 104.77 16.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.606 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.463 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.3 m-85 -87.62 119.82 28.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.239 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 30.0 p80 -123.41 147.84 46.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.46 176.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 31' ' ' CYS . 14.7 m -136.77 150.64 48.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.013 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.677 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.23 -26.72 52.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.278 0.561 . . . . 0.0 109.849 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -72.73 -16.7 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.053 173.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 56.8 m -124.15 60.69 23.53 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.702 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.65 23.81 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 114.132 -169.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.78 -36.54 78.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.216 0.531 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.576 ' HB2' ' CD ' ' A' ' 80' ' ' PRO . 7.2 t -68.22 -18.84 64.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.147 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -52.82 -26.11 13.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.2 -41.31 18.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.735 0.779 . . . . 0.0 109.738 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mmm -63.13 -39.24 94.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.193 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.9 p30 -77.97 -17.74 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.444 -175.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -74.01 -52.21 13.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 0.0 110.493 177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.86 -71.26 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.309 0.576 . . . . 0.0 111.564 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.445 ' O ' HG21 ' A' ' 47' ' ' VAL . 57.6 t -64.93 -54.34 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.675 -167.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.599 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 18.2 tp -79.76 -12.68 59.77 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.074 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 m -106.89 -3.09 20.64 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.11 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.9 133.33 38.63 Favored Pre-proline 0 C--O 1.235 0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.214 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.668 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 8.8 Cg_endo -51.87 -46.22 33.56 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.426 2.75 . . . . 0.0 113.106 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.58 93.85 Favored Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.113 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.85 HG22 HD21 ' A' ' 108' ' ' LEU . 57.4 t -61.73 -49.71 83.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.158 0.504 . . . . 0.0 109.795 174.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.532 ' HA ' HD13 ' A' ' 3' ' ' LEU . 35.3 m -56.05 -39.76 72.5 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.003 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.668 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 18.7 mtm180 -57.99 -40.76 81.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.075 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.855 HD12 HD22 ' A' ' 108' ' ' LEU . 76.3 mt -63.49 -39.83 95.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.548 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.36 -59.82 2.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.144 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.564 ' OE2' HD12 ' A' ' 3' ' ' LEU . 20.5 mm-40 -44.69 -40.17 5.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -171.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.3 -42.41 88.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.422 HH21 ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -136.01 6.18 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.95 149.8 43.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.281 0.563 . . . . 0.0 111.476 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 14' ' ' LEU . 46.6 t -117.07 119.89 63.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 168.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 3' ' ' LEU . 19.4 t -86.99 116.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.757 -173.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -90.86 117.11 29.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 p -88.15 102.23 14.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.765 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 8' ' ' TYR . 59.9 t -108.39 123.14 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 110.606 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.648 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.8 p -93.91 110.41 22.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.853 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.644 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 28.0 t -82.83 0.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.318 1.056 . . . . 0.0 109.071 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.677 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -81.43 -33.86 31.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.528 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 33.4 p -92.63 160.84 33.62 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 25.6 Cg_endo -56.61 -53.95 4.48 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.3 2.667 . . . . 0.0 114.437 -171.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -37.02 85.7 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.277 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.19 -40.84 70.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.669 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 2.0 mt-30 -59.56 -35.16 73.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.317 0.58 . . . . 0.0 110.611 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.027 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.1 mt -64.38 -32.05 73.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -68.75 -30.68 69.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.846 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 51.9 mtp180 -71.69 -47.44 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 0.0 109.151 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -64.06 -50.2 69.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.055 -174.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.65 -0.02 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 55.71 81.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.778 0.674 . . . . 0.0 111.126 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -127.88 91.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.846 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -100.03 107.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.499 2.799 . . . . 0.0 111.994 170.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.87 169.19 12.61 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.918 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 31' ' ' CYS . 83.3 m -155.76 139.88 11.56 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.576 ' CD ' ' HB2' ' A' ' 34' ' ' CYS . 64.1 Cg_endo -88.27 132.45 11.49 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.816 -1.327 . . . . 0.0 112.993 0.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 28.5 m -107.69 110.9 22.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.8 175.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 33.1 m-85 -99.87 113.19 25.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 95.0 t -102.95 115.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.552 ' CD2' HG11 ' A' ' 114' ' ' VAL . 90.5 m-85 -94.11 113.82 25.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.781 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 24.4 mt -111.54 128.13 55.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.183 0.516 . . . . 0.0 110.619 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.14 125.17 32.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.792 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.03 117.58 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.707 1.605 . . . . 0.0 110.814 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.801 ' HE2' ' HB2' ' A' ' 93' ' ' GLU . 65.2 pttt -133.83 128.55 34.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.06 -75.72 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.191 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.76 19.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.171 -0.537 . . . . 0.0 111.816 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.23 165.21 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -94.86 139.71 30.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.299 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.801 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 9.6 tp10 -117.49 136.0 53.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.554 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 34.8 tt0 -89.82 96.58 10.75 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -83.99 -4.67 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.323 -170.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.76 162.16 11.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.946 177.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.481 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 87.3 mtt180 -127.57 136.74 52.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.38 150.97 37.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.799 0.333 . . . . 0.0 110.844 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -118.02 114.46 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA3' ' HG2' ' A' ' 80' ' ' PRO . . . -79.79 89.03 1.25 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.306 -172.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 p -135.7 -23.72 1.38 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.149 0.499 . . . . 0.0 110.547 175.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -70.03 155.54 93.29 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.691 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.8 167.08 9.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.669 2.246 . . . . 0.0 111.924 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -55.07 -38.01 67.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.512 -175.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -57.99 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.984 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.541 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 27.9 tt0 -75.08 -29.5 60.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.349 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.99 -47.88 84.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.873 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.855 HD22 HD12 ' A' ' 50' ' ' LEU . 47.1 mt -69.46 -27.12 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.238 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.541 ' HE3' ' HG3' ' A' ' 106' ' ' GLU . 29.3 ttpp -61.2 -49.98 74.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.475 ' O ' HG23 ' A' ' 114' ' ' VAL . 5.8 mm-40 -68.03 -39.95 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.349 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.48 -40.65 92.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.046 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.23 -39.28 89.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.352 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -66.04 -28.67 69.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.552 HG11 ' CD2' ' A' ' 84' ' ' PHE . 97.8 t -69.95 -39.38 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.1 m -59.06 -41.0 86.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.172 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.74 -43.99 99.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.392 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -75.2 -7.41 53.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.52 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.99 -39.17 24.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.82 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.401 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.483 1.175 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.5 m -87.27 -75.16 0.41 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 51' ' ' LEU . 46.0 tp -75.1 150.06 38.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.071 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.68 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 1.9 mmt180 -90.66 104.31 16.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.52 0.2 . . . . 0.0 111.382 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -106.77 103.87 13.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.68 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.3 m-85 -111.28 166.67 10.35 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 17.4 Cg_exo -64.92 160.1 42.89 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.895 1.73 . . . . 0.0 110.836 173.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.553 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -49.2 -50.67 62.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.9 Cg_exo -58.55 -46.28 25.0 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 121.886 1.724 . . . . 0.0 112.685 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -67.47 -44.28 78.98 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.535 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.42 -41.75 73.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 111.396 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.72 -36.12 75.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.744 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.04 -44.79 60.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.576 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.429 HD23 HG22 ' A' ' 56' ' ' VAL . 6.6 tp -60.26 -43.81 95.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.996 0.426 . . . . 0.0 109.879 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.82 -46.94 82.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.896 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -65.93 -43.22 88.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.599 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.0 54.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -119.04 6.38 11.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.633 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.12 46.11 95.19 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.296 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.7 mmp_? -110.78 -173.74 2.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.836 0.35 . . . . 0.0 110.671 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.463 ' HE1' ' O ' ' A' ' 114' ' ' VAL . 81.6 mtp -113.77 155.59 25.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 43.6 t -106.73 127.43 62.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.016 0.436 . . . . 0.0 111.585 -175.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.4 ttt -109.42 103.69 12.65 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 31.7 t -85.75 108.87 17.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.486 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 82.6 t80 -104.28 103.18 12.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.526 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.89 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.0 m-85 -84.19 122.21 28.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.612 ' HA ' HG23 ' A' ' 79' ' ' THR . 8.3 p80 -132.37 145.89 51.57 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.6 0.562 . . . . 0.0 111.785 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.449 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 66.9 m -142.24 153.04 43.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.544 177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -13.65 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.42 0.629 . . . . 0.0 109.828 173.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -82.89 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.603 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -121.06 83.01 37.51 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.63 26.3 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.043 2.495 . . . . 0.0 113.909 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -83.69 -23.52 31.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.177 0.513 . . . . 0.0 110.599 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 43.9 t -83.16 -30.85 27.51 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -55.93 -29.84 60.72 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -170.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.03 -46.59 67.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.45 . . . . 0.0 110.724 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.484 ' SD ' ' HB2' ' A' ' 42' ' ' LEU . 13.9 tmm? -79.46 -44.41 21.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.672 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.475 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 7.5 t30 -53.82 -45.98 70.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.781 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.3 m -60.54 -54.87 40.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.85 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -91.78 -69.39 0.74 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.558 0.694 . . . . 0.0 111.708 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.564 HG13 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -59.6 -44.57 93.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.829 -169.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HB2' ' SD ' ' A' ' 37' ' ' MET . 26.6 tp -79.09 -27.0 42.94 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.242 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 m -88.97 -2.33 58.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.797 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 28.4 t70 -47.79 128.76 11.31 Favored Pre-proline 0 C--O 1.236 0.372 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.546 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 46.7 Cg_exo -57.1 -33.53 95.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.072 2.515 . . . . 0.0 112.686 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.23 -48.24 53.8 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.662 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.569 HG22 HD21 ' A' ' 108' ' ' LEU . 99.8 t -59.77 -53.51 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.12 0.486 . . . . 0.0 110.48 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -56.24 -32.21 64.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.625 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -67.11 -34.25 77.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.601 0.239 . . . . 0.0 111.066 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.613 HD12 HD22 ' A' ' 108' ' ' LEU . 53.8 mt -68.85 -37.37 79.07 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.713 175.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.508 ' HB3' HD11 ' A' ' 3' ' ' LEU . 3.0 mm? -67.74 -48.76 65.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.706 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 3' ' ' LEU . 21.1 mm-40 -53.79 -32.32 52.06 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.972 0.415 . . . . 0.0 111.87 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -61.45 -54.6 41.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.502 HH12 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -136.88 4.47 2.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.45 ' HE2' ' HE ' ' A' ' 54' ' ' ARG . 59.6 m-85 -112.3 149.96 31.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.429 HG22 HD23 ' A' ' 14' ' ' LEU . 47.1 t -115.39 115.98 51.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.36 -1.291 . . . . 0.0 107.775 167.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 29.8 t -89.05 129.03 40.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.871 -173.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -99.45 117.14 33.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.372 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.3 t -93.05 101.35 13.67 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG11 HD12 ' A' ' 70' ' ' LEU . 42.6 t -114.22 133.3 60.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.046 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.567 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 18.8 m -95.16 117.67 30.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.449 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 41.4 t -71.61 -23.57 22.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.074 0.464 . . . . 0.0 111.484 -174.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.38 -19.21 43.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.689 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.8 p -95.85 161.22 28.17 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.598 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -49.73 -49.96 14.47 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.765 2.977 . . . . 0.0 114.537 -168.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -60.41 -44.04 96.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.331 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -69.27 -39.24 82.21 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.695 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.678 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 55.1 mt-30 -57.67 -40.35 79.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.236 0.541 . . . . 0.0 110.264 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -67.75 -45.56 74.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.552 HD12 HG11 ' A' ' 60' ' ' VAL . 78.9 mt -66.4 -29.47 69.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.485 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -68.81 -29.22 67.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.607 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 62.7 mtm180 -75.9 -45.7 33.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.478 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -65.5 -56.56 11.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.727 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -91.27 -12.51 34.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 71' ' ' ALA . 74.7 mtt180 62.28 87.21 0.1 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.678 0.751 . . . . 0.0 110.131 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG13 HG21 ' A' ' 81' ' ' THR . 56.1 t -128.1 137.96 31.95 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.529 -171.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 60.0 Cg_endo -74.29 -138.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.902 2.401 . . . . 0.0 111.361 170.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -91.31 -104.76 1.37 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.169 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.612 HG23 ' HA ' ' A' ' 27' ' ' HIS . 1.2 m -145.1 147.57 35.01 Favored Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.885 -0.185 . . . . 0.0 110.576 -169.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.627 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 36.7 Cg_endo -90.09 131.72 8.91 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.113 -1.203 . . . . 0.0 112.83 -1.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.89 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 22.5 m -114.51 108.22 16.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.484 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 23.8 m-85 -103.06 112.53 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.45 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -112.46 120.71 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -99.34 118.85 36.9 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.803 -176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 33.4 mt -114.86 132.58 56.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.704 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 40.2 t -109.73 127.56 26.92 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.414 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.2 Cg_endo -80.56 117.57 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.469 2.113 . . . . 0.0 110.383 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -142.58 124.53 15.24 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.426 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 66.46 -77.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.147 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.86 27.25 0.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.33 161.0 39.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 110.675 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.407 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 83.0 m95 -102.55 132.7 48.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.954 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 39.3 tt0 -117.87 120.51 38.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.509 -174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.511 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.3 tt0 -84.34 115.0 22.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.743 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 32.8 m -100.76 8.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -175.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.32 166.6 11.03 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.239 -0.982 . . . . 0.0 112.888 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 83' ' ' VAL . 92.5 mtt180 -133.78 135.74 44.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 110' ' ' GLU . 69.1 mt -108.88 127.06 53.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.079 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -137.38 143.99 42.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.3 12.65 26.61 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.26 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.436 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 49.2 m 69.64 -73.29 0.09 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.109 0.564 . . . . 0.0 111.642 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 68.14 156.69 0.14 Allowed Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 123.316 0.646 . . . . 0.0 111.284 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.23 159.15 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.178 1.919 . . . . 0.0 110.557 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.564 ' HB3' HG13 ' A' ' 41' ' ' VAL . 32.1 ptt180 -59.89 -25.48 65.13 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.66 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -54.34 -53.82 48.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.734 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.583 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 22.2 mm-40 -72.81 -34.44 66.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 40.2 t80 -65.02 -43.6 91.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.613 HD22 HD12 ' A' ' 50' ' ' LEU . 88.8 mt -69.83 -30.73 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.583 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.6 mttt -55.93 -53.56 55.32 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.51 ' HB3' HD11 ' A' ' 98' ' ' LEU . 9.5 tp10 -70.72 -38.03 73.55 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.557 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -60.09 -33.93 72.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.376 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 115' ' ' CYS . 7.7 tpt180 -80.25 -38.25 31.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.454 ' HG2' ' HE3' ' A' ' 117' ' ' LYS . 7.3 tt0 -62.9 -46.31 88.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.675 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.619 HG13 HG21 ' A' ' 95' ' ' VAL . 91.5 t -60.22 -37.05 72.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.5 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 112' ' ' ARG . 52.4 t -54.02 -36.7 63.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 176.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.32 -38.29 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.289 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.743 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 96.7 mttt -53.58 -28.59 32.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.22 -34.35 24.92 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.138 -0.554 . . . . 0.0 112.684 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -119.15 -15.46 5.59 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.338 177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.56 -15.17 25.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 34.6 t -72.46 127.9 33.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 116.86 0.3 19.69 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 124' ' ' GLY . 10.8 tp10 -73.17 165.16 25.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.157 -0.521 . . . . 0.0 109.768 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.402 ' H ' ' CD ' ' A' ' 123' ' ' GLU . . . 143.83 -3.05 1.5 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -169.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -68.92 -47.5 65.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -86.27 91.83 8.6 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.796 172.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -65.79 147.8 52.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.21 -174.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -144.51 139.34 28.18 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.39 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -93.08 6.66 47.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.416 0.627 . . . . 0.0 109.913 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.6 m170 . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.546 173.935 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.1 tpp . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -145.48 41.96 1.25 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 57' ' ' VAL . 22.2 tp -132.79 153.29 51.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.261 -169.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.633 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.3 mmt180 -88.44 104.52 16.87 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 120.984 0.421 . . . . 0.0 111.201 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -99.94 113.44 26.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.009 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.8 m-85 -122.93 160.48 49.15 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 20.4 Cg_exo -62.97 158.7 41.94 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.957 1.771 . . . . 0.0 111.343 176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.573 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.7 t80 -47.1 -51.3 41.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 37.6 Cg_exo -60.79 -43.39 31.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.793 1.662 . . . . 0.0 112.266 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -68.49 -45.19 73.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.991 -177.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -54.71 -43.21 72.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.247 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.8 mp -66.97 -39.4 87.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.647 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.0 -44.19 66.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.214 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.468 ' HB3' HG11 ' A' ' 56' ' ' VAL . 14.4 tp -59.06 -51.33 70.51 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.155 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.67 96.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.689 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.15 -41.46 99.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.474 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.1 -15.47 50.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.918 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -113.51 -0.55 14.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.09 37.84 95.6 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.158 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.764 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 2.1 mmp_? -107.15 -179.68 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.277 0.231 . . . . 0.0 110.47 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.655 ' HG3' HG22 ' A' ' 86' ' ' VAL . 41.2 ttm -102.12 156.08 17.78 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.424 HG11 HD12 ' A' ' 12' ' ' LEU . 84.8 t -105.79 122.13 58.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.798 0.333 . . . . 0.0 110.702 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.8 ttt -100.38 103.58 14.97 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 48.9 t -86.97 105.64 15.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.533 ' HE1' ' CE1' ' A' ' 82' ' ' PHE . 84.2 t80 -104.9 108.82 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.507 . . . . 0.0 110.994 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.96 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 69.4 m-85 -81.02 111.25 17.32 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.579 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.513 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 22.4 p80 -119.76 156.41 30.64 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.949 0.781 . . . . 0.0 109.713 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.617 ' HA ' ' OD1' ' A' ' 63' ' ' ASP . 40.8 t -144.11 160.04 41.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' HG3' ' OD2' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -89.16 -6.28 57.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.81 0.814 . . . . 0.0 108.927 169.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -103.24 10.68 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.485 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 20.2 p -69.12 154.63 94.81 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.7 -90.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.004 1.802 . . . . 0.0 113.482 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -79.59 -17.24 54.33 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.933 0.396 . . . . 0.0 111.434 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 8.1 t -56.42 -25.76 51.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.365 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -50.81 -41.63 57.49 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 111.108 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.3 -39.35 25.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.225 0.536 . . . . 0.0 110.447 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.511 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 81.6 mtp -68.58 -48.46 64.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.62 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -63.33 -48.07 79.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.985 0.422 . . . . 0.0 111.053 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 43' ' ' SER . 10.6 m -72.68 -54.31 9.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.863 -175.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -92.3 -68.34 0.8 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.996 0.427 . . . . 0.0 112.107 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 37' ' ' MET . 95.8 t -51.66 -52.23 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -81.68 -16.33 51.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.4 m -93.59 -0.93 55.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.73 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -52.57 134.13 44.77 Favored Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.931 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.93 -39.57 85.32 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.024 2.483 . . . . 0.0 113.228 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -72.23 -41.1 54.28 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.67 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.785 HG22 HD21 ' A' ' 108' ' ' LEU . 29.0 t -63.56 -46.82 93.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -53.92 -44.24 70.42 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.92 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.2 mtt-85 -62.67 -26.12 68.48 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -70.31 -45.12 66.87 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.659 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 47' ' ' VAL . 1.6 mm? -71.78 -43.73 65.21 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.739 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.13 -32.1 9.41 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.521 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -79.31 -48.7 13.64 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -173.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.764 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -136.11 19.06 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -173.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 51' ' ' LEU . 77.8 m-85 -129.28 145.29 51.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.36 0.6 . . . . 0.0 111.43 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 14' ' ' LEU . 47.3 t -116.3 120.5 65.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 3' ' ' LEU . 35.5 t -91.89 123.36 43.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.15 -171.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -92.31 117.44 29.9 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.235 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.7 p -80.81 101.6 9.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.435 HG21 HG13 ' A' ' 24' ' ' VAL . 58.7 t -110.05 119.96 60.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.165 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.563 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 0.9 OUTLIER -103.1 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 t -66.39 -15.4 19.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.724 0.773 . . . . 0.0 110.166 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.617 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 1.6 m-20 -71.58 -32.69 68.33 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.666 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.635 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -108.71 167.02 9.78 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.087 -173.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.635 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.7 Cg_endo -51.03 -48.33 21.55 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 124.174 3.249 . . . . 0.0 114.493 -171.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -63.39 -35.57 80.86 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.912 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.3 -40.05 29.7 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.352 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -58.26 -35.57 71.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.437 0.637 . . . . 0.0 110.542 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.66 -51.18 61.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.439 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 9.3 mp -64.04 -33.71 76.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.956 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . . . -63.42 -38.94 93.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.274 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.642 ' HA ' HH21 ' A' ' 75' ' ' ARG . 25.1 ptt180 -79.06 -34.81 43.39 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.23 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -68.97 -56.06 8.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.6 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.502 ' HE1' ' HG ' ' A' ' 70' ' ' LEU . 92.0 m-85 -85.89 -6.66 59.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.981 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.695 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 1.5 mmp_? 63.08 79.1 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.847 0.832 . . . . 0.0 110.127 -174.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 71' ' ' ALA . 94.5 t -125.98 135.71 27.46 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.996 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 23.0 Cg_exo -65.56 -90.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.752 2.301 . . . . 0.0 112.067 175.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 77' ' ' PRO . . . -143.14 -75.31 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.895 172.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.674 HG22 ' HA ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -156.54 148.25 17.15 Favored Pre-proline 0 C--N 1.322 -0.587 0 O-C-N 122.672 -0.311 . . . . 0.0 111.37 -170.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.674 ' HA ' HG22 ' A' ' 79' ' ' THR . 5.1 Cg_endo -88.83 137.75 14.49 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.432 -1.07 . . . . 0.0 111.477 -3.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.96 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 6.3 m -122.71 123.93 42.23 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.924 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.696 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.7 m-85 -114.16 114.31 25.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.869 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 90.3 t -123.48 112.78 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.929 0.395 . . . . 0.0 110.316 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -99.81 120.43 39.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.317 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 94' ' ' GLU . 35.4 mt -117.16 129.33 55.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.462 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.655 HG22 ' HG3' ' A' ' 21' ' ' MET . 21.6 t -108.61 122.87 38.92 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.203 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.3 118.07 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.188 1.925 . . . . 0.0 110.888 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -154.44 140.76 18.64 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.579 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.48 -76.13 0.06 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.084 0.865 . . . . 0.0 111.291 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.6 26.06 0.12 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -154.64 176.58 12.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 0.0 110.481 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -106.28 130.43 54.13 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.216 0.532 . . . . 0.0 110.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 37.2 tt0 -101.47 112.29 24.79 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.853 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.655 ' OE1' ' HD2' ' A' ' 97' ' ' ARG . 33.2 tt0 -75.29 95.8 3.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 172.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.28 -14.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.532 -168.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -156.04 123.67 1.36 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.547 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.655 ' HD2' ' OE1' ' A' ' 94' ' ' GLU . 27.3 mtp180 -130.42 126.14 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.831 HD11 ' HG2' ' A' ' 110' ' ' GLU . 42.9 mt -136.03 135.57 39.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.785 -177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -138.01 143.2 40.48 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.19 -86.0 0.28 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.949 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.7 p 179.95 -95.48 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.319 0.248 . . . . 0.0 111.056 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.711 ' HB3' ' HB3' ' A' ' 106' ' ' GLU . 54.0 mtm180 66.65 119.13 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 123.726 0.811 . . . . 0.0 110.495 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.69 171.05 3.84 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.198 2.599 . . . . 0.0 112.932 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.486 ' HB2' HG13 ' A' ' 41' ' ' VAL . 54.8 ttp180 -46.66 -41.41 14.8 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.828 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.76 86.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.016 0.436 . . . . 0.0 111.808 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 102' ' ' ARG . 12.1 tp10 -80.77 -37.48 30.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.64 -37.28 87.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.103 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.785 HD21 HG22 ' A' ' 47' ' ' VAL . 42.6 mt -63.6 -44.78 92.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.286 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.474 ' HZ3' ' HA ' ' A' ' 106' ' ' GLU . 33.9 mtmm -61.17 -44.2 97.67 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.715 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.831 ' HG2' HD11 ' A' ' 98' ' ' LEU . 13.5 tp10 -59.05 -50.56 73.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.418 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 tp -59.44 -34.59 72.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.614 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 112' ' ' ARG . 9.3 mmm180 -60.54 -43.25 97.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.463 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -72.52 -38.74 67.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.058 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 110' ' ' GLU . 91.1 t -56.48 -38.77 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.805 0.335 . . . . 0.0 110.665 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.0 m -56.68 -35.01 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.3 t -84.66 -50.04 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -55.81 -40.76 73.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.932 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.52 ' CA ' HG21 ' A' ' 86' ' ' VAL . . . -66.54 -24.3 72.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.751 -177.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -95.61 -56.88 1.22 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.101 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.29 114.76 18.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.893 0.378 . . . . 0.0 110.738 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.5 t -143.88 -55.72 0.37 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.447 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -119.51 49.47 0.87 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.224 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -90.13 -37.76 13.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.167 0.508 . . . . 0.0 110.311 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.42 25.81 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.597 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -46.96 -36.74 8.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.443 0.297 . . . . 0.0 111.747 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -163.34 66.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.721 0.772 . . . . 0.0 110.214 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -159.45 102.31 1.55 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.121 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -80.68 85.18 6.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.875 0.369 . . . . 0.0 110.539 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 130' ' ' HIS . 5.4 p80 -74.17 100.97 3.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.671 174.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.415 ' HB3' ' O ' ' A' ' 129' ' ' HIS . 41.8 t-80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 117.825 -1.083 . . . . 0.0 109.607 -172.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.399 0.142 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -66.32 -42.48 88.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.111 0.481 . . . . 0.0 110.509 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.74 HD21 HG21 ' A' ' 57' ' ' VAL . 53.8 tp -64.59 150.83 46.18 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.88 177.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -82.28 104.88 12.91 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.273 0.559 . . . . 0.0 112.196 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.512 ' HZ2' ' HG ' ' A' ' 42' ' ' LEU . 43.0 m95 -107.9 131.37 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.669 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 89.8 m-85 -132.84 155.03 81.61 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 25.2 Cg_exo -58.09 160.85 14.7 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.003 1.802 . . . . 0.0 111.245 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.566 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 88.4 t80 -45.61 -53.95 17.47 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 19.7 Cg_exo -66.24 -42.19 11.02 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.668 1.579 . . . . 0.0 112.205 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 38.8 tt0 -69.4 -42.73 74.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.065 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.57 -44.24 94.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.204 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 8' ' ' TYR . 9.1 mp -63.01 -35.82 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.77 177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.02 -37.6 69.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.842 0.353 . . . . 0.0 110.203 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.547 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -60.12 -50.51 73.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.396 176.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.33 -43.8 93.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.199 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -57.63 -52.15 66.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.493 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.94 -13.96 59.92 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.756 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -115.91 2.9 13.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.499 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.3 44.58 96.42 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.626 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -108.7 -179.42 3.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.694 0.283 . . . . 0.0 110.919 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.478 ' SD ' ' HA3' ' A' ' 118' ' ' GLY . 87.3 mtp -100.92 158.48 15.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.8 t -110.2 125.84 67.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.008 0.432 . . . . 0.0 111.106 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 25.0 ttt -103.6 102.65 12.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 61.3 t -89.93 106.26 16.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.095 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.803 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 45.1 t80 -104.95 123.18 47.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.306 0.574 . . . . 0.0 111.36 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.914 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 67.1 m-85 -94.18 126.18 39.26 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.217 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.803 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 34.5 p80 -130.96 157.44 42.96 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.971 0.794 . . . . 0.0 110.679 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.557 ' H ' HG21 ' A' ' 79' ' ' THR . 30.3 t -143.01 159.12 42.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.565 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.73 -6.6 58.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.42 0.629 . . . . 0.0 110.121 173.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -103.38 19.68 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.375 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.712 ' HB3' ' CG2' ' A' ' 79' ' ' THR . 26.9 p -74.68 131.32 79.85 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.567 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.11 -92.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.466 2.111 . . . . 0.0 114.031 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -74.43 -17.14 60.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.071 0.463 . . . . 0.0 111.433 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.4 t -58.49 -23.46 57.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.038 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -49.29 -47.81 46.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.218 0.532 . . . . 0.0 111.714 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.783 ' HA ' HE21 ' A' ' 36' ' ' GLN . 0.0 OUTLIER -75.26 -31.7 60.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.739 -176.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.448 ' SD ' ' HA ' ' A' ' 101' ' ' SER . 83.5 mtp -67.11 -49.8 63.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.47 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 58.5 m-20 -64.55 -37.07 86.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.315 -174.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 m -64.77 -61.29 2.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.375 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.32 -70.6 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 104' ' ' ARG . 60.3 t -57.9 -44.64 86.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -170.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 15.1 tp -81.57 -11.1 59.27 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 -173.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 t -112.62 3.34 16.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.066 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' CG ' HH11 ' A' ' 104' ' ' ARG . 26.5 t70 -53.83 131.81 57.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.561 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -58.29 -28.57 84.98 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.933 2.422 . . . . 0.0 112.862 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.47 -49.48 14.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.601 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG22 HD21 ' A' ' 108' ' ' LEU . 84.4 t -58.23 -53.57 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.161 0.505 . . . . 0.0 110.102 174.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.525 ' HA ' HD13 ' A' ' 3' ' ' LEU . 32.5 m -54.36 -38.29 65.92 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.234 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.1 ttm180 -60.86 -32.08 71.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.788 0.328 . . . . 0.0 111.387 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.763 HD12 HD22 ' A' ' 108' ' ' LEU . 69.0 mt -71.83 -42.1 67.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.741 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.419 ' HB2' HD11 ' A' ' 3' ' ' LEU . 2.4 mm? -70.74 -53.19 16.47 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.195 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' OE2' HD12 ' A' ' 3' ' ' LEU . 32.9 mm-40 -45.33 -38.19 5.53 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.644 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -64.68 -51.51 62.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.644 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.58 14.61 3.43 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -173.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.409 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 74.4 m-85 -125.29 150.86 46.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.498 . . . . 0.0 111.251 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 14' ' ' LEU . 61.0 t -119.02 122.06 68.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.74 HG21 HD21 ' A' ' 3' ' ' LEU . 33.1 t -89.11 124.31 41.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.994 -173.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.96 117.58 31.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.482 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -83.99 101.64 11.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.62 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.71 114.46 36.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 110.196 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.603 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -89.17 107.62 19.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.308 -178.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.501 HG11 ' HA2' ' A' ' 78' ' ' GLY . 44.3 t -80.7 -7.79 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 122.697 1.237 . . . . 0.0 107.694 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -33.78 76.69 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.826 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.8 OUTLIER -124.64 167.14 16.66 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.204 -174.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.7 Cg_endo -50.62 -50.77 12.69 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.312 3.341 . . . . 0.0 114.76 -171.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.49 -44.1 84.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.815 0.341 . . . . 0.0 111.462 -174.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.61 -27.44 59.08 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.335 -0.936 . . . . 0.0 111.806 177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -63.89 -37.69 88.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.793 0.33 . . . . 0.0 110.314 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.7 -51.36 70.26 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.289 0.566 . . . . 0.0 109.874 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.447 ' HB3' ' CE2' ' A' ' 26' ' ' PHE . 4.0 mm? -56.91 -43.64 81.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.019 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.78 -54.68 44.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.123 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 72' ' ' ARG . 21.5 ptt85 -68.73 -23.36 64.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.102 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -72.64 -36.54 68.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.715 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -106.2 8.51 32.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.376 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 62.07 36.98 15.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.913 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.0 t -93.48 133.67 27.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.504 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.439 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 29.3 Cg_exo -61.56 -83.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.61 2.207 . . . . 0.0 111.552 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' HA2' HG11 ' A' ' 62' ' ' VAL . . . -145.5 -52.76 0.03 OUTLIER Glycine 0 N--CA 1.437 -1.236 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.807 169.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.712 ' CG2' ' HB3' ' A' ' 31' ' ' CYS . 3.6 t 175.57 158.09 0.39 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.682 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 2.4 Cg_endo -79.75 126.61 13.21 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.827 -1.322 . . . . 0.0 112.29 0.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.914 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 29.3 m -129.77 119.67 23.8 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.115 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.16 110.72 20.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 60.8 t -113.99 114.21 46.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.862 0.363 . . . . 0.0 110.056 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.6 117.55 31.19 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.857 0.361 . . . . 0.0 110.754 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 26.5 mt -110.73 136.56 49.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.21 0.529 . . . . 0.0 111.303 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.0 t -109.94 120.07 45.73 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.49 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 52.2 Cg_endo -74.95 117.49 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.72 1.614 . . . . 0.0 110.938 173.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.409 ' HE3' ' CB ' ' A' ' 93' ' ' GLU . 20.7 pttp -141.58 132.63 26.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.517 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.01 -76.8 0.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.008 0.818 . . . . 0.0 111.262 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.58 24.77 0.19 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -146.25 152.5 39.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.7 0.286 . . . . 0.0 110.695 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.49 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 32.8 m95 -92.95 120.77 33.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 7.6 tp10 -102.21 139.88 37.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.888 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -90.66 104.78 17.33 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.608 HG22 ' HD3' ' A' ' 117' ' ' LYS . 4.3 p -97.19 6.39 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.55 0.69 . . . . 0.0 110.874 -172.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.85 134.55 1.79 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.488 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -122.84 135.88 54.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 110.441 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.1 mt -114.48 136.77 52.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.737 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -137.13 136.67 38.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.856 0.36 . . . . 0.0 110.506 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.14 -174.71 18.53 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.86 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.448 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 15.5 m -92.43 127.13 37.81 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.976 0.417 . . . . 0.0 110.566 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 102' ' ' ARG . 8.6 mmm180 -127.87 137.61 31.15 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.88 157.18 58.01 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.911 1.741 . . . . 0.0 110.016 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB2' HG13 ' A' ' 41' ' ' VAL . 46.4 ttp180 -58.0 -26.82 62.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.718 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.89 -50.78 67.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.582 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -69.02 -42.67 76.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.979 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -59.18 -50.39 74.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.771 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.763 HD22 HD12 ' A' ' 50' ' ' LEU . 56.8 mt -72.23 -19.16 61.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.512 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -73.16 -49.9 25.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.409 0.623 . . . . 0.0 109.946 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 114' ' ' VAL . 50.4 mt-10 -72.76 -35.33 67.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.213 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 51.0 tp -65.54 -32.73 74.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.089 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -59.68 -47.29 86.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -56.31 -45.16 80.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.532 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 95.6 t -62.4 -45.58 98.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.922 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.444 ' HB2' HH21 ' A' ' 54' ' ' ARG . 21.0 p -67.12 -22.25 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 111.044 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 112' ' ' ARG . 80.3 t -79.23 -37.7 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 109.918 174.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.608 ' HD3' HG22 ' A' ' 95' ' ' VAL . 83.5 mttt -61.57 -27.49 68.67 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.635 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.478 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -65.0 -32.9 85.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.337 178.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.6 -41.21 4.51 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.078 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.27 37.36 1.26 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.911 0.386 . . . . 0.0 110.821 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.8 t -69.86 -24.24 63.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.52 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -167.28 119.37 0.84 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.099 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -123.81 -167.85 1.69 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 126.36 -16.56 6.67 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -92.87 7.06 45.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.402 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -113.04 96.04 5.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.062 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -147.23 132.26 18.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.801 0.334 . . . . 0.0 111.576 -175.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -130.89 -41.91 1.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -108.19 147.47 31.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.937 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.347 -0.835 . . . . 0.0 108.75 171.186 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 tpt . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.295 0.569 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.5 m -155.22 62.69 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.445 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.2 tp -54.49 135.15 46.09 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.977 -174.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.613 ' NE ' ' HA ' ' A' ' 4' ' ' ARG . 3.1 mmp_? -109.05 123.1 48.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.246 -171.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -115.56 115.98 27.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.588 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 86.2 m-85 -133.69 160.88 66.86 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.497 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 31.7 Cg_exo -58.55 166.47 6.26 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.406 2.071 . . . . 0.0 111.483 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.615 ' CD1' HD21 ' A' ' 70' ' ' LEU . 61.8 t80 -51.58 -51.43 69.76 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.5 Cg_exo -62.12 -45.69 15.11 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.866 1.71 . . . . 0.0 112.233 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 80.2 tt0 -67.09 -40.2 86.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.929 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.17 -44.81 94.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.225 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 22' ' ' VAL . 2.8 mt -63.25 -35.75 81.39 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.832 0.348 . . . . 0.0 110.332 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.73 69.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.229 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.2 tp -64.31 -44.6 91.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.628 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.75 -42.28 95.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.697 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.25 -44.74 90.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.54 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.76 -14.67 56.14 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -119.14 1.78 11.39 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.93 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.59 44.32 97.72 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.242 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.628 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 12.5 mmm180 -107.96 -178.04 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 111.342 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -101.22 165.06 11.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.546 -179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 84.1 t -122.53 133.6 68.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.737 0.303 . . . . 0.0 111.189 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 23' ' ' MET . 20.1 ptm -126.79 113.58 16.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.182 0.515 . . . . 0.0 109.645 170.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.548 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 46.5 t -87.22 109.62 19.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.281 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 88.6 t80 -97.49 103.6 15.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.378 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.964 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 77.0 m-85 -82.27 119.33 23.97 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.604 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 61' ' ' SER . 28.5 p80 -133.02 146.24 51.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.21 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 47.4 t -134.14 164.84 26.45 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.13 -17.87 30.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.114 0.483 . . . . 0.0 110.22 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.505 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 76.9 m-70 -89.56 -16.76 29.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.768 172.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.873 ' HB3' ' HB ' ' A' ' 79' ' ' THR . 63.9 m -108.84 84.9 2.78 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.332 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.566 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 57.7 Cg_endo -92.08 -0.84 4.22 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.002 2.468 . . . . 0.0 114.896 -169.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -74.58 -21.7 59.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.837 -0.539 . . . . 0.0 111.409 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 17.5 p -72.52 -30.83 64.83 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 3.2 pt20 -67.9 -27.14 66.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.651 0.262 . . . . 0.0 110.97 -176.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -64.69 -50.49 66.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.646 ' HG3' ' HB3' ' A' ' 101' ' ' SER . 11.3 tmm? -67.95 -42.41 80.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.842 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -54.67 -47.2 73.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.504 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 m -61.59 -51.76 67.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.98 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -91.01 -70.64 0.67 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.258 0.551 . . . . 0.0 112.055 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.623 ' HB ' ' SD ' ' A' ' 37' ' ' MET . 96.9 t -63.37 -41.35 92.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.533 -168.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.3 tp -80.86 -30.61 35.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.2 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.2 m -87.6 -1.56 58.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.68 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -47.01 131.16 8.98 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.049 173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.52 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 54.4 Cg_exo -52.99 -38.02 79.32 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.047 2.498 . . . . 0.0 113.305 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.7 -43.59 35.2 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.069 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -63.94 -51.09 73.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-O 121.436 0.636 . . . . 0.0 109.923 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.2 m -53.8 -39.21 65.27 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.128 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 17.7 mtp180 -60.61 -29.2 69.08 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.78 -39.11 67.0 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.599 174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.44 -43.62 72.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.584 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -55.23 -34.53 64.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.85 0.46 . . . . 0.0 111.327 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.1 -54.22 47.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.205 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -11.39 2.07 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -90.48 151.63 21.29 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -170.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 14' ' ' LEU . 90.9 t -115.41 122.73 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 163.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG22 ' SD ' ' A' ' 23' ' ' MET . 16.1 t -87.45 125.29 41.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.035 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -96.91 117.1 30.38 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.862 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.8 p -91.42 100.53 13.29 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.469 HG21 HG13 ' A' ' 24' ' ' VAL . 96.4 t -109.04 119.25 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.13 0.49 . . . . 0.0 110.985 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.629 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -96.53 119.56 35.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.467 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.623 ' HB ' ' HB2' ' A' ' 28' ' ' SER . 16.4 t -81.24 66.31 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.876 0.846 . . . . 0.0 109.606 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.629 ' OD1' ' HB2' ' A' ' 61' ' ' SER . 3.1 p-10 -163.21 -33.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 0.6 OUTLIER -94.9 164.02 20.6 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.454 175.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.6 Cg_endo -51.5 -55.03 4.37 Favored 'Trans proline' 0 N--CA 1.477 0.54 0 C-N-CA 123.497 2.798 . . . . 0.0 113.996 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 70' ' ' LEU . 10.7 pt-20 -57.68 -41.48 81.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.177 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.05 -34.23 64.96 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.642 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -68.79 -42.79 76.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.334 -0.433 . . . . 0.0 111.474 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.43 ' HB2' HH21 ' A' ' 72' ' ' ARG . 12.0 pt-20 -73.74 -33.82 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.883 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.615 HD21 ' CD1' ' A' ' 8' ' ' TYR . 5.5 mp -62.92 -36.06 82.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.435 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 75' ' ' ARG . . . -65.14 -31.96 73.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.486 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.43 HH21 ' HB2' ' A' ' 69' ' ' GLU . 56.0 mtm180 -68.89 -41.82 77.78 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.481 0.658 . . . . 0.0 109.997 173.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -71.32 -57.38 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.609 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 96.9 m-85 -82.9 -18.44 40.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.022 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 74' ' ' TYR . 10.5 ptp180 44.85 73.19 0.16 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.357 1.035 . . . . 0.0 112.114 -177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.49 HG11 ' CG2' ' A' ' 81' ' ' THR . 35.0 t -135.92 100.65 10.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.636 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.6 130.11 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.991 2.461 . . . . 0.0 111.995 172.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 151.01 -77.41 0.23 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.905 -1.14 . . . . 0.0 112.44 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.873 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.2 m 71.62 138.94 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 122.513 0.325 . . . . 0.0 110.919 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.718 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 51.5 Cg_endo -71.72 143.88 78.16 Favored 'Cis proline' 0 C--N 1.346 0.431 0 C-N-CA 123.666 -1.389 . . . . 0.0 113.191 0.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.964 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 27.6 m -120.49 122.29 40.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.894 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.553 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 4.3 m-85 -114.35 110.95 20.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.518 HG11 ' CE2' ' A' ' 74' ' ' TYR . 66.0 t -115.38 111.32 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.543 ' HB2' HG13 ' A' ' 95' ' ' VAL . 51.5 m-85 -93.1 135.83 33.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 37.2 mt -125.26 132.71 52.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.866 0.365 . . . . 0.0 110.184 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.574 HG11 ' HA2' ' A' ' 118' ' ' GLY . 16.0 t -109.01 121.41 43.0 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.736 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.4 116.76 4.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.331 1.354 . . . . 0.0 110.124 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.402 ' HE2' ' SG ' ' A' ' 121' ' ' CYS . 1.9 ptpp? -137.19 126.73 25.15 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.642 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.72 -71.55 0.11 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.156 0.91 . . . . 0.0 111.024 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.13 23.81 0.14 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.027 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.96 157.1 44.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.673 0.273 . . . . 0.0 110.903 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -93.07 124.31 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.698 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -109.05 118.53 37.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.342 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 35.6 tt0 -69.78 98.93 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.634 0.731 . . . . 0.0 109.413 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 84' ' ' PHE . 1.8 p -80.05 -28.21 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.036 -170.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.18 152.02 10.76 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.388 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -120.05 127.33 52.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 85.9 mt -111.53 137.06 49.86 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.417 ' CE1' ' HA3' ' A' ' 78' ' ' GLY . 91.0 t80 -137.87 143.09 40.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.84 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.75 23.92 59.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.745 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.646 ' HB3' ' HG3' ' A' ' 37' ' ' MET . 43.1 m 68.15 174.31 0.27 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.429 ' O ' HG11 ' A' ' 41' ' ' VAL . 4.9 mmt180 -148.61 148.73 29.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 172.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.58 149.77 88.31 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 N-CA-C 108.626 -1.336 . . . . 0.0 108.626 164.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.648 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 10.9 ptt180 -59.8 -29.53 68.29 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.576 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.73 88.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.611 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.681 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 2.0 mt-10 -80.92 -35.44 32.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.342 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -63.38 -37.18 86.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 91.2 mt -62.77 -43.2 99.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.044 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.618 ' HD3' ' HA ' ' A' ' 106' ' ' GLU . 8.2 mtpm? -52.59 -56.57 14.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 175.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 3.7 mm-40 -61.23 -40.78 95.29 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.456 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.55 -20.9 66.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.345 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 28.4 mmt180 -78.54 -45.34 22.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -58.72 -38.4 78.24 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.383 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.498 HG13 HG11 ' A' ' 95' ' ' VAL . 78.7 t -74.66 -38.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 112' ' ' ARG . 24.6 p -65.53 -31.77 73.0 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.506 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.2 t -71.26 -43.16 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.165 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 121' ' ' CYS . 30.6 mtpt -68.92 -11.5 60.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.032 0.444 . . . . 0.0 111.841 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.574 ' HA2' HG11 ' A' ' 86' ' ' VAL . . . -71.73 -33.48 63.29 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.405 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.15 -48.18 0.07 OUTLIER Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.147 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.45 26.74 1.39 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.052 0.453 . . . . 0.0 111.326 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 117' ' ' LYS . 9.5 p -69.98 111.58 5.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.406 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 77.41 -76.74 1.64 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.012 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 68.87 -62.87 0.38 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.426 0.691 . . . . 0.0 110.825 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.65 -26.75 2.24 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 130' ' ' HIS . 5.3 m-70 -127.5 38.43 4.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.985 0.421 . . . . 0.0 111.293 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 59.5 m170 -110.3 83.64 1.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.426 ' C ' ' H ' ' A' ' 129' ' ' HIS . 40.5 t-80 -152.82 79.65 1.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.513 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.1 t60 72.28 -30.25 0.21 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.796 0.839 . . . . 0.0 111.405 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 127' ' ' HIS . 23.2 p80 -145.95 174.55 11.16 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 173.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' A' ' 125' ' ' HIS . 22.2 t-80 . . . . . 0 C--O 1.246 0.904 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ttt . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 t 68.73 117.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 O-C-N 124.157 0.91 . . . . 0.0 108.59 -170.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 22.3 tp -55.34 120.85 7.72 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.4 0.619 . . . . 0.0 111.009 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.4 mmt180 -97.99 108.64 21.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.067 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -106.09 104.19 13.84 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.38 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 92.4 m-85 -116.23 168.9 7.8 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 12.4 Cg_exo -67.74 158.48 57.04 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.604 1.536 . . . . 0.0 110.094 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.542 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.7 t80 -47.11 -50.3 47.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 51.5 Cg_exo -56.57 -50.26 12.36 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.159 1.906 . . . . 0.0 112.981 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.04 -42.34 89.7 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -178.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.17 71.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.21 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.469 HD22 HG21 ' A' ' 22' ' ' VAL . 6.3 mt -70.81 -36.86 73.16 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.329 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.29 70.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.055 0.455 . . . . 0.0 110.065 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.548 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -59.75 -44.57 93.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.874 176.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.75 -53.42 33.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.455 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 7.7 tp60 -58.67 -53.14 61.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.069 -176.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.22 60.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.999 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -116.72 -0.14 12.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.094 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.43 39.26 91.44 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.814 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.667 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 74.6 mmt-85 -112.79 179.59 3.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 111.653 177.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.2 mtp -101.69 159.06 15.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.285 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.694 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 47.8 t -105.8 119.53 55.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 110.779 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 57' ' ' VAL . 10.2 tpt -99.6 103.3 14.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.235 174.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 16.4 t -94.88 106.28 17.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.445 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 90.4 t80 -106.61 104.43 14.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.226 0.536 . . . . 0.0 111.143 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.926 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 86.5 m-85 -82.38 115.82 21.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.218 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -121.3 158.37 28.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.748 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 42.8 m -137.69 162.24 34.37 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -64.62 -60.77 2.74 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -94.42 48.72 1.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.314 0.578 . . . . 0.0 110.844 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.69 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 27.3 p -76.19 149.26 81.97 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.135 173.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 33' ' ' TYR . 39.0 Cg_exo -58.93 -98.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.076 2.518 . . . . 0.0 114.053 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.433 ' H ' ' HB2' ' A' ' 32' ' ' PRO . 90.2 t80 -87.72 -17.83 30.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 0.0 111.565 -176.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 1.6 t -51.4 -38.97 56.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.665 -174.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 2.1 pp0? -56.85 -31.47 64.81 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -80.18 -48.16 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 110.084 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.53 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 15.1 ptm -68.96 -33.47 73.76 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.2 -27.73 65.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.208 0.527 . . . . 0.0 110.206 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.8 m -92.13 -61.58 1.59 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.378 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -91.45 -70.58 0.68 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.4 t -52.71 -47.03 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.223 -0.898 . . . . 0.0 113.305 -168.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.0 tp -81.89 -19.03 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.773 0.321 . . . . 0.0 110.984 -171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.2 m -92.92 -6.44 48.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.725 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.459 ' HB3' HG23 ' A' ' 47' ' ' VAL . 11.4 t70 -46.55 136.23 7.46 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.743 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 53.1 Cg_exo -56.86 -35.28 98.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.375 2.717 . . . . 0.0 113.698 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.589 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . -79.41 -24.35 61.09 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 44' ' ' ASP . 19.9 t -79.48 -43.56 23.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 109.003 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -62.77 -33.55 75.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.319 178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 15.2 ptm180 -67.95 -24.49 65.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.798 0.333 . . . . 0.0 111.161 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -71.84 -46.43 58.08 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -62.45 -44.82 95.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.911 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -50.23 -31.34 13.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.548 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -82.91 -54.49 5.04 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -171.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.667 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.56 12.04 3.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -170.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.536 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 84.4 m-85 -118.84 138.41 52.74 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.529 0.68 . . . . 0.0 112.026 -176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 14' ' ' LEU . 51.0 t -109.33 116.81 53.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.46 HG13 ' HG3' ' A' ' 23' ' ' MET . 15.5 t -89.21 127.36 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.215 0.531 . . . . 0.0 110.978 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.09 117.8 34.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.029 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.1 p -81.44 101.26 9.76 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.61 120.46 56.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.723 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.625 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 m -101.78 108.9 20.54 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.0 t -68.19 -13.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.645 0.736 . . . . 0.0 110.439 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 28' ' ' SER . 2.8 m-20 -79.72 -28.86 40.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.055 -176.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.644 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -105.43 165.38 13.25 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.654 -175.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.6 Cg_endo -49.07 -52.35 8.9 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.035 3.157 . . . . 0.0 114.495 -171.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.412 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -59.49 -39.3 83.3 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -179.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.22 -35.74 47.68 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.839 175.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -62.39 -35.65 79.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.67 0.747 . . . . 0.0 110.089 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.59 -46.66 71.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.412 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.431 ' O ' ' HD1' ' A' ' 74' ' ' TYR . 45.1 mt -66.29 -31.44 72.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.837 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.33 -33.79 76.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.283 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -85.17 -28.45 25.48 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.632 176.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.49 -50.36 52.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 110.358 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' CD1' ' HZ ' ' A' ' 26' ' ' PHE . 89.3 m-85 -85.23 -20.91 29.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.312 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 58.4 62.26 2.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.834 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.4 t -137.37 101.47 9.09 Favored Pre-proline 0 N--CA 1.463 0.224 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.791 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -96.58 128.2 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 111.292 168.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 125.44 107.85 1.65 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.72 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.69 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 0.3 OUTLIER -92.64 147.83 34.98 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 115.577 -0.312 . . . . 0.0 110.203 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.69 ' HA ' HG22 ' A' ' 79' ' ' THR . 10.3 Cg_endo -88.26 154.45 37.99 Favored 'Cis proline' 0 N--CA 1.459 -0.548 0 C-N-CA 124.595 -1.002 . . . . 0.0 112.345 -0.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.926 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 23.9 m -120.01 115.02 22.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.319 175.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 11.8 m-85 -106.48 112.35 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.606 HG22 ' HG2' ' A' ' 97' ' ' ARG . 46.5 t -118.13 129.6 74.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.463 ' CG ' HG11 ' A' ' 114' ' ' VAL . 68.1 m-85 -110.79 122.97 49.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.809 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.694 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 28.5 mt -112.86 131.36 55.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.472 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.552 HG21 ' HA2' ' A' ' 118' ' ' GLY . 15.8 t -114.13 113.54 46.4 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.726 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -77.29 116.83 4.22 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.378 1.385 . . . . 0.0 110.326 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -158.85 150.43 20.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.66 -65.49 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.038 0.836 . . . . 0.0 110.884 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.15 23.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.545 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.62 171.85 19.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 110.892 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 73.1 m95 -95.73 126.43 40.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.049 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 35.6 tt0 -103.31 112.14 24.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.064 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.429 ' HA ' HD23 ' A' ' 85' ' ' LEU . 39.4 tt0 -78.14 97.29 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 172.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 84' ' ' PHE . 15.7 m -81.42 -6.63 9.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.63 171.49 15.24 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.077 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.606 ' HG2' HG22 ' A' ' 83' ' ' VAL . 89.8 mtt180 -133.37 137.99 46.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.815 -0.693 . . . . 0.0 109.752 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.5 mt -108.38 128.28 54.63 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -138.39 144.02 40.05 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.185 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.29 -2.73 7.75 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.367 175.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.9 m 71.44 128.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.414 0.626 . . . . 0.0 110.589 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -131.8 129.46 21.97 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.551 ' HD2' ' HG3' ' A' ' 106' ' ' GLU . 27.7 Cg_exo -62.44 166.19 13.79 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.394 2.062 . . . . 0.0 110.502 168.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -55.44 -44.75 76.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.489 0.185 . . . . 0.0 111.39 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.18 85.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 120.966 0.412 . . . . 0.0 111.256 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.551 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 11.6 mm-40 -66.95 -54.64 19.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.72 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 111' ' ' LEU . 26.3 t80 -57.92 -42.77 85.5 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.863 -176.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 47' ' ' VAL . 60.4 mt -58.4 -43.75 88.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.387 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.483 ' HZ2' ' HA ' ' A' ' 106' ' ' GLU . 10.3 mtmp? -63.95 -50.17 69.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 114' ' ' VAL . 3.1 pt-20 -75.31 -33.06 61.13 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.615 HD12 ' CE2' ' A' ' 107' ' ' PHE . 4.7 tt -59.57 -43.37 93.63 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 45.1 mtm180 -65.13 -33.05 75.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.519 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.36 -37.74 77.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 110.499 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 110' ' ' GLU . 78.9 t -63.65 -34.53 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.592 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.9 m -57.25 -37.05 71.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.509 . . . . 0.0 110.209 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.2 -37.95 53.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.323 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 9.1 mtpm? -68.11 -10.8 56.79 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.059 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.552 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -63.75 -41.41 98.94 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.708 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.45 -55.05 0.91 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -97.87 87.32 3.97 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.53 -11.02 60.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.472 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.47 120.38 0.55 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.4 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -97.13 -51.35 4.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.003 0.43 . . . . 0.0 110.49 178.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.402 ' H ' ' CD ' ' A' ' 123' ' ' GLU . . . -77.17 92.16 1.04 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -80.74 19.6 0.82 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -178.29 -30.9 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.457 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -163.26 142.58 8.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.256 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -158.85 133.72 8.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -148.74 148.51 30.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 . . . . . 0 C--O 1.243 0.748 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.022 176.531 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 tpp . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.905 0.384 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -124.55 21.95 8.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 52' ' ' GLU . 4.3 tp -55.52 132.66 49.1 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.995 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' A' ' 6' ' ' TYR . 17.1 tpt180 -103.34 116.77 33.06 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.496 -169.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -108.88 127.13 53.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.754 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.56 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 30.1 m-85 -130.52 170.6 10.72 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.127 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 15.1 Cg_exo -69.65 166.65 26.74 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.506 2.137 . . . . 0.0 110.566 171.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.602 ' CD1' HD21 ' A' ' 70' ' ' LEU . 63.0 t80 -44.97 -54.04 14.45 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.8 Cg_exo -59.36 -52.82 4.18 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.881 1.721 . . . . 0.0 113.089 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -66.18 -36.39 82.96 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 120.795 0.331 . . . . 0.0 110.452 -175.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.42 -43.42 93.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.81 -32.03 70.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.64 -46.24 32.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.871 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 56' ' ' VAL . 12.0 tp -59.3 -46.37 88.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 110.305 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.428 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.64 -44.21 96.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 -14.58 59.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.141 -175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -117.92 5.44 12.15 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.548 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.22 37.18 94.11 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.472 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.809 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.7 mmp_? -108.19 175.66 5.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.549 ' SD ' HG22 ' A' ' 86' ' ' VAL . 69.5 mtm -102.62 162.67 12.74 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.97 121.2 58.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.832 0.348 . . . . 0.0 111.043 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 23.0 ttt -96.06 103.28 15.16 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 17.0 t -87.12 101.19 10.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.485 ' HH ' ' HG ' ' A' ' 34' ' ' CYS . 73.8 t80 -92.57 103.0 15.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 84.7 m-85 -81.83 112.23 18.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.254 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.609 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 17.0 p80 -131.29 138.91 49.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.093 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.6 m -94.45 153.12 18.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 164.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 63' ' ' ASP . 1.1 pm0 -85.49 -13.11 50.11 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -105.52 24.39 12.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.684 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.873 ' HB2' ' HB ' ' A' ' 79' ' ' THR . 14.8 p -73.03 161.62 78.52 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.927 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -84.25 -105.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.388 2.059 . . . . 0.0 114.415 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -70.37 -17.52 63.04 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 5.4 t -55.46 -30.89 61.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.015 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -55.03 -31.72 61.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.683 0.277 . . . . 0.0 111.589 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.76 -50.78 8.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.0 tmm? -63.43 -47.2 82.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.632 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.29 -42.48 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.291 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.5 m -68.98 -55.77 9.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.61 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -91.34 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.173 0.511 . . . . 0.0 112.102 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.02 -39.91 69.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.883 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -79.66 -28.45 40.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.763 0.315 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.6 m -88.2 -1.47 58.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -45.25 130.63 5.84 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.858 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.629 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 50.3 Cg_exo -55.66 -35.43 92.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.115 2.543 . . . . 0.0 113.259 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' NE ' ' A' ' 49' ' ' ARG . . . -75.6 -39.44 34.83 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.016 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.455 ' HA ' HD21 ' A' ' 108' ' ' LEU . 61.1 t -65.41 -44.57 94.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.36 0.6 . . . . 0.0 109.588 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.563 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 14.7 t -49.49 -46.91 48.79 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.297 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 77.5 mtm180 -50.31 -39.08 44.74 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.501 ' HB3' HD12 ' A' ' 111' ' ' LEU . 56.5 mt -73.26 -46.53 49.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.64 -35.7 73.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.105 0.478 . . . . 0.0 110.391 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -48.47 -48.5 37.69 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.304 1.041 . . . . 0.0 112.405 -177.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -76.27 -43.18 42.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -167.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.809 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.26 17.94 3.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -129.84 139.63 51.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.548 0.69 . . . . 0.0 111.878 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 14' ' ' LEU . 99.1 t -107.8 116.35 51.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.85 126.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.234 0.54 . . . . 0.0 110.973 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -95.46 117.32 30.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.901 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.3 p -86.41 101.36 13.06 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.1 t -103.88 113.55 41.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.702 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.515 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 3.0 p -91.22 114.31 26.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.237 177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 71' ' ' ALA . 99.4 t -74.16 -19.55 17.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.58 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 5.3 m-20 -82.55 -7.22 59.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.588 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.8 p -111.39 156.16 41.66 Favored Pre-proline 0 C--O 1.22 -0.472 0 O-C-N 122.36 -0.212 . . . . 0.0 111.078 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.588 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 16.2 Cg_endo -50.43 -55.3 4.22 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 124.062 3.175 . . . . 0.0 114.665 -167.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -35.48 76.14 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.199 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -75.97 -32.56 52.79 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.822 174.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 64' ' ' THR . 54.5 mt-30 -62.2 -42.91 99.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.142 0.577 . . . . 0.0 110.477 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.4 -41.55 93.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.274 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.602 HD21 ' CD1' ' A' ' 8' ' ' TYR . 3.9 mp -62.05 -34.88 77.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.234 174.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.539 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -63.78 -38.25 90.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.49 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -84.74 -27.92 26.62 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.891 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -68.88 -51.3 41.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.423 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.1 0.56 46.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.838 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 53.81 76.85 0.2 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.13 0.894 . . . . 0.0 111.161 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG11 ' CB ' ' A' ' 26' ' ' PHE . 61.6 t -128.48 84.01 64.44 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.035 -175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -102.5 105.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.638 2.892 . . . . 0.0 111.631 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 128.4 90.88 0.67 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.519 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.873 ' HB ' ' HB2' ' A' ' 31' ' ' CYS . 25.7 m -82.55 143.35 47.37 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 83.1 Cg_endo -88.76 151.0 30.17 Favored 'Cis proline' 0 C--N 1.35 0.609 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.734 0.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 91.0 m -128.05 129.16 46.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.907 171.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.739 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.2 m-85 -110.11 114.08 27.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.226 -175.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.405 HG22 ' HD3' ' A' ' 97' ' ' ARG . 91.8 t -117.79 128.73 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.962 178.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -113.18 121.71 45.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.757 0.313 . . . . 0.0 110.733 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 94' ' ' GLU . 29.5 mt -110.39 136.16 49.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.726 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.549 HG22 ' SD ' ' A' ' 21' ' ' MET . 14.6 t -109.52 133.99 20.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.412 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 86' ' ' VAL . 4.0 Cg_exo -79.58 118.11 3.81 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.47 2.113 . . . . 0.0 110.63 171.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -133.83 151.47 51.56 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.59 93.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.278 0.561 . . . . 0.0 111.134 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.54 -47.27 0.74 Allowed Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.058 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -176.95 -168.36 0.21 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.855 0.36 . . . . 0.0 110.771 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -97.67 140.35 32.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.858 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.561 ' OE2' ' HB3' ' A' ' 121' ' ' CYS . 24.2 tt0 -124.61 129.38 50.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.449 -175.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 35.5 tt0 -80.33 108.63 14.1 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG22 ' HZ2' ' A' ' 117' ' ' LYS . 5.5 p -104.34 -13.16 9.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.986 -169.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.28 140.63 7.6 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 119.874 -1.155 . . . . 0.0 113.441 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.451 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 18.6 mmt180 -127.36 126.25 42.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.739 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 89.7 mt -131.71 135.7 47.06 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 175.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -137.47 142.78 41.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.559 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.93 138.42 9.96 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.895 175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -76.44 124.41 27.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -141.33 160.57 56.78 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.94 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.81 161.3 22.1 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.54 2.16 . . . . 0.0 111.88 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.537 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 5.4 ptt180 -59.69 -28.92 67.71 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.976 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.2 91.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.945 0.402 . . . . 0.0 110.501 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.1 -47.04 81.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.776 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.06 -46.59 88.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.294 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 94.7 mt -57.46 -38.35 74.34 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.036 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -57.72 -63.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.254 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 114' ' ' VAL . 1.6 mp0 -70.12 -34.61 73.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.538 -175.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 50' ' ' LEU . 2.1 tm? -63.12 -38.55 91.64 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -57.74 -47.76 81.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.633 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 13.1 mm100 -65.26 -36.26 83.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.086 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -61.84 -37.83 79.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.732 0.301 . . . . 0.0 110.318 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.57 -34.38 74.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.537 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.06 -32.43 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.969 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 113' ' ' GLN . 7.9 mtpm? -68.05 -8.62 39.32 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -176.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.28 88.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.148 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.46 13.24 54.52 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.364 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 123' ' ' GLU . . . -157.49 -55.99 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.866 0.365 . . . . 0.0 110.135 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.561 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 61.6 m 73.92 -56.41 0.65 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.861 173.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.46 58.84 0.38 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.517 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -88.32 104.49 16.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.278 0.561 . . . . 0.0 112.242 -172.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.2 60.52 8.7 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.003 171.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -118.68 93.18 4.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.111 0.482 . . . . 0.0 111.344 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -130.05 114.97 16.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.674 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.3 m170 60.79 -92.03 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.917 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 174.44 -173.57 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.66 0.784 . . . . 0.0 109.041 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -120.15 144.76 47.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.954 0.407 . . . . 0.0 111.097 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 . . . . . 0 C--O 1.245 0.857 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.224 168.289 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 p -155.54 -33.54 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.793 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.705 HD21 HD23 ' A' ' 51' ' ' LEU . 56.8 tp -133.6 156.52 47.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.62 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.419 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 2.7 mmp_? -80.66 102.76 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.976 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.406 ' HE1' ' HB3' ' A' ' 3' ' ' LEU . 74.4 m95 -107.85 104.56 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.48 . . . . 0.0 110.235 175.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.696 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -113.52 145.35 33.16 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 31.3 Cg_exo -59.41 166.93 6.93 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 121.975 1.783 . . . . 0.0 111.389 174.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 77.8 t80 -48.71 -50.03 62.62 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -176.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 36.9 Cg_exo -60.76 -55.63 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.702 1.601 . . . . 0.0 111.986 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.1 mp0 -54.14 -44.88 71.75 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.389 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -59.4 -47.45 85.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 0.0 111.279 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.9 -39.96 94.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.69 -36.87 62.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.947 0.404 . . . . 0.0 110.484 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.84 -49.59 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.436 177.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.38 -46.98 68.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.238 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -59.25 -49.01 79.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.017 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -13.96 59.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.863 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -117.0 4.77 12.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.425 -175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.28 41.97 99.65 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.719 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.2 mmp_? -109.19 -179.93 3.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.764 0.316 . . . . 0.0 110.539 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.3 mtp -102.04 155.62 18.07 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 54.0 t -105.95 124.72 61.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.535 ' SD ' HD21 ' A' ' 51' ' ' LEU . 22.0 ttt -107.67 103.24 12.48 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 46.0 t -84.26 105.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -99.15 103.39 15.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.443 -177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.81 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 92.4 m-85 -81.67 115.9 21.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.606 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.467 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 27.8 p80 -120.12 150.42 40.63 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.543 0.527 . . . . 0.0 110.427 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.426 ' H ' HG21 ' A' ' 79' ' ' THR . 47.0 t -143.41 147.91 35.34 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 173.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' OE1' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -88.04 -26.99 22.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.111 0.481 . . . . 0.0 110.212 175.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -72.92 -21.71 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.912 ' HB3' HG22 ' A' ' 79' ' ' THR . 9.4 t -103.93 94.99 7.07 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -78.15 23.42 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.691 2.26 . . . . 0.0 113.453 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.417 ' HD2' ' HD3' ' A' ' 80' ' ' PRO . 2.7 t80 -86.65 -29.79 22.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.893 0.378 . . . . 0.0 111.092 -174.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.407 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . 28.5 p -82.81 -32.79 27.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -55.54 -34.65 64.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -168.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.37 -48.2 65.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.891 0.377 . . . . 0.0 110.759 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.4 ' HB2' ' HB2' ' A' ' 101' ' ' SER . 26.3 ttp -74.51 -44.42 51.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.141 -177.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -57.76 -45.67 85.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.751 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -64.17 -56.93 11.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.648 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -90.81 -70.13 0.7 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.171 0.51 . . . . 0.0 111.959 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.81 -41.97 76.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.797 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.3 tp -81.11 -27.05 35.74 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.25 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 t -92.55 1.11 57.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.356 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -50.82 134.63 27.85 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.074 172.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.578 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 75.0 Cg_exo -52.3 -40.58 69.85 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.139 2.559 . . . . 0.0 113.485 -178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.44 -46.84 18.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.098 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.9 -50.85 78.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.215 0.531 . . . . 0.0 110.392 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 64.0 m -59.84 -38.28 81.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.292 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -63.34 -39.95 95.96 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -176.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.71 HD22 HH22 ' A' ' 54' ' ' ARG . 64.7 mt -63.3 -38.05 89.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.953 0.406 . . . . 0.0 110.571 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.705 HD23 HD21 ' A' ' 3' ' ' LEU . 2.0 tp -70.08 -56.37 7.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.412 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HG3' HH21 ' A' ' 49' ' ' ARG . 5.0 mm-40 -46.05 -40.59 10.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.414 0.686 . . . . 0.0 112.621 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -61.73 -49.7 75.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -170.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.71 HH22 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.79 9.05 3.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -174.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -119.28 138.94 52.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.572 . . . . 0.0 111.042 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.2 t -109.32 116.04 51.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 171.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.621 HG21 HD21 ' A' ' 3' ' ' LEU . 19.6 t -87.26 119.49 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.554 -174.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.696 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.21 117.48 28.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.852 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 p -83.2 100.33 10.51 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.644 HG11 HD23 ' A' ' 70' ' ' LEU . 59.0 t -111.33 124.3 67.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.696 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.462 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -95.41 118.14 31.61 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.62 -178.339 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.7 t -87.87 10.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 122.74 1.257 . . . . 0.0 108.328 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.474 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -97.37 -24.24 15.73 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.432 175.364 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.578 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 42.4 p -108.58 152.97 42.4 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.857 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 27.2 Cg_endo -55.86 -51.57 9.37 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.042 3.161 . . . . 0.0 114.778 -168.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.4 -37.05 85.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.634 -177.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -73.49 -37.3 53.45 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.329 -0.939 . . . . 0.0 111.335 173.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 64' ' ' THR . 93.4 mt-30 -61.91 -32.07 72.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.488 0.661 . . . . 0.0 110.466 174.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 72' ' ' ARG . 6.0 tp10 -68.87 -43.45 75.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.802 175.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.644 HD23 HG11 ' A' ' 60' ' ' VAL . 23.5 tp -63.59 -31.18 72.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.807 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.53 -36.14 81.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.621 175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.425 HH21 ' CD ' ' A' ' 69' ' ' GLU . 42.0 mtm180 -65.42 -32.46 74.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.117 0.484 . . . . 0.0 110.041 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -66.04 -53.29 40.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.227 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.82 2.07 56.96 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 61.7 56.22 2.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.497 0.665 . . . . 0.0 109.947 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.447 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 55.3 t -104.45 136.33 19.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.907 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.0 Cg_exo -73.97 -143.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.233 2.622 . . . . 0.0 111.265 171.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -80.16 -71.57 1.26 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.514 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.912 HG22 ' HB3' ' A' ' 31' ' ' CYS . 14.3 t 176.7 158.42 0.46 Allowed Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.692 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 12.4 Cg_endo -87.84 127.21 8.64 Favored 'Cis proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.21 -1.162 . . . . 0.0 112.385 -1.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.81 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 7.2 m -115.95 119.65 36.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.36 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.609 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 6.1 m-85 -108.14 112.11 24.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.032 -177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.576 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 80.4 t -113.81 107.36 22.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HE1' HD12 ' A' ' 98' ' ' LEU . 96.3 m-85 -93.98 123.2 37.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.609 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.1 mt -114.56 140.51 48.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 0.0 111.211 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.31 123.31 37.08 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.408 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 5.7 Cg_exo -77.7 118.0 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.398 2.066 . . . . 0.0 110.286 171.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 93' ' ' GLU . 24.2 pttm -128.18 112.62 14.74 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 0.0 111.05 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 65.75 -80.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.547 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 23.05 1.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.09 155.1 43.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.824 0.345 . . . . 0.0 110.452 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.44 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 91.6 m95 -90.94 163.62 14.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.343 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 9.7 tp10 -148.1 140.85 24.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.681 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.465 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 37.2 tt0 -94.13 104.65 16.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -89.78 -12.5 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.616 -170.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.94 144.79 5.08 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.366 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 99.2 mtt180 -113.9 128.02 56.22 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 96.0 mt -121.72 141.83 50.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -137.66 143.93 41.59 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.326 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.21 141.37 11.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.403 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 37' ' ' MET . 3.3 p -70.21 122.45 19.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 23.4 mmt85 -108.03 142.11 24.57 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.519 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -58.92 158.25 25.63 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.022 1.815 . . . . 0.0 110.183 168.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -54.4 -49.05 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.087 -0.245 . . . . 0.0 111.567 -174.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.66 -31.48 72.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.39 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.535 ' OE1' ' HD2' ' A' ' 102' ' ' ARG . 4.5 tm-20 -76.05 -48.39 21.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 67.0 t80 -66.4 -36.76 83.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 108' ' ' LEU . 40.8 mt -62.64 -35.43 79.59 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.619 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 24.0 ttpp -60.34 -49.17 78.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 114' ' ' VAL . 4.3 mm-40 -64.1 -47.2 80.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.19 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 34.9 tp -62.62 -38.54 90.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.893 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 4.7 tpm_? -58.08 -41.91 84.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.11 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.403 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 5.9 tt0 -66.1 -56.72 10.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.008 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 110' ' ' GLU . 99.1 t -58.47 -39.92 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.252 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.457 ' CB ' HH21 ' A' ' 54' ' ' ARG . 22.8 p -63.07 -24.17 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 0.0 111.193 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.6 t -84.84 -33.52 8.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.352 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 113' ' ' GLN . 32.7 mmmt -62.94 -21.43 66.06 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.322 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.08 -17.58 77.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.58 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.17 -67.42 0.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.491 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -87.21 73.87 9.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.4 0.619 . . . . 0.0 109.725 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 38.7 t -70.5 -18.34 62.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.908 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 124' ' ' GLY . . . 118.26 3.61 14.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.525 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 71.66 -34.51 0.3 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.37 0.668 . . . . 0.0 112.338 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 122' ' ' GLY . . . 88.61 -4.84 85.1 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.005 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -159.83 27.53 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.666 0.269 . . . . 0.0 110.947 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -72.21 94.17 1.53 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.831 0.348 . . . . 0.0 110.417 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -136.15 101.46 4.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.973 0.416 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -83.03 91.64 7.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.385 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -105.1 12.26 32.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.161 0.505 . . . . 0.0 110.009 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 p80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.834 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 t -76.05 77.25 2.9 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.452 HD11 ' CB ' ' A' ' 51' ' ' LEU . 30.1 tp -56.35 141.75 40.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.301 -173.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.423 HH21 ' CD ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -79.52 102.41 8.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.319 -178.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 75.2 m95 -106.73 125.92 51.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.115 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.3 m-85 -130.62 153.38 81.48 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 24.5 Cg_exo -61.6 161.47 24.39 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.789 1.659 . . . . 0.0 110.667 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.543 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 75.6 t80 -46.92 -51.11 41.66 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.4 Cg_exo -58.7 -52.5 5.22 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 121.694 1.596 . . . . 0.0 112.23 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 37.5 mt-10 -62.23 -38.89 90.93 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.455 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.17 78.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 0.0 111.6 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.437 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.4 mm? -62.88 -40.57 97.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.931 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.28 -37.28 63.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.23 0.538 . . . . 0.0 110.31 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -60.57 -50.11 74.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.822 178.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.47 88.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.432 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 24.2 tp60 -62.65 -46.28 88.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.662 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.21 -14.49 58.39 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.918 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -114.6 3.49 14.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.41 -176.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.37 38.66 96.09 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.594 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.4 mmp_? -107.46 177.21 4.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.443 ' SD ' HG22 ' A' ' 86' ' ' VAL . 8.0 mmm -100.5 160.33 14.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.5 t -105.6 124.74 60.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 111.159 -174.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.588 ' SD ' HG13 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -113.4 103.65 11.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.601 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -92.33 109.29 21.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.833 0.349 . . . . 0.0 110.093 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 84.0 t80 -103.86 103.62 13.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.462 0.649 . . . . 0.0 111.028 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.865 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 54.6 m-85 -84.64 116.1 23.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.082 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.702 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 24.3 p80 -124.54 138.3 54.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.051 0.453 . . . . 0.0 111.039 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 39.2 t -100.46 141.47 33.27 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.026 168.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -64.65 -25.1 67.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 172.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -102.59 16.27 26.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.095 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 79' ' ' THR . 50.6 t -70.81 112.02 11.77 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.913 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.06 -67.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.484 2.789 . . . . 0.0 114.905 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -86.69 -19.49 29.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -167.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.574 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 17.1 t -70.9 -22.85 62.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -169.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -30.06 59.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.079 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -71.29 -44.53 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.221 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.547 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 51.8 ttm -66.73 -49.18 66.83 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.358 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -54.09 -44.7 71.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.233 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.5 m -72.93 -59.77 2.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.659 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.45 -67.72 0.83 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.023 0.44 . . . . 0.0 112.153 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.547 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 98.9 t -55.14 -51.59 53.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -168.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.5 tp -81.74 -21.9 37.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.769 0.319 . . . . 0.0 111.481 -170.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.6 m -92.55 -10.58 37.11 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.087 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -47.28 133.26 9.64 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.625 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.35 -33.77 57.61 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.138 2.559 . . . . 0.0 113.573 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.56 -52.41 7.38 Favored Glycine 0 CA--C 1.51 -0.247 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.01 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.445 HG22 HD21 ' A' ' 108' ' ' LEU . 62.6 t -58.38 -51.3 73.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.642 0.734 . . . . 0.0 110.184 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -52.74 -44.11 66.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.711 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 49' ' ' ARG . 45.0 ttm180 -59.39 -38.45 80.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.256 0.347 . . . . 0.0 111.598 -176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.53 HD12 HD23 ' A' ' 111' ' ' LEU . 50.2 mt -64.0 -39.88 95.11 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.623 177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.43 -52.9 13.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.094 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 3' ' ' LEU . 6.1 mm-40 -48.84 -43.12 38.28 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.092 0.557 . . . . 0.0 112.32 -176.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.09 -57.02 13.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.615 ' HD3' ' CE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.13 22.75 3.26 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -171.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.615 ' CE1' ' HD3' ' A' ' 54' ' ' ARG . 50.5 m-85 -133.23 142.02 48.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.417 0.627 . . . . 0.0 111.58 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.485 HG11 ' HB3' ' A' ' 14' ' ' LEU . 82.6 t -108.01 118.91 56.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.664 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.588 HG13 ' SD ' ' A' ' 23' ' ' MET . 17.9 t -92.23 120.63 41.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.03 0.443 . . . . 0.0 110.851 -173.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -89.95 118.17 29.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.746 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.3 p -90.07 101.32 14.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 110.039 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.534 HG11 ' HG ' ' A' ' 70' ' ' LEU . 57.3 t -111.06 120.0 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.739 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 9.8 m -88.83 109.12 19.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 8.9 p -86.48 6.9 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.466 0.65 . . . . 0.0 111.262 -170.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.524 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 5.0 m-20 -90.2 -30.65 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.203 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.647 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -92.5 165.58 19.04 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.154 -175.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.647 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.65 -50.24 14.6 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.565 2.844 . . . . 0.0 114.38 -171.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.477 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -70.85 -30.08 66.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -76.6 -33.57 47.03 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.99 172.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.701 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 40.5 mm-40 -63.83 -36.74 84.92 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -55.05 -52.57 62.78 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.901 170.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.534 ' HG ' HG11 ' A' ' 60' ' ' VAL . 3.1 mm? -53.74 -38.36 64.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.121 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' ' CG2' ' A' ' 62' ' ' VAL . . . -71.32 -34.17 70.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.635 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.701 ' HD2' ' O ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -72.14 -40.88 67.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.188 0.518 . . . . 0.0 110.475 174.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -63.11 -55.49 24.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.238 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.66 -15.87 40.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.212 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 67.55 37.55 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.764 0.665 . . . . 0.0 110.727 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -134.44 147.75 64.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.724 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.35 -150.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.218 1.946 . . . . 0.0 111.185 165.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.426 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . -159.63 56.94 0.33 Allowed Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.806 ' HA ' ' SG ' ' A' ' 31' ' ' CYS . 11.5 p -130.12 46.14 2.1 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -167.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 34.1 Cg_endo -94.4 172.79 15.78 Favored 'Cis proline' 0 C--N 1.353 0.813 0 CA-C-N 120.731 1.297 . . . . 0.0 111.215 -5.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.865 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 36.1 m -132.83 129.26 38.25 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.613 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CZ ' ' HG2' ' A' ' 80' ' ' PRO . 2.1 m-85 -124.66 114.56 19.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.99 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.14 119.17 61.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.883 0.373 . . . . 0.0 110.152 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -99.65 126.68 45.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.55 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 23.5 mt -117.04 144.87 44.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.069 0.461 . . . . 0.0 111.239 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.443 HG22 ' SD ' ' A' ' 21' ' ' MET . 90.2 t -109.15 125.91 30.45 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.372 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 74.2 Cg_endo -79.04 117.93 3.96 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.043 1.829 . . . . 0.0 110.839 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -130.06 109.41 10.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.202 0.525 . . . . 0.0 110.849 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.02 -82.06 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.674 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.56 20.37 1.67 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -144.01 157.8 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 89.3 m95 -92.56 169.93 10.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.655 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.5 tp10 -145.21 139.1 26.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.21 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.475 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 33.8 tt0 -95.2 103.19 15.03 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.8 p -99.74 9.04 8.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.689 -168.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.94 146.21 4.34 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.505 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.432 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 77.5 mtt180 -120.94 127.37 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.471 HD22 ' NH1' ' A' ' 102' ' ' ARG . 84.3 mt -111.45 128.78 56.1 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -136.96 143.27 42.76 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.605 0.241 . . . . 0.0 110.398 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 99.66 146.05 19.22 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.477 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 m -83.33 107.46 15.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.604 0.716 . . . . 0.0 110.601 -178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.591 ' NH1' ' HG3' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -108.68 152.34 42.16 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.04 178.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.87 158.61 13.58 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.797 2.331 . . . . 0.0 111.974 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.453 ' HB2' HG13 ' A' ' 41' ' ' VAL . 16.1 ttt-85 -60.92 -31.66 71.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.51 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.59 -45.1 94.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.147 0.499 . . . . 0.0 110.054 175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.87 -42.92 94.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.902 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.31 -47.38 79.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.776 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 28.9 mt -61.72 -38.57 88.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.555 0.217 . . . . 0.0 110.795 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 20.8 tttm -56.06 -56.03 25.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.647 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.591 ' HG3' ' NH1' ' A' ' 102' ' ' ARG . 6.8 mm-40 -63.96 -44.96 91.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 50' ' ' LEU . 35.0 tp -55.48 -47.87 75.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.425 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -64.46 -39.58 94.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.516 178.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 15.9 mm100 -70.49 -23.48 62.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.341 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 110' ' ' GLU . 73.8 t -73.41 -41.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 172.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 55.1 m -58.77 -37.73 76.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.493 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 112' ' ' ARG . 68.1 t -63.58 -40.0 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.977 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.852 ' HA ' ' HA ' ' A' ' 121' ' ' CYS . 62.7 mttp -64.03 -41.77 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.162 -177.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.29 -14.16 82.84 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.565 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -100.08 -35.51 4.48 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.874 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.9 -31.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.68 -0.306 . . . . 0.0 111.509 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.852 ' HA ' ' HA ' ' A' ' 117' ' ' LYS . 47.4 t 71.49 -63.1 0.44 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.368 0.667 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 117.42 39.39 0.79 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.597 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -57.25 164.69 1.66 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.477 0.656 . . . . 0.0 112.529 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.56 -43.92 3.23 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.141 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -68.86 -32.67 72.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 111.267 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -84.01 30.46 0.52 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.225 0.536 . . . . 0.0 111.146 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -85.15 -14.34 47.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.123 0.487 . . . . 0.0 109.691 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -126.66 14.57 7.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.259 0.552 . . . . 0.0 110.083 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -160.54 143.79 13.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.616 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 . . . . . 0 C--O 1.248 1.009 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.36 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tmm? . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 t -145.11 83.36 1.68 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.475 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 15.1 tp -56.11 123.5 14.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.898 -173.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -90.55 103.98 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.546 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.407 ' HE3' ' HB3' ' A' ' 59' ' ' SER . 52.5 m95 -99.7 129.89 45.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.428 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 38.2 m-85 -131.49 167.12 23.31 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.083 171.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 15.0 Cg_exo -68.09 163.05 37.45 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.965 1.777 . . . . 0.0 110.974 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.584 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.9 t80 -47.53 -52.97 33.39 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 49.0 Cg_exo -57.62 -49.74 12.56 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.972 1.781 . . . . 0.0 112.935 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -66.14 -42.61 88.83 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.19 -42.03 72.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 0.0 111.528 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.47 -37.76 77.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.938 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.6 -43.67 63.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.638 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.85 -45.66 91.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.97 0.415 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.13 -47.76 81.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.687 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -63.45 -43.02 98.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.069 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.02 -14.59 55.7 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -118.43 6.61 11.81 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.564 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.4 39.42 97.73 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.76 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 2.3 mmp_? -110.53 -179.99 3.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.582 ' SD ' HG22 ' A' ' 86' ' ' VAL . 56.0 mtm -110.58 160.22 16.85 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 93.5 t -106.07 127.93 60.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.66 0.267 . . . . 0.0 111.52 -174.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.2 ttt -105.69 103.15 12.6 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 171.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.553 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 41.1 t -86.79 107.53 16.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.499 ' HE1' ' HE2' ' A' ' 82' ' ' PHE . 65.4 t80 -98.99 103.65 15.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.569 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 88.3 m-85 -82.71 115.07 21.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.177 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.692 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 32.5 p80 -123.17 138.8 54.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.646 ' H ' HG21 ' A' ' 79' ' ' THR . 24.0 t -117.99 163.64 16.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.954 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -76.69 -2.43 32.81 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.586 0.708 . . . . 0.0 109.522 175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -112.17 14.45 20.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.475 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 30.4 p -76.8 129.95 77.54 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.834 0.349 . . . . 0.0 111.457 -174.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.62 -78.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.649 2.232 . . . . 0.0 113.829 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.541 ' CE2' ' HB2' ' A' ' 37' ' ' MET . 89.3 t80 -86.08 -17.45 35.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.701 0.286 . . . . 0.0 111.48 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.638 ' HB3' ' HB2' ' A' ' 31' ' ' CYS . 12.9 t -47.73 -44.36 27.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.133 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -57.35 -33.32 67.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.05 -45.97 13.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.902 0.382 . . . . 0.0 110.508 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.697 ' HG2' ' HB ' ' A' ' 41' ' ' VAL . 10.9 tmm? -65.42 -40.94 93.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.344 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' HB2' ' OH ' ' A' ' 25' ' ' TYR . 7.2 t30 -59.41 -41.24 89.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.32 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.3 m -77.17 -56.51 4.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -90.13 -64.65 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.146 0.498 . . . . 0.0 111.803 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.697 ' HB ' ' HG2' ' A' ' 37' ' ' MET . 77.8 t -55.71 -44.23 76.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.405 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.5 tp -81.27 -13.96 57.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.861 0.362 . . . . 0.0 111.194 -172.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -100.36 -6.78 25.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.684 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -47.19 135.55 8.94 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.746 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 80.8 Cg_exo -49.68 -45.45 31.53 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.351 2.701 . . . . 0.0 113.623 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.41 -45.64 67.69 Favored Glycine 0 CA--C 1.51 -0.254 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.111 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.707 HG22 HD21 ' A' ' 108' ' ' LEU . 43.4 t -59.41 -47.78 89.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 121.648 0.737 . . . . 0.0 109.778 174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.557 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 23.5 t -52.86 -43.14 65.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.387 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 82.7 mtt180 -62.27 -21.38 65.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.447 HD12 HD22 ' A' ' 108' ' ' LEU . 23.3 mt -80.39 -38.11 30.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.756 174.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.32 -50.53 11.63 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 48' ' ' SER . 7.1 mm-40 -44.38 -47.69 9.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.783 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -67.98 -48.27 66.27 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -168.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.783 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -134.44 16.45 3.7 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -168.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -125.18 141.01 52.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.393 0.616 . . . . 0.0 111.688 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 11' ' ' ALA . 46.2 t -106.6 114.95 47.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.94 121.07 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.806 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -94.58 117.6 30.38 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.53 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.407 ' HB3' ' HE3' ' A' ' 5' ' ' TRP . 22.3 p -85.83 101.61 12.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.92 109.07 23.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.956 0.407 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.641 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -94.96 107.87 19.91 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.158 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 28' ' ' SER . 38.3 t -75.04 -8.29 11.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.292 1.044 . . . . 0.0 108.549 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.2 -31.69 72.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.041 176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.62 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -125.11 163.51 37.39 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.069 -174.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.62 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.8 Cg_endo -50.75 -47.76 23.71 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.323 3.349 . . . . 0.0 114.85 -169.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.416 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -61.99 -36.44 81.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.082 -176.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -82.47 -31.8 29.6 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.559 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 64' ' ' THR . 96.9 mt-30 -59.22 -38.0 78.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.514 0.673 . . . . 0.0 109.479 171.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 6.0 tp10 -61.51 -50.6 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.97 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 66' ' ' GLU . 3.5 mm? -58.68 -40.25 83.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.686 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.62 -50.25 73.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.49 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.863 0.363 . . . . 0.0 110.266 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 30.4 ttt85 -65.12 -56.02 15.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.221 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.55 3.29 55.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.565 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.0 mmt-85 58.47 64.75 1.39 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.623 0.577 . . . . 0.0 109.714 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.55 92.92 48.79 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -102.31 129.03 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.712 2.941 . . . . 0.0 112.052 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 140.23 -85.09 0.21 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.853 -1.165 . . . . 0.0 112.834 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.692 ' CG2' ' HA ' ' A' ' 27' ' ' HIS . 85.0 m 75.07 137.21 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 122.49 0.316 . . . . 0.0 111.325 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HA ' HG23 ' A' ' 79' ' ' THR . 70.1 Cg_endo -76.52 137.48 49.33 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.724 -1.365 . . . . 0.0 112.881 0.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.569 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 32.7 m -124.69 129.06 49.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.997 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' HE1' ' CA ' ' A' ' 100' ' ' GLY . 1.4 m-85 -115.27 122.07 44.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.044 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.8 t -121.47 108.31 22.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.881 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HE1' HD12 ' A' ' 98' ' ' LEU . 59.1 m-85 -94.34 120.07 34.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.043 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 94' ' ' GLU . 32.4 mt -109.22 130.66 55.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.663 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.582 HG22 ' SD ' ' A' ' 21' ' ' MET . 22.6 t -108.56 123.91 35.94 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.378 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.5 117.69 4.38 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.901 1.734 . . . . 0.0 110.559 172.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -157.67 143.29 17.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.739 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.18 -77.39 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.988 0.805 . . . . 0.0 111.43 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.18 24.38 0.13 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.797 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -158.42 -177.48 6.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.687 0.28 . . . . 0.0 110.453 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -105.07 132.62 51.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.427 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.11 119.71 40.11 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.266 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.525 ' HA ' HD23 ' A' ' 85' ' ' LEU . 39.9 tt0 -77.0 95.96 4.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.75 -7.46 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.094 -169.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.74 118.3 0.6 Allowed Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.796 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.479 ' HG3' HG22 ' A' ' 83' ' ' VAL . 16.7 ttm180 -108.92 126.67 53.33 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 86.1 mt -124.41 139.03 54.28 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.032 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -102.58 117.13 34.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 164.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.568 ' CA ' ' HE1' ' A' ' 82' ' ' PHE . . . -90.78 -134.27 5.86 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.461 -167.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 33' ' ' TYR . 23.0 m 75.67 -12.09 1.03 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.793 0.837 . . . . 0.0 110.578 -173.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 100' ' ' GLY . 62.1 mtp180 -65.25 156.31 81.77 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.247 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.49 155.55 25.4 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.675 2.25 . . . . 0.0 111.543 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.51 ' HB3' HG13 ' A' ' 41' ' ' VAL . 30.8 ptt180 -67.62 -25.12 65.59 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.083 -174.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.6 74.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.107 0.479 . . . . 0.0 109.956 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 21.7 mm-40 -75.25 -37.88 60.81 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.388 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.63 -47.95 83.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.638 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.707 HD21 HG22 ' A' ' 47' ' ' VAL . 88.6 mt -68.16 -31.43 70.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.732 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' HB3' ' A' ' 109' ' ' LYS . 5.0 tmmm? -63.15 -47.9 80.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.951 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 5.4 mm-40 -69.92 -41.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.695 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 111' ' ' LEU . 4.1 tt -61.16 -36.32 79.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -63.46 -45.07 92.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.23 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 5.5 pt20 -62.81 -38.43 90.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.923 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.437 ' N ' ' HG3' ' A' ' 113' ' ' GLN . 69.9 t -66.78 -42.68 89.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.683 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 52.4 t -57.22 -30.48 64.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.864 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.3 t -84.15 -53.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.873 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -59.15 -28.13 66.29 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.463 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -62.46 -41.42 99.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.505 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -96.15 -36.42 5.2 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.755 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -130.52 98.12 4.58 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 2.6 p -84.74 -31.92 23.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.131 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.31 36.6 0.13 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.681 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.46 -72.82 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.47 43.35 77.24 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.669 175.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -144.29 151.15 38.98 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.554 -0.38 . . . . 0.0 110.8 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -159.05 160.4 35.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -59.78 119.19 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -82.3 93.74 7.2 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.567 -173.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -106.82 -5.82 18.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 164.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.7 t60 . . . . . 0 C--O 1.24 0.588 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.752 176.498 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 121.043 0.449 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -106.17 -30.69 9.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.283 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 57' ' ' VAL . 24.6 tp -79.05 149.36 32.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.724 -172.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.678 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 5.4 mmt180 -88.34 104.64 16.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.328 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -106.38 104.63 14.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.104 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.678 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 96.8 m-85 -111.12 157.39 38.95 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 19.3 Cg_exo -63.48 162.02 29.14 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.957 1.771 . . . . 0.0 111.172 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.607 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 87.3 t80 -45.82 -55.73 12.03 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.8 Cg_exo -65.0 -41.52 16.89 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.654 1.569 . . . . 0.0 112.126 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 37.1 tt0 -70.13 -36.92 75.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.847 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.68 86.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.997 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.91 -39.67 92.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.653 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.62 -38.08 70.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.778 0.323 . . . . 0.0 110.651 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.557 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -59.67 -50.08 75.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -65.52 -45.57 83.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.978 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -58.85 -46.63 87.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.729 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -14.32 58.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.933 -175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -115.29 0.37 13.46 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.686 -175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.72 41.36 97.7 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.355 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.873 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 76.6 mmt-85 -112.87 178.44 4.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 0.0 111.946 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 69.7 mtp -101.46 154.36 18.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.345 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 48.5 t -106.19 135.05 45.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.801 0.334 . . . . 0.0 110.786 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.1 ttt -118.17 103.21 9.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 38.9 t -89.58 111.18 22.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.4 t80 -102.92 109.15 20.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.435 0.636 . . . . 0.0 111.006 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 1.023 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.8 m-85 -85.49 118.87 25.28 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.563 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.554 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 29.3 p80 -133.89 163.93 28.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.943 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 22.6 m -143.36 149.68 38.08 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.555 174.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.1 -39.53 86.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -84.26 4.61 30.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.397 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 9.0 t -134.83 65.73 66.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -85.83 31.98 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.004 2.469 . . . . 0.0 114.476 -165.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -83.35 -58.11 2.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.865 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.821 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 46.6 t -74.6 -22.34 59.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -67.04 -19.75 65.74 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.296 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -69.7 -47.87 61.62 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 169.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 28.1 mtm -61.99 -35.76 79.48 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.299 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 7.3 t30 -56.24 -43.67 78.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.708 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' SER . 30.7 m -65.17 -49.73 68.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.515 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -90.87 -70.91 0.66 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.325 0.583 . . . . 0.0 111.375 -178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' A' ' 104' ' ' ARG . 71.1 t -56.04 -51.77 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.753 -173.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.6 tp -81.87 -22.57 36.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -170.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' THR . 62.1 m -93.95 -3.42 51.61 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.059 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.546 ' HB3' HG23 ' A' ' 47' ' ' VAL . 9.6 t70 -48.59 129.13 13.76 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.544 174.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.99 -36.61 76.43 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.127 2.552 . . . . 0.0 113.212 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.43 -34.85 68.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.87 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 44' ' ' ASP . 20.6 t -74.9 -49.0 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.366 0.603 . . . . 0.0 109.598 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.2 t -54.49 -37.03 64.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.886 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -63.31 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 0.0 111.262 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -69.26 -46.01 68.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.476 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.42 ' HA ' ' HB2' ' A' ' 55' ' ' PHE . 2.4 mm? -67.29 -47.25 71.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.15 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -46.01 -41.79 12.35 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.777 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -70.84 -49.95 40.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -171.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.873 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.82 16.38 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.42 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 87.4 m-85 -127.18 143.67 51.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.334 0.588 . . . . 0.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 14' ' ' LEU . 61.6 t -115.72 117.28 55.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 3' ' ' LEU . 15.2 t -91.07 131.76 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.855 -173.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -101.36 119.63 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.49 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -85.22 102.31 13.22 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.227 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -117.72 125.79 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.802 0.334 . . . . 0.0 111.301 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -109.28 121.8 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.519 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 56.5 t -68.97 -16.03 20.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.219 0.533 . . . . 0.0 110.992 -176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 28' ' ' SER . 2.1 m-20 -67.29 -34.49 77.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.909 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 61.5 p -97.04 158.29 33.59 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.024 -174.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 15.1 Cg_endo -51.02 -41.55 56.26 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.636 2.891 . . . . 0.0 113.127 -174.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.538 ' OE2' ' HG2' ' A' ' 65' ' ' PRO . 1.7 mp0 -52.0 -57.75 8.56 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.041 0.448 . . . . 0.0 110.036 175.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.11 -33.06 65.29 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.259 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.615 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 51.3 mt-30 -56.02 -51.14 68.83 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.606 0.362 . . . . 0.0 111.114 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -76.84 -29.41 55.87 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.777 -176.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.595 HD21 ' CD1' ' A' ' 8' ' ' TYR . 1.7 mp -61.61 -42.23 98.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 0.0 110.549 170.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.26 77.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.799 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 86.5 mtt180 -71.64 -27.44 63.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttm105 -80.96 -52.58 7.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.28 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -85.47 -14.02 47.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.763 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 65.05 78.08 0.29 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 77' ' ' PRO . 54.5 t -135.35 142.01 39.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.451 -171.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.446 ' O ' HG12 ' A' ' 76' ' ' VAL . 9.0 Cg_exo -73.49 -143.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.262 2.641 . . . . 0.0 111.142 169.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.49 -49.31 3.02 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.239 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.692 ' OG1' ' HA ' ' A' ' 80' ' ' PRO . 1.1 t 179.89 160.38 0.83 Allowed Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.821 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 9.9 Cg_endo -88.96 126.75 7.67 Favored 'Cis proline' 0 N--CA 1.456 -0.711 0 C-N-CA 124.246 -1.147 . . . . 0.0 112.035 -1.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 1.023 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.4 m -125.24 108.17 11.47 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.98 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.498 ' HD2' ' HB2' ' A' ' 98' ' ' LEU . 7.6 m-85 -102.67 111.59 23.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.235 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 86.7 t -110.65 108.9 26.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.88 0.372 . . . . 0.0 110.775 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.27 118.44 32.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.891 0.377 . . . . 0.0 110.538 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 32.8 mt -114.25 131.75 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.973 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.3 t -110.61 124.69 32.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.338 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.516 ' HG3' ' CZ3' ' A' ' 92' ' ' TRP . 2.7 Cg_endo -80.38 117.2 3.4 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.166 1.911 . . . . 0.0 110.387 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -146.37 133.81 20.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.406 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.14 -75.67 0.06 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.029 0.831 . . . . 0.0 111.144 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.82 29.49 0.15 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.102 -0.571 . . . . 0.0 111.713 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -150.99 165.53 33.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.587 0.232 . . . . 0.0 110.528 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.516 ' CZ3' ' HG3' ' A' ' 87' ' ' PRO . 80.0 m95 -98.99 126.47 44.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.972 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 26.5 tt0 -106.94 121.38 44.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.445 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.522 ' HA ' HD23 ' A' ' 85' ' ' LEU . 49.0 tt0 -76.25 96.46 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 117' ' ' LYS . 9.7 p -82.62 -14.51 12.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.009 -169.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.16 129.58 1.26 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.304 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.484 ' HG3' HG22 ' A' ' 83' ' ' VAL . 27.7 ttm180 -115.61 127.45 55.22 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 99.0 mt -109.37 133.89 52.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.662 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -136.93 116.54 12.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.65 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.3 173.06 18.86 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.054 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 m -109.98 120.36 42.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.745 0.307 . . . . 0.0 110.327 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 65.0 mtp180 -146.23 147.44 31.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HD2' ' HG3' ' A' ' 106' ' ' GLU . 31.4 Cg_exo -59.39 163.09 13.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.809 2.34 . . . . 0.0 112.085 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.592 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -63.73 -25.97 68.44 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.778 -176.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.61 -42.49 95.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.022 0.439 . . . . 0.0 110.337 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 6.3 mm-40 -64.89 -44.98 87.86 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.464 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.447 ' CE2' HD12 ' A' ' 111' ' ' LEU . 44.7 t80 -62.58 -37.58 86.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.516 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 104' ' ' ARG . 62.3 mt -61.68 -42.24 98.66 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.654 0.264 . . . . 0.0 110.943 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -57.31 -54.23 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.165 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 2.7 mm-40 -65.91 -41.04 91.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.126 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 111' ' ' LEU . 3.8 tt -60.98 -39.51 89.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.667 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 116' ' ' VAL . 12.6 tpt180 -59.23 -41.05 87.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.95 -43.31 75.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.571 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 110' ' ' GLU . 90.1 t -59.46 -39.63 79.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.743 177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -60.12 -40.1 88.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.666 176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 112' ' ' ARG . 97.6 t -66.55 -37.58 79.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.312 0.577 . . . . 0.0 109.997 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 121' ' ' CYS . 34.0 mtpt -72.74 -8.17 54.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.712 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.65 -27.09 11.92 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.259 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.99 -26.1 73.27 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 121' ' ' CYS . . . -151.14 -79.39 0.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 120' ' ' ALA . 48.5 t 157.55 -43.12 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.365 0 O-C-N 124.847 1.342 . . . . 0.0 109.065 172.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.9 30.79 3.57 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -81.98 -16.85 48.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.203 -0.499 . . . . 0.0 110.716 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.45 89.16 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.055 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -137.43 140.94 41.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -131.19 109.17 10.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.724 0.297 . . . . 0.0 110.447 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -93.12 100.61 12.98 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -74.54 91.61 2.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -156.91 145.62 19.9 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 80.6 t60 . . . . . 0 C--O 1.244 0.764 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.845 178.264 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' HG3' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -140.03 133.81 30.53 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 51' ' ' LEU . 14.8 tp -133.22 141.64 48.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.591 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 12.7 mmm180 -91.13 103.12 15.85 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.782 0.325 . . . . 0.0 111.851 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.497 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 46.4 m95 -102.88 113.26 26.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.335 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 90.0 m-85 -118.14 161.8 33.0 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.021 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 16.7 Cg_exo -66.18 160.95 42.46 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.274 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.589 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 91.4 t80 -47.27 -53.84 25.68 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 35.3 Cg_exo -61.42 -46.96 12.93 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.83 1.687 . . . . 0.0 112.355 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -43.97 87.22 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.541 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -54.97 -42.34 72.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.741 0.305 . . . . 0.0 111.478 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.1 -38.69 82.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.05 -41.81 63.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.755 0.312 . . . . 0.0 110.586 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 0.3 OUTLIER -57.42 -40.62 78.73 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.09 -56.07 6.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.935 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 24.9 tt0 -60.46 -49.18 78.58 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.5 -175.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -14.02 59.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 15.7 m-70 -118.3 4.35 11.89 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.295 -175.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.64 34.06 72.43 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.261 176.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 1.6 mmp_? -108.64 178.87 4.35 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.589 -0.359 . . . . 0.0 110.108 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.475 ' SD ' HG22 ' A' ' 86' ' ' VAL . 48.3 mtm -108.06 165.49 11.43 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 42.4 t -105.69 125.04 61.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.85 0.357 . . . . 0.0 110.818 -175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.551 ' SD ' HG13 ' A' ' 57' ' ' VAL . 1.4 tmt? -109.06 103.12 12.07 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.664 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 26.1 t -90.41 111.44 23.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.407 ' HE1' ' HE1' ' A' ' 82' ' ' PHE . 65.7 t80 -99.58 103.49 15.21 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.128 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.723 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 51.4 m-85 -81.39 121.67 26.53 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.639 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 25.4 p80 -135.28 138.54 43.6 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.165 0.915 . . . . 0.0 109.924 177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.426 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 1.5 t -99.39 168.12 10.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.495 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.26 -7.0 44.02 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -114.07 -80.12 0.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.382 -0.199 . . . . 0.0 111.027 174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.651 ' SG ' HG21 ' A' ' 79' ' ' THR . 4.0 m 60.42 152.47 0.1 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.897 0.879 . . . . 0.0 112.915 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.22 -89.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.364 2.043 . . . . 0.0 113.08 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.02 -16.83 54.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 5.8 t -49.5 -52.57 28.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.241 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -57.8 -39.13 76.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.099 0.249 . . . . 0.0 111.613 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -66.84 -50.6 62.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.919 0.39 . . . . 0.0 110.52 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 101' ' ' SER . 30.3 ttp -62.25 -46.13 90.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.744 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.6 -43.07 84.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.498 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.7 m -66.44 -56.77 9.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.638 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -91.89 -70.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.563 0.697 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.599 HG13 ' HA ' ' A' ' 104' ' ' ARG . 94.0 t -52.89 -48.45 51.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.065 -171.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.8 tp -81.41 -15.24 55.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -173.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.496 ' O ' ' HG3' ' A' ' 1' ' ' MET . 70.6 m -95.79 -1.09 50.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.606 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 47' ' ' VAL . 13.0 t70 -47.03 129.17 9.08 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.658 171.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.89 -37.52 85.47 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.131 2.554 . . . . 0.0 113.229 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.87 -42.59 30.28 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.026 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.698 HG22 HD23 ' A' ' 108' ' ' LEU . 8.1 t -66.66 -44.3 89.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -55.24 -40.64 71.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.688 178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -70.22 -21.37 63.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.85 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 108' ' ' LEU . 72.5 mt -70.16 -44.56 68.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 173.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 3' ' ' LEU . 3.1 mm? -66.54 -60.56 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.361 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' OE1' HD12 ' A' ' 3' ' ' LEU . 9.5 mm-40 -50.08 -34.73 22.77 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -172.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.649 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -64.61 -53.15 52.23 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.649 HH11 ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.38 11.61 3.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -123.28 145.79 48.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.039 0.447 . . . . 0.0 110.959 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 11' ' ' ALA . 22.0 t -107.98 118.09 54.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.551 HG13 ' SD ' ' A' ' 23' ' ' MET . 21.3 t -86.93 117.51 31.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.044 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -92.68 117.28 29.82 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.159 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 42.9 t -88.15 100.57 13.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.538 HG11 HD22 ' A' ' 70' ' ' LEU . 61.2 t -113.57 122.79 68.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.295 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.539 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 4.4 p -85.84 109.4 18.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.374 0.606 . . . . 0.0 109.679 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.59 HG23 ' HB2' ' A' ' 71' ' ' ALA . 5.1 p -88.99 65.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 123.091 1.424 . . . . 0.0 109.008 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.14 -38.7 0.07 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.12 -1.854 . . . . 0.0 109.075 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.653 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 3.1 p -81.63 164.66 48.22 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.511 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.653 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.3 Cg_endo -51.39 -55.23 4.2 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.534 2.823 . . . . 0.0 114.524 -170.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -63.1 -36.63 84.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.585 0.231 . . . . 0.0 111.182 -178.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.38 -34.02 64.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.649 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -71.19 -28.51 64.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.306 0.574 . . . . 0.0 110.714 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.31 -44.83 93.86 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.217 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.538 HD22 HG11 ' A' ' 60' ' ' VAL . 9.0 mp -65.86 -30.9 71.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 174.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB2' HG23 ' A' ' 62' ' ' VAL . . . -67.14 -35.24 79.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.589 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HA ' ' NH2' ' A' ' 75' ' ' ARG . 20.1 ptt180 -83.37 -33.17 25.86 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.314 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HD2' ' CE1' ' A' ' 74' ' ' TYR . 28.4 ttm180 -73.18 -56.67 4.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.526 ' CE1' ' HD2' ' A' ' 73' ' ' ARG . 90.7 m-85 -91.38 -11.89 36.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.329 -174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.741 ' HA ' ' HE ' ' A' ' 75' ' ' ARG . 1.2 mmp_? 64.74 91.16 0.08 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.686 0.616 . . . . 0.0 110.247 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.457 HG11 ' CG ' ' A' ' 26' ' ' PHE . 39.1 t -129.51 85.85 57.63 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -105.29 125.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.512 2.808 . . . . 0.0 113.196 173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . 124.95 -68.31 0.51 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.422 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.651 HG21 ' SG ' ' A' ' 31' ' ' CYS . 60.3 m 72.26 138.58 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.463 0.305 . . . . 0.0 110.836 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HA ' HG23 ' A' ' 79' ' ' THR . 73.0 Cg_endo -78.51 143.76 73.07 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.707 0.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.723 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 35.5 m -122.77 122.66 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.038 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.648 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 9.7 m-85 -106.51 122.9 47.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.053 -175.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.664 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 45.2 t -124.11 105.43 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.232 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.04 118.89 32.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.327 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 94' ' ' GLU . 38.6 mt -113.11 137.28 51.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.521 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.475 HG22 ' SD ' ' A' ' 21' ' ' MET . 13.5 t -108.28 135.87 19.9 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.968 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.21 115.39 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.405 1.403 . . . . 0.0 108.794 166.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.86 111.28 5.64 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.831 0.348 . . . . 0.0 110.572 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.22 18.25 11.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.142 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.05 -23.64 34.83 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.852 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.87 -175.53 3.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.693 0.283 . . . . 0.0 110.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 95.0 m95 -115.7 136.9 52.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.472 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 32.4 tt0 -122.37 125.22 45.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.548 ' HA ' HD23 ' A' ' 85' ' ' LEU . 35.5 tt0 -78.58 95.98 5.35 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.538 HG22 ' HD3' ' A' ' 117' ' ' LYS . 1.4 p -102.38 -11.9 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.836 -170.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.72 104.48 0.36 Allowed Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.744 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.517 ' HD3' ' CD ' ' A' ' 94' ' ' GLU . 8.5 tpt180 -111.97 124.76 53.08 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 88.9 mt -137.62 143.54 41.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.756 0.312 . . . . 0.0 110.436 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -137.82 133.16 33.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.71 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.02 149.2 15.65 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.586 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.493 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 49.2 m -76.02 151.12 37.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.586 0.231 . . . . 0.0 110.872 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.843 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 16.9 mmt-85 -130.96 165.66 33.27 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.633 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 106' ' ' GLU . 21.5 Cg_exo -67.96 154.68 72.16 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.272 1.981 . . . . 0.0 109.808 162.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.599 ' HA ' HG13 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -57.41 -42.95 83.28 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -170.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.616 ' HA ' ' HG ' ' A' ' 108' ' ' LEU . . . -79.76 -27.2 40.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.384 -175.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 25.4 mm-40 -76.9 -38.46 53.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.843 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 86.8 t80 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.042 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.698 HD23 HG22 ' A' ' 47' ' ' VAL . 4.3 pp -68.12 -22.95 64.86 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.629 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.409 ' N ' HD12 ' A' ' 108' ' ' LEU . 37.6 ttmt -67.14 -53.81 27.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.856 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.619 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 8.3 pt-20 -71.56 -32.13 67.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.195 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD12 ' CE2' ' A' ' 107' ' ' PHE . 5.9 tt -59.21 -42.53 91.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 172.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 116' ' ' VAL . 43.9 ttt180 -59.92 -43.7 94.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.252 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 110' ' ' GLU . 0.6 OUTLIER -67.97 -23.43 65.04 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.836 0.351 . . . . 0.0 110.327 -179.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 110' ' ' GLU . 93.9 t -81.73 -36.75 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 173.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.2 t -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.026 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 112' ' ' ARG . 57.9 t -65.72 -30.18 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.538 ' HD3' HG22 ' A' ' 95' ' ' VAL . 63.2 mttp -69.83 -17.28 63.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.274 -176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.5 -18.97 68.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.557 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -123.16 15.32 8.24 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -165.92 83.5 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.22 0.533 . . . . 0.0 110.05 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 10.7 p -124.04 15.39 9.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.251 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.05 26.03 17.7 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.958 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -83.93 -175.18 5.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.715 0.293 . . . . 0.0 110.441 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.17 52.29 2.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.334 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.83 -24.92 61.78 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.506 0.322 . . . . 0.0 110.412 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 45.4 m80 71.8 170.09 0.32 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.72 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -144.75 113.41 6.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.759 176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -80.54 -7.34 59.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.196 0.522 . . . . 0.0 110.202 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -134.64 143.71 47.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.17 176.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 . . . . . 0 C--O 1.243 0.74 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.216 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 m -88.05 167.64 13.5 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 174.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -55.75 155.01 6.26 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.596 0.712 . . . . 0.0 112.484 -173.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 36.7 mmt-85 -87.71 108.91 19.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.746 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.51 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.8 m95 -111.15 109.17 19.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 87.3 m-85 -124.31 156.36 67.03 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -58.53 159.75 19.1 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.935 1.757 . . . . 0.0 111.198 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.582 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 90.1 t80 -45.38 -54.02 16.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -177.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.7 Cg_exo -63.91 -39.74 31.46 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 121.643 1.562 . . . . 0.0 112.179 -178.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.19 -36.97 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.832 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.37 -48.31 70.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.038 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.532 HD13 HG21 ' A' ' 22' ' ' VAL . 4.3 mm? -56.45 -42.67 78.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.695 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.12 63.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.074 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' HB3' HG11 ' A' ' 56' ' ' VAL . 9.4 tp -61.11 -51.04 70.78 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -64.18 -38.67 91.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.681 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.441 ' HB2' ' CZ2' ' A' ' 92' ' ' TRP . 48.9 tt0 -65.86 -42.35 90.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.877 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.43 -16.04 44.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -112.06 2.11 16.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.753 -175.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.4 40.56 97.89 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.296 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -108.54 179.67 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 110.412 178.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 85.5 mtp -104.82 154.98 19.33 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 12' ' ' LEU . 85.0 t -106.15 130.54 57.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.412 . . . . 0.0 111.324 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.42 103.61 11.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.397 173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 21.6 t -84.54 113.7 23.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CD2' ' HZ3' ' A' ' 5' ' ' TRP . 56.7 t80 -104.48 106.67 17.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.995 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.08 125.61 37.76 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.892 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -141.93 160.93 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.474 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.645 ' HB2' ' HB2' ' A' ' 31' ' ' CYS . 3.4 m -142.11 150.92 41.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.89 -40.77 83.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 172.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -82.16 1.53 35.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.8 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 86.0 m -132.86 68.05 78.47 Favored Pre-proline 0 N--CA 1.445 -0.723 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.175 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 35' ' ' GLN . 91.4 Cg_endo -81.39 38.49 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.076 2.517 . . . . 0.0 114.178 -167.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -73.61 -43.06 60.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.155 0.502 . . . . 0.0 111.124 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 16.1 t -77.46 -19.16 56.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.34 -176.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 32' ' ' PRO . 15.8 mm100 -54.81 -26.25 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.78 -32.16 31.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.468 0.652 . . . . 0.0 110.424 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.2 ttm -78.97 -46.14 18.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.751 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.589 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 32.0 p30 -66.36 -21.07 66.23 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 m -78.68 -59.11 2.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.814 0.34 . . . . 0.0 110.932 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -91.23 -70.19 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.202 0.525 . . . . 0.0 111.932 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 104' ' ' ARG . 58.8 t -54.98 -49.53 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.873 -170.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 25.0 tp -81.57 -21.48 38.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.465 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -95.34 -2.22 49.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.703 0.287 . . . . 0.0 110.609 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -50.81 133.26 28.49 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.226 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.33 -44.27 39.78 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.246 2.631 . . . . 0.0 113.451 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.35 -45.65 68.21 Favored Glycine 0 CA--C 1.51 -0.263 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.028 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 108' ' ' LEU . 84.6 t -57.73 -48.18 84.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 121.323 0.582 . . . . 0.0 109.845 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.4 m -53.53 -50.91 64.45 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.013 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -54.57 -29.42 51.28 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.839 HD12 HD22 ' A' ' 108' ' ' LEU . 74.9 mt -73.42 -54.02 9.3 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.632 0.253 . . . . 0.0 111.313 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.557 ' HB2' HD21 ' A' ' 3' ' ' LEU . 3.5 mm? -68.74 -39.62 80.26 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.12 -33.75 67.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.736 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -71.56 -49.84 36.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.529 ' HD3' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -136.12 15.25 3.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -173.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 78.4 m-85 -121.2 143.46 49.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.424 0.63 . . . . 0.0 112.073 -177.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 14' ' ' LEU . 47.7 t -111.91 113.7 44.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.297 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.1 t -87.17 127.44 40.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.099 0.476 . . . . 0.0 110.881 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -93.4 117.09 29.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.986 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.7 p -83.82 102.09 12.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.098 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.04 126.03 74.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.028 0.442 . . . . 0.0 110.842 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 64' ' ' THR . 0.9 OUTLIER -113.09 132.64 55.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.468 HG13 ' CB ' ' A' ' 71' ' ' ALA . 46.3 t -79.68 -16.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.421 0.629 . . . . 0.0 111.244 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -76.21 -10.97 59.82 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.951 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.608 ' OG1' ' HD2' ' A' ' 65' ' ' PRO . 5.0 t -114.04 149.17 41.49 Favored Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.402 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.608 ' HD2' ' OG1' ' A' ' 64' ' ' THR . 19.0 Cg_endo -53.14 -50.91 12.36 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 123.523 2.815 . . . . 0.0 114.534 -169.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.25 -31.88 62.75 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.138 -174.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -74.82 -30.42 59.61 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.653 174.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 64' ' ' THR . 4.6 tt0 -69.74 -36.89 76.22 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 176.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -54.34 -48.86 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.205 170.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -59.19 -43.42 92.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.297 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.468 ' CB ' HG13 ' A' ' 62' ' ' VAL . . . -57.99 -49.19 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.257 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.88 -20.79 41.45 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.262 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -62.3 -48.84 78.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.207 0.527 . . . . 0.0 110.009 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -91.48 -15.06 29.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.007 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 65.04 79.64 0.25 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.516 0.674 . . . . 0.0 110.245 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.3 t -123.1 97.55 43.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.382 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -101.29 130.42 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.387 2.725 . . . . 0.0 113.35 176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 31' ' ' CYS . . . 104.04 -56.49 0.57 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.568 169.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.68 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 20.1 p 60.38 161.19 0.11 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 123.652 0.781 . . . . 0.0 111.638 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.68 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 45.3 Cg_endo -69.64 145.74 80.01 Favored 'Cis proline' 0 C--N 1.349 0.601 0 C-N-CA 124.035 -1.235 . . . . 0.0 112.367 -0.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.3 m -134.21 116.58 15.51 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.185 0.517 . . . . 0.0 110.037 175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 6.1 m-85 -106.27 112.34 25.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.666 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 47.0 t -108.88 113.46 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.788 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.416 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 18.0 m-85 -96.61 127.69 42.83 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.566 -175.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 25.3 mt -116.52 131.13 57.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.972 0.415 . . . . 0.0 110.73 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.507 ' CG2' HG11 ' A' ' 95' ' ' VAL . 91.7 t -109.64 129.8 23.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.774 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.39 117.88 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.841 1.694 . . . . 0.0 110.8 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' CE ' ' HG3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -131.16 125.01 31.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.15 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.808 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -155.69 25.04 0.57 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.156 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.83 166.78 23.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.483 0.183 . . . . 0.0 110.852 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.441 ' CZ2' ' HB2' ' A' ' 16' ' ' GLN . 91.3 m95 -103.25 153.21 20.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.92 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.697 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 59.0 mt-10 -119.74 133.56 55.57 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.387 167.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.484 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.1 tt0 -81.6 94.96 7.02 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 163.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.805 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 22.7 m -85.17 -5.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.943 -166.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.17 158.78 9.41 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.362 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.4 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 82.5 mtt180 -129.72 130.23 45.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 68.0 mt -108.49 134.47 51.22 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -137.52 143.4 41.63 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.843 0.354 . . . . 0.0 111.044 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.84 162.35 25.85 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.281 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.7 m -74.55 116.26 15.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.118 0.485 . . . . 0.0 109.814 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.1 mmm-85 -124.36 143.36 42.74 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.722 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.03 158.03 45.79 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.117 1.878 . . . . 0.0 110.268 169.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.536 ' HB3' HG13 ' A' ' 41' ' ' VAL . 33.5 ptt180 -62.55 -26.8 68.76 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.722 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.99 97.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.049 0.452 . . . . 0.0 110.363 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -69.18 -48.55 61.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.34 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.72 -52.4 65.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.883 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.839 HD22 HD12 ' A' ' 50' ' ' LEU . 71.0 mt -65.96 -30.23 70.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.258 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -55.57 -62.45 1.68 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.102 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.506 ' O ' HG23 ' A' ' 114' ' ' VAL . 1.1 mt-10 -70.76 -32.8 70.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.407 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 51' ' ' LEU . 2.7 tm? -62.08 -41.29 98.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.789 0.328 . . . . 0.0 110.209 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 108' ' ' LEU . 42.7 mtm180 -68.5 -32.69 72.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.267 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.483 ' HA ' ' OE1' ' A' ' 113' ' ' GLN . 12.2 mm-40 -67.42 -35.46 79.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.043 0.449 . . . . 0.0 110.651 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 110' ' ' GLU . 95.6 t -66.75 -36.36 77.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.05 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 83.2 m -58.64 -34.55 71.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.0 t -69.35 -51.46 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.131 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.805 ' HE3' ' HB ' ' A' ' 95' ' ' VAL . 16.2 mtpp -59.79 -24.36 64.05 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -53.39 -31.58 43.34 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.44 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -122.45 20.27 7.91 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' A' ' 117' ' ' LYS . . . -134.01 17.29 3.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.959 0.409 . . . . 0.0 111.046 -177.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.469 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 19.2 m -74.98 109.24 8.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.246 0.546 . . . . 0.0 109.762 174.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.18 -25.62 21.42 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -170.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.811 ' HG3' ' H ' ' A' ' 124' ' ' GLY . 7.6 tp10 -89.38 -139.68 0.13 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.811 ' H ' ' HG3' ' A' ' 123' ' ' GLU . . . 91.22 2.88 70.38 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -95.83 117.57 30.81 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -58.49 -31.49 67.9 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.527 0.517 . . . . 0.0 112.338 -170.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -160.1 156.95 27.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.082 0.467 . . . . 0.0 110.721 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.529 ' CE1' ' HB3' ' A' ' 130' ' ' HIS . 0.2 OUTLIER -169.29 -169.28 0.92 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -75.84 74.52 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.741 0.781 . . . . 0.0 109.779 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.529 ' HB3' ' CE1' ' A' ' 128' ' ' HIS . 3.0 t-160 . . . . . 0 C--O 1.245 0.826 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.135 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 m 65.88 -163.25 0.25 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -170.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 51' ' ' LEU . 17.9 tp -133.82 145.85 50.12 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.696 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.491 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.4 mmt180 -86.81 103.07 14.89 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.971 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -105.59 103.95 13.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 85.6 m-85 -118.74 149.06 45.71 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.632 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.477 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 35.7 Cg_exo -59.67 166.26 8.46 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.423 2.082 . . . . 0.0 111.487 176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.558 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 67.6 t80 -48.31 -50.99 53.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 39.1 Cg_exo -58.46 -49.25 12.56 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.823 1.682 . . . . 0.0 112.389 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 9.3 mt-10 -63.8 -42.94 97.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.704 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.507 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -59.99 -48.25 82.49 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.644 0.259 . . . . 0.0 111.54 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.508 HD13 HG21 ' A' ' 22' ' ' VAL . 4.6 mm? -63.29 -39.84 95.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.82 -37.69 48.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.08 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.454 ' HB3' HG11 ' A' ' 56' ' ' VAL . 9.8 tp -64.15 -46.71 82.87 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.93 96.92 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -64.52 -45.66 86.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.516 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.8 -14.49 59.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -116.8 3.11 12.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.576 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' C ' ' HE ' ' A' ' 20' ' ' ARG . . . 63.11 37.07 94.32 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.59 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.754 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 1.3 mmp_? -106.94 177.48 4.84 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.586 ' SD ' HG22 ' A' ' 86' ' ' VAL . 31.7 mtm -103.93 158.32 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 176.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG21 HD13 ' A' ' 12' ' ' LEU . 59.3 t -105.93 123.74 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.934 0.397 . . . . 0.0 111.17 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.416 ' HE1' HD11 ' A' ' 42' ' ' LEU . 21.1 ttt -103.4 103.58 13.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 173.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 40.6 t -85.42 108.51 17.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -106.59 103.57 13.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.095 0.474 . . . . 0.0 110.793 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.3 m-85 -80.63 120.76 24.98 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.197 176.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.563 ' HA ' HG21 ' A' ' 79' ' ' THR . 31.5 p80 -129.3 155.94 44.79 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.918 0.761 . . . . 0.0 109.316 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 31' ' ' CYS . 92.7 p -137.03 166.28 24.05 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.722 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -78.08 -5.89 52.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.761 178.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -119.58 -0.5 10.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.455 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 28' ' ' SER . 21.8 p -58.44 130.26 84.44 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.534 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.6 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 63.6 Cg_endo -76.91 -86.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.225 1.95 . . . . 0.0 114.045 -175.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.84 -18.77 64.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.578 . . . . 0.0 110.735 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 29.3 t -63.27 -42.06 99.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.499 -177.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 4.3 pt20 -66.93 -23.49 65.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.009 0.433 . . . . 0.0 110.402 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -79.3 -48.44 14.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.406 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.596 ' HG2' ' HA ' ' A' ' 34' ' ' CYS . 17.2 ptp -66.98 -39.15 87.12 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.781 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.07 -34.59 68.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.082 0.467 . . . . 0.0 110.672 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 43' ' ' SER . 26.0 m -83.25 -61.04 1.95 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.525 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -91.38 -70.6 0.68 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 104' ' ' ARG . 70.8 t -49.31 -55.97 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.077 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.416 HD11 ' HE1' ' A' ' 23' ' ' MET . 21.2 tp -83.03 -27.07 30.59 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.738 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 39' ' ' THR . 31.2 t -88.39 -4.99 58.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.09 -175.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.468 ' HB3' HG23 ' A' ' 47' ' ' VAL . 13.3 t70 -51.26 130.88 32.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.644 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.709 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 27.5 Cg_exo -62.14 -20.94 71.54 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.854 2.37 . . . . 0.0 113.504 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.87 -34.52 38.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.174 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.54 HG22 HD21 ' A' ' 108' ' ' LEU . 14.8 t -76.89 -40.54 31.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-O 121.846 0.831 . . . . 0.0 108.861 175.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.582 ' OG ' ' HA ' ' A' ' 45' ' ' PRO . 36.8 p -59.08 -33.49 70.88 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.105 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.709 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 87.3 mtt180 -56.78 -35.54 68.8 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.743 0.306 . . . . 0.0 111.45 176.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.75 -43.42 84.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.735 0.302 . . . . 0.0 110.448 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB2' HD11 ' A' ' 3' ' ' LEU . 2.7 mm? -73.94 -45.78 48.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.762 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -44.79 -48.98 10.94 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.731 ' HB3' HH11 ' A' ' 54' ' ' ARG . . . -66.87 -48.54 68.47 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -170.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.754 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.67 16.3 3.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -170.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.05 145.71 51.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.407 0.623 . . . . 0.0 111.447 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 11' ' ' ALA . 60.4 t -114.86 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 4' ' ' ARG . 21.6 t -86.95 121.31 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.193 -174.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -89.62 117.1 28.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.868 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.0 p -84.65 100.14 11.26 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.5 t -104.28 106.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.995 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.641 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -90.04 109.16 20.22 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.944 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' A' ' 71' ' ' ALA . 25.9 t -75.15 -6.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.071 0.938 . . . . 0.0 109.27 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.722 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.7 OUTLIER -77.53 -32.57 54.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.647 -1.161 . . . . 0.0 110.913 174.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.659 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 22.4 p -99.55 159.38 30.17 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.659 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 19.5 Cg_endo -51.87 -53.51 6.87 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.235 3.29 . . . . 0.0 114.835 -169.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -35.37 80.05 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.8 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.78 -39.84 54.21 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.307 174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -56.75 -39.79 74.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.658 0.742 . . . . 0.0 110.044 172.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.98 -44.87 79.35 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.899 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.43 -34.7 78.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -64.54 -38.34 90.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -83.62 -20.49 33.56 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.811 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -80.71 -48.92 11.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.591 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -86.44 -10.93 53.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.192 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 73.1 0.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.804 0.69 . . . . 0.0 109.977 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.4 t -128.04 86.42 58.14 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.626 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -103.15 122.57 0.07 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.673 2.916 . . . . 0.0 112.741 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.46 ' HA3' ' HE1' ' A' ' 99' ' ' PHE . . . 133.92 -74.58 0.43 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.999 -1.096 . . . . 0.0 112.412 175.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 27' ' ' HIS . 23.7 m 73.23 141.97 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 O-C-N 123.704 0.297 . . . . 0.0 110.586 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.551 ' HA ' ' CG2' ' A' ' 79' ' ' THR . 55.4 Cg_endo -69.08 153.99 91.36 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 124.426 -1.072 . . . . 0.0 113.32 1.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.1 m -138.94 123.82 18.77 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.432 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 1.5 m-85 -112.27 112.56 24.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.842 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 59.0 t -118.02 115.22 47.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HB2' HG22 ' A' ' 95' ' ' VAL . 49.2 m-85 -102.16 124.02 47.03 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.92 -176.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 94' ' ' GLU . 32.8 mt -117.59 132.46 56.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.586 HG22 ' SD ' ' A' ' 21' ' ' MET . 14.9 t -110.71 132.73 21.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.578 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.7 115.04 3.04 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.251 1.3 . . . . 0.0 110.748 170.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -169.13 141.52 2.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 68.99 11.41 8.33 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.66 0.6 . . . . 0.0 111.342 -177.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.15 -23.8 29.6 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.63 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.98 -177.12 3.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.811 0.339 . . . . 0.0 111.076 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.488 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 67.1 m95 -105.74 130.74 53.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.011 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.507 ' OE2' HG12 ' A' ' 95' ' ' VAL . 31.3 tt0 -97.14 119.82 36.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.238 176.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.533 ' HA ' HD23 ' A' ' 85' ' ' LEU . 33.0 tt0 -75.24 96.56 3.35 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.94 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 13.7 m -73.91 -11.73 14.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.953 -173.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.79 141.82 3.23 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.763 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -116.16 128.24 55.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.229 0.537 . . . . 0.0 109.642 173.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.579 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.3 mt -108.03 131.39 54.63 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.145 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.46 ' HE1' ' HA3' ' A' ' 78' ' ' GLY . 79.1 t80 -130.9 124.1 30.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.81 178.26 15.43 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.34 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.419 ' O ' ' HD2' ' A' ' 102' ' ' ARG . 8.0 m -112.91 126.29 55.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.502 ' HE ' ' HG2' ' A' ' 106' ' ' GLU . 24.4 mmm180 -128.05 151.02 75.3 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.779 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.07 158.94 41.05 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.254 1.969 . . . . 0.0 111.262 174.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.655 ' HB2' HG13 ' A' ' 41' ' ' VAL . 67.7 ttt180 -58.67 -34.83 71.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.386 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.64 79.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.086 0.469 . . . . 0.0 110.634 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HG2' ' HE ' ' A' ' 102' ' ' ARG . 3.9 tp10 -67.02 -48.77 67.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.409 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -66.08 -37.36 85.6 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.843 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.54 HD21 HG22 ' A' ' 47' ' ' VAL . 60.6 mt -59.06 -44.51 91.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.657 0.265 . . . . 0.0 110.73 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 113' ' ' GLN . 46.7 mtmt -65.1 -48.07 74.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.32 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -59.36 -55.56 33.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.409 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 111' ' ' LEU . 1.9 tm? -61.31 -32.39 72.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.32 0.581 . . . . 0.0 109.897 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 116' ' ' VAL . 3.6 tpm_? -65.44 -37.85 88.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.369 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 109' ' ' LYS . 29.2 mm-40 -74.37 -43.19 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.553 0.215 . . . . 0.0 110.937 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.458 ' HA ' ' HG3' ' A' ' 117' ' ' LYS . 79.5 t -62.67 -36.58 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 0.0 110.166 177.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 41.1 t -55.16 -29.73 58.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.576 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 112' ' ' ARG . 85.9 t -85.42 -54.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.245 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.94 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -70.95 -11.53 61.02 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.107 -170.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.448 ' HA3' ' SD ' ' A' ' 21' ' ' MET . . . -56.12 -41.09 85.14 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.167 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.06 -33.11 4.74 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -102.98 65.89 0.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.899 0.38 . . . . 0.0 111.213 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 7.7 p -71.6 122.59 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 114.44 41.26 0.89 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -166.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.64 ' CD ' ' H ' ' A' ' 123' ' ' GLU . 3.7 mp0 -43.54 104.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.165 1.386 . . . . 0.0 113.147 -170.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.51 -1.4 4.18 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.223 -0.898 . . . . 0.0 113.42 175.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.6 m80 59.19 25.28 13.8 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-O 121.09 0.471 . . . . 0.0 110.305 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -142.96 106.71 4.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.885 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -103.0 159.94 15.06 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 174.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -71.26 118.1 13.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.818 0.342 . . . . 0.0 110.934 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -63.38 147.25 51.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.455 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 . . . . . 0 C--O 1.244 0.785 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 169.778 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 t 68.78 -171.35 0.18 Allowed 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.466 ' HB3' ' NE1' ' A' ' 5' ' ' TRP . 11.3 tp -133.66 155.42 49.74 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.436 -176.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -102.17 103.8 14.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.68 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.466 ' NE1' ' HB3' ' A' ' 3' ' ' LEU . 13.2 m95 -104.35 139.78 38.83 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.539 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 86.1 m-85 -138.91 166.63 23.58 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.68 159.35 41.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.54 1.494 . . . . 0.0 110.884 173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.544 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 60.4 t80 -50.84 -51.36 67.37 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 31.2 Cg_exo -60.85 -43.69 29.71 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.834 1.689 . . . . 0.0 112.386 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -65.71 -46.07 80.33 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.491 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -55.15 -41.82 72.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.45 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.38 -38.78 91.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.044 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.47 -47.79 58.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.878 0.371 . . . . 0.0 110.399 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.446 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -54.21 -51.4 64.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.857 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -63.42 -43.96 95.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.357 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -62.39 -47.45 84.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.369 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.35 -15.45 57.88 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -112.58 -1.73 14.79 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.554 -175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.43 32.46 81.88 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.264 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 24.9 mmt180 -97.44 177.63 5.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.935 0.397 . . . . 0.0 110.675 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 88.1 mtp -104.5 156.25 18.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.474 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 49.9 t -105.95 124.69 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 24.0 ttt -104.39 103.47 13.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.684 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 37.5 t -84.5 104.54 12.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.896 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 65.9 t80 -102.33 108.84 20.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.077 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 1.004 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 90.7 m-85 -90.1 124.97 35.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.858 176.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 23.5 p80 -128.08 155.85 43.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.564 177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.437 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 38.2 t -143.1 159.48 42.2 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -74.87 -9.05 58.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.57 0.7 . . . . 0.0 109.935 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -97.86 15.96 22.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.998 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.586 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 31.8 p -84.84 115.22 59.93 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 120.839 0.352 . . . . 0.0 110.562 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 79' ' ' THR . 38.0 Cg_endo -68.0 -69.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.497 2.132 . . . . 0.0 113.866 -174.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -85.88 -17.19 36.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 44.5 t -55.46 -46.92 76.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.487 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -56.6 -38.25 71.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.38 . . . . 0.0 111.638 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -72.2 -38.93 68.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.42 ' HE1' ' H ' ' A' ' 102' ' ' ARG . 50.8 ttm -65.32 -49.38 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.856 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 77.6 m-20 -52.36 -49.27 64.69 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.363 0.415 . . . . 0.0 111.018 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 43' ' ' SER . 21.9 m -59.86 -59.99 4.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.888 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.05 -68.4 0.79 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.096 0.474 . . . . 0.0 112.071 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 104' ' ' ARG . 68.6 t -58.9 -44.35 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.804 -170.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 21.1 tp -81.74 -34.68 30.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.334 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 39' ' ' THR . 33.4 t -85.74 -0.99 56.74 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.406 ' OD2' HG23 ' A' ' 47' ' ' VAL . 22.1 t70 -49.87 128.46 20.83 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.117 174.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -51.57 -35.63 57.16 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.222 2.614 . . . . 0.0 113.242 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.86 -48.22 28.56 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.817 . . . . 0.0 111.962 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.712 HG22 HD21 ' A' ' 108' ' ' LEU . 59.6 t -61.36 -57.5 11.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-O 121.107 0.479 . . . . 0.0 110.762 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.68 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 54.9 m -52.23 -47.41 65.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.085 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -58.5 -36.56 73.98 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.471 HD13 HD12 ' A' ' 111' ' ' LEU . 76.7 mt -62.68 -40.38 96.92 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.583 0.23 . . . . 0.0 110.593 176.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.5 mm? -74.53 -40.58 61.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.292 177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.6 mt-10 -49.48 -50.21 42.32 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.204 0.526 . . . . 0.0 112.023 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.14 82.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -168.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 ptt180 -135.23 11.95 3.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 86.4 m-85 -121.38 145.64 47.69 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.353 0.597 . . . . 0.0 111.246 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 11' ' ' ALA . 20.1 t -111.98 113.66 44.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 3' ' ' LEU . 21.8 t -87.03 117.4 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.767 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 8' ' ' TYR . . . -90.31 117.27 28.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.45 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.1 p -85.14 101.41 12.44 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 176.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -102.9 125.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.565 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.606 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.7 m -100.48 108.52 20.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.057 0.456 . . . . 0.0 110.571 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.36 -11.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.054 0.93 . . . . 0.0 109.636 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.474 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 6.8 m-20 -77.68 -32.34 53.06 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.609 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.616 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.2 p -109.1 165.46 12.6 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.778 -174.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 13.3 Cg_endo -49.73 -52.95 7.86 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.092 3.194 . . . . 0.0 114.491 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -56.43 -43.37 79.37 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.606 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.34 -31.15 52.59 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.98 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -60.19 -41.32 92.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.724 0.297 . . . . 0.0 111.065 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.1 pt-20 -79.25 -30.64 43.22 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.882 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.408 ' HB3' ' HE1' ' A' ' 26' ' ' PHE . 1.9 mm? -63.83 -44.19 93.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.042 0.449 . . . . 0.0 110.247 172.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.01 79.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.449 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.8 ptm180 -65.39 -30.68 71.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.111 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -66.51 -41.39 88.92 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 110.276 -179.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -92.33 -6.09 50.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.24 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 65.38 33.11 9.21 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.683 0.614 . . . . 0.0 111.439 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.1 t -130.26 144.99 55.46 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 17.0 Cg_exo -69.63 -116.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.378 2.052 . . . . 0.0 111.282 168.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.496 ' HA2' ' OG1' ' A' ' 81' ' ' THR . . . 168.14 63.32 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 12.5 p -137.86 47.72 1.76 Allowed Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -168.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.657 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 43.5 Cg_endo -93.08 174.38 16.62 Favored 'Cis proline' 0 C--N 1.356 0.949 0 CA-C-N 121.0 1.393 . . . . 0.0 112.507 -3.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 1.004 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 62.8 m -139.18 131.64 28.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.675 0.274 . . . . 0.0 111.022 170.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -127.75 112.23 14.56 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.684 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 57.4 t -111.43 121.63 64.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.735 0.303 . . . . 0.0 110.199 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -97.49 116.62 30.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.668 0.27 . . . . 0.0 110.357 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 29.3 mt -112.93 137.04 51.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.213 0.53 . . . . 0.0 111.408 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.522 HG21 ' HA2' ' A' ' 118' ' ' GLY . 58.8 t -109.98 123.33 36.46 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.03 175.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HB3' ' CZ3' ' A' ' 92' ' ' TRP . 59.5 Cg_endo -77.11 116.42 4.18 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.778 1.652 . . . . 0.0 111.193 173.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -147.85 135.33 20.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.684 0.278 . . . . 0.0 110.574 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 63.0 24.16 14.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.554 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.22 17.56 77.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.343 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.31 167.02 20.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 87' ' ' PRO . 65.7 m95 -106.36 126.12 51.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.943 0.401 . . . . 0.0 110.026 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 5.8 tp10 -114.04 137.44 51.71 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.623 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 38.1 tt0 -88.29 112.91 23.35 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.537 HG22 ' HE2' ' A' ' 117' ' ' LYS . 8.7 p -98.93 7.46 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.499 0.666 . . . . 0.0 110.336 -175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.46 138.49 2.88 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.504 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -122.94 133.06 54.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.153 0.502 . . . . 0.0 110.508 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.98 128.39 56.48 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.923 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -137.18 143.42 42.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.986 0.422 . . . . 0.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.02 -177.27 28.82 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.353 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.6 m -88.79 107.84 19.18 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.497 ' HB3' ' OE1' ' A' ' 106' ' ' GLU . 4.1 mmm180 -111.29 143.65 28.87 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.658 -177.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.69 151.27 82.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.26 1.973 . . . . 0.0 110.925 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.689 ' HB2' HG13 ' A' ' 41' ' ' VAL . 22.6 ttp180 -59.21 -27.35 65.64 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.376 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.89 92.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.65 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.497 ' OE1' ' HB3' ' A' ' 102' ' ' ARG . 50.0 tt0 -82.84 -38.27 23.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 111' ' ' LEU . 37.2 t80 -58.38 -51.4 69.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.675 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 47' ' ' VAL . 57.8 mt -70.59 -28.23 64.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.4 ttpp -56.7 -55.62 31.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.249 0.547 . . . . 0.0 109.879 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 114' ' ' VAL . 20.8 tp10 -73.74 -31.64 63.46 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.112 -178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -60.31 -46.58 89.39 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -60.82 -38.06 84.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.022 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -69.83 -48.52 58.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 110' ' ' GLU . 55.5 t -58.36 -42.45 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.505 0.322 . . . . 0.0 111.75 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.0 p -63.05 -23.85 67.64 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.964 0.412 . . . . 0.0 110.497 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -86.11 -50.12 14.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.661 173.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.537 ' HE2' HG22 ' A' ' 95' ' ' VAL . 38.2 mtpt -55.22 -34.3 63.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.236 -175.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 86' ' ' VAL . . . -68.41 -24.09 75.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.949 -0.644 . . . . 0.0 113.152 -177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -101.07 -39.55 3.06 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.507 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -158.96 99.9 1.55 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 117' ' ' LYS . 4.9 p -79.64 48.07 0.9 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.314 0.578 . . . . 0.0 111.308 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.36 25.79 69.72 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.902 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -61.64 158.94 14.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.072 0.463 . . . . 0.0 111.456 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.85 52.43 19.68 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -167.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -70.26 13.54 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -168.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -129.26 13.05 6.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.005 0.431 . . . . 0.0 110.044 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.46 129.43 34.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.436 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 60.16 30.07 19.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.487 0.661 . . . . 0.0 109.993 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -155.07 105.99 2.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.893 -177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.4 p80 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.858 175.92 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -90.59 3.15 54.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.36 0.6 . . . . 0.0 110.322 173.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.1 tp -72.68 136.27 45.58 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.588 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 23.0 mmt180 -88.3 106.38 18.19 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.646 -172.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -110.24 108.71 18.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 171.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 94.2 m-85 -133.17 154.26 81.1 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.43 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 34.6 Cg_exo -57.05 161.71 10.37 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.09 1.86 . . . . 0.0 111.504 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.569 ' O ' HD23 ' A' ' 12' ' ' LEU . 82.9 t80 -45.81 -53.66 19.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 20.9 Cg_exo -65.17 -40.68 18.91 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.485 1.457 . . . . 0.0 112.146 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.43 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 31.6 tt0 -71.08 -37.33 72.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.926 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.23 79.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.005 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.569 HD23 ' O ' ' A' ' 8' ' ' TYR . 4.6 mm? -61.18 -34.5 75.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.593 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -39.05 64.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.784 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.5 tp -64.22 -47.31 80.19 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.008 0.432 . . . . 0.0 110.138 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.52 89.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.434 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -62.77 -51.65 66.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.226 178.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.72 -14.38 59.95 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.029 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -118.68 3.62 11.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.765 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.67 44.4 95.7 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.458 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 2.8 mmp_? -107.43 174.86 5.7 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.671 -0.311 . . . . 0.0 110.791 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 79.6 mtp -100.52 156.55 17.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 24.6 t -106.79 127.54 62.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 120.953 0.406 . . . . 0.0 111.598 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 22.2 ttt -111.07 104.25 12.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 19.1 t -88.38 107.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -93.02 103.97 16.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 110.137 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.692 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 59.8 m-85 -87.41 122.48 31.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.302 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 62' ' ' VAL . 32.5 p80 -132.62 137.21 46.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 169.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.527 ' N ' ' HB3' ' A' ' 31' ' ' CYS . 50.6 m -60.81 167.01 3.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.751 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.502 ' N ' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -53.5 -38.22 63.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.285 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -102.05 -48.7 4.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . 23.3 p 41.19 78.45 0.37 Allowed Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.467 1.107 . . . . 0.0 112.879 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.663 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 69.4 Cg_endo -79.24 -59.18 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.434 2.089 . . . . 0.0 114.297 -174.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HD2' ' HG ' ' A' ' 101' ' ' SER . 33.9 t80 -67.22 -23.66 65.75 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -169.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.698 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 22.6 p -82.68 -21.64 34.85 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -173.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.663 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 8.3 pt20 -61.79 -30.84 71.07 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.64 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -66.02 -43.56 87.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.358 0.599 . . . . 0.0 109.551 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.42 ' SD ' ' HB3' ' A' ' 101' ' ' SER . 64.2 mmm -59.41 -44.4 92.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.704 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -62.79 -54.62 36.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.598 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.523 ' O ' ' HB3' ' A' ' 43' ' ' SER . 58.4 m -70.57 -37.65 74.01 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -91.27 -71.78 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.864 -0.523 . . . . 0.0 112.011 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.83 -45.53 94.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.285 -168.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.6 tp -80.93 -31.45 35.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.673 0.273 . . . . 0.0 111.451 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 39' ' ' THR . 33.1 t -83.82 -4.48 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.934 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.81 129.15 14.42 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.351 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.33 -48.38 15.27 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.334 2.69 . . . . 0.0 113.547 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.12 -37.07 86.75 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.409 -176.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.558 ' HA ' HD21 ' A' ' 108' ' ' LEU . 34.8 t -66.63 -57.26 10.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 121.11 0.481 . . . . 0.0 109.882 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.673 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 50.1 m -52.35 -46.27 66.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.721 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -63.08 -32.35 73.71 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.665 HD22 HH22 ' A' ' 54' ' ' ARG . 61.4 mt -61.51 -41.55 97.48 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.222 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 55' ' ' PHE . 3.2 mm? -72.77 -40.66 65.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.673 ' HG3' ' O ' ' A' ' 48' ' ' SER . 36.2 mt-10 -57.68 -34.16 69.12 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -175.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.459 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -67.67 -52.84 33.17 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -172.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.665 HH22 HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -135.88 15.8 3.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -172.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 77.0 m-85 -121.49 146.4 46.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.474 0.654 . . . . 0.0 111.871 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.475 HG11 ' HB3' ' A' ' 14' ' ' LEU . 56.9 t -113.16 115.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.11 125.73 40.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.022 0.439 . . . . 0.0 110.582 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -89.85 116.91 28.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.888 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.3 p -83.48 101.28 11.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.1 t -101.61 103.09 14.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.453 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.6 p -94.17 110.77 22.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.292 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.502 ' HB ' ' N ' ' A' ' 29' ' ' GLU . 97.1 t -70.28 -13.65 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.473 0.654 . . . . 0.0 110.367 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -73.94 -27.89 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.837 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.478 ' HB ' ' OE2' ' A' ' 66' ' ' GLU . 76.2 p -91.47 151.91 43.09 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.741 ' O ' ' HG2' ' A' ' 68' ' ' GLN . 43.6 Cg_endo -61.58 -36.92 73.51 Favored 'Trans proline' 0 N--CA 1.471 0.203 0 C-N-CA 122.741 2.294 . . . . 0.0 113.565 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.2 mp0 -57.3 -52.65 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.515 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -72.12 -29.77 66.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.825 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.741 ' HG2' ' O ' ' A' ' 65' ' ' PRO . 2.1 pt20 -62.39 -47.46 84.07 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.008 0.432 . . . . 0.0 110.512 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.432 ' HA ' ' CD ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -72.62 -33.11 66.44 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.122 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 66' ' ' GLU . 1.9 mm? -59.19 -42.88 91.93 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.477 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . -62.19 -41.56 98.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.449 176.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.432 ' CD ' ' HA ' ' A' ' 69' ' ' GLU . 4.5 mtp180 -61.96 -43.81 98.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.12 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -64.45 -48.8 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.598 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -86.17 -6.65 58.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.458 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 57.45 46.74 17.55 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.738 0.649 . . . . 0.0 110.592 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.5 t -122.23 120.18 28.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.313 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -93.35 105.76 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.601 2.867 . . . . 0.0 110.61 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' HIS . . . -81.47 92.28 1.5 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.362 -168.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.86 48.26 0.81 Allowed Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.698 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 Cg_endo -94.11 173.34 15.81 Favored 'Cis proline' 0 C--N 1.356 0.955 0 CA-C-N 120.541 1.229 . . . . 0.0 112.13 -4.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 18.0 m -142.67 137.95 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.833 167.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.21 118.19 21.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.755 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' A' ' 97' ' ' ARG . 86.6 t -115.27 126.89 72.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -104.72 122.97 46.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.585 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.616 ' HB2' ' HB ' ' A' ' 22' ' ' VAL . 35.4 mt -117.5 130.94 56.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.428 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.87 127.95 26.23 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.963 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.478 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 58.4 Cg_endo -73.52 117.75 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 121.973 1.782 . . . . 0.0 110.432 171.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -164.04 143.78 8.0 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.716 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.06 -76.28 0.06 Allowed 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.042 0.839 . . . . 0.0 111.187 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.47 22.43 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.852 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -161.9 -171.39 2.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.48 ' CE2' HD12 ' A' ' 12' ' ' LEU . 58.9 m95 -103.41 128.37 50.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.078 0.466 . . . . 0.0 109.997 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 35.5 tt0 -94.81 115.2 27.2 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.453 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.488 ' HA ' HD23 ' A' ' 85' ' ' LEU . 34.9 tt0 -73.88 103.01 4.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 171.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.545 HG22 ' HD3' ' A' ' 117' ' ' LYS . 9.0 p -102.39 6.93 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.607 -167.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.8 146.54 4.54 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.068 -1.063 . . . . 0.0 113.468 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HG2' HG22 ' A' ' 83' ' ' VAL . 77.7 mtt180 -123.42 126.58 47.05 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 174.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.527 HD21 ' HG3' ' A' ' 110' ' ' GLU . 83.4 mt -109.57 131.7 54.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -137.15 142.14 42.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.44 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.98 136.86 7.92 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.391 -177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.44 ' HG ' ' HD2' ' A' ' 33' ' ' TYR . 11.8 m -66.18 122.37 17.31 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.913 0.387 . . . . 0.0 110.595 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 102' ' ' ARG . 4.0 mmp_? -124.01 157.2 64.42 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.776 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -56.87 154.87 30.07 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.373 2.049 . . . . 0.0 112.041 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -31.07 67.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.628 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.421 ' O ' ' HE3' ' A' ' 109' ' ' LYS . . . -67.81 -38.33 83.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.291 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.43 -32.81 48.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.895 0.379 . . . . 0.0 110.538 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.69 -49.86 71.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.74 175.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.651 HD22 HD12 ' A' ' 50' ' ' LEU . 24.1 mt -70.5 -20.69 62.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 105' ' ' ALA . 1.0 OUTLIER -59.8 -61.2 2.79 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.527 ' HG3' HD21 ' A' ' 98' ' ' LEU . 2.1 tm-20 -67.85 -38.72 83.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.4 HD12 HD13 ' A' ' 50' ' ' LEU . 3.0 tm? -58.69 -44.34 90.27 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 110.551 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -64.65 -36.95 85.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 109.954 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 22.2 mt-30 -65.98 -38.96 89.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 176.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.539 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 72.4 t -61.51 -34.9 63.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.923 176.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.4 m -58.35 -34.99 71.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.326 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -84.24 -40.11 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.545 ' HD3' HG22 ' A' ' 95' ' ' VAL . 96.9 mttt -52.0 -57.2 10.18 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.027 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -51.68 -34.6 36.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 115.86 -0.609 . . . . 0.0 114.153 -170.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.09 -17.94 72.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.944 -178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -140.82 -83.89 0.22 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.752 -0.264 . . . . 0.0 111.447 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 90.7 m 57.82 24.73 11.13 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -168.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.04 -129.51 10.73 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -168.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -137.33 -51.09 0.64 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.274 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.466 ' H ' ' CD ' ' A' ' 123' ' ' GLU . . . -112.9 30.77 7.21 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 174.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.3 m170 57.97 43.45 21.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 122.911 0.484 . . . . 0.0 110.996 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -72.88 92.61 1.63 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.495 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -74.02 82.31 1.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.574 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.448 ' HB2' ' H ' ' A' ' 129' ' ' HIS . 1.2 m80 61.31 -89.74 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.055 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.448 ' H ' ' HB2' ' A' ' 128' ' ' HIS . 27.3 m80 -157.41 -30.61 0.08 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 175.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 . . . . . 0 C--O 1.242 0.672 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.788 167.151 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.5 ttp . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 120.64 0.257 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p -125.42 23.46 7.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.792 -0.185 . . . . 0.0 111.211 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 57' ' ' VAL . 27.7 tp -120.39 146.13 46.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.276 -171.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.531 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 3.0 mmp_? -77.09 103.76 7.21 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.878 0.371 . . . . 0.0 111.297 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -105.64 115.08 29.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.754 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.531 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 94.5 m-85 -121.97 159.41 51.63 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.592 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 14.4 Cg_exo -67.88 157.91 59.69 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 121.964 1.776 . . . . 0.0 110.761 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.59 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 92.6 t80 -43.78 -53.14 13.18 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 32.2 Cg_exo -59.13 -52.02 5.68 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.787 1.658 . . . . 0.0 112.766 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 4.4 mm-40 -70.34 -30.6 67.6 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.32 -47.18 87.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.2 0.524 . . . . 0.0 110.259 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 8' ' ' TYR . 11.0 mp -64.45 -40.39 95.64 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.823 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.81 -36.51 65.0 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.04 0.448 . . . . 0.0 110.741 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -61.79 -37.92 86.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.191 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.12 -49.03 12.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HB2' ' CH2' ' A' ' 92' ' ' TRP . 46.3 tt0 -57.52 -54.32 48.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 122.913 0.485 . . . . 0.0 112.308 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.84 60.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.612 -172.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -110.35 -22.87 11.5 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.23 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.8 6.83 54.09 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.043 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 20' ' ' ARG . 4.0 mpt_? -85.9 -177.82 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.664 0.268 . . . . 0.0 111.402 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.77 158.74 17.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.346 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 85' ' ' LEU . 38.8 t -106.36 135.62 44.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.67 0.272 . . . . 0.0 110.747 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.559 ' HG2' ' CD1' ' A' ' 84' ' ' PHE . 6.2 tmm? -125.69 104.74 8.53 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.581 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 35.2 t -91.16 120.31 39.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -175.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 44.0 t80 -108.74 124.33 50.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.081 0.467 . . . . 0.0 111.388 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.911 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 72.6 m-85 -104.22 132.55 50.36 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.393 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.902 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 30.4 p80 -135.84 161.69 34.9 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.491 0.494 . . . . 0.0 110.644 175.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.583 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 40.4 m -143.79 164.42 30.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 173.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.8 -32.89 20.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.051 0.453 . . . . 0.0 109.995 178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -76.54 -7.11 54.52 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.242 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.716 ' HB3' HG22 ' A' ' 79' ' ' THR . 5.0 t -113.89 87.52 12.73 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.24 27.11 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.047 2.498 . . . . 0.0 113.687 -171.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -86.05 -48.43 8.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.025 0.441 . . . . 0.0 111.503 -177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.59 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 14.1 t -83.08 -20.45 34.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -171.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -53.21 -29.81 34.25 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.972 0.415 . . . . 0.0 111.547 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -79.37 -32.24 43.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.451 0.643 . . . . 0.0 110.326 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -80.28 -49.88 10.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.994 -176.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.0 p30 -64.65 -23.05 67.13 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -174.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.8 m -75.69 -60.42 2.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.499 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.65 -69.46 0.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.744 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.5 t -55.71 -43.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 20.9 tp -80.9 -23.93 38.61 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -173.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -105.69 9.06 33.25 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.068 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.97 135.24 21.43 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.766 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 10.1 Cg_endo -52.02 -34.21 56.13 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 123.057 2.505 . . . . 0.0 113.561 -177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.61 -45.69 10.64 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.804 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.613 HG22 HD21 ' A' ' 108' ' ' LEU . 43.0 t -63.34 -51.96 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.292 0.568 . . . . 0.0 109.807 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.442 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 7.6 t -53.21 -41.33 65.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.525 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HE ' ' HB2' ' A' ' 49' ' ' ARG . 14.2 ttm180 -61.84 -35.38 78.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.772 -176.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD13 HD12 ' A' ' 111' ' ' LEU . 76.2 mt -69.28 -40.14 77.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.903 0.382 . . . . 0.0 110.911 176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HB3' HD11 ' A' ' 3' ' ' LEU . 4.2 mm? -70.85 -48.72 52.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.846 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 48' ' ' SER . 12.0 mm-40 -53.0 -33.6 52.35 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.801 0.44 . . . . 0.0 112.182 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -68.11 -57.99 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -173.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.484 ' HD3' ' HB3' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -135.91 18.88 3.25 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -174.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 76.2 m-85 -124.97 146.18 49.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.413 0.625 . . . . 0.0 111.245 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 14' ' ' LEU . 39.7 t -115.12 120.09 63.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.569 HG21 HD21 ' A' ' 3' ' ' LEU . 19.0 t -91.58 124.6 44.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.77 -173.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.581 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -93.96 117.96 30.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.591 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 p -82.66 102.43 11.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.04 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -116.73 129.4 73.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.15 0.5 . . . . 0.0 110.485 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.605 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 2.2 m -112.97 114.45 26.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.811 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.583 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 32.4 t -74.84 -7.46 10.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 122.015 0.912 . . . . 0.0 109.583 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.01 -29.37 39.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.012 175.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.614 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 2.9 p -109.11 158.51 34.14 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.614 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.0 Cg_endo -52.29 -50.4 14.15 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.301 3.334 . . . . 0.0 114.914 -167.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -38.62 84.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.991 0.424 . . . . 0.0 110.83 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -77.3 -31.02 53.28 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.606 175.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 64' ' ' THR . 92.4 mt-30 -62.36 -39.68 93.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.638 0.375 . . . . 0.0 111.117 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.55 ' OE2' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -77.9 -33.7 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.642 179.113 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.55 HD12 ' OE2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -61.27 -42.21 98.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.931 0.395 . . . . 0.0 110.531 170.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.2 96.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.564 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 8.1 ptm180 -71.9 -21.46 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.969 0.414 . . . . 0.0 110.484 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 73' ' ' ARG . 45.6 ttm105 -75.2 -52.42 10.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.983 177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.45 -8.12 57.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.711 -176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 64.06 72.19 0.47 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.468 0.651 . . . . 0.0 109.698 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 56.0 t -123.6 136.96 27.85 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.959 -175.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 76' ' ' VAL . 8.9 Cg_exo -73.62 -138.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.204 2.603 . . . . 0.0 111.553 173.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 79' ' ' THR . . . -88.12 -69.18 1.28 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.807 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' A' ' 27' ' ' HIS . 6.6 t 178.44 156.09 0.56 Allowed Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.69 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 1.0 OUTLIER -84.29 132.75 18.39 Favored 'Cis proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.354 -1.102 . . . . 0.0 112.701 0.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.911 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 31.4 m -126.41 121.13 31.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.914 0.388 . . . . 0.0 110.584 174.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.652 ' HD1' ' HB2' ' A' ' 98' ' ' LEU . 8.8 m-85 -119.45 115.96 25.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.903 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 98.2 t -114.01 118.14 57.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.754 0.312 . . . . 0.0 110.548 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.559 ' CD1' ' HG2' ' A' ' 23' ' ' MET . 26.2 m-85 -96.93 118.71 33.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.707 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 94' ' ' GLU . 42.0 mt -115.78 130.06 56.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.077 0.465 . . . . 0.0 110.516 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -110.01 135.14 20.52 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.6 116.64 4.64 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.574 1.516 . . . . 0.0 109.338 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -151.07 128.4 11.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.761 -171.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.12 -79.8 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.931 0.77 . . . . 0.0 111.341 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.67 21.09 0.27 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -152.07 -169.3 3.32 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.499 ' CH2' ' HB2' ' A' ' 16' ' ' GLN . 85.6 m95 -107.89 135.76 48.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.242 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -116.3 118.29 32.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.589 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 36.2 tt0 -77.62 108.17 10.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.87 ' HB ' ' HD2' ' A' ' 117' ' ' LYS . 31.1 m -88.35 12.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.073 0.463 . . . . 0.0 111.329 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 94' ' ' GLU . . . 142.09 155.02 6.31 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.301 178.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -130.76 135.5 47.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.652 ' HB2' ' HD1' ' A' ' 82' ' ' PHE . 81.9 mt -108.18 129.75 55.17 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.719 -177.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 80' ' ' PRO . 88.3 t80 -137.41 143.23 41.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.649 173.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.25 145.77 10.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.583 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m -70.09 125.76 27.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.954 0.407 . . . . 0.0 110.607 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.636 ' HB3' ' HB2' ' A' ' 106' ' ' GLU . 92.9 mtt180 -137.89 142.75 37.28 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.789 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.473 ' HD2' ' HG2' ' A' ' 106' ' ' GLU . 24.5 Cg_exo -64.21 166.38 17.05 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.489 2.126 . . . . 0.0 111.518 173.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -55.54 -33.17 63.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.872 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.547 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -60.88 -47.25 87.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.212 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 102' ' ' ARG . 17.4 mm-40 -72.3 -38.42 68.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.929 0.395 . . . . 0.0 110.602 -176.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -65.3 -39.37 92.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.345 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.613 HD21 HG22 ' A' ' 47' ' ' VAL . 53.4 mt -67.35 -34.62 77.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.061 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 98.5 mttt -55.94 -53.3 58.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.216 0.531 . . . . 0.0 109.871 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.516 ' O ' HG23 ' A' ' 114' ' ' VAL . 4.3 mm-40 -62.53 -44.16 97.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.432 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.461 HD12 HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -57.71 -41.57 82.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.281 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 14.4 mmt180 -63.09 -49.55 74.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.852 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 6.9 pt20 -66.97 -23.04 65.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.066 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 110' ' ' GLU . 56.7 t -75.21 -41.92 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.838 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 85.4 m -56.75 -37.95 71.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.949 0.404 . . . . 0.0 110.525 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.86 -32.39 56.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.87 ' HD2' ' HB ' ' A' ' 95' ' ' VAL . 54.2 mttp -71.19 -8.52 54.09 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.482 -176.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.46 -20.96 72.17 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.222 173.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -110.42 -58.53 0.49 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.711 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -99.94 119.31 38.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.7 p -145.88 96.59 2.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.268 0.556 . . . . 0.0 111.899 -171.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 120.62 -83.68 0.36 Allowed Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.11 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 56.3 -93.96 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.913 0.485 . . . . 0.0 111.024 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.58 33.53 26.13 Favored Glycine 0 C--N 1.335 0.522 0 O-C-N 123.486 0.491 . . . . 0.0 114.284 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -94.48 -6.09 44.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.244 0.522 . . . . 0.0 111.534 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -110.21 102.18 10.89 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 169.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -69.77 -17.76 63.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.286 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -78.94 108.7 12.6 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -62.72 -30.12 71.18 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.754 0.312 . . . . 0.0 111.41 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.004 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -85.95 140.22 30.53 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 51' ' ' LEU . 26.6 tp -58.5 137.79 57.15 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.379 0.424 . . . . 0.0 110.77 -177.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.642 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -77.35 103.58 7.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.71 -174.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HH2' HD21 ' A' ' 42' ' ' LEU . 43.7 m95 -114.0 102.67 10.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 169.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.7 m-85 -117.06 161.13 34.26 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD2' ' OE1' ' A' ' 10' ' ' GLU . 27.4 Cg_exo -60.02 162.04 17.49 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 121.934 1.756 . . . . 0.0 111.436 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.651 ' CD1' HD21 ' A' ' 70' ' ' LEU . 87.8 t80 -49.1 -52.89 43.93 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 21.1 Cg_exo -65.25 -40.51 19.2 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 121.632 1.555 . . . . 0.0 111.951 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.431 ' OE1' ' HD2' ' A' ' 7' ' ' PRO . 33.2 tt0 -69.46 -39.23 77.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.781 -177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.56 82.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.019 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.96 -34.6 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.72 -38.45 64.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.682 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.463 ' HB3' HG11 ' A' ' 56' ' ' VAL . 11.1 tp -65.23 -44.6 87.69 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 109.71 177.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.14 87.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -50.85 71.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.552 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.77 -14.12 60.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.197 -172.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -118.23 -9.9 10.36 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.036 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.67 3.2 89.71 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.714 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.773 ' HG3' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -73.07 169.75 16.33 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 122.466 0.306 . . . . 0.0 111.521 175.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.559 ' SD ' HG22 ' A' ' 86' ' ' VAL . 68.1 mtm -101.4 167.84 9.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.39 125.95 62.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.079 0.466 . . . . 0.0 111.242 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.79 ' HG3' HG13 ' A' ' 57' ' ' VAL . 5.4 tpt -103.67 102.77 12.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.19 108.53 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.954 0.407 . . . . 0.0 110.067 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.776 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 72.6 t80 -103.7 103.55 13.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.419 0.628 . . . . 0.0 110.743 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 70' ' ' LEU . 60.3 m-85 -77.29 105.38 8.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.24 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.776 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 24.4 p80 -104.15 138.29 40.85 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.618 175.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.685 ' OG ' ' HA2' ' A' ' 78' ' ' GLY . 49.3 m -122.67 144.06 49.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.627 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -42.81 62.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.303 0.573 . . . . 0.0 110.13 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.564 ' O ' ' HD3' ' A' ' 32' ' ' PRO . 91.5 m-70 -101.87 42.74 1.11 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.263 178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 28.3 p -93.58 100.91 5.02 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 120.913 0.387 . . . . 0.0 110.617 176.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 30' ' ' HIS . 93.4 Cg_endo -88.41 -7.69 5.71 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.268 1.978 . . . . 0.0 114.152 -176.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -84.58 -34.51 23.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.709 ' HB3' ' HG3' ' A' ' 80' ' ' PRO . 29.2 p -80.96 -23.18 38.98 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -170.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -55.13 -32.41 62.05 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -84.18 -33.37 24.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.232 0.539 . . . . 0.0 110.402 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.0 ttp -80.73 -35.26 33.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.596 -173.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.606 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 38.3 p30 -72.14 -22.69 61.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 111.229 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.9 m -71.34 -59.94 2.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.609 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -91.48 -67.74 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.463 0.649 . . . . 0.0 111.482 -177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.578 HG13 ' HA ' ' A' ' 104' ' ' ARG . 59.1 t -60.01 -58.95 4.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.98 -168.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.606 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 19.5 tp -78.84 -10.59 59.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.089 -169.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -101.05 -9.87 21.02 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.755 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 31.6 t70 -56.67 133.25 78.11 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.341 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 44' ' ' ASP . 66.4 Cg_exo -53.25 -48.74 20.41 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.191 2.594 . . . . 0.0 113.086 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.59 -43.14 99.27 Favored Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.37 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.769 HG22 HD21 ' A' ' 108' ' ' LEU . 50.0 t -60.07 -56.47 17.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 175.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 m -56.91 -36.53 70.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.579 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.476 ' HA ' ' HB2' ' A' ' 52' ' ' GLU . 99.7 mtt180 -75.44 -21.16 58.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.457 HD12 HD22 ' A' ' 108' ' ' LEU . 69.1 mt -70.68 -36.52 73.36 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.163 169.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB2' HD11 ' A' ' 3' ' ' LEU . 1.5 mm? -70.45 -49.35 49.6 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.076 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 49' ' ' ARG . 17.1 mm-40 -45.88 -39.16 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.991 0.516 . . . . 0.0 112.124 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.503 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -68.13 -57.18 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.773 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -135.75 20.7 3.3 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -171.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.472 ' HB2' ' HA ' ' A' ' 51' ' ' LEU . 96.2 m-85 -133.58 140.36 47.11 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.481 0.657 . . . . 0.0 111.674 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 14' ' ' LEU . 46.9 t -110.44 115.35 49.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.79 HG13 ' HG3' ' A' ' 23' ' ' MET . 20.8 t -86.76 126.35 40.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.523 . . . . 0.0 110.359 -174.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -96.17 116.52 29.12 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.521 175.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 44.3 t -87.01 100.71 12.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.509 HG11 HD22 ' A' ' 70' ' ' LEU . 59.4 t -110.24 119.0 58.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.027 -174.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.633 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.0 p -90.43 111.97 23.42 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 21.6 m -74.29 -0.41 2.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.526 0.679 . . . . 0.0 110.346 -178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -29.49 31.12 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.086 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.655 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 1.5 p -95.63 166.73 14.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.977 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.655 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 17.5 Cg_endo -51.86 -55.85 3.52 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.511 2.807 . . . . 0.0 114.6 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -62.98 -35.66 80.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.84 0.353 . . . . 0.0 110.938 -178.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.95 -40.88 62.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.724 174.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 5.9 mt-30 -62.29 -30.87 71.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.259 0.552 . . . . 0.0 110.594 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' CD ' HH21 ' A' ' 73' ' ' ARG . 5.3 tp10 -66.05 -53.43 38.49 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.631 173.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.651 HD21 ' CD1' ' A' ' 8' ' ' TYR . 6.7 mp -58.62 -37.48 75.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 176.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.42 -55.9 28.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.983 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 69' ' ' GLU . 36.4 ptt180 -66.27 -23.34 66.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.462 HH21 ' CD ' ' A' ' 69' ' ' GLU . 14.2 ttm180 -83.49 -51.21 7.55 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.316 -175.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.26 4.12 51.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.637 -176.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 68.67 22.13 7.61 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.793 0.437 . . . . 0.0 111.072 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.97 119.78 66.47 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.32 -83.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.974 2.449 . . . . 0.0 112.589 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.685 ' HA2' ' OG ' ' A' ' 28' ' ' SER . . . -174.8 120.98 0.81 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.632 ' HB ' ' C ' ' A' ' 80' ' ' PRO . 31.2 m -146.56 -61.04 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -165.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.709 ' HG3' ' HB3' ' A' ' 34' ' ' CYS . 17.8 Cg_endo -79.39 172.74 58.12 Favored 'Cis proline' 0 N--CA 1.492 1.414 0 CA-C-N 123.111 2.147 . . . . 0.0 115.915 4.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 m -125.97 143.12 51.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.254 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' HD1' ' HD1' ' A' ' 25' ' ' TYR . 1.2 m-85 -118.27 127.99 54.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.91 117.69 41.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.727 0.299 . . . . 0.0 110.716 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.86 125.77 42.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.78 0.324 . . . . 0.0 110.416 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 94' ' ' GLU . 31.8 mt -117.1 142.23 47.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.577 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.559 HG22 ' SD ' ' A' ' 21' ' ' MET . 10.9 t -108.59 139.84 21.22 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 21' ' ' MET . 41.2 Cg_endo -72.66 114.47 4.03 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 160.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' HE2' ' SG ' ' A' ' 121' ' ' CYS . 17.5 mttp -142.21 113.36 7.59 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.848 0.356 . . . . 0.0 110.706 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 64.35 15.77 9.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.669 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.4 37.83 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.985 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.04 178.29 4.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.629 0.252 . . . . 0.0 110.403 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -109.4 128.74 55.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.252 0.549 . . . . 0.0 110.319 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 23.7 tt0 -109.96 124.66 51.8 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.373 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 78.2 tt0 -77.08 100.15 5.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 171.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 86' ' ' VAL . 14.8 p -94.4 -7.12 10.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.467 -169.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.84 125.71 0.97 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.939 -1.124 . . . . 0.0 112.89 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -114.87 128.5 56.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.112 0.482 . . . . 0.0 109.995 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 97.0 mt -117.24 141.46 48.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.882 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 79' ' ' THR . 79.6 t80 -137.42 127.76 26.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.847 0.356 . . . . 0.0 110.608 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.96 154.02 30.22 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.843 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 p -66.23 142.39 57.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.886 0.374 . . . . 0.0 110.698 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.617 ' HB2' ' HB2' ' A' ' 107' ' ' PHE . 0.1 OUTLIER -123.82 132.95 24.31 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -56.94 140.86 93.27 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.928 1.752 . . . . 0.0 109.683 170.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.578 ' HA ' HG13 ' A' ' 41' ' ' VAL . 16.7 ttp180 -51.23 -34.91 34.31 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.07 -54.6 43.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.885 0.374 . . . . 0.0 111.074 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.71 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 10.3 pt-20 -88.99 -20.04 24.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.851 -175.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 102' ' ' ARG . 70.7 t80 -60.82 -43.25 98.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 171.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.769 HD21 HG22 ' A' ' 47' ' ' VAL . 89.1 mt -68.42 -34.26 75.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.881 174.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 106' ' ' GLU . 14.8 ttpt -55.65 -52.77 62.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.211 171.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.71 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 28.9 mm-40 -57.03 -45.05 83.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.499 0.666 . . . . 0.0 109.694 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 50' ' ' LEU . 20.9 tp -61.46 -41.37 97.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.736 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 108' ' ' LEU . 26.7 mmt180 -62.35 -41.33 98.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.823 0.344 . . . . 0.0 110.298 176.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' LYS . 10.5 mt-30 -56.4 -37.24 69.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.516 176.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.513 ' HA ' ' HZ2' ' A' ' 117' ' ' LYS . 61.7 t -76.98 -37.35 26.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.758 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.9 m -54.92 -42.42 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.782 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.5 -47.56 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.289 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.576 ' HZ2' ' HB2' ' A' ' 117' ' ' LYS . 10.4 mtmp? -68.99 -13.25 62.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.576 -176.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.25 -33.12 69.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.73 -45.14 1.06 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.854 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 117' ' ' LYS . . . -100.63 94.15 5.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.941 0.4 . . . . 0.0 111.219 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.569 ' SG ' ' HE2' ' A' ' 88' ' ' LYS . 25.7 p -127.04 -39.97 1.9 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 176.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -81.07 74.14 2.47 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.439 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -143.57 148.59 36.14 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -91.03 40.7 2.96 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.975 -174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 69.53 -57.01 0.55 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.444 0.698 . . . . 0.0 112.169 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -144.13 19.23 1.76 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.51 0.671 . . . . 0.0 109.359 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -96.69 27.97 3.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.731 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -73.58 86.38 1.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.191 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -124.4 27.12 7.11 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 172.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 . . . . . 0 C--O 1.242 0.682 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.597 -179.22 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.956 0.407 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p -144.48 -51.5 0.29 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.718 HD21 HD23 ' A' ' 51' ' ' LEU . 6.7 tp -64.35 129.78 41.23 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.668 175.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.756 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 34.9 mmt180 -78.03 110.97 13.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.106 -173.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -108.6 104.47 13.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.943 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.756 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 97.0 m-85 -110.49 160.27 29.15 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.936 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 20.0 Cg_exo -62.69 165.71 15.34 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 121.915 1.743 . . . . 0.0 110.552 170.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.568 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 93.5 t80 -49.87 -53.26 44.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 23.6 Cg_exo -64.42 -47.51 5.74 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.809 1.673 . . . . 0.0 112.198 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 31.2 tt0 -64.91 -35.39 81.01 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.437 -177.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.84 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.37 . . . . 0.0 111.139 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 8' ' ' TYR . 10.7 mp -62.05 -30.88 71.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.021 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.33 -44.04 76.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.736 0.303 . . . . 0.0 110.608 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.573 HD22 ' CE2' ' A' ' 6' ' ' TYR . 13.3 tp -61.72 -47.32 85.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.262 0.553 . . . . 0.0 110.247 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.91 89.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.246 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -68.1 -39.23 82.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.39 -18.88 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -116.02 -8.56 11.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 38.21 63.06 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.659 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -101.22 176.99 5.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 75.5 mtp -107.47 149.99 27.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.9 t -106.94 131.56 56.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.067 0.461 . . . . 0.0 111.536 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.465 ' SD ' HD21 ' A' ' 51' ' ' LEU . 20.5 ttt -107.93 107.25 17.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.829 172.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.491 HG13 HG21 ' A' ' 60' ' ' VAL . 40.9 t -84.75 103.1 11.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.54 ' OH ' ' HB3' ' A' ' 38' ' ' ASN . 92.7 t80 -97.67 108.02 20.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.74 -176.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.935 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 74.8 m-85 -86.47 118.66 26.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.085 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.591 ' HA ' ' OG1' ' A' ' 79' ' ' THR . 33.5 p80 -135.36 179.3 6.41 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 171.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 31' ' ' CYS . 93.7 p -143.86 166.52 24.7 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -56.76 -22.22 34.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -130.52 23.58 5.11 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 34' ' ' CYS . 23.0 p -52.45 110.78 2.09 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 173.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 35' ' ' GLN . 12.9 Cg_endo -56.19 -81.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.289 2.659 . . . . 0.0 114.532 -167.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -77.78 -17.66 57.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.32 0.581 . . . . 0.0 110.499 -174.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 37.3 t -62.94 -36.85 84.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -176.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 32' ' ' PRO . 4.3 pt20 -72.03 -17.15 62.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.019 0.438 . . . . 0.0 111.212 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -81.79 -40.25 22.87 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.711 0.767 . . . . 0.0 109.716 171.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.592 ' SD ' ' HG3' ' A' ' 80' ' ' PRO . 75.9 mtp -69.39 -43.22 73.94 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.892 -170.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.54 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 30.1 p-10 -66.02 -35.08 79.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.863 0.363 . . . . 0.0 110.445 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' A' ' 43' ' ' SER . 85.6 m -66.8 -55.94 12.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.585 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.97 -69.84 0.71 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.874 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.5 -51.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.788 -169.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 23.6 tp -76.87 -27.25 54.97 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.575 -173.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' THR . 69.7 m -87.78 -0.71 57.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.748 0.309 . . . . 0.0 111.019 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.38 130.16 61.55 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.837 171.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.9 -43.09 24.7 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.508 2.805 . . . . 0.0 113.762 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.97 -43.45 65.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.453 -177.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -65.68 -49.62 76.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 121.659 0.742 . . . . 0.0 109.831 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 32.4 m -59.58 -32.27 70.21 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.656 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.765 ' HA ' ' HE ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -63.86 -42.07 97.62 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.833 ' HA ' HH21 ' A' ' 54' ' ' ARG . 64.8 mt -60.33 -45.03 94.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.654 0.264 . . . . 0.0 111.223 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.718 HD23 HD21 ' A' ' 3' ' ' LEU . 6.2 tp -72.34 -31.8 65.95 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.396 0.617 . . . . 0.0 111.051 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.595 ' HA ' HD13 ' A' ' 3' ' ' LEU . 8.3 tp10 -61.74 -35.95 79.59 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.282 1.033 . . . . 0.0 113.741 -168.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -91.5 -31.17 16.06 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -168.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.833 HH21 ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -134.48 5.08 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -170.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.7 142.6 48.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.551 0.691 . . . . 0.0 111.956 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.479 HG22 HD23 ' A' ' 14' ' ' LEU . 43.8 t -107.87 115.21 48.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.4 t -86.51 126.71 40.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.852 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -94.95 116.98 29.39 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.717 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.7 p -82.42 101.06 10.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG13 ' HA2' ' A' ' 67' ' ' GLY . 99.8 t -115.17 123.14 70.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 -175.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.525 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 1.9 t -116.39 129.34 56.19 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.011 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 t -78.54 65.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.104 0.954 . . . . 0.0 110.0 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.67 -36.41 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.882 -1.508 . . . . 0.0 109.039 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.569 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 30.7 p -82.89 160.53 60.62 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.201 174.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.569 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 15.6 Cg_endo -52.92 -55.39 3.77 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.062 2.508 . . . . 0.0 113.415 -174.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.473 ' O ' HD13 ' A' ' 70' ' ' LEU . 10.2 pt-20 -57.03 -44.85 83.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.983 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -68.91 -39.08 85.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.38 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -63.03 -48.68 77.69 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.049 0.54 . . . . 0.0 111.663 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 11.4 pt-20 -73.48 -29.05 62.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.588 -177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.672 ' HG ' ' HE2' ' A' ' 74' ' ' TYR . 5.3 mp -67.28 -40.61 86.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.809 173.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.55 78.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.031 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 69' ' ' GLU . 9.3 ptm180 -83.48 -19.51 35.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.719 0.295 . . . . 0.0 111.371 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 48.0 ttt180 -72.69 -44.03 62.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.672 ' HE2' ' HG ' ' A' ' 70' ' ' LEU . 53.3 m-85 -102.45 -2.35 28.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.181 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 26.2 ptt180 45.95 71.19 0.31 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.526 1.13 . . . . 0.0 112.551 -176.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG11 HG21 ' A' ' 81' ' ' THR . 13.5 t -137.74 94.65 11.53 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.882 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -97.83 128.08 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.415 2.743 . . . . 0.0 111.416 169.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 124.33 42.19 0.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.99 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -47.03 152.36 1.0 Allowed Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 122.795 0.438 . . . . 0.0 110.741 173.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 34' ' ' CYS . 58.6 Cg_endo -67.01 151.63 83.25 Favored 'Cis proline' 0 C--N 1.351 0.676 0 N-CA-C 114.841 1.054 . . . . 0.0 114.841 4.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.935 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 45.3 m -141.02 133.63 28.64 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.34 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 3.0 m-85 -123.14 111.88 17.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -175.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 39.5 t -119.12 112.49 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 110.146 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -95.5 122.33 38.12 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.394 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 94' ' ' GLU . 30.9 mt -113.55 135.76 53.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 -177.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 t -109.12 130.74 22.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.478 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.81 116.89 4.09 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 121.633 1.556 . . . . 0.0 110.212 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 90' ' ' GLY . 35.8 ttpt -151.79 134.93 15.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.333 -175.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 71.14 -37.61 0.4 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.742 0.817 . . . . 0.0 112.024 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 88' ' ' LYS . . . 149.7 -10.92 0.95 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -116.51 -179.13 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -108.16 136.71 47.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.042 0.449 . . . . 0.0 110.489 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -117.33 126.23 52.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.104 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.596 ' HB3' ' CE1' ' A' ' 126' ' ' HIS . 53.3 tt0 -77.3 99.69 5.61 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 171.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 117' ' ' LYS . 4.9 p -96.7 -10.43 8.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.176 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.15 126.79 1.48 Allowed Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 0.0 112.449 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -122.41 127.53 49.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.972 0.415 . . . . 0.0 109.975 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 82' ' ' PHE . 99.0 mt -117.72 139.17 51.41 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.278 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -137.26 142.87 41.99 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.798 0.332 . . . . 0.0 110.838 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.06 168.93 45.37 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.635 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.463 ' HA ' ' SD ' ' A' ' 37' ' ' MET . 10.9 m -65.38 131.76 47.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.022 0.439 . . . . 0.0 110.32 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.5 133.94 23.51 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 106' ' ' GLU . 12.4 Cg_endo -59.87 154.4 50.37 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.716 1.611 . . . . 0.0 110.991 171.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -30.69 64.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.839 0.352 . . . . 0.0 110.437 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.04 63.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.31 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 103' ' ' PRO . 22.9 tp10 -73.19 -42.27 62.9 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CE2' HD12 ' A' ' 111' ' ' LEU . 9.8 t80 -66.24 -44.85 82.57 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.405 -178.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 mt -56.65 -47.88 78.78 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.852 0.358 . . . . 0.0 111.023 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 ttpp -52.26 -58.85 5.38 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.32 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 114' ' ' VAL . 2.3 tp10 -78.98 -28.43 43.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.519 -172.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 50' ' ' LEU . 3.4 tt -61.22 -43.19 99.27 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 116' ' ' VAL . 22.6 tpt180 -61.43 -45.8 92.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.471 ' HB3' ' NZ ' ' A' ' 117' ' ' LYS . 34.4 mt-30 -64.73 -43.65 92.7 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.42 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 110' ' ' GLU . 54.6 t -58.72 -40.87 80.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.0 t -56.43 -28.54 59.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.651 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 112' ' ' ARG . 59.2 t -83.88 -34.33 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.885 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 121' ' ' CYS . 13.6 mptt -57.4 -28.5 63.29 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.615 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.85 -38.94 93.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.018 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.2 60.33 2.26 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.837 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.81 144.72 0.05 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.218 0.599 . . . . 0.0 110.363 -175.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 117' ' ' LYS . 20.7 p -171.0 -52.12 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.559 0.695 . . . . 0.0 109.437 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.62 -177.33 41.24 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.709 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -116.06 92.96 4.05 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.143 0.496 . . . . 0.0 109.891 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -100.39 34.98 5.12 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.395 -174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -70.82 81.97 0.63 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.499 0.666 . . . . 0.0 110.812 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.596 ' CE1' ' HB3' ' A' ' 94' ' ' GLU . 17.5 p-80 -87.37 97.29 10.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.71 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -81.92 73.09 8.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.875 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -166.14 122.6 1.32 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.936 -177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -115.9 -37.83 3.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.113 0.482 . . . . 0.0 110.509 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.8 t60 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.471 -0.776 . . . . 0.0 109.146 177.527 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 tpp . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.755 0.312 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m -86.15 27.31 0.92 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.697 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 18.8 tp -65.55 133.0 50.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.4 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -107.36 117.31 33.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.93 -172.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 36.8 m95 -111.24 123.14 49.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.215 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.555 ' HB3' ' HB3' ' A' ' 10' ' ' GLU . 37.0 m-85 -132.06 160.92 65.73 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.232 175.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 26.2 Cg_exo -61.22 162.16 20.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.003 1.802 . . . . 0.0 110.929 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.545 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 72.6 t80 -49.92 -50.24 69.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 34.7 Cg_exo -61.33 -46.61 14.41 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.808 1.672 . . . . 0.0 112.42 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 0.8 OUTLIER -68.01 -40.61 82.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.219 -177.575 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -65.03 -35.92 82.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 177.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.0 -41.41 64.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.197 0.522 . . . . 0.0 110.228 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -57.23 -47.96 80.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.724 177.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -71.9 -41.92 67.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.455 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -61.05 -51.4 69.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.842 0.353 . . . . 0.0 111.532 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.28 -15.35 58.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.927 -173.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -112.86 -4.57 13.95 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.331 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.19 49.04 49.19 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.101 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -114.64 178.75 4.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 89.3 mtp -105.22 151.48 24.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.88 125.36 61.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.106 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 21.0 ttt -101.21 102.78 13.75 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 83' ' ' VAL . 39.6 t -83.3 102.91 9.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.435 ' CD2' ' HZ3' ' A' ' 5' ' ' TRP . 24.7 t80 -98.61 108.8 21.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.176 -175.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.614 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 96.4 m-85 -93.23 125.36 37.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.377 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 25.4 p80 -127.56 150.12 49.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.621 ' OG ' ' HB ' ' A' ' 62' ' ' VAL . 24.5 m -142.96 141.21 31.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.522 0.201 . . . . 0.0 110.825 173.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -75.89 -22.41 56.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 166.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.416 ' HE1' ' HA ' ' A' ' 63' ' ' ASP . 29.1 m80 -72.64 -11.99 60.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.047 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.552 ' SG ' ' HA2' ' A' ' 78' ' ' GLY . 10.9 t -137.61 77.55 39.45 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.483 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.53 17.71 0.29 Allowed 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 122.975 2.45 . . . . 0.0 114.702 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' HB3' ' OG ' ' A' ' 101' ' ' SER . 57.3 m-85 -77.27 -18.28 57.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.205 0.526 . . . . 0.0 110.712 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.545 ' SG ' ' HB3' ' A' ' 80' ' ' PRO . 13.2 t -83.43 -30.93 26.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.814 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.448 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 10.6 mm100 -52.2 -42.01 63.15 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -170.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.56 -32.36 73.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.035 0.445 . . . . 0.0 110.925 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.49 ' HG3' ' HB ' ' A' ' 41' ' ' VAL . 45.2 ttm -77.61 -51.89 9.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.251 -177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 35' ' ' GLN . 2.2 p-10 -65.49 -17.1 64.3 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 m -81.34 -62.33 1.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.679 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -92.88 -68.52 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.449 0.642 . . . . 0.0 112.116 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' HB ' ' HG3' ' A' ' 37' ' ' MET . 89.6 t -52.67 -47.29 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.434 -168.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 21.4 tp -81.3 -18.43 45.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.982 0.42 . . . . 0.0 110.88 -173.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 m -87.41 -10.99 50.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.573 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -47.58 130.01 10.74 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.083 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.13 -31.96 94.49 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.013 2.475 . . . . 0.0 113.181 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.36 -44.53 13.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.707 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG22 HD21 ' A' ' 108' ' ' LEU . 48.5 t -61.52 -52.88 55.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-O 121.548 0.69 . . . . 0.0 109.495 175.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.753 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 34.1 t -50.46 -44.37 55.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.316 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -57.39 -41.12 79.61 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.589 0.555 . . . . 0.0 111.763 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.709 HD12 HD22 ' A' ' 108' ' ' LEU . 76.2 mt -61.97 -35.87 79.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 120.598 0.237 . . . . 0.0 110.945 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.98 -38.7 57.16 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.43 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.753 ' HG3' ' O ' ' A' ' 48' ' ' SER . 55.9 mt-10 -55.55 -39.08 70.15 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.058 0.456 . . . . 0.0 111.436 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' A' ' 54' ' ' ARG . . . -62.74 -53.33 56.01 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -169.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.647 ' HE ' ' HE1' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -136.7 5.82 2.91 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.647 ' HE1' ' HE ' ' A' ' 54' ' ' ARG . 80.3 m-85 -110.44 143.17 41.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.739 . . . . 0.0 112.525 -173.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' A' ' 14' ' ' LEU . 49.0 t -110.76 115.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 168.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.7 t -86.54 123.58 39.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.1 0.476 . . . . 0.0 110.916 -173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' TYR . . . -90.39 116.95 28.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.841 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.8 p -82.44 101.04 10.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.92 118.62 57.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.162 0.506 . . . . 0.0 110.323 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 63' ' ' ASP . 2.6 m -102.11 110.82 22.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.278 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.621 ' HB ' ' OG ' ' A' ' 28' ' ' SER . 6.1 t -82.67 28.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 122.574 1.178 . . . . 0.0 109.03 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.511 ' OD1' ' HG3' ' A' ' 29' ' ' GLU . 25.5 m-20 -113.42 -20.04 11.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.84 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 4.1 p -115.24 161.36 30.09 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.996 176.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 18.5 Cg_endo -51.96 -56.48 2.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.425 2.75 . . . . 0.0 114.025 -170.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -46.22 66.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -71.22 -36.46 63.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.879 177.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -63.75 -36.62 84.48 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.577 0.351 . . . . 0.0 111.018 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' OE1' ' HD3' ' A' ' 72' ' ' ARG . 6.3 mm-40 -68.67 -39.06 80.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.177 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.9 mt -67.96 -41.19 82.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.449 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.11 93.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.551 0.215 . . . . 0.0 111.321 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HD3' ' OE1' ' A' ' 69' ' ' GLU . 9.3 ptm180 -73.38 -20.92 60.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.0 110.491 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -74.64 -56.27 4.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.287 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -75.7 -9.09 58.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.919 -178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.4 ttm105 68.79 42.63 1.37 Allowed 'General case' 0 CA--C 1.528 0.127 0 O-C-N 123.834 0.708 . . . . 0.0 110.793 170.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.635 HG11 HG21 ' A' ' 81' ' ' THR . 33.7 t -122.31 104.3 37.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.134 -178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -93.64 128.81 0.65 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.236 2.624 . . . . 0.0 111.765 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.552 ' HA2' ' SG ' ' A' ' 31' ' ' CYS . . . 108.88 150.96 14.45 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.255 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.626 ' HB ' ' HA ' ' A' ' 80' ' ' PRO . 39.8 p -141.74 162.76 44.81 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 72.4 Cg_endo -78.09 142.14 68.68 Favored 'Cis proline' 0 C--N 1.345 0.347 0 C-N-CA 123.755 -1.352 . . . . 0.0 113.222 1.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.635 HG21 HG11 ' A' ' 76' ' ' VAL . 87.3 m -123.52 122.05 37.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.749 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 80' ' ' PRO . 7.5 m-85 -115.82 112.27 21.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.184 -177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.541 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 46.8 t -106.77 118.41 54.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.616 ' HB2' HG22 ' A' ' 95' ' ' VAL . 79.3 m-85 -95.91 104.91 16.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.926 0.393 . . . . 0.0 110.593 -177.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 94' ' ' GLU . 78.5 mt -105.52 126.3 51.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.557 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.2 t -110.25 132.47 21.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.09 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -82.56 116.45 2.6 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.153 1.902 . . . . 0.0 109.855 171.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -161.73 141.36 10.11 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.207 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 70.19 -72.13 0.11 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.13 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.15 25.82 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.759 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -162.97 165.12 25.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.601 0.239 . . . . 0.0 110.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -87.33 134.81 33.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -120.35 117.56 28.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.339 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.535 ' HA ' HD23 ' A' ' 85' ' ' LEU . 14.6 tt0 -77.05 112.05 13.28 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 170.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 84' ' ' PHE . 24.3 m -77.66 -18.08 14.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.422 0.629 . . . . 0.0 109.827 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.28 162.41 11.79 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.024 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.88 138.45 53.31 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.093 178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.405 ' HB2' ' HD2' ' A' ' 82' ' ' PHE . 77.3 mt -111.87 130.72 55.73 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.775 -175.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -137.19 133.99 35.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.0 176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.73 159.97 8.42 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.074 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 33' ' ' TYR . 73.6 m -94.88 17.11 14.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.068 0.461 . . . . 0.0 111.585 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 106' ' ' GLU . 14.1 mmt180 -57.87 140.71 81.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.78 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 102' ' ' ARG . 30.9 Cg_exo -62.29 172.3 4.38 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.344 2.696 . . . . 0.0 112.381 177.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 39.9 ptt180 -51.78 -26.13 9.04 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.839 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 109' ' ' LYS . . . -53.34 -63.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.266 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.726 ' HA ' ' HD2' ' A' ' 109' ' ' LYS . 3.0 mp0 -70.07 -33.0 71.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 110.952 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.06 -47.05 87.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.301 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.709 HD22 HD12 ' A' ' 50' ' ' LEU . 75.7 mt -70.48 -33.31 71.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 -178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.726 ' HD2' ' HA ' ' A' ' 106' ' ' GLU . 94.7 mttt -57.06 -51.29 69.87 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.358 0.599 . . . . 0.0 110.53 176.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 114' ' ' VAL . 11.6 mm-40 -68.91 -36.41 77.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.773 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 111' ' ' LEU . 4.1 tt -64.44 -34.88 79.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 116' ' ' VAL . 10.3 mmm180 -61.29 -41.33 96.77 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.471 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -67.62 -33.38 74.87 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.382 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.597 HG13 HG21 ' A' ' 95' ' ' VAL . 77.9 t -64.45 -45.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 31.4 p -65.39 -25.54 67.6 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.995 0.426 . . . . 0.0 110.7 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 112' ' ' ARG . 87.6 t -77.19 -43.68 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.217 175.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.601 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 63.7 mttm -61.25 -37.0 81.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.281 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.87 70.12 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.056 -0.593 . . . . 0.0 113.092 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -109.94 11.47 32.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.928 -177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.18 -72.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.767 0.284 . . . . 0.0 110.724 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 117' ' ' LYS . 42.2 t 64.0 -87.87 0.03 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.287 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.2 -48.38 80.01 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.236 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.04 41.93 1.1 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.332 0.587 . . . . 0.0 110.315 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.61 29.21 3.32 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 174.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -122.42 -64.01 1.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 78.6 m80 57.01 -150.6 0.44 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -171.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -155.84 -25.46 0.11 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.568 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -77.77 35.58 0.2 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -174.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -110.27 5.83 22.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 171.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.4 p-80 . . . . . 0 C--O 1.243 0.713 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.7 177.429 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m -127.32 -26.28 3.09 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.564 HD12 ' OE2' ' A' ' 52' ' ' GLU . 17.5 tp -116.21 148.42 40.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.698 0.285 . . . . 0.0 111.701 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -95.5 107.64 19.81 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.373 0.606 . . . . 0.0 112.086 -177.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.45 ' HZ3' ' CD2' ' A' ' 25' ' ' TYR . 57.5 m95 -105.9 132.49 51.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.755 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 96.9 m-85 -135.21 153.65 78.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 10' ' ' GLU . 24.9 Cg_exo -59.8 164.38 11.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.006 1.804 . . . . 0.0 111.443 176.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.558 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 86.4 t80 -48.59 -53.37 36.48 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 8' ' ' TYR . 18.5 Cg_exo -65.89 -44.08 8.36 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.573 1.515 . . . . 0.0 112.194 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . 26.0 tt0 -67.5 -38.72 84.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.223 -176.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.38 77.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.076 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 8' ' ' TYR . 7.9 mp -60.17 -41.21 92.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.849 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.49 -38.58 74.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.801 0.334 . . . . 0.0 110.39 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HB3' HG11 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -58.43 -47.97 82.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.509 177.029 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 20' ' ' ARG . . . -70.62 -43.43 69.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.293 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -63.93 -46.35 85.17 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.982 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.6 57.32 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -115.94 0.18 12.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.591 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.67 45.64 57.94 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.972 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 83.5 mmt-85 -117.57 177.63 4.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.085 0.469 . . . . 0.0 111.77 176.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.3 mtp -102.1 152.21 21.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.625 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.7 t -107.99 129.29 62.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.624 0.249 . . . . 0.0 111.316 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 63.3 ttp -109.77 104.25 13.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 24.4 t -81.05 107.33 13.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.019 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 52.9 t80 -94.97 104.77 16.65 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.606 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.463 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 87.3 m-85 -87.62 119.82 28.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.239 176.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.588 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 30.0 p80 -123.41 147.84 46.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.46 176.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 31' ' ' CYS . 14.7 m -136.77 150.64 48.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.013 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.677 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.23 -26.72 52.95 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.278 0.561 . . . . 0.0 109.849 172.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -72.73 -16.7 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.053 173.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 28' ' ' SER . 56.8 m -124.15 60.69 23.53 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.702 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -86.65 23.81 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.742 2.295 . . . . 0.0 114.132 -169.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -68.78 -36.54 78.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.216 0.531 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.576 ' HB2' ' CD ' ' A' ' 80' ' ' PRO . 7.2 t -68.22 -18.84 64.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.147 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -52.82 -26.11 13.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.2 -41.31 18.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.735 0.779 . . . . 0.0 109.738 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.9 mmm -63.13 -39.24 94.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.193 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.599 ' HA ' ' HB3' ' A' ' 42' ' ' LEU . 33.9 p30 -77.97 -17.74 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.444 -175.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -74.01 -52.21 13.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 0.0 110.493 177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -89.86 -71.26 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.309 0.576 . . . . 0.0 111.564 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.445 ' O ' HG21 ' A' ' 47' ' ' VAL . 57.6 t -64.93 -54.34 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.675 -167.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.599 ' HB3' ' HA ' ' A' ' 38' ' ' ASN . 18.2 tp -79.76 -12.68 59.77 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.074 -169.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.0 m -106.89 -3.09 20.64 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.11 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.9 133.33 38.63 Favored Pre-proline 0 C--O 1.235 0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.214 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.668 ' O ' ' HG3' ' A' ' 49' ' ' ARG . 8.8 Cg_endo -51.87 -46.22 33.56 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.426 2.75 . . . . 0.0 113.106 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.58 93.85 Favored Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.113 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.85 HG22 HD21 ' A' ' 108' ' ' LEU . 57.4 t -61.73 -49.71 83.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.158 0.504 . . . . 0.0 109.795 174.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.532 ' HA ' HD13 ' A' ' 3' ' ' LEU . 35.3 m -56.05 -39.76 72.5 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.003 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.668 ' HG3' ' O ' ' A' ' 45' ' ' PRO . 18.7 mtm180 -57.99 -40.76 81.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 111.075 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.855 HD12 HD22 ' A' ' 108' ' ' LEU . 76.3 mt -63.49 -39.83 95.49 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.548 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.36 -59.82 2.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.144 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.564 ' OE2' HD12 ' A' ' 3' ' ' LEU . 20.5 mm-40 -44.69 -40.17 5.71 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -171.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.3 -42.41 88.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.422 HH21 ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -136.01 6.18 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -173.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -122.95 149.8 43.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.281 0.563 . . . . 0.0 111.476 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 14' ' ' LEU . 46.6 t -117.07 119.89 63.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 168.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 3' ' ' LEU . 19.4 t -86.99 116.51 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.757 -173.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . . . -90.86 117.11 29.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.7 p -88.15 102.23 14.59 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.765 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 8' ' ' TYR . 59.9 t -108.39 123.14 63.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.15 0.5 . . . . 0.0 110.606 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.648 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 2.8 p -93.91 110.41 22.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.853 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.644 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 28.0 t -82.83 0.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 122.318 1.056 . . . . 0.0 109.071 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.677 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.5 OUTLIER -81.43 -33.86 31.89 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.528 174.251 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.648 ' HB ' ' HD2' ' A' ' 65' ' ' PRO . 33.4 p -92.63 160.84 33.62 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.474 -178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 64' ' ' THR . 25.6 Cg_endo -56.61 -53.95 4.48 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.3 2.667 . . . . 0.0 114.437 -171.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -37.02 85.7 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 121.083 -0.247 . . . . 0.0 111.277 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' A' ' 61' ' ' SER . . . -70.19 -40.84 70.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.669 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 2.0 mt-30 -59.56 -35.16 73.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.317 0.58 . . . . 0.0 110.611 173.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.027 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.1 mt -64.38 -32.05 73.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB2' HG13 ' A' ' 62' ' ' VAL . . . -68.75 -30.68 69.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.846 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 68' ' ' GLN . 51.9 mtp180 -71.69 -47.44 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.832 0.825 . . . . 0.0 109.151 173.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -64.06 -50.2 69.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.055 -174.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -96.65 -0.02 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 55.71 81.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.778 0.674 . . . . 0.0 111.126 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 74.6 t -127.88 91.59 44.64 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.846 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -100.03 107.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.499 2.799 . . . . 0.0 111.994 170.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 127.87 169.19 12.61 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.918 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 31' ' ' CYS . 83.3 m -155.76 139.88 11.56 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.576 ' CD ' ' HB2' ' A' ' 34' ' ' CYS . 64.1 Cg_endo -88.27 132.45 11.49 Favored 'Cis proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.816 -1.327 . . . . 0.0 112.993 0.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 26' ' ' PHE . 28.5 m -107.69 110.9 22.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.8 175.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 33.1 m-85 -99.87 113.19 25.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.473 -177.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 95.0 t -102.95 115.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.552 ' CD2' HG11 ' A' ' 114' ' ' VAL . 90.5 m-85 -94.11 113.82 25.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.781 -176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 93' ' ' GLU . 24.4 mt -111.54 128.13 55.93 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.183 0.516 . . . . 0.0 110.619 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.14 125.17 32.11 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.792 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.03 117.58 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.707 1.605 . . . . 0.0 110.814 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.801 ' HE2' ' HB2' ' A' ' 93' ' ' GLU . 65.2 pttt -133.83 128.55 34.93 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 67.06 -75.72 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.191 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.76 19.76 0.21 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.171 -0.537 . . . . 0.0 111.816 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.23 165.21 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.684 0.278 . . . . 0.0 110.537 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -94.86 139.71 30.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.299 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.801 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . 9.6 tp10 -117.49 136.0 53.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.554 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' CD ' ' HE ' ' A' ' 97' ' ' ARG . 34.8 tt0 -89.82 96.58 10.75 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 175.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.0 p -83.99 -4.67 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.323 -170.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.76 162.16 11.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.946 177.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.481 ' HE ' ' CD ' ' A' ' 94' ' ' GLU . 87.3 mtt180 -127.57 136.74 52.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.8 mt -117.38 150.97 37.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.799 0.333 . . . . 0.0 110.844 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -118.02 114.46 23.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' HA3' ' HG2' ' A' ' 80' ' ' PRO . . . -79.79 89.03 1.25 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.306 -172.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.2 p -135.7 -23.72 1.38 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.149 0.499 . . . . 0.0 110.547 175.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -70.03 155.54 93.29 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.691 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.8 167.08 9.12 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.669 2.246 . . . . 0.0 111.924 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -55.07 -38.01 67.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.512 -175.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -57.99 9.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.984 -178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.541 ' HG3' ' HE3' ' A' ' 109' ' ' LYS . 27.9 tt0 -75.08 -29.5 60.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.349 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.99 -47.88 84.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.873 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.855 HD22 HD12 ' A' ' 50' ' ' LEU . 47.1 mt -69.46 -27.12 64.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.238 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.541 ' HE3' ' HG3' ' A' ' 106' ' ' GLU . 29.3 ttpp -61.2 -49.98 74.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 175.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.475 ' O ' HG23 ' A' ' 114' ' ' VAL . 5.8 mm-40 -68.03 -39.95 82.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.349 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -60.48 -40.65 92.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.046 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.23 -39.28 89.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.352 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -66.04 -28.67 69.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.691 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.552 HG11 ' CD2' ' A' ' 84' ' ' PHE . 97.8 t -69.95 -39.38 77.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 61.1 m -59.06 -41.0 86.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.172 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.74 -43.99 99.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.392 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 121' ' ' CYS . 35.6 mtmm -75.2 -7.41 53.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.52 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.99 -39.17 24.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.82 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.51 -43.19 6.24 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.401 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.33 -31.88 22.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.478 0.18 . . . . 0.0 111.101 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' LYS . 17.2 t 68.98 -57.59 0.51 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.069 0.856 . . . . 0.0 111.334 -178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.42 27.27 5.33 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.93 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -67.17 -66.26 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.067 0.461 . . . . 0.0 110.116 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.99 175.4 47.96 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.532 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -172.39 23.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 0.0 110.295 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -83.74 135.21 34.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.236 0.541 . . . . 0.0 110.898 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -136.88 87.52 2.29 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.532 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -127.67 93.4 3.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.784 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -119.76 -40.27 2.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 171.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 66.3 t60 . . . . . 0 C--O 1.241 0.645 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.911 175.109 . . . . . . . . 0 0 . 1 stop_ save_